API_Name,sYear,ProductSaleGroup,Vet,AmountSold_g,InChIKey_string,PEC_gL,Desc_Short,Desc_Long,B_Statement,P_Statement,PNEC_gL,RQ
13C-urea,2016,Prescription,Human,83.45,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.3961423188868128e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2017,Prescription,Human,88.4,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.5731174223660045e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2018,Prescription,Human,186,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.28727573913674e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2019,Prescription,Human,204.6,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.910323687535979e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
4-aminosalicylic acid,2016,Prescription,Human,12390799.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.557833198371694e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2017,Prescription,Human,13384234.35,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.895837849662278e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2018,Prescription,Human,14345104.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.07776993427825e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2019,Prescription,Human,15501228.04,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.477872691628001e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
abacavir,2016,Prescription,Human,221508,MCGSCOLBFJQGHM-SCZZXKLOSA-N,6.36027193255818e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.135762845099675e-4
abacavir,2017,Prescription,Human,252378,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.346133810202347e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.311809608964705e-4
abacavir,2018,Prescription,Human,264834,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.52822786612118e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.3443264046644965e-4
abacavir,2019,Prescription,Human,248130,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.167784049796199e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.2799614374636072e-4
abiraterone,2016,Prescription,Human,107280,GZOSMCIZMLWJML-VJLLXTKPSA-N,3.0803852363112915e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,23.695271048548395
abiraterone,2017,Prescription,Human,81902,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.3839758272242136e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,18.33827559403241
abiraterone,2018,Prescription,Human,76356,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.1705119695565857e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,16.696245919666044
abiraterone,2019,Prescription,Human,71596,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.0682088696619058e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,15.909298997399274
acamprosate,2016,Prescription,Human,72615.87144,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.0850564719020765e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2017,Prescription,Human,72869.8572,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.12107125708872e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2018,Prescription,Human,74400.48504,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.114924083505365e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2019,Prescription,Human,60915.18384,AFCGFAGUEYAMAO-UHFFFAOYSA-N,1.7596698630506396e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acarbose,2016,Prescription,Human,24421.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,7.012269579472055e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2017,Prescription,Human,23097,XUFXOAAUWZOOIT-UGEKTDRHSA-N,6.722996957509911e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2018,Prescription,Human,19867.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,5.647577997166622e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2019,Prescription,Human,11034.06,XUFXOAAUWZOOIT-UGEKTDRHSA-N,3.187432364989894e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acetazolamide,2016,Prescription,Human,124689.75,BZKPWHYZMXOIDC-UHFFFAOYSA-N,3.580280248129622e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2017,Prescription,Human,156871,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.56614822583685e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2018,Prescription,Human,159839,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.5436175638057925e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2019,Prescription,Human,181725.25,BZKPWHYZMXOIDC-UHFFFAOYSA-N,5.2495359222795586e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetic acid,2016,OTC,Human,7512.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.157102357176414e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2017,OTC,Human,7935,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.309693070868127e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2018,OTC,Human,8785,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.4972428692643144e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2019,OTC,Human,8982.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.594793867218569e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetylsalicylic acid,2016,OTC,Human,1037340,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.978567133701673e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.010524972203892837
acetylsalicylic acid,2016,Prescription,Human,9996951.32,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.8704755084126283e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10143022997924482
acetylsalicylic acid,2017,OTC,Human,874785,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.5462947107742594e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.008997507811923178
acetylsalicylic acid,2017,Prescription,Human,9322959.785,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.7136957297286334e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.09589030847097645
acetylsalicylic acid,2018,OTC,Human,828605,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.3554102762512895e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.00832300450972187
acetylsalicylic acid,2018,Prescription,Human,9515922.04,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.705016329978956e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.09558361590031647
acetylsalicylic acid,2019,OTC,Human,1137295,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,3.285328239597376e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.01160893370882465
acetylsalicylic acid,2019,Prescription,Human,9001627.415,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.6003192442447585e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.09188407223479712
aciclovir,2016,OTC,Human,18314.8,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.258821730610928e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.6294108653054638e-5
aciclovir,2016,Prescription,Human,415563.82,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1932295449973182e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.966147724986591e-4
aciclovir,2017,OTC,Human,18232.8,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.3071420066193314e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.6535710033096655e-5
aciclovir,2017,Prescription,Human,391196.225,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1386807942435652e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.693403971217826e-4
aciclovir,2018,OTC,Human,20978.6,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.963421657045913e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.981710828522956e-5
aciclovir,2018,Prescription,Human,394010.34,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1200222105650637e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.600111052825318e-4
aciclovir,2019,OTC,Human,20316.15,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.868769432284168e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.934384716142084e-5
aciclovir,2019,Prescription,Human,410013.645,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.184415131112643e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.922075655563215e-4
acitretin,2016,Prescription,Human,11715.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.3639311368386403e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2017,Prescription,Human,12354,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.5959607054196405e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2018,Prescription,Human,12336.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.506799847089268e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2019,Prescription,Human,12033.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.476142722090137e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
aclidinium bromide,2016,Prescription,Human,822.6033600000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.361982891017955e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2017,Prescription,Human,914.54928,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.6620392375342587e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2018,Prescription,Human,869.6434800000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.472067136291638e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2019,Prescription,Human,789.1182,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.2795425169725094e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
adapalene,2016,Prescription,Human,227444.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,6.530723361255141e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2017,Prescription,Human,245696.46,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.1516497945662e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2018,Prescription,Human,267527.88,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.60480467455207e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2019,Prescription,Human,287075.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,8.292804630938534e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adefovir dipivoxil,2016,Prescription,Human,17.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,5.082291077806661e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2017,Prescription,Human,15.3,WOZSCQDILHKSGG-UHFFFAOYSA-N,4.453472461787316e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2018,Prescription,Human,7.5,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.1319660238454594e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2019,Prescription,Human,8.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.5131874917674978e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adrenaline,2016,Prescription,Human,61.06681194,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.7534424489986398e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2016,Prescription,Vet,63.1158048,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.812276223749304e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2017,Prescription,Human,61.3362035,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.7853535503126323e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2017,Prescription,Vet,64.1815072,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.868173691968655e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2018,Prescription,Human,55.67994009,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.5827698730884092e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2018,Prescription,Vet,62.9051504,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.788155245035848e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2019,Prescription,Human,57.71426155,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.6672041405064124e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2019,Prescription,Vet,58.675890912,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.6949829322799148e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
afatinib,2016,Prescription,Human,264.32,ULXXDDBFHOBEHA-CWDCEQMOSA-N,7.58955467619128e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.3717358363097752e-5
afatinib,2017,Prescription,Human,294.28,ULXXDDBFHOBEHA-CWDCEQMOSA-N,8.565803111469092e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.6768134723340914e-5
afatinib,2018,Prescription,Human,200.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,5.706846652629526e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,1.783389578946727e-5
afatinib,2019,Prescription,Human,235.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,6.81044923056443e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.128265384551384e-5
aglepristone,2016,Prescription,Vet,1039.2,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.9839078463597076e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2017,Prescription,Vet,942.9,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.7445615583132415e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2018,Prescription,Vet,1002,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.8483066078575337e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2019,Prescription,Vet,873,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.5218536555322136e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
albendazole,2016,Prescription,Vet,269372.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.734629679980084e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2017,Prescription,Vet,296590,HXHWSAZORRCQMX-UHFFFAOYSA-N,8.633041813343138e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2018,Prescription,Vet,249897.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.103639725918942e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2019,Prescription,Vet,237595,HXHWSAZORRCQMX-UHFFFAOYSA-N,6.863457265591939e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
alectinib,2017,Prescription,Human,1377.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.00987167539752e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2018,Prescription,Human,5241.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,1.4899884147451146e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2019,Prescription,Human,15187.2,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.387158744249581e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alendronic acid,2016,Prescription,Human,150355.3996,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.3172311067069784e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.9247555515517984e-4
alendronic acid,2017,Prescription,Human,146830.7834,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.2739009831016874e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.885364530092443e-4
alendronic acid,2018,Prescription,Human,144256.8582,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.1006762718545634e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.727887519867785e-4
alendronic acid,2019,Prescription,Human,140754.6266,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.0660088158566066e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.696371650778733e-4
alfaxalone,2016,Prescription,Vet,36.7,DUHUCHOQIDJXAT-OLVMNOGESA-N,1.0537857771497428e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2017,Prescription,Vet,121.2,DUHUCHOQIDJXAT-OLVMNOGESA-N,3.5278487736511277e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2018,Prescription,Vet,153.9,DUHUCHOQIDJXAT-OLVMNOGESA-N,4.3747942809308825e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2019,Prescription,Vet,203.3,DUHUCHOQIDJXAT-OLVMNOGESA-N,5.872770311222212e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfentanil,2016,Prescription,Human,192.995,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.5415636528886813e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2017,Prescription,Human,186.595,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.4313444052758434e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2018,Prescription,Human,189.865,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.3971430548989084e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2019,Prescription,Human,194.61,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.621740434170953e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alimemazine,2016,Prescription,Human,175565.67,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.0411064305658113e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2017,Prescription,Human,171501.43,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.9920058540009476e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2018,Prescription,Human,171914.52,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.88687887527601e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2019,Prescription,Human,177117.34,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.1164262467026576e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
aliskiren,2016,Prescription,Human,2866.5,UXOWGYHJODZGMF-QORCZRPOSA-N,8.230727330244515e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
aliskiren,2017,Prescription,Human,1440.6,UXOWGYHJODZGMF-QORCZRPOSA-N,4.1932499532358207e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
alitretinoin,2016,Prescription,Human,2679.6,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,7.69407184863883e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2017,Prescription,Human,3087,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,8.98553561407676e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2018,Prescription,Human,3252.2999999999997,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,9.245057465803447e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2019,Prescription,Human,3581.1,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,1.0344799685940903e-9,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
allopurinol,2016,Prescription,Human,2871723.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,8.245726693031095e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2017,Prescription,Human,3206720.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.33401488590888e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2018,Prescription,Human,3212108.7,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.13080881773121e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2019,Prescription,Human,3196137.4,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.232750040977348e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
almotriptan,2016,Prescription,Human,1701.9375,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.886859757759645e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2017,Prescription,Human,1715.025,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.992036999200516e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2018,Prescription,Human,1813.0875,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.153921264345206e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2019,Prescription,Human,1760.9625,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.086929802840945e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
alprazolam,2016,Prescription,Human,1920.512000000001,VREFGVBLTWBCJP-UHFFFAOYSA-N,5.514463843175499e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2017,Prescription,Human,1699.571,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.947054016570148e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2018,Prescription,Human,1621.41,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.6090547076310224e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2019,Prescription,Human,1583.6755,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.5747970777225734e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprostadil,2016,Prescription,Human,11.99234,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.4434216149166065e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2017,Prescription,Human,12.92188,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.7612573029098216e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2018,Prescription,Human,11.87954,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.3769034211884118e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2019,Prescription,Human,12.05914,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.483549403387714e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
altrenogest,2016,Prescription,Vet,44.88,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.2886622800675872e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2017,Prescription,Vet,53.13,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.5464901431030068e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2018,Prescription,Vet,32.34,VWAUPFMBXBWEQY-ANULTFPQSA-N,9.193037494821622e-12,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2019,Prescription,Vet,1860.06,VWAUPFMBXBWEQY-ANULTFPQSA-N,5.373194857398912e-10,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
ambrisentan,2016,Prescription,Human,117.9,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.3853227009796914e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2017,Prescription,Human,130.95,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.811648489353261e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2018,Prescription,Human,126.6,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.5987586482511356e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2019,Prescription,Human,124.65,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.600791044239295e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
amfetamine,2016,Prescription,Human,2363.055,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.78516008071549e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2017,Prescription,Human,2438.82,KWTSXDURSIMDCE-UHFFFAOYSA-N,7.098835104088981e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2018,Prescription,Human,2229.57,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.337823317046829e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2019,Prescription,Human,2190,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.326299548242322e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amifampridine,2016,Prescription,Human,100,OYTKINVCDFNREN-UHFFFAOYSA-N,2.8713508914161926e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2017,Prescription,Human,132,OYTKINVCDFNREN-UHFFFAOYSA-N,3.8422115356596445e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2018,Prescription,Human,208,OYTKINVCDFNREN-UHFFFAOYSA-N,5.912652439464741e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2019,Prescription,Human,296,OYTKINVCDFNREN-UHFFFAOYSA-N,8.550614914519304e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amiloride,2016,Prescription,Human,14693.575,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4.219040967434068e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2017,Prescription,Human,12526.4375,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.6461532320620876e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2018,Prescription,Human,11403.3175,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.241531395882979e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2019,Prescription,Human,9697.7625,XSDQTOBWRPYKKA-UHFFFAOYSA-N,2.80141326587723e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiodarone,2016,Prescription,Human,292305.6,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.39311945125945e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3497133104691438
amiodarone,2017,Prescription,Human,302692.68,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.81067656708889e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3671115236287038
amiodarone,2018,Prescription,Human,314712.87,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.94609528142524e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.37275397005938504
amiodarone,2019,Prescription,Human,339226.26,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,9.799301074839877e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.40830421145166157
amisulpride,2016,Prescription,Human,77174.37,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.2159469609398305e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2017,Prescription,Human,78455.64,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.283660341254244e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2018,Prescription,Human,78187.365,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.222570742320049e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2019,Prescription,Human,83282.625,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.405802890017967e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amitriptyline,2016,Prescription,Human,389459.21,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1182740498037463e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2017,Prescription,Human,392819.36,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.14340536092609e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2018,Prescription,Human,388703.665,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1049373428322769e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2019,Prescription,Human,425743.685,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.2298548320011518e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amlodipine,2016,Prescription,Human,435018.7804,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.249091562884325e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2017,Prescription,Human,435269.7111,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.2669684129633796e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2018,Prescription,Human,468062.1878,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.330523575248497e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2019,Prescription,Human,523293.8289,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.5116500061041397e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amorolfine,2016,OTC,Human,1636.5,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.698965733802601e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2016,Prescription,Human,1200,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.4456210696994305e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2017,OTC,Human,1574.5500000000002,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.583147101115829e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2017,Prescription,Human,1230.5,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.5816979504766606e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2018,OTC,Human,1747.35,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.96705444235515e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2018,Prescription,Human,1233.75,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.507084109225781e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2019,OTC,Human,1648.05,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.760757064146465e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2019,Prescription,Human,1229.25,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.55096060259218e-10,antifungal,topical antifungal,NA,NA,NA,NA
amoxicillin,2016,Prescription,Human,2507626.75,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.20027630395159e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.231123466604604
amoxicillin,2016,Prescription,Vet,356437.2,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,1.0234562719538917e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,1.3121234255819125
amoxicillin,2017,Prescription,Human,2498091.5,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.271360589722201e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.322257166310514
amoxicillin,2017,Prescription,Vet,275927.6,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.031607634294547e-8,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,1.0296932864480188
amoxicillin,2018,Prescription,Human,2433165.5,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,6.916568235190599e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,8.867395173321281
amoxicillin,2018,Prescription,Vet,260232.4,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.397421801383482e-8,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,0.9483874104337798
amoxicillin,2019,Prescription,Human,2586406,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.471405986014262e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.578725623095208
amoxicillin,2019,Prescription,Vet,264767.4,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.648392159859795e-8,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,0.9805630974179225
amphotericin B,2016,Prescription,Human,654.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.879299158431898e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2017,Prescription,Human,449.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3083894585447048e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2018,Prescription,Human,483,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3729861193564758e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2019,Prescription,Human,492.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.4226952180407962e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
ampicillin,2016,Prescription,Human,481355,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.3821391083376416e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2017,Prescription,Human,497867.5,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.4491759482803242e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2018,Prescription,Human,107865,AVKUERGKIZMTKX-NJBDSQKTSA-N,3.06619353549454e-8,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
amsacrine,2017,Prescription,Human,4.95,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.4408293258723668e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2018,Prescription,Human,3.69,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.048927283731966e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2019,Prescription,Human,2.835,XCPGHVQEEXUHNC-UHFFFAOYSA-N,8.189524757656158e-13,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
anagrelide,2016,Prescription,Human,101.95,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9273422337988077e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2017,Prescription,Human,103.55,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.0140985190723957e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2018,Prescription,Human,103.05,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9293213167636613e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2019,Prescription,Human,107.9,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.1169302340426793e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anastrozole,2016,Prescription,Human,258.244,YBBLVLTVTVSKRW-UHFFFAOYSA-N,7.415091396028832e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,7.415091396028832e-5
anastrozole,2017,Prescription,Human,216.812,YBBLVLTVTVSKRW-UHFFFAOYSA-N,6.310890662647265e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,6.310890662647265e-5
anastrozole,2018,Prescription,Human,177.948,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.0583878668166905e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.0583878668166906e-5
anastrozole,2019,Prescription,Human,184.894,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.341072277044366e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.341072277044366e-5
anidulafungin,2016,Prescription,Human,768.5,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.2066331600533438e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2017,Prescription,Human,506.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,1.473429908599176e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2018,Prescription,Human,906.7,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.5774047917609037e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2019,Prescription,Human,1058.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,3.0568448319406516e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
antazoline,2016,OTC,Human,178.99,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.1394309605458425e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2016,Prescription,Human,178.116,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.1143353537548647e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2017,OTC,Human,183.943,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.3541508826048637e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2017,Prescription,Human,184.173,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.3608456451291186e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2018,OTC,Human,166.22199999999998,REYFJDPCWQRWAA-UHFFFAOYSA-N,4.7250620855418647e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2018,Prescription,Human,180.537,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.1319833339598365e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2019,OTC,Human,194.41,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.6159629916611415e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2019,Prescription,Human,216.27,REYFJDPCWQRWAA-UHFFFAOYSA-N,6.247437457983412e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
apixaban,2016,Prescription,Human,88236.5689,QNZCBYKSOIHPEH-UHFFFAOYSA-N,2.533581507665213e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,7.037726410181147e-5
apixaban,2017,Prescription,Human,134931.107,QNZCBYKSOIHPEH-UHFFFAOYSA-N,3.9275292108691354e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.0909803363525375e-4
apixaban,2018,Prescription,Human,179092.2148,QNZCBYKSOIHPEH-UHFFFAOYSA-N,5.090913561184439e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.4141426558845663e-4
apixaban,2019,Prescription,Human,224196.9254,QNZCBYKSOIHPEH-UHFFFAOYSA-N,6.47642423687369e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.7990067324649136e-4
apomorphine,2016,Prescription,Human,621.15,VMWNQDUVQKEIOC-CYBMUJFWSA-N,1.7835396062031677e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2017,Prescription,Human,737.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.1459624656553584e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2018,Prescription,Human,817.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.3231323106502687e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2019,Prescription,Human,1014.95,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.931907637666003e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apraclonidine,2016,Prescription,Human,40.525,IEJXVRYNEISIKR-UHFFFAOYSA-N,1.163614948746412e-11,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2017,Prescription,Human,30.07,IEJXVRYNEISIKR-UHFFFAOYSA-N,8.752674308885267e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2018,Prescription,Human,23.5,IEJXVRYNEISIKR-UHFFFAOYSA-N,6.6801602080491065e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2019,Prescription,Human,26.725,IEJXVRYNEISIKR-UHFFFAOYSA-N,7.720107553734069e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apremilast,2016,Prescription,Human,342.96,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,9.847585017200974e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2017,Prescription,Human,377.28,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,1.098173915283084e-10,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2018,Prescription,Human,165.12,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,4.693736398098163e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2019,Prescription,Human,75.6,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,2.1838732687083088e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
aprepitant,2016,Prescription,Human,3657.135,ATALOFNDEOCMKK-OITMNORJSA-N,1.0500917842279361e-9,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,5.833843245710757e-4
aprepitant,2017,Prescription,Human,1379.32,ATALOFNDEOCMKK-OITMNORJSA-N,4.014878193459137e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,2.230487885255076e-4
aprepitant,2018,Prescription,Human,924.14,ATALOFNDEOCMKK-OITMNORJSA-N,2.626980108368724e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.45943339353818e-4
aprepitant,2019,Prescription,Human,867.26,ATALOFNDEOCMKK-OITMNORJSA-N,2.505272395529058e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.3918179975161435e-4
aripiprazole,2016,Prescription,Human,22934.58255,CEUORZQYGODEFX-UHFFFAOYSA-N,6.5853234049200765e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.0252311241567819
aripiprazole,2017,Prescription,Human,23956.4052,CEUORZQYGODEFX-UHFFFAOYSA-N,6.973149728210356e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026717048767089482
aripiprazole,2018,Prescription,Human,24564.66095,CEUORZQYGODEFX-UHFFFAOYSA-N,6.982803004357777e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026754034499455084
aripiprazole,2019,Prescription,Human,25654.9684,CEUORZQYGODEFX-UHFFFAOYSA-N,7.411005251100049e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.028394656134482943
arsenic trioxide,2016,Prescription,Human,4.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.205967374394801e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2017,Prescription,Human,7.5,QTLQKAJBUDWPIB-UHFFFAOYSA-N,2.1830747361702525e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2018,Prescription,Human,1.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,3.411145638152735e-13,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2019,Prescription,Human,6.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.7910071780412057e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
articaine,2016,Prescription,Human,106270.4,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0513960777115544e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2017,Prescription,Human,96838.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.8187511701472516e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2018,Prescription,Human,102442,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.9120381788636876e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2019,Prescription,Human,104114.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0075863571020085e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
asenapine,2016,Prescription,Human,118.2,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,3.39393675365394e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2017,Prescription,Human,74.1,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,2.1568778393362097e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2018,Prescription,Human,0.6,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,1.7055728190763679e-13,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
ataluren,2016,Prescription,Human,1245,OOUGLTULBSNHNF-UHFFFAOYSA-N,3.5748318598131596e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2017,Prescription,Human,1590,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.628118440680935e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2018,Prescription,Human,1593.75,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.5304278006716013e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2019,Prescription,Human,1586.25,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.582234090593327e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
atazanavir,2016,Prescription,Human,53994.45,AXRYRYVKAWYZBR-GASGPIRDSA-N,1.5503701213902704e-8,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2017,Prescription,Human,32043,AXRYRYVKAWYZBR-GASGPIRDSA-N,9.326968502813788e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2018,Prescription,Human,21825,AXRYRYVKAWYZBR-GASGPIRDSA-N,6.204021129390287e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2019,Prescription,Human,18564,AXRYRYVKAWYZBR-GASGPIRDSA-N,5.362622137605958e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atenolol,2016,Prescription,Human,501458.971,METKIMKYRPQLGS-UHFFFAOYSA-N,1.4398646633894968e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2017,Prescription,Human,451634.084,METKIMKYRPQLGS-UHFFFAOYSA-N,1.314601278365058e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2018,Prescription,Human,395443.916,METKIMKYRPQLGS-UHFFFAOYSA-N,1.124097324331197e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2019,Prescription,Human,358400.45499999996,METKIMKYRPQLGS-UHFFFAOYSA-N,1.035319012126184e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atipamezole,2016,Prescription,Vet,307.6,HSWPZIDYAHLZDD-UHFFFAOYSA-N,8.83227534199621e-11,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2017,Prescription,Vet,346.7,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0091626813736354e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2018,Prescription,Vet,363.8,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0341456526333044e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2019,Prescription,Vet,368.3,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0639160381815744e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atomoxetine,2016,Prescription,Human,40642.94568,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1670015830804793e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003646879947126498
atomoxetine,2017,Prescription,Human,40555.651,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1804802280938378e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.0036890007127932433
atomoxetine,2018,Prescription,Human,39326.5652,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1179053445459094e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003493454201705967
atomoxetine,2019,Prescription,Human,44075.1952,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.2732095318833437e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003978779787135449
atorvastatin,2016,Prescription,Human,2983202.8998,XUKUURHRXDUEBC-KAYWLYCHSA-N,8.565822305616101e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2017,Prescription,Human,3296228.5658,XUKUURHRXDUEBC-KAYWLYCHSA-N,9.594551075520914e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2018,Prescription,Human,3605848.4058,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.025006171773722e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2019,Prescription,Human,3907533.054,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.1287773787334314e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atovaquone,2016,Prescription,Human,230454,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.617142983304274e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2017,Prescription,Human,244364.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.112872274642556e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2018,Prescription,Human,240341.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.831991721713967e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2019,Prescription,Human,243922.5,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.046241102996066e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atropine,2016,Prescription,Human,508.2525,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.4593712689395084e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2017,Prescription,Human,471.785,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.3732558858721104e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2018,Prescription,Human,420.61,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.195634972386185e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2019,Prescription,Human,430.44,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.2434211769613815e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
avanafil,2017,Prescription,Human,516.8,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.5042840315370487e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2018,Prescription,Human,2318.4,WEAJZXNPAWBCOA-INIZCTEOSA-N,6.590333372911083e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2019,Prescription,Human,3580.7999999999997,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.0343933069564434e-9,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
axitinib,2016,Prescription,Human,110.544,RITAVMQDGBJQJZ-FMIVXFBMSA-N,3.174106129407116e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2017,Prescription,Human,68.152,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.9837454589263338e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2018,Prescription,Human,42.952,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.2209627287494687e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2019,Prescription,Human,38.36,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.1081134733816234e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
azacitidine,2016,Prescription,Human,668.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,1.9200723410900078e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2017,Prescription,Human,810.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.360049328115788e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2018,Prescription,Human,826.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.3499950825507217e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2019,Prescription,Human,968.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.798593151752129e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azathioprine,2016,Prescription,Human,249961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.177264580070059e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2017,Prescription,Human,246332.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.17016343263545e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2018,Prescription,Human,237961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,6.764337333223939e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2019,Prescription,Human,186067.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,5.3749714209706786e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azelaic acid,2016,Prescription,Human,138112.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.965694499907189e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2017,Prescription,Human,138474,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.0306545468858606e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2018,Prescription,Human,140379,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.990443446152023e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2019,Prescription,Human,148864.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.3002804525083084e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelastine,2016,Prescription,Human,1689.66,MBUVEWMHONZEQD-UHFFFAOYSA-N,4.851606747190284e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,4.410551588354804e-5
azelastine,2017,Prescription,Human,2350.41,MBUVEWMHONZEQD-UHFFFAOYSA-N,6.84149425418923e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,6.219540231081118e-5
azelastine,2018,Prescription,Human,2914.575,MBUVEWMHONZEQD-UHFFFAOYSA-N,8.285033165265838e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,7.531848332059854e-5
azelastine,2019,Prescription,Human,3834.09,MBUVEWMHONZEQD-UHFFFAOYSA-N,1.1075617276219363e-9,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,1.0068742978381239e-4
azithromycin,2016,Prescription,Human,169157.32,MQTOSJVFKKJCRP-BICOPXKESA-N,4.857100215715743e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2017,Prescription,Human,150059.395,MQTOSJVFKKJCRP-BICOPXKESA-N,4.3678783219932367e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2018,Prescription,Human,140032.74,MQTOSJVFKKJCRP-BICOPXKESA-N,3.980600585413133e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2019,Prescription,Human,140015.9025,MQTOSJVFKKJCRP-BICOPXKESA-N,4.0446691357648e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
aztreonam,2016,Prescription,Human,2810,WZPBZJONDBGPKJ-VEHQQRBSSA-N,8.068496004879502e-10,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2017,Prescription,Human,4266.3,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2418202329230862e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2018,Prescription,Human,4353.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2375352113081611e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2019,Prescription,Human,3906.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.1284789582287047e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
baclofen,2016,Prescription,Human,53586.095,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5386448164576278e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2017,Prescription,Human,54551.2975,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5878607919674327e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2018,Prescription,Human,53989.755,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5347243106098735e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2019,Prescription,Human,58862.845,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.7003835147568854e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
balsalazide,2016,Prescription,Human,451212.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.2955892705255842e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2017,Prescription,Human,451368.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.313828079865768e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2018,Prescription,Human,418080,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.188443140332413e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2019,Prescription,Human,389025,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.123784786189484e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
bambuterol,2016,Prescription,Human,564.13,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.6198151783746168e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2814298286966436e-6
bambuterol,2017,Prescription,Human,540.39,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.5729490089053902e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2154211393033667e-6
bambuterol,2018,Prescription,Human,375.4,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.0671200604687804e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,1.5029860006602542e-6
baricitinib,2017,Prescription,Human,16.464,XUZMWHLSFXCVMG-UHFFFAOYSA-N,4.7922856608409385e-12,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2018,Prescription,Human,39.144,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.1127157071654222e-11,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2019,Prescription,Human,349.944,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.010890670826535e-10,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
barium sulfate,2016,OTC,Human,0.582,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.671126218804224e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2017,OTC,Human,0.762,TZCXTZWJZNENPQ-UHFFFAOYSA-L,2.218003931948977e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2018,OTC,Human,0.48,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.3644582552610941e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
bazedoxifene,2019,Prescription,Human,10.08,UCJGJABZCDBEDK-UHFFFAOYSA-N,2.911831024944412e-12,sex hormone,selective estrogen receptor modulator for postmenopausal osteoporosis,NA,NA,NA,NA
beclometasone,2016,Prescription,Human,1182.338,NBMKJKDGKREAPL-DVTGEIKXSA-N,3.3949072702552384e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2017,Prescription,Human,1665.07992,NBMKJKDGKREAPL-DVTGEIKXSA-N,4.846658542741847e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2018,Prescription,Human,2285.73212,NBMKJKDGKREAPL-DVTGEIKXSA-N,6.497470959269671e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2019,Prescription,Human,2988.30912,NBMKJKDGKREAPL-DVTGEIKXSA-N,8.632392071170964e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
bedaquiline,2017,Prescription,Human,131.6,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.83056847040007e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2018,Prescription,Human,112.8,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.206476899863571e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2019,Prescription,Human,94,QUIJNHUBAXPXFS-XLJNKUFUSA-N,2.7153979796108598e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
benazepril,2016,Prescription,Vet,2973.635,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.53834950799639e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2017,Prescription,Vet,3536.02,XPCFTKFZXHTYIP-PMACEKPBSA-N,1.0292527904790314e-9,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2018,Prescription,Vet,3202.885,XPCFTKFZXHTYIP-PMACEKPBSA-N,9.104589331045688e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2019,Prescription,Vet,2978.66,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.604518453135835e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
bendamustine,2016,Prescription,Human,556.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.59683001448883e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2017,Prescription,Human,447.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3014763885468323e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2018,Prescription,Human,484.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.376184068392244e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2019,Prescription,Human,476.75,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3771978582760402e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendroflumethiazide,2016,Prescription,Human,17372.80875,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.9883429890715535e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2017,Prescription,Human,15819.7025,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.604745714863918e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2018,Prescription,Human,14377.175,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.086886482517379e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2019,Prescription,Human,12909.53,HDWIHXWEUNVBIY-UHFFFAOYSA-N,3.729203370183594e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
benzocaine,2016,Prescription,Vet,1401000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.022762598874086e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2017,Prescription,Vet,1830800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,5.329030969307332e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2018,Prescription,Vet,1531000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.352053310009865e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2019,Prescription,Vet,2376800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,6.865912678658609e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzoyl peroxide,2016,OTC,Human,229856,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.599972304973605e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2016,Prescription,Human,56707.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6282713067498374e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2017,OTC,Human,215799,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.281404599877391e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2017,Prescription,Human,57331.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6687859898232646e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2018,OTC,Human,217246,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.17548121088441e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2018,Prescription,Human,56955,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6190149985082423e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2019,OTC,Human,212620.2,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.142004909621885e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2019,Prescription,Human,58629,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6936283845383524e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzydamine,2016,OTC,Human,14606.52,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.194044422248845e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2017,OTC,Human,12815.22,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,3.7302110693951665e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2018,OTC,Human,14215.2,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.0408431229557295e-09,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2019,OTC,Human,16450.41,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.752064901890456e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzyl benzoate,2016,OTC,Human,13167,SESFRYSPDFLNCH-UHFFFAOYSA-N,3.780707718727701e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2017,OTC,Human,16005,SESFRYSPDFLNCH-UHFFFAOYSA-N,4.658681486987319e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2018,OTC,Human,39666,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.1275541906913866e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2019,OTC,Human,69201,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.999023995606927e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzylpenicillin,2016,Prescription,Human,1586592,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.5556623535138e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2016,Prescription,Vet,2680366.6602798253,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.69627319931672e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2017,Prescription,Human,1576992,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.590255192456799e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2017,Prescription,Vet,2651326.7808762896,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.717392683550174e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2018,Prescription,Human,1700454,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.833746870816142e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2018,Prescription,Vet,2541785.572625092,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.225333974316361e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2019,Prescription,Human,1638450,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.733025340099377e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2019,Prescription,Vet,2596336.894533958,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.500093572134726e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
betamethasone,2016,Prescription,Human,20172.1725,UREBDLICKHMUKA-DVTGEIKXSA-N,5.792138548967621e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011138727978783885
betamethasone,2016,Prescription,Vet,338.505,UREBDLICKHMUKA-DVTGEIKXSA-N,9.719666334988383e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.8691666028823813e-5
betamethasone,2017,Prescription,Human,21547.6575,UREBDLICKHMUKA-DVTGEIKXSA-N,6.272019561586595e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0012061576079974222
betamethasone,2017,Prescription,Vet,328.71400000000006,UREBDLICKHMUKA-DVTGEIKXSA-N,9.568096384339579e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.840018535449919e-5
betamethasone,2018,Prescription,Human,20650.2625,UREBDLICKHMUKA-DVTGEIKXSA-N,5.870087737798666e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011288630264997435
betamethasone,2018,Prescription,Vet,323.812,UREBDLICKHMUKA-DVTGEIKXSA-N,9.204749094845945e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.7701440567011433e-5
betamethasone,2019,Prescription,Human,21506.696,UREBDLICKHMUKA-DVTGEIKXSA-N,6.212684985798401e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011947471126535388
betamethasone,2019,Prescription,Vet,310.862,UREBDLICKHMUKA-DVTGEIKXSA-N,8.979936667423312e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.726910897581406e-5
betaxolol,2016,Prescription,Human,151.875,NWIUTZDMDHAVTP-UHFFFAOYSA-N,4.360864166338343e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2017,Prescription,Human,136.6375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.977198323512838e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2018,Prescription,Human,124.7625,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.546525480666922e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2019,Prescription,Human,112.375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.2462005101996854e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
bexarotene,2016,Prescription,Human,907.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.605750933960194e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2017,Prescription,Human,1027.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.9908123885532457e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2018,Prescription,Human,997.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.835514811714461e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2019,Prescription,Human,720,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.0798793035317224e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bicalutamide,2016,Prescription,Human,185064.1,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3138396850413545e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05313839685041355
bicalutamide,2017,Prescription,Human,182527.5,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3129489854175446e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05312948985417545
bicalutamide,2018,Prescription,Human,167758.4,LKJPYSCBVHEWIU-UHFFFAOYSA-N,4.7687361201956816e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.04768736120195682
bicalutamide,2019,Prescription,Human,178994.2,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.170643500447471e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.051706435004474714
bictegravir,2019,Prescription,Human,355.5,SOLUWJRYJLAZCX-LYOVBCGYSA-N,1.026940406118788e-10,antiviral,HIV therapy used as part of combination with emtricitabine and tenofovir,NA,NA,NA,NA
bilastine,2016,Prescription,Human,7,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,2.009945623991335e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2017,Prescription,Human,29.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,8.499437639489517e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2018,Prescription,Human,52.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.48384835259644e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2019,Prescription,Human,34.8,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.0052749967069991e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bimatoprost,2016,Prescription,Human,106.0422,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.0448436549773417e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2017,Prescription,Human,120.2427,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.499984007718651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2018,Prescription,Human,132.5379,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.7675506622910276e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2019,Prescription,Human,138.7122,AQOKCDNYWBIDND-FTOWTWDKSA-N,4.0070088045465694e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
binimetinib,2019,Prescription,Human,27.72,ACWZRVQXLIRSDF-UHFFFAOYSA-N,8.007535318597132e-12,antineoplastic,small molecule kinase inhibitor for melanomas,NA,NA,NA,NA
biperiden,2016,Prescription,Human,3012.098,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.64879027733293e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2017,Prescription,Human,2900.302,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.44210136461874e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2018,Prescription,Human,2793.662,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.941323288144204e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2019,Prescription,Human,2678.254,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.736729255834791e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
bisacodyl,2016,OTC,Human,48059.886,KHOITXIGCFIULA-UHFFFAOYSA-N,1.3799679650746061e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.00965012562989235
bisacodyl,2016,Prescription,Human,14159.3875,KHOITXIGCFIULA-UHFFFAOYSA-N,4.0656569920032294e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002843116777624636
bisacodyl,2017,OTC,Human,45423.313,KHOITXIGCFIULA-UHFFFAOYSA-N,1.3221664939127176e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.009245919537851172
bisacodyl,2017,Prescription,Human,14005.7375,KHOITXIGCFIULA-UHFFFAOYSA-N,4.076742893024308e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002850869155961054
bisacodyl,2018,OTC,Human,43338.509999999995,KHOITXIGCFIULA-UHFFFAOYSA-N,1.2319497445878223e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.00861503317893582
bisacodyl,2018,Prescription,Human,13918.1875,KHOITXIGCFIULA-UHFFFAOYSA-N,3.956413715134744e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002766722877716604
bisacodyl,2019,OTC,Human,40632.485,KHOITXIGCFIULA-UHFFFAOYSA-N,1.1737592305911552e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.008208106507630455
bisacodyl,2019,Prescription,Human,13469.6625,KHOITXIGCFIULA-UHFFFAOYSA-N,3.891010036014912e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002720986039171267
bisoprolol,2016,Prescription,Human,60569.89545000001,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.7391742329334313e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2017,Prescription,Human,62497.81535,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8191653567522458e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2018,Prescription,Human,64300.5406,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8278209049879405e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2019,Prescription,Human,65651.6428,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.89649295975802e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bleomycin,2016,Prescription,Human,50.55,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.4514678756108851e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2017,Prescription,Human,47.25,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.3753370837872592e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2018,Prescription,Human,42.45,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.20669276949653e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2019,Prescription,Human,39.3,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.135267453177732e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
boric acid,2016,OTC,Human,304470,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.742402059094882e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2017,OTC,Human,273870,KGBXLFKZBHKPEV-UHFFFAOYSA-N,7.971715706599294e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2018,OTC,Human,288630,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.204658046166867e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2019,OTC,Human,107190,KGBXLFKZBHKPEV-UHFFFAOYSA-N,3.096420313132852e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
bortezomib,2016,Prescription,Human,31.9165,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.164347072588489e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.036521571686331e-5
bortezomib,2017,Prescription,Human,33.929,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.875939029802732e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.1946531177339404e-5
bortezomib,2018,Prescription,Human,38.2515,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.0873453114816611e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.4163229144036915e-5
bortezomib,2019,Prescription,Human,44.9005,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.297050287058696e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.8823339712415467e-5
bosentan,2016,Prescription,Human,7290.99,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.093499063580654e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2017,Prescription,Human,7220.29,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.1016576915763616e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2018,Prescription,Human,7065.73,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.008519505822077e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2019,Prescription,Human,6926.5,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.000872777210066e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosutinib,2016,Prescription,Human,406,UBPYILGKFZZVDX-UHFFFAOYSA-N,1.1657684619149743e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2017,Prescription,Human,274.4,UBPYILGKFZZVDX-UHFFFAOYSA-N,7.9871427680682306e-11,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2018,Prescription,Human,882,UBPYILGKFZZVDX-UHFFFAOYSA-N,2.50719204404226e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2019,Prescription,Human,1461.6,UBPYILGKFZZVDX-UHFFFAOYSA-N,4.2221549861693967e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
brexpiprazole,2019,Prescription,Human,21.42,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,6.187640928006875e-12,antipsychotic,atypical antipsychotic for schizophrenia and major depressive disordered,NA,NA,NA,NA
brigatinib,2019,Prescription,Human,3.36,AILRADAXUVEEIR-UHFFFAOYSA-N,9.706103416481373e-13,antineoplastic,multikinase inhibitor for metastatic non-small cell lung cancer,NA,NA,NA,NA
brimonidine,2016,Prescription,Human,882.3695,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.53359245038346e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2017,Prescription,Human,899.191,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6173348734555536e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2018,Prescription,Human,832.37,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.3661127456909935e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2019,Prescription,Human,921.451,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6618150890536244e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brinzolamide,2016,Prescription,Human,7857.45,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.2561496061758163e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2017,Prescription,Human,7438.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.1652754001546774e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2018,Prescription,Human,8149.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.316693773258256e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2019,Prescription,Human,8000.1,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.3110058911366855e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brivaracetam,2016,Prescription,Human,2293.442,MSYKRHVOOPPJKU-BDAKNGLRSA-N,6.585276731111336e-10,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,6.585276731111335e-7
brivaracetam,2017,Prescription,Human,8006.044,MSYKRHVOOPPJKU-BDAKNGLRSA-N,2.330372319075658e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,2.330372319075658e-6
brivaracetam,2018,Prescription,Human,12378.084,MSYKRHVOOPPJKU-BDAKNGLRSA-N,3.5186206037740134e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,3.518620603774013e-6
brivaracetam,2019,Prescription,Human,16399.99,MSYKRHVOOPPJKU-BDAKNGLRSA-N,4.737499969323225e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,4.7374999693232245e-6
bromfenac,2016,Prescription,Human,48.2625,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.38578572396974e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2017,Prescription,Human,35.046,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.0201071627176356e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2018,Prescription,Human,42.057,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.19552126753158e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2019,Prescription,Human,46.0485,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.3302128070650074e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromhexine,2016,OTC,Human,73347.64,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.10606811497274e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2017,OTC,Human,69613.14,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.0262758298597715e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2018,OTC,Human,68129.81999999999,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.936672819342758e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2019,OTC,Human,67677.172,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.955004852282731e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromocriptine,2016,Prescription,Human,486.4525,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.3967758195066355e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2017,Prescription,Human,438.3275,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.2758689218915549e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2018,Prescription,Human,387.02,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.1001513207315595e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2019,Prescription,Human,357.735,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.0333966981235012e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bronopol,2016,Prescription,Vet,843000,LVDKZNITIUWNER-UHFFFAOYSA-N,2.42054880146385e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2017,Prescription,Vet,661500,LVDKZNITIUWNER-UHFFFAOYSA-N,1.925471917302163e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2018,Prescription,Vet,1066500,LVDKZNITIUWNER-UHFFFAOYSA-N,3.031655685908243e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2019,Prescription,Vet,1841000,LVDKZNITIUWNER-UHFFFAOYSA-N,5.318135830280418e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
budesonide,2016,Prescription,Human,19347.71718,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.555408497166138e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.459777322286207e-4
budesonide,2017,Prescription,Human,19341.64924,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.629902108228075e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.546397800265203e-4
budesonide,2018,Prescription,Human,19227.645,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.465691447808271e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.355455171870082e-4
budesonide,2019,OTC,Human,155.75424,VOVIALXJUBGFJZ-KWVAZRHASA-N,4.4993058362960105e-11,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,5.2317509724372215e-6
budesonide,2019,Prescription,Human,19075.08304,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.510259781672914e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.407278815898737e-4
bumetanide,2016,Prescription,Human,21770.992,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251215728621479e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2017,Prescription,Human,21814.135,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.349584934654302e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2018,Prescription,Human,22903.821,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.510689091765085e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2019,Prescription,Human,21639.479,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251042293237408e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bupivacaine,2016,Prescription,Human,26533.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.618828098529268e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2017,Prescription,Human,26503.6,LEBVLXFERQHONN-UHFFFAOYSA-N,7.714578610341587e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2018,Prescription,Human,25890.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.359816763344213e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2019,Prescription,Human,24763.25,LEBVLXFERQHONN-UHFFFAOYSA-N,7.153412661553046e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
buprenorphine,2016,Prescription,Human,19979.31948,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.73676367987869e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2016,Prescription,Vet,10.434,RMRJXGBAOAMLHD-IHFGGWKQSA-N,2.995967520103655e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2017,Prescription,Human,20312.04976,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.912363022785205e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2017,Prescription,Vet,13.818,RMRJXGBAOAMLHD-IHFGGWKQSA-N,4.022096893920074e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2018,Prescription,Human,20225.73776,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.7494114282037565e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2018,Prescription,Vet,15.0018,RMRJXGBAOAMLHD-IHFGGWKQSA-N,4.2644437195366406e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2019,Prescription,Human,20433.1613,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.902570735221576e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2019,Prescription,Vet,15.9408,RMRJXGBAOAMLHD-IHFGGWKQSA-N,4.604852778019235e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
bupropion,2016,Prescription,Human,620904.9600000001,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.7828360103807357e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.017828360103807357
bupropion,2017,Prescription,Human,650137.38,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.8923979857572258e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.018923979857572257
bupropion,2018,Prescription,Human,725158.185,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.0613501497779205e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.020613501497779203
bupropion,2019,Prescription,Human,854769.33,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.4691903316120517e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.024691903316120516
buspirone,2016,Prescription,Human,10485.42,QWCRAEMEVRGPNT-UHFFFAOYSA-N,3.0107320063873173e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2017,Prescription,Human,9892.25,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.8794028078506912e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2018,Prescription,Human,9247.26,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.628645884488688e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2019,Prescription,Human,9514.23,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.748395842505642e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
busulfan,2016,Prescription,Human,26.88,COVZYZSDYWQREU-UHFFFAOYSA-N,7.718191196126725e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2017,Prescription,Human,34.08,COVZYZSDYWQREU-UHFFFAOYSA-N,9.919891601157628e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2018,Prescription,Human,50.4,COVZYZSDYWQREU-UHFFFAOYSA-N,1.4326811680241487e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2019,Prescription,Human,42.24,COVZYZSDYWQREU-UHFFFAOYSA-N,1.220195858071944e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
butorphanol,2016,Prescription,Vet,668.16,IFKLAQQSCNILHL-QHAWAJNXSA-N,1.9185218116086432e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2017,Prescription,Vet,711.66,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.071475955657229e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2018,Prescription,Vet,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0387280430692847e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2019,Prescription,Vet,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0717908840179884e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
cabazitaxel,2016,Prescription,Human,2.88,BMQGVNUXMIRLCK-OAGWZNDDSA-N,8.269490567278635e-13,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,9.291562435144534e-7
cabazitaxel,2017,Prescription,Human,10.08,BMQGVNUXMIRLCK-OAGWZNDDSA-N,2.9340524454128196e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,3.2966881409132805e-6
cabazitaxel,2018,Prescription,Human,33.84,BMQGVNUXMIRLCK-OAGWZNDDSA-N,9.619430699590714e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.0808349100663725e-5
cabazitaxel,2019,Prescription,Human,37.8,BMQGVNUXMIRLCK-OAGWZNDDSA-N,1.0919366343541544e-11,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.2268950947799489e-5
cabergoline,2016,Prescription,Human,90.38238,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.5951952738131703e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2016,Prescription,Vet,4.0637,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.1668308617447981e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2017,Prescription,Human,80.04612,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.3299554973393653e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2017,Prescription,Vet,4.2784,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.245342260164108e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2018,Prescription,Human,62.6782,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.7817039044772065e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2018,Prescription,Vet,4.3835,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.2460630754035428e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2019,Prescription,Human,43.588,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.2591358205880656e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2019,Prescription,Vet,4.46275,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.2891640780328049e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabozantinib,2016,Prescription,Human,248.64,ONIQOQHATWINJY-UHFFFAOYSA-N,7.13932685641722e-11,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2017,Prescription,Human,566.04,ONIQOQHATWINJY-UHFFFAOYSA-N,1.647610164882413e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2018,Prescription,Human,891.64,ONIQOQHATWINJY-UHFFFAOYSA-N,2.5345949140020866e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2019,Prescription,Human,1194.96,ONIQOQHATWINJY-UHFFFAOYSA-N,3.4519063507614824e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
caffeine,2016,OTC,Human,1247931.265,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.583248550183888e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.00895812137545972
caffeine,2016,Prescription,Human,11808,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.3904911325842403e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,8.4762278314606e-5
caffeine,2017,OTC,Human,1190861.865,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.4663206023334533e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.008665801505833633
caffeine,2017,Prescription,Human,11290.2,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.2863133848412513e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,8.215783462103127e-5
caffeine,2018,OTC,Human,1109769.9,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.154655628115164e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007886639070287908
caffeine,2018,Prescription,Human,9306.6,RYYVLZVUVIJVGH-UHFFFAOYSA-N,2.645513999669354e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,6.613784999173384e-5
caffeine,2019,OTC,Human,1036837.5,RYYVLZVUVIJVGH-UHFFFAOYSA-N,2.99513452413274e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007487836310331849
caffeine,2019,Prescription,Human,8738.6,RYYVLZVUVIJVGH-UHFFFAOYSA-N,2.524337955811432e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,6.310844889528579e-5
calcipotriol,2016,Prescription,Human,249.97125,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.177551715159199e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2017,Prescription,Human,249.35925,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.258265052071494e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2018,Prescription,Human,259.86625,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.387013543255066e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2019,Prescription,Human,271.7295,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.849507822347545e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcium folinate,2016,Prescription,Human,6309.45,KVUAALJSMIVURS-ZEDZUCNESA-L,1.8116644881845895e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2017,Prescription,Human,6863.55,KVUAALJSMIVURS-ZEDZUCNESA-L,1.997819014058845e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2018,Prescription,Human,7372.3,KVUAALJSMIVURS-ZEDZUCNESA-L,2.0956657490127843e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2019,Prescription,Human,8149.15,KVUAALJSMIVURS-ZEDZUCNESA-L,2.354062281441047e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium polystyrene sulfonate,2016,OTC,Human,2230800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.405409568571243e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2017,OTC,Human,2436600,IJBYVKWTVVYTPL-UHFFFAOYSA-M,7.092373202869917e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2018,OTC,Human,2256900,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.415512158955756e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2019,OTC,Human,1675800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,4.840919078970084e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
canagliflozin,2019,Prescription,Human,11529,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,3.330406734780171e-9,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes treatment and symptom relief,low,moderate,5.6e-5,5.9471548835360196e-5
candesartan,2016,Prescription,Human,792375.8210400001,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.275189020079842e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0022751890200798422
candesartan,2017,Prescription,Human,832738.27648,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.4239065243005956e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.002423906524300596
candesartan,2018,Prescription,Human,885051.03496,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.5158649812053066e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0025158649812053067
candesartan,2019,Prescription,Human,954982.78608,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.7586790722178533e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0027586790722178537
capecitabine,2016,Prescription,Human,223845,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.427375402890577e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2017,Prescription,Human,215490,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.27241033196437e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2018,Prescription,Human,209496,GAGWJHPBXLXJQN-UORFTKCHSA-N,5.955178055087046e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2019,Prescription,Human,253584,GAGWJHPBXLXJQN-UORFTKCHSA-N,7.325334907038727e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
captopril,2016,Prescription,Human,28587.95,FAKRSMQSSFJEIM-RQJHMYQMSA-N,8.208603571626155e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2017,Prescription,Human,26218.65,FAKRSMQSSFJEIM-RQJHMYQMSA-N,7.631636324198692e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2018,Prescription,Human,23300.325,FAKRSMQSSFJEIM-RQJHMYQMSA-N,6.623400165940928e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2019,Prescription,Human,20354.975,FAKRSMQSSFJEIM-RQJHMYQMSA-N,5.879984892556337e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
carbachol,2016,Prescription,Human,3.92,AIXAANGOTKPUOY-UHFFFAOYSA-N,1.1255695494351477e-12,ophthalmological,"lowers pressure in eye, used for post-surgery relief",low,NA,NA,NA
carbamazepine,2016,Prescription,Human,2233819.725,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.414080258641825e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.256563210345673
carbamazepine,2017,Prescription,Human,2129609.475,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.198795523708394e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.24795182094833576
carbamazepine,2018,Prescription,Human,1989509.9,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.655423347872237e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22621693391488945
carbamazepine,2019,Prescription,Human,1926617.325,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.565460416796042e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22261841667184168
carbamide,2016,OTC,Human,2357855,XSQUKJJJFZCRTK-UHFFFAOYSA-N,6.770229056080127e-7,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2017,OTC,Human,5509474,XSQUKJJJFZCRTK-UHFFFAOYSA-N,1.603679133198249e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2018,OTC,Human,8185423.5,XSQUKJJJFZCRTK-UHFFFAOYSA-N,2.3268059723714912e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2019,OTC,Human,10434144,XSQUKJJJFZCRTK-UHFFFAOYSA-N,3.0141333549541256e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbimazole,2016,Prescription,Human,17307.765,CFOYWRHIYXMDOT-UHFFFAOYSA-N,4.969666646117198e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2016,Prescription,Vet,1518,CFOYWRHIYXMDOT-UHFFFAOYSA-N,4.3587106531697804e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2017,Prescription,Human,18267.76,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.317318045656198e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2017,Prescription,Vet,1849,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.382006916238395e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2018,Prescription,Human,20357.775,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.7869446161454006e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2018,Prescription,Vet,1856.5,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.277326564358794e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2019,Prescription,Human,21393.505,CFOYWRHIYXMDOT-UHFFFAOYSA-N,6.179987261042004e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2019,Prescription,Vet,1712,CFOYWRHIYXMDOT-UHFFFAOYSA-N,4.945490788397652e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carfilzomib,2016,Prescription,Human,34.9,BLMPQMFVWMYDKT-NZTKNTHTSA-N,1.0021014611042511e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2017,Prescription,Human,105.36,BLMPQMFVWMYDKT-NZTKNTHTSA-N,3.066783389371971e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2018,Prescription,Human,313.56,BLMPQMFVWMYDKT-NZTKNTHTSA-N,8.913323552493097e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2019,Prescription,Human,334.15999999999997,BLMPQMFVWMYDKT-NZTKNTHTSA-N,9.652950945391116e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carglumic acid,2016,Prescription,Human,34,LCQLHJZYVOQKHU-VKHMYHEASA-N,9.762593030815054e-12,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2017,Prescription,Human,701,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.0404471867404627e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2018,Prescription,Human,828,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.3536904903253875e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2019,Prescription,Human,575,LCQLHJZYVOQKHU-VKHMYHEASA-N,1.661014721570473e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
cariprazine,2019,Prescription,Human,5.376,KPWSJANDNDDRMB-UHFFFAOYSA-N,1.5529765466370198e-12,antipsychotic,atypical antipsychotic for schizophrenia and bipolar I disorder,NA,NA,NA,NA
carmustine,2019,Prescription,Human,40.4,DLGOEMSEDOSKAD-UHFFFAOYSA-N,1.1670433869816887e-11,antineoplastic,"alkylating antineoplastic for brain tumours, lymphomas and multiple myeloma",NA,NA,NA,NA
carprofen,2016,Prescription,Vet,107750.8,PUXBGTOOZJQSKH-UHFFFAOYSA-N,3.093903556308079e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2017,Prescription,Vet,95846.4,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.7898647252382464e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2018,Prescription,Vet,92620.6,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.6328529641090772e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2019,Prescription,Vet,88610.1,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.5596987926927265e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carvedilol,2016,Prescription,Human,175604.29374999998,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.042215453955734e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2017,Prescription,Human,175251.63125,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.10116544872667e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2018,Prescription,Human,172444.5,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4.901944199986911e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2019,Prescription,Human,173981.75,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.025847791905976e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
caspofungin,2016,Prescription,Human,153.09,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3957510796690496e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.791502159338098e-6
caspofungin,2017,Prescription,Human,148.74,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3294738167728455e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.65894763354569e-6
caspofungin,2018,Prescription,Human,98.77,JYIKNQVWKBUSNH-OGZDCFRISA-N,2.807657122336214e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,5.615314244672427e-6
caspofungin,2019,Prescription,Human,110.72,JYIKNQVWKBUSNH-OGZDCFRISA-N,3.1983921734310044e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,6.3967843468620086e-6
cefalexin,2016,Prescription,Human,396285,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.137873288004866e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2016,Prescription,Vet,43487.75,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.2486858972818454e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2017,Prescription,Human,333696,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.713110762147583e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2017,Prescription,Vet,31738.5,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.238335668525276e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2018,Prescription,Human,330273,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.38841086124682e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2018,Prescription,Vet,32342.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.193677084628776e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2019,Prescription,Human,288896,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,8.345400156570841e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2019,Prescription,Vet,28361.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,8.192774569067927e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2016,Prescription,Human,706160,XIURVHNZVLADCM-IUODEOHRSA-N,2.0276331454824586e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2017,Prescription,Human,607370,XIURVHNZVLADCM-IUODEOHRSA-N,1.7679121366769685e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2018,Prescription,Human,535650,XIURVHNZVLADCM-IUODEOHRSA-N,1.522650134230427e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2019,Prescription,Human,15320,XIURVHNZVLADCM-IUODEOHRSA-N,4.425520962514721e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2017,Prescription,Human,49420,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.4385007128204518e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2018,Prescription,Human,154120,MLYYVTUWGNIJIB-BXKDBHETSA-N,4.3810480479341637e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2019,Prescription,Human,522400,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.509067983562461e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2016,Prescription,Human,921690,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.646495403109391e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2017,Prescription,Human,894152,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.602667521994805e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2018,Prescription,Human,964915,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.742887994531789e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2019,Prescription,Human,910315,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.629646289159001e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefovecin,2016,Prescription,Vet,527.68,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.5151544383824963e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2017,Prescription,Vet,497.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.4483973182910902e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2018,Prescription,Vet,480,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.3644582552610938e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2019,Prescription,Vet,401.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.1601104559699164e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
ceftaroline fosamil,2016,Prescription,Human,168,ZCCUWMICIWSJIX-NQJJCJBVSA-N,4.823869497579204e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2017,Prescription,Human,120,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.492919577872404e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2018,Prescription,Human,132,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.752260201968009e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2019,Prescription,Human,186,ZCCUWMICIWSJIX-NQJJCJBVSA-N,5.3730215341236165e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftazidime,2016,Prescription,Human,46670,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3400594610239373e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010308149700184132
ceftazidime,2017,Prescription,Human,51020,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.4850729738587506e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.011423638260451927
ceftazidime,2018,Prescription,Human,47690,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3556461290291995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010428047146378457
ceftazidime,2019,Prescription,Human,59760,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.7262998219313297e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.013279229399471766
ceftolozane,2016,Prescription,Human,320,JHFNIHVVXRKLEF-DCZLAGFPSA-N,9.188322852531816e-11,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2017,Prescription,Human,1000,JHFNIHVVXRKLEF-DCZLAGFPSA-N,2.91076631489367e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2018,Prescription,Human,1460,JHFNIHVVXRKLEF-DCZLAGFPSA-N,4.150227193085828e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2019,Prescription,Human,2470,JHFNIHVVXRKLEF-DCZLAGFPSA-N,7.135141499615771e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftriaxone,2016,Prescription,Human,85970,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.4685003613505007e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2017,Prescription,Human,91200,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6546188791830273e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2018,Prescription,Human,93290,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6518814715272387e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2019,Prescription,Human,89470,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.5845389067636563e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
cefuroxime,2016,Prescription,Human,217464.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,6.244176037640995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,8.216021102159204e-4
cefuroxime,2017,Prescription,Human,189003.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,5.501457488885845e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,7.238759853797164e-4
cefuroxime,2018,Prescription,Human,152747,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.3420188565909655e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.713182706040743e-4
cefuroxime,2019,Prescription,Human,154180.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.4538520962222035e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.860331705555531e-4
celecoxib,2016,Prescription,Human,313284,RZEKVGVHFLEQIL-UHFFFAOYSA-N,8.995482926664306e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2017,Prescription,Human,331813.5,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.658315586269709e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2018,Prescription,Human,341206.4,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.699206025581646e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2019,Prescription,Human,385292.6,RZEKVGVHFLEQIL-UHFFFAOYSA-N,1.1130029229776757e-7,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
ceritinib,2016,Prescription,Human,1822.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,5.233036999606011e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2017,Prescription,Human,2272.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,6.614716450595866e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2018,Prescription,Human,1507.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,4.2852517079293736e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2019,Prescription,Human,742.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,2.1448755317670892e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cetirizine,2016,OTC,Human,104287.25,ZKLPARSLTMPFCP-UHFFFAOYSA-N,2.9944528825084335e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2016,Prescription,Human,544487.14,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.5634136348036533e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2017,OTC,Human,112178.55,ZKLPARSLTMPFCP-UHFFFAOYSA-N,3.2652554459361536e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2017,Prescription,Human,545903.63,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.5889978973821778e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2018,OTC,Human,112028.92,ZKLPARSLTMPFCP-UHFFFAOYSA-N,3.1845580150413475e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2018,Prescription,Human,558260.25,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.5869225139512966e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2019,OTC,Human,124215.34,ZKLPARSLTMPFCP-UHFFFAOYSA-N,3.588234928432724e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2019,Prescription,Human,585536.83,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.6914526863507956e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetylpyridinium,2016,OTC,Human,33935.98,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.744210642408209e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2017,OTC,Human,33221.51,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.67000522379032e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2018,OTC,Human,36098.61,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0261468003739724e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2019,OTC,Human,37280.55,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0769311717955496e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
chlorambucil,2016,Prescription,Human,51.2,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.4701316564050907e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2017,Prescription,Human,40.1,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.1672172922723618e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2018,Prescription,Human,34.95,JCKYGMPEJWAADB-UHFFFAOYSA-N,9.934961671119842e-12,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2019,Prescription,Human,35,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.0110524392168096e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chloramphenicol,2016,Prescription,Human,20504.68,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.887613119620378e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2017,Prescription,Human,20191.535,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.877283992399656e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2018,Prescription,Human,20336.5725,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.7809175481959885e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2019,Prescription,Human,20842.3125,WIIZWVCIJKGZOK-RKDXNWHRSA-N,6.020763112012572e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chlorhexidine,2016,OTC,Human,1163914.85,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.342007942080045e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.978580883428625
chlorhexidine,2016,Prescription,Human,882173.75,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.5330303834464657e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.0155123612457926
chlorhexidine,2016,Prescription,Vet,5506.14,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.5810059997262355e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.0188214999967409
chlorhexidine,2017,OTC,Human,1173260.5,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.415087141995305e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,4.065579930946792
chlorhexidine,2017,Prescription,Human,940169.375,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.736613347044635e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.257873032195994
chlorhexidine,2017,Prescription,Vet,4495.555,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.3085510060751814e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.015577988167561684
chlorhexidine,2018,OTC,Human,1131496.75,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.2164168361220797e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.829067662050095
chlorhexidine,2018,Prescription,Human,950756.25,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.702640029278293e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.2174286062836823
chlorhexidine,2018,Prescription,Vet,4256.28,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.2098992463963936e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.014403562457099924
chlorhexidine,2019,OTC,Human,1190193.5,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.438137260899977e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,4.093020548690449
chlorhexidine,2019,Prescription,Human,995010.625,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.874308341293978e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.421795644397593
chlorhexidine,2019,Prescription,Vet,4247.835,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.2270811251830102e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.014608108633131073
chlorprothixene,2016,Prescription,Human,205340.135,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.8960357967577135e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2017,Prescription,Human,196536.425,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.720716055396262e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2018,Prescription,Human,177104.97,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.0344237159222583e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2019,Prescription,Human,163988.0150000001,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,4.737156644802082e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ciclesonide,2016,Prescription,Human,960.6624,LUKZNWIVRBCLON-GXOBDPJESA-N,2.7583988385900185e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2017,Prescription,Human,1141.9296000000002,LUKZNWIVRBCLON-GXOBDPJESA-N,3.3238902136600033e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2018,Prescription,Human,1112.1216,LUKZNWIVRBCLON-GXOBDPJESA-N,3.1613406207795335e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2019,Prescription,Human,1184.5728,LUKZNWIVRBCLON-GXOBDPJESA-N,3.421900625342532e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclopirox,2016,Prescription,Human,4128.96,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.18556929766218e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2017,Prescription,Human,4164.864,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.212294583731331e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2018,Prescription,Human,4593.6,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.3057865502848672e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2019,Prescription,Human,4581.984,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.323607457043541e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclosporin,2016,Prescription,Human,163505.09,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.6948048592258486e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.002324160821398935
ciclosporin,2016,Prescription,Vet,24001.71,PMATZTZNYRCHOR-CGLBZJNRSA-N,6.891733140401294e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,3.411749079406581e-4
ciclosporin,2017,Prescription,Human,154730.36,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.5038391977937096e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0022296233652444107
ciclosporin,2017,Prescription,Vet,19318.213,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.623080366434099e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,2.783703151700049e-4
ciclosporin,2018,Prescription,Human,146391.753,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.1613632475623545e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.002060080815624928
ciclosporin,2018,Prescription,Vet,17522.682,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.98103502275312e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,2.46585892215501e-4
ciclosporin,2019,Prescription,Human,144361.567,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.1702032698431686e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0020644570642787963
ciclosporin,2019,Prescription,Vet,19511.151,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.636227660136427e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,2.790211712938825e-4
cilastatin,2016,Prescription,Human,8080,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.320051520264283e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2017,Prescription,Human,8565,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.493071348706428e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2018,Prescription,Human,7635,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.1703414122746773e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2019,Prescription,Human,7800,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.253202578826033e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cimicoxib,2016,Prescription,Vet,78.06400000000001,KYXDNECMRLFQMZ-UHFFFAOYSA-N,2.2414913598751367e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2017,Prescription,Vet,59.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.7231736584170528e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2018,Prescription,Vet,67.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.910241557365532e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2019,Prescription,Vet,20.48,KYXDNECMRLFQMZ-UHFFFAOYSA-N,5.916101130045789e-12,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cinacalcet,2016,Prescription,Human,8650.3032,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.483805580434034e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.004967611160868068
cinacalcet,2017,Prescription,Human,8726.9364,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.540207250533943e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.005080414501067886
cinacalcet,2018,Prescription,Human,9831.4188,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.7947001130393992e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.0055894002260787985
cinacalcet,2019,Prescription,Human,10500.5376,VDHAWDNDOKGFTD-MRXNPFEDSA-N,3.0333126153050927e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.006066625230610185
ciprofloxacin,2016,Prescription,Human,969510.6875,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.783805376790651e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,55.676107535813024
ciprofloxacin,2017,Prescription,Human,811026.0705,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.360707366511979e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,47.21414733023958
ciprofloxacin,2018,Prescription,Human,753169.644,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.140976121599707e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,42.81952243199414
ciprofloxacin,2019,Prescription,Human,643892.9005,MYSWGUAQZAJSOK-UHFFFAOYSA-N,1.86002710755689e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,37.200542151137796
cisatracurium,2016,Prescription,Human,598.65,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7189342111463034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2017,Prescription,Human,589.05,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7145868977881162e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2018,Prescription,Human,563.75,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.6025277945905034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2019,Prescription,Human,607.8,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7557647787313624e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
citalopram,2016,Prescription,Human,141802.8492,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4.071657374557759e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2017,Prescription,Human,130996.3988,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.812999049994176e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2018,Prescription,Human,120262.5316,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.4186084175045466e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2019,Prescription,Human,112427.9148,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.2477290712742756e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
cladribine,2016,Prescription,Human,2.45,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.034809683969674e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2017,Prescription,Human,2.65,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.713530734468226e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2018,Prescription,Human,27.46,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.805838268639509e-12,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2019,Prescription,Human,73.98,PTOAARAWEBMLNO-KVQBGUIXSA-N,2.1370759843788452e-11,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
clarithromycin,2016,Prescription,Human,111591.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.2041835299947006e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2670152941662251
clarithromycin,2017,Prescription,Human,114924.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.345183633559976e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2787653027966647
clarithromycin,2018,Prescription,Human,109722.25,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.118988120798366e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2599156767331972
clarithromycin,2019,Prescription,Human,102942,AGOYDEPGAOXOCK-KCBOHYOISA-N,2.9737074342244804e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.24780895285204005
clenbuterol,2016,Prescription,Vet,2.813375,STJMRWALKKWQGH-UHFFFAOYSA-N,8.078186814138032e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2017,Prescription,Vet,2.4495,STJMRWALKKWQGH-UHFFFAOYSA-N,7.129922088332045e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2018,Prescription,Vet,2.11225,STJMRWALKKWQGH-UHFFFAOYSA-N,6.004326978490097e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2019,Prescription,Vet,1.854875,STJMRWALKKWQGH-UHFFFAOYSA-N,5.358216837692228e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clindamycin,2016,Prescription,Human,701983.264,KDLRVYVGXIQJDK-AWPVFWJPSA-N,2.0156402708456487e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2016,Prescription,Vet,28568.4,KDLRVYVGXIQJDK-AWPVFWJPSA-N,8.202990080633436e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2017,Prescription,Human,618713.59,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.800930676338933e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2017,Prescription,Vet,18754.800000000003,KDLRVYVGXIQJDK-AWPVFWJPSA-N,5.459084008256781e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2018,Prescription,Human,625784.3400000001,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.778867934846074e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2018,Prescription,Vet,25726.4,KDLRVYVGXIQJDK-AWPVFWJPSA-N,7.313041428781043e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2019,Prescription,Human,620770.74,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.7932336310612112e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2019,Prescription,Vet,26131.2,KDLRVYVGXIQJDK-AWPVFWJPSA-N,7.5485752856178e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clobetasol,2016,Prescription,Human,9347.55,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.684009602505743e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0035786794700076573
clobetasol,2017,Prescription,Human,10366.3175,FCSHDIVRCWTZOX-DVTGEIKXSA-N,3.017392778849276e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0040231903717990345
clobetasol,2018,Prescription,Human,10203.0325,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.900335817358799e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.003867114423145065
clobetasol,2019,Prescription,Human,8940.44,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.582643905620438e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0034435252074939172
clodronic acid,2016,Prescription,Human,1824,ACSIXWWBWUQEHA-UHFFFAOYSA-N,5.237344025943134e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clodronic acid,2017,Prescription,Human,384,ACSIXWWBWUQEHA-UHFFFAOYSA-N,1.1177342649191694e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clofarabine,2016,Prescription,Human,0.46,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.320821410051449e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2018,Prescription,Human,0.4,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.1370485460509118e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2019,Prescription,Human,0.92,WDDPHFBMKLOVOX-AYQXTPAHSA-N,2.657623554512757e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clomethiazole,2016,Prescription,Human,460391.4,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.321945256790349e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2017,Prescription,Human,429892.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.2513174812553216e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2018,Prescription,Human,414868.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1793149146047161e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2019,Prescription,Human,396804.9,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1462587486805209e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomifene,2016,Prescription,Human,5009.75,GKIRPKYJQBWNGO-OCEACIFDSA-N,1.4384750128272271e-9,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomifene,2017,Prescription,Human,690.5,GKIRPKYJQBWNGO-OCEACIFDSA-N,2.009884140434079e-10,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomipramine,2016,Prescription,Human,40026.38,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.1492978189316326e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2016,Prescription,Vet,3964.2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.138260920375207e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2017,Prescription,Human,35982.48,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.047365907103352e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2017,Prescription,Vet,3487.2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.0150424293297206e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2018,Prescription,Human,32714.545,GDLIGKIOYRNHDA-UHFFFAOYSA-N,9.299506456741781e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2018,Prescription,Vet,4347.6,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.235858064702736e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2019,Prescription,Human,33971.37,GDLIGKIOYRNHDA-UHFFFAOYSA-N,9.813381857724788e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2019,Prescription,Vet,4734.6,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.367693965347402e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clonazepam,2016,Prescription,Human,4984.8025,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.4313117101908662e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2017,Prescription,Human,4228.349,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.2307735836814334e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2018,Prescription,Human,3799.52775,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.080061875954398e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2019,Prescription,Human,3491.1915,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.0085079090994264e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonidine,2016,Prescription,Human,74.4451249999999,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.1375807603033958e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2017,Prescription,Human,78.385925,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.281631100517816e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2018,Prescription,Human,82.532525,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.3460871888290132e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2019,Prescription,Human,76.5191000000001,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.210423505762145e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clopidogrel,2016,Prescription,Human,583192.05,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.674549012634337e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.005401771008497861
clopidogrel,2017,Prescription,Human,654759.825,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.9058528429556747e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006147912396631208
clopidogrel,2018,Prescription,Human,751511.1,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.136261508990303e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006891166158033236
clopidogrel,2019,Prescription,Human,881861.775,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.547452853330901e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.00821758984945452
cloprostenol,2016,Prescription,Vet,19.2025,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.513711549241944e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2017,Prescription,Vet,19.609,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.707721666874999e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2018,Prescription,Vet,19.0495,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.4150515694992115e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2019,Prescription,Vet,18.258000000000003,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.274227267205861e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
clotrimazole,2016,OTC,Human,205849.5,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.910661453225775e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2017,OTC,Human,189772.8,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.5238427372305347e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2018,OTC,Human,193022.2,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4868902966387065e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2019,OTC,Human,190337,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4983053749488544e-8,antifungal,topical antifungal,NA,NA,NA,NA
cloxacillin,2016,Prescription,Human,636745,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8283183233548037e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2017,Prescription,Human,511970,LQOLIRLGBULYKD-JKIFEVAISA-N,1.4902250302361122e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2018,Prescription,Human,601620,LQOLIRLGBULYKD-JKIFEVAISA-N,1.7101778656878738e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2019,Prescription,Human,645520,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8647273444663859e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
clozapine,2016,Prescription,Human,342467.625,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.833447203249364e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2017,Prescription,Human,343189.72500000003,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.989450911476223e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2018,Prescription,Human,347240.5,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.87073264137479e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2019,Prescription,Human,345373.15,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.976867592785517e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
cobicistat,2016,Prescription,Human,27459,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,7.884442412739723e-9,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,1.6290170274255628e-5
cobicistat,2017,Prescription,Human,47232,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.3748131458505782e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,2.8405230286168972e-5
cobicistat,2018,Prescription,Human,57780,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.642466624770542e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.393526084236657e-5
cobicistat,2019,Prescription,Human,60192,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.73877909775252e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.592518797009339e-5
cobimetinib,2016,Prescription,Human,1.26,BSMCAPRUBJMWDF-KRWDZBQOSA-N,3.6179021231844026e-13,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2017,Prescription,Human,40.32,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.173620978165128e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2018,Prescription,Human,51.66,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.4684981972247523e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2019,Prescription,Human,151.2,BSMCAPRUBJMWDF-KRWDZBQOSA-N,4.3677465374166176e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
codeine,2016,Prescription,Human,1943129.045,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.579405315497444e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2017,Prescription,Human,1785329.695,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.19667753718539e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2018,Prescription,Human,1718023.555,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.883690463234922e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2019,Prescription,Human,1730315.635,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.998399552519236e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
colchicine,2016,Prescription,Human,949.577,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.7265687654183137e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2017,Prescription,Human,1010.748,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.9420512312461473e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2018,Prescription,Human,718.022,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.0410646778314195e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2019,Prescription,Human,810.6,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.3415974492261306e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colesevelam,2016,Prescription,Human,386912.25,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1109608339373449e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2017,Prescription,Human,399217.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1620288513160637e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2018,Prescription,Human,418837.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1905964260164969e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2019,Prescription,Human,418050,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.2076299206131066e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colestipol,2016,Prescription,Human,540250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.551247319087598e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2017,Prescription,Human,439250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.278554103817045e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2018,Prescription,Human,388250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.1036477450106661e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2019,Prescription,Human,358500,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.0356065698835037e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestyramine,2016,Prescription,Human,2181800,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.264713374891849e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2017,Prescription,Human,2395000,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.97128532417034e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2018,Prescription,Human,2466400,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.011041334949922e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2019,Prescription,Human,2465200,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.121275637592226e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colistin,2016,Prescription,Human,2972.2000000000003,YKQOSKADJPQZHB-QNPLFGSASA-N,8.534229119467207e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2017,Prescription,Human,2832,YKQOSKADJPQZHB-QNPLFGSASA-N,8.243290203778873e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2018,Prescription,Human,3049.2,YKQOSKADJPQZHB-QNPLFGSASA-N,8.667721066546101e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2019,Prescription,Human,3225.6,YKQOSKADJPQZHB-QNPLFGSASA-N,9.317859279822118e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
cortisone,2016,Prescription,Human,33984.45,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.7581280801789e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2017,Prescription,Human,33982.4,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.891482521924266e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2018,Prescription,Human,34960.275,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.937882464572511e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2019,Prescription,Human,37744.17,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,1.0903238612775408e-8,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
crizotinib,2016,Prescription,Human,4302,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.235255153487246e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2017,Prescription,Human,4521,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.3159574509634283e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2018,Prescription,Human,3807,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.082185953703955e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2019,Prescription,Human,2367,KTEIFNKAUNYNJU-GFCCVEGCSA-N,6.837603210360539e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cromoglicic acid,2016,OTC,Human,6337.64,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.819758826347492e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2016,Prescription,Human,29221.35,IMZMKUWMOSJXDT-UHFFFAOYSA-N,8.390474937088456e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2017,OTC,Human,6854.6,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.995213878207015e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2017,Prescription,Human,28845.37,IMZMKUWMOSJXDT-UHFFFAOYSA-N,8.396213133664442e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2018,OTC,Human,6688.5599999999995,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.9013043557935715e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2018,Prescription,Human,21649.81,IMZMKUWMOSJXDT-UHFFFAOYSA-N,6.154221245694623e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2019,OTC,Human,4095.14,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.1829717959812361e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2019,Prescription,Human,21868.2,IMZMKUWMOSJXDT-UHFFFAOYSA-N,6.317113414651725e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cyclizine,2016,OTC,Human,30906,UVKZSORBKUEBAZ-UHFFFAOYSA-N,8.874197065010884e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2017,OTC,Human,32557.85,UVKZSORBKUEBAZ-UHFFFAOYSA-N,9.476829306536088e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2018,OTC,Human,5394.9,UVKZSORBKUEBAZ-UHFFFAOYSA-N,1.5335658002725155e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2019,OTC,Human,2,UVKZSORBKUEBAZ-UHFFFAOYSA-N,5.777442509810341e-13,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclopentolate,2016,Prescription,Human,1167.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.3528764359066884e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2017,Prescription,Human,1186.1,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.4524599260953816e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2018,Prescription,Human,1249.8,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5527081821360735e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2019,Prescription,Human,1219.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5233733146078363e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclophosphamide,2016,Prescription,Human,18538.6,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.323082563560823e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2017,Prescription,Human,18727.8,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.451224939206568e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2018,Prescription,Human,17952.3,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.1031591533174464e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2019,Prescription,Human,19087.5,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.513846695300244e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyproterone acetate,2016,Prescription,Human,6064.857768,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.741433475845922e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2017,Prescription,Human,6365.400638,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.8528193757893078e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2018,Prescription,Human,7399.896064,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.103510265124766e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2019,Prescription,Human,7875.951566,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.275142869130786e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cytarabine,2016,Prescription,Human,9321.5,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.676529733433604e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2017,Prescription,Human,8311.4,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.4192543149607252e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2018,Prescription,Human,8661,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.461994364336736e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2019,Prescription,Human,5360,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,1.5483545926291714e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
dabigatran etexilate,2016,Prescription,Human,1083636.35,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.11150019954349e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.00311150019954349
dabigatran etexilate,2017,Prescription,Human,1085194.7,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.1587481778611416e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0031587481778611415
dabigatran etexilate,2018,Prescription,Human,1086955.6,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.089803211504742e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030898032115047416
dabigatran etexilate,2019,Prescription,Human,1070971.9,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.0937392909361745e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030937392909361743
dabrafenib,2016,Prescription,Human,5592.3,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.6057455590066775e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.5292814847682644e-4
dabrafenib,2017,Prescription,Human,6479.8,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8861183567248e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.796303196880762e-4
dabrafenib,2018,Prescription,Human,6400.4,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8193913785360638e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.7327536938438703e-4
dabrafenib,2019,Prescription,Human,5114.9,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.4775520346714455e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.4071924139728053e-4
dacarbazine,2016,Prescription,Human,14,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4.019891247982669e-12,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2017,Prescription,Human,36,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.0478758733617211e-11,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2019,Prescription,Human,606.5,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.7520094410999858e-10,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
daclatasvir,2016,Prescription,Human,1207.92,FKRSSPOQAMALKA-CUPIEXAXSA-N,3.468362168759447e-10,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,4.817169678832565e-6
daclatasvir,2017,Prescription,Human,168.84,FKRSSPOQAMALKA-CUPIEXAXSA-N,4.914537846066473e-11,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,6.825747008425656e-7
dacomitinib,2019,Prescription,Human,1.35,LVXJQMNHJWSHET-AATRIKPKSA-N,3.8997736941219803e-13,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,NA,NA,NA,NA
dapagliflozin,2016,Prescription,Human,30510.7733,JVHXJTBJCFBINQ-ADAARDCZSA-N,8.760713611275237e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,8.760713611275237e-5
dapagliflozin,2017,Prescription,Human,34991.5867,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0185233187104137e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0185233187104136e-4
dapagliflozin,2018,Prescription,Human,38308.9301,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0889778317742752e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0889778317742752e-4
dapagliflozin,2019,Prescription,Human,43180.9882,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.2473783842114937e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.2473783842114936e-4
dapoxetine,2016,Prescription,Human,23.4,USRHYDPUVLEVMC-FQEVSTJZSA-N,6.7189610859138906e-12,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2017,Prescription,Human,61.56,USRHYDPUVLEVMC-FQEVSTJZSA-N,1.7918677434485435e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2018,Prescription,Human,93.33,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.6530185200732896e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2019,Prescription,Human,85.86,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.480256069461579e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapsone,2016,Prescription,Human,7560,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1707412739106415e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2017,Prescription,Human,7500,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1830747361702526e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2018,Prescription,Human,7240,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.0580578683521504e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2019,Prescription,Human,8300,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.397638641571291e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
daptomycin,2016,Prescription,Human,319,DOAKLVKFURWEDJ-RWDRXURGSA-N,9.159609343617655e-11,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2017,Prescription,Human,466,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.3564171027404504e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2018,Prescription,Human,546.5,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5534925760420582e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2019,Prescription,Human,543,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5685756414135075e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
darifenacin,2016,Prescription,Human,6419.03955,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8431314933928294e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2017,Prescription,Human,6370.61775,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8543379551763703e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2018,Prescription,Human,5534.04495,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.5731194410444727e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2019,Prescription,Human,5167.35135,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.4927037676307927e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darunavir,2016,Prescription,Human,62424,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.792412080457644e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.9068213621889832e-5
darunavir,2017,Prescription,Human,57120,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.6626297190672643e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.768755020284324e-5
darunavir,2018,Prescription,Human,82536,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,2.346185969921451e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,2.4959425211930332e-5
darunavir,2019,Prescription,Human,154224,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,4.4551014681649504e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,4.73946964698399e-5
dasabuvir,2016,Prescription,Human,12446,NBRBXGKOEOGLOI-UHFFFAOYSA-N,3.573683319456593e-9,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2017,Prescription,Human,3066,NBRBXGKOEOGLOI-UHFFFAOYSA-N,8.924409521463991e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2018,Prescription,Human,1596,NBRBXGKOEOGLOI-UHFFFAOYSA-N,4.536823698743137e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2019,Prescription,Human,84,NBRBXGKOEOGLOI-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasatinib,2016,Prescription,Human,1740,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,4.996150551064175e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,2.775639195035653e-4
dasatinib,2017,Prescription,Human,2038.8,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,5.934470362805215e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.2969279793362307e-4
dasatinib,2018,Prescription,Human,2379,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,6.762596227637798e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.756997904243221e-4
dasatinib,2019,Prescription,Human,2601,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,7.513563984008349e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,4.1742022133379715e-4
daunorubicin,2016,Prescription,Human,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.504587867102085e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2017,Prescription,Human,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.525241549004283e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2018,Prescription,Human,59.8,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.699887576346113e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2019,Prescription,Human,44.2,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.2768147946680854e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
decitabine,2016,Prescription,Human,16.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,4.665945198551313e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2017,Prescription,Human,33.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.678297997021454e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2018,Prescription,Human,33.2,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.437502932222569e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2019,Prescription,Human,25.6,XAUDJQYHKZQPEU-KVQBGUIXSA-N,7.395126412557236e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
deferasirox,2016,Prescription,Human,21378,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.138373935669537e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.019182418548967302
deferasirox,2017,Prescription,Human,21690.3,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.3135394599938174e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.01972981081248068
deferasirox,2018,Prescription,Human,20962.8,BOFQWVMAQOTZIW-UHFFFAOYSA-N,5.9589303152890124e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.018621657235278165
deferasirox,2019,Prescription,Human,26090.1,BOFQWVMAQOTZIW-UHFFFAOYSA-N,7.536702641260139e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.023552195753937934
deferiprone,2016,Prescription,Human,18100,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.197145113463308e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2017,Prescription,Human,19650,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.719655808766062e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2018,Prescription,Human,20600,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.855800012162195e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2019,Prescription,Human,16450,TZXKOCQBRNJULO-UHFFFAOYSA-N,4.7519464643190056e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferoxamine,2016,Prescription,Human,6300,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.808951061592201e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2017,Prescription,Human,6655,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.9371149825617374e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2018,Prescription,Human,7530,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.1404938879408415e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2019,Prescription,Human,8240,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.38030631404186e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
degarelix,2016,Prescription,Human,642.5600000000001,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.845015228788389e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2017,Prescription,Human,624.72,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.8184139322403736e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2018,Prescription,Human,569.6,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.6191571295764982e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2019,Prescription,Human,548.0799999999999,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.5832503453884256e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
deoxycholic acid,2017,Prescription,Human,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.3286130519149364e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2018,Prescription,Human,0.56,KXGVEGMKQFWNSR-LLQZFEROSA-N,1.5918679644712765e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2019,Prescription,Human,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.310977003924136e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
dequalinium,2016,Prescription,Human,158.34,PCSWXVJAIHCTMO-UHFFFAOYSA-P,4.5464970014684004e-11,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2017,Prescription,Human,530.7,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.544743683314071e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2018,Prescription,Human,628.86,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.7876108716739408e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2019,Prescription,Human,663.18,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.9157421618280107e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
desloratadine,2016,Prescription,Human,169054.615,JAUOIFJMECXRGI-UHFFFAOYSA-N,4.854151194782713e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0013483753318840868
desloratadine,2017,Prescription,Human,195117.744,JAUOIFJMECXRGI-UHFFFAOYSA-N,5.6794215667324655e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0015776171018701292
desloratadine,2018,Prescription,Human,215869.1405,JAUOIFJMECXRGI-UHFFFAOYSA-N,6.136342308569623e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0017045395301582287
desloratadine,2019,Prescription,Human,258165.445,JAUOIFJMECXRGI-UHFFFAOYSA-N,7.457680082535517e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0020715778007043104
deslorelin,2016,Prescription,Vet,55.3472,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.5892123205739028e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2017,Prescription,Vet,63.8824,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.859467380345634e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2018,Prescription,Vet,72.9675,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.074189744599247e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2019,Prescription,Vet,80.6896,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.3308976256979624e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
desogestrel,2016,Prescription,Human,3250.642437,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.333735059155252e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4569389107982413
desogestrel,2017,Prescription,Human,3210.205131,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.344156959213623e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4607988737828235
desogestrel,2018,Prescription,Human,3032.343783,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.619805223966676e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.1925204533209914
desogestrel,2019,Prescription,Human,2996.976339,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.657429250917183e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.206455278117475
desonide,2016,Prescription,Human,3116.4700000000003,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.948478912571823e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2017,Prescription,Human,3100.3500000000004,WBGKWQHBNHJJPZ-LECWWXJVSA-N,9.024394344380591e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2018,Prescription,Human,3008.225,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.55124465611001e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2019,Prescription,Human,1222.965,WBGKWQHBNHJJPZ-LECWWXJVSA-N,3.5328049895051015e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desoximetasone,2016,Prescription,Human,4289.125,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2315582892145476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2017,Prescription,Human,4195.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2213211611504476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2018,Prescription,Human,3734.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.0616835471079744e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2019,Prescription,Human,4119.25,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.1899365029268124e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoxycortone,2016,Prescription,Vet,2,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.742701782832385e-13,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2017,Prescription,Vet,7,ZESRJSPZRDMNHY-YFWFAHHUSA-N,2.037536420425569e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2018,Prescription,Vet,20.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.770521371208377e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2019,Prescription,Vet,25.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,7.308464774910081e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
detomidine,2016,Prescription,Vet,573.7252,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.647366364447933e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2017,Prescription,Vet,633.9336000000001,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.8452325687592778e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2018,Prescription,Vet,582.1104,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.6547194599027866e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2019,Prescription,Vet,611.5088,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.7664784681215546e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
dexamethasone,2016,Prescription,Human,6451.2916000000005,UREBDLICKHMUKA-CXSFZGCWSA-N,1.8523921886445795e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2016,Prescription,Vet,701,UREBDLICKHMUKA-CXSFZGCWSA-N,2.012816974882751e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2017,Prescription,Human,7196.3464,UREBDLICKHMUKA-CXSFZGCWSA-N,2.094688269142633e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2017,Prescription,Vet,668.24,UREBDLICKHMUKA-CXSFZGCWSA-N,1.9450904822645463e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2018,Prescription,Human,7540.4134,UREBDLICKHMUKA-CXSFZGCWSA-N,2.143454023273203e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2018,Prescription,Vet,712.9399999999999,UREBDLICKHMUKA-CXSFZGCWSA-N,2.0266184760538424e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2019,Prescription,Human,9675.3578,UREBDLICKHMUKA-CXSFZGCWSA-N,2.794941172567253e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2019,Prescription,Vet,691.5,UREBDLICKHMUKA-CXSFZGCWSA-N,1.9975507477669256e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamfetamine,2016,Prescription,Human,14420.52,KWTSXDURSIMDCE-QMMMGPOBSA-N,4.140637295668503e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2017,Prescription,Human,18878.343,KWTSXDURSIMDCE-QMMMGPOBSA-N,5.4950444885408724e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2018,Prescription,Human,21401.635,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.083674489965575e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2019,Prescription,Human,24003.256,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.933871579413006e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexchlorpheniramine,2016,Prescription,Human,173.3,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.976051094824262e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2017,Prescription,Human,176.75,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.1447794615745616e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2018,Prescription,Human,202.15,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.7463590896047954e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2019,Prescription,Human,167.85,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.8487186263583276e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexketoprofen,2016,Prescription,Human,10.5,DKYWVDODHFEZIM-NSHDSACASA-N,3.0149184359870024e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2017,Prescription,Human,15.5,DKYWVDODHFEZIM-NSHDSACASA-N,4.511687788085189e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2018,Prescription,Human,30.5,DKYWVDODHFEZIM-NSHDSACASA-N,8.669995163638201e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2019,Prescription,Human,35.5,DKYWVDODHFEZIM-NSHDSACASA-N,1.0254960454913355e-11,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexmedetomidine,2016,Prescription,Human,19.5878,CUHVIMMYOGQXCV-NSHDSACASA-N,5.62434469908821e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2016,Prescription,Vet,23.6414,CUHVIMMYOGQXCV-NSHDSACASA-N,6.788275496432678e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2017,Prescription,Human,21.122400000000003,CUHVIMMYOGQXCV-NSHDSACASA-N,6.1482370409710065e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2017,Prescription,Vet,30.2513,CUHVIMMYOGQXCV-NSHDSACASA-N,8.80544650217429e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2018,Prescription,Human,23.33,CUHVIMMYOGQXCV-NSHDSACASA-N,6.631835644841943e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2018,Prescription,Vet,34.6813,CUHVIMMYOGQXCV-NSHDSACASA-N,9.858580435038872e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2019,Prescription,Human,25.4738,CUHVIMMYOGQXCV-NSHDSACASA-N,7.358670750320333e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2019,Prescription,Vet,39.0958,CUHVIMMYOGQXCV-NSHDSACASA-N,1.1293686843752156e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexrazoxane,2017,Prescription,Human,50,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.4553831574468352e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2018,Prescription,Human,60,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.7055728190763675e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2019,Prescription,Human,95,BMKDZUISNHGIBY-ZETCQYMHSA-N,2.744285192159912e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
diatrizoic acid,2016,Prescription,Human,849520,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.439270009275884e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2017,Prescription,Human,785510,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.286436048012127e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2018,Prescription,Human,732970,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.083556181997342e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2019,Prescription,Human,672660,YVPYQUNUQOZFHG-UHFFFAOYSA-N,1.943127239324512e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diazepam,2016,Prescription,Human,110876.03,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.183639875771885e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2017,Prescription,Human,104435.425,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.0398711717160426e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2018,Prescription,Human,97114.912,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.7606092372365562e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2019,Prescription,Human,100692.162,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.9087158857175474e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2019,Prescription,Vet,0.7,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.0221048784336193e-13,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
dibrompropamidine,2016,OTC,Human,4940.7,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4186483349219983e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2017,OTC,Human,5152.6875,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4998269206173676e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2018,OTC,Human,5390.475,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.5323079403184471e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2019,OTC,Human,8406,GMJFVGRUYJHMCO-UHFFFAOYSA-N,2.428259086873286e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dichlorobenzyl alcohol,2016,OTC,Human,3892.752,DBHODFSFBXJZNY-UHFFFAOYSA-N,1.1177456925262164e-9,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2017,OTC,Human,3343.536,DBHODFSFBXJZNY-UHFFFAOYSA-N,9.732251961434322e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2018,OTC,Human,2321.3088,DBHODFSFBXJZNY-UHFFFAOYSA-N,6.598601989937966e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2019,OTC,Human,722.9088,DBHODFSFBXJZNY-UHFFFAOYSA-N,2.0882820159179909e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
diclofenac,2016,OTC,Human,659978.525,DCOPUUMXTXDBNB-UHFFFAOYSA-N,1.895029926074294e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,3.790059852148588
diclofenac,2016,Prescription,Human,1478062.913,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.2440372628117643e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.48807452562353
diclofenac,2017,OTC,Human,784703.18,DCOPUUMXTXDBNB-UHFFFAOYSA-N,2.2840875835339447e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,4.568175167067889
diclofenac,2017,Prescription,Human,1463757.029,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.260654653202037e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.521309306404074
diclofenac,2018,OTC,Human,835605.09,DCOPUUMXTXDBNB-UHFFFAOYSA-N,2.375308881643103e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,4.750617763286207
diclofenac,2018,Prescription,Human,1438068.671,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.087884728704793e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.175769457409586
diclofenac,2019,OTC,Human,800363.28,DCOPUUMXTXDBNB-UHFFFAOYSA-N,2.3120264185816185e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,4.624052837163237
diclofenac,2019,Prescription,Human,1413002.575,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.081770571638237e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.163541143276474
dicloxacillin,2016,Prescription,Human,2807037.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.059989627863681e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2017,Prescription,Human,2699355,YFAGHNZHGGCZAX-JKIFEVAISA-N,7.857191605939803e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2018,Prescription,Human,2868295,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.153476648487749e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2019,Prescription,Human,2968317.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.574641853556979e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dienogest,2016,Prescription,Human,1035.628,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.9736513809755686e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06758298593126293
dienogest,2017,Prescription,Human,994.407,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.89448639889447e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06578378179305615
dienogest,2018,Prescription,Human,959.019,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.7261278989629975e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06195745224915904
dienogest,2019,Prescription,Human,1100.813,AZFLJNIPTRTECV-FUMNGEBKSA-N,3.179941910775926e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.07227140706308922
digoxin,2016,Prescription,Human,582.2961875,LTMHDMANZUZIPE-PUGKRICDSA-N,1.671976677046375e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2017,Prescription,Human,531.9445625,LTMHDMANZUZIPE-PUGKRICDSA-N,1.5483663139158506e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2018,Prescription,Human,481.7478125,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3694266244158302e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2019,Prescription,Human,452.9559375,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3084634441917479e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
dihydrostreptomycin,2016,Prescription,Vet,274265,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.875110522342622e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2017,Prescription,Vet,252650,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.354051094578859e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2018,Prescription,Vet,189635,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.3906050257591166e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2019,Prescription,Vet,179655,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.189732170499885e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
diltiazem,2016,Prescription,Human,293739.3,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.434286008989685e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2017,Prescription,Human,288176.4,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.388141578673244e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2018,Prescription,Human,287198.1,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.163954550839608e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2019,Prescription,Human,263529.6,HSUGRBWQSSZJOP-RTWAWAEBSA-N,7.612635568166577e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
dimethyl fumarate,2016,Prescription,Human,169174.32,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.857588345367282e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.013128617149641303
dimethyl fumarate,2017,Prescription,Human,159363.8184,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.63870834411552e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012537049578690593
dimethyl fumarate,2018,Prescription,Human,158516.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.506014231339342e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.01217841684145768
dimethyl fumarate,2019,Prescription,Human,161051.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.6523190901913344e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012573835378895499
dimethylaminodiphenylbuten,2016,Prescription,Human,9409,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7016540537334955e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2017,Prescription,Human,10666.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.104768889781333e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2018,Prescription,Human,11326,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.2195529581431566e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2019,Prescription,Human,11148.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.220490891031029e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimeticone,2016,OTC,Human,52363,NA,1.503525467272261e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2017,OTC,Human,66244,NA,1.9282080376381627e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2018,OTC,Human,83859,NA,2.3837938505820853e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2019,OTC,Human,75511,NA,2.1813023067914432e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dinoprost,2016,Prescription,Vet,8.5,PXGPLTODNUVGFL-YNNPMVKQSA-N,2.4406482577037636e-12,sex hormone,"prostaglandin for labour and abortion induction in humans, uterine infections in animals",NA,NA,NA,NA
dinoprostone,2016,Prescription,Human,0.1915,XEYBRNLFEZDVAW-ARSRFYASSA-N,5.498636957062009e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dinoprostone,2017,Prescription,Human,0.117,XEYBRNLFEZDVAW-ARSRFYASSA-N,3.4055965884255945e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dipyridamole,2016,Prescription,Human,2103356.67,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.039475049370695e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.25164479372377896
dipyridamole,2017,Prescription,Human,2164230.735,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.299569921095569e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.2624820800456487
dipyridamole,2018,Prescription,Human,1924232.88,IZEKFCXSFNUWAM-UHFFFAOYSA-N,5.469865496168396e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.22791106234034986
dipyridamole,2019,Prescription,Human,1605438.675,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4.637664823919294e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.1932360343299706
disopyramide,2016,Prescription,Human,15559,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.467534851954454e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2017,Prescription,Human,15085.5,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.391036524332846e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2018,Prescription,Human,13962.25,UVTNFZQICZKOEM-UHFFFAOYSA-N,3.968939015524835e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2019,Prescription,Human,14100,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.07309696941629e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disulfiram,2016,Prescription,Human,149374,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.289051680544024e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2017,Prescription,Human,143818,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.1862058987537786e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2018,Prescription,Human,132497.8,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.7664107711236126e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2019,Prescription,Human,104326,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.0136873363923685e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
dobutamine,2016,Prescription,Human,1156.25,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.3199994681999727e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2017,Prescription,Human,1098.75,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.19820448848942e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2018,Prescription,Human,1325,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.7664733087936447e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2019,Prescription,Human,1527.5,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4.412521716867648e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
docetaxel,2016,Prescription,Human,898.46,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.5797939219017925e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2017,Prescription,Human,908.76,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.645187996322772e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2018,Prescription,Human,867.26,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.4652918051202836e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2019,Prescription,Human,995.14,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.8746820696063313e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docusate sodium,2016,OTC,Human,30162.96,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.660844208375097e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2017,OTC,Human,28812.120000000003,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.386534835667422e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2018,OTC,Human,29620.08,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.419867224477923e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2019,OTC,Human,28856.28,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.335774937349496e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
dolutegravir,2016,Prescription,Human,17530.5,RHWKPHLQXYSBKR-BMIGLBTASA-N,5.033621680197156e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,5.298549137049638e-4
dolutegravir,2017,Prescription,Human,21798,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.344888413205222e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,6.678829908637076e-4
dolutegravir,2018,Prescription,Human,23759.85,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.754025724221938e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.109500762338881e-4
dolutegravir,2019,Prescription,Human,25429.35,RHWKPHLQXYSBKR-BMIGLBTASA-N,7.345830384342279e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.732453036149767e-4
donepezil,2016,Prescription,Human,20993.0096,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.027829682846869e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2017,Prescription,Human,21579.606,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2813190233477345e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2018,Prescription,Human,21094.7276,ADEBPBSSDYVVLD-UHFFFAOYSA-N,5.99643233673001e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2019,Prescription,Human,21592.6614,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2375179936150445e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
dopamine,2016,Prescription,Human,1146,VYFYYTLLBUKUHU-UHFFFAOYSA-N,3.2905681215629567e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2017,Prescription,Human,522,VYFYYTLLBUKUHU-UHFFFAOYSA-N,1.5194200163744958e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2018,Prescription,Human,784,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.228615150259787e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2019,Prescription,Human,749,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.1636522199239727e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
doramectin,2016,Prescription,Vet,1018.5,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.9244708829073923e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2017,Prescription,Vet,663,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.929838066774503e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2018,Prescription,Vet,818,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.3252642766741144e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2019,Prescription,Vet,692,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.998995108394378e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doravirine,2019,Prescription,Human,84,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,NNRTI antiviral for used in combination for treatment of HIV,NA,NA,NA,NA
dorzolamide,2016,Prescription,Human,20753.1,IAVUPMFITXYVAF-XPUUQOCRSA-N,5.958943218464939e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2017,Prescription,Human,21312.92,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.203692960802359e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2018,Prescription,Human,21852.98,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.211974783969913e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2019,Prescription,Human,23854.88,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.891009888921225e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
doxazosin,2016,Prescription,Human,20090.384,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.768654200729361e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2017,Prescription,Human,20391.00000000001,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.935343592699686e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2018,Prescription,Human,14713.708,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4.182550072104416e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2019,Prescription,Human,8302.724,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,2.3984255292411272e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxepin,2016,Prescription,Human,22507.01,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.462552322661317e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2017,Prescription,Human,20741.165,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.0372684413651585e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2018,Prescription,Human,18060.3,ODQWQRRAPPTVAG-GZTJUZNOSA-N,5.13385946406082e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2019,Prescription,Human,16463.375,ODQWQRRAPPTVAG-GZTJUZNOSA-N,4.755810128997441e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxorubicin,2016,Prescription,Human,599.3,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.7208005892257238e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2017,Prescription,Human,563.9200000000001,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6414393402948387e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2018,Prescription,Human,574.9,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6342230228116726e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2019,Prescription,Human,677.84,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.9580908154249206e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxycycline,2016,Prescription,Human,340453.015,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.775600681055805e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2016,Prescription,Vet,1170,SGKRLCUYIXIAHR-AKNGSSGZSA-N,3.3594805429569447e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2017,Prescription,Human,315952.585,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.196641415215793e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2017,Prescription,Vet,1239.6,SGKRLCUYIXIAHR-AKNGSSGZSA-N,3.6081859239421925e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2018,Prescription,Human,302663.49,SGKRLCUYIXIAHR-AKNGSSGZSA-N,8.603577031179868e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2018,Prescription,Vet,931.6,SGKRLCUYIXIAHR-AKNGSSGZSA-N,2.6481860637525737e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2019,Prescription,Human,317078.855,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.159524279194945e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2019,Prescription,Vet,1004.4,SGKRLCUYIXIAHR-AKNGSSGZSA-N,2.9014316284267525e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxylamine,2016,Prescription,Human,1619.26275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,4.6494715406495356e-10,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2017,Prescription,Human,7104.46275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.0679430858116852e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2018,Prescription,Human,9141.454,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.598569244872822e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2019,Prescription,Human,11257.61175,HCFDWZZGGLSKEP-UHFFFAOYSA-N,3.252010234169519e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
dronedarone,2016,Prescription,Human,449262,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.2899888441794218e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.32249721104485546
dronedarone,2017,Prescription,Human,519206,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.5112873352906828e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.3778218338226707
dronedarone,2018,Prescription,Human,585632.8,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.664732309399311e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4161830773498278
dronedarone,2019,Prescription,Human,675602.7999999999,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.951628168233447e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4879070420583618
droperidol,2016,Prescription,Human,35.725,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0257901059584348e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2017,Prescription,Human,37.6,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0944481344000199e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2018,Prescription,Human,37.55,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0674043226052932e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2019,Prescription,Human,36.7,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0601607005501975e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
drospirenone,2016,Prescription,Human,37983.771,METQSPRSQINEEU-HXCATZOESA-N,1.0906473472019854e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.47419449878347186
drospirenone,2017,Prescription,Human,35234.64,METQSPRSQINEEU-HXCATZOESA-N,1.025598032294051e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.4459121879539352
drospirenone,2018,Prescription,Human,34171.074,METQSPRSQINEEU-HXCATZOESA-N,9.713542502174529e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.4223279348771534
drospirenone,2019,Prescription,Human,33596.514,METQSPRSQINEEU-HXCATZOESA-N,9.705096408251912e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.421960713402257
duloxetine,2016,Prescription,Human,71834.2884,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.0626144803158793e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.04796777861199719
duloxetine,2017,Prescription,Human,78300.54119999999,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.27914577762904e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.05300339017741953
duloxetine,2018,Prescription,Human,88763.8248,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.5232194482689467e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.0586795220527662
duloxetine,2019,Prescription,Human,103103.28,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.9783663638643915e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.06926433404335794
dutasteride,2016,Prescription,Human,3128.1749999999997,JWJOTENAMICLJG-QWBYCMEYSA-N,8.982088074755847e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002138592398751392
dutasteride,2017,Prescription,Human,3410.16,JWJOTENAMICLJG-QWBYCMEYSA-N,9.926178856397798e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.0023633759181899516
dutasteride,2018,Prescription,Human,3810.36,JWJOTENAMICLJG-QWBYCMEYSA-N,1.083141074482638e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002578907320196757
dutasteride,2019,Prescription,Human,4359,JWJOTENAMICLJG-QWBYCMEYSA-N,1.2591935950131636e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.00299807998812658
dydrogesterone,2019,Prescription,Human,82.11,JGMOKGBVKVMRFX-HQZYFCCVSA-N,2.3719290224026353e-11,sex hormone,progestin for various reproductive and gynaecological disordered,NA,NA,NA,NA
ebastine,2016,OTC,Human,1712.9,MJJALKDDGIKVBE-UHFFFAOYSA-N,4.918336941906795e-10,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2016,Prescription,Human,32977.13,MJJALKDDGIKVBE-UHFFFAOYSA-N,9.468891162184769e-9,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2017,OTC,Human,1411.9,MJJALKDDGIKVBE-UHFFFAOYSA-N,4.1097109599983724e-10,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2017,Prescription,Human,36360.45,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0583677305437557e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2018,OTC,Human,92.4,MJJALKDDGIKVBE-UHFFFAOYSA-N,2.6265821413776058e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2018,Prescription,Human,38118.13000000001,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0835541073669913e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2019,Prescription,Human,42561.2,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.2294744307426991e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
econazole,2016,OTC,Human,11350.8,LEZWWPYKPKIXLL-UHFFFAOYSA-N,3.259212969828692e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.01629606484914346
econazole,2016,Prescription,Human,3740.2794,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.0739654589335624e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.0053698272946678125
econazole,2017,OTC,Human,12144.9,LEZWWPYKPKIXLL-UHFFFAOYSA-N,3.535096581775213e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.017675482908876067
econazole,2017,Prescription,Human,3978.2457,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.157974357593059e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.005789871787965295
econazole,2018,OTC,Human,12261.3,LEZWWPYKPKIXLL-UHFFFAOYSA-N,3.4854233344235103e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.017427116672117552
econazole,2018,Prescription,Human,3951.8622,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.123364792175889e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.005616823960879445
econazole,2019,OTC,Human,17028.9,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.919174537765466e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.024595872688827333
econazole,2019,Prescription,Human,4475.9286,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.292971008225794e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.00646485504112897
edoxaban,2016,Prescription,Human,130.05,HGVDHZBSSITLCT-JLJPHGGASA-N,3.734191834286759e-11,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,1.6095654458132582e-7
edoxaban,2017,Prescription,Human,5286.4800000000005,HGVDHZBSSITLCT-JLJPHGGASA-N,1.538770790835909e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,6.632632719120298e-6
edoxaban,2018,Prescription,Human,21279.33,HGVDHZBSSITLCT-JLJPHGGASA-N,6.048907809359386e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,2.6072878488618042e-5
edoxaban,2019,Prescription,Human,40912.29,HGVDHZBSSITLCT-JLJPHGGASA-N,1.1818420170984423e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,5.094146625424321e-5
efavirenz,2016,Prescription,Human,137592,XPOQHMRABVBWPR-ZDUSSCGKSA-N,3.950749118517368e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.015195188917374492
efavirenz,2017,Prescription,Human,87066,XPOQHMRABVBWPR-ZDUSSCGKSA-N,2.5342877997253232e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.00974726076817432
efavirenz,2018,Prescription,Human,62352,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.7724312735841613e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.006817043359939081
efavirenz,2019,Prescription,Human,64836,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.8729313128303163e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.0072035819724242936
eflornithine,2016,Prescription,Human,5385.45,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.5463516658177332e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2017,Prescription,Human,6365.25,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8527755285876934e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2018,Prescription,Human,6444.6,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8319557649699262e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2019,Prescription,Human,7903.95,VLCYCQAOQCDTCN-UHFFFAOYSA-N,2.283230836270772e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
elbasvir,2017,Prescription,Human,4765.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.3871547950257275e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2018,Prescription,Human,3778.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.0741129090269935e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2019,Prescription,Human,861,BVAZQCUMNICBAQ-PZHYSIFUSA-N,2.4871890004733516e-10,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
eletriptan,2016,Prescription,Human,36486.6,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0476583143474606e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2017,Prescription,Human,36664.8,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0672266478231344e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2018,Prescription,Human,37340,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.061434817738526e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2019,Prescription,Human,37276.2,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0768055124209611e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eliglustat,2016,Prescription,Human,70.56,FJZZPCZKBUKGGU-AUSIDOKSSA-N,2.0260251889832654e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2017,Prescription,Human,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.916914264336375e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2018,Prescription,Human,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.872036726218221e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2019,Prescription,Human,56.448,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.6306253739688706e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eltrombopag,2016,Prescription,Human,1215.55,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,3.490270576060953e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2017,Prescription,Human,1726.9,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.026602349189878e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2018,Prescription,Human,2057.3,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.848124934476351e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2019,Prescription,Human,2347.8,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,6.782139762266361e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eluxadoline,2017,Prescription,Human,1661.8,QFNHIDANIVGXPE-FNZWTVRRSA-N,4.8371114620903e-10,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2018,Prescription,Human,8265.6,QFNHIDANIVGXPE-FNZWTVRRSA-N,2.349597115559604e-9,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2019,Prescription,Human,316.4,QFNHIDANIVGXPE-FNZWTVRRSA-N,9.13991405051996e-11,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
elvitegravir,2016,Prescription,Human,25407,JUZYLCPPVHEVSV-LJQANCHMSA-N,7.29524120982112e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2017,Prescription,Human,43587,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.2687157136727041e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2018,Prescription,Human,47475,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.3495344930941758e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2019,Prescription,Human,33624,JUZYLCPPVHEVSV-LJQANCHMSA-N,9.713036347493145e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
emedastine,2016,Prescription,Human,31.7375,KBUZBQVCBVDWKX-UHFFFAOYSA-N,9.112949891632142e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2017,Prescription,Human,30.6275,KBUZBQVCBVDWKX-UHFFFAOYSA-N,8.914949530940588e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2018,Prescription,Human,39.182500000000005,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1138101163909964e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2019,Prescription,Human,38.427499999999995,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1100633602286842e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emodepside,2016,Prescription,Vet,2393.946124,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,6.873859337149738e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2017,Prescription,Vet,2639.01194,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.681547059554194e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2018,Prescription,Vet,2740.303384,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.789644946288983e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2019,Prescription,Vet,2591.797656,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.486980977300601e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
empagliflozin,2016,Prescription,Human,19498.119,OBWASQILIWPZMG-QZMOQZSNSA-N,5.5985941371589e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,2.3327475571495418e-5
empagliflozin,2017,Prescription,Human,44557.269,OBWASQILIWPZMG-QZMOQZSNSA-N,1.2969579768885596e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,5.403991570368998e-5
empagliflozin,2018,Prescription,Human,68882.715,OBWASQILIWPZMG-QZMOQZSNSA-N,1.958074773469733e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,8.15864488945722e-5
empagliflozin,2019,Prescription,Human,96535.977,OBWASQILIWPZMG-QZMOQZSNSA-N,2.7886552862293668e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,1.1619397025955695e-4
emtricitabine,2016,Prescription,Human,185142,XQSPYNMVSIKCOC-NTSWFWBYSA-N,5.316076467385768e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,8.714879454730768e-5
emtricitabine,2017,Prescription,Human,208338,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.064232325123176e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,9.941364467415043e-5
emtricitabine,2018,Prescription,Human,222060,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.312325003401636e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.0348073776068256e-4
emtricitabine,2019,Prescription,Human,248202,XQSPYNMVSIKCOC-NTSWFWBYSA-N,7.169863929099732e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.175387529360612e-4
enalapril,2016,Prescription,Human,318584.1288,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.147668222209313e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2017,Prescription,Human,313478.8807,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.124637663721314e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2018,Prescription,Human,305892.9873,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.695379411415875e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2019,Prescription,Human,307256.2993,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.875778024914148e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
encorafenib,2019,Prescription,Human,126.35,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,3.6498993055726825e-11,antineoplastic,small molecule BRAF inhibitor for melanomas,NA,NA,NA,NA
enoxaparin,2016,Prescription,Human,100177.6,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.876450410599348e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2017,Prescription,Human,95914.2,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.7918382247997445e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2018,Prescription,Human,90336.4,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.5679218068868392e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2019,Prescription,Human,101000.1,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.917611356175477e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enrofloxacin,2016,Prescription,Vet,18469.15,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.3031410316199375e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2017,Prescription,Vet,18206.94,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.299614764929015e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2018,Prescription,Vet,18346.29,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.215155592482095e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2019,Prescription,Vet,12959.97,SPFYMRJSYKOXGV-UHFFFAOYSA-N,3.743774080193336e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
entacapone,2016,Prescription,Human,28821,JRURYQJSLYLRLN-BJMVGYQFSA-N,8.275520404150609e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2017,Prescription,Human,31330.2,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.119489079888166e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2018,Prescription,Human,32387,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.20639781523772e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2019,Prescription,Human,33673,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.72719108164218e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entecavir,2016,Prescription,Human,52.455,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.5061671100923637e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2017,Prescription,Human,63.5925,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.8510290687987572e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2018,Prescription,Human,63.141,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.7948595561550154e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2019,Prescription,Human,57.366,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.6571438350889002e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
enzalutamide,2016,Prescription,Human,26960.64,WXCXUHSOUPDCQV-UHFFFAOYSA-N,7.741345769715105e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2017,Prescription,Human,33116.16,WXCXUHSOUPDCQV-UHFFFAOYSA-N,9.639340300662918e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2018,Prescription,Human,37022.72,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.0524157486712504e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2019,Prescription,Human,40185.6,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.160849968611172e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
ephedrine,2016,Prescription,Human,18558.75,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.328868335607026e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2017,Prescription,Human,17555.5,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.109995804111582e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2018,Prescription,Human,15878.85,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.51375582636513e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2019,Prescription,Human,15576.15,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.499515557459117e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
epinephrine,2016,Prescription,Human,271.69765,UCTWMZQNUQWSLP-VIFPVBQESA-N,7.801392895231848e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2017,Prescription,Human,291.7274,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.491502890515115e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2018,Prescription,Human,306.95865000000003,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.725672167006269e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2019,Prescription,Human,324.8584,UCTWMZQNUQWSLP-VIFPVBQESA-N,9.384253649144859e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epirubicin,2016,Prescription,Human,1315.33,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.7767739680064606e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2017,Prescription,Human,1127.27,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.281219543790187e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2018,Prescription,Human,1006.18,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8601887651637655e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2019,Prescription,Human,988.13,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8544321336094456e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
eplerenone,2016,Prescription,Human,15919.925,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.571169084002893e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2017,Prescription,Human,17031.66,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.9575182214721925e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2018,Prescription,Human,23322.025,JUKPWJGBANNWMW-VWBFHTRKSA-N,6.629568654303253e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2019,Prescription,Human,31719.375,JUKPWJGBANNWMW-VWBFHTRKSA-N,9.162843275480769e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
epoprostenol,2016,Prescription,Human,0.524,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.504587867102085e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2017,Prescription,Human,0.495,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.440829325872367e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2018,Prescription,Human,0.4785,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.3601943232134034e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2019,Prescription,Human,0.528,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.52524482258993e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
eprinomectin,2016,Prescription,Vet,4106.3564,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.1790790109612587e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2017,Prescription,Vet,5427.3816,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.579783953935371e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2018,Prescription,Vet,5763.41,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.638319240198821e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2019,Prescription,Vet,5112.176,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.4767651470016094e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprosartan,2016,Prescription,Human,462785.4,OROAFUQRIXKEMV-LDADJPATSA-N,1.3288192708243993e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2017,Prescription,Human,420487.62,OROAFUQRIXKEMV-LDADJPATSA-N,1.22394120012581e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2018,Prescription,Human,382502.232,OROAFUQRIXKEMV-LDADJPATSA-N,1.0873090168920713e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2019,Prescription,Human,333412.464,OROAFUQRIXKEMV-LDADJPATSA-N,9.631356714071049e-8,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eribulin,2016,Prescription,Human,1.826,UFNVPOGXISZXJD-JBQZKEIOSA-N,5.243086727725968e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2017,Prescription,Human,1.51976,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.423666214722804e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2018,Prescription,Human,1.41328,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.017419922907082e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2019,Prescription,Human,1.19416,UFNVPOGXISZXJD-JBQZKEIOSA-N,3.4495953737575586e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
erlotinib,2016,Prescription,Human,2868,AAKJLRGGTJKAMG-UHFFFAOYSA-N,8.23503435658164e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,5.924485148619885e-4
erlotinib,2017,Prescription,Human,3227.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,9.393770589740595e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,6.758108337942874e-4
erlotinib,2018,Prescription,Human,2084.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,5.924733580266531e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,4.2623982591845545e-4
erlotinib,2019,Prescription,Human,1297.5,AAKJLRGGTJKAMG-UHFFFAOYSA-N,3.748115828239459e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,2.696486207366517e-4
ertapenem,2016,Prescription,Human,3578,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.0273693489487138e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,7.902841145759337e-5
ertapenem,2017,Prescription,Human,4296,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2504652088783204e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.61896314521785e-5
ertapenem,2018,Prescription,Human,4515,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2834435463549666e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.872642664268974e-5
ertapenem,2019,Prescription,Human,4674,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.3501883145426768e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,1.038606395802059e-4
ertugliflozin,2018,Prescription,Human,68.39,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.9440687516105464e-11,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
ertugliflozin,2019,Prescription,Human,560.28,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.6184927446982687e-10,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
erythromycin,2016,Prescription,Human,1270675,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.6485537939502707e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2017,Prescription,Human,1150366,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.348446602598972e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2018,Prescription,Human,864442.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.457282719424038e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2019,Prescription,Human,867991.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.507385495127021e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythropoietin,2016,Prescription,Human,1012.9224,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.9084556361754294e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2017,Prescription,Human,948.5448,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.7609922520075536e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2018,Prescription,Human,1127.196,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.2041914322860087e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2019,Prescription,Human,1287.3504,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.7187964629906733e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
escitalopram,2016,Prescription,Human,396431.7842,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.1382947569483817e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2017,Prescription,Human,389371.3374,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.133368972889018e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2018,Prescription,Human,374910.2026,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0657277519149569e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2019,Prescription,Human,372772.82579999993,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0768367851395225e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
esketamine,2016,Prescription,Human,450.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.294261414305849e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2017,Prescription,Human,615.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.7908489752383303e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2018,Prescription,Human,814.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,2.314604446554887e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2019,Prescription,Human,1047.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,3.0266576948268923e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
eslicarbazepine,2016,Prescription,Human,150333.6,BMPDWHIDQYTSHX-AWEZNQCLSA-N,4.316605163698053e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2017,Prescription,Human,180806.64,BMPDWHIDQYTSHX-AWEZNQCLSA-N,5.2628587722110654e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2018,Prescription,Human,239031.12,BMPDWHIDQYTSHX-AWEZNQCLSA-N,6.794749686423025e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2019,Prescription,Human,301821.68,BMPDWHIDQYTSHX-AWEZNQCLSA-N,8.718787022071867e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
esmolol,2016,Prescription,Human,89,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5555022933604115e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2017,Prescription,Human,86,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5032590308085564e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2018,Prescription,Human,136.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,3.880178163398736e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2019,Prescription,Human,142.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4.1164277882398677e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esomeprazole,2016,Prescription,Human,1635560.512,SUBDBMMJDZJVOS-DEOSSOPVSA-N,4.696268134096325e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.004696268134096324
esomeprazole,2017,Prescription,Human,1758601.6008,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.118878300926725e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005118878300926725
esomeprazole,2018,Prescription,Human,1831296.4908,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.205682530630692e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005205682530630692
esomeprazole,2019,Prescription,Human,1967701.7156,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.684141769167089e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005684141769167089
estradiol,2016,Prescription,Human,16764.89485500001,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.8137895786403016e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.034473946600754
estradiol,2017,Prescription,Human,16335.55707,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.754898925437914e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.887247313594786
estradiol,2018,Prescription,Human,16243.17705,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.617320211987509e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.543300529968773
estradiol,2019,Prescription,Human,16651.18926,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.810064433481069e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.025161083702672
estriol,2016,OTC,Human,1073.595,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3.082667960269967e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2016,Prescription,Human,2045.7432,PROQIPRRNZUXQM-ZXXIGWHRSA-N,5.874046560928613e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2016,Prescription,Vet,69.57,PROQIPRRNZUXQM-ZXXIGWHRSA-N,1.997598815158245e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,OTC,Human,1049.8425,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3.055846184943757e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,Prescription,Human,1834.4844,PROQIPRRNZUXQM-ZXXIGWHRSA-N,5.339755396717926e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,Prescription,Vet,79.71,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.3201718296017443e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,OTC,Human,1013.085,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.87981706568997e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,Prescription,Human,1613.0562,PROQIPRRNZUXQM-ZXXIGWHRSA-N,4.5853080172710216e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,Prescription,Vet,85.92,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.4423802769173582e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,OTC,Human,991.86,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.8652070638902417e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,Prescription,Human,1431.418799999999,PROQIPRRNZUXQM-ZXXIGWHRSA-N,4.13496991223085e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,Prescription,Vet,96.15,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.7775054865913217e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
ethambutol,2016,Prescription,Human,10609.5,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.046359728248009e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2017,Prescription,Human,11253,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.275485334149847e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2018,Prescription,Human,9966,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.8329564524858467e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2019,Prescription,Human,8679,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.507121177132197e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethinylestradiol,2016,Prescription,Human,2284.45398675,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.559468991253887e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.741339975011105
ethinylestradiol,2017,Prescription,Human,2211.705453,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.437757731059046e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.393593517311558
ethinylestradiol,2018,Prescription,Human,2102.425479,BFPYWIDHMRZLRN-SLHNCBLASA-N,5.976399585193354e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.075427386266725
ethinylestradiol,2019,Prescription,Human,2094.9751485,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.051799239970065e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.290854971343045
ethylmorphine,2016,Prescription,Human,168526.865,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.838997640453264e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2017,Prescription,Human,165954.01750000002,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.830533639602747e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2018,Prescription,Human,163302.13,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.642061237087925e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2019,Prescription,Human,161539.45,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.6664244272069105e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
etonogestrel,2016,Prescription,Human,3305.33,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.490762241924683e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.5150971266387714
etonogestrel,2017,Prescription,Human,3368.545,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.805047316203499e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.6314990060012957
etonogestrel,2018,Prescription,Human,3550.718,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0093346848342003e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.738276610497038
etonogestrel,2019,Prescription,Human,3539.2419999999997,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0223883591653083e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.7866235524641048
etoposide,2016,Prescription,Human,3659.2,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0506847181870131e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2017,Prescription,Human,3609.8,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0507284243503171e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2018,Prescription,Human,3554.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0103529118071891e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2019,Prescription,Human,3086.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,8.915460409013827e-10,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoricoxib,2016,Prescription,Human,393101.82,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.1287332612743277e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0015049776816991036
etoricoxib,2017,Prescription,Human,442147.1478,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.286987024042553e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0017159826987234042
etoricoxib,2018,Prescription,Human,475405.017,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.3513964584128973e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.00180186194455053
etoricoxib,2019,Prescription,Human,530281.7112,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.5318360502309253e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.002042448066974567
etravirine,2016,Prescription,Human,3480,PYGWGZALEOIKDF-UHFFFAOYSA-N,9.99230110212835e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0020392451228833366
etravirine,2017,Prescription,Human,2556,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.43991870086822e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0015183507552792286
etravirine,2018,Prescription,Human,2508,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.129294383739217e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0014549580374977995
etravirine,2019,Prescription,Human,2280,PYGWGZALEOIKDF-UHFFFAOYSA-N,6.586284461183787e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.001344139685955875
everolimus,2016,Prescription,Human,802.059,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.30299282461838e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.16449948747274143
everolimus,2017,Prescription,Human,689.892,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0081143945146237e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14343674246533028
everolimus,2018,Prescription,Human,706.9499999999999,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0095911740767302e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14354222671976644
everolimus,2019,Prescription,Human,764.208,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.2075838927685703e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.1576845637691836
exemestane,2016,Prescription,Human,7017.25,BFYIZQONLCFLEV-DAELLWKTSA-N,2.0148987042790278e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2017,Prescription,Human,6853,BFYIZQONLCFLEV-DAELLWKTSA-N,1.9947481555966323e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2018,Prescription,Human,7102.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.01897182458165e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2019,Prescription,Human,7537.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.177373645884772e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
ezetimibe,2016,Prescription,Human,125693.8396,OLNTVTPDXPETLC-XPWALMASSA-N,3.60911118380984e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.007218222367619679
ezetimibe,2017,Prescription,Human,145311.6734,OLNTVTPDXPETLC-XPWALMASSA-N,4.229683240935505e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.00845936648187101
ezetimibe,2018,Prescription,Human,181550.2022,OLNTVTPDXPETLC-XPWALMASSA-N,5.1607848361689764e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.010321569672337952
ezetimibe,2019,Prescription,Human,206958.4234,OLNTVTPDXPETLC-XPWALMASSA-N,5.978451965572435e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.01195690393114487
famotidine,2016,OTC,Human,35431.3512,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0173584185220018e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2017,OTC,Human,35443.1328,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0316667704854297e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2018,OTC,Human,32979.636,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.374861790772076e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2019,OTC,Human,32563.0032,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.406543946738508e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
fampridine,2016,Prescription,Human,10753.12,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.0875980697505288e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2017,Prescription,Human,10847.76,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.157529440005096e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2018,Prescription,Human,11444.16,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.2531413721935e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2019,Prescription,Human,11673.2,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.372062095275904e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
febantel,2016,Prescription,Vet,9568.5,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.747452100451584e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2017,Prescription,Vet,9452.1,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.7512854285006462e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2018,Prescription,Vet,6800.0999999999995,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.933010954500201e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2019,Prescription,Vet,5323.8,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.5378974216864144e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febuxostat,2017,Prescription,Human,1906.24,BQSJTQLCZDPROO-UHFFFAOYSA-N,5.54861918010291e-10,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2018,Prescription,Human,8012.48,BQSJTQLCZDPROO-UHFFFAOYSA-N,2.2776446835655022e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2019,Prescription,Human,11303.04,BQSJTQLCZDPROO-UHFFFAOYSA-N,3.2651331893043335e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
felbamate,2016,Prescription,Human,12748.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.6606278244486747e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2017,Prescription,Human,11507.4,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.3495352292007413e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2018,Prescription,Human,13672.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.886659340111226e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2019,Prescription,Human,13081.2,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.778794047966552e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felodipine,2016,Prescription,Human,33237.5734,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.543673601060114e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.19087347202120228
felodipine,2017,Prescription,Human,32285.259199999997,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.397484494697096e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.18794968989394192
felodipine,2018,Prescription,Human,32900.6745,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.352416026079829e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.1870483205215966
felodipine,2019,Prescription,Human,34789.8125,RZTAMFZIAATZDJ-UHFFFAOYSA-N,1.004980708229156e-8,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.2009961416458312
felypressin,2016,Prescription,Human,0.2567052,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.370907048511722e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2017,Prescription,Human,0.2695356,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.845551451446542e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2018,Prescription,Human,0.28032480000000004,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.968572656550318e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2019,Prescription,Human,0.27459,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.932139693844107e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
fenbendazole,2016,Prescription,Vet,847857.125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.4344953116623203e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2017,Prescription,Vet,907688.6125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.6420694376775737e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2018,Prescription,Vet,823748.175,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.341604161739605e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2019,Prescription,Vet,813966.575,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.3513225459848633e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fentanyl,2016,Prescription,Human,7604.661799999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.183565243834866e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.967175895346726e-4
fentanyl,2016,Prescription,Vet,34.1385,PJMPHNIQZUBGLI-UHFFFAOYSA-N,9.80236124066117e-12,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,8.830956072667721e-7
fentanyl,2017,Prescription,Human,7559.500399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.200393912174522e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9823368578148848e-4
fentanyl,2017,Prescription,Vet,14.763,PJMPHNIQZUBGLI-UHFFFAOYSA-N,4.2971643106775255e-12,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,3.871319198808581e-7
fentanyl,2018,Prescription,Human,7407.0344,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.1055394237672713e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.8968823637542984e-4
fentanyl,2018,Prescription,Vet,0.33799999999999997,PJMPHNIQZUBGLI-UHFFFAOYSA-N,9.608060214130205e-14,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,8.655910102820004e-9
fentanyl,2019,Prescription,Human,7367.005899999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.128122652834179e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9172276151659272e-4
fentanyl,2019,Prescription,Vet,0.3515,PJMPHNIQZUBGLI-UHFFFAOYSA-N,1.0153855210991673e-13,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,9.147617307199705e-9
fesoterodine,2016,Prescription,Human,14490.68992,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.160785541902763e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2017,Prescription,Human,13885.55616,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.04176091340923e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2018,Prescription,Human,13299.2664,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.780477880915936e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2019,Prescription,Human,12869.67024,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.7176889965908515e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fexofenadine,2016,OTC,Human,129518.4,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.71892773294799e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,1.8594638664739947e-4
fexofenadine,2016,Prescription,Human,1047457.68,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.007618543188737e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0015038092715943686
fexofenadine,2017,OTC,Human,128352,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.7360267804923234e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,1.8680133902461616e-4
fexofenadine,2017,Prescription,Human,1152328.6800000002,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.3541595054298877e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0016770797527149437
fexofenadine,2018,OTC,Human,121611.6,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.4569573240731274e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,1.7284786620365636e-4
fexofenadine,2018,Prescription,Human,1223734.74,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.478614517172476e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.001739307258586238
fexofenadine,2019,OTC,Human,141428.4,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4.085472251272304e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,2.042736125636152e-4
fexofenadine,2019,Prescription,Human,1397175.3,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4.036049985938508e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.002018024992969254
fidaxomicin,2016,Prescription,Human,212,ZVGNESXIJDCBKN-UUEYKCAUSA-N,6.087263889802327e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2017,Prescription,Human,284,ZVGNESXIJDCBKN-UUEYKCAUSA-N,8.266576334298023e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2018,Prescription,Human,276,ZVGNESXIJDCBKN-UUEYKCAUSA-N,7.845634967751289e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2019,Prescription,Human,352,ZVGNESXIJDCBKN-UUEYKCAUSA-N,1.0168298817266201e-10,antibacterial,macrolide antibiotic,NA,NA,NA,NA
finasteride,2016,Prescription,Human,24501.47,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.03523177255071e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407046354510142
finasteride,2017,Prescription,Human,24178.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.0377730483351405e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407554609667028
finasteride,2018,Prescription,Human,24142.09,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.862682083282563e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0013725364166565124
finasteride,2019,Prescription,Human,21924.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.333353805546802e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0012666707611093603
fingolimod,2016,Prescription,Human,207.1825,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.948936560608354e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.930510620989337e-5
fingolimod,2017,Prescription,Human,215.565,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.27459340670054e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.090932712660364e-5
fingolimod,2018,Prescription,Human,216.0795,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.142322032660199e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.0257744003252214e-5
fingolimod,2019,Prescription,Human,204.3895,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.904242929294403e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.9084940538396075e-5
firocoxib,2016,Prescription,Vet,50877.425952,FULAPETWGIGNMT-UHFFFAOYSA-N,1.4608694236023652e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2017,Prescription,Vet,64354.385976000005,FULAPETWGIGNMT-UHFFFAOYSA-N,1.8732057891460643e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2018,Prescription,Vet,73775.904472,FULAPETWGIGNMT-UHFFFAOYSA-N,2.097169622836964e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2019,Prescription,Vet,88211.24,FULAPETWGIGNMT-UHFFFAOYSA-N,2.5481768390954117e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
flecainide,2016,Prescription,Human,444214.9499999999,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.2754969926628992e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2017,Prescription,Human,454880.21,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.324049992579759e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2018,Prescription,Human,452896.64,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.287413665058358e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2019,Prescription,Human,460916.9,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.331460445775001e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
florfenicol,2016,Prescription,Vet,17160,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.927238129670187e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2017,Prescription,Vet,17930,AYIRNRDRBQJXIF-NXEZZACHSA-N,5.219004002604351e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2018,Prescription,Vet,16690,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.7443350583974295e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2019,Prescription,Vet,13650,AYIRNRDRBQJXIF-NXEZZACHSA-N,3.943104512945557e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
flubendazole,2016,Prescription,Vet,250,CPEUVMUXAHMANV-UHFFFAOYSA-N,7.178377228540482e-11,anthelminthic,"imidazole anthelmintic for human, veterinary infections",NA,NA,NA,NA
fluconazole,2016,OTC,Human,8535.9,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.4509564074039473e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2016,Prescription,Human,75710.72,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.1739204336176176e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2017,OTC,Human,8902.5,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.5913097118340893e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2017,Prescription,Human,72238.825,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.102703384374987e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2018,OTC,Human,9445.2,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.684912731790018e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2018,Prescription,Human,71045.101,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.0195432199022546e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2019,OTC,Human,9142.05,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.640883414840581e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2019,Prescription,Human,71737.762,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.0723039786872845e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fludarabine,2016,Prescription,Human,96.65,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.7751606365537495e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2017,Prescription,Human,87.45,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5454651423745147e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2018,Prescription,Human,89.9,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5555166072494243e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2019,Prescription,Human,81.4,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.351419101492809e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludrocortisone,2016,Prescription,Human,77.24,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.2178314285298668e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2017,Prescription,Human,80.97,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.356847485169405e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2018,Prescription,Human,80.31,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.282909218333718e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2019,Prescription,Human,82.49,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.382906163171275e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
flumazenil,2016,Prescription,Human,7.015,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.014252650328459e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2017,Prescription,Human,6.9399999999999995,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.020071822536207e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2018,Prescription,Human,7.92,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.2513561211808053e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2019,Prescription,Human,7.4,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.137653728629826e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flunixin,2016,Prescription,Vet,19223.8,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.5198275266406615e-09,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2017,Prescription,Vet,19617,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.710050279926913e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2018,Prescription,Vet,16167.95,NOOCSNJCXJYGPE-UHFFFAOYSA-N,4.59593601003096e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2019,Prescription,Vet,6154.15,NOOCSNJCXJYGPE-UHFFFAOYSA-N,1.7777623910874652e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
fluocinolone acetonide,2016,Prescription,Human,197.62,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.67436363161668e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2017,Prescription,Human,202.68375,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.899650320763299e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2018,Prescription,Human,184.275,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.238240520588294e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2019,Prescription,Human,228.4431875,FEBLZLNTKCEFIT-VSXGLTOVSA-N,6.599086912695372e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2016,Prescription,Human,21.3,WJOHZNCJWYWUJD-IUGZLZTKSA-N,6.1159773987164904e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2017,Prescription,Human,16.9,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.919195072170302e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2018,Prescription,Human,17.1,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.860882534367648e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2019,Prescription,Human,19,WJOHZNCJWYWUJD-IUGZLZTKSA-N,5.4885703843198235e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluorescein,2016,OTC,Human,971.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,2.7892302559216897e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,2.7892302559216894e-5
fluorescein,2016,Prescription,Human,3048,GNBHRKFJIUUOQI-UHFFFAOYSA-N,8.751877517036556e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,8.751877517036554e-5
fluorescein,2017,OTC,Human,1022.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,2.9753853270843097e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,2.9753853270843096e-5
fluorescein,2017,Prescription,Human,2868,GNBHRKFJIUUOQI-UHFFFAOYSA-N,8.348077791115045e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,8.348077791115045e-5
fluorescein,2018,OTC,Human,1034.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,2.9398390158146325e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,2.9398390158146322e-5
fluorescein,2018,Prescription,Human,2544,GNBHRKFJIUUOQI-UHFFFAOYSA-N,7.231628752883799e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,7.231628752883798e-5
fluorescein,2019,OTC,Human,1107.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,3.198969917681986e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,3.1989699176819856e-5
fluorescein,2019,Prescription,Human,1650,GNBHRKFJIUUOQI-UHFFFAOYSA-N,4.76639007059353e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,4.76639007059353e-5
fluoxetine,2016,Prescription,Human,96105.48,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.7595255566798107e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08623517364624408
fluoxetine,2017,Prescription,Human,90741.92,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.641285240847762e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08254016377649256
fluoxetine,2018,Prescription,Human,88383.38,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5124048431016308e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07851265134692596
fluoxetine,2019,Prescription,Human,87378.72,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5241276569040754e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07887898927825235
flupentixol,2016,Prescription,Human,2253.712499999999,NJMYODHXAKYRHW-DVZOWYKESA-N,6.471199395870812e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2017,Prescription,Human,2129.6025,NJMYODHXAKYRHW-DVZOWYKESA-N,6.198775221113346e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2018,Prescription,Human,1947.4855,NJMYODHXAKYRHW-DVZOWYKESA-N,5.535963890575582e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2019,Prescription,Human,1965.812,NJMYODHXAKYRHW-DVZOWYKESA-N,5.678682907547641e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flurbiprofen,2016,OTC,Human,3806.18,SYTBZMRGLBWNTM-UHFFFAOYSA-N,1.0928878335890484e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2017,OTC,Human,7265.44,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.1147998014881067e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2018,OTC,Human,8077.02,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.295990961856034e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2019,OTC,Human,10417.54,SYTBZMRGLBWNTM-UHFFFAOYSA-N,3.009336922182481e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flutamide,2016,Prescription,Human,14427,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.142497931046141e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2017,Prescription,Human,13860,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.034322112442627e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2018,Prescription,Human,11466,MKXKFYHWDHIYRV-UHFFFAOYSA-N,3.259349657254938e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2019,Prescription,Human,8505,MKXKFYHWDHIYRV-UHFFFAOYSA-N,2.456857427296847e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
fluticasone,2016,Prescription,Human,17882.717,MGNNYOODZCAHBA-GQKYHHCASA-N,5.134755539889351e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08853026792912673
fluticasone,2017,Prescription,Human,17071.5354,MGNNYOODZCAHBA-GQKYHHCASA-N,4.969125018583484e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08567456928592214
fluticasone,2018,Prescription,Human,16322.98,MGNNYOODZCAHBA-GQKYHHCASA-N,4.640005169054528e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08000008912162979
fluticasone,2019,Prescription,Human,15177.8022,MGNNYOODZCAHBA-GQKYHHCASA-N,4.384443981788646e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.07559386175497665
fluticasone furoate,2016,Prescription,Human,1262.8347,XTULMSXFIHGYFS-VLSRWLAYSA-N,3.6260415415563003e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.006251795761303965
fluticasone furoate,2017,Prescription,Human,1501.49244,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.3704936164195046e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.0075353338214129385
fluticasone furoate,2018,Prescription,Human,1645.16016,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.676567419872213e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.008063047275641746
fluticasone furoate,2019,Prescription,Human,1907.83512,XTULMSXFIHGYFS-VLSRWLAYSA-N,5.511203861998557e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.009502075624135442
fluvastatin,2016,Prescription,Human,146666.31,FJLGEFLZQAZZCD-MCBHFWOFSA-N,4.2113043995922366e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0022164759997853876
fluvastatin,2017,Prescription,Human,135773.68839999998,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.9520547864358945e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.00208002883496626
fluvastatin,2018,Prescription,Human,133801.1248,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8034593603454146e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020018207159712706
fluvastatin,2019,Prescription,Human,133494.1104,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8562727411713746e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020296172321954604
fluvoxamine,2016,Prescription,Human,18077.03999999999,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.190552491816614e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2017,Prescription,Human,17547.885000000002,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.107779255562791e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2018,Prescription,Human,16008.705,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.55066868610199e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2019,Prescription,Human,15773.355,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.556482584966474e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fomepizole,2016,Prescription,Human,3.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.0049728119956673e-12,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2017,Prescription,Human,62,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.8046751152340755e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2018,Prescription,Human,126.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.5959160268860076e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2019,Prescription,Human,132.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.827555662749351e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
formoterol,2016,Prescription,Human,396.45546,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.1383627384778168e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.211024189870018e-6
formoterol,2017,Prescription,Human,409.81806,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.192884604283073e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.2690261747692265e-6
formoterol,2018,Prescription,Human,431.31168,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.22605579659694e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3043146772307874e-6
formoterol,2019,Prescription,Human,453.85374,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.311056945356205e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3947414312300055e-6
fosfomycin,2017,Prescription,Human,1240,YMDXZJFXQJVXBF-STHAYSLISA-N,3.609350230468151e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2018,Prescription,Human,1320,YMDXZJFXQJVXBF-STHAYSLISA-N,3.7522602019680086e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2019,Prescription,Human,500,YMDXZJFXQJVXBF-STHAYSLISA-N,1.4443606274525851e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosphenytoin,2016,Prescription,Human,1890,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.426853184776604e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2017,Prescription,Human,2225,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.476455050638416e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2018,Prescription,Human,1840,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.230423311834193e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2019,Prescription,Human,2205,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.3696303670659e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
frovatriptan,2016,Prescription,Human,14.49,XPSQPHWEGNHMSK-SECBINFHSA-N,4.160587441662063e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2017,Prescription,Human,13.265,XPSQPHWEGNHMSK-SECBINFHSA-N,3.8611315167064535e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2018,Prescription,Human,11.145,XPSQPHWEGNHMSK-SECBINFHSA-N,3.1681015114343525e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2019,Prescription,Human,12.255,XPSQPHWEGNHMSK-SECBINFHSA-N,3.540127897886287e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
fulvestrant,2016,Prescription,Human,3410,VWUXBMIQPBEWFH-WCCTWKNTSA-N,9.791306539729215e-10,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,1.7177730771454764
fulvestrant,2017,Prescription,Human,4920,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4320970269276854e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.512450924434536
fulvestrant,2018,Prescription,Human,5496.25,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.5623757678080807e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.7410101189615452
fulvestrant,2019,Prescription,Human,5082.5,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4681925778055527e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.575776452290443
furosemide,2016,Prescription,Human,910025.21,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.6130016979447076e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001840142040806132
furosemide,2017,Prescription,Human,856371.59,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.492697577203933e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001755420829016854
furosemide,2017,Prescription,Vet,48.5,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,1.41172166272343e-11,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,9.941701850164999e-8
furosemide,2018,Prescription,Human,838894.93,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.3846606511149533e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0016793384867006711
furosemide,2018,Prescription,Vet,651.5,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,1.8519678193804224e-10,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,1.3042026897045227e-6
furosemide,2019,Prescription,Human,874731.6799999999,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.526855996354908e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001779476053771062
furosemide,2019,Prescription,Vet,713.5,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.0611026153748388e-10,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,1.4514807150527033e-6
fusidic acid,2016,Prescription,Human,44554.85,IECPWNUMDGFDKC-MZJAQBGESA-N,1.2793260826441476e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0029751769363817386
fusidic acid,2016,Prescription,Vet,1261,IECPWNUMDGFDKC-MZJAQBGESA-N,3.620773474075819e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,8.420403428083298e-5
fusidic acid,2017,Prescription,Human,41795.05,IECPWNUMDGFDKC-MZJAQBGESA-N,1.216556236692967e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0028292005504487604
fusidic acid,2017,Prescription,Vet,1249,IECPWNUMDGFDKC-MZJAQBGESA-N,3.6355471273021936e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,8.454760761167891e-5
fusidic acid,2018,Prescription,Human,38300.05,IECPWNUMDGFDKC-MZJAQBGESA-N,1.0887254041544306e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0025319195445451873
fusidic acid,2018,Prescription,Vet,1212.15,IECPWNUMDGFDKC-MZJAQBGESA-N,3.445683487739032e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,8.013217413346585e-5
fusidic acid,2019,Prescription,Human,32566.15,IECPWNUMDGFDKC-MZJAQBGESA-N,9.407452969543e-9,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.002187779760358837
fusidic acid,2019,Prescription,Vet,1160.1,IECPWNUMDGFDKC-MZJAQBGESA-N,3.3512055278154876e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,7.793501227477877e-5
gabapentin,2016,Prescription,Human,9489062.7,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.724642864234914e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2017,Prescription,Human,10268756.8,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.988995138927531e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2018,Prescription,Human,11241014.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.195394798340554e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2019,Prescription,Human,12516304.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.615611484201523e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gadobenic acid,2016,Prescription,Human,27758.74,MXZROTBGJUUXID-UHFFFAOYSA-K,7.970508284359032e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.245916622144574e-5
gadobenic acid,2017,Prescription,Human,9260.15,MXZROTBGJUUXID-UHFFFAOYSA-K,2.6954132690862613e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.4503756991693283e-5
gadobenic acid,2018,Prescription,Human,1103.87,MXZROTBGJUUXID-UHFFFAOYSA-K,3.1378844463230494e-10,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.852622223930045e-6
gadobenic acid,2019,Prescription,Human,295.59000000000003,MXZROTBGJUUXID-UHFFFAOYSA-K,8.538771157374194e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.76251923397654e-7
gadobutrol,2016,Prescription,Human,24717.93,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,7.097385033946305e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,7.097385033946304e-5
gadobutrol,2017,Prescription,Human,27529.878,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,8.013304153553233e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,8.013304153553232e-5
gadobutrol,2018,Prescription,Human,33539.282999999996,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,9.533948242685014e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,9.533948242685014e-5
gadobutrol,2019,Prescription,Human,35852.337,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,1.0356740792992308e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.0356740792992307e-4
gadodiamide,2016,Prescription,Human,54.43456,HZHFFEYYPYZMNU-UHFFFAOYSA-K,1.563007223798482e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2017,Prescription,Human,11.966728,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.4832348761894896e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2018,Prescription,Human,1.079816,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.0695080320062783e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadopentetic acid,2016,Prescription,Human,4.7376,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3603311983173353e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.801655991586676e-9
gadopentetic acid,2017,Prescription,Human,4.7752,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3899491306880253e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.949745653440126e-9
gadopentetic acid,2018,Prescription,Human,2.5192,IZOOGPBRAOKZFK-UHFFFAOYSA-K,7.161131743028642e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,3.580565871514321e-9
gadoteric acid,2016,Prescription,Human,108961.9125,GFSTXYOTEVLASN-UHFFFAOYSA-K,3.1286788458728824e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2017,Prescription,Human,142024.05,GFSTXYOTEVLASN-UHFFFAOYSA-K,4.133988206447743e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2018,Prescription,Human,319547.13,GFSTXYOTEVLASN-UHFFFAOYSA-K,9.083514989031043e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2019,Prescription,Human,385126.77,GFSTXYOTEVLASN-UHFFFAOYSA-K,1.112523886331975e-7,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteridol,2016,Prescription,Human,42593.25,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.2230016635581276e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2017,Prescription,Human,58862.475,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.7133490944127083e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2018,Prescription,Human,30038.715,DPNNNPAKRZOSMO-UHFFFAOYSA-K,8.538869303996928e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2019,Prescription,Human,6940.6050000000005,DPNNNPAKRZOSMO-UHFFFAOYSA-K,2.00494731854011e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoxetic acid,2016,Prescription,Human,6676.624,PCZHWPSNPWAQNF-LMOVPXPDSA-K,1.917093027405074e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.917093027405074e-5
gadoxetic acid,2017,Prescription,Human,6966.912,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.027905276842849e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.027905276842849e-5
gadoxetic acid,2018,Prescription,Human,7266.2715,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.0655258610715444e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.0655258610715445e-5
gadoxetic acid,2019,Prescription,Human,8001.063,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.3112840749935326e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.3112840749935324e-5
galantamine,2016,Prescription,Human,1093.11776,ASUTZQLVASHGKV-JDFRZJQESA-N,3.138724654598872e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,7.133465124088344e-4
galantamine,2017,Prescription,Human,925.65984,ASUTZQLVASHGKV-JDFRZJQESA-N,2.6943794813218644e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,6.123589730276964e-4
galantamine,2018,Prescription,Human,764.51872,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1732372475117604e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.939175562526728e-4
galantamine,2019,Prescription,Human,746.7734399999999,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1572203087266508e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.902773428924206e-4
gamithromycin,2016,Prescription,Vet,1867.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,5.36224778971974e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2017,Prescription,Vet,4732.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.3775201585234294e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2018,Prescription,Vet,3067.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,8.719741037527928e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2019,Prescription,Vet,4057.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.1720986491777726e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
ganciclovir,2016,Prescription,Human,2415,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.934312402770105e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2017,Prescription,Human,2742.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,7.982776618595891e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2018,Prescription,Human,1800,IRSCQMHQWWYFCW-UHFFFAOYSA-N,5.116718457229103e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2019,Prescription,Human,2387.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.896821996086095e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
gefitinib,2016,Prescription,Human,2130,XGALLCVXEZPNRQ-UHFFFAOYSA-N,6.115977398716491e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.9112429370989035e-4
gefitinib,2017,Prescription,Human,1815,XGALLCVXEZPNRQ-UHFFFAOYSA-N,5.283040861532012e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.6509502692287536e-4
gefitinib,2018,Prescription,Human,4035,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.1469977208288571e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,3.5843678775901786e-4
gefitinib,2019,Prescription,Human,4710,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.360587711060335e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,4.251836597063547e-4
gemcitabine,2016,Prescription,Human,12382.2742,SDUQYLNIPVEERB-QPPQHZFASA-N,3.555385406192972e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,6.584047048505503e-4
gemcitabine,2017,Prescription,Human,14020.49296,SDUQYLNIPVEERB-QPPQHZFASA-N,4.081037862617184e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.557477523365156e-4
gemcitabine,2018,Prescription,Human,14185.31396,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0323476533734255e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.467310469210047e-4
gemcitabine,2019,Prescription,Human,14058.91928,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0612298945132105e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.52079610095039e-4
gentamicin,2016,Prescription,Human,26079.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,7.488253416742118e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2017,Prescription,Human,32411.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,9.434142918528172e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2018,Prescription,Human,35897.6,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.0204328471679302e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2019,Prescription,Human,39705.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.1469725517026077e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
glecaprevir,2017,Prescription,Human,8.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,2.445043704510683e-12,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2018,Prescription,Human,663.6,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.8863635378984627e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2019,Prescription,Human,512.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.4801807710134094e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glibenclamide,2016,Prescription,Human,1259.04625,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.6151635722717145e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,6.342392232055639e-6
glibenclamide,2017,Prescription,Human,1163.73775,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.387368642070151e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,5.942752003631843e-6
glibenclamide,2018,Prescription,Human,968.8315,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.7540211211083096e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.831616001944402e-6
glibenclamide,2019,Prescription,Human,841.27225,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.4302010297368963e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.263510578485783e-6
glimepiride,2016,Prescription,Human,26242.2288,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.535064705762769e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0024306660341170223
glimepiride,2017,Prescription,Human,24436.9377,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.1130215096315215e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0022945230676230713
glimepiride,2018,Prescription,Human,21204.7452,WIGIZIANZCJQQY-UHFFFAOYSA-N,6.027706174760012e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0019444213466967783
glimepiride,2019,Prescription,Human,19094.0382,WIGIZIANZCJQQY-UHFFFAOYSA-N,5.515735399031126e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0017792694835584279
glipizide,2016,Prescription,Human,7067.205,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,2.0292425376570974e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2017,Prescription,Human,6028.63,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.7547933128957426e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2018,Prescription,Human,5159.665,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.4666973965899443e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2019,Prescription,Human,4390.65,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.2683363977849384e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glycerol phenylbutyrate,2019,Prescription,Human,0.006215,ZSDBFLMJVAGKOU-UHFFFAOYSA-N,1.7953402599235634e-15,metabolic,treatment for hyperammonaemia from inborn urea cycle disorders,NA,NA,NA,NA
glyceryl trinitrate,2016,Prescription,Human,14910.57,SNIOPGDIGTZGOP-UHFFFAOYSA-N,4.2813478461023535e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.010703369615255883
glyceryl trinitrate,2017,Prescription,Human,12876.8725,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.748156671418064e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.00937039167854516
glyceryl trinitrate,2018,Prescription,Human,11425.0175,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.2476998842453053e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008119249710613263
glyceryl trinitrate,2019,Prescription,Human,11939.82375,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.449082264644655e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008622705661611638
glycopyrronium bromide,2016,Prescription,Human,160.46486,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.607509188019745e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.3962149054605287e-6
glycopyrronium bromide,2017,Prescription,Human,162.98399,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.7440830795896675e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.43760093320899e-6
glycopyrronium bromide,2018,Prescription,Human,180.48884,ANGKOCUUWGHLCE-UHFFFAOYSA-N,5.1306143275103894e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.5547316143970876e-6
glycopyrronium bromide,2019,Prescription,Human,210.60877,ANGKOCUUWGHLCE-UHFFFAOYSA-N,6.083900303684343e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.843606152631619e-6
grapiprant,2019,Prescription,Vet,5966.4,HZVLFTCYCLXTGV-UHFFFAOYSA-N,1.7235266495266206e-9,analgesic,analgesic and anti-inflammatory small molecule used for pain relief in dogs,NA,NA,NA,NA
grazoprevir,2017,Prescription,Human,9531.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.774309590051455e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2018,Prescription,Human,7557.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.148225818053987e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2019,Prescription,Human,1722,OBMNJSNZOWALQB-NCQNOWPTSA-N,4.974378000946702e-10,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
guanfacine,2016,Prescription,Human,30.436,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.739243573114325e-12,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2017,Prescription,Human,224.224,INJOMKTZOLKMBF-UHFFFAOYSA-N,6.526636661907183e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2018,Prescription,Human,310.576,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.8284997309577e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2019,Prescription,Human,411.46,INJOMKTZOLKMBF-UHFFFAOYSA-N,1.1885932475432814e-10,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
haloperidol,2016,Prescription,Human,2485.3250000000003,LNEPOXFFQSENCJ-UHFFFAOYSA-N,7.13624015420895e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,5.097314395863536e-4
haloperidol,2017,Prescription,Human,2278.565,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.632370248295694e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.73740732021121e-4
haloperidol,2018,Prescription,Human,2117.817,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.020151851629759e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.300108465449828e-4
haloperidol,2019,Prescription,Human,2022.669,LNEPOXFFQSENCJ-UHFFFAOYSA-N,5.842926931937785e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.173519237098418e-4
hexaminolevulinate,2016,Prescription,Human,146.965,RYQOILLJDKPETL-UHFFFAOYSA-N,4.219880837569808e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2017,Prescription,Human,159.545,RYQOILLJDKPETL-UHFFFAOYSA-N,4.6439821170971056e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2018,Prescription,Human,152.915,RYQOILLJDKPETL-UHFFFAOYSA-N,4.346794460484379e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2019,Prescription,Human,157.165,RYQOILLJDKPETL-UHFFFAOYSA-N,4.540058760271711e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hyaluronic acid,2016,Prescription,Vet,83.367,KIUKXJAPPMFGSW-MNSSHETKSA-N,2.3937590976469373e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2017,Prescription,Vet,122.815,KIUKXJAPPMFGSW-MNSSHETKSA-N,3.574857649636661e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2018,Prescription,Vet,144.586,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.110032526982928e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2019,Prescription,Vet,154.713,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.469227315101436e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hydralazine,2016,Prescription,Human,6614.35,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992119768638694e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2017,Prescription,Human,6524.85,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992313589733966e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2018,Prescription,Human,6598.325,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.875653961905345e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2019,Prescription,Human,7004.025,RPTUSVTUFVMDQK-UHFFFAOYSA-N,2.0232675887387187e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydrochlorothiazide,2016,Prescription,Human,1370138.17798,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.9341474787062307e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.9341474787062304e-4
hydrochlorothiazide,2017,Prescription,Human,1344980.24186,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.91492318220363e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.91492318220363e-4
hydrochlorothiazide,2018,Prescription,Human,1305368.66112,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.710668845467304e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.710668845467304e-4
hydrochlorothiazide,2019,Prescription,Human,1274101.87638,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.680525171213466e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.680525171213466e-4
hydrocodone,2016,Prescription,Human,133.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.8289464137034926e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2017,Prescription,Human,112.25,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.267335188468145e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2018,Prescription,Human,67.65,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.9230333535086045e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2019,Prescription,Human,55.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.5989072145900118e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocortisone,2016,OTC,Human,68937.65,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.9794418277963747e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2016,Prescription,Human,100827.2289,JYGXADMDTFJGBT-VWUMJDOOSA-N,2.895103535810395e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2016,Prescription,Vet,31.2798,JYGXADMDTFJGBT-VWUMJDOOSA-N,8.981528161332023e-12,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,OTC,Human,67050.5,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.9516833679677804e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,Prescription,Human,105709.01878,JYGXADMDTFJGBT-VWUMJDOOSA-N,3.0769425104528646e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,Prescription,Vet,30.1587,JYGXADMDTFJGBT-VWUMJDOOSA-N,8.778492806098373e-12,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,OTC,Human,66646.68000000001,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.8945127648280097e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,Prescription,Human,106135.98397,JYGXADMDTFJGBT-VWUMJDOOSA-N,3.017044156419284e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,Prescription,Vet,32.6895,JYGXADMDTFJGBT-VWUMJDOOSA-N,9.29238711153282e-12,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,OTC,Human,69407.56,JYGXADMDTFJGBT-VWUMJDOOSA-N,2.0049909382310592e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,Prescription,Human,115914.77487,JYGXADMDTFJGBT-VWUMJDOOSA-N,3.3484547392451676e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,Prescription,Vet,37.9731,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.0969370108463951e-11,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone aceponate,2016,Prescription,Vet,211.844832,MFBMYAOAMQLLPK-FZNHGJLXSA-N,6.082808472051136e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2017,Prescription,Vet,240.605664,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.003468619438246e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2018,Prescription,Vet,256.53952,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.29244720551497e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2019,Prescription,Vet,275.802176,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.967156079602967e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydromorphone,2016,Prescription,Human,2001.73168,WVLOADHCBXTIJK-YNHQPCIGSA-N,5.747674043744033e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2017,Prescription,Human,1683.50176,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.900280214072207e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2018,Prescription,Human,1407.76,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.001728652971579e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2019,Prescription,Human,1406.8,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.0638530614005936e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydroxycarbamide,2016,Prescription,Human,451650,VSNHCAURESNICA-UHFFFAOYSA-N,1.2968456301081234e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2017,Prescription,Human,473350,VSNHCAURESNICA-UHFFFAOYSA-N,1.377811235154919e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2018,Prescription,Human,509900,VSNHCAURESNICA-UHFFFAOYSA-N,1.4494526340783996e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2019,Prescription,Human,547400,VSNHCAURESNICA-UHFFFAOYSA-N,1.5812860149350906e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxychloroquine,2016,Prescription,Human,573923.8,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.647936614734969e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2017,Prescription,Human,572213.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.6655800718040404e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2018,Prescription,Human,566380.4,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.610005025829335e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2019,Prescription,Human,565996.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.63500640862406e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxyzine,2016,Prescription,Human,167392.595,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.806428768697197e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2017,Prescription,Human,150496.77,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.380609286163002e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2018,Prescription,Human,147143.27,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1827260303669184e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2019,Prescription,Human,143352.105,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1410427264889787e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hyoscyamine,2016,Prescription,Human,150.3642,RKUNBYITZUJHSG-VFSICIBPSA-N,4.3174837970708273e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2017,Prescription,Human,161.3546,RKUNBYITZUJHSG-VFSICIBPSA-N,4.6966553443314215e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2018,Prescription,Human,166.2378,RKUNBYITZUJHSG-VFSICIBPSA-N,4.7255112197175556e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2019,Prescription,Human,182.076,RKUNBYITZUJHSG-VFSICIBPSA-N,5.259668112081138e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
ibandronic acid,2016,Prescription,Human,369.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0621126947348496e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2017,Prescription,Human,351.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0242986662110824e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2018,Prescription,Human,306.45,MPBVHIBUJCELCL-UHFFFAOYSA-N,8.711213173432547e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2019,Prescription,Human,258.75,MPBVHIBUJCELCL-UHFFFAOYSA-N,7.474566247067129e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibrutinib,2016,Prescription,Human,10386.6,XYFPWWZEPKGCCK-GOSISDBHSA-N,2.982357316878343e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0019241014947602212
ibrutinib,2017,Prescription,Human,14044.8,XYFPWWZEPKGCCK-GOSISDBHSA-N,4.0881130739418615e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.002637492305768943
ibrutinib,2018,Prescription,Human,19324.199999999997,XYFPWWZEPKGCCK-GOSISDBHSA-N,5.493138378399256e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0035439602441285525
ibrutinib,2019,Prescription,Human,22408.4,XYFPWWZEPKGCCK-GOSISDBHSA-N,6.473162136841701e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0041762336366720654
ibuprofen,2016,OTC,Human,21759223,HEFNNWSXXWATRW-UHFFFAOYSA-N,6.247836435757372e-6,analgesic,NSAID for many minor pains,low,low,1e-6,6.247836435757372
ibuprofen,2016,Prescription,Human,17459917.08,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.01335484717108e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.0133548471710805
ibuprofen,2017,OTC,Human,21844919.85,HEFNNWSXXWATRW-UHFFFAOYSA-N,6.358545685093209e-6,analgesic,NSAID for many minor pains,low,low,1e-6,6.358545685093209
ibuprofen,2017,Prescription,Human,18112489.64,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.272122472297258e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.272122472297258
ibuprofen,2018,OTC,Human,20575823.65,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.848927591258115e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.848927591258116
ibuprofen,2018,Prescription,Human,17436985.8,HEFNNWSXXWATRW-UHFFFAOYSA-N,4.956674837850099e-6,analgesic,NSAID for many minor pains,low,low,1e-6,4.956674837850099
ibuprofen,2019,OTC,Human,20877430.85,HEFNNWSXXWATRW-UHFFFAOYSA-N,6.030907824420792e-6,analgesic,NSAID for many minor pains,low,low,1e-6,6.030907824420792
ibuprofen,2019,Prescription,Human,17736528.2,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.123588599956494e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.123588599956495
ibutilide,2016,Prescription,Human,0.33408,ALOBUEHUHMBRLE-UHFFFAOYSA-N,9.592609058043216e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2017,Prescription,Human,0.2262,ALOBUEHUHMBRLE-UHFFFAOYSA-N,6.584153404289482e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2018,Prescription,Human,0.20532,ALOBUEHUHMBRLE-UHFFFAOYSA-N,5.83647018687933e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2019,Prescription,Human,0.15399,ALOBUEHUHMBRLE-UHFFFAOYSA-N,4.4483418604284714e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
icatibant,2016,Prescription,Human,43.26,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.2421463956266448e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2017,Prescription,Human,47.28,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3762103136817271e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2018,Prescription,Human,46.11,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3107327114601884e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2019,Prescription,Human,48.03,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3874528187309534e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
idarubicin,2016,Prescription,Human,5.855,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.681175946924181e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2017,Prescription,Human,5.95,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.7319059573617337e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2018,Prescription,Human,5.125,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.4568434496277306e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2019,Prescription,Human,4.675,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.3504771866681672e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idebenone,2017,Prescription,Human,2430,JGPMMRGNQUBGND-UHFFFAOYSA-N,7.073162145191619e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2018,Prescription,Human,1890,JGPMMRGNQUBGND-UHFFFAOYSA-N,5.372554380090558e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2019,Prescription,Human,2376,JGPMMRGNQUBGND-UHFFFAOYSA-N,6.863601701654684e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idelalisib,2016,Prescription,Human,1251,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.5920599651616565e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2017,Prescription,Human,978,IFSDAJWBUCMOAH-HNNXBMFYSA-N,2.8467294559660096e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2018,Prescription,Human,1401,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9825125325433184e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2019,Prescription,Human,1368,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9517706767102734e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
ifosfamide,2016,Prescription,Human,11382,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.26817158460991e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2017,Prescription,Human,10942.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.1851060400723987e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2018,Prescription,Human,10785.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.065909273358027e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2019,Prescription,Human,11104.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.207780517509446e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
iloprost,2016,Prescription,Human,0.22312,HIFJCPQKFCZDDL-ACWOEMLNSA-N,6.406558108927811e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2017,Prescription,Human,0.10449,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0414597224323963e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2018,Prescription,Human,0.10188,HIFJCPQKFCZDDL-ACWOEMLNSA-N,2.8960626467916725e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2019,Prescription,Human,0.10397,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0034034887249056e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
imatinib,2016,Prescription,Human,62640,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.7986141983831033e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.873556456649066e-4
imatinib,2017,Prescription,Human,62232,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8114280930846287e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8869042636298215e-4
imatinib,2018,Prescription,Human,63588,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8075660736571344e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8828813267261817e-4
imatinib,2019,Prescription,Human,68550,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.9802184202374945e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,2.0627275210807235e-4
imepitoin,2016,Prescription,Vet,57400,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6481554116728947e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2017,Prescription,Vet,60530,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.7618868504051385e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2018,Prescription,Vet,57240,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6271164693988546e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2019,Prescription,Vet,63500,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.8343379968647833e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imidacloprid,2016,Prescription,Vet,1438919.32,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.1316422721579817e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2017,Prescription,Vet,1373892.38,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.9990796599930937e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2018,Prescription,Vet,1254248.23,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.565352815771074e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2019,Prescription,Vet,1391246.68,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.018923855332252e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imipenem,2016,Prescription,Human,8080,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.320051520264283e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2017,Prescription,Human,8565,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.493071348706428e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2018,Prescription,Human,7635,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.1703414122746773e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2019,Prescription,Human,7800,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.253202578826033e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imiquimod,2016,Prescription,Human,2332.6499999999996,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.697856656861981e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2017,Prescription,Human,2716.05,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.905786849566952e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2018,Prescription,Human,2518.2375,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.158395719964706e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2019,Prescription,Human,2211.3,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.387829310971804e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
indacaterol,2016,Prescription,Human,462.6642000000001,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.3284712630963598e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.3284712630963596e-6
indacaterol,2017,Prescription,Human,419.40825,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.2207994062885028e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.2207994062885028e-6
indacaterol,2018,Prescription,Human,377.676,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.0735898666958103e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.0735898666958103e-6
indacaterol,2019,Prescription,Human,330.53625,QZZUEBNBZAPZLX-QFIPXVFZSA-N,9.548270908916491e-11,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,9.54827090891649e-7
ingenol mebutate,2016,Prescription,Human,1.582302,VDJHFHXMUKFKET-WDUFCVPESA-N,4.543344258189625e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2017,Prescription,Human,1.6694165,VDJHFHXMUKFKET-WDUFCVPESA-N,4.859281313727689e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2018,Prescription,Human,1.4774685,VDJHFHXMUKFKET-WDUFCVPESA-N,4.199883524402553e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2019,Prescription,Human,1.5530915,VDJHFHXMUKFKET-WDUFCVPESA-N,4.4864484268625544e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
iodixanol,2016,Prescription,Human,1870054,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.369581219896417e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.369581219896416e-4
iodixanol,2017,Prescription,Human,1640141,NBQNWMBBSKPBAY-UHFFFAOYSA-N,4.77406717447602e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,4.774067174476019e-4
iodixanol,2018,Prescription,Human,1766954,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.022781191597107e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.022781191597106e-4
iodixanol,2019,Prescription,Human,1825304,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.272794461463427e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.272794461463427e-4
iohexol,2016,Prescription,Human,11716927,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.3643408786108454e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2017,Prescription,Human,12923588,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.761754461796406e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2018,Prescription,Human,15893883,NTHXOOBQLCIOLC-UHFFFAOYSA-N,4.518029139063326e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2019,Prescription,Human,17866262,NTHXOOBQLCIOLC-UHFFFAOYSA-N,5.161065078510456e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iomeprol,2016,Prescription,Human,3157700,NJKDOADNQSYQEV-UHFFFAOYSA-N,9.066864709824912e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,9.066864709824912e-4
iomeprol,2017,Prescription,Human,3951115,NJKDOADNQSYQEV-UHFFFAOYSA-N,1.1500772448271104e-6,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,0.0011500772448271104
iomeprol,2018,Prescription,Human,1280985,NJKDOADNQSYQEV-UHFFFAOYSA-N,3.641355329407568e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,3.6413553294075676e-4
iomeprol,2019,Prescription,Human,715315,NJKDOADNQSYQEV-UHFFFAOYSA-N,2.066345644452492e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,2.066345644452492e-4
ipratropium bromide,2016,Prescription,Human,3013.797,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.653668702497446e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2017,Prescription,Human,3072.089,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.94213317755538e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2018,Prescription,Human,2951.438,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.389820716648526e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2019,Prescription,Human,2945.5260000000003,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.508803563075807e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
irbesartan,2016,Prescription,Human,3025751.303,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.687993701072755e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012340900143569256
irbesartan,2017,Prescription,Human,2907397.66675,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.462755192376352e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012020959080080045
irbesartan,2018,Prescription,Human,2783303.261,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.911877315347028e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0011238462095663393
irbesartan,2019,Prescription,Human,2669838.14,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.712418182174487e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0010955139463316034
irinotecan,2016,Prescription,Human,3416.08,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.808764353149027e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2017,Prescription,Human,3671.28,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.068623815654283e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2018,Prescription,Human,3442.8199999999997,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.786633688287496e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2019,Prescription,Human,3573.76,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.03235964719299e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
isavuconazole,2017,Prescription,Human,89.2,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.596403552885154e-11,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2018,Prescription,Human,355.6,DDFOUSQFMYRUQK-RCDICMHDSA-N,1.0108361574392606e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2019,Prescription,Human,774.4,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.2370257397985638e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isoniazid,2016,Prescription,Human,6652,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.910022612970051e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2017,Prescription,Human,5565,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.6198414542383272e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2018,Prescription,Human,5374.5,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.527766852687656e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2019,Prescription,Human,5328,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.5391106846134748e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoprenaline,2016,Prescription,Human,6.9,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.981232115077173e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2017,Prescription,Human,8.89,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.587671253940473e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2018,Prescription,Human,8.21,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.3337921407694967e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2019,Prescription,Human,6.6,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.9065560282374125e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isosorbide dinitrate,2016,Prescription,Human,8179.22,MOYKHGMNXAOIAT-JGWLITMVSA-N,2.348541063808915e-9,cardiac,nitrate for angina,NA,NA,NA,NA
isosorbide mononitrate,2016,Prescription,Human,384007.5385,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.1026203879825129e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2017,Prescription,Human,375319.61719999986,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0924676990645467e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2018,Prescription,Human,355909.5727,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0117161554103408e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2019,Prescription,Human,330703.8683,YWXYYJSYQOXTPL-SLPGGIOYSA-N,9.553112934375701e-8,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isotretinoin,2016,Prescription,Human,66031.8,SHGAZHPCJJPHSC-XFYACQKRSA-N,1.8960046779181575e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2017,Prescription,Human,71597.4,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.0840330015396805e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2018,Prescription,Human,80914.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.300084336621817e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2019,Prescription,Human,88999.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.5709388070955626e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isradipine,2016,Prescription,Human,665.265,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.9102092507779935e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2017,Prescription,Human,629.785,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.83315696362531e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2018,Prescription,Human,212.305,HMJIYCCIJYRONP-UHFFFAOYSA-N,6.03502728923347e-11,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
itraconazole,2016,Prescription,Human,979.2,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.811626792874736e-10,antifungal,azole antifungal,high,high,0.001,2.811626792874736e-7
itraconazole,2016,Prescription,Vet,143.38,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4.116942908112537e-11,antifungal,azole antifungal,high,high,0.001,4.1169429081125365e-8
itraconazole,2017,Prescription,Human,787.6,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.2925195496102548e-10,antifungal,azole antifungal,high,high,0.001,2.2925195496102546e-7
itraconazole,2017,Prescription,Vet,147.5,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4.293380314468163e-11,antifungal,azole antifungal,high,high,0.001,4.293380314468163e-8
itraconazole,2018,Prescription,Human,882.8,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.5094661411343616e-10,antifungal,azole antifungal,high,high,0.001,2.5094661411343614e-7
itraconazole,2018,Prescription,Vet,53.56,VHVPQPYKVGDNFY-ZPGVKDDISA-N,1.5225080031621708e-11,antifungal,azole antifungal,high,high,0.001,1.5225080031621707e-8
itraconazole,2019,Prescription,Human,865.2,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.4993216297439537e-10,antifungal,azole antifungal,high,high,0.001,2.499321629743954e-7
itraconazole,2019,Prescription,Vet,97.76,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.8240138987952948e-11,antifungal,azole antifungal,high,high,0.001,2.8240138987952946e-8
ivabradine,2016,Prescription,Human,252.77,ACRHBAYQBXXRTO-OAQYLSRUSA-N,7.257913648232709e-11,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2017,Prescription,Human,358.8172,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.0444330189644651e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2018,Prescription,Human,415.38,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.1807680626465693e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2019,Prescription,Human,567,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.6379049515312314e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivacaftor,2016,Prescription,Human,1848,PURKAOJPTOLRMP-UHFFFAOYSA-N,5.306256447337124e-10,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2017,Prescription,Human,4300.8,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.2518623767094694e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2018,Prescription,Human,5390,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.5321729158036032e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2019,Prescription,Human,6815.2,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.9687213096429715e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivermectin,2016,Prescription,Human,2397,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.882628086724613e-10,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2016,Prescription,Vet,21872.320855,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.280310798434522e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2017,Prescription,Human,4034.1,AZSNMRSAGSSBNP-XPNPUAGNSA-N,1.1742322390912555e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2017,Prescription,Vet,21223.830293,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.177761028988425e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2018,Prescription,Human,5319.6,AZSNMRSAGSSBNP-XPNPUAGNSA-N,1.5121608613931074e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2018,Prescription,Vet,21035.707825,AZSNMRSAGSSBNP-XPNPUAGNSA-N,5.979655249392009e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2019,Prescription,Human,6941.7,AZSNMRSAGSSBNP-XPNPUAGNSA-N,2.0052636335175223e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2019,Prescription,Vet,20507.764439,AZSNMRSAGSSBNP-XPNPUAGNSA-N,5.924121502552771e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ixazomib,2017,Prescription,Human,0.012,MXAYKZJJDUDWDS-LBPRGKRZSA-N,3.4929195778724047e-15,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2018,Prescription,Human,0.24,MXAYKZJJDUDWDS-LBPRGKRZSA-N,6.822291276305471e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2019,Prescription,Human,0.192,MXAYKZJJDUDWDS-LBPRGKRZSA-N,5.546344809417927e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ketamine,2016,Prescription,Human,9954.5,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.858286244860249e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2017,Prescription,Human,10247.3,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.9827495658609903e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2017,Prescription,Vet,950,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.765227999148987e-10,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2018,Prescription,Human,10124.7,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.8780688535504166e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2018,Prescription,Vet,2530,YQEZLKZALYSWHR-UHFFFAOYSA-N,7.191832053772016e-10,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2019,Prescription,Human,11634.2,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.3607960823817732e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2019,Prescription,Vet,130,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.7553376313767216e-11,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketobemidone,2016,Prescription,Human,11949.92,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.4312413444352184e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2017,Prescription,Human,9811.485,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.8558940037084523e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2018,Prescription,Human,9591.935,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7266239363912132e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2019,Prescription,Human,9099.27,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.628525465312097e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketoconazole,2016,OTC,Human,163146,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.6844941253098624e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2016,Prescription,Human,11966.4,XMAYWYJOQHXEEK-OZXSUGGESA-N,3.4359733307042726e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2016,Prescription,Vet,820,XMAYWYJOQHXEEK-OZXSUGGESA-N,2.354507730961278e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,OTC,Human,163381.2,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.7556449344690575e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,Prescription,Human,13242.6,XMAYWYJOQHXEEK-OZXSUGGESA-N,3.854611400161091e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,Prescription,Vet,372,XMAYWYJOQHXEEK-OZXSUGGESA-N,1.0828050691404451e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,OTC,Human,176262,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.0104612706006455e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,Prescription,Human,14608.2,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.1525581426052334e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,Prescription,Vet,608,XMAYWYJOQHXEEK-OZXSUGGESA-N,1.7283137899973855e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,OTC,Human,205199.52,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.9276421492033875e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,Prescription,Human,16575,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.788055480005321e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,Prescription,Vet,524,XMAYWYJOQHXEEK-OZXSUGGESA-N,1.5136899375703094e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoprofen,2016,Prescription,Human,275090.3,DKYWVDODHFEZIM-UHFFFAOYSA-N,7.89880778124948e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2016,Prescription,Vet,39083.6,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.122227296997539e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2017,Prescription,Human,260377,DKYWVDODHFEZIM-UHFFFAOYSA-N,7.578966007730691e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2017,Prescription,Vet,40776.8,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.1869173586915622e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2018,Prescription,Human,243322.6,DKYWVDODHFEZIM-UHFFFAOYSA-N,6.916740213783189e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2018,Prescription,Vet,43647.6,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.2407360029652945e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2019,Prescription,Human,228045.9,DKYWVDODHFEZIM-UHFFFAOYSA-N,6.58761038423979e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2019,Prescription,Vet,51828.8,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.497189561762291e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketorolac,2016,Prescription,Human,1791.15,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.143020149160112e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2017,Prescription,Human,1966.53,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.724109281227848e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2018,Prescription,Human,2210.76,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.284353609168783e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2019,Prescription,Human,2277.54,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.579178206896721e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketotifen,2016,OTC,Human,50.216,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,1.4418775636335551e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2016,Prescription,Human,109.956,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,3.157222586165589e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2017,OTC,Human,57.8945,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,1.685173604176116e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2017,Prescription,Human,118.14,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,3.438779324415382e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2018,OTC,Human,54.67325,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,1.55415348550945e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2018,Prescription,Human,125.97,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,3.580850133650834e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2019,OTC,Human,79.99925,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,2.3109553385147247e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2019,Prescription,Human,170.256,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4.9182212597513465e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
labetalol,2016,Prescription,Human,207503.95,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.9581665180488116e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2017,Prescription,Human,207948.35,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.052890524177192e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2018,Prescription,Human,206306.84999999992,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.864522595821087e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2019,Prescription,Human,213303.15,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.161733431432258e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
lacosamide,2016,Prescription,Human,59488.407,VPPJLAIAVCUEMN-GFCCVEGCSA-N,1.7081209046837927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,1.7081209046837927e-5
lacosamide,2017,Prescription,Human,69342.464,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.01839708402927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.01839708402927e-5
lacosamide,2018,Prescription,Human,74852.92,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.1277850963416305e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.1277850963416306e-5
lacosamide,2019,Prescription,Human,92119.712,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.6610817005014293e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.6610817005014292e-5
lamivudine,2016,Prescription,Human,118844.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.4124397387982256e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.4124397387982256e-5
lamivudine,2017,Prescription,Human,130937.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.8112817327975845e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.8112817327975845e-5
lamivudine,2018,Prescription,Human,137233.2,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.90102026324785e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.90102026324785e-5
lamivudine,2019,Prescription,Human,140562,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4.0604443703198054e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,4.060444370319805e-5
lamotrigine,2016,Prescription,Human,2377299.3282,PYZRQGJRPPTADH-UHFFFAOYSA-N,6.826060545190186e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004550707030126791
lamotrigine,2017,Prescription,Human,2487666.8492,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.241016867329032e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004827344578219355
lamotrigine,2018,Prescription,Human,2516154.5068,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.152474558990972e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004768316372660649
lamotrigine,2019,Prescription,Human,2623016.7694,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.577164293738475e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.005051442862492317
lansoprazole,2016,Prescription,Human,292300.8531,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.392983151103988e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2017,Prescription,Human,283156.6404,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.2420281071478007e-08,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2018,Prescription,Human,267404.1549,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.601287638425445e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2019,Prescription,Human,261259.5957,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.547061471465214e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lapatinib,2016,Prescription,Human,4305,BCFGMOOMADDAQU-UHFFFAOYSA-N,1.236116558754671e-9,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.01236116558754671
lapatinib,2017,Prescription,Human,2373,BCFGMOOMADDAQU-UHFFFAOYSA-N,6.907248465242679e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.006907248465242679
lapatinib,2018,Prescription,Human,1323,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.76078806606339e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.00376078806606339
lapatinib,2019,Prescription,Human,1155,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.3364730494154715e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.0033364730494154717
latanoprost,2016,Prescription,Human,54.728325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.571442247744651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2017,Prescription,Human,55.9576,GGXICVAJURFBLW-CEYXHVGTSA-N,1.6287949714229405e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2018,Prescription,Human,57.58145,GGXICVAJURFBLW-CEYXHVGTSA-N,1.636822600050082e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2019,Prescription,Human,60.533325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.7486390255758248e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
ledipasvir,2016,Prescription,Human,1960.56,VRTWBAAJJOHBQU-KMWAZVGDSA-N,5.62945570367493e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2017,Prescription,Human,216.72,VRTWBAAJJOHBQU-KMWAZVGDSA-N,6.308212757637562e-11,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2018,Prescription,Human,549.36,VRTWBAAJJOHBQU-KMWAZVGDSA-N,1.5616224731463223e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2019,Prescription,Human,3354.12,VRTWBAAJJOHBQU-KMWAZVGDSA-N,9.68911773550253e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
leflunomide,2016,Prescription,Human,10861.2,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.118631630184955e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011812998599185435
leflunomide,2017,Prescription,Human,10776.8,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.13687464223461e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.001188210091755534
leflunomide,2018,Prescription,Human,10363,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.945808520681399e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011158365608641661
leflunomide,2019,Prescription,Human,8645,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.4972995248655198e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,9.459467897217878e-4
lenalidomide,2016,Prescription,Human,1184.7675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,3.4018832172459336e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2017,Prescription,Human,1734.9675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.050084956435282e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2018,Prescription,Human,2057.9475,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.84996553181027e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2019,Prescription,Human,2054.115,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.933765660519534e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenvatinib,2016,Prescription,Human,13.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,3.824639387366369e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2017,Prescription,Human,14.94,WOSKHXYHFSIKNG-UHFFFAOYSA-N,4.348684874451143e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2018,Prescription,Human,43.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.2314235753731374e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2019,Prescription,Human,48.84,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.4108514608956851e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lercanidipine,2016,Prescription,Human,207515.2234,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,5.9584902169202033e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2017,Prescription,Human,213714.6424,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.220733820974667e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2018,Prescription,Human,231386.8572,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.57745223886375e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2019,Prescription,Human,259667.2152,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,7.50106203750275e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lesinurad,2018,Prescription,Human,126,FGQFOYHRJSUHMR-UHFFFAOYSA-N,3.5817029200603715e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
lesinurad,2019,Prescription,Human,264,FGQFOYHRJSUHMR-UHFFFAOYSA-N,7.626224112949649e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
letermovir,2019,Prescription,Human,376.32,FWYSMLBETOMXAG-QHCPKHFHSA-N,1.0870835826459135e-10,antiviral,antiviral for prevention of cytomegalovirus infection after bone marrow transplants,NA,NA,NA,NA
letrozole,2016,Prescription,Human,6260.475,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.797602047193879e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.035952040943877585
letrozole,2017,Prescription,Human,6850.075,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.9938967564495253e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.03987793512899051
letrozole,2018,Prescription,Human,7181.225,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.041350361278614e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.04082700722557229
letrozole,2019,Prescription,Human,7892.875,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.2800315774809646e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.0456006315496193
leuprorelin,2016,Prescription,Human,138.3825,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.973447147314013e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2017,Prescription,Human,121.35875,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.532469615176022e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2018,Prescription,Human,106.8375,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.036985600967857e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2019,Prescription,Human,100.965,GFIJNRVAKGFPGQ-LIJARHBVSA-N,2.9165974150150054e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
levetiracetam,2016,Prescription,Human,4353771.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.2501205677547414e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2017,Prescription,Human,4592883,HPHUVLMMVZITSG-LURJTMIESA-N,1.3368809124647785e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2018,Prescription,Human,4874655.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.38567998719352e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2019,Prescription,Human,5139031.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.48452295236772e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levocabastine,2016,OTC,Human,805.044,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.3115638070292574e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.311563807029257e-5
levocabastine,2016,Prescription,Human,850.47,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.4419977926227287e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.4419977926227286e-5
levocabastine,2017,OTC,Human,936.232,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.7251525685255304e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.7251525685255302e-5
levocabastine,2017,Prescription,Human,962.88,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.8027186692848174e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.802718669284817e-5
levocabastine,2018,OTC,Human,884.898,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.515429960758399e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.515429960758399e-5
levocabastine,2018,Prescription,Human,1005.12,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.8571755865167307e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.8571755865167306e-5
levocabastine,2019,OTC,Human,1064.4955,ZCGOMHNNNFPNMX-YHYDXASRSA-N,3.0750307766009066e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,3.0750307766009064e-5
levocabastine,2019,Prescription,Human,1171.314,ZCGOMHNNNFPNMX-YHYDXASRSA-N,3.3835996479679947e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,3.3835996479679944e-5
levocetirizine,2016,Prescription,Human,710.082,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0388945836785928e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2017,Prescription,Human,766.039499999999,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.2297619724779864e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2018,Prescription,Human,713.385,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0278834425613237e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2019,Prescription,Human,715.95,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0681799824493566e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levofloxacin,2017,Prescription,Human,40.32,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.173620978165128e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,1.5859742948177405e-6
levofloxacin,2018,Prescription,Human,53.76,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.5281932458924248e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,2.0651260079627363e-6
levofloxacin,2019,Prescription,Human,134.4,GSDSWSVVBLHKDQ-JTQLQIEISA-N,3.882441366592549e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,5.246542387287228e-6
levomepromazine,2016,Prescription,Human,102377.38,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.939613813238543e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2017,Prescription,Human,92423.555,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.6902337059672243e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2018,Prescription,Human,85520.88999999998,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.4310350907869983e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2019,Prescription,Human,74070.30500000001,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.1396846441080873e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomethadone,2016,Prescription,Human,169.915,USSIQXCVUWKGNF-QGZVFWFLSA-N,4.878855867149824e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2017,Prescription,Human,310.805,USSIQXCVUWKGNF-QGZVFWFLSA-N,9.046807245005271e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2018,Prescription,Human,449.595,USSIQXCVUWKGNF-QGZVFWFLSA-N,1.2780283526543988e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2019,Prescription,Human,765.625,USSIQXCVUWKGNF-QGZVFWFLSA-N,2.211677210786771e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levonorgestrel,2016,OTC,Human,44.3625,WWYNJERNGUHSAO-XUDSTZEESA-N,1.2738030392045083e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.2738030392045083
levonorgestrel,2016,Prescription,Human,7241.0969,WWYNJERNGUHSAO-XUDSTZEESA-N,2.0791730038646032e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,207.91730038646034
levonorgestrel,2017,OTC,Human,51.6075,WWYNJERNGUHSAO-XUDSTZEESA-N,1.5021737259587508e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.5021737259587509
levonorgestrel,2017,Prescription,Human,7390.17125,WWYNJERNGUHSAO-XUDSTZEESA-N,2.151106153579565e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,215.1106153579565
levonorgestrel,2018,OTC,Human,57.8685,WWYNJERNGUHSAO-XUDSTZEESA-N,1.6449823446786796e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.6449823446786798
levonorgestrel,2018,Prescription,Human,7236.39905,WWYNJERNGUHSAO-XUDSTZEESA-N,2.057034254611674e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,205.70342546116743
levonorgestrel,2019,OTC,Human,56.646,WWYNJERNGUHSAO-XUDSTZEESA-N,1.636345042053583e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.636345042053583
levonorgestrel,2019,Prescription,Human,7322.5549,WWYNJERNGUHSAO-XUDSTZEESA-N,2.1152819979840003e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,211.52819979840004
levosimendan,2016,Prescription,Human,15.0375,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.3177939029671e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2017,Prescription,Human,15.15,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.4098109670639096e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2018,Prescription,Human,14.4875,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.118247702728146e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2019,Prescription,Human,16.3625,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.7266701533385855e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levothyroxine sodium,2016,Prescription,Human,7200.401575,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.0674879480930807e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2016,Prescription,Vet,187.85,YDTFRJLNMPSCFM-YDALLXLXSA-M,5.3938326495253176e-11,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2017,Prescription,Human,6888.65885,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.0051276135374168e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2017,Prescription,Vet,244.75,YDTFRJLNMPSCFM-YDALLXLXSA-M,7.124100555702258e-11,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2018,Prescription,Human,7289.32385,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.072078771334183e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2018,Prescription,Vet,290.28,YDTFRJLNMPSCFM-YDALLXLXSA-M,8.251561298691466e-11,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2019,Prescription,Human,7354.0511,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.124380372222875e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2019,Prescription,Vet,351.62,YDTFRJLNMPSCFM-YDALLXLXSA-M,1.015732167649756e-10,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
lidocaine,2016,OTC,Human,92747.5,NNJVILVZKWQKPM-UHFFFAOYSA-N,2.6631061680162333e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2016,Prescription,Human,481621.74,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.3829050124744177e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2016,Prescription,Vet,63792,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.8316921606522176e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,OTC,Human,59894,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.7433743766424147e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,Prescription,Human,504422.064,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.468254752380339e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,Prescription,Vet,62688,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.8247011874805442e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,OTC,Human,59996,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.7054591142217624e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,Prescription,Human,504164.8,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.4331496320251217e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,Prescription,Vet,57816,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.6434899684619878e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,OTC,Human,56952,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.6451845290935926e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,Prescription,Human,539792.75,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.559310790168713e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,Prescription,Vet,53640.48,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.549523946993157e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
linagliptin,2016,Prescription,Human,10846.965,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.1145442621910243e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,9.73295081934695e-6
linagliptin,2017,Prescription,Human,12320.0925,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.586091024537414e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.1206534451679418e-5
linagliptin,2018,Prescription,Human,12987.468,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.6918454015706853e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.153701687990839e-5
linagliptin,2019,Prescription,Human,13415.778,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.875444305968918e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.2110763456152868e-5
linezolid,2016,Prescription,Human,22374,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.4243604844545905e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2017,Prescription,Human,21606,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.2890016999592645e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2018,Prescription,Human,22014,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.257746673191193e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2019,Prescription,Human,23940,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.915598684242978e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
liothyronine sodium,2016,Prescription,Human,40.16572,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.153298759263732e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2017,Prescription,Human,45.3151,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3190166663603817e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2018,Prescription,Human,46.2898,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3158437446746874e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2019,Prescription,Human,58.48984,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.6896084400400264e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
lipegfilgrastim,2016,Prescription,Human,20.958,GAQMWPRWVIGRRV-IVDGIBIRSA-N,6.017777198230056e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2017,Prescription,Human,7.524,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.1900605753259976e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2018,Prescription,Human,71.616,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.0357717168495523e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2019,Prescription,Human,38.256,GAQMWPRWVIGRRV-IVDGIBIRSA-N,1.1051092032765219e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lisdexamfetamine,2016,Prescription,Human,45990.978,VOBHXZCDAVEXEY-JSGCOSHPSA-N,1.320562356774025e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2017,Prescription,Human,74352.40800000001,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.1642248463763068e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2018,Prescription,Human,105380.181,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.995559539715798e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2019,Prescription,Human,157686.582,VOBHXZCDAVEXEY-JSGCOSHPSA-N,4.5551258103674713e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisinopril,2016,Prescription,Human,151188.9495,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.3411652491910275e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.61763770765919e-4
lisinopril,2017,Prescription,Human,144476.25209999998,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.2053660791476584e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.504471732623049e-4
lisinopril,2018,Prescription,Human,137568.0606,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.9105390822068435e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.258782568505703e-4
lisinopril,2019,Prescription,Human,132054.1359,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.814675891724659e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.178896576437216e-4
loperamide,2016,OTC,Human,10560.304,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.032233830402598e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.064467660805196e-5
loperamide,2016,Prescription,Human,17681.255999999998,RDOIQAHITMMDAJ-UHFFFAOYSA-N,5.07690901769579e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.0153818035391579e-4
loperamide,2017,OTC,Human,10889.86,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.169783766190798e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.339567532381595e-5
loperamide,2017,Prescription,Human,19023.837,RDOIQAHITMMDAJ-UHFFFAOYSA-N,5.537394391962785e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.1074788783925569e-4
loperamide,2018,OTC,Human,10890.152,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.095657874468357e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.191315748936714e-5
loperamide,2018,Prescription,Human,20381.942,RDOIQAHITMMDAJ-UHFFFAOYSA-N,5.793814379198503e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.1587628758397005e-4
loperamide,2019,OTC,Human,11464.092,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.311656622858832e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.623313245717664e-5
loperamide,2019,Prescription,Human,21066.849,RDOIQAHITMMDAJ-UHFFFAOYSA-N,6.085625448017774e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.2171250896035547e-4
lopinavir,2016,Prescription,Human,27612,KJHKTHWMRKYKJE-SUGCFTRWSA-N,7.928374081378391e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2017,Prescription,Human,17604,KJHKTHWMRKYKJE-SUGCFTRWSA-N,5.124113020738817e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2018,Prescription,Human,11149.2,KJHKTHWMRKYKJE-SUGCFTRWSA-N,3.1692954124077063e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2019,Prescription,Human,9900,KJHKTHWMRKYKJE-SUGCFTRWSA-N,2.8598340423561183e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
loratadine,2016,OTC,Human,268.8,JCCNYMKQOSZNPW-UHFFFAOYSA-N,7.718191196126726e-11,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2016,Prescription,Human,115171.43,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.306975881961776e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2017,OTC,Human,540.32,JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.5727452552633478e-10,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2017,Prescription,Human,113953.49,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.3169198015657266e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2018,OTC,Human,570.64,JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.6221134557962303e-10,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2018,Prescription,Human,110787.4,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.149266302269019e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2019,OTC,Human,438.06,JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.265433232923759e-10,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2019,Prescription,Human,113677.5,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.2838261045448254e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
losartan,2016,Prescription,Human,3027866.1195,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.694066081315213e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.694066081315212e-4
losartan,2017,Prescription,Human,3039786.7165,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.848108778849434e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.848108778849434e-4
losartan,2018,Prescription,Human,3032960.4255,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.621558105111824e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.621558105111823e-4
losartan,2019,Prescription,Human,3082248.4125,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.903756502086469e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.903756502086469e-4
lovastatin,2016,Prescription,Human,7570.83319999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.1738518657583276e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2017,Prescription,Human,7141.514799999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.0787280717154603e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2018,Prescription,Human,7115.6232,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.022702253451534e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2019,Prescription,Human,6928.0512,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.001320875651127e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
loxapine,2016,Prescription,Human,0.4732,XJGVXQDUIWGIRW-UHFFFAOYSA-N,1.3587232418181425e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2017,Prescription,Human,1.4651,XJGVXQDUIWGIRW-UHFFFAOYSA-N,4.2645637279507163e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2018,Prescription,Human,0.3003,XJGVXQDUIWGIRW-UHFFFAOYSA-N,8.53639195947722e-14,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
lumacaftor,2016,Prescription,Human,1344,UFSKUSARDNFIRC-UHFFFAOYSA-N,3.8590955980633625e-10,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2017,Prescription,Human,5040,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.4670262227064096e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2018,Prescription,Human,6608,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.8784041980761063e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2019,Prescription,Human,8512,UFSKUSARDNFIRC-UHFFFAOYSA-N,2.458879532175281e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lurasidone,2016,Prescription,Human,4085.01016,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.1729497564360203e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2017,Prescription,Human,5081.82864,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.479201562337391e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2018,Prescription,Human,6887.00166,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.9577138060383033e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2019,Prescription,Human,9104.99996,PQXKDMSYBGKCJA-CVTJIBDQSA-N,2.630180691036272e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lymecycline,2016,Prescription,Human,1073133.9,PZTCVADFMACKLU-UEPZRUIBSA-N,3.081343980373935e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2017,Prescription,Human,1097286.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.193944873064205e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2018,Prescription,Human,1083620.4,PZTCVADFMACKLU-UEPZRUIBSA-N,3.080322500727768e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2019,Prescription,Human,1146855.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.312946148027023e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
macitentan,2016,Prescription,Human,356.7,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.0242108629681559e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2017,Prescription,Human,436.8,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.2714227263455548e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2018,Prescription,Human,479.1,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.3618998960324794e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2019,Prescription,Human,525.6,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.5183118915781576e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macrogol,2016,OTC,Human,20729440.74266,LYCAIKOWRPUZTN-UHFFFAOYSA-N,5.952149815499594e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.006265420858420625
macrogol,2016,Prescription,Human,68677249.2,LYCAIKOWRPUZTN-UHFFFAOYSA-N,1.9719648071043203e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.020757524285308634
macrogol,2017,OTC,Human,23530761.3096,LYCAIKOWRPUZTN-UHFFFAOYSA-N,6.849254738378695e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.00720974182987231
macrogol,2017,Prescription,Human,83741585.91,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.437521874226024e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.025658124991852882
macrogol,2018,OTC,Human,25538652.30416,LYCAIKOWRPUZTN-UHFFFAOYSA-N,7.259671867636223e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.007641759860669709
macrogol,2018,Prescription,Human,93882515.82,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.6687244528183177e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.028091836345455975
macrogol,2019,OTC,Human,33252746.68248,LYCAIKOWRPUZTN-UHFFFAOYSA-N,9.605791612565738e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.01011135959217446
macrogol,2019,Prescription,Human,99923381.43,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.886507957988376e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.03038429429461448
malathion,2016,OTC,Human,8060.525,JXSJBGJIGXNWCI-UHFFFAOYSA-N,2.3144595644032507e-9,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
malathion,2017,OTC,Human,2174.975,JXSJBGJIGXNWCI-UHFFFAOYSA-N,6.33084396573586e-10,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
maraviroc,2016,Prescription,Human,855,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.4550050121608447e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.668483708870483e-7
maraviroc,2017,Prescription,Human,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1481455403915282e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3349408047734003e-7
maraviroc,2018,Prescription,Human,954,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.7118607823314245e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.9476747634037224e-7
maraviroc,2019,Prescription,Human,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1318762861200159e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3172568327391477e-7
maropitant,2016,Prescription,Vet,756.792,OMPCVMLFFSQFIX-CONSDPRKSA-N,2.173015383816643e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2017,Prescription,Vet,1060.856,OMPCVMLFFSQFIX-CONSDPRKSA-N,3.0879039097528395e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2018,Prescription,Vet,1442.464,OMPCVMLFFSQFIX-CONSDPRKSA-N,4.100378984826955e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2019,Prescription,Vet,1906.536,OMPCVMLFFSQFIX-CONSDPRKSA-N,5.507451066441885e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
mavacoxib,2016,Prescription,Vet,159.82,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.588992994661359e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2017,Prescription,Vet,170.18,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.953542114686048e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2018,Prescription,Vet,114.23,TTZNQDOUNXBMJV-UHFFFAOYSA-N,3.2471263853848907e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2019,Prescription,Vet,61.95,TTZNQDOUNXBMJV-UHFFFAOYSA-N,1.7895628174137533e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mebendazole,2016,OTC,Human,61423.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.7636756007363508e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20041768190185807
mebendazole,2017,OTC,Human,63877.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.859316020497259e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.21128591142014308
mebendazole,2018,OTC,Human,62027.4,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.763204124632958e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20036410507192706
mebendazole,2019,OTC,Human,65777.40000000001,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.9001257347239938e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.2159233789459084
mecillinam,2016,Prescription,Human,11634,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.340529627073598e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2017,Prescription,Human,11510,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.3502920284426143e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2018,Prescription,Human,4429,BWWVAEOLVKTZFQ-NTZNESFSSA-N,1.258997002614872e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2019,Prescription,Human,7300,BWWVAEOLVKTZFQ-NTZNESFSSA-N,2.108766516080774e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
meclozine,2016,OTC,Human,49589.25,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.4238813719216044e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2016,Prescription,Human,12709.35,OCJYIGYOJCODJL-UHFFFAOYSA-N,3.649300345182039e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2017,OTC,Human,51284.5,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.4927719507616442e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2017,Prescription,Human,21575.475,OCJYIGYOJCODJL-UHFFFAOYSA-N,6.28011658578305e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2018,OTC,Human,55553.25,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.5791685535225702e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2018,Prescription,Human,27466.825,OCJYIGYOJCODJL-UHFFFAOYSA-N,7.807778357721209e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2019,OTC,Human,57038.75,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.647690494782223e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2019,Prescription,Human,26470.475,OCJYIGYOJCODJL-UHFFFAOYSA-N,7.646582375993594e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
medetomidine,2016,Prescription,Vet,80.34,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.3068433061637697e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2017,Prescription,Vet,76.09,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.2148020890025934e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2018,Prescription,Vet,69.92,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9875608584969936e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2019,Prescription,Vet,65.86,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9025118184805452e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medroxyprogesterone acetate,2016,Prescription,Human,13012.812,PSGAAPLEWMOORI-PEINSRQWSA-N,3.736434933603133e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2016,Prescription,Vet,4201.5999999999995,PSGAAPLEWMOORI-PEINSRQWSA-N,1.2064267905374272e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2017,Prescription,Human,12746.064,PSGAAPLEWMOORI-PEINSRQWSA-N,3.710081373867887e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2017,Prescription,Vet,3708.8,PSGAAPLEWMOORI-PEINSRQWSA-N,1.0795450108677643e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2018,Prescription,Human,13125.68,PSGAAPLEWMOORI-PEINSRQWSA-N,3.731133839982383e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2018,Prescription,Vet,1931.4,PSGAAPLEWMOORI-PEINSRQWSA-N,5.490238904606826e-10,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2019,Prescription,Human,14449.096,PSGAAPLEWMOORI-PEINSRQWSA-N,4.173941072936527e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2019,Prescription,Vet,0.1,PSGAAPLEWMOORI-PEINSRQWSA-N,2.88872125490517e-14,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
mefloquine,2016,Prescription,Human,8634,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.4791243596487406e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2017,Prescription,Human,8060,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.346077649804298e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2018,Prescription,Human,7916,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.250219072634754e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2019,Prescription,Human,7282,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.103566817821945e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
megestrol acetate,2016,Prescription,Human,5134.128,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.4741883009444832e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2017,Prescription,Human,4752.24,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.3832660112290292e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2018,Prescription,Human,5703.456,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.621276588066337e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2019,Prescription,Human,2689.824,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,7.770151760754046e-10,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
meglumine amidotrizoate,2016,Prescription,Human,1.51536,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.351130286816442e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2017,Prescription,Human,1.40118,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.078507545102713e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2018,Prescription,Human,1.30746,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.7166137300493133e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2019,Prescription,Human,1.19988,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.466118859335616e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
melatonin,2016,Prescription,Human,15101.247,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.33609790349461e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2017,Prescription,Human,16070.9346,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.677873508253918e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2018,Prescription,Human,16984.3194,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.827998919858573e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2019,Prescription,Human,18836.218200000003,DRLFMBDRBRZALE-UHFFFAOYSA-N,5.441258387637162e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
meloxicam,2016,Prescription,Human,14181.045,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,4.071875620196314e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2016,Prescription,Vet,47618.354,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.3672900320567182e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2017,Prescription,Human,12728.6625,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,3.705016203865025e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2017,Prescription,Vet,51174.7995,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.4895788255603744e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2018,Prescription,Human,11115.81,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,3.159803899669546e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2018,Prescription,Vet,51568.2015,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.465888713450886e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2019,Prescription,Human,4957.8225,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.432176723379709e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2019,Prescription,Vet,58075.633,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.6776431543917213e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
melphalan,2016,Prescription,Human,53.05,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.5232516478962898e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2017,Prescription,Human,46,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.3389525048510883e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2018,Prescription,Human,33.5,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,9.522781573176384e-12,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2019,Prescription,Human,38.4,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.1092689618835856e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
memantine,2016,Prescription,Human,33363.1714,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.579737193986122e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2017,Prescription,Human,32400.4736,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.431020714148164e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2018,Prescription,Human,31011.5332,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.815404683967393e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2019,Prescription,Human,30630.0316,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.848162332133703e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
menbutone,2019,Prescription,Vet,900,FHGJSJFIQNQBCK-UHFFFAOYSA-N,2.5998491294146534e-10,alimentary,choleretic veterinary bile excretion stimulator,NA,NA,NA,NA
mepivacaine,2016,Prescription,Human,7922.4,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.2747990302155646e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2016,Prescription,Vet,36,INWLQCZOYSRPNW-UHFFFAOYSA-N,1.0336863209098294e-11,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2017,Prescription,Human,7439.7,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.165522815291444e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2017,Prescription,Vet,1176,INWLQCZOYSRPNW-UHFFFAOYSA-N,3.4230611863149555e-10,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2018,Prescription,Human,8097.6,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.3018410766254652e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2018,Prescription,Vet,1750.8,INWLQCZOYSRPNW-UHFFFAOYSA-N,4.976861486064841e-10,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2019,Prescription,Human,7316.1,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.113417357301172e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2019,Prescription,Vet,1779,INWLQCZOYSRPNW-UHFFFAOYSA-N,5.139035112476298e-10,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mercaptopurine,2016,Prescription,Human,5904.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.6953173500644054e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2017,Prescription,Human,6181.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.7992174283936496e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2018,Prescription,Human,6047.5,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.719075270560722e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2019,Prescription,Human,5930.75,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.713228358252884e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
meropenem,2016,Prescription,Human,152350,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4.374503083072569e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2017,Prescription,Human,136675,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.9782898608809246e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2018,Prescription,Human,129585,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.683610896000185e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2019,Prescription,Human,124545,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.5977578869216446e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
mesna,2016,Prescription,Human,20386,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.85353592724105e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2017,Prescription,Human,18418,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.361049398771162e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2018,Prescription,Human,19076,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.422584516116798e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2019,Prescription,Human,18950,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.474126778045298e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
metamizole sodium,2016,Prescription,Vet,32750,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.40367416938803e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2017,Prescription,Vet,34150,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.940266965361884e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2018,Prescription,Vet,31700,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.011109727453477e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2019,Prescription,Vet,33100,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.561667353736114e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metformin,2016,Prescription,Human,69488813.456,XZWYZXLIPXDOLR-UHFFFAOYSA-N,1.9952676646033913e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.019952676646033913
metformin,2017,Prescription,Human,73431045.754,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1374061444815902e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021374061444815903
metformin,2018,Prescription,Human,74897300.814,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1290466748424115e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021290466748424115
metformin,2019,Prescription,Human,78024938.926,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.25392299488214e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.0225392299488214
methadone,2016,Prescription,Human,97993.623,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.813740767541523e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2016,Prescription,Vet,9.3,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.67035632901706e-12,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2017,Prescription,Human,96735.085,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8157322688637596e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2017,Prescription,Vet,44.6,USSIQXCVUWKGNF-UHFFFAOYSA-N,1.298201776442577e-11,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2018,Prescription,Human,95331.685,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.7099188455458378e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2018,Prescription,Vet,79.8,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.2684118493715688e-11,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2019,Prescription,Human,98344.18,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8408892306221993e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2019,Prescription,Vet,101.8,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.940718237493463e-11,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methenamine,2016,Prescription,Human,15596938,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.478428182966309e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2017,Prescription,Human,15766796,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.5893458690600255e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2018,Prescription,Human,15759884,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.479938297032757e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2019,Prescription,Human,13120813,VKYKSIONXSXAKP-UHFFFAOYSA-N,3.7902371394736073e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methoprene,2016,Prescription,Vet,3529.836,NFGXHKASABOEEW-LDRANXPESA-N,1.0135397745152971e-9,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2017,Prescription,Vet,2461.1454,NFGXHKASABOEEW-LDRANXPESA-N,7.163819126375508e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2018,Prescription,Vet,2021.0688,NFGXHKASABOEEW-LDRANXPESA-N,5.745133351272152e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2019,Prescription,Vet,1957.203,NFGXHKASABOEEW-LDRANXPESA-N,5.653813906264164e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoxsalen,2019,Prescription,Human,0.0576,QXKHYNVANLEOEG-UHFFFAOYSA-N,1.663903442825378e-14,dermatological,psoralen agent used with ultraviolet light A for psoriasis,NA,NA,NA,NA
methyl aminolevulinate,2016,Prescription,Human,1325.44,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.805803325518678e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2017,Prescription,Human,1259.2,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.6652369437141094e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2018,Prescription,Human,1025.92,YUUAYBAIHCDHHD-UHFFFAOYSA-N,2.9163021109113783e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2019,Prescription,Human,1140.48,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.294528816794249e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methylnaltrexone bromide,2016,Prescription,Human,129.564,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.7202370689544754e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2017,Prescription,Human,124.5,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.623904062042619e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2018,Prescription,Human,46.355999999999995,IFGIYSGOEZJNBE-KNLJMPJLSA-N,1.3177255600184014e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2019,Prescription,Human,97.212,IFGIYSGOEZJNBE-KNLJMPJLSA-N,2.8081837063184145e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylphenidate,2016,Prescription,Human,449505.8977,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.290689160057731e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2017,Prescription,Human,471897.4314,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3735831474039664e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2018,Prescription,Human,476990.1956,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3559025209688e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2019,Prescription,Human,494619.477,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.4288177962999792e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylprednisolone,2016,Prescription,Human,25117.601,VHRSUDSXCMQTMA-PJHHCJLFSA-N,7.2121446021586255e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2017,Prescription,Human,22609.799,VHRSUDSXCMQTMA-PJHHCJLFSA-N,6.5811841315716595e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2018,Prescription,Human,20784.897,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.9083592284169894e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2019,Prescription,Human,18925.627,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.467086097730718e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylrosaniline,2016,OTC,Human,2093.2799999999997,QFVDKARCPMTZCS-UHFFFAOYSA-N,6.010541393983686e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2016,OTC,Vet,710,QFVDKARCPMTZCS-UHFFFAOYSA-N,2.0386591329054967e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2017,OTC,Human,1951.62,QFVDKARCPMTZCS-UHFFFAOYSA-N,5.680709755472784e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2017,OTC,Vet,600,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.7464597889362018e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2018,OTC,Human,713.4,QFVDKARCPMTZCS-UHFFFAOYSA-N,2.0279260818818006e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2018,OTC,Vet,65,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.8477038873327316e-11,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2019,OTC,Human,614.28,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.774483692463148e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
metoclopramide,2016,Prescription,Human,64982.585,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.865878033662785e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2016,Prescription,Vet,0.625,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.7945943071351206e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2017,Prescription,Human,64692.28,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8830410945766948e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2017,Prescription,Vet,1,TTWJBBZEZQICBI-UHFFFAOYSA-N,2.910766314893671e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2018,Prescription,Human,64784.445,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8415764748491313e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2018,Prescription,Vet,1.05,TTWJBBZEZQICBI-UHFFFAOYSA-N,2.9847524333836434e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2019,Prescription,Human,65946.56,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.905012295598791e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2019,Prescription,Vet,1.15,TTWJBBZEZQICBI-UHFFFAOYSA-N,3.3220294431409464e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoprolol,2016,Prescription,Human,6866147.1280000005,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.971511767657754e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2700701051585964
metoprolol,2017,Prescription,Human,6845990.6295,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.992707891642631e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2729736837866618
metoprolol,2018,Prescription,Human,6856705.0345,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.949101622544548e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.26700022226637643
metoprolol,2019,Prescription,Human,6798429.0755,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.963876657036216e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2690241995940022
metronidazole,2016,OTC,Human,2750.675,VAOCPAMSLUNLGC-UHFFFAOYSA-N,7.898153113246235e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,6.318522490596988e-5
metronidazole,2016,Prescription,Human,990402.15,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.843792096263014e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.022750336770104112
metronidazole,2017,OTC,Human,2604.625,VAOCPAMSLUNLGC-UHFFFAOYSA-N,7.581454712929925e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,6.06516377034394e-5
metronidazole,2017,Prescription,Human,1001759.105,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.915886658472031e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.023327093267776246
metronidazole,2018,OTC,Human,2358.725,VAOCPAMSLUNLGC-UHFFFAOYSA-N,6.704962079459842e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,5.363969663567873e-5
metronidazole,2018,Prescription,Human,957577.125,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.722029194282155e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02177623355425724
metronidazole,2019,OTC,Human,1378.425,VAOCPAMSLUNLGC-UHFFFAOYSA-N,3.981885595792659e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,3.185508476634127e-5
metronidazole,2019,Prescription,Human,986561.775,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.8499019687194724e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02279921574975578
metyrapone,2016,Prescription,Human,325,FJLBFSROUSIWMA-UHFFFAOYSA-N,9.331890397102626e-11,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2017,Prescription,Human,1712.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,4.98468731425541e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2018,Prescription,Human,3100,FJLBFSROUSIWMA-UHFFFAOYSA-N,8.812126231894564e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2019,Prescription,Human,2187.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,6.31907774510506e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
mianserin,2016,Prescription,Human,173771.217,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.9895813883542663e-08,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2017,Prescription,Human,165837.76499999998,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.8271498009925243e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2018,Prescription,Human,149158.389,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.240008233593657e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2019,Prescription,Human,156068.376,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.50838034969732e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
micafungin,2016,Prescription,Human,384.3,PIEUQSKUWLMALL-YABMTYFHSA-N,1.1034601475712428e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2017,Prescription,Human,607.1999999999999,PIEUQSKUWLMALL-YABMTYFHSA-N,1.7674173064034363e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2018,Prescription,Human,335.65000000000003,PIEUQSKUWLMALL-YABMTYFHSA-N,9.541258612049711e-11,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2019,Prescription,Human,349.85,PIEUQSKUWLMALL-YABMTYFHSA-N,1.0106191310285739e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
miconazole,2016,OTC,Human,19218.4091573575,BYBLEWFAAKGYCD-UHFFFAOYSA-N,5.518279626557957e-9,antifungal,azole antifungal,high,high,2e-7,0.027591398132789786
miconazole,2016,Prescription,Human,52647.2884432937,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.5116883860229682e-8,antifungal,azole antifungal,high,high,2e-7,0.07558441930114841
miconazole,2016,Prescription,Vet,9780,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.808181171805036e-9,antifungal,azole antifungal,high,high,2e-7,0.01404090585902518
miconazole,2017,OTC,Human,19801.9677668942,BYBLEWFAAKGYCD-UHFFFAOYSA-N,5.763890074448586e-9,antifungal,azole antifungal,high,high,2e-7,0.02881945037224293
miconazole,2017,Prescription,Human,55299.911762216594,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.609651203740523e-8,antifungal,azole antifungal,high,high,2e-7,0.08048256018702617
miconazole,2017,Prescription,Vet,7985,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.3242469024425952e-9,antifungal,azole antifungal,high,high,2e-7,0.011621234512212976
miconazole,2018,OTC,Human,20029.346744051298,BYBLEWFAAKGYCD-UHFFFAOYSA-N,5.693584898418272e-9,antifungal,azole antifungal,high,high,2e-7,0.028467924492091363
miconazole,2018,Prescription,Human,55801.0568696431,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.5862127645432982e-8,antifungal,azole antifungal,high,high,2e-7,0.07931063822716491
miconazole,2018,Prescription,Vet,7560,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.149021752036223e-9,antifungal,azole antifungal,high,high,2e-7,0.010745108760181116
miconazole,2019,OTC,Human,23891.87675259866,BYBLEWFAAKGYCD-UHFFFAOYSA-N,6.9016972194806475e-9,antifungal,azole antifungal,high,high,2e-7,0.034508486097403236
miconazole,2019,Prescription,Human,59997.467062016294,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.7331595834251934e-8,antifungal,azole antifungal,high,high,2e-7,0.08665797917125967
miconazole,2019,Prescription,Vet,7545,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.179540186825951e-9,antifungal,azole antifungal,high,high,2e-7,0.010897700934129756
midazolam,2016,Prescription,Human,6162.6,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.769498700344143e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2017,Prescription,Human,6242.8,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8171331950618206e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2018,Prescription,Human,6157.85,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.7504435973249015e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2019,Prescription,Human,6539.32,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8890272676626482e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midodrine,2019,Prescription,Human,340.25,PTKSEFOSCHHMPD-UHFFFAOYSA-N,9.828874069814841e-11,cardiac,"antihypotensive, constricts blood vessels",NA,NA,NA,NA
midostaurin,2018,Prescription,Human,72.8,BMGQWWVMWDBQGC-IIFHNQTCSA-N,2.0694283538126592e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
midostaurin,2019,Prescription,Human,61.6,BMGQWWVMWDBQGC-IIFHNQTCSA-N,1.779452293021585e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
mifepristone,2016,Prescription,Human,2740.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.8697985231935e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2017,Prescription,Human,2626.4,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.644836649436736e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2018,Prescription,Human,2763.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.856436928938774e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2019,Prescription,Human,2751,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.946872172244123e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
miglustat,2016,Prescription,Human,630,UQRORFVVSGFNRO-UTINFBMNSA-N,1.8089510615922014e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2017,Prescription,Human,814.8,UQRORFVVSGFNRO-UTINFBMNSA-N,2.3716923933753617e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2018,Prescription,Human,915.6,UQRORFVVSGFNRO-UTINFBMNSA-N,2.602704121910537e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2019,Prescription,Human,1008,UQRORFVVSGFNRO-UTINFBMNSA-N,2.911831024944412e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
milbemycin oxime,2016,Prescription,Vet,3482.1718499999997,LKMMLHTWKLEARD-LEBVNCHQSA-N,9.998537245561872e-10,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2017,Prescription,Vet,3796.2692,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.105005250962834e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2018,Prescription,Vet,4060.1456,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.1541456628087514e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2019,Prescription,Vet,3846.8674,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.111252762318179e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milrinone,2019,Prescription,Human,10.1,PZRHRDRVRGEVNW-UHFFFAOYSA-N,2.9176084674542226e-12,vasodilator,inotropic vasodilator for life-threatening heart failure,low,high,NA,NA
minoxidil,2016,OTC,Human,62955,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,1.807658953691064e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2017,OTC,Human,85104,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,2.4771785646271093e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2018,OTC,Human,105543,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.000187867396284e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2019,OTC,Human,117723,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.4006893229120146e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
mirabegron,2016,Prescription,Human,303287.5425,PBAPPPCECJKMCM-IBGZPJMESA-N,8.708449555128015e-8,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2017,Prescription,Human,372761.0925000001,PBAPPPCECJKMCM-IBGZPJMESA-N,1.0850204315519639e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2018,Prescription,Human,436381.155,PBAPPPCECJKMCM-IBGZPJMESA-N,1.240466394541919e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2019,Prescription,Human,516175.395,PBAPPPCECJKMCM-IBGZPJMESA-N,1.491086834795572e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirtazapine,2016,Prescription,Human,319535.925,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.174997630882476e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002867186759650774
mirtazapine,2017,Prescription,Human,326906.742,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.515491327252358e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002973591039766362
mirtazapine,2018,Prescription,Human,337860.4368,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.60409296078915e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0030012790502466093
mirtazapine,2019,Prescription,Human,363507.1445999999,RONZAEMNMFQXRA-UHFFFAOYSA-N,1.050070814915907e-7,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0032814712966122094
misoprostol,2016,Prescription,Human,676.244,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.941733812214852e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2017,Prescription,Human,658.3222000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.916222084106694e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2018,Prescription,Human,621.0586000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7654344453560368e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2019,Prescription,Human,591.4346,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7084896999063375e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
mitomycin,2017,Prescription,Human,39.42,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.1474240813310847e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2018,Prescription,Human,54.8,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.5577565080897488e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2019,Prescription,Human,58.72,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.696257120880316e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitotane,2016,Prescription,Human,9600,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.756496855759545e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2017,Prescription,Human,7300,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.124859409872379e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2018,Prescription,Human,4750,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.3502451484354574e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2019,Prescription,Human,5800,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.6754583278449986e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitoxantrone,2016,Prescription,Human,4.75,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.3638916734226917e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2017,Prescription,Human,4.35,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.2661833469787465e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2018,Prescription,Human,3.26,KKZJGLLVHKMTCM-UHFFFAOYSA-N,9.26694565031493e-13,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2019,Prescription,Human,3.49,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.0081637179619046e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mivacurium chloride,2016,Prescription,Human,233.4205,WMSYWJSZGVOIJW-ONUALHDOSA-L,6.702321607498134e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2017,Prescription,Human,272.68949999999995,WMSYWJSZGVOIJW-ONUALHDOSA-L,7.937354110251972e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2018,Prescription,Human,285.5295,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.116522570741094e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2019,Prescription,Human,299.3325,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.646881550339019e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
moclobemide,2016,Prescription,Human,74501.91,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.1392112569070896e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2017,Prescription,Human,70062.95999999999,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.0393690388974263e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2018,Prescription,Human,61765.23,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.7557516242000038e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2019,Prescription,Human,56384.52,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.6287916137162566e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
modafinil,2016,Prescription,Human,36860.1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.0583828099269e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2017,Prescription,Human,41133.87,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.1973108319721531e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2018,Prescription,Human,44110.41,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.25389193890524e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2019,Prescription,Human,48698.369999999995,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.4067601649823629e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
mometasone,2016,OTC,Human,174.696,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.016135153268432e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.0035829536809060232
mometasone,2016,Prescription,Human,14397.729,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.134093199851877e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.2952923714179912
mometasone,2017,OTC,Human,192.582,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.605611984548528e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.004004008560391806
mometasone,2017,Prescription,Human,15102.452,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.395970855389853e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.3139979182421324
mometasone,2018,OTC,Human,182.529,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.188608351553172e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.00370614882253798
mometasone,2018,Prescription,Human,15135.753,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.3025214855089324e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.307322963250638
mometasone,2019,OTC,Human,178.983,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.1703199636669206e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.003693085688333515
mometasone,2019,Prescription,Human,16555.013,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.782281792833141e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.34159155663093865
montelukast,2016,Prescription,Human,90571.20506,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6006171038566978e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.01368745844135104
montelukast,2017,Prescription,Human,89291.39282,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5990637843039453e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013679283075283922
montelukast,2018,Prescription,Human,91333.7439,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5962725176720332e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013664592198273859
montelukast,2019,Prescription,Human,93387.5145,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6977049807891482e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.014198447267311306
morphine,2016,Prescription,Human,143800.62,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.1290203842320125e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2017,Prescription,Human,145812.63,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.244264916900542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2018,Prescription,Human,144049.465,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.094780868441542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2019,Prescription,Human,148051.625,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.2767987596074974e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
moxidectin,2016,Prescription,Vet,834.5274000000001,YZBLFMPOMVTDJY-LSGXYNIPSA-N,2.3962209939012376e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2017,Prescription,Vet,642.7746,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.8709666537492526e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2018,Prescription,Vet,574.6335,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6334654642178663e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2019,Prescription,Vet,573.168,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6557225842314866e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxonidine,2016,Prescription,Human,700.267344,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.0107132624240496e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2017,Prescription,Human,705.406072,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.053272232699059e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2018,Prescription,Human,674.0434680000001,WPNJAUFVNXKLIM-UHFFFAOYSA-N,1.9160503631612855e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2019,Prescription,Human,750.183784,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.1670718419259892e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
mycophenolic acid,2016,Prescription,Human,2255457,HPNSFSBZBAHARI-RUDMXATFSA-N,6.476208467500891e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,9.523835981618959
mycophenolic acid,2017,Prescription,Human,2364479,HPNSFSBZBAHARI-RUDMXATFSA-N,6.88244582547347e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.121243860990397
mycophenolic acid,2018,Prescription,Human,2429535,HPNSFSBZBAHARI-RUDMXATFSA-N,6.906248098324504e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.156247203418388
mycophenolic acid,2019,Prescription,Human,2551838.8,HPNSFSBZBAHARI-RUDMXATFSA-N,7.371550980651704e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.840516148017212
nabumetone,2016,Prescription,Human,394630,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1331212022795721e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2017,Prescription,Human,378785.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1025560739701565e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2018,Prescription,Human,335474.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,9.536269811553915e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2019,Prescription,Human,310164.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,8.959787836670347e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nalmefene,2016,Prescription,Human,468.90648,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.346395039338829e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2017,Prescription,Human,351.8172,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.0240576547602094e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2018,Prescription,Human,325.60416,WJBLNOPPDWQMCH-MBPVOVBZSA-N,9.255693417903209e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2019,Prescription,Human,290.92392,WJBLNOPPDWQMCH-MBPVOVBZSA-N,8.403981112643315e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
naloxegol,2016,Prescription,Human,1748.1625,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,5.01958795271536e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2017,Prescription,Human,2825.69,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,8.224923268331894e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2018,Prescription,Human,3741.99,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.0637060722092626e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2019,Prescription,Human,4433.4825,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.280709513100011e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxone,2016,Prescription,Human,41013.1332,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.1776309657359104e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2017,Prescription,Human,44180.59196,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.2859937884923013e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2018,Prescription,Human,47347.738,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.3459169162924874e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2019,Prescription,Human,49400.0052,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.4270284501366594e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naltrexone,2016,Prescription,Human,7338.439,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.107123336425335e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2017,Prescription,Human,7045.358,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.050739074276664e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2018,Prescription,Human,14907.313,DQCKKXVULJGBQN-XFWGSAIBSA-N,4.237584643043964e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2019,Prescription,Human,25436.735,DQCKKXVULJGBQN-XFWGSAIBSA-N,7.347963704989027e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
nandrolone,2018,Prescription,Vet,8.5,NPAGDVCDWIYMMC-IZPLOLCNSA-N,2.4162281603581873e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
nandrolone,2019,Prescription,Vet,18,NPAGDVCDWIYMMC-IZPLOLCNSA-N,5.1996982588293064e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
naphazoline,2016,OTC,Human,28.7736,CNIIGCLFLJGOGP-UHFFFAOYSA-N,8.261910200925295e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2017,OTC,Human,21.1104,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.1447441213931325e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2018,OTC,Human,21.5712,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.131875399143357e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2019,OTC,Human,17.814,CNIIGCLFLJGOGP-UHFFFAOYSA-N,5.145968043488071e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naproxen,2016,OTC,Human,803170,CMWTZPSULFXXJA-VIFPVBQESA-N,2.3061828954587438e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.015374552636391625
naproxen,2016,Prescription,Human,11033028.075,CMWTZPSULFXXJA-VIFPVBQESA-N,3.1679694998171128e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.21119796665447418
naproxen,2017,OTC,Human,793955,CMWTZPSULFXXJA-VIFPVBQESA-N,2.311017469541404e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.015406783130276026
naproxen,2017,Prescription,Human,12158180.85,CMWTZPSULFXXJA-VIFPVBQESA-N,3.5389623268565293e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.23593082179043529
naproxen,2018,OTC,Human,757045,CMWTZPSULFXXJA-VIFPVBQESA-N,2.151992291362781e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.014346615275751873
naproxen,2018,Prescription,Human,12796983.4,CMWTZPSULFXXJA-VIFPVBQESA-N,3.637697842201913e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.24251318948012754
naproxen,2019,OTC,Human,885185,CMWTZPSULFXXJA-VIFPVBQESA-N,2.557052724023234e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.017047018160154893
naproxen,2019,Prescription,Human,13793243.375,CMWTZPSULFXXJA-VIFPVBQESA-N,3.984483531144243e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.2656322354096162
naratriptan,2016,Prescription,Human,313.875,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.012452610432576e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.012452610432576e-7
naratriptan,2017,Prescription,Human,330.645,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.624303281880175e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.624303281880174e-7
naratriptan,2018,Prescription,Human,414.585,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.178508178661293e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.178508178661293e-6
naratriptan,2019,Prescription,Human,417.045,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.2047267557519268e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.2047267557519267e-6
nebivolol,2016,Prescription,Human,25.200000000000003,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,7.235804246368806e-12,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2017,Prescription,Human,47.4,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,1.3797032332595995e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2018,Prescription,Human,81.6,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,2.3195790339438596e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2019,Prescription,Human,109.65,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,3.1674828560035196e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nelarabine,2017,Prescription,Human,7.5,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,2.1830747361702525e-12,antineoplastic,antimetabolite for leukaemia and lymphoma,low,high,1e-4,2.1830747361702525e-8
neomycin,2016,Prescription,Vet,32200,PGBHMTALBVVCIT-VCIWKGPPSA-N,9.24574987036014e-9,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2017,Prescription,Vet,40100,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.1672172922723617e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2018,Prescription,Vet,36800,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0460846623668388e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2019,Prescription,Vet,35300,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0197186029815252e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neostigmine,2016,Prescription,Human,120.3,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.45423512237368e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2017,Prescription,Human,118.1,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.4376150178894244e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2018,Prescription,Human,111.25,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.162416268704098e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2019,Prescription,Human,117.525,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.394969654827302e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
nepafenac,2016,Prescription,Human,271.246,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.788424438930766e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2017,Prescription,Human,299.604,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.720772310074031e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2018,Prescription,Human,273.159,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.764876094768023e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2019,Prescription,Human,301.9,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.72104946855871e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
netupitant,2016,Prescription,Human,1442.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,4.1424979310461407e-10,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2017,Prescription,Human,6062.4,WAXQNWCZJDTGBU-UHFFFAOYSA-N,1.7646229707411384e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2018,Prescription,Human,7616.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.165139415176495e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2019,Prescription,Human,8313,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.4013939792026683e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
nevirapine,2016,Prescription,Human,15546.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4.464031803866926e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,1.0381469311318433e-4
nevirapine,2017,Prescription,Human,12474.4,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.6310063318509604e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,8.444200771746419e-5
nevirapine,2018,Prescription,Human,10636.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.023639493658584e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.031719752694381e-5
nevirapine,2019,Prescription,Human,11765.6,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.398753879671227e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.904078789933086e-5
nicotine,2016,OTC,Human,413358.859,SNICXCGAKADSCV-JTQLQIEISA-N,1.1868983282644304e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.4904538546547233
nicotine,2017,OTC,Human,443459.232,SNICXCGAKADSCV-JTQLQIEISA-N,1.2908061945342172e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5333909894769492
nicotine,2018,OTC,Human,452518.281,SNICXCGAKADSCV-JTQLQIEISA-N,1.2863381336812697e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5315446833393676
nicotine,2019,OTC,Human,468355.722,SNICXCGAKADSCV-JTQLQIEISA-N,1.3529491289978573e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5590698880156435
nifedipine,2016,Prescription,Human,540610.2034,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.5522815894412792e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2017,Prescription,Human,574190.8116,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.6713352727267377e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2018,Prescription,Human,406169.141,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.1545850780619945e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2019,Prescription,Human,319523.88,HYIMSNHJOBLJNT-UHFFFAOYSA-N,9.23015423605769e-8,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nilotinib,2016,Prescription,Human,16940,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.864068410059031e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707955423303963
nilotinib,2017,Prescription,Human,16475.2,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.7955457191136206e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018444406611975463
nilotinib,2018,Prescription,Human,17110.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.8638388605873805e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707072540720696
nilotinib,2019,Prescription,Human,17972.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,5.191725388165769e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.019968174569868342
nimodipine,2016,Prescription,Human,1004.4,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.8839848353384235e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2017,Prescription,Human,1195.15,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.47880236124517e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2018,Prescription,Human,1105.75,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.1432285744894886e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2019,Prescription,Human,957.05,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.7646506770069927e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nintedanib,2016,Prescription,Human,5280,CPMDPSXJELVGJG-UHFFFAOYSA-N,1.5160732706677494e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,3.9896665017572354e-4
nintedanib,2017,Prescription,Human,9339,CPMDPSXJELVGJG-UHFFFAOYSA-N,2.718364661479198e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,7.153591214418942e-4
nintedanib,2018,Prescription,Human,13311,CPMDPSXJELVGJG-UHFFFAOYSA-N,3.7838132991209215e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,9.957403418739267e-4
nintedanib,2019,Prescription,Human,19167,CPMDPSXJELVGJG-UHFFFAOYSA-N,5.536812029276741e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,0.0014570557971780897
nitisinone,2016,Prescription,Human,304.62,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.746709085432006e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2017,Prescription,Human,293.09999999999997,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.531456068953345e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2018,Prescription,Human,317.58,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.027596931371212e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2019,Prescription,Human,343.08,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.91062488132866e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitrazepam,2016,Prescription,Human,25991.235,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.462995578625774e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2017,Prescription,Human,24605.77,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.162164646802122e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2018,Prescription,Human,23234.9275,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.604810132868335e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2019,Prescription,Human,22517.1975,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.5045907019147564e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrofurantoin,2016,Prescription,Human,118891.905,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.4138037740391936e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2017,Prescription,Human,108327.375,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.1531567413085466e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2018,Prescription,Human,25611.025,NXFQHRVNIOXGAQ-YCRREMRBSA-N,7.280244684780888e-9,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2019,Prescription,Human,516.25,NXFQHRVNIOXGAQ-YCRREMRBSA-N,1.4913023478447943e-10,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nomegestrol acetate,2016,Prescription,Human,763.98,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1936546540241427e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2017,Prescription,Human,724.92,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.110072716992719e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2018,Prescription,Human,763.56,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1705119695565852e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2019,Prescription,Human,391.02,IIVBFTNIGYRNQY-YQLZSBIMSA-N,1.1295477850930195e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
norelgestromin,2016,Prescription,Human,1316.304,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.7795706637747e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2017,Prescription,Human,1229.58,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.579020045466959e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2018,Prescription,Human,1179.954,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.354162450267394e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2019,Prescription,Human,1153.602,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.332434617101115e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norepinephrine,2016,Prescription,Human,563.84,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.6189824866161062e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2017,Prescription,Human,608.43,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.7709975489707555e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2018,Prescription,Human,598.5500000000001,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.701451018096933e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2019,Prescription,Human,625.4,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.8066062728176936e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norethisterone,2016,Prescription,Human,11628.66711,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.338998367228066e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.677996734456132
norethisterone,2017,Prescription,Human,11288.048196,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.285687044981306e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.571374089962612
norethisterone,2018,Prescription,Human,11405.604126,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.242181397075145e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.4843627941502895
norethisterone,2019,Prescription,Human,11396.149746,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.292029999535235e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.58405999907047
nortriptyline,2016,Prescription,Human,20790.865,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.969786875106372e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2017,Prescription,Human,20722.4,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.0318063883752604e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2018,Prescription,Human,20970.165,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.9610239059244294e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2019,Prescription,Human,22060.04,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.372530643205826e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
noscapine,2016,OTC,Human,230103.48,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.60707832415968e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2017,OTC,Human,184830.55,AKNNEGZIBPJZJG-MSOLQXFVSA-N,5.3799853890327026e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2018,OTC,Human,211380.54,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.008748391761414e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2019,OTC,Human,220222.27,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.361607521524653e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
nystatin,2016,Prescription,Human,10140,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.911549803896019e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2017,Prescription,Human,7980,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.3227915192851486e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2018,Prescription,Human,540,VQOXZBDYSJBXMA-RKEBNKJGSA-N,1.5350155371687308e-10,antifungal,topical antifungal,NA,NA,NA,NA
obeticholic acid,2017,Prescription,Human,5.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,1.615475304765987e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2018,Prescription,Human,29.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,8.399946133951109e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2019,Prescription,Human,73.5,ZXERDUOLZKYMJM-ZWECCWDJSA-N,2.1232101223553004e-11,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
oclacitinib,2016,Prescription,Vet,1577.108,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,4.528430461659608e-10,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2017,Prescription,Vet,6505.176,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,1.893504717325474e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2018,Prescription,Vet,7525.44,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.139197652598343e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2019,Prescription,Vet,7460.288,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.1550692513313983e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
ofloxacin,2016,Prescription,Human,9395,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.697634162485513e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2017,Prescription,Human,7144,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.079451455360038e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2018,Prescription,Human,6572,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.868170761161648e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2019,Prescription,Human,5720,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.6523485578057572e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
olanzapine,2016,Prescription,Human,57957.4664,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6641622281186404e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015128747528351276
olanzapine,2017,Prescription,Human,57756.7583,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6811642651709542e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015283311501554129
olanzapine,2018,Prescription,Human,57485.9054,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6341066288372564e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01485551480761142
olanzapine,2019,Prescription,Human,59245.3109,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.7114318885029498e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01555847171366318
olaparib,2016,Prescription,Human,2822.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,8.104100755933063e-10,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,2.532531486229082e-5
olaparib,2017,Prescription,Human,7750.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.2559603246951904e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.04987601467247e-5
olaparib,2018,Prescription,Human,8892.8,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.5278863275803867e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.899644773688709e-5
olaparib,2019,Prescription,Human,8372,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.4184374346066086e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.557616983145652e-5
olmesartan medoxomil,2016,Prescription,Human,20498.5319,UQGKUQLKSCSZGY-UHFFFAOYSA-N,5.8858477843788265e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2017,Prescription,Human,21258.5905,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.187878912951858e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2018,Prescription,Human,21317.3982,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.0597291572245804e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2019,Prescription,Human,22177.519,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.406467051636326e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olodaterol,2016,Prescription,Human,3.993,COUYJEVMBVSIHV-SFHVURJKSA-N,1.1465304109424858e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2017,Prescription,Human,7.77735,COUYJEVMBVSIHV-SFHVURJKSA-N,2.263804839913829e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2018,Prescription,Human,10.5654,COUYJEVMBVSIHV-SFHVURJKSA-N,3.003343177111576e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2019,Prescription,Human,13.5762,COUYJEVMBVSIHV-SFHVURJKSA-N,3.9217857500843574e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olopatadine,2016,Prescription,Human,689.9449999999999,JBIMVDZLSHOPLA-LSCVHKIXSA-N,1.9810741907781447e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2017,Prescription,Human,754.46,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.1960567539346784e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2018,Prescription,Human,789.41,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.2439937318451255e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2019,Prescription,Human,870.375,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.514270762238088e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olsalazine,2016,Prescription,Human,79768.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2904335358193255e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2017,Prescription,Human,76207.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2182222394225936e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2018,Prescription,Human,75384,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.1428816898875483e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2019,Prescription,Human,69604,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.0106655422641947e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
ombitasvir,2016,Prescription,Human,641.9,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.8431201372000538e-10,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2017,Prescription,Human,158.2,PIDFDZJZLOTZTM-KHVQSSSXSA-N,4.604832310161786e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2018,Prescription,Human,80.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,2.28831019892746e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2019,Prescription,Human,3.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.0110524392168097e-12,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
omeprazole,2016,Prescription,Human,233745.29,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.711647468058364e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.711647468058365e-4
omeprazole,2016,Prescription,Vet,37349.2504,SUBDBMMJDZJVOS-UHFFFAOYSA-N,1.0724280342976656e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,1.0724280342976656e-4
omeprazole,2017,Prescription,Human,228766.28,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.658851818075335e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.658851818075336e-4
omeprazole,2017,Prescription,Vet,47751.519199999995,SUBDBMMJDZJVOS-UHFFFAOYSA-N,1.3899351357235831e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,1.3899351357235832e-4
omeprazole,2018,Prescription,Human,219546.17,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.240866334738656e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.240866334738656e-4
omeprazole,2018,Prescription,Vet,63915.8387,SUBDBMMJDZJVOS-UHFFFAOYSA-N,1.81688528658649e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,1.81688528658649e-4
omeprazole,2019,Prescription,Human,224747.59,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.492331402217129e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.49233140221713e-4
omeprazole,2019,Prescription,Vet,75262.3956,SUBDBMMJDZJVOS-UHFFFAOYSA-N,2.1741208186480143e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,2.1741208186480145e-4
ondansetron,2016,Prescription,Human,10158.28,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.9167986333255283e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.114995729142276e-4
ondansetron,2017,Prescription,Human,9773.56,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.8448549224592172e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.890171632685055e-4
ondansetron,2018,Prescription,Human,9582.092,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.723825944181518e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.511956075567245e-4
ondansetron,2019,Prescription,Human,10485.448,FELGMEQIXOGIFQ-UHFFFAOYSA-N,3.028953650480291e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.46548015775091e-4
opium,2016,Prescription,Human,454.8,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.3058903854160843e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2017,Prescription,Human,436,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.2690941132936402e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2018,Prescription,Human,525.2,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.4929447409648472e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2019,Prescription,Human,709.5,LGFMXOTUSSVQJV-NEYUFSEYSA-N,2.0495477303552183e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
osaterone acetate,2016,Prescription,Vet,118.545,KKTIOMQDFOYCEN-OFUYBIASSA-N,3.4038429142293254e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2017,Prescription,Vet,146.73749999999998,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.271185721317099e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2018,Prescription,Vet,163.1175,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.6368129052614894e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2019,Prescription,Vet,183.09375,KKTIOMQDFOYCEN-OFUYBIASSA-N,5.289068072652936e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
oseltamivir,2016,Prescription,Human,3850.05,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.105484449949691e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2017,Prescription,Human,3546.9,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.0324197042296358e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2018,Prescription,Human,6644.25,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.8887087005246924e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2019,Prescription,Human,5278.95,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.524941506858165e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
osimertinib,2017,Prescription,Human,9.6,DUYJMQONPNNFPI-UHFFFAOYSA-N,2.794335662297923e-12,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,3.725780883063897e-5
osimertinib,2018,Prescription,Human,120,DUYJMQONPNNFPI-UHFFFAOYSA-N,3.411145638152735e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,4.548194184203647e-4
osimertinib,2019,Prescription,Human,208.8,DUYJMQONPNNFPI-UHFFFAOYSA-N,6.031649980241996e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,8.042199973655995e-4
oxaliplatin,2016,Prescription,Human,1864.3,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.353059466867208e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2017,Prescription,Human,1898.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.526235387141378e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2018,Prescription,Human,1834.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.21493102539425e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2019,Prescription,Human,1978.35,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.714901694641644e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxazepam,2016,Prescription,Human,541952.175,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5561348607911946e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2017,Prescription,Human,517128.355,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5052397962103758e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2018,Prescription,Human,502380.275,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.428076903133518e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2019,Prescription,Human,456991.805,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.320121940420979e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxcarbazepine,2016,Prescription,Human,952201.5,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.734104625832836e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021360192389319032
oxcarbazepine,2017,Prescription,Human,961171.05,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.79774431519098e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021857377462429533
oxcarbazepine,2018,Prescription,Human,958318.8,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.724137495483137e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021282324183462008
oxcarbazepine,2019,Prescription,Human,1066227,CTRLABGOLIVAIY-UHFFFAOYSA-N,3.0800325974537753e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.02406275466760762
oxfendazole,2016,Prescription,Vet,160650,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.6128252070601145e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2017,Prescription,Vet,149895,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.3630931677098666e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2018,Prescription,Vet,157455,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.4758494704611585e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2019,Prescription,Vet,145575,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.2052559668282024e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxybuprocaine,2016,Prescription,Human,449.44,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.2904999446380936e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2017,Prescription,Human,468.12,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.362587927328025e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2018,Prescription,Human,482.52,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.3716216611012146e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2019,Prescription,Human,531.92,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.5365686099091578e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybutynin,2016,Prescription,Human,369.9768,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0623332144833104e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2017,Prescription,Human,369.3288,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0750298301601012e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2018,Prescription,Human,343.6828,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.769600701067656e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2019,Prescription,Human,341.0924,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.853208657666163e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxyclozanide,2018,Prescription,Vet,748,JYWIYHUXVMAGLG-UHFFFAOYSA-N,2.1262807811152047e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxyclozanide,2019,Prescription,Vet,1496,JYWIYHUXVMAGLG-UHFFFAOYSA-N,4.3215269973381347e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxycodone,2016,Prescription,Human,329517.24381,BRUQQQPBMZOVGD-XFKAJCMBSA-N,9.461596317508505e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2017,Prescription,Human,358341.92017,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.0430495904451526e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2018,Prescription,Human,363479.17312,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.033233663289709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2019,Prescription,Human,376641.07752,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.08801108610241e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxymetazoline,2016,OTC,Human,781.9186,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2451626691249012e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2017,OTC,Human,769.4276,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2396239398294808e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2018,OTC,Human,679.2178,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9307590298547475e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2019,OTC,Human,681.5715,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9688700787875991e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxytetracycline,2016,Prescription,Human,2904.75,OWFJMIVZYSDULZ-PXOLEDIWSA-N,8.340556501841185e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2016,Prescription,Vet,106765,OWFJMIVZYSDULZ-PXOLEDIWSA-N,3.0655977792204984e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2017,Prescription,Human,2863.35,OWFJMIVZYSDULZ-PXOLEDIWSA-N,8.33454272775079e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2017,Prescription,Vet,88270,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.5693334261566425e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2018,Prescription,Human,2754,OWFJMIVZYSDULZ-PXOLEDIWSA-N,7.828579239560528e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2018,Prescription,Vet,96410,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.74057125811921e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2019,Prescription,Human,3040.65,OWFJMIVZYSDULZ-PXOLEDIWSA-N,8.783590283727406e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2019,Prescription,Vet,75930,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.193406048849496e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
palbociclib,2016,Prescription,Human,92.4,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.6531282236685623e-11,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2017,Prescription,Human,6135.15,AHJRHEGDXFFMBM-UHFFFAOYSA-N,1.7857987956819902e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2018,Prescription,Human,7519.575,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.137530455167696e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2019,Prescription,Human,7089.6,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.0479878208775703e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palifermin,2016,Prescription,Human,0.075,NA,2.1535131685621443e-14,antineoplastic,"treatment for chemotherapy-caused mouth sores, ulcers",NA,NA,NA,NA
paliperidone,2016,Prescription,Human,1382.118,PMXMIIMHBWHSKN-UHFFFAOYSA-N,3.9685457513423646e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.5874183005369458e-6
paliperidone,2017,Prescription,Human,1423.691,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.1440318056172836e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.6576127222469135e-6
paliperidone,2018,Prescription,Human,1506.598,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.2826876634580284e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.7130750653832113e-6
paliperidone,2019,Prescription,Human,1561.067,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.5094874232310496e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.8037949692924198e-6
pamidronic acid,2016,Prescription,Human,105.6,WRUUGTRCQOWXEG-UHFFFAOYSA-N,3.032146541335499e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2017,Prescription,Human,41.43000000000001,WRUUGTRCQOWXEG-UHFFFAOYSA-N,1.2059304842604478e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2018,Prescription,Human,26.639999999999997,WRUUGTRCQOWXEG-UHFFFAOYSA-N,7.572743316699072e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2019,Prescription,Human,14.25,WRUUGTRCQOWXEG-UHFFFAOYSA-N,4.116427788239868e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
panobinostat,2016,Prescription,Human,8.55,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.455005012160845e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2017,Prescription,Human,9.81,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.8554617549106904e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2018,Prescription,Human,4.05,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.151261652876548e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2019,Prescription,Human,4.23,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.2219290908248873e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
pantoprazole,2016,OTC,Human,25919.18,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.442306059777676e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,2.8624254076067986e-4
pantoprazole,2016,Prescription,Human,1800959.7952,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.171187513352244e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.01988918274366248
pantoprazole,2017,OTC,Human,26950.56,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.844678221552075e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,3.017183931366183e-4
pantoprazole,2017,Prescription,Human,1948644.096,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.672047594353227e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.021815567670589335
pantoprazole,2018,OTC,Human,26676.44,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.583101828953595e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,2.9165776265206137e-4
pantoprazole,2018,Prescription,Human,2128075.5328,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.049312976141899e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.023266588369776537
pantoprazole,2019,OTC,Human,25204.34,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.280831267385658e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,2.800319718225253e-4
pantoprazole,2019,Prescription,Human,2337829.9232,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.753338989501163e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.025974380728850627
papaverine,2016,Prescription,Human,90,XQYZDYMELSJDRZ-UHFFFAOYSA-N,2.5842158022745735e-11,vasodilator,"peripheral vasodilator for chest pain, circulation issues, heart attacks, etc.",low,NA,NA,NA
paracetamol,2016,OTC,Human,88627560.68,RZVAJINKPMORJF-UHFFFAOYSA-N,2.5448082536256073e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.7660959278539208
paracetamol,2016,Prescription,Human,170332790.485,RZVAJINKPMORJF-UHFFFAOYSA-N,4.890852097965124e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,5.3161435847447
paracetamol,2017,OTC,Human,87693173.74,RZVAJINKPMORJF-UHFFFAOYSA-N,2.5525433616851017e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.7745036540055454
paracetamol,2017,Prescription,Human,180694158.55,RZVAJINKPMORJF-UHFFFAOYSA-N,5.259584700053961e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,5.716939891363001
paracetamol,2018,OTC,Human,88368184.41,RZVAJINKPMORJF-UHFFFAOYSA-N,2.5119728900137335e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.730405315232319
paracetamol,2018,Prescription,Human,190993515.55,RZVAJINKPMORJF-UHFFFAOYSA-N,5.4292224790319925e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,5.901328781556513
paracetamol,2019,OTC,Human,90825833.23,RZVAJINKPMORJF-UHFFFAOYSA-N,2.6237051494597333e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.8518534233257973
paracetamol,2019,Prescription,Human,205670085.125,RZVAJINKPMORJF-UHFFFAOYSA-N,5.941235463987432e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,6.4578646347689475
parecoxib,2016,Prescription,Human,511.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.4689831160485242e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2017,Prescription,Human,679.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.9781567876017383e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2018,Prescription,Human,777.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.2104223735229722e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2019,Prescription,Human,964.8,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.7870382667325083e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
paritaprevir,2016,Prescription,Human,3851.4,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.1058720823200323e-9,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2017,Prescription,Human,949.2,UAUIUKWPKRJZJV-QPLHLKROSA-N,2.7628993860970716e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2018,Prescription,Human,483,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.3729861193564758e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2019,Prescription,Human,21,UAUIUKWPKRJZJV-QPLHLKROSA-N,6.066314635300858e-12,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paroxetine,2016,Prescription,Human,96786.6296,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.7790837517912887e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19850598227080632
paroxetine,2017,Prescription,Human,92756.0448,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.6999117070660822e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19285083621900587
paroxetine,2018,Prescription,Human,89049.5236,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.531340783397659e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.18081005595697563
paroxetine,2019,Prescription,Human,86480.4608,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.4981794524695342e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.17844138946210958
pazopanib,2016,Prescription,Human,22512,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.463985126756133e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.0399907042225835e-4
pazopanib,2017,Prescription,Human,22806,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.638293657746504e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.148933536091565e-4
pazopanib,2018,Prescription,Human,16614,CUIHSIWYWATEQL-UHFFFAOYSA-N,4.7227311360224615e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,2.9517069600140384e-4
pazopanib,2019,Prescription,Human,20970,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.057648471536143e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,3.7860302947100895e-4
pemetrexed,2016,Prescription,Human,1646.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,4.726530702360195e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,3.938775585300162e-6
pemetrexed,2017,Prescription,Human,1209.8,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.5214450877583614e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.934537573131968e-6
pemetrexed,2018,Prescription,Human,1256.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.570616696736375e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.975513913946979e-6
pemetrexed,2019,Prescription,Human,2052.4,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,5.928811503567371e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,4.9406762529728095e-6
penciclovir,2016,OTC,Human,602.44,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.7298166310247712e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2017,OTC,Human,481.24,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.4007771813794298e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2018,OTC,Human,379.14,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0777514643743568e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2019,OTC,Human,373.28,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0783018700310018e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
pentobarbital,2016,Prescription,Vet,243500,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,6.99173942059843e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2017,Prescription,Vet,254220,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.39975012572269e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2018,Prescription,Vet,286010,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,8.130181366400533e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2019,Prescription,Vet,260620,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.528585334533856e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentoxifylline,2016,Prescription,Human,149479.2,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4.2920723416817944e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2017,Prescription,Human,134452.4,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.9135951687660967e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2018,Prescription,Human,121401.6,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.450987819206359e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2019,Prescription,Human,116492,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.3651291642641314e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
perampanel,2016,Prescription,Human,565.26064,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.6230616425464876e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2017,Prescription,Human,644.51352,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.8760282435095475e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2018,Prescription,Human,695.6502,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.9774701211750648e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2019,Prescription,Human,782.96424,PRMWGUBFXWROHD-UHFFFAOYSA-N,2.2617654419186732e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
pergolide,2016,Prescription,Vet,54.68,YEHCICAEULNIGD-MZMPZRCHSA-N,1.5700546674263742e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2017,Prescription,Vet,63.9,YEHCICAEULNIGD-MZMPZRCHSA-N,1.859979675217055e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2018,Prescription,Vet,67.22,YEHCICAEULNIGD-MZMPZRCHSA-N,1.910810081638557e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2019,Prescription,Vet,87.72,YEHCICAEULNIGD-MZMPZRCHSA-N,2.5339862848028156e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
perindopril,2016,Prescription,Human,34.35,IPVQLZZIHOAWMC-QXKUPLGCSA-N,9.86309031201462e-12,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2017,Prescription,Human,51.45,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.4975892690127932e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2018,Prescription,Human,61.5,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.7482121395532767e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2019,Prescription,Human,84.75,IPVQLZZIHOAWMC-QXKUPLGCSA-N,2.4481912635321318e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perphenazine,2016,Prescription,Human,2466.96,RGCVKNLCSQQDEP-UHFFFAOYSA-N,7.08350779508809e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2017,Prescription,Human,2298.168,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.689430000366557e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2018,Prescription,Human,2226.756,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.329824180525361e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2019,Prescription,Human,2184.558,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.310579127173128e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
pethidine,2016,Prescription,Human,21194.6,XADCESSVHJOZHK-UHFFFAOYSA-N,6.0857133603209644e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2017,Prescription,Human,19139.9,XADCESSVHJOZHK-UHFFFAOYSA-N,5.571177619043336e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2018,Prescription,Human,18886.2,XADCESSVHJOZHK-UHFFFAOYSA-N,5.368631562606682e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2019,Prescription,Human,16755.7,XADCESSVHJOZHK-UHFFFAOYSA-N,4.840254673081457e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
phenazone,2016,OTC,Human,8277984,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.376899673752898e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2017,OTC,Human,7763021,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.2596340028612176e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2018,OTC,Human,7343160.5,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.0873824924858714e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2019,OTC,Human,6807970,VEQOALNAAJBPNY-UHFFFAOYSA-N,1.9666327641756753e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenobarbital,2016,Prescription,Human,94013.10499999992,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.6994461284655386e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2016,Prescription,Vet,1337.5,DDBREPKUVSBGFI-UHFFFAOYSA-N,3.840431817269157e-10,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2017,Prescription,Human,89700.9,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.6109835813564562e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2017,Prescription,Vet,3840,DDBREPKUVSBGFI-UHFFFAOYSA-N,1.117734264919169e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2018,Prescription,Human,84657.1,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.4064808116971666e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2018,Prescription,Vet,5742.5,DDBREPKUVSBGFI-UHFFFAOYSA-N,1.63237531892434e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2019,Prescription,Human,15432.46,DDBREPKUVSBGFI-UHFFFAOYSA-N,4.458007521747385e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2019,Prescription,Vet,13450,DDBREPKUVSBGFI-UHFFFAOYSA-N,3.8853300878474544e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenoxymethylpenicillin,2016,Prescription,Human,13360655.2,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.836312921842438e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2017,Prescription,Human,12987487.15,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.780354011133439e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2018,Prescription,Human,12311053.9,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.4995664843373515e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2019,Prescription,Human,12955160.4,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.7423847208185777e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenylbutazone,2018,Prescription,Vet,736,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.0921693247336774e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylbutazone,2019,Prescription,Vet,1024,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.958050565022895e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylpropanolamine,2016,Prescription,Human,231900.7625,DLNKOYKMWOXYQA-VXNVDRBHSA-N,6.658684611244698e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2017,Prescription,Human,276868.0875,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.058983027640334e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2018,Prescription,Human,262740.8425,DLNKOYKMWOXYQA-VXNVDRBHSA-N,7.468727323820415e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2019,Prescription,Human,279732.4,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.080689295656351e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenytoin,2016,Prescription,Human,34721.4,CXOFVDLJLONNDW-UHFFFAOYSA-N,9.969732284121821e-9,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2017,Prescription,Human,101386.1,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.9511124467844112e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2018,Prescription,Human,100090.875,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.8452045972928387e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2019,Prescription,Human,95765.575,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.7664005199071523e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
pibrentasvir,2017,Prescription,Human,3.36,VJYSBPDEJWLKKJ-NLIMODCCSA-N,9.78017481804273e-13,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2018,Prescription,Human,265.44,VJYSBPDEJWLKKJ-NLIMODCCSA-N,7.545454151593849e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2019,Prescription,Human,204.96,VJYSBPDEJWLKKJ-NLIMODCCSA-N,5.920723084053637e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pilocarpine,2016,Prescription,Human,4093.357,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.175346427083471e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2017,Prescription,Human,3945.289,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.1483814323720534e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2018,Prescription,Human,3294.01,QCHFTSOMWOSFHM-WPRPVWTQSA-N,9.36362320294291e-10,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2019,Prescription,Human,3521.756,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.0173371411789814e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pimecrolimus,2016,Prescription,Human,2820.3,KASDHRXLYQOAKZ-XDSKOBMDSA-N,8.098070919061089e-10,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2017,Prescription,Human,3484.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0143438454141463e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2018,Prescription,Human,3640.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0349415866155399e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2019,Prescription,Human,4461.6,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.2888318750884911e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimobendan,2016,Prescription,Vet,2620.3125,GLBJJMFZWDBELO-UHFFFAOYSA-N,7.523836632663991e-10,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2017,Prescription,Vet,3819.9125,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.1118872630841268e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2018,Prescription,Vet,4348.78875,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.236195981317515e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2019,Prescription,Vet,5381.145,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.5544627937226683e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pioglitazone,2016,Prescription,Human,13208.934,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.792748441555765e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2017,Prescription,Human,11602.8321,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.377313283404698e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2018,Prescription,Human,13893.6366,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.949434823847433e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2019,Prescription,Human,11930.8368,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.446486185296478e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
piperacillin,2016,Prescription,Human,1429560,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.104768380332933e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2017,Prescription,Human,1165680,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.393022077945254e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2018,Prescription,Human,1198320,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.406370034259322e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2019,Prescription,Human,141960,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.10082869346338e-8,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piracetam,2016,Prescription,Human,108088.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.1036087223210664e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2017,Prescription,Human,109509.6,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.187568548374798e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2018,Prescription,Human,103096.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.9306516635625412e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2019,Prescription,Human,99360,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.8702334388737772e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
pirfenidone,2016,Prescription,Human,41245.092,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1842913168074289e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.1172559592522914e-5
pirfenidone,2017,Prescription,Human,39966.696,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1633371243439557e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.0974878531546753e-5
pirfenidone,2018,Prescription,Human,47300.652,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.3445784395965037e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.2684702260344375e-5
pirfenidone,2019,Prescription,Human,60286.464,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.7415078993987538e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.6429319805648622e-5
piroxicam,2016,Prescription,Human,32908.44,QYSPLQLAKJAUJT-UHFFFAOYSA-N,9.449167852911632e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2017,Prescription,Human,28692.1,QYSPLQLAKJAUJT-UHFFFAOYSA-N,8.351599818356068e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2018,Prescription,Human,26629.96,QYSPLQLAKJAUJT-UHFFFAOYSA-N,7.569889324848484e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2019,Prescription,Human,21773.14,QYSPLQLAKJAUJT-UHFFFAOYSA-N,6.2896532304025965e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
pitolisant,2018,Prescription,Human,73.71000000000001,NNACHAUCXXVJSP-UHFFFAOYSA-N,2.0952962082353174e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pitolisant,2019,Prescription,Human,238.95,NNACHAUCXXVJSP-UHFFFAOYSA-N,6.902599438595904e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pivmecillinam,2016,Prescription,Human,1939166,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.568026022703973e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2017,Prescription,Human,1795218,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.225460082290785e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2018,Prescription,Human,1816464,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.163519375384559e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2019,Prescription,Human,1848556,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.339963008082483e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pixantrone,2018,Prescription,Human,0.928,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.637952626838116e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
pixantrone,2019,Prescription,Human,0.957,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.764506240944248e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
plerixafor,2016,Prescription,Human,1.584,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.548219812003249e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2017,Prescription,Human,1.56,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.540795451234126e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2018,Prescription,Human,1.152,YIQPUIGJQJDJOS-UHFFFAOYSA-N,3.274699812626625e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2019,Prescription,Human,1.752,YIQPUIGJQJDJOS-UHFFFAOYSA-N,5.061039638593859e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
podophyllotoxin,2016,Prescription,Human,253.79,YJGVMLPVUAXIQN-XVVDYKMHSA-N,7.287201427325156e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2017,Prescription,Human,234.99,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.840009763368636e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2018,Prescription,Human,241.1675,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.85547888074333e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2019,Prescription,Human,221.865,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.409061412195355e-11,dermatological,topical treatment for warts,low,NA,NA,NA
pomalidomide,2016,Prescription,Human,41.265,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.1848629453428919e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2017,Prescription,Human,67.977,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.9786516178752705e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2018,Prescription,Human,73.815,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.098280960668701e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2019,Prescription,Human,78.246,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.2603088331130995e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
ponatinib,2016,Prescription,Human,50.85,PHXJVRSECIGDHY-UHFFFAOYSA-N,1.460081928285134e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2017,Prescription,Human,92.25,PHXJVRSECIGDHY-UHFFFAOYSA-N,2.6851819254894103e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2018,Prescription,Human,119.7,PHXJVRSECIGDHY-UHFFFAOYSA-N,3.402617774057353e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2019,Prescription,Human,145.35,PHXJVRSECIGDHY-UHFFFAOYSA-N,4.198756344004665e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
posaconazole,2016,Prescription,Human,4580.1,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.3151074217775304e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.207579077506172e-4
posaconazole,2017,Prescription,Human,4315.2,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2560538802029162e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.0635460492754057e-4
posaconazole,2018,Prescription,Human,4299.6,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2222134821501252e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,2.981008493049086e-4
posaconazole,2019,Prescription,Human,5096.7,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.472294561987518e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.59096234631102e-4
potassium permanganate,2016,OTC,Human,125805,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.6123029889461414e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2017,OTC,Human,123675,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.5998902399447475e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2018,OTC,Human,113475,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.2256645940781804e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2019,OTC,Human,109695,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.1687827805682274e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
pradofloxacin,2016,Prescription,Vet,173.46,LZLXHGFNOWILIY-APPDUMDISA-N,4.980645256250528e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2017,Prescription,Vet,141.09,LZLXHGFNOWILIY-APPDUMDISA-N,4.1068001936834786e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2018,Prescription,Vet,134.535,LZLXHGFNOWILIY-APPDUMDISA-N,3.8243206535739845e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pramipexole,2016,Prescription,Human,1579.1929008,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.5344169434302027e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.477738490614576e-6
pramipexole,2017,Prescription,Human,1642.4982564,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.780928597000707e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.8298979957152965e-6
pramipexole,2018,Prescription,Human,1668.3206548,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.742403937217611e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.774862767453731e-6
pramipexole,2019,Prescription,Human,1717.1190604,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.960278326980276e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,7.086111895686109e-6
prasterone,2019,Prescription,Human,206.388,FMGSKLZLMKYGDP-USOAJAOKSA-N,5.961974023573682e-11,sex hormone,androgen and estrogen for various gynaecological disorders and applications,NA,NA,NA,NA
prasugrel,2016,Prescription,Human,3764.3088,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.080865142844582e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.688763909708326e-5
prasugrel,2017,Prescription,Human,3945.018,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1483025506049195e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,6.043697634762734e-5
prasugrel,2018,Prescription,Human,3797.7856,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.0795666486732724e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.681929729859328e-5
prasugrel,2019,Prescription,Human,3890.2712,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1237909102785442e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.9146890014660216e-5
pravastatin,2016,Prescription,Human,178725.6696,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.131841107249159e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2017,Prescription,Human,172430.986,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.01906305692702e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2018,Prescription,Human,167017.8404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.74768481478458e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2019,Prescription,Human,160755.9404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.6437910188574885e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
praziquantel,2016,Prescription,Vet,38681.070297,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.1106692567822336e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2017,Prescription,Vet,42742.837181,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2441441066943952e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2018,Prescription,Vet,44943.927322,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2775856803824488e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2019,Prescription,Vet,45877.980674,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.3252869790511244e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
prednisone,2016,Prescription,Human,409.723,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1764585012837168e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2017,Prescription,Human,378.1,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1005607436612966e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2018,Prescription,Human,3.58,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.017658448715566e-12,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
pregabalin,2016,Prescription,Human,1791066.915,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.1427815829713e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2017,Prescription,Human,1945696.37,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.663467452806891e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2018,Prescription,Human,1993165.606,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.66581513585246e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2019,Prescription,Human,1993225.119,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.757871767066187e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
prilocaine,2016,Prescription,Human,14261.4,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.094948360284289e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2017,Prescription,Human,14974.2,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.358639695248079e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2018,Prescription,Human,15573.6,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.426984809194619e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2019,Prescription,Human,15255,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.4067442743578375e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
probenecid,2016,Prescription,Human,389706,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1189826704902389e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2017,Prescription,Human,389573.5,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1339574209752294e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2018,Prescription,Human,368371,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.047139274893301e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2019,Prescription,Human,363917.75,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.0512569394622663e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
procaine,2016,Prescription,Vet,1895397.839720175,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.442352276668849e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2017,Prescription,Vet,1880531.9541237105,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.473789066144465e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2018,Prescription,Vet,1809090.6423749097,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.142559711466751e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2019,Prescription,Vet,1847522.5354660428,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.336977617117049e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
prochlorperazine,2016,Prescription,Human,9142.84000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.625230178407565e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2017,Prescription,Human,8558.645,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.4912215567133136e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2018,Prescription,Human,8061.03000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.291445610293198e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2019,Prescription,Human,7872.605,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.2741761394972713e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
progesterone,2016,Prescription,Human,60222.649999999994,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.7292035976094535e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2016,Prescription,Vet,4567.8,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.3115756601810883e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2017,Prescription,Human,61691,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.7956808473210542e-08,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2017,Prescription,Vet,5575.2,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.6228104358795187e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2018,Prescription,Human,64068,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.821210656209745e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2018,Prescription,Vet,5492.4,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.5612813585825066e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2019,Prescription,Human,83775.6,RJKFOVLPORLFTN-LEKSSAKUSA-N,2.4200435636243363e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2019,Prescription,Vet,5023.2,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.4510624607639651e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
proguanil,2016,Prescription,Human,92181.6,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.6468571933217093e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005293714386643418
proguanil,2017,Prescription,Human,97745.7,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.845148909857022e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005690297819714044
proguanil,2018,Prescription,Human,96136.5,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.7327966886855868e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005465593377371173
proguanil,2019,Prescription,Human,97569,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.8184964411984258e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005636992882396851
promethazine,2016,Prescription,Human,59833.65,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.7180340426418446e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2017,Prescription,Human,56488.675,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.6442533236297622e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2018,Prescription,Human,54111.375,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.5381815067141412e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2019,Prescription,Human,54277.4,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.567922790409899e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
propentofylline,2016,Prescription,Vet,22908,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.577690622056214e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2017,Prescription,Vet,23214,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.757052923394166e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2018,Prescription,Vet,23299,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.6230235186100484e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2019,Prescription,Vet,23473,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.780695401638906e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propofol,2016,Prescription,Human,283568,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.14223229577107e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2016,Prescription,Vet,6393.1,OLBCVFGFOZPWHH-UHFFFAOYSA-N,1.8356833383912863e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2017,Prescription,Human,301468,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.775028994183649e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2017,Prescription,Vet,6341,OLBCVFGFOZPWHH-UHFFFAOYSA-N,1.8457169202740758e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2018,Prescription,Human,298188,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.476355796245733e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2018,Prescription,Vet,7119,OLBCVFGFOZPWHH-UHFFFAOYSA-N,2.02366214983411e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2019,Prescription,Human,324548,OLBCVFGFOZPWHH-UHFFFAOYSA-N,9.375287058369633e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2019,Prescription,Vet,7609,OLBCVFGFOZPWHH-UHFFFAOYSA-N,2.1980280028573444e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propranolol,2016,Prescription,Human,80145.38,AQHHHDLHHXJYJD-UHFFFAOYSA-N,2.3012550830588952e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.10005456882864762
propranolol,2017,Prescription,Human,144543.47999999998,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4.2073229262150694e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.1829270837484813
propranolol,2018,Prescription,Human,206155.41,AQHHHDLHHXJYJD-UHFFFAOYSA-N,5.8602177300257395e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.25479207521851044
propranolol,2019,Prescription,Human,226062.42,AQHHHDLHHXJYJD-UHFFFAOYSA-N,6.530313175892996e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.2839266598214346
propylthiouracil,2016,Prescription,Human,22577.6,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482821188603823e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2017,Prescription,Human,19912.7,KNAHARQHSZJURB-UHFFFAOYSA-N,5.796121639858319e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2018,Prescription,Human,21872.3,KNAHARQHSZJURB-UHFFFAOYSA-N,6.217466728447339e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2019,Prescription,Human,22440,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482290496007202e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
proxymetacaine,2016,Prescription,Human,394.275,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.1321018727131192e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2017,Prescription,Human,376.725,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.096558439978318e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2018,Prescription,Human,375.45,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.0672621915370369e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2019,Prescription,Human,334.35,KCLANYCVBBTKTO-UHFFFAOYSA-N,9.658439515775437e-11,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
prucalopride,2016,Prescription,Human,121.4864,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.4883008293494413e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2017,Prescription,Human,136.16176,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.9633506438463625e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2018,Prescription,Human,146.34536,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.1600444702324305e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2019,Prescription,Human,171.09511999999998,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.9424610975455065e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
pyrantel,2016,Prescription,Vet,12345.304542809828,YSAUAVHXTIETRK-AATRIKPKSA-N,3.544770120380137e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2017,Prescription,Vet,16631.893990675977,YSAUAVHXTIETRK-AATRIKPKSA-N,4.8411556780942094e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2018,Prescription,Vet,32461.605806916097,YSAUAVHXTIETRK-AATRIKPKSA-N,9.227605421307946e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2019,Prescription,Vet,23870.71177254078,YSAUAVHXTIETRK-AATRIKPKSA-N,6.895583246705363e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrazinamide,2016,Prescription,Human,15432,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.431068695633469e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2017,Prescription,Human,16368,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.764342304217959e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2018,Prescription,Human,14496,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.120663930888504e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2019,Prescription,Human,12624,IPEHBUMCGVEMRF-UHFFFAOYSA-N,3.646721712192287e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyridostigmine,2016,Prescription,Human,39028.42,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.1206428855756556e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2017,Prescription,Human,43240.814999999995,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2586390773054892e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2018,Prescription,Human,43505.77,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2367043130831344e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2019,Prescription,Human,46642.03,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.347358234329246e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyrvinium,2016,OTC,Human,1437.2,QMHSXPLYMTVAMK-UHFFFAOYSA-N,4.126705501143352e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2017,OTC,Human,2412.8,QMHSXPLYMTVAMK-UHFFFAOYSA-N,7.023096964575448e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2018,OTC,Human,1334,QMHSXPLYMTVAMK-UHFFFAOYSA-N,3.792056901079791e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2019,OTC,Human,2815.6,QMHSXPLYMTVAMK-UHFFFAOYSA-N,8.133483565310996e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
quetiapine,2016,Prescription,Human,2024105.925,URKOMYMAXPYINW-UHFFFAOYSA-N,5.811918352069548e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.058119183520695485
quetiapine,2017,Prescription,Human,2167664.5,URKOMYMAXPYINW-UHFFFAOYSA-N,6.30956480859083e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06309564808590831
quetiapine,2018,Prescription,Human,2235867.525,URKOMYMAXPYINW-UHFFFAOYSA-N,6.355724796159251e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06355724796159251
quetiapine,2019,Prescription,Human,2349528.8000000003,URKOMYMAXPYINW-UHFFFAOYSA-N,6.78713378357184e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06787133783571841
quinagolide,2016,Prescription,Human,4.388625,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.260128230584139e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2017,Prescription,Human,3.9095775,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.1379866492466208e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2018,Prescription,Human,3.453975,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,9.818343129615491e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2019,Prescription,Human,3.0753,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,8.883684475209872e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinine,2016,Prescription,Human,8640.39999999999,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.480962024219244e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2017,Prescription,Human,7407.3,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.1560919324311883e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2018,Prescription,Human,7110.7,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.021302774101054e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2019,Prescription,Human,5907.6,LOUPRKONTZGTKE-WZBLMQSHSA-N,1.7065409685477783e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
raloxifene,2016,Prescription,Human,5740.56,GZUITABIAKMVPG-UHFFFAOYSA-N,1.648316207322814e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2017,Prescription,Human,4662,GZUITABIAKMVPG-UHFFFAOYSA-N,1.356999256003429e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2018,Prescription,Human,4193.28,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1919907317960915e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2019,Prescription,Human,3911.04,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1297904376784318e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raltegravir,2016,Prescription,Human,82722,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.3752388843973032e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,6.250628643150798e-5
raltegravir,2017,Prescription,Human,66102,CZFFBEXEKNGXKS-UHFFFAOYSA-N,1.9240747494710138e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.0633546038710884e-5
raltegravir,2018,Prescription,Human,77430,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.201041723018052e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.7922150605738206e-5
raltegravir,2019,Prescription,Human,132873,CZFFBEXEKNGXKS-UHFFFAOYSA-N,3.8383305930301476e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,1.0100869981658282e-4
raltitrexed,2016,Prescription,Human,0.08,IVTVGDXNLFLDRM-HNNXBMFYSA-N,2.2970807131329543e-14,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2017,Prescription,Human,0.012,IVTVGDXNLFLDRM-HNNXBMFYSA-N,3.4929195778724047e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2018,Prescription,Human,0.006,IVTVGDXNLFLDRM-HNNXBMFYSA-N,1.7055728190763676e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
ramipril,2016,Prescription,Human,138640.30915,HDACQVRGBOVJII-JBDAPHQKSA-N,3.98084975264069e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,3.9808497526406904e-4
ramipril,2017,Prescription,Human,140762.69305,HDACQVRGBOVJII-JBDAPHQKSA-N,4.097273053236573e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0972730532365734e-4
ramipril,2018,Prescription,Human,143805.1765,HDACQVRGBOVJII-JBDAPHQKSA-N,4.0878366713479934e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0878366713479935e-4
ramipril,2019,Prescription,Human,146951.5148,HDACQVRGBOVJII-JBDAPHQKSA-N,4.245019642432717e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.2450196424327174e-4
ranitidine,2016,OTC,Human,32202.9,VMXUWOKSQNHOCA-UKTHLTGXSA-N,9.246582562118653e-9,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.0014913842842126858
ranitidine,2016,Prescription,Human,1030498.385,VMXUWOKSQNHOCA-UKTHLTGXSA-N,2.958922456372697e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.04772455574794673
ranitidine,2017,Prescription,Human,1466133.64,VMXUWOKSQNHOCA-UKTHLTGXSA-N,4.267572412444443e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.06883181310394262
ranitidine,2018,OTC,Human,13401.75,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.809610088009452e-9,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,6.144532400015245e-4
ranitidine,2018,Prescription,Human,1779118.775,VMXUWOKSQNHOCA-UKTHLTGXSA-N,5.057361040914072e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.08157033936958182
ranitidine,2019,OTC,Human,18132,VMXUWOKSQNHOCA-UKTHLTGXSA-N,5.2378293793940555e-9,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,8.448111902248477e-4
ranitidine,2019,Prescription,Human,1216805.17,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.515010957657499e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.05669372512350805
rasagiline,2016,Prescription,Human,654.68592,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8798329999896302e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2017,Prescription,Human,657.60604,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.9141375097026192e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2018,Prescription,Human,636.54976,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8094699477426418e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2019,Prescription,Human,603.1502399999999,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.7423329181891542e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
reboxetine,2016,Prescription,Human,458.3568,CBQGYUDMJHNJBX-RTBURBONSA-N,1.3161032062666736e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2017,Prescription,Human,415.8912,CBQGYUDMJHNJBX-RTBURBONSA-N,1.2105620956207064e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2018,Prescription,Human,400.032,CBQGYUDMJHNJBX-RTBURBONSA-N,1.1371395099345956e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2019,Prescription,Human,366.5136,CBQGYUDMJHNJBX-RTBURBONSA-N,1.0587556265318115e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
regorafenib,2016,Prescription,Human,594.72,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.7076498021430383e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2017,Prescription,Human,769.4399999999999,FNHKPVJBJVTLMP-UHFFFAOYSA-N,2.239660033331785e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2018,Prescription,Human,584.64,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.6619101549080123e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2019,Prescription,Human,665.28,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.9218084764633115e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
remifentanil,2016,Prescription,Human,427.1749999999999,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2265693170407118e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2017,Prescription,Human,393.86,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.1464344207840208e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2018,Prescription,Human,452.21,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2854618075242068e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2019,Prescription,Human,475.56,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.373760279982703e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
repaglinide,2016,Prescription,Human,223.8552,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.427668280681501e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2017,Prescription,Human,209.0634,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.085347023971414e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2018,Prescription,Human,175.029,FAEKWTJYAYMJKF-QHCPKHFHSA-N,4.975411749168626e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2019,Prescription,Human,132.615,FAEKWTJYAYMJKF-QHCPKHFHSA-N,3.8308776921924916e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
retapamulin,2016,Prescription,Human,115.25,STZYTFJPGGDRJD-FJJJPKKESA-N,3.3092319023571617e-11,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retapamulin,2017,Prescription,Human,29.7,STZYTFJPGGDRJD-FJJJPKKESA-N,8.644975955234199e-12,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retigabine,2016,Prescription,Human,583.254,PCOBBVZJEWWZFR-UHFFFAOYSA-N,1.6747268928220602e-10,anticonvulsant,potassium channel opener for partial epilepsies,low,high,3.2e-6,5.2335215400689384e-5
ribavirin,2016,Prescription,Human,70760.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,2.0317908615732298e-8,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.002944624437062652
ribavirin,2017,Prescription,Human,31796.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,9.255305436141105e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.0013413486139334935
ribavirin,2018,Prescription,Human,6628.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,1.884316850515571e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,2.730893986254451e-4
ribavirin,2019,Prescription,Human,2826.4,IWUCXVSUMQZMFG-AFCXAGJDSA-N,8.164681754863973e-10,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,1.1832872108498512e-4
ribociclib,2018,Prescription,Human,7593.6,RHXHGRAEPCAFML-UHFFFAOYSA-N,2.1585729598230502e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
ribociclib,2019,Prescription,Human,20668.2,RHXHGRAEPCAFML-UHFFFAOYSA-N,5.970466864063105e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
rifampicin,2016,Prescription,Human,55719,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5998880031881885e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2017,Prescription,Human,54300,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.580546108987263e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2018,Prescription,Human,53874,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5314338342486704e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2019,Prescription,Human,51981,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5015861955122566e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifaximin,2016,Prescription,Human,48192.144,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.3837655563365753e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2017,Prescription,Human,66513.524,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.9360532514407172e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2018,Prescription,Human,87425.492,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.4851757141596402e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2019,Prescription,Human,102902.184,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.972557260969627e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rilpivirine,2016,Prescription,Human,5196,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.4919539231798536e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,7.459769615899268e-4
rilpivirine,2017,Prescription,Human,6089.25,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.772438378296628e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.86219189148314e-4
rilpivirine,2018,Prescription,Human,6192.75,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7603643458891961e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.801821729445981e-4
rilpivirine,2019,Prescription,Human,5976,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7262998219313296e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.631499109656648e-4
riluzole,2016,Prescription,Human,8909.74,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.5582989891286512e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2017,Prescription,Human,9853.592,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.868150367430575e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2018,Prescription,Human,9749.6,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.771442126144492e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2019,Prescription,Human,9594.872,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.7716910684494483e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
rimexolone,2016,Prescription,Human,231.15,QTTRZHGPGKRAFB-OOKHYKNYSA-N,6.63712758550853e-11,steroid,ophthalmic steroid for eye swelling,low,NA,NA,NA
riociguat,2016,Prescription,Human,32.361,WXXSNCNJFUAIDG-UHFFFAOYSA-N,9.29197861971194e-12,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,3.0973262065706466e-5
riociguat,2017,Prescription,Human,41.349,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.203572763545384e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.011909211817947e-5
riociguat,2018,Prescription,Human,52.395,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.489391464258438e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.964638214194793e-5
riociguat,2019,Prescription,Human,58.695,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.69553494056659e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,5.6517831352219665e-5
risedronic acid,2016,Prescription,Human,490.4844,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.4083528191657364e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2017,Prescription,Human,432.6042000000001,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.2592097330415243e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2018,Prescription,Human,402.9018,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.1452972647282379e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2019,Prescription,Human,369.0666,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.0661305318955846e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risperidone,2016,Prescription,Human,5740.854,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.6484006250390214e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.8420700431707266e-4
risperidone,2017,Prescription,Human,5595.1026,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.628603617645399e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.807937271802412e-4
risperidone,2018,Prescription,Human,5455.5387,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5508030866898703e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.673798425327362e-4
risperidone,2019,Prescription,Human,5474.955199999999,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5815619455893587e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.726830940671308e-4
ritonavir,2016,Prescription,Human,28187.6,NCDNCNXCDXHOMX-XGKFQTDJSA-N,8.093649038688306e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.005395766025792204
ritonavir,2017,Prescription,Human,17255.8,NCDNCNXCDXHOMX-XGKFQTDJSA-N,5.022760137654219e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0033485067584361457
ritonavir,2018,Prescription,Human,11269.3,NCDNCNXCDXHOMX-XGKFQTDJSA-N,3.203435295002884e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0021356235300019227
ritonavir,2019,Prescription,Human,8426,NCDNCNXCDXHOMX-XGKFQTDJSA-N,2.4340365293830966e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0016226910195887311
rivaroxaban,2016,Prescription,Human,169070.3082,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,4.854601801620805e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.005644885815838145
rivaroxaban,2017,Prescription,Human,184161.8191,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.3605201952582177e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006233163017742113
rivaroxaban,2018,Prescription,Human,194185.2613,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.5199517256420345e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006418548518188412
rivaroxaban,2019,Prescription,Human,197577.293,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.7074572577572665e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.0066365782066944955
rivastigmine,2016,Prescription,Human,14043.4674,XSVMFMHYUFZWBK-NSHDSACASA-N,4.032372263756424e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.064744527512848e-5
rivastigmine,2017,Prescription,Human,14294.810880000001,XSVMFMHYUFZWBK-NSHDSACASA-N,4.160885398727954e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.321770797455908e-5
rivastigmine,2018,Prescription,Human,13959.97764,XSVMFMHYUFZWBK-NSHDSACASA-N,3.968293069616309e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.936586139232617e-5
rivastigmine,2019,Prescription,Human,13529.56272,XSVMFMHYUFZWBK-NSHDSACASA-N,3.908313539883661e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.816627079767322e-5
rizatriptan,2016,Prescription,Human,13631.64,ULFRLSNUDGIQQP-UHFFFAOYSA-N,3.914122166546462e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.077210590152564e-6
rizatriptan,2017,Prescription,Human,14095.38,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.102835729962594e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.273787218711035e-6
rizatriptan,2018,Prescription,Human,14536.35,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.132133908096793e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.304306154267493e-6
rizatriptan,2019,Prescription,Human,15653.52,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.521865593808318e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.710276660216998e-6
robenacoxib,2016,Prescription,Vet,20767.56,ZEXGDYFACFXQPF-UHFFFAOYSA-N,5.963095191853927e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2017,Prescription,Vet,26627.086,ZEXGDYFACFXQPF-UHFFFAOYSA-N,7.750522499257684e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2018,Prescription,Vet,31275.343,ZEXGDYFACFXQPF-UHFFFAOYSA-N,8.890395821348391e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2019,Prescription,Vet,38554.181,ZEXGDYFACFXQPF-UHFFFAOYSA-N,1.1137228212016108e-8,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
rocuronium bromide,2016,Prescription,Human,4201,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.2062545094839426e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2017,Prescription,Human,5250.5,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.5282978536349215e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2018,Prescription,Human,5285,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.502325391469767e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2019,Prescription,Human,6153,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.7774301881431511e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
roflumilast,2016,Prescription,Human,136.6287,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.923089395380356e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.670344518309948e-4
roflumilast,2017,Prescription,Human,141.20925,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.1102712825139894e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.89318009823094e-4
roflumilast,2018,Prescription,Human,145.1148,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.125064308761721e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.910790843763954e-4
roflumilast,2019,Prescription,Human,136.0363,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.929709512486563e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.678225610103051e-4
romifidine,2016,Prescription,Vet,74.6,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.1420277649964795e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2017,Prescription,Vet,76.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.223825464578764e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2018,Prescription,Vet,49.2,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.3985697116426216e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2019,Prescription,Vet,51.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.4848027250212575e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
ropinirole,2016,Prescription,Human,6947.193105,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9947829114882182e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.116848299200341e-5
ropinirole,2017,Prescription,Human,6837.88758,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9903492832893796e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.1099207551396556e-5
ropinirole,2018,Prescription,Human,6481.99653,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.8425861824858886e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.879040910134201e-5
ropinirole,2019,Prescription,Human,6159.6087,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.7793392573588803e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.7802175896232505e-5
ropivacaine,2016,Prescription,Human,15131.475,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.344777422969184e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2017,Prescription,Human,16307,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.746586629697108e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2018,Prescription,Human,16020.725,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.554085516982873e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2019,Prescription,Human,15631.05,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.515374637148546e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
rosuvastatin,2016,Prescription,Human,102287.8436,BPRHUIZQVSMCRT-VEUZHWNKSA-N,2.9370429090190012e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.01631690505010556
rosuvastatin,2017,Prescription,Human,119689.1873,BPRHUIZQVSMCRT-VEUZHWNKSA-N,3.483872546498393e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.019354847480546628
rosuvastatin,2018,Prescription,Human,142017.5348,BPRHUIZQVSMCRT-VEUZHWNKSA-N,4.037020786451869e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.02242789325806594
rosuvastatin,2019,Prescription,Human,173128.051,BPRHUIZQVSMCRT-VEUZHWNKSA-N,5.0011868074400643e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.027784371152444802
rotigotine,2016,Prescription,Human,966.602,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.775453514344674e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002643289061280642
rotigotine,2017,Prescription,Human,936.432,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.725734721788509e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025959378302747704
rotigotine,2018,Prescription,Human,950.628,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.702275463088215e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025735956791316334
rotigotine,2019,Prescription,Human,893.172,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.5801249406861605e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002457261848272534
rufinamide,2016,Prescription,Human,43827.4,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.2584384405845405e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2017,Prescription,Human,38479.56,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1200500705992988e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2018,Prescription,Human,39283.96,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1166942400280545e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2019,Prescription,Human,38156,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1022204820216169e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rupatadine,2016,Prescription,Human,270.68,WUZYKBABMWJHDL-UHFFFAOYSA-N,7.772172592885349e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
rupatadine,2017,Prescription,Human,170.66,WUZYKBABMWJHDL-UHFFFAOYSA-N,4.9675137929975375e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ruxolitinib,2016,Prescription,Human,1009.96,HFNKQEVNSGCOJV-OAHLLOKOSA-N,2.8999495462946977e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2017,Prescription,Human,1403.92,HFNKQEVNSGCOJV-OAHLLOKOSA-N,4.0864830448055216e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2018,Prescription,Human,1772.68,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.039058041533826e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2019,Prescription,Human,2014.04,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.818000156229208e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
sacubitril,2016,Prescription,Human,10512.61008,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.018539232431885e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2017,Prescription,Human,33489.81272,PYNXFZCZUAOOQC-UTKZUKDTSA-N,9.748101875747356e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2018,Prescription,Human,67862.4016,PYNXFZCZUAOOQC-UTKZUKDTSA-N,1.9290711267700764e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2019,Prescription,Human,117765.8384,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.4019268048780754e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
safinamide,2016,Prescription,Human,77,NEMGRZFTLSKBAP-LBPRGKRZSA-N,2.2109401863904684e-11,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2017,Prescription,Human,1774.1,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.16399051925286e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2018,Prescription,Human,2206,NEMGRZFTLSKBAP-LBPRGKRZSA-N,6.270822731470778e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2019,Prescription,Human,1818.5,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.253139602045053e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
salbutamol,2016,Prescription,Human,44240.736,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.2703067675050846e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2017,Prescription,Human,45049.084,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.311273562240154e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2018,Prescription,Human,40589.565,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.1538076467022245e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2019,Prescription,Human,45475.561,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.3136621963943664e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salicylic acid,2016,OTC,Human,6766,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.942756013132196e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.942756013132196e-5
salicylic acid,2016,Prescription,Human,132.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3.804539931126455e-11,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,3.8045399311264546e-7
salicylic acid,2017,OTC,Human,6086,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.7714923792442875e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.7714923792442875e-5
salicylic acid,2017,Prescription,Human,2015,YGSDEFSMJLZEOE-UHFFFAOYSA-N,5.865194124510744e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,5.8651941245107436e-6
salicylic acid,2018,OTC,Human,6414,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.823257343592637e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.823257343592637e-5
salicylic acid,2018,Prescription,Human,2337.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,6.644627440985016e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,6.644627440985016e-6
salicylic acid,2019,OTC,Human,2382,YGSDEFSMJLZEOE-UHFFFAOYSA-N,6.880934029184116e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,6.8809340291841155e-6
salicylic acid,2019,Prescription,Human,3395,YGSDEFSMJLZEOE-UHFFFAOYSA-N,9.80720866040305e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,9.8072086604030508e-06
salmeterol,2016,Prescription,Human,2013.138,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.780425590843811e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.627466177656278e-5
salmeterol,2017,Prescription,Human,1872.411,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.450150866436371e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.477341302925623e-5
salmeterol,2018,Prescription,Human,1761.201,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.006427590883529e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.2756489049470588e-5
salmeterol,2019,Prescription,Human,1623.759,GIIZNNXWQWCKIB-UHFFFAOYSA-N,4.690587136143565e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.1320850618834385e-5
sapropterin,2016,Prescription,Human,7272,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.088046368237855e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2017,Prescription,Human,10284,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.99343207823665e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2018,Prescription,Human,10692,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.039330763594087e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2019,Prescription,Human,12744,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.6813863672511494e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
saquinavir,2016,Prescription,Human,1860,QWAXKHKRTORLEM-UGJKXSETSA-N,5.340712658034117e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
saquinavir,2017,Prescription,Human,720,QWAXKHKRTORLEM-UGJKXSETSA-N,2.0957517467234422e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
sarolaner,2017,Prescription,Vet,21.2325,FLEFKKUZMDEUIP-QFIPXVFZSA-N,6.180284578097985e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2018,Prescription,Vet,339.66749999999996,FLEFKKUZMDEUIP-QFIPXVFZSA-N,9.6554609253937e-11,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2019,Prescription,Vet,28.5,FLEFKKUZMDEUIP-QFIPXVFZSA-N,8.232855576479736e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
saxagliptin,2016,Prescription,Human,2371.77395,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.810195245570204e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.168626574284425e-7
saxagliptin,2017,Prescription,Human,2300.15765,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.695221406564984e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.04760148059472e-7
saxagliptin,2018,Prescription,Human,2266.2689,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.442144394263496e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.781204625540522e-7
saxagliptin,2019,Prescription,Human,2118.3939,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.119449485191458e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.441525773885745e-7
scopolamine,2016,Prescription,Human,44.57,STECJAGHUSJQJN-USLFZFAMSA-N,1.279761092304197e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2017,Prescription,Human,49.73,STECJAGHUSJQJN-USLFZFAMSA-N,1.4475240883966219e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2018,Prescription,Human,44.759,STECJAGHUSJQJN-USLFZFAMSA-N,1.272328896817319e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2019,Prescription,Human,46.662,STECJAGHUSJQJN-USLFZFAMSA-N,1.3479351119638504e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
selamectin,2016,Prescription,Vet,3724.74,AFJYYKSVHJGXSN-XHKIUTQPSA-N,1.0695035519293551e-9,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2017,Prescription,Vet,3312.63,AFJYYKSVHJGXSN-XHKIUTQPSA-N,9.642291817706216e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2018,Prescription,Vet,3004.11,AFJYYKSVHJGXSN-XHKIUTQPSA-N,8.53954726919251e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2019,Prescription,Vet,2728.845,AFJYYKSVHJGXSN-XHKIUTQPSA-N,7.882872552841698e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selegiline,2016,Prescription,Human,8055.545,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3130296316593256e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2017,Prescription,Human,8197.21,MEZLKOACVSPNER-GFCCVEGCSA-N,2.386016274410954e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2018,Prescription,Human,8213.96,MEZLKOACVSPNER-GFCCVEGCSA-N,2.334917818830086e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2019,Prescription,Human,8113.04,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3436311089895843e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
sertindole,2016,Prescription,Human,470.36672,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.3505879007645107e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2017,Prescription,Human,380.9377599999999,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.1088207998790492e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2018,Prescription,Human,370.31064,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.0526529369979566e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2019,Prescription,Human,287.06552,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,8.292522691744052e-11,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertraline,2016,Prescription,Human,714581.3295,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.051813737449193e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2017,Prescription,Human,761735.099,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.217232867041395e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2018,Prescription,Human,779108.4285,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.2147102646048393e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2019,Prescription,Human,854781.554,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.469225643340672e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sevelamer,2016,Prescription,Human,1675254.24,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,4.810242755372756e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2017,Prescription,Human,1746681.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.084180566956749e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2018,Prescription,Human,1820013.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.173608179723959e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2019,Prescription,Human,1904202.72,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.500710870912238e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sildenafil,2016,Prescription,Human,114983.038,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.3015664865904194e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2017,Prescription,Human,132569.13999999998,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.85877787106423e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2018,Prescription,Human,147312.64800000002,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.1875408055827446e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2019,OTC,Human,8860.2,BNRNXUUZRGQAQC-UHFFFAOYSA-N,2.559464806271079e-9,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2019,Prescription,Human,153678.198,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.4393347697812537e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
silver nitrate,2016,Prescription,Human,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7945943071351204e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2017,Prescription,Human,20,SQGYOTSLMSWVJD-UHFFFAOYSA-N,5.821532629787339e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2018,Prescription,Human,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7766383532045496e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2019,Prescription,Human,1,SQGYOTSLMSWVJD-UHFFFAOYSA-N,2.888721254905171e-13,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver sulfadiazine,2016,Prescription,Human,8238,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.3654188643486595e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2017,Prescription,Human,7642,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.224407617841742e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2018,Prescription,Human,7036.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.00021052357181e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2019,Prescription,Human,6227.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,1.7989511614921946e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
simeprevir,2016,Prescription,Human,63,JTZZSQYMACOLNN-VDWJNHBNSA-N,1.8089510615922013e-11,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,1.6749546866594455e-4
simeprevir,2017,Prescription,Human,21,JTZZSQYMACOLNN-VDWJNHBNSA-N,6.112609261276707e-12,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,5.659823390071025e-5
simvastatin,2016,Prescription,Human,2294448.885,RYMZZMVNJRMUDD-HGQWONQESA-N,6.58816785125364e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,3.29408392562682
simvastatin,2017,Prescription,Human,2024665.9194,RYMZZMVNJRMUDD-HGQWONQESA-N,5.893329357102742e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.9466646785513713
simvastatin,2018,Prescription,Human,1838137.0484,RYMZZMVNJRMUDD-HGQWONQESA-N,5.225127645813836e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.6125638229069184
simvastatin,2019,Prescription,Human,1689347.999800001,RYMZZMVNJRMUDD-HGQWONQESA-N,4.880055473953799e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.4400277369768997
sitagliptin,2016,Prescription,Human,667651.558,MFFMDFFZMYYVKS-SECBINFHSA-N,1.9170618962187098e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0022822165431175116
sitagliptin,2017,Prescription,Human,805702.4115,MFFMDFFZMYYVKS-SECBINFHSA-N,2.3452114392227986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0027919183800271413
sitagliptin,2018,Prescription,Human,920545.22,MFFMDFFZMYYVKS-SECBINFHSA-N,2.6167615099377914e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0031151922737354663
sitagliptin,2019,Prescription,Human,1017783.571,MFFMDFFZMYYVKS-SECBINFHSA-N,2.940093034440986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0035001107552868884
sodium amidotrizoate,2016,Prescription,Human,0.2296,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.592621646691579e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2017,Prescription,Human,0.2123,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.179556886519263e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2018,Prescription,Human,0.1981,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.63123292431714e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2019,Prescription,Human,0.1818,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.2516952414175994e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium phenylbutyrate,2016,Prescription,Human,1629.412,VPZRWNZGLKXFOE-UHFFFAOYSA-M,4.67861359868424e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2017,Prescription,Human,2586.248,VPZRWNZGLKXFOE-UHFFFAOYSA-M,7.527963560361124e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2018,Prescription,Human,4668.524,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3270846066009467e-9,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2019,Prescription,Human,461.168,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3321858036821078e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sofosbuvir,2016,Prescription,Human,23553.6,TTZHDVOVKQGIBA-IQWMDFIBSA-N,6.763065035606043e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2017,Prescription,Human,20339.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,5.920265823188534e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2018,Prescription,Human,67704,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.9245683690457733e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2019,Prescription,Human,56347.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.6277135429439263e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
solifenacin,2016,Prescription,Human,32045.152,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.20128757607674e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2017,Prescription,Human,31389.454,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.136736534610438e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2018,Prescription,Human,31586.715399999997,FBOUYBDGKBSUES-VXKWHMMOSA-N,8.978907205023485e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2019,Prescription,Human,33839.6869,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.775342280736606e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
sorafenib,2016,Prescription,Human,6899.2,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.9810024070058596e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.11652955335328585
sorafenib,2017,Prescription,Human,4838.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.408345173798153e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08284383375283252
sorafenib,2018,Prescription,Human,5174.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.4708859991714591e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08652270583361524
sorafenib,2019,Prescription,Human,7145.6,MLDQJTXFUGDVEO-UHFFFAOYSA-N,2.064164659905038e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.1214214505826493
sotalol,2016,Prescription,Human,211630.16,ZBMZVLHSJCTVON-UHFFFAOYSA-N,6.076644485665516e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2017,Prescription,Human,196055.88,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.706728513408357e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2018,Prescription,Human,176920.36,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.029175952620097e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2019,Prescription,Human,158257.8,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4.5716267061453147e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
spiramycin,2016,Prescription,Human,12807.96,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.677614736322293e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2017,Prescription,Human,10700.58,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.114688781382491e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2018,Prescription,Human,8354.5,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3748680194955852e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2019,Prescription,Human,8231.74,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3779202302853086e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spironolactone,2016,Prescription,Human,216466.675,LXMSZDCAJNLERA-ZHYRCANASA-N,6.215517802231492e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2017,Prescription,Human,222218.45,LXMSZDCAJNLERA-ZHYRCANASA-N,6.468259788078834e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2018,Prescription,Human,231659.475,LXMSZDCAJNLERA-ZHYRCANASA-N,6.585201730691689e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2019,Prescription,Human,243515.625,LXMSZDCAJNLERA-ZHYRCANASA-N,7.034487618390169e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
stiripentol,2016,Prescription,Human,12165.75,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.493213710724654e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2017,Prescription,Human,11735.85,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.416031685664488e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2018,Prescription,Human,15855,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.506976174409301e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2019,Prescription,Human,17010,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.913714854593695e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
streptozocin,2019,Prescription,Human,92,ZSJLQEPLLKMAKR-GKHCUFPYSA-N,2.6576235545127567e-11,antineoplastic,alkylating agent for pancreatic cancer,NA,NA,NA,NA
sucralfate,2016,Prescription,Human,383530.2,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.1012497816550309e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2017,Prescription,Human,422074.8,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2285611102054828e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2018,Prescription,Human,428604.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2183605931518314e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2019,Prescription,Human,487990.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.409668818413927e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sufentanil,2016,Prescription,Human,0.99815,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.8660388922670725e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2017,Prescription,Human,0.8852500000000001,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.5767558802596216e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2018,Prescription,Human,0.9484,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.6959421026867123e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2019,Prescription,Human,1.11825,GGCSSNBKKAUURC-UHFFFAOYSA-N,3.230312543297707e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sugammadex,2016,Prescription,Human,1915,WHRODDIHRRDWEW-VTHZAVIASA-N,5.498636957062008e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,5.498636957062008e-7
sugammadex,2017,Prescription,Human,2108,WHRODDIHRRDWEW-VTHZAVIASA-N,6.135895391795857e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.135895391795857e-7
sugammadex,2018,Prescription,Human,2350,WHRODDIHRRDWEW-VTHZAVIASA-N,6.680160208049105e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.680160208049105e-7
sugammadex,2019,Prescription,Human,3229,WHRODDIHRRDWEW-VTHZAVIASA-N,9.327680932088795e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,9.327680932088795e-7
sulfadiazine,2016,Prescription,Vet,1076297.5836,SEEPANYCNGTZFQ-UHFFFAOYSA-N,3.090428026098954e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2017,Prescription,Vet,1008298.9074,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.934922495004012e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2018,Prescription,Vet,937990.3008,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.6663512693362434e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2019,Prescription,Vet,963879.6822,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.784379725142381e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadoxine,2016,Prescription,Vet,52700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.5132019197763336e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2017,Prescription,Vet,50700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.4757585216510908e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2018,Prescription,Vet,69900,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.986992334223968e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2019,Prescription,Vet,104140,PJSFRIWCGOHTNF-UHFFFAOYSA-N,3.0083143148582445e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfamethoxazole,2016,Prescription,Human,1420137.76,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.077713823109795e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2017,Prescription,Human,1478592.4,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.303836951377788e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2018,Prescription,Human,1629399.2,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.631764978241297e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2019,Prescription,Human,1759706,JLKIGFTWXXRPMT-UHFFFAOYSA-N,5.083300124584158e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfanilamide,2016,Prescription,Vet,1250,FDDDEECHVMSUSB-UHFFFAOYSA-N,3.5891886142702405e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfasalazine,2016,Prescription,Human,2687662,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.717220679525427e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2017,Prescription,Human,2588001.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.533067589094291e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2018,Prescription,Human,2561204.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.280534632160131e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2019,Prescription,Human,2272402,NCEXYHBECQHGNR-UHFFFAOYSA-N,6.56433595708902e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfathiazole,2016,Prescription,Vet,10120,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.905807102113187e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2017,Prescription,Vet,7690,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.238379296153232e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2018,Prescription,Vet,6580,JNMRHUJNCSQMMB-UHFFFAOYSA-N,1.8704448582537503e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2019,Prescription,Vet,3000,JNMRHUJNCSQMMB-UHFFFAOYSA-N,8.66616376471551e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sumatriptan,2016,Prescription,Human,136688.55,KQKPFRSPSRPDEB-UHFFFAOYSA-N,3.9248078988888685e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.5699231595555475e-4
sumatriptan,2017,Prescription,Human,145086.492,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.2231287365968994e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.6892514946387598e-4
sumatriptan,2018,Prescription,Human,146788.308,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.1726358047168354e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.669054321886734e-4
sumatriptan,2019,Prescription,Human,153388.296,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.4309603090888574e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.772384123635543e-4
suxamethonium,2016,Prescription,Human,7300,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.096086150733821e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2017,Prescription,Human,7064,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.0561653248408886e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2018,Prescription,Human,6366,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.809612761040026e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2019,Prescription,Human,4928,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.423561834417268e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxibuzone,2016,Prescription,Vet,82566,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3707595770066937e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2017,Prescription,Vet,79515,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3144958352877022e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2018,Prescription,Vet,68823,ONWXNHPOAGOMTG-UHFFFAOYSA-N,1.9563773021215475e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2019,Prescription,Vet,71199,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.056740646279932e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
tacrolimus,2016,Prescription,Human,4975.231,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.4285633966851472e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2017,Prescription,Human,5531.2725,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.6100241671497699e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2018,Prescription,Human,6047.978,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.719211147861975e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2019,Prescription,Human,6737.598,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.9463042549606566e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tadalafil,2016,Prescription,Human,24370.78,WOXKDUGGOYFFRN-IIBYNOLFSA-N,6.9977060877507925e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.4578554349480816e-4
tadalafil,2017,Prescription,Human,26047.2452,WOXKDUGGOYFFRN-IIBYNOLFSA-N,7.581744392393584e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.5795300817486634e-4
tadalafil,2018,Prescription,Human,31090.7,WOXKDUGGOYFFRN-IIBYNOLFSA-N,8.837908807676271e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.841231001599223e-4
tadalafil,2019,Prescription,Human,36057.74,WOXKDUGGOYFFRN-IIBYNOLFSA-N,1.0416075994184435e-8,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,2.1700158321217574e-4
tafamidis,2018,Prescription,Human,3.6,TXEIIPDJKFWEEC-UHFFFAOYSA-N,1.0233436914458206e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafamidis,2019,Prescription,Human,10.8,TXEIIPDJKFWEEC-UHFFFAOYSA-N,3.1198189552975847e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafluprost,2016,Prescription,Human,12.05685,WSNODXPBBALQOF-VEJSHDCNSA-N,3.4619446995171325e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2017,Prescription,Human,14.321745,WSNODXPBBALQOF-VEJSHDCNSA-N,4.168725291649685e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2018,Prescription,Human,16.55181,WSNODXPBBALQOF-VEJSHDCNSA-N,4.705052873752735e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2019,Prescription,Human,18.6948,WSNODXPBBALQOF-VEJSHDCNSA-N,5.400406611620119e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tamoxifen,2016,Prescription,Human,28435.44,NKANXQFJJICGDU-QPLCGJKRSA-N,8.164812599181166e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.0800471823449134
tamoxifen,2017,Prescription,Human,30268.52,NKANXQFJJICGDU-QPLCGJKRSA-N,8.810458841768536e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.086377047468319
tamoxifen,2018,Prescription,Human,30379.12,NKANXQFJJICGDU-QPLCGJKRSA-N,8.635633556576543e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08466307408408376
tamoxifen,2019,Prescription,Human,31762.74,NKANXQFJJICGDU-QPLCGJKRSA-N,9.175370215202666e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08995460995296733
tamsulosin,2016,Prescription,Human,8000.67796,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.2972753792379887e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2017,Prescription,Human,8528.67572,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.4824981996427518e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2018,Prescription,Human,9143.26032,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.599082713255248e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2019,Prescription,Human,9985.11236,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.884420630694833e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tapentadol,2016,Prescription,Human,87252.395,KWTWDQCKEHXFFR-SMDDNHRTSA-N,2.5053224216144777e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2017,Prescription,Human,121340.285,KWTWDQCKEHXFFR-SMDDNHRTSA-N,3.5319321421759774e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2018,Prescription,Human,144810.5,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.1164142119476396e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2019,Prescription,Human,157934.555,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.562289059124896e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tedizolid,2016,Prescription,Human,154.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,4.4448511799122665e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,1.4816170599707555e-5
tedizolid,2017,Prescription,Human,318,XFALPSLJIHVRKE-GFCCVEGCSA-N,9.256236881361871e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,3.08541229378729e-5
tedizolid,2018,Prescription,Human,104.4,XFALPSLJIHVRKE-GFCCVEGCSA-N,2.96769670519288e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,9.892322350642933e-6
tedizolid,2019,Prescription,Human,208.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,6.031649980241996e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,2.0105499934139986e-5
teicoplanin,2016,Prescription,Human,83.19999999999999,BJNLLBUOHPVGFT-CAYRISATSA-N,2.388963941658272e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2017,Prescription,Human,62,BJNLLBUOHPVGFT-CAYRISATSA-N,1.8046751152340755e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2018,Prescription,Human,53.2,BJNLLBUOHPVGFT-CAYRISATSA-N,1.5122745662477126e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
telbivudine,2016,Prescription,Human,168,IQFYYKKMVGJFEH-CSMHCCOUSA-N,4.823869497579204e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,high,9.49e-5,5.083108005879034e-7
telmisartan,2016,Prescription,Human,192901.0776,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.538866811219043e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011303809818814373
telmisartan,2016,Prescription,Vet,236.2,RMMXLENWKUUMAY-UHFFFAOYSA-N,6.782130805525047e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.3841083276581728e-6
telmisartan,2017,Prescription,Human,187423.3088,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.455454538809545e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011133580691448052
telmisartan,2017,Prescription,Vet,248.72,RMMXLENWKUUMAY-UHFFFAOYSA-N,7.239657978403536e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.4774812200823544e-6
telmisartan,2018,Prescription,Human,190488.4576,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.4148655938390185e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011050746109875548
telmisartan,2018,Prescription,Vet,260.36,RMMXLENWKUUMAY-UHFFFAOYSA-N,7.401048986245385e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.5104181604582419e-6
telmisartan,2019,Prescription,Human,187408.5584,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.4137108600121697e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011048389510228919
telmisartan,2019,Prescription,Vet,323.14,RMMXLENWKUUMAY-UHFFFAOYSA-N,9.334613863100567e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.9050232373674627e-6
temozolomide,2016,Prescription,Human,4205.3,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.2074891903672515e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,1.6099855871563355e-5
temozolomide,2017,Prescription,Human,5184.75,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.5091595651144955e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.0122127534859943e-5
temozolomide,2018,Prescription,Human,5879.1,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.671205526771979e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.228274035695972e-5
temozolomide,2019,Prescription,Human,5574.7,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.610375437971985e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.1471672506293138e-5
tenofovir alafenamide,2016,Prescription,Human,1915.35,LDEKQSIMHVQZJK-CAQYMETFSA-N,5.499641929874004e-10,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,5.499641929874004e-7
tenofovir alafenamide,2017,Prescription,Human,9023.4,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.6265008765811543e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.6265008765811544e-6
tenofovir alafenamide,2018,Prescription,Human,10650.9,LDEKQSIMHVQZJK-CAQYMETFSA-N,3.0276475897834133e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,3.0276475897834133e-6
tenofovir alafenamide,2019,Prescription,Human,7790.1,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.250342744783677e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.250342744783677e-6
tenofovir disoproxil,2016,Prescription,Human,227416.35,JFVZFKDSXNQEJW-CQSZACIVSA-N,6.529921392951168e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2017,Prescription,Human,165110.4,JFVZFKDSXNQEJW-CQSZACIVSA-N,4.805977905586198e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2018,Prescription,Human,176664.6,JFVZFKDSXNQEJW-CQSZACIVSA-N,5.0219056642166474e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2019,Prescription,Human,260675.1,JFVZFKDSXNQEJW-CQSZACIVSA-N,7.530177019945309e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
terazosin,2016,Prescription,Human,625.77914,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7968314914686584e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2017,Prescription,Human,613.15072,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7847384617288004e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2018,Prescription,Human,402.0905,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.14299104601471e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2019,Prescription,Human,378.028,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.0920175185492918e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terbinafine,2016,OTC,Human,12387.92,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.557006513479248e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.06711333044300469
terbinafine,2016,Prescription,Human,590570.7,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.6957357058892846e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.199501331866575
terbinafine,2017,OTC,Human,11978.89,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.486774950181663e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.0657882066072012
terbinafine,2017,Prescription,Human,603526.9249999999,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.756725843421358e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.314577063059166
terbinafine,2018,OTC,Human,13448.63,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.822936296969168e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.07213087352772016
terbinafine,2018,Prescription,Human,624966.255,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7765424289465834e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.3519668470690256
terbinafine,2019,OTC,Human,12555.31,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.626879085892344e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.06843168086589328
terbinafine,2019,Prescription,Human,598459.4,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7287823889777958e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.2618535641090487
terbutaline,2016,Prescription,Human,7447.31,XWTYSIMOBUGWOL-UHFFFAOYSA-N,2.138384020715272e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,8.909933419646967e-6
terbutaline,2017,Prescription,Human,6583.112499999999,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.916190211215545e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,7.984125880064771e-6
terbutaline,2018,Prescription,Human,5325.1125,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.5137278564206339e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.3071994017526415e-6
terbutaline,2019,Prescription,Human,5165.37,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.492131410844952e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.217214211853967e-6
teriflunomide,2016,Prescription,Human,5294.744,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.5203067904220535e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.067689301406845e-5
teriflunomide,2017,Prescription,Human,5747.896,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6730782058312064e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.576927352770688e-5
teriflunomide,2018,Prescription,Human,5942.72,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6892902838969187e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.630967612989729e-5
teriflunomide,2019,Prescription,Human,5944.68,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.717252346960967e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.72417448986989e-5
testosterone,2016,Prescription,Human,96412.3,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.7683354354848542e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2017,Prescription,Human,107058.65,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1162271213799125e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2018,Prescription,Human,103507.86,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.942336542946033e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2019,Prescription,Human,107993.53,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1196320550323916e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
tetrabenazine,2017,Prescription,Human,84,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.4450437045106828e-11,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2018,Prescription,Human,425.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,1.20981965299817e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2019,Prescription,Human,789.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.2809343028731223e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetracaine,2016,Prescription,Human,1543.9,GKCBAIGFKIBETG-UHFFFAOYSA-N,4.43307864125746e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2017,Prescription,Human,1059.6,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.0842479872613326e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2018,Prescription,Human,1220.4,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.469135114001332e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2019,Prescription,Human,1359.05,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.9259166214788715e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracycline,2016,Prescription,Human,759502,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.1807967447323814e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2017,Prescription,Human,695828,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.025392703359833e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2018,Prescription,Human,615128,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.748575995088013e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2019,Prescription,Human,598636,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.7292925371514117e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetryzoline,2016,OTC,Human,143.192,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.111544768436675e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2016,Prescription,Human,142.4928,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.091468283003892e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2017,OTC,Human,147.1544,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.2833207060838907e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2017,Prescription,Human,147.3384,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.2886765161032956e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2018,OTC,Human,132.9776,BYJAVTDNIXVSPW-UHFFFAOYSA-N,3.7800496684334925e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2018,Prescription,Human,144.4296,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.1055866671678687e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2019,OTC,Human,155.528,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.492770393328913e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2019,Prescription,Human,173.016,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.9979499663867294e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
thalidomide,2016,Prescription,Human,2161.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,6.206712086885242e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2017,Prescription,Human,953.4,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.775124604619625e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2018,Prescription,Human,754.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.145042082125045e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2019,Prescription,Human,784,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.2647574638456536e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
theophylline,2016,Prescription,Human,358271.19,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,1.0287223007752401e-7,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2017,Prescription,Human,331665.26,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,9.65400066628451e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2018,Prescription,Human,282589.38,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,8.032946091460716e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2019,Prescription,Human,250207.92,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,7.227809366496124e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
thiamazole,2016,Prescription,Vet,855.2,PMRYVIKBURPHAH-UHFFFAOYSA-N,2.455579282339128e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2017,Prescription,Vet,1147.775,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.3409048070770823e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2018,Prescription,Vet,1379.275,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.9207565833859286e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2019,Prescription,Vet,1568.675,PMRYVIKBURPHAH-UHFFFAOYSA-N,4.5314648145383674e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiopental,2016,Prescription,Human,28305,IUJDSEJGGMCXSG-UHFFFAOYSA-N,8.127358698153533e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2017,Prescription,Human,26995,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.857613667055463e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2018,Prescription,Human,26225,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.45477453004629e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2019,Prescription,Human,24325,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.026814452556827e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiosulfate,2016,Prescription,Human,9705,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.786646040119415e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2017,Prescription,Human,12195,DHCDFWKWKRSZHF-UHFFFAOYSA-M,3.54967952101283e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2018,Prescription,Human,8400,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.3878019467069147e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2019,Prescription,Human,14745,DHCDFWKWKRSZHF-UHFFFAOYSA-M,4.259419490357674e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiotepa,2016,Prescription,Human,9.92,FOCVUCIESVLUNU-UHFFFAOYSA-N,2.848380084284863e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2017,Prescription,Human,12.445,FOCVUCIESVLUNU-UHFFFAOYSA-N,3.622448678885173e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2018,Prescription,Human,21.13,FOCVUCIESVLUNU-UHFFFAOYSA-N,6.006458944513941e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2019,Prescription,Human,16.064999999999998,FOCVUCIESVLUNU-UHFFFAOYSA-N,4.640730696005156e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
tiamulin,2016,Prescription,Vet,59790,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.7167806979777416e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2017,Prescription,Vet,42310,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.2315452278315118e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2018,Prescription,Vet,34025,UURAUHCOJAIIRQ-QGLSALSOSA-N,9.672019194845568e-9,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2019,Prescription,Vet,45030,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.3007911810837985e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tibolone,2016,Prescription,Human,4755.3492,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3654276164415276e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2017,Prescription,Human,4531.9197,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3191359204563027e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2018,Prescription,Human,4267.83,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.2131824740731155e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2019,Prescription,Human,4168.3635,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.204124024062091e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
ticagrelor,2016,Prescription,Human,387609.4764,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1129628155825037e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002099929840721705
ticagrelor,2017,Prescription,Human,386672.9004,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1255144533665553e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002123612176163312
ticagrelor,2018,Prescription,Human,385345.3596,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.0953909521516144e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0020667753814181404
ticagrelor,2019,Prescription,Human,400039.44,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1556024331283617e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0021803819492987957
ticlopidine,2016,Prescription,Human,16633.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.776061505237124e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2017,Prescription,Human,15354.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.469336138203486e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2018,Prescription,Human,13498.25,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.83704138418293e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2019,Prescription,Human,11178.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.229157054795745e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
tigecycline,2016,Prescription,Human,66,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.8950915883346872e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2017,Prescription,Human,43,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.2516295154042782e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2018,Prescription,Human,39.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.1228354392252754e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2019,Prescription,Human,45.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.3143681709818526e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tiludronic acid,2016,Prescription,Vet,131,DKJJVAGXPKPDRL-UHFFFAOYSA-N,3.761469667755212e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2017,Prescription,Vet,94,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.73612033600005e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2018,Prescription,Vet,81.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.316736412578733e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2019,Prescription,Vet,38.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,1.1121576831384906e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
timolol,2016,Prescription,Human,10924.096,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.136691278751606e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2017,Prescription,Human,11247.6531,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.273928976508936e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2018,Prescription,Human,12316.64175,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.501154898516864e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2019,Prescription,Human,12960.5875,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.743952458730827e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
tiotropium bromide,2016,Prescription,Human,128.35005,DQHNAVOVODVIMG-RGECMCKFSA-M,3.6853803048081294e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2017,Prescription,Human,120.37791,DQHNAVOVODVIMG-RGECMCKFSA-M,3.503919654853019e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2018,Prescription,Human,113.09136,DQHNAVOVODVIMG-RGECMCKFSA-M,3.2147591614730063e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2019,Prescription,Human,109.02105,DQHNAVOVODVIMG-RGECMCKFSA-M,3.1493142436707934e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tipiracil,2017,Prescription,Human,32.1004,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,9.343676301461275e-12,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2018,Prescription,Human,109.648,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.116877474434759e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2019,Prescription,Human,105.4338,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.045688590454208e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tivozanib,2019,Prescription,Human,0.14973,SPMVMDHWKHCIDT-UHFFFAOYSA-N,4.3252823349695124e-14,antineoplastic,vascular endothelial growth factor inhibitor for carcinomas,NA,NA,NA,NA
tobramycin,2016,Prescription,Human,8141.445000000001,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.3376945358165907e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.583714776110962e-4
tobramycin,2017,Prescription,Human,7700.825,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.2415302006891046e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.395157256253146e-4
tobramycin,2018,Prescription,Human,6408.112,NLVFBUXFDBBNBW-PBSUHMDJSA-N,1.82158360813285e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.5717325649663726e-4
tobramycin,2019,Prescription,Human,7014.999,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.0264376714438513e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.973407198909512e-4
toceranib,2016,Prescription,Vet,22.6,SRSGVKWWVXWSJT-ATVHPVEESA-N,6.489253014600596e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2017,Prescription,Vet,29.7,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.644975955234199e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2018,Prescription,Vet,0.3,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.527864095381839e-14,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
tofacitinib,2017,Prescription,Human,74.48,UJLAWZDWDVHWOW-YPMHNXCESA-N,2.1679387513328056e-11,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2018,Prescription,Human,1246.77,UJLAWZDWDVHWOW-YPMHNXCESA-N,3.544095039399737e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2019,Prescription,Human,1742.23,UJLAWZDWDVHWOW-YPMHNXCESA-N,5.032816831933436e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tolfenamic acid,2016,Prescription,Human,5740,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6481554116728947e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2017,Prescription,Human,5654,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6457472744408811e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2018,Prescription,Human,6188,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.7590141007407603e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2019,Prescription,Human,6716,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.940065194794312e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolterodine,2016,Prescription,Human,8240.384320000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.366103486284402e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2017,Prescription,Human,7516.001920000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.187732521141215e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2018,Prescription,Human,6333.6224,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.8004090352888715e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2019,Prescription,Human,5581.835840000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.6124367832399459e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
toltrazuril,2016,Prescription,Vet,289252.16,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.30544447460059e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2017,Prescription,Vet,304975,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.877109568846971e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2018,Prescription,Vet,292275,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.308271594925757e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2019,Prescription,Vet,294300,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.501506653185917e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
tolvaptan,2016,Prescription,Human,460.29,GYHCTFXIZSNGJT-UHFFFAOYSA-N,1.321654101809959e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,6.608270509049795e-6
tolvaptan,2017,Prescription,Human,1392.84,GYHCTFXIZSNGJT-UHFFFAOYSA-N,4.0542317540365004e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,2.02711587701825e-5
tolvaptan,2018,Prescription,Human,2364.285,GYHCTFXIZSNGJT-UHFFFAOYSA-N,6.720767054249949e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,3.360383527124974e-5
tolvaptan,2019,Prescription,Human,3174.18,GYHCTFXIZSNGJT-UHFFFAOYSA-N,9.169321232894894e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,4.5846606164474465e-5
topiramate,2016,Prescription,Human,174637.829,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.0144648597413863e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.391897698646652e-4
topiramate,2017,Prescription,Human,178766.903,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.2034867947026414e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.595147091078109e-4
topiramate,2018,Prescription,Human,179698.065,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.1081355884103056e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.492618912269146e-4
topiramate,2019,Prescription,Human,185006.215,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.3443138556005584e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.74657403828017e-4
topotecan,2016,Prescription,Human,2.498,UCFGDBYHRUNTLO-QHCPKHFHSA-N,7.17263452675765e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2017,Prescription,Human,0.8325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,2.4232129571489804e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2018,Prescription,Human,1.3325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.7877929690320994e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2019,Prescription,Human,1.2625,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.6470105843177783e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
torasemide,2018,Prescription,Vet,1.8,NGBFQHCMQULJNZ-UHFFFAOYSA-N,5.116718457229103e-13,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
torasemide,2019,Prescription,Vet,10.89,NGBFQHCMQULJNZ-UHFFFAOYSA-N,3.145817446591731e-12,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
trabectedin,2016,Prescription,Human,0.25225000000000003,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.242982623597347e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2017,Prescription,Human,0.289,PKVRCIRHQMSYJX-AIFWHQITSA-N,8.412114650042706e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2018,Prescription,Human,0.36625,PKVRCIRHQMSYJX-AIFWHQITSA-N,1.041110074977866e-13,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2019,Prescription,Human,0.27399999999999997,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.915096238440167e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
tramadol,2016,Prescription,Human,2502289.3175,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.184950662384841e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2017,Prescription,Human,2555566.15,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.438655864902504e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2018,Prescription,Human,2494378.925,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.090574824928215e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2019,Prescription,Human,2404390.2125,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,6.945613111934709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
trametinib,2016,Prescription,Human,24.42,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,7.011838876838343e-12,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2017,Prescription,Human,44.474999999999994,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2945633185489595e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2018,Prescription,Human,44.37,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2612710997069735e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2019,Prescription,Human,35.4,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.0226073242364304e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
travoprost,2016,Prescription,Human,12.95085,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.71864346920974e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2017,Prescription,Human,11.07165,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.2226985870292506e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2018,Prescription,Human,12.309325,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.4990750235295346e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2019,Prescription,Human,10.812275,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.1233648606379802e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
treosulfan,2019,Prescription,Human,1247,YCPOZVAOBBQLRI-WDSKDSINSA-N,3.602235404866747e-10,antineoplastic,"alkylating agent, pre-bone marrow transplantation",NA,NA,NA,NA
treprostinil,2016,Prescription,Human,34.57,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.926260031625778e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2017,Prescription,Human,33.79,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.835479378025712e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2018,Prescription,Human,34.379999999999995,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.772932253307584e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2019,Prescription,Human,33.21,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.593443287540072e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
tretinoin,2016,Prescription,Human,95.0475,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.729147238518806e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2017,Prescription,Human,106.53,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.1008393552562266e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2018,Prescription,Human,105.3975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.996051853310024e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2019,Prescription,Human,111.6975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.226629423697703e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
triamcinolone,2016,OTC,Human,12.85845,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.692112186973054e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.692112186973054e-7
triamcinolone,2016,Prescription,Human,6896.6119,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.9802592726816523e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.9802592726816522e-4
triamcinolone,2017,OTC,Human,12.4476,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.623205478127045e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.6232054781270445e-7
triamcinolone,2017,Prescription,Human,6800.86435,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.9795726862141236e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.9795726862141235e-4
triamcinolone,2017,Prescription,Vet,12.744,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.709480591700493e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.7094805917004925e-7
triamcinolone,2018,OTC,Human,10.8075,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.072163040361307e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.072163040361307e-7
triamcinolone,2018,Prescription,Human,6607.786300000001,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.8783434512575335e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.8783434512575334e-4
triamcinolone,2018,Prescription,Vet,9.69075,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.7547132994107178e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.7547132994107173e-7
triamcinolone,2019,OTC,Human,13.00695,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.757345292648881e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.75734529264888e-7
triamcinolone,2019,Prescription,Human,6986.1163,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.0180942645049463e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.018094264504946e-4
triamcinolone,2019,Prescription,Vet,7.83225,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.2625187048731023e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.2625187048731022e-7
tricaine mesilate,2016,Prescription,Vet,5447000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.5640248305544e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2017,Prescription,Vet,5504000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.602085779717476e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2018,Prescription,Vet,5756000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.636212857767262e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2019,Prescription,Vet,5653000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.632994125397893e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
trientine,2019,Prescription,Human,21.6,VILCJCGEZXAXTO-UHFFFAOYSA-N,6.239637910595169e-12,chelating agent,iron-chelating agent for copper build-up from Wilson's disease,NA,NA,NA,NA
trifluridine,2017,Prescription,Human,78.4,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,2.2820407908766374e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2018,Prescription,Human,267.8,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.612540015810854e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2019,Prescription,Human,257.5,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.438457231380814e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trilostane,2016,Prescription,Vet,3720.3,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.068228672133566e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2017,Prescription,Vet,3850.5,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.1207905695498074e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2018,Prescription,Vet,4262.1,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.2115536520308975e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2019,Prescription,Vet,4884.9,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.4111114458086266e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trimethoprim,2016,Prescription,Human,571679.532,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.641492533812592e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2016,Prescription,Vet,227053.5244,IEDVJHCEMCRBQM-UHFFFAOYSA-N,6.519503396851282e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2017,Prescription,Human,563572.4400000001,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.6404276743544342e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2017,Prescription,Vet,212978.4526,IEDVJHCEMCRBQM-UHFFFAOYSA-N,6.199305056262582e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2018,Prescription,Human,591461.06,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.681299845796828e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2018,Prescription,Vet,202683.0232,IEDVJHCEMCRBQM-UHFFFAOYSA-N,5.76151092096908e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2019,Prescription,Human,628483.9400000001,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.815514915844546e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2019,Prescription,Vet,214736.6218,IEDVJHCEMCRBQM-UHFFFAOYSA-N,6.203142436001932e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimipramine,2016,Prescription,Human,77649.3,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.2295838677284336e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2017,Prescription,Human,74164.78,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.1587634337549975e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2018,Prescription,Human,70475.37,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.0033479247725008e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2019,Prescription,Human,35509.555,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,1.0257720628072416e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
tropicamide,2016,Prescription,Human,346.4,BGDKAVGWHJFAGW-UHFFFAOYSA-N,9.946359487865692e-11,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2017,Prescription,Human,348.65,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.014838675687678e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2018,Prescription,Human,356.2,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0125417302583368e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2019,Prescription,Human,352.45,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0181298062913271e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
ulipristal,2016,OTC,Human,2977.5,HKDLNTKNLJPAIY-WKWWZUSTSA-N,8.549447279191714e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0018190313359982369
ulipristal,2016,Prescription,Human,902.02,HKDLNTKNLJPAIY-WKWWZUSTSA-N,2.5900159310752337e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,5.510672193777093e-4
ulipristal,2017,OTC,Human,2643,HKDLNTKNLJPAIY-WKWWZUSTSA-N,7.69315537026397e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0016368415681412703
ulipristal,2017,Prescription,Human,1026.06,HKDLNTKNLJPAIY-WKWWZUSTSA-N,2.9866208850597986e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,6.354512521403827e-4
ulipristal,2018,OTC,Human,2374.53,HKDLNTKNLJPAIY-WKWWZUSTSA-N,6.749889710135678e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0014361467468373783
ulipristal,2018,Prescription,Human,427.56,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.2153911908738195e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,2.5859387039868503e-4
ulipristal,2019,OTC,Human,2310,HKDLNTKNLJPAIY-WKWWZUSTSA-N,6.672946098830943e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0014197757657087114
ulipristal,2019,Prescription,Human,479.78,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.3859506836784023e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,2.948831241868941e-4
umeclidinium bromide,2016,Prescription,Human,83.67060000000001,PEJHHXHHNGORMP-UHFFFAOYSA-M,2.4024765189532772e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,2.518319202257104e-6
umeclidinium bromide,2017,Prescription,Human,133.8126,PEJHHXHHNGORMP-UHFFFAOYSA-M,3.8949720858834067e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,4.082779964238372e-6
umeclidinium bromide,2018,Prescription,Human,184.46145,PEJHHXHHNGORMP-UHFFFAOYSA-M,5.2435405881235734e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,5.4963737821001815e-6
umeclidinium bromide,2019,Prescription,Human,249.24749999999997,PEJHHXHHNGORMP-UHFFFAOYSA-M,7.200065509819764e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,7.547238479894931e-6
ursodeoxycholic acid,2016,Prescription,Human,638521.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.8334185603756817e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2017,Prescription,Human,675813,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.967133715567236e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2018,Prescription,Human,723487.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.056600314247181e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2019,Prescription,Human,777307.75,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.2454254190275147e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
valaciclovir,2016,Prescription,Human,1190973.91,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.419703998131928e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.001709851999065964
valaciclovir,2017,Prescription,Human,1372743.409999999,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.9957352768202675e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0019978676384101337
valaciclovir,2018,Prescription,Human,1685439.98,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4.791067696787694e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.002395533848393847
valaciclovir,2019,Prescription,Human,1955930.05,HDOVUKNUBWVHOX-QMMMGPOBSA-N,5.650136708542733e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0028250683542713666
valganciclovir,2016,Prescription,Human,38610,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.108628579175792e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2017,Prescription,Human,45603,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3273967625809605e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2018,Prescription,Human,39771,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.1305389431247702e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2019,Prescription,Human,46013,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3291873110195162e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valproic acid,2016,Prescription,Human,5039748.3,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.447088577371824e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2017,Prescription,Human,5053161.15,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4708571259149362e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2018,Prescription,Human,5088836.65,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.446563578493273e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2019,Prescription,Human,5090799.85,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4705901731163052e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valsartan,2016,Prescription,Human,5444853.22112,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.563408415009324e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002791800741088079
valsartan,2017,Prescription,Human,5833926.01488,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6981195327694572e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.003032356308516888
valsartan,2018,Prescription,Human,5759581.4616,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6372309316935163e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002923626663738422
valsartan,2019,Prescription,Human,6585188.6816,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.9022774512098876e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.0033969240200176568
vancomycin,2016,Prescription,Human,70943,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0370224628973895e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2017,Prescription,Human,68898,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0054597756354408e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2018,Prescription,Human,66420.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,1.8880833238243645e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2019,Prescription,Human,71977.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0792293412493692e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vandetanib,2016,Prescription,Human,174,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.996150551064175e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.9961505510641754e-5
vandetanib,2017,Prescription,Human,159,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.6281184406809357e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.628118440680936e-5
vandetanib,2018,Prescription,Human,78,UHTHHESEBZOYNR-UHFFFAOYSA-N,2.217244664799278e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,2.2172446647992782e-5
vandetanib,2019,Prescription,Human,33,UHTHHESEBZOYNR-UHFFFAOYSA-N,9.532780141187063e-12,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,9.532780141187063e-6
vardenafil,2016,Prescription,Human,3477.78,SECKRCOLJRRGGV-UHFFFAOYSA-N,9.985926703149406e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2017,Prescription,Human,3440.2799999999997,SECKRCOLJRRGGV-UHFFFAOYSA-N,1.0013851137802395e-9,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2018,Prescription,Human,2986.24,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.488749625397685e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2019,Prescription,Human,2997.28,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.65830644290217e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
varenicline,2016,Prescription,Human,1794.48112,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.152584963541526e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2017,Prescription,Human,1721.50796,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.01090738078932e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2018,Prescription,Human,1538.3765,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.3730219065097255e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2019,Prescription,Human,1447.68306,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.1819528257881567e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
vecuronium,2016,Prescription,Human,260,BGSZAXLLHYERSY-XQIGCQGXSA-N,7.465512317682101e-11,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
vedaprofen,2016,Prescription,Vet,1737,VZUGVMQFWFVFBX-UHFFFAOYSA-N,4.987536498389927e-10,analgesic,veterinary NSAID,NA,NA,NA,NA
velpatasvir,2016,Prescription,Human,408.8,FHCUMDQMBHQXKK-CDIODLITSA-N,1.1738082444109396e-10,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2017,Prescription,Human,4194.4,FHCUMDQMBHQXKK-CDIODLITSA-N,1.2208918231190007e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2018,Prescription,Human,16290.4,FHCUMDQMBHQXKK-CDIODLITSA-N,4.630743908646943e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2019,Prescription,Human,10329.2,FHCUMDQMBHQXKK-CDIODLITSA-N,2.983817958616648e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
vemurafenib,2016,Prescription,Human,7190.4,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.064616144963899e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2017,Prescription,Human,4139.52,GPXBXXGIAQBQNI-UHFFFAOYSA-N,1.2049175375828647e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2018,Prescription,Human,3454.08,GPXBXXGIAQBQNI-UHFFFAOYSA-N,9.81864160485883e-10,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2019,Prescription,Human,7620.48,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.201344254857975e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
venetoclax,2017,Prescription,Human,1.19,LQBVNQSMGBZMKD-UHFFFAOYSA-N,3.4638119147234674e-13,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2018,Prescription,Human,604.59,LQBVNQSMGBZMKD-UHFFFAOYSA-N,1.7186204511423018e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2019,Prescription,Human,2093.9100000000003,LQBVNQSMGBZMKD-UHFFFAOYSA-N,6.048722322858486e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venlafaxine,2016,Prescription,Human,1370348.3595,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.934750983601042e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2017,Prescription,Human,1367537.226,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.980581291803933e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2018,Prescription,Human,1355433.264,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.852983555250604e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2019,Prescription,Human,1388562.3345,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4.011169529430894e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
verapamil,2016,Prescription,Human,768375.1111999999,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.206274560486136e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2017,Prescription,Human,762674.224,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.2199664404568698e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2018,Prescription,Human,740412.9216,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1047135899564695e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2019,Prescription,Human,728917.0784,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1056382574374586e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
vernakalant,2016,Prescription,Human,2,VBHQKCBVWWUUKN-KZNAEPCWSA-N,5.742701782832385e-13,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2017,Prescription,Human,6,VBHQKCBVWWUUKN-KZNAEPCWSA-N,1.7464597889362021e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2018,Prescription,Human,11,VBHQKCBVWWUUKN-KZNAEPCWSA-N,3.1268835016400072e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2019,Prescription,Human,9,VBHQKCBVWWUUKN-KZNAEPCWSA-N,2.5998491294146532e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
verteporfin,2016,Prescription,Human,3.315,NJLRKAMQPVVOIU-IDLGWYNRSA-N,9.51852820504468e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2017,Prescription,Human,3.06,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.906944923574631e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2018,Prescription,Human,2.85,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.101470890612746e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2019,Prescription,Human,2.46,NJLRKAMQPVVOIU-IDLGWYNRSA-N,7.106254287066719e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
vigabatrin,2016,Prescription,Human,42639.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2243296633454077e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2017,Prescription,Human,43862,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2767203210386615e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2018,Prescription,Human,39305.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.1173065406701028e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2019,Prescription,Human,43813.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2656498870178769e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vilanterol,2016,Prescription,Human,119.1465,DAFYYTQWSAWIGS-DEOSSOPVSA-N,3.4211140898411936e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2017,Prescription,Human,163.98558,DAFYYTQWSAWIGS-DEOSSOPVSA-N,4.7732370239230105e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2018,Prescription,Human,201.80028,DAFYYTQWSAWIGS-DEOSSOPVSA-N,5.736417874166672e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2019,Prescription,Human,248.78238,DAFYYTQWSAWIGS-DEOSSOPVSA-N,7.186629489518949e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vildagliptin,2016,Prescription,Human,388078.935,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1143107959520966e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.9898407070573156e-4
vildagliptin,2017,Prescription,Human,401346.72,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1682265131690617e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,2.0861187735161818e-4
vildagliptin,2018,Prescription,Human,370008.915,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0517952470665637e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8782057983331496e-4
vildagliptin,2019,Prescription,Human,354183.27,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0231367401808169e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8270298931800304e-4
vinblastine,2016,Prescription,Human,23.24,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.6730194716512315e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2017,Prescription,Human,22.14,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.444436621174586e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2018,Prescription,Human,20.97,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.960977002671905e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2019,Prescription,Human,18.35,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.300803502750989e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2016,Prescription,Human,13.13,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.770083720429461e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2017,Prescription,Human,12.7,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.696673219914961e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2018,Prescription,Human,12.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.5077947645670624e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2019,Prescription,Human,13.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.853554154043497e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinflunine,2016,Prescription,Human,59.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7127608067297588e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2017,Prescription,Human,61.2,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7813889847149263e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2018,Prescription,Human,13.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.880178163398736e-12,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2019,Prescription,Human,1.3,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.755337631376722e-13,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinorelbine,2016,Prescription,Human,578.29,GBABOYUKABKIAF-IELIFDKJSA-N,1.66047350699707e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2017,Prescription,Human,528.64,GBABOYUKABKIAF-IELIFDKJSA-N,1.5387475047053895e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2018,Prescription,Human,485.12,GBABOYUKABKIAF-IELIFDKJSA-N,1.3790124766505454e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2019,Prescription,Human,399.45,GBABOYUKABKIAF-IELIFDKJSA-N,1.1538997052718703e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vismodegib,2016,Prescription,Human,201.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,5.7886433970950434e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2017,Prescription,Human,340.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,9.902427003268264e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2018,Prescription,Human,306.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,8.71547710548024e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2019,Prescription,Human,361.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,1.0434061172717476e-10,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
voriconazole,2016,Prescription,Human,5863.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.683501741146228e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2017,Prescription,Human,4776.8,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.3904148532984082e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2018,Prescription,Human,4883.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.388080438805302e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2019,Prescription,Human,6599.4,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.906382704962118e-9,antifungal,azole antifungal,NA,NA,NA,NA
vortioxetine,2016,Prescription,Human,12130.0606,YQNWZWMKLDQSAC-UHFFFAOYSA-N,3.482966031674243e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2017,Prescription,Human,19275.368,YQNWZWMKLDQSAC-UHFFFAOYSA-N,5.6106091881579385e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2018,Prescription,Human,23910.0946,YQNWZWMKLDQSAC-UHFFFAOYSA-N,6.796734575217439e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2019,Prescription,Human,30263.8252,YQNWZWMKLDQSAC-UHFFFAOYSA-N,8.742375510997473e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
voxilaprevir,2017,Prescription,Human,8.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,2.445043704510683e-12,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2018,Prescription,Human,316.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.994053999262711e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2019,Prescription,Human,288.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.331072099146512e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
warfarin,2016,Prescription,Human,102193.1675,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.934324425977693e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.002667567659979721
warfarin,2017,Prescription,Human,86658.63,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.522430210988341e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0022931183736257647
warfarin,2018,Prescription,Human,72666.24,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.065626063474665e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0018778418758860593
warfarin,2019,Prescription,Human,61197.5,PJVWKTKQMONHTI-UHFFFAOYSA-N,1.7678251899705918e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0016071138090641745
xylazine,2016,Prescription,Vet,7361,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.113601391171459e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2017,Prescription,Vet,7566,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2022857938485508e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2018,Prescription,Vet,8115,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.306787237800787e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2019,Prescription,Vet,7709,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2269152154063958e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylometazoline,2016,OTC,Human,50032.31,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.4366031791811128e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.0070768629516310974
xylometazoline,2017,OTC,Human,56242.875,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6370986600277533e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008064525418855927
xylometazoline,2018,OTC,Human,57843.65,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6442759532694454e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008099881543199239
xylometazoline,2019,OTC,Human,61488.13,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.7762206805537227e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.00874985556923016
zanamivir,2016,Prescription,Human,1.5,ARAIBEBZBOPLMB-UFGQHTETSA-N,4.307026337124289e-13,antiviral,neuraminidase inhibitor for influenza,low,high,NA,NA
zidovudine,2016,Prescription,Human,17280,HBOMLICNUCNMMY-XLPZGREQSA-N,4.961694340367181e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2017,Prescription,Human,11970,HBOMLICNUCNMMY-XLPZGREQSA-N,3.484187278927723e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2018,Prescription,Human,8154,HBOMLICNUCNMMY-XLPZGREQSA-N,2.317873461124783e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2019,Prescription,Human,5940,HBOMLICNUCNMMY-XLPZGREQSA-N,1.7159004254136711e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
ziprasidone,2016,Prescription,Human,18900.4104,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.426971025017188e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2017,Prescription,Human,17402.2128,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.065377482285146e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2018,Prescription,Human,17195.976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.8881648771815934e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2019,Prescription,Human,16329.2976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.717078905479198e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
zofenopril,2016,Prescription,Human,3.36,IAIDUHCBNLFXEF-MNEFBYGVSA-N,9.647738995158406e-13,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2017,Prescription,Human,17.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,5.1345917794724335e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2018,Prescription,Human,38.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,1.0983888954851808e-11,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2019,Prescription,Human,26.88,IAIDUHCBNLFXEF-MNEFBYGVSA-N,7.764882733185099e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zoledronic acid,2016,Prescription,Human,111.713,XRASPMIURGNCCH-UHFFFAOYSA-N,3.207672221327771e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.0347329746218615e-6
zoledronic acid,2017,Prescription,Human,141.513,XRASPMIURGNCCH-UHFFFAOYSA-N,4.11911273519548e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.328746043611445e-6
zoledronic acid,2018,Prescription,Human,160.505,XRASPMIURGNCCH-UHFFFAOYSA-N,4.5625494220975386e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.4717901361604963e-6
zoledronic acid,2019,Prescription,Human,181.311,XRASPMIURGNCCH-UHFFFAOYSA-N,5.2375693944811136e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.6895385143487462e-6
zolmitriptan,2016,Prescription,Human,3741.645,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.074357570611294e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0743575706112941e-5
zolmitriptan,2017,Prescription,Human,3886.32,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.1312169344897568e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.1312169344897569e-5
zolmitriptan,2018,Prescription,Human,3826.47,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.087720537501858e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0877205375018581e-5
zolmitriptan,2019,Prescription,Human,3796.875,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.0968113514718067e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0968113514718068e-5
zolpidem,2016,Prescription,Human,112751.9255,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.237503417933171e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.01471592462696896
zolpidem,2017,Prescription,Human,111564.9205,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.247394125151903e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014760882387054104
zolpidem,2018,Prescription,Human,111729.2415,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.1760392899736555e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014436542227152979
zolpidem,2019,Prescription,Human,114395.1865,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.30455806701391e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.015020718486426861
zonisamide,2016,Prescription,Human,64870.078,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8626475629153796e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2017,Prescription,Human,65644.614,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.9107613118539744e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2018,Prescription,Human,63057.96,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.7924990433734136e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2019,Prescription,Human,65638.636,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8961172295618372e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zopiclone,2016,Prescription,Human,393691.9724500001,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.130427796037707e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2017,Prescription,Human,374501.7356,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0900870368536956e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2018,Prescription,Human,356499.65585,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0133935383797323e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2019,Prescription,Human,360740.1669,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0420777876220686e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zuclopenthixol,2016,Prescription,Human,16454.122,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.724555787217078e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2017,Prescription,Human,15475.242,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.504481312842775e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2018,Prescription,Human,14533.664,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.131370379998119e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2019,Prescription,Human,13971.81,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.0360664516496606e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
13C-urea,2016,Total,Human,83.45,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.3961423188868128e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2017,Total,Human,88.4,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.5731174223660045e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2018,Total,Human,186,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.28727573913674e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2019,Total,Human,204.6,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.910323687535979e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
4-aminosalicylic acid,2016,Total,Human,12390799.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.557833198371694e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2017,Total,Human,13384234.35,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.895837849662278e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2018,Total,Human,14345104.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.07776993427825e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2019,Total,Human,15501228.04,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.477872691628001e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
abacavir,2016,Total,Human,221508,MCGSCOLBFJQGHM-SCZZXKLOSA-N,6.36027193255818e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.135762845099675e-4
abacavir,2017,Total,Human,252378,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.346133810202347e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.311809608964705e-4
abacavir,2018,Total,Human,264834,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.52822786612118e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.3443264046644965e-4
abacavir,2019,Total,Human,248130,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.167784049796199e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.2799614374636072e-4
abiraterone,2016,Total,Human,107280,GZOSMCIZMLWJML-VJLLXTKPSA-N,3.0803852363112915e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,23.695271048548395
abiraterone,2017,Total,Human,81902,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.3839758272242136e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,18.33827559403241
abiraterone,2018,Total,Human,76356,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.1705119695565857e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,16.696245919666044
abiraterone,2019,Total,Human,71596,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.0682088696619058e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,15.909298997399274
acamprosate,2016,Total,Human,72615.87144,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.0850564719020765e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2017,Total,Human,72869.8572,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.12107125708872e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2018,Total,Human,74400.48504,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.114924083505365e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2019,Total,Human,60915.18384,AFCGFAGUEYAMAO-UHFFFAOYSA-N,1.7596698630506396e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acarbose,2016,Total,Human,24421.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,7.012269579472055e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2017,Total,Human,23097,XUFXOAAUWZOOIT-UGEKTDRHSA-N,6.722996957509911e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2018,Total,Human,19867.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,5.647577997166622e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2019,Total,Human,11034.06,XUFXOAAUWZOOIT-UGEKTDRHSA-N,3.187432364989894e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acetazolamide,2016,Total,Human,124689.75,BZKPWHYZMXOIDC-UHFFFAOYSA-N,3.580280248129622e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2017,Total,Human,156871,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.56614822583685e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2018,Total,Human,159839,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.5436175638057925e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2019,Total,Human,181725.25,BZKPWHYZMXOIDC-UHFFFAOYSA-N,5.2495359222795586e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetic acid,2016,Total,Human,7512.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.157102357176414e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2017,Total,Human,7935,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.309693070868127e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2018,Total,Human,8785,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.4972428692643144e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2019,Total,Human,8982.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.594793867218569e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetylsalicylic acid,2016,Total,Human,11034291.32,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,3.168332221782796e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.11195520218313768
acetylsalicylic acid,2017,Total,Human,10197744.785,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.9683252008060594e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10488781628289963
acetylsalicylic acid,2018,Total,Human,10344527.04,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.940557357604085e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10390662041003834
acetylsalicylic acid,2019,Total,Human,10138922.415,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.928852068204496e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10349300594362176
aciclovir,2016,Total,Human,433878.62,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.2458177623034278e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,6.229088811517139e-4
aciclovir,2017,Total,Human,409429.025,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1917522143097584e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.958761071548792e-4
aciclovir,2018,Total,Human,414988.94,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1796564271355229e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.898282135677614e-4
aciclovir,2019,Total,Human,430329.795,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.243102825435485e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,6.215514127177425e-4
acitretin,2016,Total,Human,11715.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.3639311368386403e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2017,Total,Human,12354,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.5959607054196405e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2018,Total,Human,12336.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.506799847089268e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2019,Total,Human,12033.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.476142722090137e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
aclidinium bromide,2016,Total,Human,822.6033600000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.361982891017955e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2017,Total,Human,914.54928,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.6620392375342587e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2018,Total,Human,869.6434800000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.472067136291638e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2019,Total,Human,789.1182,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.2795425169725094e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
adapalene,2016,Total,Human,227444.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,6.530723361255141e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2017,Total,Human,245696.46,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.1516497945662e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2018,Total,Human,267527.88,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.60480467455207e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2019,Total,Human,287075.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,8.292804630938534e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adefovir dipivoxil,2016,Total,Human,17.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,5.082291077806661e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2017,Total,Human,15.3,WOZSCQDILHKSGG-UHFFFAOYSA-N,4.453472461787316e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2018,Total,Human,7.5,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.1319660238454594e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2019,Total,Human,8.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.5131874917674978e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adrenaline,2016,Total,Human,61.06681194,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.7534424489986398e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2016,Total,Vet,63.1158048,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.812276223749304e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2017,Total,Human,61.3362035,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.7853535503126323e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2017,Total,Vet,64.1815072,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.868173691968655e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2018,Total,Human,55.67994009,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.5827698730884092e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2018,Total,Vet,62.9051504,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.788155245035848e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2019,Total,Human,57.71426155,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.6672041405064124e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2019,Total,Vet,58.675890912,UCTWMZQNUQWSLP-VIFPVBQESA-N,1.6949829322799148e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
afatinib,2016,Total,Human,264.32,ULXXDDBFHOBEHA-CWDCEQMOSA-N,7.58955467619128e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.3717358363097752e-5
afatinib,2017,Total,Human,294.28,ULXXDDBFHOBEHA-CWDCEQMOSA-N,8.565803111469092e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.6768134723340914e-5
afatinib,2018,Total,Human,200.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,5.706846652629526e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,1.783389578946727e-5
afatinib,2019,Total,Human,235.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,6.81044923056443e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.128265384551384e-5
aglepristone,2016,Total,Vet,1039.2,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.9839078463597076e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2017,Total,Vet,942.9,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.7445615583132415e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2018,Total,Vet,1002,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.8483066078575337e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2019,Total,Vet,873,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.5218536555322136e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
albendazole,2016,Total,Vet,269372.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.734629679980084e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2017,Total,Vet,296590,HXHWSAZORRCQMX-UHFFFAOYSA-N,8.633041813343138e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2018,Total,Vet,249897.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.103639725918942e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2019,Total,Vet,237595,HXHWSAZORRCQMX-UHFFFAOYSA-N,6.863457265591939e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
alectinib,2017,Total,Human,1377.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.00987167539752e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2018,Total,Human,5241.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,1.4899884147451146e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2019,Total,Human,15187.2,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.387158744249581e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alendronic acid,2016,Total,Human,150355.3996,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.3172311067069784e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.9247555515517984e-4
alendronic acid,2017,Total,Human,146830.7834,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.2739009831016874e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.885364530092443e-4
alendronic acid,2018,Total,Human,144256.8582,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.1006762718545634e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.727887519867785e-4
alendronic acid,2019,Total,Human,140754.6266,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.0660088158566066e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.696371650778733e-4
alfaxalone,2016,Total,Vet,36.7,DUHUCHOQIDJXAT-OLVMNOGESA-N,1.0537857771497428e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2017,Total,Vet,121.2,DUHUCHOQIDJXAT-OLVMNOGESA-N,3.5278487736511277e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2018,Total,Vet,153.9,DUHUCHOQIDJXAT-OLVMNOGESA-N,4.3747942809308825e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2019,Total,Vet,203.3,DUHUCHOQIDJXAT-OLVMNOGESA-N,5.872770311222212e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfentanil,2016,Total,Human,192.995,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.5415636528886813e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2017,Total,Human,186.595,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.4313444052758434e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2018,Total,Human,189.865,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.3971430548989084e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2019,Total,Human,194.61,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.621740434170953e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alimemazine,2016,Total,Human,175565.67,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.0411064305658113e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2017,Total,Human,171501.43,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.9920058540009476e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2018,Total,Human,171914.52,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.88687887527601e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2019,Total,Human,177117.34,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.1164262467026576e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
aliskiren,2016,Total,Human,2866.5,UXOWGYHJODZGMF-QORCZRPOSA-N,8.230727330244515e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
aliskiren,2017,Total,Human,1440.6,UXOWGYHJODZGMF-QORCZRPOSA-N,4.1932499532358207e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
alitretinoin,2016,Total,Human,2679.6,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,7.69407184863883e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2017,Total,Human,3087,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,8.98553561407676e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2018,Total,Human,3252.2999999999997,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,9.245057465803447e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2019,Total,Human,3581.1,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,1.0344799685940903e-9,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
allopurinol,2016,Total,Human,2871723.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,8.245726693031095e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2017,Total,Human,3206720.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.33401488590888e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2018,Total,Human,3212108.7,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.13080881773121e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2019,Total,Human,3196137.4,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.232750040977348e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
almotriptan,2016,Total,Human,1701.9375,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.886859757759645e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2017,Total,Human,1715.025,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.992036999200516e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2018,Total,Human,1813.0875,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.153921264345206e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2019,Total,Human,1760.9625,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.086929802840945e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
alprazolam,2016,Total,Human,1920.512000000001,VREFGVBLTWBCJP-UHFFFAOYSA-N,5.514463843175499e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2017,Total,Human,1699.571,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.947054016570148e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2018,Total,Human,1621.41,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.6090547076310224e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2019,Total,Human,1583.6755,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.5747970777225734e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprostadil,2016,Total,Human,11.99234,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.4434216149166065e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2017,Total,Human,12.92188,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.7612573029098216e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2018,Total,Human,11.87954,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.3769034211884118e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2019,Total,Human,12.05914,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.483549403387714e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
altrenogest,2016,Total,Vet,44.88,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.2886622800675872e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2017,Total,Vet,53.13,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.5464901431030068e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2018,Total,Vet,32.34,VWAUPFMBXBWEQY-ANULTFPQSA-N,9.193037494821622e-12,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2019,Total,Vet,1860.06,VWAUPFMBXBWEQY-ANULTFPQSA-N,5.373194857398912e-10,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
ambrisentan,2016,Total,Human,117.9,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.3853227009796914e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2017,Total,Human,130.95,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.811648489353261e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2018,Total,Human,126.6,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.5987586482511356e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2019,Total,Human,124.65,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.600791044239295e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
amfetamine,2016,Total,Human,2363.055,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.78516008071549e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2017,Total,Human,2438.82,KWTSXDURSIMDCE-UHFFFAOYSA-N,7.098835104088981e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2018,Total,Human,2229.57,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.337823317046829e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2019,Total,Human,2190,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.326299548242322e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amifampridine,2016,Total,Human,100,OYTKINVCDFNREN-UHFFFAOYSA-N,2.8713508914161926e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2017,Total,Human,132,OYTKINVCDFNREN-UHFFFAOYSA-N,3.8422115356596445e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2018,Total,Human,208,OYTKINVCDFNREN-UHFFFAOYSA-N,5.912652439464741e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2019,Total,Human,296,OYTKINVCDFNREN-UHFFFAOYSA-N,8.550614914519304e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amiloride,2016,Total,Human,14693.575,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4.219040967434068e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2017,Total,Human,12526.4375,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.6461532320620876e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2018,Total,Human,11403.3175,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.241531395882979e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2019,Total,Human,9697.7625,XSDQTOBWRPYKKA-UHFFFAOYSA-N,2.80141326587723e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiodarone,2016,Total,Human,292305.6,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.39311945125945e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3497133104691438
amiodarone,2017,Total,Human,302692.68,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.81067656708889e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3671115236287038
amiodarone,2018,Total,Human,314712.87,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.94609528142524e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.37275397005938504
amiodarone,2019,Total,Human,339226.26,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,9.799301074839877e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.40830421145166157
amisulpride,2016,Total,Human,77174.37,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.2159469609398305e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2017,Total,Human,78455.64,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.283660341254244e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2018,Total,Human,78187.365,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.222570742320049e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2019,Total,Human,83282.625,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.405802890017967e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amitriptyline,2016,Total,Human,389459.21,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1182740498037463e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2017,Total,Human,392819.36,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.14340536092609e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2018,Total,Human,388703.665,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1049373428322769e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2019,Total,Human,425743.685,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.2298548320011518e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amlodipine,2016,Total,Human,435018.7804,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.249091562884325e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2017,Total,Human,435269.7111,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.2669684129633796e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2018,Total,Human,468062.1878,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.330523575248497e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2019,Total,Human,523293.8289,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.5116500061041397e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amorolfine,2016,Total,Human,2836.5,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.144586803502031e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2017,Total,Human,2805.05,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.16484505159249e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2018,Total,Human,2981.1,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.474138551580931e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2019,Total,Human,2877.3,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.311717666738646e-10,antifungal,topical antifungal,NA,NA,NA,NA
amoxicillin,2016,Total,Human,2507626.75,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.20027630395159e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.231123466604604
amoxicillin,2016,Total,Vet,356437.2,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,1.0234562719538917e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,1.3121234255819125
amoxicillin,2017,Total,Human,2498091.5,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.271360589722201e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.322257166310514
amoxicillin,2017,Total,Vet,275927.6,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.031607634294547e-8,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,1.0296932864480188
amoxicillin,2018,Total,Human,2433165.5,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,6.916568235190599e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,8.867395173321281
amoxicillin,2018,Total,Vet,260232.4,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.397421801383482e-8,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,0.9483874104337798
amoxicillin,2019,Total,Human,2586406,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.471405986014262e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.578725623095208
amoxicillin,2019,Total,Vet,264767.4,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.648392159859795e-8,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,0.9805630974179225
amphotericin B,2016,Total,Human,654.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.879299158431898e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2017,Total,Human,449.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3083894585447048e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2018,Total,Human,483,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3729861193564758e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2019,Total,Human,492.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.4226952180407962e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
ampicillin,2016,Total,Human,481355,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.3821391083376416e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2017,Total,Human,497867.5,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.4491759482803242e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2018,Total,Human,107865,AVKUERGKIZMTKX-NJBDSQKTSA-N,3.06619353549454e-8,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
amsacrine,2017,Total,Human,4.95,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.4408293258723668e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2018,Total,Human,3.69,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.048927283731966e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2019,Total,Human,2.835,XCPGHVQEEXUHNC-UHFFFAOYSA-N,8.189524757656158e-13,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
anagrelide,2016,Total,Human,101.95,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9273422337988077e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2017,Total,Human,103.55,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.0140985190723957e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2018,Total,Human,103.05,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9293213167636613e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2019,Total,Human,107.9,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.1169302340426793e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anastrozole,2016,Total,Human,258.244,YBBLVLTVTVSKRW-UHFFFAOYSA-N,7.415091396028832e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,7.415091396028832e-5
anastrozole,2017,Total,Human,216.812,YBBLVLTVTVSKRW-UHFFFAOYSA-N,6.310890662647265e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,6.310890662647265e-5
anastrozole,2018,Total,Human,177.948,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.0583878668166905e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.0583878668166906e-5
anastrozole,2019,Total,Human,184.894,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.341072277044366e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.341072277044366e-5
anidulafungin,2016,Total,Human,768.5,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.2066331600533438e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2017,Total,Human,506.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,1.473429908599176e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2018,Total,Human,906.7,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.5774047917609037e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2019,Total,Human,1058.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,3.0568448319406516e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
antazoline,2016,Total,Human,357.106,REYFJDPCWQRWAA-UHFFFAOYSA-N,1.0253766314300707e-10,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2017,Total,Human,368.116,REYFJDPCWQRWAA-UHFFFAOYSA-N,1.0714996527733983e-10,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2018,Total,Human,346.759,REYFJDPCWQRWAA-UHFFFAOYSA-N,9.857045419501701e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2019,Total,Human,410.6799999999999,REYFJDPCWQRWAA-UHFFFAOYSA-N,1.1863400449644552e-10,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
apixaban,2016,Total,Human,88236.5689,QNZCBYKSOIHPEH-UHFFFAOYSA-N,2.533581507665213e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,7.037726410181147e-5
apixaban,2017,Total,Human,134931.107,QNZCBYKSOIHPEH-UHFFFAOYSA-N,3.9275292108691354e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.0909803363525375e-4
apixaban,2018,Total,Human,179092.2148,QNZCBYKSOIHPEH-UHFFFAOYSA-N,5.090913561184439e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.4141426558845663e-4
apixaban,2019,Total,Human,224196.9254,QNZCBYKSOIHPEH-UHFFFAOYSA-N,6.47642423687369e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.7990067324649136e-4
apomorphine,2016,Total,Human,621.15,VMWNQDUVQKEIOC-CYBMUJFWSA-N,1.7835396062031677e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2017,Total,Human,737.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.1459624656553584e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2018,Total,Human,817.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.3231323106502687e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2019,Total,Human,1014.95,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.931907637666003e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apraclonidine,2016,Total,Human,40.525,IEJXVRYNEISIKR-UHFFFAOYSA-N,1.163614948746412e-11,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2017,Total,Human,30.07,IEJXVRYNEISIKR-UHFFFAOYSA-N,8.752674308885267e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2018,Total,Human,23.5,IEJXVRYNEISIKR-UHFFFAOYSA-N,6.6801602080491065e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2019,Total,Human,26.725,IEJXVRYNEISIKR-UHFFFAOYSA-N,7.720107553734069e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apremilast,2016,Total,Human,342.96,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,9.847585017200974e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2017,Total,Human,377.28,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,1.098173915283084e-10,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2018,Total,Human,165.12,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,4.693736398098163e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2019,Total,Human,75.6,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,2.1838732687083088e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
aprepitant,2016,Total,Human,3657.135,ATALOFNDEOCMKK-OITMNORJSA-N,1.0500917842279361e-9,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,5.833843245710757e-4
aprepitant,2017,Total,Human,1379.32,ATALOFNDEOCMKK-OITMNORJSA-N,4.014878193459137e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,2.230487885255076e-4
aprepitant,2018,Total,Human,924.14,ATALOFNDEOCMKK-OITMNORJSA-N,2.626980108368724e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.45943339353818e-4
aprepitant,2019,Total,Human,867.26,ATALOFNDEOCMKK-OITMNORJSA-N,2.505272395529058e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.3918179975161435e-4
aripiprazole,2016,Total,Human,22934.58255,CEUORZQYGODEFX-UHFFFAOYSA-N,6.5853234049200765e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.0252311241567819
aripiprazole,2017,Total,Human,23956.4052,CEUORZQYGODEFX-UHFFFAOYSA-N,6.973149728210356e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026717048767089482
aripiprazole,2018,Total,Human,24564.66095,CEUORZQYGODEFX-UHFFFAOYSA-N,6.982803004357777e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026754034499455084
aripiprazole,2019,Total,Human,25654.9684,CEUORZQYGODEFX-UHFFFAOYSA-N,7.411005251100049e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.028394656134482943
arsenic trioxide,2016,Total,Human,4.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.205967374394801e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2017,Total,Human,7.5,QTLQKAJBUDWPIB-UHFFFAOYSA-N,2.1830747361702525e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2018,Total,Human,1.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,3.411145638152735e-13,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2019,Total,Human,6.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.7910071780412057e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
articaine,2016,Total,Human,106270.4,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0513960777115544e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2017,Total,Human,96838.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.8187511701472516e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2018,Total,Human,102442,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.9120381788636876e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2019,Total,Human,104114.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0075863571020085e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
asenapine,2016,Total,Human,118.2,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,3.39393675365394e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2017,Total,Human,74.1,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,2.1568778393362097e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2018,Total,Human,0.6,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,1.7055728190763679e-13,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
ataluren,2016,Total,Human,1245,OOUGLTULBSNHNF-UHFFFAOYSA-N,3.5748318598131596e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2017,Total,Human,1590,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.628118440680935e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2018,Total,Human,1593.75,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.5304278006716013e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2019,Total,Human,1586.25,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.582234090593327e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
atazanavir,2016,Total,Human,53994.45,AXRYRYVKAWYZBR-GASGPIRDSA-N,1.5503701213902704e-8,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2017,Total,Human,32043,AXRYRYVKAWYZBR-GASGPIRDSA-N,9.326968502813788e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2018,Total,Human,21825,AXRYRYVKAWYZBR-GASGPIRDSA-N,6.204021129390287e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2019,Total,Human,18564,AXRYRYVKAWYZBR-GASGPIRDSA-N,5.362622137605958e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atenolol,2016,Total,Human,501458.971,METKIMKYRPQLGS-UHFFFAOYSA-N,1.4398646633894968e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2017,Total,Human,451634.084,METKIMKYRPQLGS-UHFFFAOYSA-N,1.314601278365058e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2018,Total,Human,395443.916,METKIMKYRPQLGS-UHFFFAOYSA-N,1.124097324331197e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2019,Total,Human,358400.45499999996,METKIMKYRPQLGS-UHFFFAOYSA-N,1.035319012126184e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atipamezole,2016,Total,Vet,307.6,HSWPZIDYAHLZDD-UHFFFAOYSA-N,8.83227534199621e-11,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2017,Total,Vet,346.7,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0091626813736354e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2018,Total,Vet,363.8,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0341456526333044e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2019,Total,Vet,368.3,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0639160381815744e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atomoxetine,2016,Total,Human,40642.94568,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1670015830804793e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003646879947126498
atomoxetine,2017,Total,Human,40555.651,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1804802280938378e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.0036890007127932433
atomoxetine,2018,Total,Human,39326.5652,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1179053445459094e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003493454201705967
atomoxetine,2019,Total,Human,44075.1952,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.2732095318833437e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003978779787135449
atorvastatin,2016,Total,Human,2983202.8998,XUKUURHRXDUEBC-KAYWLYCHSA-N,8.565822305616101e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2017,Total,Human,3296228.5658,XUKUURHRXDUEBC-KAYWLYCHSA-N,9.594551075520914e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2018,Total,Human,3605848.4058,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.025006171773722e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2019,Total,Human,3907533.054,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.1287773787334314e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atovaquone,2016,Total,Human,230454,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.617142983304274e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2017,Total,Human,244364.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.112872274642556e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2018,Total,Human,240341.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.831991721713967e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2019,Total,Human,243922.5,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.046241102996066e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atropine,2016,Total,Human,508.2525,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.4593712689395084e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2017,Total,Human,471.785,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.3732558858721104e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2018,Total,Human,420.61,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.195634972386185e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2019,Total,Human,430.44,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.2434211769613815e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
avanafil,2017,Total,Human,516.8,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.5042840315370487e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2018,Total,Human,2318.4,WEAJZXNPAWBCOA-INIZCTEOSA-N,6.590333372911083e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2019,Total,Human,3580.7999999999997,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.0343933069564434e-9,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
axitinib,2016,Total,Human,110.544,RITAVMQDGBJQJZ-FMIVXFBMSA-N,3.174106129407116e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2017,Total,Human,68.152,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.9837454589263338e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2018,Total,Human,42.952,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.2209627287494687e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2019,Total,Human,38.36,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.1081134733816234e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
azacitidine,2016,Total,Human,668.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,1.9200723410900078e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2017,Total,Human,810.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.360049328115788e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2018,Total,Human,826.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.3499950825507217e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2019,Total,Human,968.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.798593151752129e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azathioprine,2016,Total,Human,249961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.177264580070059e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2017,Total,Human,246332.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.17016343263545e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2018,Total,Human,237961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,6.764337333223939e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2019,Total,Human,186067.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,5.3749714209706786e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azelaic acid,2016,Total,Human,138112.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.965694499907189e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2017,Total,Human,138474,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.0306545468858606e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2018,Total,Human,140379,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.990443446152023e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2019,Total,Human,148864.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.3002804525083084e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelastine,2016,Total,Human,1689.66,MBUVEWMHONZEQD-UHFFFAOYSA-N,4.851606747190284e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,4.410551588354804e-5
azelastine,2017,Total,Human,2350.41,MBUVEWMHONZEQD-UHFFFAOYSA-N,6.84149425418923e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,6.219540231081118e-5
azelastine,2018,Total,Human,2914.575,MBUVEWMHONZEQD-UHFFFAOYSA-N,8.285033165265838e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,7.531848332059854e-5
azelastine,2019,Total,Human,3834.09,MBUVEWMHONZEQD-UHFFFAOYSA-N,1.1075617276219363e-9,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,1.0068742978381239e-4
azithromycin,2016,Total,Human,169157.32,MQTOSJVFKKJCRP-BICOPXKESA-N,4.857100215715743e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2017,Total,Human,150059.395,MQTOSJVFKKJCRP-BICOPXKESA-N,4.3678783219932367e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2018,Total,Human,140032.74,MQTOSJVFKKJCRP-BICOPXKESA-N,3.980600585413133e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2019,Total,Human,140015.9025,MQTOSJVFKKJCRP-BICOPXKESA-N,4.0446691357648e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
aztreonam,2016,Total,Human,2810,WZPBZJONDBGPKJ-VEHQQRBSSA-N,8.068496004879502e-10,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2017,Total,Human,4266.3,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2418202329230862e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2018,Total,Human,4353.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2375352113081611e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2019,Total,Human,3906.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.1284789582287047e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
baclofen,2016,Total,Human,53586.095,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5386448164576278e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2017,Total,Human,54551.2975,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5878607919674327e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2018,Total,Human,53989.755,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5347243106098735e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2019,Total,Human,58862.845,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.7003835147568854e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
balsalazide,2016,Total,Human,451212.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.2955892705255842e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2017,Total,Human,451368.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.313828079865768e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2018,Total,Human,418080,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.188443140332413e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2019,Total,Human,389025,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.123784786189484e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
bambuterol,2016,Total,Human,564.13,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.6198151783746168e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2814298286966436e-6
bambuterol,2017,Total,Human,540.39,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.5729490089053902e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2154211393033667e-6
bambuterol,2018,Total,Human,375.4,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.0671200604687804e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,1.5029860006602542e-6
baricitinib,2017,Total,Human,16.464,XUZMWHLSFXCVMG-UHFFFAOYSA-N,4.7922856608409385e-12,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2018,Total,Human,39.144,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.1127157071654222e-11,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2019,Total,Human,349.944,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.010890670826535e-10,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
barium sulfate,2016,Total,Human,0.582,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.671126218804224e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2017,Total,Human,0.762,TZCXTZWJZNENPQ-UHFFFAOYSA-L,2.218003931948977e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2018,Total,Human,0.48,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.3644582552610941e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
bazedoxifene,2019,Total,Human,10.08,UCJGJABZCDBEDK-UHFFFAOYSA-N,2.911831024944412e-12,sex hormone,selective estrogen receptor modulator for postmenopausal osteoporosis,NA,NA,NA,NA
beclometasone,2016,Total,Human,1182.338,NBMKJKDGKREAPL-DVTGEIKXSA-N,3.3949072702552384e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2017,Total,Human,1665.07992,NBMKJKDGKREAPL-DVTGEIKXSA-N,4.846658542741847e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2018,Total,Human,2285.73212,NBMKJKDGKREAPL-DVTGEIKXSA-N,6.497470959269671e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2019,Total,Human,2988.30912,NBMKJKDGKREAPL-DVTGEIKXSA-N,8.632392071170964e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
bedaquiline,2017,Total,Human,131.6,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.83056847040007e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2018,Total,Human,112.8,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.206476899863571e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2019,Total,Human,94,QUIJNHUBAXPXFS-XLJNKUFUSA-N,2.7153979796108598e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
benazepril,2016,Total,Vet,2973.635,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.53834950799639e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2017,Total,Vet,3536.02,XPCFTKFZXHTYIP-PMACEKPBSA-N,1.0292527904790314e-9,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2018,Total,Vet,3202.885,XPCFTKFZXHTYIP-PMACEKPBSA-N,9.104589331045688e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2019,Total,Vet,2978.66,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.604518453135835e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
bendamustine,2016,Total,Human,556.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.59683001448883e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2017,Total,Human,447.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3014763885468323e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2018,Total,Human,484.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.376184068392244e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2019,Total,Human,476.75,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3771978582760402e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendroflumethiazide,2016,Total,Human,17372.80875,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.9883429890715535e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2017,Total,Human,15819.7025,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.604745714863918e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2018,Total,Human,14377.175,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.086886482517379e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2019,Total,Human,12909.53,HDWIHXWEUNVBIY-UHFFFAOYSA-N,3.729203370183594e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
benzocaine,2016,Total,Vet,1401000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.022762598874086e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2017,Total,Vet,1830800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,5.329030969307332e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2018,Total,Vet,1531000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.352053310009865e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2019,Total,Vet,2376800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,6.865912678658609e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzoyl peroxide,2016,Total,Human,286563.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,8.228243611723443e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2017,Total,Human,273130.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,7.950190589700657e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2018,Total,Human,274201,OMPJBNCRMGITSC-UHFFFAOYSA-N,7.794496209392651e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2019,Total,Human,271249.2,OMPJBNCRMGITSC-UHFFFAOYSA-N,7.835633294160235e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzydamine,2016,Total,Human,14606.52,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.194044422248845e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2017,Total,Human,12815.22,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,3.7302110693951665e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2018,Total,Human,14215.2,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.0408431229557295e-09,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2019,Total,Human,16450.41,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.752064901890456e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzyl benzoate,2016,Total,Human,13167,SESFRYSPDFLNCH-UHFFFAOYSA-N,3.780707718727701e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2017,Total,Human,16005,SESFRYSPDFLNCH-UHFFFAOYSA-N,4.658681486987319e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2018,Total,Human,39666,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.1275541906913866e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2019,Total,Human,69201,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.999023995606927e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzylpenicillin,2016,Total,Human,1586592,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.5556623535138e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2016,Total,Vet,2680366.6602798253,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.69627319931672e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2017,Total,Human,1576992,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.590255192456799e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2017,Total,Vet,2651326.7808762896,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.717392683550174e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2018,Total,Human,1700454,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.833746870816142e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2018,Total,Vet,2541785.572625092,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.225333974316361e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2019,Total,Human,1638450,JGSARLDLIJGVTE-MBNYWOFBSA-N,4.733025340099377e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2019,Total,Vet,2596336.894533958,JGSARLDLIJGVTE-MBNYWOFBSA-N,7.500093572134726e-7,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
betamethasone,2016,Total,Human,20172.1725,UREBDLICKHMUKA-DVTGEIKXSA-N,5.792138548967621e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011138727978783885
betamethasone,2016,Total,Vet,338.505,UREBDLICKHMUKA-DVTGEIKXSA-N,9.719666334988383e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.8691666028823813e-5
betamethasone,2017,Total,Human,21547.6575,UREBDLICKHMUKA-DVTGEIKXSA-N,6.272019561586595e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0012061576079974222
betamethasone,2017,Total,Vet,328.71400000000006,UREBDLICKHMUKA-DVTGEIKXSA-N,9.568096384339579e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.840018535449919e-5
betamethasone,2018,Total,Human,20650.2625,UREBDLICKHMUKA-DVTGEIKXSA-N,5.870087737798666e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011288630264997435
betamethasone,2018,Total,Vet,323.812,UREBDLICKHMUKA-DVTGEIKXSA-N,9.204749094845945e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.7701440567011433e-5
betamethasone,2019,Total,Human,21506.696,UREBDLICKHMUKA-DVTGEIKXSA-N,6.212684985798401e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011947471126535388
betamethasone,2019,Total,Vet,310.862,UREBDLICKHMUKA-DVTGEIKXSA-N,8.979936667423312e-11,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,1.726910897581406e-5
betaxolol,2016,Total,Human,151.875,NWIUTZDMDHAVTP-UHFFFAOYSA-N,4.360864166338343e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2017,Total,Human,136.6375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.977198323512838e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2018,Total,Human,124.7625,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.546525480666922e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2019,Total,Human,112.375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.2462005101996854e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
bexarotene,2016,Total,Human,907.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.605750933960194e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2017,Total,Human,1027.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.9908123885532457e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2018,Total,Human,997.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.835514811714461e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2019,Total,Human,720,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.0798793035317224e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bicalutamide,2016,Total,Human,185064.1,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3138396850413545e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05313839685041355
bicalutamide,2017,Total,Human,182527.5,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3129489854175446e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05312948985417545
bicalutamide,2018,Total,Human,167758.4,LKJPYSCBVHEWIU-UHFFFAOYSA-N,4.7687361201956816e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.04768736120195682
bicalutamide,2019,Total,Human,178994.2,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.170643500447471e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.051706435004474714
bictegravir,2019,Total,Human,355.5,SOLUWJRYJLAZCX-LYOVBCGYSA-N,1.026940406118788e-10,antiviral,HIV therapy used as part of combination with emtricitabine and tenofovir,NA,NA,NA,NA
bilastine,2016,Total,Human,7,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,2.009945623991335e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2017,Total,Human,29.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,8.499437639489517e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2018,Total,Human,52.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.48384835259644e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2019,Total,Human,34.8,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.0052749967069991e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bimatoprost,2016,Total,Human,106.0422,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.0448436549773417e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2017,Total,Human,120.2427,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.499984007718651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2018,Total,Human,132.5379,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.7675506622910276e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2019,Total,Human,138.7122,AQOKCDNYWBIDND-FTOWTWDKSA-N,4.0070088045465694e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
binimetinib,2019,Total,Human,27.72,ACWZRVQXLIRSDF-UHFFFAOYSA-N,8.007535318597132e-12,antineoplastic,small molecule kinase inhibitor for melanomas,NA,NA,NA,NA
biperiden,2016,Total,Human,3012.098,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.64879027733293e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2017,Total,Human,2900.302,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.44210136461874e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2018,Total,Human,2793.662,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.941323288144204e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2019,Total,Human,2678.254,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.736729255834791e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
bisacodyl,2016,Total,Human,62219.2735,KHOITXIGCFIULA-UHFFFAOYSA-N,1.7865336642749293e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.012493242407516987
bisacodyl,2017,Total,Human,59429.0505,KHOITXIGCFIULA-UHFFFAOYSA-N,1.7298407832151483e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.012096788693812225
bisacodyl,2018,Total,Human,57256.697499999995,KHOITXIGCFIULA-UHFFFAOYSA-N,1.6275911161012967e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.011381756056652424
bisacodyl,2019,Total,Human,54102.1475,KHOITXIGCFIULA-UHFFFAOYSA-N,1.5628602341926464e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.010929092546801723
bisoprolol,2016,Total,Human,60569.89545000001,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.7391742329334313e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2017,Total,Human,62497.81535,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8191653567522458e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2018,Total,Human,64300.5406,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8278209049879405e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2019,Total,Human,65651.6428,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.89649295975802e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bleomycin,2016,Total,Human,50.55,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.4514678756108851e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2017,Total,Human,47.25,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.3753370837872592e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2018,Total,Human,42.45,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.20669276949653e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2019,Total,Human,39.3,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.135267453177732e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
boric acid,2016,Total,Human,304470,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.742402059094882e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2017,Total,Human,273870,KGBXLFKZBHKPEV-UHFFFAOYSA-N,7.971715706599294e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2018,Total,Human,288630,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.204658046166867e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2019,Total,Human,107190,KGBXLFKZBHKPEV-UHFFFAOYSA-N,3.096420313132852e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
bortezomib,2016,Total,Human,31.9165,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.164347072588489e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.036521571686331e-5
bortezomib,2017,Total,Human,33.929,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.875939029802732e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.1946531177339404e-5
bortezomib,2018,Total,Human,38.2515,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.0873453114816611e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.4163229144036915e-5
bortezomib,2019,Total,Human,44.9005,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.297050287058696e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.8823339712415467e-5
bosentan,2016,Total,Human,7290.99,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.093499063580654e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2017,Total,Human,7220.29,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.1016576915763616e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2018,Total,Human,7065.73,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.008519505822077e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2019,Total,Human,6926.5,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.000872777210066e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosutinib,2016,Total,Human,406,UBPYILGKFZZVDX-UHFFFAOYSA-N,1.1657684619149743e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2017,Total,Human,274.4,UBPYILGKFZZVDX-UHFFFAOYSA-N,7.9871427680682306e-11,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2018,Total,Human,882,UBPYILGKFZZVDX-UHFFFAOYSA-N,2.50719204404226e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2019,Total,Human,1461.6,UBPYILGKFZZVDX-UHFFFAOYSA-N,4.2221549861693967e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
brexpiprazole,2019,Total,Human,21.42,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,6.187640928006875e-12,antipsychotic,atypical antipsychotic for schizophrenia and major depressive disordered,NA,NA,NA,NA
brigatinib,2019,Total,Human,3.36,AILRADAXUVEEIR-UHFFFAOYSA-N,9.706103416481373e-13,antineoplastic,multikinase inhibitor for metastatic non-small cell lung cancer,NA,NA,NA,NA
brimonidine,2016,Total,Human,882.3695,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.53359245038346e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2017,Total,Human,899.191,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6173348734555536e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2018,Total,Human,832.37,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.3661127456909935e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2019,Total,Human,921.451,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6618150890536244e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brinzolamide,2016,Total,Human,7857.45,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.2561496061758163e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2017,Total,Human,7438.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.1652754001546774e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2018,Total,Human,8149.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.316693773258256e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2019,Total,Human,8000.1,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.3110058911366855e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brivaracetam,2016,Total,Human,2293.442,MSYKRHVOOPPJKU-BDAKNGLRSA-N,6.585276731111336e-10,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,6.585276731111335e-7
brivaracetam,2017,Total,Human,8006.044,MSYKRHVOOPPJKU-BDAKNGLRSA-N,2.330372319075658e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,2.330372319075658e-6
brivaracetam,2018,Total,Human,12378.084,MSYKRHVOOPPJKU-BDAKNGLRSA-N,3.5186206037740134e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,3.518620603774013e-6
brivaracetam,2019,Total,Human,16399.99,MSYKRHVOOPPJKU-BDAKNGLRSA-N,4.737499969323225e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,4.7374999693232245e-6
bromfenac,2016,Total,Human,48.2625,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.38578572396974e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2017,Total,Human,35.046,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.0201071627176356e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2018,Total,Human,42.057,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.19552126753158e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2019,Total,Human,46.0485,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.3302128070650074e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromhexine,2016,Total,Human,73347.64,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.10606811497274e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2017,Total,Human,69613.14,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.0262758298597715e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2018,Total,Human,68129.81999999999,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.936672819342758e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2019,Total,Human,67677.172,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.955004852282731e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromocriptine,2016,Total,Human,486.4525,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.3967758195066355e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2017,Total,Human,438.3275,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.2758689218915549e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2018,Total,Human,387.02,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.1001513207315595e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2019,Total,Human,357.735,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.0333966981235012e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bronopol,2016,Total,Vet,843000,LVDKZNITIUWNER-UHFFFAOYSA-N,2.42054880146385e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2017,Total,Vet,661500,LVDKZNITIUWNER-UHFFFAOYSA-N,1.925471917302163e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2018,Total,Vet,1066500,LVDKZNITIUWNER-UHFFFAOYSA-N,3.031655685908243e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2019,Total,Vet,1841000,LVDKZNITIUWNER-UHFFFAOYSA-N,5.318135830280418e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
budesonide,2016,Total,Human,19347.71718,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.555408497166138e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.459777322286207e-4
budesonide,2017,Total,Human,19341.64924,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.629902108228075e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.546397800265203e-4
budesonide,2018,Total,Human,19227.645,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.465691447808271e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.355455171870082e-4
budesonide,2019,Total,Human,19230.83728,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.5552528400358745e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.459596325623109e-4
bumetanide,2016,Total,Human,21770.992,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251215728621479e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2017,Total,Human,21814.135,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.349584934654302e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2018,Total,Human,22903.821,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.510689091765085e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2019,Total,Human,21639.479,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251042293237408e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bupivacaine,2016,Total,Human,26533.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.618828098529268e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2017,Total,Human,26503.6,LEBVLXFERQHONN-UHFFFAOYSA-N,7.714578610341587e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2018,Total,Human,25890.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.359816763344213e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2019,Total,Human,24763.25,LEBVLXFERQHONN-UHFFFAOYSA-N,7.153412661553046e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
buprenorphine,2016,Total,Human,19979.31948,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.73676367987869e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2016,Total,Vet,10.434,RMRJXGBAOAMLHD-IHFGGWKQSA-N,2.995967520103655e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2017,Total,Human,20312.04976,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.912363022785205e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2017,Total,Vet,13.818,RMRJXGBAOAMLHD-IHFGGWKQSA-N,4.022096893920074e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2018,Total,Human,20225.73776,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.7494114282037565e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2018,Total,Vet,15.0018,RMRJXGBAOAMLHD-IHFGGWKQSA-N,4.2644437195366406e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2019,Total,Human,20433.1613,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.902570735221576e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2019,Total,Vet,15.9408,RMRJXGBAOAMLHD-IHFGGWKQSA-N,4.604852778019235e-12,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
bupropion,2016,Total,Human,620904.9600000001,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.7828360103807357e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.017828360103807357
bupropion,2017,Total,Human,650137.38,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.8923979857572258e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.018923979857572257
bupropion,2018,Total,Human,725158.185,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.0613501497779205e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.020613501497779203
bupropion,2019,Total,Human,854769.33,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.4691903316120517e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.024691903316120516
buspirone,2016,Total,Human,10485.42,QWCRAEMEVRGPNT-UHFFFAOYSA-N,3.0107320063873173e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2017,Total,Human,9892.25,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.8794028078506912e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2018,Total,Human,9247.26,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.628645884488688e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2019,Total,Human,9514.23,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.748395842505642e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
busulfan,2016,Total,Human,26.88,COVZYZSDYWQREU-UHFFFAOYSA-N,7.718191196126725e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2017,Total,Human,34.08,COVZYZSDYWQREU-UHFFFAOYSA-N,9.919891601157628e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2018,Total,Human,50.4,COVZYZSDYWQREU-UHFFFAOYSA-N,1.4326811680241487e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2019,Total,Human,42.24,COVZYZSDYWQREU-UHFFFAOYSA-N,1.220195858071944e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
butorphanol,2016,Total,Vet,668.16,IFKLAQQSCNILHL-QHAWAJNXSA-N,1.9185218116086432e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2017,Total,Vet,711.66,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.071475955657229e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2018,Total,Vet,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0387280430692847e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2019,Total,Vet,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0717908840179884e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
cabazitaxel,2016,Total,Human,2.88,BMQGVNUXMIRLCK-OAGWZNDDSA-N,8.269490567278635e-13,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,9.291562435144534e-7
cabazitaxel,2017,Total,Human,10.08,BMQGVNUXMIRLCK-OAGWZNDDSA-N,2.9340524454128196e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,3.2966881409132805e-6
cabazitaxel,2018,Total,Human,33.84,BMQGVNUXMIRLCK-OAGWZNDDSA-N,9.619430699590714e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.0808349100663725e-5
cabazitaxel,2019,Total,Human,37.8,BMQGVNUXMIRLCK-OAGWZNDDSA-N,1.0919366343541544e-11,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.2268950947799489e-5
cabergoline,2016,Total,Human,90.38238,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.5951952738131703e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2016,Total,Vet,4.0637,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.1668308617447981e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2017,Total,Human,80.04612,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.3299554973393653e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2017,Total,Vet,4.2784,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.245342260164108e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2018,Total,Human,62.6782,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.7817039044772065e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2018,Total,Vet,4.3835,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.2460630754035428e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2019,Total,Human,43.588,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.2591358205880656e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2019,Total,Vet,4.46275,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.2891640780328049e-12,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabozantinib,2016,Total,Human,248.64,ONIQOQHATWINJY-UHFFFAOYSA-N,7.13932685641722e-11,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2017,Total,Human,566.04,ONIQOQHATWINJY-UHFFFAOYSA-N,1.647610164882413e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2018,Total,Human,891.64,ONIQOQHATWINJY-UHFFFAOYSA-N,2.5345949140020866e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2019,Total,Human,1194.96,ONIQOQHATWINJY-UHFFFAOYSA-N,3.4519063507614824e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
caffeine,2016,Total,Human,1259739.265,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.6171534615097297e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.009042883653774324
caffeine,2017,Total,Human,1202152.065,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.499183736181866e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.008747959340454664
caffeine,2018,Total,Human,1119076.5,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.181110768111858e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007952776920279644
caffeine,2019,Total,Human,1045576.1,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.020377903690854e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007550944759227135
calcipotriol,2016,Total,Human,249.97125,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.177551715159199e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2017,Total,Human,249.35925,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.258265052071494e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2018,Total,Human,259.86625,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.387013543255066e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2019,Total,Human,271.7295,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.849507822347545e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcium folinate,2016,Total,Human,6309.45,KVUAALJSMIVURS-ZEDZUCNESA-L,1.8116644881845895e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2017,Total,Human,6863.55,KVUAALJSMIVURS-ZEDZUCNESA-L,1.997819014058845e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2018,Total,Human,7372.3,KVUAALJSMIVURS-ZEDZUCNESA-L,2.0956657490127843e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2019,Total,Human,8149.15,KVUAALJSMIVURS-ZEDZUCNESA-L,2.354062281441047e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium polystyrene sulfonate,2016,Total,Human,2230800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.405409568571243e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2017,Total,Human,2436600,IJBYVKWTVVYTPL-UHFFFAOYSA-M,7.092373202869917e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2018,Total,Human,2256900,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.415512158955756e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2019,Total,Human,1675800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,4.840919078970084e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
canagliflozin,2019,Total,Human,11529,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,3.330406734780171e-9,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes treatment and symptom relief,low,moderate,5.6e-5,5.9471548835360196e-5
candesartan,2016,Total,Human,792375.8210400001,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.275189020079842e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0022751890200798422
candesartan,2017,Total,Human,832738.27648,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.4239065243005956e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.002423906524300596
candesartan,2018,Total,Human,885051.03496,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.5158649812053066e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0025158649812053067
candesartan,2019,Total,Human,954982.78608,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.7586790722178533e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0027586790722178537
capecitabine,2016,Total,Human,223845,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.427375402890577e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2017,Total,Human,215490,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.27241033196437e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2018,Total,Human,209496,GAGWJHPBXLXJQN-UORFTKCHSA-N,5.955178055087046e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2019,Total,Human,253584,GAGWJHPBXLXJQN-UORFTKCHSA-N,7.325334907038727e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
captopril,2016,Total,Human,28587.95,FAKRSMQSSFJEIM-RQJHMYQMSA-N,8.208603571626155e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2017,Total,Human,26218.65,FAKRSMQSSFJEIM-RQJHMYQMSA-N,7.631636324198692e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2018,Total,Human,23300.325,FAKRSMQSSFJEIM-RQJHMYQMSA-N,6.623400165940928e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2019,Total,Human,20354.975,FAKRSMQSSFJEIM-RQJHMYQMSA-N,5.879984892556337e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
carbachol,2016,Total,Human,3.92,AIXAANGOTKPUOY-UHFFFAOYSA-N,1.1255695494351477e-12,ophthalmological,"lowers pressure in eye, used for post-surgery relief",low,NA,NA,NA
carbamazepine,2016,Total,Human,2233819.725,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.414080258641825e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.256563210345673
carbamazepine,2017,Total,Human,2129609.475,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.198795523708394e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.24795182094833576
carbamazepine,2018,Total,Human,1989509.9,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.655423347872237e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22621693391488945
carbamazepine,2019,Total,Human,1926617.325,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.565460416796042e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22261841667184168
carbamide,2016,Total,Human,2357855,XSQUKJJJFZCRTK-UHFFFAOYSA-N,6.770229056080127e-7,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2017,Total,Human,5509474,XSQUKJJJFZCRTK-UHFFFAOYSA-N,1.603679133198249e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2018,Total,Human,8185423.5,XSQUKJJJFZCRTK-UHFFFAOYSA-N,2.3268059723714912e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2019,Total,Human,10434144,XSQUKJJJFZCRTK-UHFFFAOYSA-N,3.0141333549541256e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbimazole,2016,Total,Human,17307.765,CFOYWRHIYXMDOT-UHFFFAOYSA-N,4.969666646117198e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2016,Total,Vet,1518,CFOYWRHIYXMDOT-UHFFFAOYSA-N,4.3587106531697804e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2017,Total,Human,18267.76,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.317318045656198e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2017,Total,Vet,1849,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.382006916238395e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2018,Total,Human,20357.775,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.7869446161454006e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2018,Total,Vet,1856.5,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.277326564358794e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2019,Total,Human,21393.505,CFOYWRHIYXMDOT-UHFFFAOYSA-N,6.179987261042004e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2019,Total,Vet,1712,CFOYWRHIYXMDOT-UHFFFAOYSA-N,4.945490788397652e-10,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carfilzomib,2016,Total,Human,34.9,BLMPQMFVWMYDKT-NZTKNTHTSA-N,1.0021014611042511e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2017,Total,Human,105.36,BLMPQMFVWMYDKT-NZTKNTHTSA-N,3.066783389371971e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2018,Total,Human,313.56,BLMPQMFVWMYDKT-NZTKNTHTSA-N,8.913323552493097e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2019,Total,Human,334.15999999999997,BLMPQMFVWMYDKT-NZTKNTHTSA-N,9.652950945391116e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carglumic acid,2016,Total,Human,34,LCQLHJZYVOQKHU-VKHMYHEASA-N,9.762593030815054e-12,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2017,Total,Human,701,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.0404471867404627e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2018,Total,Human,828,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.3536904903253875e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2019,Total,Human,575,LCQLHJZYVOQKHU-VKHMYHEASA-N,1.661014721570473e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
cariprazine,2019,Total,Human,5.376,KPWSJANDNDDRMB-UHFFFAOYSA-N,1.5529765466370198e-12,antipsychotic,atypical antipsychotic for schizophrenia and bipolar I disorder,NA,NA,NA,NA
carmustine,2019,Total,Human,40.4,DLGOEMSEDOSKAD-UHFFFAOYSA-N,1.1670433869816887e-11,antineoplastic,"alkylating antineoplastic for brain tumours, lymphomas and multiple myeloma",NA,NA,NA,NA
carprofen,2016,Total,Vet,107750.8,PUXBGTOOZJQSKH-UHFFFAOYSA-N,3.093903556308079e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2017,Total,Vet,95846.4,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.7898647252382464e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2018,Total,Vet,92620.6,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.6328529641090772e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2019,Total,Vet,88610.1,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.5596987926927265e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carvedilol,2016,Total,Human,175604.29374999998,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.042215453955734e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2017,Total,Human,175251.63125,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.10116544872667e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2018,Total,Human,172444.5,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4.901944199986911e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2019,Total,Human,173981.75,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.025847791905976e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
caspofungin,2016,Total,Human,153.09,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3957510796690496e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.791502159338098e-6
caspofungin,2017,Total,Human,148.74,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3294738167728455e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.65894763354569e-6
caspofungin,2018,Total,Human,98.77,JYIKNQVWKBUSNH-OGZDCFRISA-N,2.807657122336214e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,5.615314244672427e-6
caspofungin,2019,Total,Human,110.72,JYIKNQVWKBUSNH-OGZDCFRISA-N,3.1983921734310044e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,6.3967843468620086e-6
cefalexin,2016,Total,Human,396285,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.137873288004866e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2016,Total,Vet,43487.75,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.2486858972818454e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2017,Total,Human,333696,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.713110762147583e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2017,Total,Vet,31738.5,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.238335668525276e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2018,Total,Human,330273,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.38841086124682e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2018,Total,Vet,32342.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.193677084628776e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2019,Total,Human,288896,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,8.345400156570841e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2019,Total,Vet,28361.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,8.192774569067927e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2016,Total,Human,706160,XIURVHNZVLADCM-IUODEOHRSA-N,2.0276331454824586e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2017,Total,Human,607370,XIURVHNZVLADCM-IUODEOHRSA-N,1.7679121366769685e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2018,Total,Human,535650,XIURVHNZVLADCM-IUODEOHRSA-N,1.522650134230427e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2019,Total,Human,15320,XIURVHNZVLADCM-IUODEOHRSA-N,4.425520962514721e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2017,Total,Human,49420,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.4385007128204518e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2018,Total,Human,154120,MLYYVTUWGNIJIB-BXKDBHETSA-N,4.3810480479341637e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2019,Total,Human,522400,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.509067983562461e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2016,Total,Human,921690,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.646495403109391e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2017,Total,Human,894152,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.602667521994805e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2018,Total,Human,964915,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.742887994531789e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2019,Total,Human,910315,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.629646289159001e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefovecin,2016,Total,Vet,527.68,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.5151544383824963e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2017,Total,Vet,497.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.4483973182910902e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2018,Total,Vet,480,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.3644582552610938e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2019,Total,Vet,401.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.1601104559699164e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
ceftaroline fosamil,2016,Total,Human,168,ZCCUWMICIWSJIX-NQJJCJBVSA-N,4.823869497579204e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2017,Total,Human,120,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.492919577872404e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2018,Total,Human,132,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.752260201968009e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2019,Total,Human,186,ZCCUWMICIWSJIX-NQJJCJBVSA-N,5.3730215341236165e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftazidime,2016,Total,Human,46670,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3400594610239373e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010308149700184132
ceftazidime,2017,Total,Human,51020,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.4850729738587506e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.011423638260451927
ceftazidime,2018,Total,Human,47690,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3556461290291995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010428047146378457
ceftazidime,2019,Total,Human,59760,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.7262998219313297e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.013279229399471766
ceftolozane,2016,Total,Human,320,JHFNIHVVXRKLEF-DCZLAGFPSA-N,9.188322852531816e-11,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2017,Total,Human,1000,JHFNIHVVXRKLEF-DCZLAGFPSA-N,2.91076631489367e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2018,Total,Human,1460,JHFNIHVVXRKLEF-DCZLAGFPSA-N,4.150227193085828e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2019,Total,Human,2470,JHFNIHVVXRKLEF-DCZLAGFPSA-N,7.135141499615771e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftriaxone,2016,Total,Human,85970,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.4685003613505007e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2017,Total,Human,91200,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6546188791830273e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2018,Total,Human,93290,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6518814715272387e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2019,Total,Human,89470,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.5845389067636563e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
cefuroxime,2016,Total,Human,217464.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,6.244176037640995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,8.216021102159204e-4
cefuroxime,2017,Total,Human,189003.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,5.501457488885845e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,7.238759853797164e-4
cefuroxime,2018,Total,Human,152747,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.3420188565909655e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.713182706040743e-4
cefuroxime,2019,Total,Human,154180.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.4538520962222035e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.860331705555531e-4
celecoxib,2016,Total,Human,313284,RZEKVGVHFLEQIL-UHFFFAOYSA-N,8.995482926664306e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2017,Total,Human,331813.5,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.658315586269709e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2018,Total,Human,341206.4,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.699206025581646e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2019,Total,Human,385292.6,RZEKVGVHFLEQIL-UHFFFAOYSA-N,1.1130029229776757e-7,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
ceritinib,2016,Total,Human,1822.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,5.233036999606011e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2017,Total,Human,2272.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,6.614716450595866e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2018,Total,Human,1507.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,4.2852517079293736e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2019,Total,Human,742.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,2.1448755317670892e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cetirizine,2016,Total,Human,648774.39,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.862858923054497e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2017,Total,Human,658082.18,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.915523441975793e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2018,Total,Human,670289.17,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.9053783154554314e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2019,Total,Human,709752.1699999999,ZKLPARSLTMPFCP-UHFFFAOYSA-N,2.0502761791940677e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetylpyridinium,2016,Total,Human,33935.98,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.744210642408209e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2017,Total,Human,33221.51,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.67000522379032e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2018,Total,Human,36098.61,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0261468003739724e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2019,Total,Human,37280.55,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0769311717955496e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
chlorambucil,2016,Total,Human,51.2,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.4701316564050907e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2017,Total,Human,40.1,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.1672172922723618e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2018,Total,Human,34.95,JCKYGMPEJWAADB-UHFFFAOYSA-N,9.934961671119842e-12,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2019,Total,Human,35,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.0110524392168096e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chloramphenicol,2016,Total,Human,20504.68,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.887613119620378e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2017,Total,Human,20191.535,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.877283992399656e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2018,Total,Human,20336.5725,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.7809175481959885e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2019,Total,Human,20842.3125,WIIZWVCIJKGZOK-RKDXNWHRSA-N,6.020763112012572e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chlorhexidine,2016,Total,Human,2046088.6,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,5.87503832552651e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,6.994093244674417
chlorhexidine,2016,Total,Vet,5506.14,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.5810059997262355e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.0188214999967409
chlorhexidine,2017,Total,Human,2113429.875,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,6.15170048903994e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,7.3234529631427865
chlorhexidine,2017,Total,Vet,4495.555,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.3085510060751814e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.015577988167561684
chlorhexidine,2018,Total,Human,2082253,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,5.919056865400373e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,7.046496268333777
chlorhexidine,2018,Total,Vet,4256.28,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.2098992463963936e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.014403562457099924
chlorhexidine,2019,Total,Human,2185204.125,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,6.312445602193955e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,7.514816193088041
chlorhexidine,2019,Total,Vet,4247.835,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,1.2270811251830102e-9,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,0.014608108633131073
chlorprothixene,2016,Total,Human,205340.135,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.8960357967577135e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2017,Total,Human,196536.425,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.720716055396262e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2018,Total,Human,177104.97,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.0344237159222583e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2019,Total,Human,163988.0150000001,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,4.737156644802082e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ciclesonide,2016,Total,Human,960.6624,LUKZNWIVRBCLON-GXOBDPJESA-N,2.7583988385900185e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2017,Total,Human,1141.9296000000002,LUKZNWIVRBCLON-GXOBDPJESA-N,3.3238902136600033e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2018,Total,Human,1112.1216,LUKZNWIVRBCLON-GXOBDPJESA-N,3.1613406207795335e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2019,Total,Human,1184.5728,LUKZNWIVRBCLON-GXOBDPJESA-N,3.421900625342532e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclopirox,2016,Total,Human,4128.96,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.18556929766218e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2017,Total,Human,4164.864,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.212294583731331e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2018,Total,Human,4593.6,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.3057865502848672e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2019,Total,Human,4581.984,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.323607457043541e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclosporin,2016,Total,Human,163505.09,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.6948048592258486e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.002324160821398935
ciclosporin,2016,Total,Vet,24001.71,PMATZTZNYRCHOR-CGLBZJNRSA-N,6.891733140401294e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,3.411749079406581e-4
ciclosporin,2017,Total,Human,154730.36,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.5038391977937096e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0022296233652444107
ciclosporin,2017,Total,Vet,19318.213,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.623080366434099e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,2.783703151700049e-4
ciclosporin,2018,Total,Human,146391.753,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.1613632475623545e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.002060080815624928
ciclosporin,2018,Total,Vet,17522.682,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.98103502275312e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,2.46585892215501e-4
ciclosporin,2019,Total,Human,144361.567,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.1702032698431686e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0020644570642787963
ciclosporin,2019,Total,Vet,19511.151,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.636227660136427e-9,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,2.790211712938825e-4
cilastatin,2016,Total,Human,8080,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.320051520264283e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2017,Total,Human,8565,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.493071348706428e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2018,Total,Human,7635,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.1703414122746773e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2019,Total,Human,7800,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.253202578826033e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cimicoxib,2016,Total,Vet,78.06400000000001,KYXDNECMRLFQMZ-UHFFFAOYSA-N,2.2414913598751367e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2017,Total,Vet,59.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.7231736584170528e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2018,Total,Vet,67.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.910241557365532e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2019,Total,Vet,20.48,KYXDNECMRLFQMZ-UHFFFAOYSA-N,5.916101130045789e-12,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cinacalcet,2016,Total,Human,8650.3032,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.483805580434034e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.004967611160868068
cinacalcet,2017,Total,Human,8726.9364,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.540207250533943e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.005080414501067886
cinacalcet,2018,Total,Human,9831.4188,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.7947001130393992e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.0055894002260787985
cinacalcet,2019,Total,Human,10500.5376,VDHAWDNDOKGFTD-MRXNPFEDSA-N,3.0333126153050927e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.006066625230610185
ciprofloxacin,2016,Total,Human,969510.6875,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.783805376790651e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,55.676107535813024
ciprofloxacin,2017,Total,Human,811026.0705,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.360707366511979e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,47.21414733023958
ciprofloxacin,2018,Total,Human,753169.644,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.140976121599707e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,42.81952243199414
ciprofloxacin,2019,Total,Human,643892.9005,MYSWGUAQZAJSOK-UHFFFAOYSA-N,1.86002710755689e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,37.200542151137796
cisatracurium,2016,Total,Human,598.65,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7189342111463034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2017,Total,Human,589.05,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7145868977881162e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2018,Total,Human,563.75,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.6025277945905034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2019,Total,Human,607.8,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7557647787313624e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
citalopram,2016,Total,Human,141802.8492,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4.071657374557759e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2017,Total,Human,130996.3988,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.812999049994176e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2018,Total,Human,120262.5316,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.4186084175045466e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2019,Total,Human,112427.9148,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.2477290712742756e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
cladribine,2016,Total,Human,2.45,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.034809683969674e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2017,Total,Human,2.65,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.713530734468226e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2018,Total,Human,27.46,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.805838268639509e-12,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2019,Total,Human,73.98,PTOAARAWEBMLNO-KVQBGUIXSA-N,2.1370759843788452e-11,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
clarithromycin,2016,Total,Human,111591.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.2041835299947006e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2670152941662251
clarithromycin,2017,Total,Human,114924.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.345183633559976e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2787653027966647
clarithromycin,2018,Total,Human,109722.25,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.118988120798366e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2599156767331972
clarithromycin,2019,Total,Human,102942,AGOYDEPGAOXOCK-KCBOHYOISA-N,2.9737074342244804e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.24780895285204005
clenbuterol,2016,Total,Vet,2.813375,STJMRWALKKWQGH-UHFFFAOYSA-N,8.078186814138032e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2017,Total,Vet,2.4495,STJMRWALKKWQGH-UHFFFAOYSA-N,7.129922088332045e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2018,Total,Vet,2.11225,STJMRWALKKWQGH-UHFFFAOYSA-N,6.004326978490097e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2019,Total,Vet,1.854875,STJMRWALKKWQGH-UHFFFAOYSA-N,5.358216837692228e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clindamycin,2016,Total,Human,701983.264,KDLRVYVGXIQJDK-AWPVFWJPSA-N,2.0156402708456487e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2016,Total,Vet,28568.4,KDLRVYVGXIQJDK-AWPVFWJPSA-N,8.202990080633436e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2017,Total,Human,618713.59,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.800930676338933e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2017,Total,Vet,18754.800000000003,KDLRVYVGXIQJDK-AWPVFWJPSA-N,5.459084008256781e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2018,Total,Human,625784.3400000001,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.778867934846074e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2018,Total,Vet,25726.4,KDLRVYVGXIQJDK-AWPVFWJPSA-N,7.313041428781043e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2019,Total,Human,620770.74,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.7932336310612112e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2019,Total,Vet,26131.2,KDLRVYVGXIQJDK-AWPVFWJPSA-N,7.5485752856178e-9,antibacterial,lincomycin antibiotic,low,high,NA,NA
clobetasol,2016,Total,Human,9347.55,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.684009602505743e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0035786794700076573
clobetasol,2017,Total,Human,10366.3175,FCSHDIVRCWTZOX-DVTGEIKXSA-N,3.017392778849276e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0040231903717990345
clobetasol,2018,Total,Human,10203.0325,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.900335817358799e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.003867114423145065
clobetasol,2019,Total,Human,8940.44,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.582643905620438e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0034435252074939172
clodronic acid,2016,Total,Human,1824,ACSIXWWBWUQEHA-UHFFFAOYSA-N,5.237344025943134e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clodronic acid,2017,Total,Human,384,ACSIXWWBWUQEHA-UHFFFAOYSA-N,1.1177342649191694e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clofarabine,2016,Total,Human,0.46,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.320821410051449e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2018,Total,Human,0.4,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.1370485460509118e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2019,Total,Human,0.92,WDDPHFBMKLOVOX-AYQXTPAHSA-N,2.657623554512757e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clomethiazole,2016,Total,Human,460391.4,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.321945256790349e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2017,Total,Human,429892.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.2513174812553216e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2018,Total,Human,414868.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1793149146047161e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2019,Total,Human,396804.9,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1462587486805209e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomifene,2016,Total,Human,5009.75,GKIRPKYJQBWNGO-OCEACIFDSA-N,1.4384750128272271e-9,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomifene,2017,Total,Human,690.5,GKIRPKYJQBWNGO-OCEACIFDSA-N,2.009884140434079e-10,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomipramine,2016,Total,Human,40026.38,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.1492978189316326e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2016,Total,Vet,3964.2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.138260920375207e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2017,Total,Human,35982.48,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.047365907103352e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2017,Total,Vet,3487.2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.0150424293297206e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2018,Total,Human,32714.545,GDLIGKIOYRNHDA-UHFFFAOYSA-N,9.299506456741781e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2018,Total,Vet,4347.6,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.235858064702736e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2019,Total,Human,33971.37,GDLIGKIOYRNHDA-UHFFFAOYSA-N,9.813381857724788e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2019,Total,Vet,4734.6,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.367693965347402e-9,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clonazepam,2016,Total,Human,4984.8025,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.4313117101908662e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2017,Total,Human,4228.349,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.2307735836814334e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2018,Total,Human,3799.52775,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.080061875954398e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2019,Total,Human,3491.1915,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.0085079090994264e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonidine,2016,Total,Human,74.4451249999999,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.1375807603033958e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2017,Total,Human,78.385925,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.281631100517816e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2018,Total,Human,82.532525,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.3460871888290132e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2019,Total,Human,76.5191000000001,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.210423505762145e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clopidogrel,2016,Total,Human,583192.05,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.674549012634337e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.005401771008497861
clopidogrel,2017,Total,Human,654759.825,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.9058528429556747e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006147912396631208
clopidogrel,2018,Total,Human,751511.1,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.136261508990303e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006891166158033236
clopidogrel,2019,Total,Human,881861.775,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.547452853330901e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.00821758984945452
cloprostenol,2016,Total,Vet,19.2025,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.513711549241944e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2017,Total,Vet,19.609,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.707721666874999e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2018,Total,Vet,19.0495,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.4150515694992115e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2019,Total,Vet,18.258000000000003,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.274227267205861e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
clotrimazole,2016,Total,Human,205849.5,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.910661453225775e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2017,Total,Human,189772.8,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.5238427372305347e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2018,Total,Human,193022.2,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4868902966387065e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2019,Total,Human,190337,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4983053749488544e-8,antifungal,topical antifungal,NA,NA,NA,NA
cloxacillin,2016,Total,Human,636745,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8283183233548037e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2017,Total,Human,511970,LQOLIRLGBULYKD-JKIFEVAISA-N,1.4902250302361122e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2018,Total,Human,601620,LQOLIRLGBULYKD-JKIFEVAISA-N,1.7101778656878738e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2019,Total,Human,645520,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8647273444663859e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
clozapine,2016,Total,Human,342467.625,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.833447203249364e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2017,Total,Human,343189.72500000003,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.989450911476223e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2018,Total,Human,347240.5,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.87073264137479e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2019,Total,Human,345373.15,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.976867592785517e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
cobicistat,2016,Total,Human,27459,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,7.884442412739723e-9,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,1.6290170274255628e-5
cobicistat,2017,Total,Human,47232,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.3748131458505782e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,2.8405230286168972e-5
cobicistat,2018,Total,Human,57780,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.642466624770542e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.393526084236657e-5
cobicistat,2019,Total,Human,60192,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.73877909775252e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.592518797009339e-5
cobimetinib,2016,Total,Human,1.26,BSMCAPRUBJMWDF-KRWDZBQOSA-N,3.6179021231844026e-13,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2017,Total,Human,40.32,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.173620978165128e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2018,Total,Human,51.66,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.4684981972247523e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2019,Total,Human,151.2,BSMCAPRUBJMWDF-KRWDZBQOSA-N,4.3677465374166176e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
codeine,2016,Total,Human,1943129.045,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.579405315497444e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2017,Total,Human,1785329.695,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.19667753718539e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2018,Total,Human,1718023.555,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.883690463234922e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2019,Total,Human,1730315.635,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.998399552519236e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
colchicine,2016,Total,Human,949.577,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.7265687654183137e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2017,Total,Human,1010.748,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.9420512312461473e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2018,Total,Human,718.022,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.0410646778314195e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2019,Total,Human,810.6,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.3415974492261306e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colesevelam,2016,Total,Human,386912.25,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1109608339373449e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2017,Total,Human,399217.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1620288513160637e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2018,Total,Human,418837.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1905964260164969e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2019,Total,Human,418050,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.2076299206131066e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colestipol,2016,Total,Human,540250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.551247319087598e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2017,Total,Human,439250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.278554103817045e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2018,Total,Human,388250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.1036477450106661e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2019,Total,Human,358500,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.0356065698835037e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestyramine,2016,Total,Human,2181800,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.264713374891849e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2017,Total,Human,2395000,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.97128532417034e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2018,Total,Human,2466400,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.011041334949922e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2019,Total,Human,2465200,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.121275637592226e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colistin,2016,Total,Human,2972.2000000000003,YKQOSKADJPQZHB-QNPLFGSASA-N,8.534229119467207e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2017,Total,Human,2832,YKQOSKADJPQZHB-QNPLFGSASA-N,8.243290203778873e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2018,Total,Human,3049.2,YKQOSKADJPQZHB-QNPLFGSASA-N,8.667721066546101e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2019,Total,Human,3225.6,YKQOSKADJPQZHB-QNPLFGSASA-N,9.317859279822118e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
cortisone,2016,Total,Human,33984.45,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.7581280801789e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2017,Total,Human,33982.4,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.891482521924266e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2018,Total,Human,34960.275,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.937882464572511e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2019,Total,Human,37744.17,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,1.0903238612775408e-8,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
crizotinib,2016,Total,Human,4302,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.235255153487246e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2017,Total,Human,4521,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.3159574509634283e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2018,Total,Human,3807,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.082185953703955e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2019,Total,Human,2367,KTEIFNKAUNYNJU-GFCCVEGCSA-N,6.837603210360539e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cromoglicic acid,2016,Total,Human,35558.99,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.0210233763435949e-8,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2017,Total,Human,35699.97,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.039142701187146e-8,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2018,Total,Human,28338.370000000003,IMZMKUWMOSJXDT-UHFFFAOYSA-N,8.055525601488194e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2019,Total,Human,25963.34,IMZMKUWMOSJXDT-UHFFFAOYSA-N,7.50008521063296e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cyclizine,2016,Total,Human,30906,UVKZSORBKUEBAZ-UHFFFAOYSA-N,8.874197065010884e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2017,Total,Human,32557.85,UVKZSORBKUEBAZ-UHFFFAOYSA-N,9.476829306536088e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2018,Total,Human,5394.9,UVKZSORBKUEBAZ-UHFFFAOYSA-N,1.5335658002725155e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2019,Total,Human,2,UVKZSORBKUEBAZ-UHFFFAOYSA-N,5.777442509810341e-13,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclopentolate,2016,Total,Human,1167.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.3528764359066884e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2017,Total,Human,1186.1,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.4524599260953816e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2018,Total,Human,1249.8,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5527081821360735e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2019,Total,Human,1219.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5233733146078363e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclophosphamide,2016,Total,Human,18538.6,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.323082563560823e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2017,Total,Human,18727.8,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.451224939206568e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2018,Total,Human,17952.3,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.1031591533174464e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2019,Total,Human,19087.5,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.513846695300244e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyproterone acetate,2016,Total,Human,6064.857768,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.741433475845922e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2017,Total,Human,6365.400638,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.8528193757893078e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2018,Total,Human,7399.896064,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.103510265124766e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2019,Total,Human,7875.951566,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.275142869130786e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cytarabine,2016,Total,Human,9321.5,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.676529733433604e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2017,Total,Human,8311.4,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.4192543149607252e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2018,Total,Human,8661,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.461994364336736e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2019,Total,Human,5360,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,1.5483545926291714e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
dabigatran etexilate,2016,Total,Human,1083636.35,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.11150019954349e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.00311150019954349
dabigatran etexilate,2017,Total,Human,1085194.7,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.1587481778611416e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0031587481778611415
dabigatran etexilate,2018,Total,Human,1086955.6,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.089803211504742e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030898032115047416
dabigatran etexilate,2019,Total,Human,1070971.9,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.0937392909361745e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030937392909361743
dabrafenib,2016,Total,Human,5592.3,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.6057455590066775e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.5292814847682644e-4
dabrafenib,2017,Total,Human,6479.8,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8861183567248e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.796303196880762e-4
dabrafenib,2018,Total,Human,6400.4,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8193913785360638e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.7327536938438703e-4
dabrafenib,2019,Total,Human,5114.9,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.4775520346714455e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.4071924139728053e-4
dacarbazine,2016,Total,Human,14,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4.019891247982669e-12,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2017,Total,Human,36,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.0478758733617211e-11,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2019,Total,Human,606.5,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.7520094410999858e-10,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
daclatasvir,2016,Total,Human,1207.92,FKRSSPOQAMALKA-CUPIEXAXSA-N,3.468362168759447e-10,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,4.817169678832565e-6
daclatasvir,2017,Total,Human,168.84,FKRSSPOQAMALKA-CUPIEXAXSA-N,4.914537846066473e-11,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,6.825747008425656e-7
dacomitinib,2019,Total,Human,1.35,LVXJQMNHJWSHET-AATRIKPKSA-N,3.8997736941219803e-13,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,NA,NA,NA,NA
dapagliflozin,2016,Total,Human,30510.7733,JVHXJTBJCFBINQ-ADAARDCZSA-N,8.760713611275237e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,8.760713611275237e-5
dapagliflozin,2017,Total,Human,34991.5867,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0185233187104137e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0185233187104136e-4
dapagliflozin,2018,Total,Human,38308.9301,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0889778317742752e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0889778317742752e-4
dapagliflozin,2019,Total,Human,43180.9882,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.2473783842114937e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.2473783842114936e-4
dapoxetine,2016,Total,Human,23.4,USRHYDPUVLEVMC-FQEVSTJZSA-N,6.7189610859138906e-12,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2017,Total,Human,61.56,USRHYDPUVLEVMC-FQEVSTJZSA-N,1.7918677434485435e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2018,Total,Human,93.33,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.6530185200732896e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2019,Total,Human,85.86,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.480256069461579e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapsone,2016,Total,Human,7560,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1707412739106415e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2017,Total,Human,7500,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1830747361702526e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2018,Total,Human,7240,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.0580578683521504e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2019,Total,Human,8300,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.397638641571291e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
daptomycin,2016,Total,Human,319,DOAKLVKFURWEDJ-RWDRXURGSA-N,9.159609343617655e-11,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2017,Total,Human,466,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.3564171027404504e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2018,Total,Human,546.5,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5534925760420582e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2019,Total,Human,543,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5685756414135075e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
darifenacin,2016,Total,Human,6419.03955,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8431314933928294e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2017,Total,Human,6370.61775,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8543379551763703e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2018,Total,Human,5534.04495,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.5731194410444727e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2019,Total,Human,5167.35135,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.4927037676307927e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darunavir,2016,Total,Human,62424,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.792412080457644e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.9068213621889832e-5
darunavir,2017,Total,Human,57120,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.6626297190672643e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.768755020284324e-5
darunavir,2018,Total,Human,82536,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,2.346185969921451e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,2.4959425211930332e-5
darunavir,2019,Total,Human,154224,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,4.4551014681649504e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,4.73946964698399e-5
dasabuvir,2016,Total,Human,12446,NBRBXGKOEOGLOI-UHFFFAOYSA-N,3.573683319456593e-9,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2017,Total,Human,3066,NBRBXGKOEOGLOI-UHFFFAOYSA-N,8.924409521463991e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2018,Total,Human,1596,NBRBXGKOEOGLOI-UHFFFAOYSA-N,4.536823698743137e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2019,Total,Human,84,NBRBXGKOEOGLOI-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasatinib,2016,Total,Human,1740,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,4.996150551064175e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,2.775639195035653e-4
dasatinib,2017,Total,Human,2038.8,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,5.934470362805215e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.2969279793362307e-4
dasatinib,2018,Total,Human,2379,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,6.762596227637798e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.756997904243221e-4
dasatinib,2019,Total,Human,2601,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,7.513563984008349e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,4.1742022133379715e-4
daunorubicin,2016,Total,Human,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.504587867102085e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2017,Total,Human,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.525241549004283e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2018,Total,Human,59.8,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.699887576346113e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2019,Total,Human,44.2,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.2768147946680854e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
decitabine,2016,Total,Human,16.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,4.665945198551313e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2017,Total,Human,33.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.678297997021454e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2018,Total,Human,33.2,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.437502932222569e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2019,Total,Human,25.6,XAUDJQYHKZQPEU-KVQBGUIXSA-N,7.395126412557236e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
deferasirox,2016,Total,Human,21378,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.138373935669537e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.019182418548967302
deferasirox,2017,Total,Human,21690.3,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.3135394599938174e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.01972981081248068
deferasirox,2018,Total,Human,20962.8,BOFQWVMAQOTZIW-UHFFFAOYSA-N,5.9589303152890124e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.018621657235278165
deferasirox,2019,Total,Human,26090.1,BOFQWVMAQOTZIW-UHFFFAOYSA-N,7.536702641260139e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.023552195753937934
deferiprone,2016,Total,Human,18100,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.197145113463308e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2017,Total,Human,19650,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.719655808766062e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2018,Total,Human,20600,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.855800012162195e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2019,Total,Human,16450,TZXKOCQBRNJULO-UHFFFAOYSA-N,4.7519464643190056e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferoxamine,2016,Total,Human,6300,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.808951061592201e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2017,Total,Human,6655,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.9371149825617374e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2018,Total,Human,7530,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.1404938879408415e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2019,Total,Human,8240,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.38030631404186e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
degarelix,2016,Total,Human,642.5600000000001,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.845015228788389e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2017,Total,Human,624.72,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.8184139322403736e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2018,Total,Human,569.6,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.6191571295764982e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2019,Total,Human,548.0799999999999,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.5832503453884256e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
deoxycholic acid,2017,Total,Human,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.3286130519149364e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2018,Total,Human,0.56,KXGVEGMKQFWNSR-LLQZFEROSA-N,1.5918679644712765e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2019,Total,Human,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.310977003924136e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
dequalinium,2016,Total,Human,158.34,PCSWXVJAIHCTMO-UHFFFAOYSA-P,4.5464970014684004e-11,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2017,Total,Human,530.7,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.544743683314071e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2018,Total,Human,628.86,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.7876108716739408e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2019,Total,Human,663.18,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.9157421618280107e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
desloratadine,2016,Total,Human,169054.615,JAUOIFJMECXRGI-UHFFFAOYSA-N,4.854151194782713e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0013483753318840868
desloratadine,2017,Total,Human,195117.744,JAUOIFJMECXRGI-UHFFFAOYSA-N,5.6794215667324655e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0015776171018701292
desloratadine,2018,Total,Human,215869.1405,JAUOIFJMECXRGI-UHFFFAOYSA-N,6.136342308569623e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0017045395301582287
desloratadine,2019,Total,Human,258165.445,JAUOIFJMECXRGI-UHFFFAOYSA-N,7.457680082535517e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0020715778007043104
deslorelin,2016,Total,Vet,55.3472,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.5892123205739028e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2017,Total,Vet,63.8824,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.859467380345634e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2018,Total,Vet,72.9675,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.074189744599247e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2019,Total,Vet,80.6896,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.3308976256979624e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
desogestrel,2016,Total,Human,3250.642437,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.333735059155252e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4569389107982413
desogestrel,2017,Total,Human,3210.205131,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.344156959213623e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4607988737828235
desogestrel,2018,Total,Human,3032.343783,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.619805223966676e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.1925204533209914
desogestrel,2019,Total,Human,2996.976339,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.657429250917183e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.206455278117475
desonide,2016,Total,Human,3116.4700000000003,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.948478912571823e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2017,Total,Human,3100.3500000000004,WBGKWQHBNHJJPZ-LECWWXJVSA-N,9.024394344380591e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2018,Total,Human,3008.225,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.55124465611001e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2019,Total,Human,1222.965,WBGKWQHBNHJJPZ-LECWWXJVSA-N,3.5328049895051015e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desoximetasone,2016,Total,Human,4289.125,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2315582892145476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2017,Total,Human,4195.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2213211611504476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2018,Total,Human,3734.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.0616835471079744e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2019,Total,Human,4119.25,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.1899365029268124e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoxycortone,2016,Total,Vet,2,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.742701782832385e-13,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2017,Total,Vet,7,ZESRJSPZRDMNHY-YFWFAHHUSA-N,2.037536420425569e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2018,Total,Vet,20.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.770521371208377e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2019,Total,Vet,25.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,7.308464774910081e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
detomidine,2016,Total,Vet,573.7252,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.647366364447933e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2017,Total,Vet,633.9336000000001,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.8452325687592778e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2018,Total,Vet,582.1104,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.6547194599027866e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2019,Total,Vet,611.5088,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.7664784681215546e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
dexamethasone,2016,Total,Human,6451.2916000000005,UREBDLICKHMUKA-CXSFZGCWSA-N,1.8523921886445795e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2016,Total,Vet,701,UREBDLICKHMUKA-CXSFZGCWSA-N,2.012816974882751e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2017,Total,Human,7196.3464,UREBDLICKHMUKA-CXSFZGCWSA-N,2.094688269142633e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2017,Total,Vet,668.24,UREBDLICKHMUKA-CXSFZGCWSA-N,1.9450904822645463e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2018,Total,Human,7540.4134,UREBDLICKHMUKA-CXSFZGCWSA-N,2.143454023273203e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2018,Total,Vet,712.9399999999999,UREBDLICKHMUKA-CXSFZGCWSA-N,2.0266184760538424e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2019,Total,Human,9675.3578,UREBDLICKHMUKA-CXSFZGCWSA-N,2.794941172567253e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2019,Total,Vet,691.5,UREBDLICKHMUKA-CXSFZGCWSA-N,1.9975507477669256e-10,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamfetamine,2016,Total,Human,14420.52,KWTSXDURSIMDCE-QMMMGPOBSA-N,4.140637295668503e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2017,Total,Human,18878.343,KWTSXDURSIMDCE-QMMMGPOBSA-N,5.4950444885408724e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2018,Total,Human,21401.635,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.083674489965575e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2019,Total,Human,24003.256,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.933871579413006e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexchlorpheniramine,2016,Total,Human,173.3,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.976051094824262e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2017,Total,Human,176.75,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.1447794615745616e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2018,Total,Human,202.15,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.7463590896047954e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2019,Total,Human,167.85,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.8487186263583276e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexketoprofen,2016,Total,Human,10.5,DKYWVDODHFEZIM-NSHDSACASA-N,3.0149184359870024e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2017,Total,Human,15.5,DKYWVDODHFEZIM-NSHDSACASA-N,4.511687788085189e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2018,Total,Human,30.5,DKYWVDODHFEZIM-NSHDSACASA-N,8.669995163638201e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2019,Total,Human,35.5,DKYWVDODHFEZIM-NSHDSACASA-N,1.0254960454913355e-11,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexmedetomidine,2016,Total,Human,19.5878,CUHVIMMYOGQXCV-NSHDSACASA-N,5.62434469908821e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2016,Total,Vet,23.6414,CUHVIMMYOGQXCV-NSHDSACASA-N,6.788275496432678e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2017,Total,Human,21.122400000000003,CUHVIMMYOGQXCV-NSHDSACASA-N,6.1482370409710065e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2017,Total,Vet,30.2513,CUHVIMMYOGQXCV-NSHDSACASA-N,8.80544650217429e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2018,Total,Human,23.33,CUHVIMMYOGQXCV-NSHDSACASA-N,6.631835644841943e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2018,Total,Vet,34.6813,CUHVIMMYOGQXCV-NSHDSACASA-N,9.858580435038872e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2019,Total,Human,25.4738,CUHVIMMYOGQXCV-NSHDSACASA-N,7.358670750320333e-12,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2019,Total,Vet,39.0958,CUHVIMMYOGQXCV-NSHDSACASA-N,1.1293686843752156e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexrazoxane,2017,Total,Human,50,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.4553831574468352e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2018,Total,Human,60,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.7055728190763675e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2019,Total,Human,95,BMKDZUISNHGIBY-ZETCQYMHSA-N,2.744285192159912e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
diatrizoic acid,2016,Total,Human,849520,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.439270009275884e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2017,Total,Human,785510,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.286436048012127e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2018,Total,Human,732970,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.083556181997342e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2019,Total,Human,672660,YVPYQUNUQOZFHG-UHFFFAOYSA-N,1.943127239324512e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diazepam,2016,Total,Human,110876.03,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.183639875771885e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2017,Total,Human,104435.425,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.0398711717160426e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2018,Total,Human,97114.912,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.7606092372365562e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2019,Total,Human,100692.162,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.9087158857175474e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2019,Total,Vet,0.7,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.0221048784336193e-13,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
dibrompropamidine,2016,Total,Human,4940.7,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4186483349219983e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2017,Total,Human,5152.6875,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4998269206173676e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2018,Total,Human,5390.475,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.5323079403184471e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2019,Total,Human,8406,GMJFVGRUYJHMCO-UHFFFAOYSA-N,2.428259086873286e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dichlorobenzyl alcohol,2016,Total,Human,3892.752,DBHODFSFBXJZNY-UHFFFAOYSA-N,1.1177456925262164e-9,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2017,Total,Human,3343.536,DBHODFSFBXJZNY-UHFFFAOYSA-N,9.732251961434322e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2018,Total,Human,2321.3088,DBHODFSFBXJZNY-UHFFFAOYSA-N,6.598601989937966e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2019,Total,Human,722.9088,DBHODFSFBXJZNY-UHFFFAOYSA-N,2.0882820159179909e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
diclofenac,2016,Total,Human,2138041.438,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.139067188886058e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,12.278134377772117
diclofenac,2017,Total,Human,2248460.2090000003,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.544742236735982e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,13.089484473471964
diclofenac,2018,Total,Human,2273673.761,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.463193610347895e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,12.92638722069579
diclofenac,2019,Total,Human,2213365.855,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.393796990219855e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,12.787593980439711
dicloxacillin,2016,Total,Human,2807037.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.059989627863681e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2017,Total,Human,2699355,YFAGHNZHGGCZAX-JKIFEVAISA-N,7.857191605939803e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2018,Total,Human,2868295,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.153476648487749e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2019,Total,Human,2968317.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.574641853556979e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dienogest,2016,Total,Human,1035.628,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.9736513809755686e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06758298593126293
dienogest,2017,Total,Human,994.407,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.89448639889447e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06578378179305615
dienogest,2018,Total,Human,959.019,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.7261278989629975e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06195745224915904
dienogest,2019,Total,Human,1100.813,AZFLJNIPTRTECV-FUMNGEBKSA-N,3.179941910775926e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.07227140706308922
digoxin,2016,Total,Human,582.2961875,LTMHDMANZUZIPE-PUGKRICDSA-N,1.671976677046375e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2017,Total,Human,531.9445625,LTMHDMANZUZIPE-PUGKRICDSA-N,1.5483663139158506e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2018,Total,Human,481.7478125,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3694266244158302e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2019,Total,Human,452.9559375,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3084634441917479e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
dihydrostreptomycin,2016,Total,Vet,274265,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.875110522342622e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2017,Total,Vet,252650,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.354051094578859e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2018,Total,Vet,189635,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.3906050257591166e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2019,Total,Vet,179655,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.189732170499885e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
diltiazem,2016,Total,Human,293739.3,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.434286008989685e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2017,Total,Human,288176.4,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.388141578673244e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2018,Total,Human,287198.1,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.163954550839608e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2019,Total,Human,263529.6,HSUGRBWQSSZJOP-RTWAWAEBSA-N,7.612635568166577e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
dimethyl fumarate,2016,Total,Human,169174.32,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.857588345367282e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.013128617149641303
dimethyl fumarate,2017,Total,Human,159363.8184,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.63870834411552e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012537049578690593
dimethyl fumarate,2018,Total,Human,158516.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.506014231339342e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.01217841684145768
dimethyl fumarate,2019,Total,Human,161051.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.6523190901913344e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012573835378895499
dimethylaminodiphenylbuten,2016,Total,Human,9409,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7016540537334955e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2017,Total,Human,10666.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.104768889781333e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2018,Total,Human,11326,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.2195529581431566e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2019,Total,Human,11148.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.220490891031029e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimeticone,2016,Total,Human,52363,NA,1.503525467272261e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2017,Total,Human,66244,NA,1.9282080376381627e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2018,Total,Human,83859,NA,2.3837938505820853e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2019,Total,Human,75511,NA,2.1813023067914432e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dinoprost,2016,Total,Vet,8.5,PXGPLTODNUVGFL-YNNPMVKQSA-N,2.4406482577037636e-12,sex hormone,"prostaglandin for labour and abortion induction in humans, uterine infections in animals",NA,NA,NA,NA
dinoprostone,2016,Total,Human,0.1915,XEYBRNLFEZDVAW-ARSRFYASSA-N,5.498636957062009e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dinoprostone,2017,Total,Human,0.117,XEYBRNLFEZDVAW-ARSRFYASSA-N,3.4055965884255945e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dipyridamole,2016,Total,Human,2103356.67,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.039475049370695e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.25164479372377896
dipyridamole,2017,Total,Human,2164230.735,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.299569921095569e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.2624820800456487
dipyridamole,2018,Total,Human,1924232.88,IZEKFCXSFNUWAM-UHFFFAOYSA-N,5.469865496168396e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.22791106234034986
dipyridamole,2019,Total,Human,1605438.675,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4.637664823919294e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.1932360343299706
disopyramide,2016,Total,Human,15559,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.467534851954454e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2017,Total,Human,15085.5,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.391036524332846e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2018,Total,Human,13962.25,UVTNFZQICZKOEM-UHFFFAOYSA-N,3.968939015524835e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2019,Total,Human,14100,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.07309696941629e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disulfiram,2016,Total,Human,149374,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.289051680544024e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2017,Total,Human,143818,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.1862058987537786e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2018,Total,Human,132497.8,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.7664107711236126e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2019,Total,Human,104326,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.0136873363923685e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
dobutamine,2016,Total,Human,1156.25,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.3199994681999727e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2017,Total,Human,1098.75,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.19820448848942e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2018,Total,Human,1325,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.7664733087936447e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2019,Total,Human,1527.5,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4.412521716867648e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
docetaxel,2016,Total,Human,898.46,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.5797939219017925e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2017,Total,Human,908.76,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.645187996322772e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2018,Total,Human,867.26,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.4652918051202836e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2019,Total,Human,995.14,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.8746820696063313e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docusate sodium,2016,Total,Human,30162.96,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.660844208375097e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2017,Total,Human,28812.120000000003,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.386534835667422e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2018,Total,Human,29620.08,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.419867224477923e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2019,Total,Human,28856.28,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.335774937349496e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
dolutegravir,2016,Total,Human,17530.5,RHWKPHLQXYSBKR-BMIGLBTASA-N,5.033621680197156e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,5.298549137049638e-4
dolutegravir,2017,Total,Human,21798,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.344888413205222e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,6.678829908637076e-4
dolutegravir,2018,Total,Human,23759.85,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.754025724221938e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.109500762338881e-4
dolutegravir,2019,Total,Human,25429.35,RHWKPHLQXYSBKR-BMIGLBTASA-N,7.345830384342279e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.732453036149767e-4
donepezil,2016,Total,Human,20993.0096,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.027829682846869e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2017,Total,Human,21579.606,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2813190233477345e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2018,Total,Human,21094.7276,ADEBPBSSDYVVLD-UHFFFAOYSA-N,5.99643233673001e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2019,Total,Human,21592.6614,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2375179936150445e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
dopamine,2016,Total,Human,1146,VYFYYTLLBUKUHU-UHFFFAOYSA-N,3.2905681215629567e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2017,Total,Human,522,VYFYYTLLBUKUHU-UHFFFAOYSA-N,1.5194200163744958e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2018,Total,Human,784,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.228615150259787e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2019,Total,Human,749,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.1636522199239727e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
doramectin,2016,Total,Vet,1018.5,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.9244708829073923e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2017,Total,Vet,663,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.929838066774503e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2018,Total,Vet,818,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.3252642766741144e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2019,Total,Vet,692,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.998995108394378e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doravirine,2019,Total,Human,84,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,NNRTI antiviral for used in combination for treatment of HIV,NA,NA,NA,NA
dorzolamide,2016,Total,Human,20753.1,IAVUPMFITXYVAF-XPUUQOCRSA-N,5.958943218464939e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2017,Total,Human,21312.92,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.203692960802359e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2018,Total,Human,21852.98,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.211974783969913e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2019,Total,Human,23854.88,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.891009888921225e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
doxazosin,2016,Total,Human,20090.384,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.768654200729361e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2017,Total,Human,20391.00000000001,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.935343592699686e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2018,Total,Human,14713.708,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4.182550072104416e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2019,Total,Human,8302.724,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,2.3984255292411272e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxepin,2016,Total,Human,22507.01,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.462552322661317e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2017,Total,Human,20741.165,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.0372684413651585e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2018,Total,Human,18060.3,ODQWQRRAPPTVAG-GZTJUZNOSA-N,5.13385946406082e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2019,Total,Human,16463.375,ODQWQRRAPPTVAG-GZTJUZNOSA-N,4.755810128997441e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxorubicin,2016,Total,Human,599.3,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.7208005892257238e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2017,Total,Human,563.9200000000001,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6414393402948387e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2018,Total,Human,574.9,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6342230228116726e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2019,Total,Human,677.84,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.9580908154249206e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxycycline,2016,Total,Human,340453.015,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.775600681055805e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2016,Total,Vet,1170,SGKRLCUYIXIAHR-AKNGSSGZSA-N,3.3594805429569447e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2017,Total,Human,315952.585,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.196641415215793e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2017,Total,Vet,1239.6,SGKRLCUYIXIAHR-AKNGSSGZSA-N,3.6081859239421925e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2018,Total,Human,302663.49,SGKRLCUYIXIAHR-AKNGSSGZSA-N,8.603577031179868e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2018,Total,Vet,931.6,SGKRLCUYIXIAHR-AKNGSSGZSA-N,2.6481860637525737e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2019,Total,Human,317078.855,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.159524279194945e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2019,Total,Vet,1004.4,SGKRLCUYIXIAHR-AKNGSSGZSA-N,2.9014316284267525e-10,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxylamine,2016,Total,Human,1619.26275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,4.6494715406495356e-10,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2017,Total,Human,7104.46275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.0679430858116852e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2018,Total,Human,9141.454,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.598569244872822e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2019,Total,Human,11257.61175,HCFDWZZGGLSKEP-UHFFFAOYSA-N,3.252010234169519e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
dronedarone,2016,Total,Human,449262,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.2899888441794218e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.32249721104485546
dronedarone,2017,Total,Human,519206,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.5112873352906828e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.3778218338226707
dronedarone,2018,Total,Human,585632.8,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.664732309399311e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4161830773498278
dronedarone,2019,Total,Human,675602.7999999999,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.951628168233447e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4879070420583618
droperidol,2016,Total,Human,35.725,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0257901059584348e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2017,Total,Human,37.6,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0944481344000199e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2018,Total,Human,37.55,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0674043226052932e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2019,Total,Human,36.7,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0601607005501975e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
drospirenone,2016,Total,Human,37983.771,METQSPRSQINEEU-HXCATZOESA-N,1.0906473472019854e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.47419449878347186
drospirenone,2017,Total,Human,35234.64,METQSPRSQINEEU-HXCATZOESA-N,1.025598032294051e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.4459121879539352
drospirenone,2018,Total,Human,34171.074,METQSPRSQINEEU-HXCATZOESA-N,9.713542502174529e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.4223279348771534
drospirenone,2019,Total,Human,33596.514,METQSPRSQINEEU-HXCATZOESA-N,9.705096408251912e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.421960713402257
duloxetine,2016,Total,Human,71834.2884,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.0626144803158793e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.04796777861199719
duloxetine,2017,Total,Human,78300.54119999999,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.27914577762904e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.05300339017741953
duloxetine,2018,Total,Human,88763.8248,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.5232194482689467e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.0586795220527662
duloxetine,2019,Total,Human,103103.28,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.9783663638643915e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.06926433404335794
dutasteride,2016,Total,Human,3128.1749999999997,JWJOTENAMICLJG-QWBYCMEYSA-N,8.982088074755847e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002138592398751392
dutasteride,2017,Total,Human,3410.16,JWJOTENAMICLJG-QWBYCMEYSA-N,9.926178856397798e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.0023633759181899516
dutasteride,2018,Total,Human,3810.36,JWJOTENAMICLJG-QWBYCMEYSA-N,1.083141074482638e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002578907320196757
dutasteride,2019,Total,Human,4359,JWJOTENAMICLJG-QWBYCMEYSA-N,1.2591935950131636e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.00299807998812658
dydrogesterone,2019,Total,Human,82.11,JGMOKGBVKVMRFX-HQZYFCCVSA-N,2.3719290224026353e-11,sex hormone,progestin for various reproductive and gynaecological disordered,NA,NA,NA,NA
ebastine,2016,Total,Human,34690.03,MJJALKDDGIKVBE-UHFFFAOYSA-N,9.960724856375446e-9,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2017,Total,Human,37772.35,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0994648401437392e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2018,Total,Human,38210.53000000001,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0861806895083691e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2019,Total,Human,42561.2,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.2294744307426991e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
econazole,2016,Total,Human,15091.0794,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.333178428762254e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.02166589214381127
econazole,2017,Total,Human,16123.1457,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.693070939368272e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.023465354696841363
econazole,2018,Total,Human,16213.1622,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.6087881265994e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.023043940632997
econazole,2019,Total,Human,21504.8286,LEZWWPYKPKIXLL-UHFFFAOYSA-N,6.212145545991261e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.031060727729956307
edoxaban,2016,Total,Human,130.05,HGVDHZBSSITLCT-JLJPHGGASA-N,3.734191834286759e-11,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,1.6095654458132582e-7
edoxaban,2017,Total,Human,5286.4800000000005,HGVDHZBSSITLCT-JLJPHGGASA-N,1.538770790835909e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,6.632632719120298e-6
edoxaban,2018,Total,Human,21279.33,HGVDHZBSSITLCT-JLJPHGGASA-N,6.048907809359386e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,2.6072878488618042e-5
edoxaban,2019,Total,Human,40912.29,HGVDHZBSSITLCT-JLJPHGGASA-N,1.1818420170984423e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,5.094146625424321e-5
efavirenz,2016,Total,Human,137592,XPOQHMRABVBWPR-ZDUSSCGKSA-N,3.950749118517368e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.015195188917374492
efavirenz,2017,Total,Human,87066,XPOQHMRABVBWPR-ZDUSSCGKSA-N,2.5342877997253232e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.00974726076817432
efavirenz,2018,Total,Human,62352,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.7724312735841613e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.006817043359939081
efavirenz,2019,Total,Human,64836,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.8729313128303163e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.0072035819724242936
eflornithine,2016,Total,Human,5385.45,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.5463516658177332e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2017,Total,Human,6365.25,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8527755285876934e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2018,Total,Human,6444.6,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8319557649699262e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2019,Total,Human,7903.95,VLCYCQAOQCDTCN-UHFFFAOYSA-N,2.283230836270772e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
elbasvir,2017,Total,Human,4765.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.3871547950257275e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2018,Total,Human,3778.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.0741129090269935e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2019,Total,Human,861,BVAZQCUMNICBAQ-PZHYSIFUSA-N,2.4871890004733516e-10,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
eletriptan,2016,Total,Human,36486.6,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0476583143474606e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2017,Total,Human,36664.8,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0672266478231344e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2018,Total,Human,37340,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.061434817738526e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2019,Total,Human,37276.2,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0768055124209611e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eliglustat,2016,Total,Human,70.56,FJZZPCZKBUKGGU-AUSIDOKSSA-N,2.0260251889832654e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2017,Total,Human,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.916914264336375e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2018,Total,Human,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.872036726218221e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2019,Total,Human,56.448,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.6306253739688706e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eltrombopag,2016,Total,Human,1215.55,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,3.490270576060953e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2017,Total,Human,1726.9,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.026602349189878e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2018,Total,Human,2057.3,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.848124934476351e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2019,Total,Human,2347.8,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,6.782139762266361e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eluxadoline,2017,Total,Human,1661.8,QFNHIDANIVGXPE-FNZWTVRRSA-N,4.8371114620903e-10,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2018,Total,Human,8265.6,QFNHIDANIVGXPE-FNZWTVRRSA-N,2.349597115559604e-9,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2019,Total,Human,316.4,QFNHIDANIVGXPE-FNZWTVRRSA-N,9.13991405051996e-11,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
elvitegravir,2016,Total,Human,25407,JUZYLCPPVHEVSV-LJQANCHMSA-N,7.29524120982112e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2017,Total,Human,43587,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.2687157136727041e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2018,Total,Human,47475,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.3495344930941758e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2019,Total,Human,33624,JUZYLCPPVHEVSV-LJQANCHMSA-N,9.713036347493145e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
emedastine,2016,Total,Human,31.7375,KBUZBQVCBVDWKX-UHFFFAOYSA-N,9.112949891632142e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2017,Total,Human,30.6275,KBUZBQVCBVDWKX-UHFFFAOYSA-N,8.914949530940588e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2018,Total,Human,39.182500000000005,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1138101163909964e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2019,Total,Human,38.427499999999995,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1100633602286842e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emodepside,2016,Total,Vet,2393.946124,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,6.873859337149738e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2017,Total,Vet,2639.01194,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.681547059554194e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2018,Total,Vet,2740.303384,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.789644946288983e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2019,Total,Vet,2591.797656,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.486980977300601e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
empagliflozin,2016,Total,Human,19498.119,OBWASQILIWPZMG-QZMOQZSNSA-N,5.5985941371589e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,2.3327475571495418e-5
empagliflozin,2017,Total,Human,44557.269,OBWASQILIWPZMG-QZMOQZSNSA-N,1.2969579768885596e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,5.403991570368998e-5
empagliflozin,2018,Total,Human,68882.715,OBWASQILIWPZMG-QZMOQZSNSA-N,1.958074773469733e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,8.15864488945722e-5
empagliflozin,2019,Total,Human,96535.977,OBWASQILIWPZMG-QZMOQZSNSA-N,2.7886552862293668e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,1.1619397025955695e-4
emtricitabine,2016,Total,Human,185142,XQSPYNMVSIKCOC-NTSWFWBYSA-N,5.316076467385768e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,8.714879454730768e-5
emtricitabine,2017,Total,Human,208338,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.064232325123176e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,9.941364467415043e-5
emtricitabine,2018,Total,Human,222060,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.312325003401636e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.0348073776068256e-4
emtricitabine,2019,Total,Human,248202,XQSPYNMVSIKCOC-NTSWFWBYSA-N,7.169863929099732e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.175387529360612e-4
enalapril,2016,Total,Human,318584.1288,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.147668222209313e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2017,Total,Human,313478.8807,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.124637663721314e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2018,Total,Human,305892.9873,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.695379411415875e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2019,Total,Human,307256.2993,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.875778024914148e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
encorafenib,2019,Total,Human,126.35,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,3.6498993055726825e-11,antineoplastic,small molecule BRAF inhibitor for melanomas,NA,NA,NA,NA
enoxaparin,2016,Total,Human,100177.6,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.876450410599348e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2017,Total,Human,95914.2,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.7918382247997445e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2018,Total,Human,90336.4,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.5679218068868392e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2019,Total,Human,101000.1,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.917611356175477e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enrofloxacin,2016,Total,Vet,18469.15,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.3031410316199375e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2017,Total,Vet,18206.94,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.299614764929015e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2018,Total,Vet,18346.29,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.215155592482095e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2019,Total,Vet,12959.97,SPFYMRJSYKOXGV-UHFFFAOYSA-N,3.743774080193336e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
entacapone,2016,Total,Human,28821,JRURYQJSLYLRLN-BJMVGYQFSA-N,8.275520404150609e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2017,Total,Human,31330.2,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.119489079888166e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2018,Total,Human,32387,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.20639781523772e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2019,Total,Human,33673,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.72719108164218e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entecavir,2016,Total,Human,52.455,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.5061671100923637e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2017,Total,Human,63.5925,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.8510290687987572e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2018,Total,Human,63.141,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.7948595561550154e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2019,Total,Human,57.366,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.6571438350889002e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
enzalutamide,2016,Total,Human,26960.64,WXCXUHSOUPDCQV-UHFFFAOYSA-N,7.741345769715105e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2017,Total,Human,33116.16,WXCXUHSOUPDCQV-UHFFFAOYSA-N,9.639340300662918e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2018,Total,Human,37022.72,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.0524157486712504e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2019,Total,Human,40185.6,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.160849968611172e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
ephedrine,2016,Total,Human,18558.75,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.328868335607026e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2017,Total,Human,17555.5,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.109995804111582e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2018,Total,Human,15878.85,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.51375582636513e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2019,Total,Human,15576.15,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.499515557459117e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
epinephrine,2016,Total,Human,271.69765,UCTWMZQNUQWSLP-VIFPVBQESA-N,7.801392895231848e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2017,Total,Human,291.7274,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.491502890515115e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2018,Total,Human,306.95865000000003,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.725672167006269e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2019,Total,Human,324.8584,UCTWMZQNUQWSLP-VIFPVBQESA-N,9.384253649144859e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epirubicin,2016,Total,Human,1315.33,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.7767739680064606e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2017,Total,Human,1127.27,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.281219543790187e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2018,Total,Human,1006.18,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8601887651637655e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2019,Total,Human,988.13,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8544321336094456e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
eplerenone,2016,Total,Human,15919.925,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.571169084002893e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2017,Total,Human,17031.66,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.9575182214721925e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2018,Total,Human,23322.025,JUKPWJGBANNWMW-VWBFHTRKSA-N,6.629568654303253e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2019,Total,Human,31719.375,JUKPWJGBANNWMW-VWBFHTRKSA-N,9.162843275480769e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
epoprostenol,2016,Total,Human,0.524,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.504587867102085e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2017,Total,Human,0.495,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.440829325872367e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2018,Total,Human,0.4785,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.3601943232134034e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2019,Total,Human,0.528,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.52524482258993e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
eprinomectin,2016,Total,Vet,4106.3564,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.1790790109612587e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2017,Total,Vet,5427.3816,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.579783953935371e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2018,Total,Vet,5763.41,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.638319240198821e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2019,Total,Vet,5112.176,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.4767651470016094e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprosartan,2016,Total,Human,462785.4,OROAFUQRIXKEMV-LDADJPATSA-N,1.3288192708243993e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2017,Total,Human,420487.62,OROAFUQRIXKEMV-LDADJPATSA-N,1.22394120012581e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2018,Total,Human,382502.232,OROAFUQRIXKEMV-LDADJPATSA-N,1.0873090168920713e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2019,Total,Human,333412.464,OROAFUQRIXKEMV-LDADJPATSA-N,9.631356714071049e-8,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eribulin,2016,Total,Human,1.826,UFNVPOGXISZXJD-JBQZKEIOSA-N,5.243086727725968e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2017,Total,Human,1.51976,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.423666214722804e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2018,Total,Human,1.41328,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.017419922907082e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2019,Total,Human,1.19416,UFNVPOGXISZXJD-JBQZKEIOSA-N,3.4495953737575586e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
erlotinib,2016,Total,Human,2868,AAKJLRGGTJKAMG-UHFFFAOYSA-N,8.23503435658164e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,5.924485148619885e-4
erlotinib,2017,Total,Human,3227.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,9.393770589740595e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,6.758108337942874e-4
erlotinib,2018,Total,Human,2084.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,5.924733580266531e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,4.2623982591845545e-4
erlotinib,2019,Total,Human,1297.5,AAKJLRGGTJKAMG-UHFFFAOYSA-N,3.748115828239459e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,2.696486207366517e-4
ertapenem,2016,Total,Human,3578,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.0273693489487138e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,7.902841145759337e-5
ertapenem,2017,Total,Human,4296,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2504652088783204e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.61896314521785e-5
ertapenem,2018,Total,Human,4515,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2834435463549666e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.872642664268974e-5
ertapenem,2019,Total,Human,4674,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.3501883145426768e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,1.038606395802059e-4
ertugliflozin,2018,Total,Human,68.39,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.9440687516105464e-11,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
ertugliflozin,2019,Total,Human,560.28,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.6184927446982687e-10,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
erythromycin,2016,Total,Human,1270675,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.6485537939502707e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2017,Total,Human,1150366,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.348446602598972e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2018,Total,Human,864442.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.457282719424038e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2019,Total,Human,867991.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.507385495127021e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythropoietin,2016,Total,Human,1012.9224,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.9084556361754294e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2017,Total,Human,948.5448,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.7609922520075536e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2018,Total,Human,1127.196,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.2041914322860087e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2019,Total,Human,1287.3504,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.7187964629906733e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
escitalopram,2016,Total,Human,396431.7842,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.1382947569483817e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2017,Total,Human,389371.3374,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.133368972889018e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2018,Total,Human,374910.2026,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0657277519149569e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2019,Total,Human,372772.82579999993,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0768367851395225e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
esketamine,2016,Total,Human,450.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.294261414305849e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2017,Total,Human,615.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.7908489752383303e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2018,Total,Human,814.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,2.314604446554887e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2019,Total,Human,1047.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,3.0266576948268923e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
eslicarbazepine,2016,Total,Human,150333.6,BMPDWHIDQYTSHX-AWEZNQCLSA-N,4.316605163698053e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2017,Total,Human,180806.64,BMPDWHIDQYTSHX-AWEZNQCLSA-N,5.2628587722110654e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2018,Total,Human,239031.12,BMPDWHIDQYTSHX-AWEZNQCLSA-N,6.794749686423025e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2019,Total,Human,301821.68,BMPDWHIDQYTSHX-AWEZNQCLSA-N,8.718787022071867e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
esmolol,2016,Total,Human,89,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5555022933604115e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2017,Total,Human,86,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5032590308085564e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2018,Total,Human,136.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,3.880178163398736e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2019,Total,Human,142.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4.1164277882398677e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esomeprazole,2016,Total,Human,1635560.512,SUBDBMMJDZJVOS-DEOSSOPVSA-N,4.696268134096325e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.004696268134096324
esomeprazole,2017,Total,Human,1758601.6008,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.118878300926725e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005118878300926725
esomeprazole,2018,Total,Human,1831296.4908,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.205682530630692e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005205682530630692
esomeprazole,2019,Total,Human,1967701.7156,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.684141769167089e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005684141769167089
estradiol,2016,Total,Human,16764.89485500001,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.8137895786403016e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.034473946600754
estradiol,2017,Total,Human,16335.55707,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.754898925437914e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.887247313594786
estradiol,2018,Total,Human,16243.17705,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.617320211987509e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.543300529968773
estradiol,2019,Total,Human,16651.18926,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.810064433481069e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.025161083702672
estriol,2016,Total,Human,3119.3382,PROQIPRRNZUXQM-ZXXIGWHRSA-N,8.956714521198583e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2016,Total,Vet,69.57,PROQIPRRNZUXQM-ZXXIGWHRSA-N,1.997598815158245e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,Total,Human,2884.3269,PROQIPRRNZUXQM-ZXXIGWHRSA-N,8.395601581661682e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,Total,Vet,79.71,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.3201718296017443e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,Total,Human,2626.1412,PROQIPRRNZUXQM-ZXXIGWHRSA-N,7.465125082960991e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,Total,Vet,85.92,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.4423802769173582e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,Total,Human,2423.278799999999,PROQIPRRNZUXQM-ZXXIGWHRSA-N,7.000176976121092e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,Total,Vet,96.15,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.7775054865913217e-11,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
ethambutol,2016,Total,Human,10609.5,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.046359728248009e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2017,Total,Human,11253,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.275485334149847e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2018,Total,Human,9966,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.8329564524858467e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2019,Total,Human,8679,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.507121177132197e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethinylestradiol,2016,Total,Human,2284.45398675,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.559468991253887e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.741339975011105
ethinylestradiol,2017,Total,Human,2211.705453,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.437757731059046e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.393593517311558
ethinylestradiol,2018,Total,Human,2102.425479,BFPYWIDHMRZLRN-SLHNCBLASA-N,5.976399585193354e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.075427386266725
ethinylestradiol,2019,Total,Human,2094.9751485,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.051799239970065e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.290854971343045
ethylmorphine,2016,Total,Human,168526.865,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.838997640453264e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2017,Total,Human,165954.01750000002,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.830533639602747e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2018,Total,Human,163302.13,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.642061237087925e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2019,Total,Human,161539.45,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.6664244272069105e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
etonogestrel,2016,Total,Human,3305.33,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.490762241924683e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.5150971266387714
etonogestrel,2017,Total,Human,3368.545,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.805047316203499e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.6314990060012957
etonogestrel,2018,Total,Human,3550.718,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0093346848342003e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.738276610497038
etonogestrel,2019,Total,Human,3539.2419999999997,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0223883591653083e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.7866235524641048
etoposide,2016,Total,Human,3659.2,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0506847181870131e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2017,Total,Human,3609.8,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0507284243503171e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2018,Total,Human,3554.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0103529118071891e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2019,Total,Human,3086.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,8.915460409013827e-10,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoricoxib,2016,Total,Human,393101.82,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.1287332612743277e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0015049776816991036
etoricoxib,2017,Total,Human,442147.1478,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.286987024042553e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0017159826987234042
etoricoxib,2018,Total,Human,475405.017,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.3513964584128973e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.00180186194455053
etoricoxib,2019,Total,Human,530281.7112,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.5318360502309253e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.002042448066974567
etravirine,2016,Total,Human,3480,PYGWGZALEOIKDF-UHFFFAOYSA-N,9.99230110212835e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0020392451228833366
etravirine,2017,Total,Human,2556,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.43991870086822e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0015183507552792286
etravirine,2018,Total,Human,2508,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.129294383739217e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0014549580374977995
etravirine,2019,Total,Human,2280,PYGWGZALEOIKDF-UHFFFAOYSA-N,6.586284461183787e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.001344139685955875
everolimus,2016,Total,Human,802.059,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.30299282461838e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.16449948747274143
everolimus,2017,Total,Human,689.892,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0081143945146237e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14343674246533028
everolimus,2018,Total,Human,706.9499999999999,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0095911740767302e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14354222671976644
everolimus,2019,Total,Human,764.208,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.2075838927685703e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.1576845637691836
exemestane,2016,Total,Human,7017.25,BFYIZQONLCFLEV-DAELLWKTSA-N,2.0148987042790278e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2017,Total,Human,6853,BFYIZQONLCFLEV-DAELLWKTSA-N,1.9947481555966323e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2018,Total,Human,7102.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.01897182458165e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2019,Total,Human,7537.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.177373645884772e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
ezetimibe,2016,Total,Human,125693.8396,OLNTVTPDXPETLC-XPWALMASSA-N,3.60911118380984e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.007218222367619679
ezetimibe,2017,Total,Human,145311.6734,OLNTVTPDXPETLC-XPWALMASSA-N,4.229683240935505e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.00845936648187101
ezetimibe,2018,Total,Human,181550.2022,OLNTVTPDXPETLC-XPWALMASSA-N,5.1607848361689764e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.010321569672337952
ezetimibe,2019,Total,Human,206958.4234,OLNTVTPDXPETLC-XPWALMASSA-N,5.978451965572435e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.01195690393114487
famotidine,2016,Total,Human,35431.3512,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0173584185220018e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2017,Total,Human,35443.1328,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0316667704854297e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2018,Total,Human,32979.636,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.374861790772076e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2019,Total,Human,32563.0032,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.406543946738508e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
fampridine,2016,Total,Human,10753.12,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.0875980697505288e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2017,Total,Human,10847.76,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.157529440005096e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2018,Total,Human,11444.16,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.2531413721935e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2019,Total,Human,11673.2,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.372062095275904e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
febantel,2016,Total,Vet,9568.5,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.747452100451584e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2017,Total,Vet,9452.1,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.7512854285006462e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2018,Total,Vet,6800.0999999999995,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.933010954500201e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2019,Total,Vet,5323.8,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.5378974216864144e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febuxostat,2017,Total,Human,1906.24,BQSJTQLCZDPROO-UHFFFAOYSA-N,5.54861918010291e-10,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2018,Total,Human,8012.48,BQSJTQLCZDPROO-UHFFFAOYSA-N,2.2776446835655022e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2019,Total,Human,11303.04,BQSJTQLCZDPROO-UHFFFAOYSA-N,3.2651331893043335e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
felbamate,2016,Total,Human,12748.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.6606278244486747e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2017,Total,Human,11507.4,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.3495352292007413e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2018,Total,Human,13672.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.886659340111226e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2019,Total,Human,13081.2,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.778794047966552e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felodipine,2016,Total,Human,33237.5734,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.543673601060114e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.19087347202120228
felodipine,2017,Total,Human,32285.259199999997,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.397484494697096e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.18794968989394192
felodipine,2018,Total,Human,32900.6745,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.352416026079829e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.1870483205215966
felodipine,2019,Total,Human,34789.8125,RZTAMFZIAATZDJ-UHFFFAOYSA-N,1.004980708229156e-8,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.2009961416458312
felypressin,2016,Total,Human,0.2567052,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.370907048511722e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2017,Total,Human,0.2695356,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.845551451446542e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2018,Total,Human,0.28032480000000004,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.968572656550318e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2019,Total,Human,0.27459,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.932139693844107e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
fenbendazole,2016,Total,Vet,847857.125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.4344953116623203e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2017,Total,Vet,907688.6125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.6420694376775737e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2018,Total,Vet,823748.175,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.341604161739605e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2019,Total,Vet,813966.575,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.3513225459848633e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fentanyl,2016,Total,Human,7604.661799999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.183565243834866e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.967175895346726e-4
fentanyl,2016,Total,Vet,34.1385,PJMPHNIQZUBGLI-UHFFFAOYSA-N,9.80236124066117e-12,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,8.830956072667721e-7
fentanyl,2017,Total,Human,7559.500399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.200393912174522e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9823368578148848e-4
fentanyl,2017,Total,Vet,14.763,PJMPHNIQZUBGLI-UHFFFAOYSA-N,4.2971643106775255e-12,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,3.871319198808581e-7
fentanyl,2018,Total,Human,7407.0344,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.1055394237672713e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.8968823637542984e-4
fentanyl,2018,Total,Vet,0.33799999999999997,PJMPHNIQZUBGLI-UHFFFAOYSA-N,9.608060214130205e-14,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,8.655910102820004e-9
fentanyl,2019,Total,Human,7367.005899999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.128122652834179e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9172276151659272e-4
fentanyl,2019,Total,Vet,0.3515,PJMPHNIQZUBGLI-UHFFFAOYSA-N,1.0153855210991673e-13,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,9.147617307199705e-9
fesoterodine,2016,Total,Human,14490.68992,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.160785541902763e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2017,Total,Human,13885.55616,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.04176091340923e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2018,Total,Human,13299.2664,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.780477880915936e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2019,Total,Human,12869.67024,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.7176889965908515e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fexofenadine,2016,Total,Human,1176976.08,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.3795113164835365e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0016897556582417682
fexofenadine,2017,Total,Human,1280680.6800000002,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.7277621834791203e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0018638810917395601
fexofenadine,2018,Total,Human,1345346.34,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.824310249579789e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0019121551247898944
fexofenadine,2019,Total,Human,1538603.7,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4.444597211065739e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0022222986055328692
fidaxomicin,2016,Total,Human,212,ZVGNESXIJDCBKN-UUEYKCAUSA-N,6.087263889802327e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2017,Total,Human,284,ZVGNESXIJDCBKN-UUEYKCAUSA-N,8.266576334298023e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2018,Total,Human,276,ZVGNESXIJDCBKN-UUEYKCAUSA-N,7.845634967751289e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2019,Total,Human,352,ZVGNESXIJDCBKN-UUEYKCAUSA-N,1.0168298817266201e-10,antibacterial,macrolide antibiotic,NA,NA,NA,NA
finasteride,2016,Total,Human,24501.47,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.03523177255071e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407046354510142
finasteride,2017,Total,Human,24178.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.0377730483351405e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407554609667028
finasteride,2018,Total,Human,24142.09,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.862682083282563e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0013725364166565124
finasteride,2019,Total,Human,21924.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.333353805546802e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0012666707611093603
fingolimod,2016,Total,Human,207.1825,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.948936560608354e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.930510620989337e-5
fingolimod,2017,Total,Human,215.565,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.27459340670054e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.090932712660364e-5
fingolimod,2018,Total,Human,216.0795,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.142322032660199e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.0257744003252214e-5
fingolimod,2019,Total,Human,204.3895,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.904242929294403e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.9084940538396075e-5
firocoxib,2016,Total,Vet,50877.425952,FULAPETWGIGNMT-UHFFFAOYSA-N,1.4608694236023652e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2017,Total,Vet,64354.385976000005,FULAPETWGIGNMT-UHFFFAOYSA-N,1.8732057891460643e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2018,Total,Vet,73775.904472,FULAPETWGIGNMT-UHFFFAOYSA-N,2.097169622836964e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2019,Total,Vet,88211.24,FULAPETWGIGNMT-UHFFFAOYSA-N,2.5481768390954117e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
flecainide,2016,Total,Human,444214.9499999999,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.2754969926628992e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2017,Total,Human,454880.21,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.324049992579759e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2018,Total,Human,452896.64,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.287413665058358e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2019,Total,Human,460916.9,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.331460445775001e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
florfenicol,2016,Total,Vet,17160,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.927238129670187e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2017,Total,Vet,17930,AYIRNRDRBQJXIF-NXEZZACHSA-N,5.219004002604351e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2018,Total,Vet,16690,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.7443350583974295e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2019,Total,Vet,13650,AYIRNRDRBQJXIF-NXEZZACHSA-N,3.943104512945557e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
flubendazole,2016,Total,Vet,250,CPEUVMUXAHMANV-UHFFFAOYSA-N,7.178377228540482e-11,anthelminthic,"imidazole anthelmintic for human, veterinary infections",NA,NA,NA,NA
fluconazole,2016,Total,Human,84246.62,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.4190160743580123e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2017,Total,Human,81141.325,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.3618343555583962e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2018,Total,Human,80490.30099999999,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.2880344930812563e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2019,Total,Human,80879.812,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.3363923201713427e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fludarabine,2016,Total,Human,96.65,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.7751606365537495e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2017,Total,Human,87.45,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5454651423745147e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2018,Total,Human,89.9,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5555166072494243e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2019,Total,Human,81.4,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.351419101492809e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludrocortisone,2016,Total,Human,77.24,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.2178314285298668e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2017,Total,Human,80.97,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.356847485169405e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2018,Total,Human,80.31,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.282909218333718e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2019,Total,Human,82.49,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.382906163171275e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
flumazenil,2016,Total,Human,7.015,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.014252650328459e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2017,Total,Human,6.9399999999999995,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.020071822536207e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2018,Total,Human,7.92,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.2513561211808053e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2019,Total,Human,7.4,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.137653728629826e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flunixin,2016,Total,Vet,19223.8,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.5198275266406615e-09,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2017,Total,Vet,19617,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.710050279926913e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2018,Total,Vet,16167.95,NOOCSNJCXJYGPE-UHFFFAOYSA-N,4.59593601003096e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2019,Total,Vet,6154.15,NOOCSNJCXJYGPE-UHFFFAOYSA-N,1.7777623910874652e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
fluocinolone acetonide,2016,Total,Human,197.62,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.67436363161668e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2017,Total,Human,202.68375,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.899650320763299e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2018,Total,Human,184.275,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.238240520588294e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2019,Total,Human,228.4431875,FEBLZLNTKCEFIT-VSXGLTOVSA-N,6.599086912695372e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2016,Total,Human,21.3,WJOHZNCJWYWUJD-IUGZLZTKSA-N,6.1159773987164904e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2017,Total,Human,16.9,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.919195072170302e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2018,Total,Human,17.1,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.860882534367648e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2019,Total,Human,19,WJOHZNCJWYWUJD-IUGZLZTKSA-N,5.4885703843198235e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluorescein,2016,Total,Human,4019.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,1.1541107772958246e-9,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,1.1541107772958245e-4
fluorescein,2017,Total,Human,3890.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,1.1323463118199355e-9,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,1.1323463118199355e-4
fluorescein,2018,Total,Human,3578.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,1.017146776869843e-9,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,1.0171467768698428e-4
fluorescein,2019,Total,Human,2757.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,7.965359988275516e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,7.965359988275516e-5
fluoxetine,2016,Total,Human,96105.48,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.7595255566798107e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08623517364624408
fluoxetine,2017,Total,Human,90741.92,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.641285240847762e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08254016377649256
fluoxetine,2018,Total,Human,88383.38,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5124048431016308e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07851265134692596
fluoxetine,2019,Total,Human,87378.72,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5241276569040754e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07887898927825235
flupentixol,2016,Total,Human,2253.712499999999,NJMYODHXAKYRHW-DVZOWYKESA-N,6.471199395870812e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2017,Total,Human,2129.6025,NJMYODHXAKYRHW-DVZOWYKESA-N,6.198775221113346e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2018,Total,Human,1947.4855,NJMYODHXAKYRHW-DVZOWYKESA-N,5.535963890575582e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2019,Total,Human,1965.812,NJMYODHXAKYRHW-DVZOWYKESA-N,5.678682907547641e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flurbiprofen,2016,Total,Human,3806.18,SYTBZMRGLBWNTM-UHFFFAOYSA-N,1.0928878335890484e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2017,Total,Human,7265.44,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.1147998014881067e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2018,Total,Human,8077.02,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.295990961856034e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2019,Total,Human,10417.54,SYTBZMRGLBWNTM-UHFFFAOYSA-N,3.009336922182481e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flutamide,2016,Total,Human,14427,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.142497931046141e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2017,Total,Human,13860,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.034322112442627e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2018,Total,Human,11466,MKXKFYHWDHIYRV-UHFFFAOYSA-N,3.259349657254938e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2019,Total,Human,8505,MKXKFYHWDHIYRV-UHFFFAOYSA-N,2.456857427296847e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
fluticasone,2016,Total,Human,17882.717,MGNNYOODZCAHBA-GQKYHHCASA-N,5.134755539889351e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08853026792912673
fluticasone,2017,Total,Human,17071.5354,MGNNYOODZCAHBA-GQKYHHCASA-N,4.969125018583484e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08567456928592214
fluticasone,2018,Total,Human,16322.98,MGNNYOODZCAHBA-GQKYHHCASA-N,4.640005169054528e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08000008912162979
fluticasone,2019,Total,Human,15177.8022,MGNNYOODZCAHBA-GQKYHHCASA-N,4.384443981788646e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.07559386175497665
fluticasone furoate,2016,Total,Human,1262.8347,XTULMSXFIHGYFS-VLSRWLAYSA-N,3.6260415415563003e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.006251795761303965
fluticasone furoate,2017,Total,Human,1501.49244,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.3704936164195046e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.0075353338214129385
fluticasone furoate,2018,Total,Human,1645.16016,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.676567419872213e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.008063047275641746
fluticasone furoate,2019,Total,Human,1907.83512,XTULMSXFIHGYFS-VLSRWLAYSA-N,5.511203861998557e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.009502075624135442
fluvastatin,2016,Total,Human,146666.31,FJLGEFLZQAZZCD-MCBHFWOFSA-N,4.2113043995922366e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0022164759997853876
fluvastatin,2017,Total,Human,135773.68839999998,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.9520547864358945e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.00208002883496626
fluvastatin,2018,Total,Human,133801.1248,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8034593603454146e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020018207159712706
fluvastatin,2019,Total,Human,133494.1104,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8562727411713746e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020296172321954604
fluvoxamine,2016,Total,Human,18077.03999999999,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.190552491816614e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2017,Total,Human,17547.885000000002,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.107779255562791e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2018,Total,Human,16008.705,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.55066868610199e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2019,Total,Human,15773.355,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.556482584966474e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fomepizole,2016,Total,Human,3.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.0049728119956673e-12,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2017,Total,Human,62,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.8046751152340755e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2018,Total,Human,126.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.5959160268860076e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2019,Total,Human,132.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.827555662749351e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
formoterol,2016,Total,Human,396.45546,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.1383627384778168e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.211024189870018e-6
formoterol,2017,Total,Human,409.81806,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.192884604283073e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.2690261747692265e-6
formoterol,2018,Total,Human,431.31168,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.22605579659694e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3043146772307874e-6
formoterol,2019,Total,Human,453.85374,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.311056945356205e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3947414312300055e-6
fosfomycin,2017,Total,Human,1240,YMDXZJFXQJVXBF-STHAYSLISA-N,3.609350230468151e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2018,Total,Human,1320,YMDXZJFXQJVXBF-STHAYSLISA-N,3.7522602019680086e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2019,Total,Human,500,YMDXZJFXQJVXBF-STHAYSLISA-N,1.4443606274525851e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosphenytoin,2016,Total,Human,1890,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.426853184776604e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2017,Total,Human,2225,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.476455050638416e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2018,Total,Human,1840,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.230423311834193e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2019,Total,Human,2205,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.3696303670659e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
frovatriptan,2016,Total,Human,14.49,XPSQPHWEGNHMSK-SECBINFHSA-N,4.160587441662063e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2017,Total,Human,13.265,XPSQPHWEGNHMSK-SECBINFHSA-N,3.8611315167064535e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2018,Total,Human,11.145,XPSQPHWEGNHMSK-SECBINFHSA-N,3.1681015114343525e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2019,Total,Human,12.255,XPSQPHWEGNHMSK-SECBINFHSA-N,3.540127897886287e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
fulvestrant,2016,Total,Human,3410,VWUXBMIQPBEWFH-WCCTWKNTSA-N,9.791306539729215e-10,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,1.7177730771454764
fulvestrant,2017,Total,Human,4920,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4320970269276854e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.512450924434536
fulvestrant,2018,Total,Human,5496.25,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.5623757678080807e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.7410101189615452
fulvestrant,2019,Total,Human,5082.5,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4681925778055527e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.575776452290443
furosemide,2016,Total,Human,910025.21,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.6130016979447076e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001840142040806132
furosemide,2017,Total,Human,856371.59,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.492697577203933e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001755420829016854
furosemide,2017,Total,Vet,48.5,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,1.41172166272343e-11,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,9.941701850164999e-8
furosemide,2018,Total,Human,838894.93,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.3846606511149533e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0016793384867006711
furosemide,2018,Total,Vet,651.5,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,1.8519678193804224e-10,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,1.3042026897045227e-6
furosemide,2019,Total,Human,874731.6799999999,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.526855996354908e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001779476053771062
furosemide,2019,Total,Vet,713.5,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.0611026153748388e-10,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,1.4514807150527033e-6
fusidic acid,2016,Total,Human,44554.85,IECPWNUMDGFDKC-MZJAQBGESA-N,1.2793260826441476e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0029751769363817386
fusidic acid,2016,Total,Vet,1261,IECPWNUMDGFDKC-MZJAQBGESA-N,3.620773474075819e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,8.420403428083298e-5
fusidic acid,2017,Total,Human,41795.05,IECPWNUMDGFDKC-MZJAQBGESA-N,1.216556236692967e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0028292005504487604
fusidic acid,2017,Total,Vet,1249,IECPWNUMDGFDKC-MZJAQBGESA-N,3.6355471273021936e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,8.454760761167891e-5
fusidic acid,2018,Total,Human,38300.05,IECPWNUMDGFDKC-MZJAQBGESA-N,1.0887254041544306e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0025319195445451873
fusidic acid,2018,Total,Vet,1212.15,IECPWNUMDGFDKC-MZJAQBGESA-N,3.445683487739032e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,8.013217413346585e-5
fusidic acid,2019,Total,Human,32566.15,IECPWNUMDGFDKC-MZJAQBGESA-N,9.407452969543e-9,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.002187779760358837
fusidic acid,2019,Total,Vet,1160.1,IECPWNUMDGFDKC-MZJAQBGESA-N,3.3512055278154876e-10,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,7.793501227477877e-5
gabapentin,2016,Total,Human,9489062.7,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.724642864234914e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2017,Total,Human,10268756.8,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.988995138927531e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2018,Total,Human,11241014.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.195394798340554e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2019,Total,Human,12516304.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.615611484201523e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gadobenic acid,2016,Total,Human,27758.74,MXZROTBGJUUXID-UHFFFAOYSA-K,7.970508284359032e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.245916622144574e-5
gadobenic acid,2017,Total,Human,9260.15,MXZROTBGJUUXID-UHFFFAOYSA-K,2.6954132690862613e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.4503756991693283e-5
gadobenic acid,2018,Total,Human,1103.87,MXZROTBGJUUXID-UHFFFAOYSA-K,3.1378844463230494e-10,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.852622223930045e-6
gadobenic acid,2019,Total,Human,295.59000000000003,MXZROTBGJUUXID-UHFFFAOYSA-K,8.538771157374194e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.76251923397654e-7
gadobutrol,2016,Total,Human,24717.93,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,7.097385033946305e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,7.097385033946304e-5
gadobutrol,2017,Total,Human,27529.878,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,8.013304153553233e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,8.013304153553232e-5
gadobutrol,2018,Total,Human,33539.282999999996,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,9.533948242685014e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,9.533948242685014e-5
gadobutrol,2019,Total,Human,35852.337,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,1.0356740792992308e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.0356740792992307e-4
gadodiamide,2016,Total,Human,54.43456,HZHFFEYYPYZMNU-UHFFFAOYSA-K,1.563007223798482e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2017,Total,Human,11.966728,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.4832348761894896e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2018,Total,Human,1.079816,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.0695080320062783e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadopentetic acid,2016,Total,Human,4.7376,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3603311983173353e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.801655991586676e-9
gadopentetic acid,2017,Total,Human,4.7752,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3899491306880253e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.949745653440126e-9
gadopentetic acid,2018,Total,Human,2.5192,IZOOGPBRAOKZFK-UHFFFAOYSA-K,7.161131743028642e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,3.580565871514321e-9
gadoteric acid,2016,Total,Human,108961.9125,GFSTXYOTEVLASN-UHFFFAOYSA-K,3.1286788458728824e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2017,Total,Human,142024.05,GFSTXYOTEVLASN-UHFFFAOYSA-K,4.133988206447743e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2018,Total,Human,319547.13,GFSTXYOTEVLASN-UHFFFAOYSA-K,9.083514989031043e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2019,Total,Human,385126.77,GFSTXYOTEVLASN-UHFFFAOYSA-K,1.112523886331975e-7,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteridol,2016,Total,Human,42593.25,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.2230016635581276e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2017,Total,Human,58862.475,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.7133490944127083e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2018,Total,Human,30038.715,DPNNNPAKRZOSMO-UHFFFAOYSA-K,8.538869303996928e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2019,Total,Human,6940.6050000000005,DPNNNPAKRZOSMO-UHFFFAOYSA-K,2.00494731854011e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoxetic acid,2016,Total,Human,6676.624,PCZHWPSNPWAQNF-LMOVPXPDSA-K,1.917093027405074e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.917093027405074e-5
gadoxetic acid,2017,Total,Human,6966.912,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.027905276842849e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.027905276842849e-5
gadoxetic acid,2018,Total,Human,7266.2715,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.0655258610715444e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.0655258610715445e-5
gadoxetic acid,2019,Total,Human,8001.063,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.3112840749935326e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.3112840749935324e-5
galantamine,2016,Total,Human,1093.11776,ASUTZQLVASHGKV-JDFRZJQESA-N,3.138724654598872e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,7.133465124088344e-4
galantamine,2017,Total,Human,925.65984,ASUTZQLVASHGKV-JDFRZJQESA-N,2.6943794813218644e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,6.123589730276964e-4
galantamine,2018,Total,Human,764.51872,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1732372475117604e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.939175562526728e-4
galantamine,2019,Total,Human,746.7734399999999,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1572203087266508e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.902773428924206e-4
gamithromycin,2016,Total,Vet,1867.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,5.36224778971974e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2017,Total,Vet,4732.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.3775201585234294e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2018,Total,Vet,3067.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,8.719741037527928e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2019,Total,Vet,4057.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.1720986491777726e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
ganciclovir,2016,Total,Human,2415,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.934312402770105e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2017,Total,Human,2742.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,7.982776618595891e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2018,Total,Human,1800,IRSCQMHQWWYFCW-UHFFFAOYSA-N,5.116718457229103e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2019,Total,Human,2387.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.896821996086095e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
gefitinib,2016,Total,Human,2130,XGALLCVXEZPNRQ-UHFFFAOYSA-N,6.115977398716491e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.9112429370989035e-4
gefitinib,2017,Total,Human,1815,XGALLCVXEZPNRQ-UHFFFAOYSA-N,5.283040861532012e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.6509502692287536e-4
gefitinib,2018,Total,Human,4035,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.1469977208288571e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,3.5843678775901786e-4
gefitinib,2019,Total,Human,4710,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.360587711060335e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,4.251836597063547e-4
gemcitabine,2016,Total,Human,12382.2742,SDUQYLNIPVEERB-QPPQHZFASA-N,3.555385406192972e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,6.584047048505503e-4
gemcitabine,2017,Total,Human,14020.49296,SDUQYLNIPVEERB-QPPQHZFASA-N,4.081037862617184e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.557477523365156e-4
gemcitabine,2018,Total,Human,14185.31396,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0323476533734255e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.467310469210047e-4
gemcitabine,2019,Total,Human,14058.91928,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0612298945132105e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.52079610095039e-4
gentamicin,2016,Total,Human,26079.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,7.488253416742118e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2017,Total,Human,32411.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,9.434142918528172e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2018,Total,Human,35897.6,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.0204328471679302e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2019,Total,Human,39705.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.1469725517026077e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
glecaprevir,2017,Total,Human,8.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,2.445043704510683e-12,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2018,Total,Human,663.6,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.8863635378984627e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2019,Total,Human,512.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.4801807710134094e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glibenclamide,2016,Total,Human,1259.04625,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.6151635722717145e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,6.342392232055639e-6
glibenclamide,2017,Total,Human,1163.73775,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.387368642070151e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,5.942752003631843e-6
glibenclamide,2018,Total,Human,968.8315,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.7540211211083096e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.831616001944402e-6
glibenclamide,2019,Total,Human,841.27225,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.4302010297368963e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.263510578485783e-6
glimepiride,2016,Total,Human,26242.2288,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.535064705762769e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0024306660341170223
glimepiride,2017,Total,Human,24436.9377,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.1130215096315215e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0022945230676230713
glimepiride,2018,Total,Human,21204.7452,WIGIZIANZCJQQY-UHFFFAOYSA-N,6.027706174760012e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0019444213466967783
glimepiride,2019,Total,Human,19094.0382,WIGIZIANZCJQQY-UHFFFAOYSA-N,5.515735399031126e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0017792694835584279
glipizide,2016,Total,Human,7067.205,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,2.0292425376570974e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2017,Total,Human,6028.63,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.7547933128957426e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2018,Total,Human,5159.665,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.4666973965899443e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2019,Total,Human,4390.65,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.2683363977849384e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glycerol phenylbutyrate,2019,Total,Human,0.006215,ZSDBFLMJVAGKOU-UHFFFAOYSA-N,1.7953402599235634e-15,metabolic,treatment for hyperammonaemia from inborn urea cycle disorders,NA,NA,NA,NA
glyceryl trinitrate,2016,Total,Human,14910.57,SNIOPGDIGTZGOP-UHFFFAOYSA-N,4.2813478461023535e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.010703369615255883
glyceryl trinitrate,2017,Total,Human,12876.8725,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.748156671418064e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.00937039167854516
glyceryl trinitrate,2018,Total,Human,11425.0175,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.2476998842453053e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008119249710613263
glyceryl trinitrate,2019,Total,Human,11939.82375,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.449082264644655e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008622705661611638
glycopyrronium bromide,2016,Total,Human,160.46486,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.607509188019745e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.3962149054605287e-6
glycopyrronium bromide,2017,Total,Human,162.98399,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.7440830795896675e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.43760093320899e-6
glycopyrronium bromide,2018,Total,Human,180.48884,ANGKOCUUWGHLCE-UHFFFAOYSA-N,5.1306143275103894e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.5547316143970876e-6
glycopyrronium bromide,2019,Total,Human,210.60877,ANGKOCUUWGHLCE-UHFFFAOYSA-N,6.083900303684343e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.843606152631619e-6
grapiprant,2019,Total,Vet,5966.4,HZVLFTCYCLXTGV-UHFFFAOYSA-N,1.7235266495266206e-9,analgesic,analgesic and anti-inflammatory small molecule used for pain relief in dogs,NA,NA,NA,NA
grazoprevir,2017,Total,Human,9531.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.774309590051455e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2018,Total,Human,7557.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.148225818053987e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2019,Total,Human,1722,OBMNJSNZOWALQB-NCQNOWPTSA-N,4.974378000946702e-10,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
guanfacine,2016,Total,Human,30.436,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.739243573114325e-12,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2017,Total,Human,224.224,INJOMKTZOLKMBF-UHFFFAOYSA-N,6.526636661907183e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2018,Total,Human,310.576,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.8284997309577e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2019,Total,Human,411.46,INJOMKTZOLKMBF-UHFFFAOYSA-N,1.1885932475432814e-10,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
haloperidol,2016,Total,Human,2485.3250000000003,LNEPOXFFQSENCJ-UHFFFAOYSA-N,7.13624015420895e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,5.097314395863536e-4
haloperidol,2017,Total,Human,2278.565,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.632370248295694e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.73740732021121e-4
haloperidol,2018,Total,Human,2117.817,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.020151851629759e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.300108465449828e-4
haloperidol,2019,Total,Human,2022.669,LNEPOXFFQSENCJ-UHFFFAOYSA-N,5.842926931937785e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.173519237098418e-4
hexaminolevulinate,2016,Total,Human,146.965,RYQOILLJDKPETL-UHFFFAOYSA-N,4.219880837569808e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2017,Total,Human,159.545,RYQOILLJDKPETL-UHFFFAOYSA-N,4.6439821170971056e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2018,Total,Human,152.915,RYQOILLJDKPETL-UHFFFAOYSA-N,4.346794460484379e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2019,Total,Human,157.165,RYQOILLJDKPETL-UHFFFAOYSA-N,4.540058760271711e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hyaluronic acid,2016,Total,Vet,83.367,KIUKXJAPPMFGSW-MNSSHETKSA-N,2.3937590976469373e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2017,Total,Vet,122.815,KIUKXJAPPMFGSW-MNSSHETKSA-N,3.574857649636661e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2018,Total,Vet,144.586,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.110032526982928e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2019,Total,Vet,154.713,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.469227315101436e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hydralazine,2016,Total,Human,6614.35,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992119768638694e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2017,Total,Human,6524.85,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992313589733966e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2018,Total,Human,6598.325,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.875653961905345e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2019,Total,Human,7004.025,RPTUSVTUFVMDQK-UHFFFAOYSA-N,2.0232675887387187e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydrochlorothiazide,2016,Total,Human,1370138.17798,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.9341474787062307e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.9341474787062304e-4
hydrochlorothiazide,2017,Total,Human,1344980.24186,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.91492318220363e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.91492318220363e-4
hydrochlorothiazide,2018,Total,Human,1305368.66112,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.710668845467304e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.710668845467304e-4
hydrochlorothiazide,2019,Total,Human,1274101.87638,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.680525171213466e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.680525171213466e-4
hydrocodone,2016,Total,Human,133.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.8289464137034926e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2017,Total,Human,112.25,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.267335188468145e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2018,Total,Human,67.65,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.9230333535086045e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2019,Total,Human,55.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.5989072145900118e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocortisone,2016,Total,Human,169764.8789,JYGXADMDTFJGBT-VWUMJDOOSA-N,4.8745453636067705e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2016,Total,Vet,31.2798,JYGXADMDTFJGBT-VWUMJDOOSA-N,8.981528161332023e-12,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,Total,Human,172759.51877999998,JYGXADMDTFJGBT-VWUMJDOOSA-N,5.028625878420643e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,Total,Vet,30.1587,JYGXADMDTFJGBT-VWUMJDOOSA-N,8.778492806098373e-12,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,Total,Human,172782.66397,JYGXADMDTFJGBT-VWUMJDOOSA-N,4.9115569212472934e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,Total,Vet,32.6895,JYGXADMDTFJGBT-VWUMJDOOSA-N,9.29238711153282e-12,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,Total,Human,185322.33487,JYGXADMDTFJGBT-VWUMJDOOSA-N,5.3534456774762264e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,Total,Vet,37.9731,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.0969370108463951e-11,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone aceponate,2016,Total,Vet,211.844832,MFBMYAOAMQLLPK-FZNHGJLXSA-N,6.082808472051136e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2017,Total,Vet,240.605664,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.003468619438246e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2018,Total,Vet,256.53952,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.29244720551497e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2019,Total,Vet,275.802176,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.967156079602967e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydromorphone,2016,Total,Human,2001.73168,WVLOADHCBXTIJK-YNHQPCIGSA-N,5.747674043744033e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2017,Total,Human,1683.50176,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.900280214072207e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2018,Total,Human,1407.76,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.001728652971579e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2019,Total,Human,1406.8,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.0638530614005936e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydroxycarbamide,2016,Total,Human,451650,VSNHCAURESNICA-UHFFFAOYSA-N,1.2968456301081234e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2017,Total,Human,473350,VSNHCAURESNICA-UHFFFAOYSA-N,1.377811235154919e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2018,Total,Human,509900,VSNHCAURESNICA-UHFFFAOYSA-N,1.4494526340783996e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2019,Total,Human,547400,VSNHCAURESNICA-UHFFFAOYSA-N,1.5812860149350906e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxychloroquine,2016,Total,Human,573923.8,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.647936614734969e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2017,Total,Human,572213.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.6655800718040404e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2018,Total,Human,566380.4,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.610005025829335e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2019,Total,Human,565996.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.63500640862406e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxyzine,2016,Total,Human,167392.595,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.806428768697197e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2017,Total,Human,150496.77,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.380609286163002e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2018,Total,Human,147143.27,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1827260303669184e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2019,Total,Human,143352.105,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1410427264889787e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hyoscyamine,2016,Total,Human,150.3642,RKUNBYITZUJHSG-VFSICIBPSA-N,4.3174837970708273e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2017,Total,Human,161.3546,RKUNBYITZUJHSG-VFSICIBPSA-N,4.6966553443314215e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2018,Total,Human,166.2378,RKUNBYITZUJHSG-VFSICIBPSA-N,4.7255112197175556e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2019,Total,Human,182.076,RKUNBYITZUJHSG-VFSICIBPSA-N,5.259668112081138e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
ibandronic acid,2016,Total,Human,369.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0621126947348496e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2017,Total,Human,351.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0242986662110824e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2018,Total,Human,306.45,MPBVHIBUJCELCL-UHFFFAOYSA-N,8.711213173432547e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2019,Total,Human,258.75,MPBVHIBUJCELCL-UHFFFAOYSA-N,7.474566247067129e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibrutinib,2016,Total,Human,10386.6,XYFPWWZEPKGCCK-GOSISDBHSA-N,2.982357316878343e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0019241014947602212
ibrutinib,2017,Total,Human,14044.8,XYFPWWZEPKGCCK-GOSISDBHSA-N,4.0881130739418615e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.002637492305768943
ibrutinib,2018,Total,Human,19324.199999999997,XYFPWWZEPKGCCK-GOSISDBHSA-N,5.493138378399256e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0035439602441285525
ibrutinib,2019,Total,Human,22408.4,XYFPWWZEPKGCCK-GOSISDBHSA-N,6.473162136841701e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0041762336366720654
ibuprofen,2016,Total,Human,39219140.08,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.1261191282928453e-5,analgesic,NSAID for many minor pains,low,low,1e-6,11.261191282928452
ibuprofen,2017,Total,Human,39957409.49,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.1630668157390468e-5,analgesic,NSAID for many minor pains,low,low,1e-6,11.630668157390469
ibuprofen,2018,Total,Human,38012809.45,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.0805602429108217e-5,analgesic,NSAID for many minor pains,low,low,1e-6,10.805602429108218
ibuprofen,2019,Total,Human,38613959.05,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.1154496424377285e-5,analgesic,NSAID for many minor pains,low,low,1e-6,11.154496424377285
ibutilide,2016,Total,Human,0.33408,ALOBUEHUHMBRLE-UHFFFAOYSA-N,9.592609058043216e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2017,Total,Human,0.2262,ALOBUEHUHMBRLE-UHFFFAOYSA-N,6.584153404289482e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2018,Total,Human,0.20532,ALOBUEHUHMBRLE-UHFFFAOYSA-N,5.83647018687933e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2019,Total,Human,0.15399,ALOBUEHUHMBRLE-UHFFFAOYSA-N,4.4483418604284714e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
icatibant,2016,Total,Human,43.26,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.2421463956266448e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2017,Total,Human,47.28,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3762103136817271e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2018,Total,Human,46.11,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3107327114601884e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2019,Total,Human,48.03,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3874528187309534e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
idarubicin,2016,Total,Human,5.855,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.681175946924181e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2017,Total,Human,5.95,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.7319059573617337e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2018,Total,Human,5.125,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.4568434496277306e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2019,Total,Human,4.675,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.3504771866681672e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idebenone,2017,Total,Human,2430,JGPMMRGNQUBGND-UHFFFAOYSA-N,7.073162145191619e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2018,Total,Human,1890,JGPMMRGNQUBGND-UHFFFAOYSA-N,5.372554380090558e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2019,Total,Human,2376,JGPMMRGNQUBGND-UHFFFAOYSA-N,6.863601701654684e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idelalisib,2016,Total,Human,1251,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.5920599651616565e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2017,Total,Human,978,IFSDAJWBUCMOAH-HNNXBMFYSA-N,2.8467294559660096e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2018,Total,Human,1401,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9825125325433184e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2019,Total,Human,1368,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9517706767102734e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
ifosfamide,2016,Total,Human,11382,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.26817158460991e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2017,Total,Human,10942.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.1851060400723987e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2018,Total,Human,10785.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.065909273358027e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2019,Total,Human,11104.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.207780517509446e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
iloprost,2016,Total,Human,0.22312,HIFJCPQKFCZDDL-ACWOEMLNSA-N,6.406558108927811e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2017,Total,Human,0.10449,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0414597224323963e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2018,Total,Human,0.10188,HIFJCPQKFCZDDL-ACWOEMLNSA-N,2.8960626467916725e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2019,Total,Human,0.10397,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0034034887249056e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
imatinib,2016,Total,Human,62640,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.7986141983831033e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.873556456649066e-4
imatinib,2017,Total,Human,62232,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8114280930846287e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8869042636298215e-4
imatinib,2018,Total,Human,63588,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8075660736571344e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8828813267261817e-4
imatinib,2019,Total,Human,68550,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.9802184202374945e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,2.0627275210807235e-4
imepitoin,2016,Total,Vet,57400,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6481554116728947e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2017,Total,Vet,60530,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.7618868504051385e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2018,Total,Vet,57240,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6271164693988546e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2019,Total,Vet,63500,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.8343379968647833e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imidacloprid,2016,Total,Vet,1438919.32,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.1316422721579817e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2017,Total,Vet,1373892.38,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.9990796599930937e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2018,Total,Vet,1254248.23,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.565352815771074e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2019,Total,Vet,1391246.68,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.018923855332252e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imipenem,2016,Total,Human,8080,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.320051520264283e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2017,Total,Human,8565,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.493071348706428e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2018,Total,Human,7635,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.1703414122746773e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2019,Total,Human,7800,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.253202578826033e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imiquimod,2016,Total,Human,2332.6499999999996,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.697856656861981e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2017,Total,Human,2716.05,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.905786849566952e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2018,Total,Human,2518.2375,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.158395719964706e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2019,Total,Human,2211.3,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.387829310971804e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
indacaterol,2016,Total,Human,462.6642000000001,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.3284712630963598e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.3284712630963596e-6
indacaterol,2017,Total,Human,419.40825,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.2207994062885028e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.2207994062885028e-6
indacaterol,2018,Total,Human,377.676,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.0735898666958103e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.0735898666958103e-6
indacaterol,2019,Total,Human,330.53625,QZZUEBNBZAPZLX-QFIPXVFZSA-N,9.548270908916491e-11,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,9.54827090891649e-7
ingenol mebutate,2016,Total,Human,1.582302,VDJHFHXMUKFKET-WDUFCVPESA-N,4.543344258189625e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2017,Total,Human,1.6694165,VDJHFHXMUKFKET-WDUFCVPESA-N,4.859281313727689e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2018,Total,Human,1.4774685,VDJHFHXMUKFKET-WDUFCVPESA-N,4.199883524402553e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2019,Total,Human,1.5530915,VDJHFHXMUKFKET-WDUFCVPESA-N,4.4864484268625544e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
iodixanol,2016,Total,Human,1870054,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.369581219896417e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.369581219896416e-4
iodixanol,2017,Total,Human,1640141,NBQNWMBBSKPBAY-UHFFFAOYSA-N,4.77406717447602e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,4.774067174476019e-4
iodixanol,2018,Total,Human,1766954,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.022781191597107e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.022781191597106e-4
iodixanol,2019,Total,Human,1825304,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.272794461463427e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.272794461463427e-4
iohexol,2016,Total,Human,11716927,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.3643408786108454e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2017,Total,Human,12923588,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.761754461796406e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2018,Total,Human,15893883,NTHXOOBQLCIOLC-UHFFFAOYSA-N,4.518029139063326e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2019,Total,Human,17866262,NTHXOOBQLCIOLC-UHFFFAOYSA-N,5.161065078510456e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iomeprol,2016,Total,Human,3157700,NJKDOADNQSYQEV-UHFFFAOYSA-N,9.066864709824912e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,9.066864709824912e-4
iomeprol,2017,Total,Human,3951115,NJKDOADNQSYQEV-UHFFFAOYSA-N,1.1500772448271104e-6,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,0.0011500772448271104
iomeprol,2018,Total,Human,1280985,NJKDOADNQSYQEV-UHFFFAOYSA-N,3.641355329407568e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,3.6413553294075676e-4
iomeprol,2019,Total,Human,715315,NJKDOADNQSYQEV-UHFFFAOYSA-N,2.066345644452492e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,2.066345644452492e-4
ipratropium bromide,2016,Total,Human,3013.797,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.653668702497446e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2017,Total,Human,3072.089,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.94213317755538e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2018,Total,Human,2951.438,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.389820716648526e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2019,Total,Human,2945.5260000000003,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.508803563075807e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
irbesartan,2016,Total,Human,3025751.303,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.687993701072755e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012340900143569256
irbesartan,2017,Total,Human,2907397.66675,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.462755192376352e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012020959080080045
irbesartan,2018,Total,Human,2783303.261,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.911877315347028e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0011238462095663393
irbesartan,2019,Total,Human,2669838.14,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.712418182174487e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0010955139463316034
irinotecan,2016,Total,Human,3416.08,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.808764353149027e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2017,Total,Human,3671.28,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.068623815654283e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2018,Total,Human,3442.8199999999997,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.786633688287496e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2019,Total,Human,3573.76,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.03235964719299e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
isavuconazole,2017,Total,Human,89.2,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.596403552885154e-11,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2018,Total,Human,355.6,DDFOUSQFMYRUQK-RCDICMHDSA-N,1.0108361574392606e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2019,Total,Human,774.4,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.2370257397985638e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isoniazid,2016,Total,Human,6652,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.910022612970051e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2017,Total,Human,5565,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.6198414542383272e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2018,Total,Human,5374.5,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.527766852687656e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2019,Total,Human,5328,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.5391106846134748e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoprenaline,2016,Total,Human,6.9,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.981232115077173e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2017,Total,Human,8.89,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.587671253940473e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2018,Total,Human,8.21,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.3337921407694967e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2019,Total,Human,6.6,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.9065560282374125e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isosorbide dinitrate,2016,Total,Human,8179.22,MOYKHGMNXAOIAT-JGWLITMVSA-N,2.348541063808915e-9,cardiac,nitrate for angina,NA,NA,NA,NA
isosorbide mononitrate,2016,Total,Human,384007.5385,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.1026203879825129e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2017,Total,Human,375319.61719999986,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0924676990645467e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2018,Total,Human,355909.5727,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0117161554103408e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2019,Total,Human,330703.8683,YWXYYJSYQOXTPL-SLPGGIOYSA-N,9.553112934375701e-8,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isotretinoin,2016,Total,Human,66031.8,SHGAZHPCJJPHSC-XFYACQKRSA-N,1.8960046779181575e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2017,Total,Human,71597.4,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.0840330015396805e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2018,Total,Human,80914.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.300084336621817e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2019,Total,Human,88999.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.5709388070955626e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isradipine,2016,Total,Human,665.265,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.9102092507779935e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2017,Total,Human,629.785,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.83315696362531e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2018,Total,Human,212.305,HMJIYCCIJYRONP-UHFFFAOYSA-N,6.03502728923347e-11,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
itraconazole,2016,Total,Human,979.2,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.811626792874736e-10,antifungal,azole antifungal,high,high,0.001,2.811626792874736e-7
itraconazole,2016,Total,Vet,143.38,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4.116942908112537e-11,antifungal,azole antifungal,high,high,0.001,4.1169429081125365e-8
itraconazole,2017,Total,Human,787.6,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.2925195496102548e-10,antifungal,azole antifungal,high,high,0.001,2.2925195496102546e-7
itraconazole,2017,Total,Vet,147.5,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4.293380314468163e-11,antifungal,azole antifungal,high,high,0.001,4.293380314468163e-8
itraconazole,2018,Total,Human,882.8,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.5094661411343616e-10,antifungal,azole antifungal,high,high,0.001,2.5094661411343614e-7
itraconazole,2018,Total,Vet,53.56,VHVPQPYKVGDNFY-ZPGVKDDISA-N,1.5225080031621708e-11,antifungal,azole antifungal,high,high,0.001,1.5225080031621707e-8
itraconazole,2019,Total,Human,865.2,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.4993216297439537e-10,antifungal,azole antifungal,high,high,0.001,2.499321629743954e-7
itraconazole,2019,Total,Vet,97.76,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.8240138987952948e-11,antifungal,azole antifungal,high,high,0.001,2.8240138987952946e-8
ivabradine,2016,Total,Human,252.77,ACRHBAYQBXXRTO-OAQYLSRUSA-N,7.257913648232709e-11,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2017,Total,Human,358.8172,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.0444330189644651e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2018,Total,Human,415.38,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.1807680626465693e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2019,Total,Human,567,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.6379049515312314e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivacaftor,2016,Total,Human,1848,PURKAOJPTOLRMP-UHFFFAOYSA-N,5.306256447337124e-10,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2017,Total,Human,4300.8,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.2518623767094694e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2018,Total,Human,5390,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.5321729158036032e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2019,Total,Human,6815.2,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.9687213096429715e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivermectin,2016,Total,Human,2397,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.882628086724613e-10,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2016,Total,Vet,21872.320855,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.280310798434522e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2017,Total,Human,4034.1,AZSNMRSAGSSBNP-XPNPUAGNSA-N,1.1742322390912555e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2017,Total,Vet,21223.830293,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.177761028988425e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2018,Total,Human,5319.6,AZSNMRSAGSSBNP-XPNPUAGNSA-N,1.5121608613931074e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2018,Total,Vet,21035.707825,AZSNMRSAGSSBNP-XPNPUAGNSA-N,5.979655249392009e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2019,Total,Human,6941.7,AZSNMRSAGSSBNP-XPNPUAGNSA-N,2.0052636335175223e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2019,Total,Vet,20507.764439,AZSNMRSAGSSBNP-XPNPUAGNSA-N,5.924121502552771e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ixazomib,2017,Total,Human,0.012,MXAYKZJJDUDWDS-LBPRGKRZSA-N,3.4929195778724047e-15,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2018,Total,Human,0.24,MXAYKZJJDUDWDS-LBPRGKRZSA-N,6.822291276305471e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2019,Total,Human,0.192,MXAYKZJJDUDWDS-LBPRGKRZSA-N,5.546344809417927e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ketamine,2016,Total,Human,9954.5,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.858286244860249e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2017,Total,Human,10247.3,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.9827495658609903e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2017,Total,Vet,950,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.765227999148987e-10,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2018,Total,Human,10124.7,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.8780688535504166e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2018,Total,Vet,2530,YQEZLKZALYSWHR-UHFFFAOYSA-N,7.191832053772016e-10,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2019,Total,Human,11634.2,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.3607960823817732e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2019,Total,Vet,130,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.7553376313767216e-11,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketobemidone,2016,Total,Human,11949.92,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.4312413444352184e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2017,Total,Human,9811.485,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.8558940037084523e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2018,Total,Human,9591.935,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7266239363912132e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2019,Total,Human,9099.27,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.628525465312097e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketoconazole,2016,Total,Human,175112.4,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.028091458380289e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2016,Total,Vet,820,XMAYWYJOQHXEEK-OZXSUGGESA-N,2.354507730961278e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,Total,Human,176623.80000000002,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.1411060744851666e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,Total,Vet,372,XMAYWYJOQHXEEK-OZXSUGGESA-N,1.0828050691404451e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,Total,Human,190870.2,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.4257170848611686e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,Total,Vet,608,XMAYWYJOQHXEEK-OZXSUGGESA-N,1.7283137899973855e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,Total,Human,221774.52,XMAYWYJOQHXEEK-OZXSUGGESA-N,6.406447697203918e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,Total,Vet,524,XMAYWYJOQHXEEK-OZXSUGGESA-N,1.5136899375703094e-10,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoprofen,2016,Total,Human,275090.3,DKYWVDODHFEZIM-UHFFFAOYSA-N,7.89880778124948e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2016,Total,Vet,39083.6,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.122227296997539e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2017,Total,Human,260377,DKYWVDODHFEZIM-UHFFFAOYSA-N,7.578966007730691e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2017,Total,Vet,40776.8,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.1869173586915622e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2018,Total,Human,243322.6,DKYWVDODHFEZIM-UHFFFAOYSA-N,6.916740213783189e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2018,Total,Vet,43647.6,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.2407360029652945e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2019,Total,Human,228045.9,DKYWVDODHFEZIM-UHFFFAOYSA-N,6.58761038423979e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2019,Total,Vet,51828.8,DKYWVDODHFEZIM-UHFFFAOYSA-N,1.497189561762291e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketorolac,2016,Total,Human,1791.15,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.143020149160112e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2017,Total,Human,1966.53,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.724109281227848e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2018,Total,Human,2210.76,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.284353609168783e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2019,Total,Human,2277.54,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.579178206896721e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketotifen,2016,Total,Human,160.172,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4.599100149799144e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2017,Total,Human,176.0345,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,5.123952928591498e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2018,Total,Human,180.64325,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,5.135003619160285e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2019,Total,Human,250.25525,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,7.229176598266072e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
labetalol,2016,Total,Human,207503.95,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.9581665180488116e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2017,Total,Human,207948.35,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.052890524177192e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2018,Total,Human,206306.84999999992,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.864522595821087e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2019,Total,Human,213303.15,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.161733431432258e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
lacosamide,2016,Total,Human,59488.407,VPPJLAIAVCUEMN-GFCCVEGCSA-N,1.7081209046837927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,1.7081209046837927e-5
lacosamide,2017,Total,Human,69342.464,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.01839708402927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.01839708402927e-5
lacosamide,2018,Total,Human,74852.92,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.1277850963416305e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.1277850963416306e-5
lacosamide,2019,Total,Human,92119.712,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.6610817005014293e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.6610817005014292e-5
lamivudine,2016,Total,Human,118844.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.4124397387982256e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.4124397387982256e-5
lamivudine,2017,Total,Human,130937.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.8112817327975845e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.8112817327975845e-5
lamivudine,2018,Total,Human,137233.2,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.90102026324785e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.90102026324785e-5
lamivudine,2019,Total,Human,140562,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4.0604443703198054e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,4.060444370319805e-5
lamotrigine,2016,Total,Human,2377299.3282,PYZRQGJRPPTADH-UHFFFAOYSA-N,6.826060545190186e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004550707030126791
lamotrigine,2017,Total,Human,2487666.8492,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.241016867329032e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004827344578219355
lamotrigine,2018,Total,Human,2516154.5068,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.152474558990972e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004768316372660649
lamotrigine,2019,Total,Human,2623016.7694,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.577164293738475e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.005051442862492317
lansoprazole,2016,Total,Human,292300.8531,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.392983151103988e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2017,Total,Human,283156.6404,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.2420281071478007e-08,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2018,Total,Human,267404.1549,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.601287638425445e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2019,Total,Human,261259.5957,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.547061471465214e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lapatinib,2016,Total,Human,4305,BCFGMOOMADDAQU-UHFFFAOYSA-N,1.236116558754671e-9,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.01236116558754671
lapatinib,2017,Total,Human,2373,BCFGMOOMADDAQU-UHFFFAOYSA-N,6.907248465242679e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.006907248465242679
lapatinib,2018,Total,Human,1323,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.76078806606339e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.00376078806606339
lapatinib,2019,Total,Human,1155,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.3364730494154715e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.0033364730494154717
latanoprost,2016,Total,Human,54.728325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.571442247744651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2017,Total,Human,55.9576,GGXICVAJURFBLW-CEYXHVGTSA-N,1.6287949714229405e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2018,Total,Human,57.58145,GGXICVAJURFBLW-CEYXHVGTSA-N,1.636822600050082e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2019,Total,Human,60.533325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.7486390255758248e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
ledipasvir,2016,Total,Human,1960.56,VRTWBAAJJOHBQU-KMWAZVGDSA-N,5.62945570367493e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2017,Total,Human,216.72,VRTWBAAJJOHBQU-KMWAZVGDSA-N,6.308212757637562e-11,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2018,Total,Human,549.36,VRTWBAAJJOHBQU-KMWAZVGDSA-N,1.5616224731463223e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2019,Total,Human,3354.12,VRTWBAAJJOHBQU-KMWAZVGDSA-N,9.68911773550253e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
leflunomide,2016,Total,Human,10861.2,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.118631630184955e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011812998599185435
leflunomide,2017,Total,Human,10776.8,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.13687464223461e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.001188210091755534
leflunomide,2018,Total,Human,10363,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.945808520681399e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011158365608641661
leflunomide,2019,Total,Human,8645,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.4972995248655198e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,9.459467897217878e-4
lenalidomide,2016,Total,Human,1184.7675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,3.4018832172459336e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2017,Total,Human,1734.9675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.050084956435282e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2018,Total,Human,2057.9475,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.84996553181027e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2019,Total,Human,2054.115,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.933765660519534e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenvatinib,2016,Total,Human,13.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,3.824639387366369e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2017,Total,Human,14.94,WOSKHXYHFSIKNG-UHFFFAOYSA-N,4.348684874451143e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2018,Total,Human,43.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.2314235753731374e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2019,Total,Human,48.84,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.4108514608956851e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lercanidipine,2016,Total,Human,207515.2234,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,5.9584902169202033e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2017,Total,Human,213714.6424,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.220733820974667e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2018,Total,Human,231386.8572,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.57745223886375e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2019,Total,Human,259667.2152,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,7.50106203750275e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lesinurad,2018,Total,Human,126,FGQFOYHRJSUHMR-UHFFFAOYSA-N,3.5817029200603715e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
lesinurad,2019,Total,Human,264,FGQFOYHRJSUHMR-UHFFFAOYSA-N,7.626224112949649e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
letermovir,2019,Total,Human,376.32,FWYSMLBETOMXAG-QHCPKHFHSA-N,1.0870835826459135e-10,antiviral,antiviral for prevention of cytomegalovirus infection after bone marrow transplants,NA,NA,NA,NA
letrozole,2016,Total,Human,6260.475,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.797602047193879e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.035952040943877585
letrozole,2017,Total,Human,6850.075,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.9938967564495253e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.03987793512899051
letrozole,2018,Total,Human,7181.225,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.041350361278614e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.04082700722557229
letrozole,2019,Total,Human,7892.875,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.2800315774809646e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.0456006315496193
leuprorelin,2016,Total,Human,138.3825,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.973447147314013e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2017,Total,Human,121.35875,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.532469615176022e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2018,Total,Human,106.8375,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.036985600967857e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2019,Total,Human,100.965,GFIJNRVAKGFPGQ-LIJARHBVSA-N,2.9165974150150054e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
levetiracetam,2016,Total,Human,4353771.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.2501205677547414e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2017,Total,Human,4592883,HPHUVLMMVZITSG-LURJTMIESA-N,1.3368809124647785e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2018,Total,Human,4874655.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.38567998719352e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2019,Total,Human,5139031.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.48452295236772e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levocabastine,2016,Total,Human,1655.514,ZCGOMHNNNFPNMX-YHYDXASRSA-N,4.753561599651986e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,4.7535615996519857e-5
levocabastine,2017,Total,Human,1899.112,ZCGOMHNNNFPNMX-YHYDXASRSA-N,5.527871237810347e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,5.527871237810347e-5
levocabastine,2018,Total,Human,1890.018,ZCGOMHNNNFPNMX-YHYDXASRSA-N,5.37260554727513e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,5.37260554727513e-5
levocabastine,2019,Total,Human,2235.8095000000003,ZCGOMHNNNFPNMX-YHYDXASRSA-N,6.458630424568903e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,6.458630424568902e-5
levocetirizine,2016,Total,Human,710.082,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0388945836785928e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2017,Total,Human,766.039499999999,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.2297619724779864e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2018,Total,Human,713.385,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0278834425613237e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2019,Total,Human,715.95,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0681799824493566e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levofloxacin,2017,Total,Human,40.32,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.173620978165128e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,1.5859742948177405e-6
levofloxacin,2018,Total,Human,53.76,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.5281932458924248e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,2.0651260079627363e-6
levofloxacin,2019,Total,Human,134.4,GSDSWSVVBLHKDQ-JTQLQIEISA-N,3.882441366592549e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,5.246542387287228e-6
levomepromazine,2016,Total,Human,102377.38,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.939613813238543e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2017,Total,Human,92423.555,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.6902337059672243e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2018,Total,Human,85520.88999999998,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.4310350907869983e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2019,Total,Human,74070.30500000001,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.1396846441080873e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomethadone,2016,Total,Human,169.915,USSIQXCVUWKGNF-QGZVFWFLSA-N,4.878855867149824e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2017,Total,Human,310.805,USSIQXCVUWKGNF-QGZVFWFLSA-N,9.046807245005271e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2018,Total,Human,449.595,USSIQXCVUWKGNF-QGZVFWFLSA-N,1.2780283526543988e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2019,Total,Human,765.625,USSIQXCVUWKGNF-QGZVFWFLSA-N,2.211677210786771e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levonorgestrel,2016,Total,Human,7285.4594,WWYNJERNGUHSAO-XUDSTZEESA-N,2.0919110342566478e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,209.19110342566478
levonorgestrel,2017,Total,Human,7441.77875,WWYNJERNGUHSAO-XUDSTZEESA-N,2.1661278908391526e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,216.61278908391526
levonorgestrel,2018,Total,Human,7294.26755,WWYNJERNGUHSAO-XUDSTZEESA-N,2.073484078058461e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,207.3484078058461
levonorgestrel,2019,Total,Human,7379.2009,WWYNJERNGUHSAO-XUDSTZEESA-N,2.131645448404536e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,213.16454484045363
levosimendan,2016,Total,Human,15.0375,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.3177939029671e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2017,Total,Human,15.15,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.4098109670639096e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2018,Total,Human,14.4875,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.118247702728146e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2019,Total,Human,16.3625,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.7266701533385855e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levothyroxine sodium,2016,Total,Human,7200.401575,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.0674879480930807e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2016,Total,Vet,187.85,YDTFRJLNMPSCFM-YDALLXLXSA-M,5.3938326495253176e-11,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2017,Total,Human,6888.65885,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.0051276135374168e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2017,Total,Vet,244.75,YDTFRJLNMPSCFM-YDALLXLXSA-M,7.124100555702258e-11,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2018,Total,Human,7289.32385,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.072078771334183e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2018,Total,Vet,290.28,YDTFRJLNMPSCFM-YDALLXLXSA-M,8.251561298691466e-11,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2019,Total,Human,7354.0511,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.124380372222875e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2019,Total,Vet,351.62,YDTFRJLNMPSCFM-YDALLXLXSA-M,1.015732167649756e-10,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
lidocaine,2016,Total,Human,574369.24,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.649215629276041e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2016,Total,Vet,63792,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.8316921606522176e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,Total,Human,564316.064,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.6425921900445808e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,Total,Vet,62688,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.8247011874805442e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,Total,Human,564160.8,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.603695543447298e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,Total,Vet,57816,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.6434899684619878e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,Total,Human,596744.75,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.7238292430780722e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,Total,Vet,53640.48,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.549523946993157e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
linagliptin,2016,Total,Human,10846.965,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.1145442621910243e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,9.73295081934695e-6
linagliptin,2017,Total,Human,12320.0925,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.586091024537414e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.1206534451679418e-5
linagliptin,2018,Total,Human,12987.468,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.6918454015706853e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.153701687990839e-5
linagliptin,2019,Total,Human,13415.778,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.875444305968918e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.2110763456152868e-5
linezolid,2016,Total,Human,22374,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.4243604844545905e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2017,Total,Human,21606,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.2890016999592645e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2018,Total,Human,22014,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.257746673191193e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2019,Total,Human,23940,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.915598684242978e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
liothyronine sodium,2016,Total,Human,40.16572,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.153298759263732e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2017,Total,Human,45.3151,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3190166663603817e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2018,Total,Human,46.2898,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3158437446746874e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2019,Total,Human,58.48984,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.6896084400400264e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
lipegfilgrastim,2016,Total,Human,20.958,GAQMWPRWVIGRRV-IVDGIBIRSA-N,6.017777198230056e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2017,Total,Human,7.524,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.1900605753259976e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2018,Total,Human,71.616,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.0357717168495523e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2019,Total,Human,38.256,GAQMWPRWVIGRRV-IVDGIBIRSA-N,1.1051092032765219e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lisdexamfetamine,2016,Total,Human,45990.978,VOBHXZCDAVEXEY-JSGCOSHPSA-N,1.320562356774025e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2017,Total,Human,74352.40800000001,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.1642248463763068e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2018,Total,Human,105380.181,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.995559539715798e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2019,Total,Human,157686.582,VOBHXZCDAVEXEY-JSGCOSHPSA-N,4.5551258103674713e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisinopril,2016,Total,Human,151188.9495,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.3411652491910275e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.61763770765919e-4
lisinopril,2017,Total,Human,144476.25209999998,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.2053660791476584e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.504471732623049e-4
lisinopril,2018,Total,Human,137568.0606,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.9105390822068435e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.258782568505703e-4
lisinopril,2019,Total,Human,132054.1359,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.814675891724659e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.178896576437216e-4
loperamide,2016,Total,Human,28241.56,RDOIQAHITMMDAJ-UHFFFAOYSA-N,8.109142848098388e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.6218285696196775e-4
loperamide,2017,Total,Human,29913.697,RDOIQAHITMMDAJ-UHFFFAOYSA-N,8.707178158153583e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.7414356316307165e-4
loperamide,2018,Total,Human,31272.093999999997,RDOIQAHITMMDAJ-UHFFFAOYSA-N,8.889472253666859e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.7778944507333715e-4
loperamide,2019,Total,Human,32530.941000000003,RDOIQAHITMMDAJ-UHFFFAOYSA-N,9.397282070876609e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.8794564141753217e-4
lopinavir,2016,Total,Human,27612,KJHKTHWMRKYKJE-SUGCFTRWSA-N,7.928374081378391e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2017,Total,Human,17604,KJHKTHWMRKYKJE-SUGCFTRWSA-N,5.124113020738817e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2018,Total,Human,11149.2,KJHKTHWMRKYKJE-SUGCFTRWSA-N,3.1692954124077063e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2019,Total,Human,9900,KJHKTHWMRKYKJE-SUGCFTRWSA-N,2.8598340423561183e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
loratadine,2016,Total,Human,115440.23,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.3146940731579034e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2017,Total,Human,114493.81,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.3326472541183606e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2018,Total,Human,111358.04,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.1654874368269816e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2019,Total,Human,114115.56,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.2964804368740634e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
losartan,2016,Total,Human,3027866.1195,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.694066081315213e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.694066081315212e-4
losartan,2017,Total,Human,3039786.7165,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.848108778849434e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.848108778849434e-4
losartan,2018,Total,Human,3032960.4255,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.621558105111824e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.621558105111823e-4
losartan,2019,Total,Human,3082248.4125,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.903756502086469e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.903756502086469e-4
lovastatin,2016,Total,Human,7570.83319999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.1738518657583276e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2017,Total,Human,7141.514799999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.0787280717154603e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2018,Total,Human,7115.6232,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.022702253451534e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2019,Total,Human,6928.0512,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.001320875651127e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
loxapine,2016,Total,Human,0.4732,XJGVXQDUIWGIRW-UHFFFAOYSA-N,1.3587232418181425e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2017,Total,Human,1.4651,XJGVXQDUIWGIRW-UHFFFAOYSA-N,4.2645637279507163e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2018,Total,Human,0.3003,XJGVXQDUIWGIRW-UHFFFAOYSA-N,8.53639195947722e-14,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
lumacaftor,2016,Total,Human,1344,UFSKUSARDNFIRC-UHFFFAOYSA-N,3.8590955980633625e-10,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2017,Total,Human,5040,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.4670262227064096e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2018,Total,Human,6608,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.8784041980761063e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2019,Total,Human,8512,UFSKUSARDNFIRC-UHFFFAOYSA-N,2.458879532175281e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lurasidone,2016,Total,Human,4085.01016,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.1729497564360203e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2017,Total,Human,5081.82864,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.479201562337391e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2018,Total,Human,6887.00166,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.9577138060383033e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2019,Total,Human,9104.99996,PQXKDMSYBGKCJA-CVTJIBDQSA-N,2.630180691036272e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lymecycline,2016,Total,Human,1073133.9,PZTCVADFMACKLU-UEPZRUIBSA-N,3.081343980373935e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2017,Total,Human,1097286.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.193944873064205e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2018,Total,Human,1083620.4,PZTCVADFMACKLU-UEPZRUIBSA-N,3.080322500727768e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2019,Total,Human,1146855.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.312946148027023e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
macitentan,2016,Total,Human,356.7,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.0242108629681559e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2017,Total,Human,436.8,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.2714227263455548e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2018,Total,Human,479.1,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.3618998960324794e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2019,Total,Human,525.6,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.5183118915781576e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macrogol,2016,Total,Human,89406689.94266,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.5671797886542795e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.027022945143729257
macrogol,2017,Total,Human,107272347.2196,LYCAIKOWRPUZTN-UHFFFAOYSA-N,3.122447348063893e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.03286786682172519
macrogol,2018,Total,Human,119421168.12416,LYCAIKOWRPUZTN-UHFFFAOYSA-N,3.39469163958194e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.035733596206125685
macrogol,2019,Total,Human,133176128.11248,LYCAIKOWRPUZTN-UHFFFAOYSA-N,3.84708711924495e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.04049565388678895
malathion,2016,Total,Human,8060.525,JXSJBGJIGXNWCI-UHFFFAOYSA-N,2.3144595644032507e-9,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
malathion,2017,Total,Human,2174.975,JXSJBGJIGXNWCI-UHFFFAOYSA-N,6.33084396573586e-10,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
maraviroc,2016,Total,Human,855,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.4550050121608447e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.668483708870483e-7
maraviroc,2017,Total,Human,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1481455403915282e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3349408047734003e-7
maraviroc,2018,Total,Human,954,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.7118607823314245e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.9476747634037224e-7
maraviroc,2019,Total,Human,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1318762861200159e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3172568327391477e-7
maropitant,2016,Total,Vet,756.792,OMPCVMLFFSQFIX-CONSDPRKSA-N,2.173015383816643e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2017,Total,Vet,1060.856,OMPCVMLFFSQFIX-CONSDPRKSA-N,3.0879039097528395e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2018,Total,Vet,1442.464,OMPCVMLFFSQFIX-CONSDPRKSA-N,4.100378984826955e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2019,Total,Vet,1906.536,OMPCVMLFFSQFIX-CONSDPRKSA-N,5.507451066441885e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
mavacoxib,2016,Total,Vet,159.82,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.588992994661359e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2017,Total,Vet,170.18,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.953542114686048e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2018,Total,Vet,114.23,TTZNQDOUNXBMJV-UHFFFAOYSA-N,3.2471263853848907e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2019,Total,Vet,61.95,TTZNQDOUNXBMJV-UHFFFAOYSA-N,1.7895628174137533e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mebendazole,2016,Total,Human,61423.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.7636756007363508e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20041768190185807
mebendazole,2017,Total,Human,63877.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.859316020497259e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.21128591142014308
mebendazole,2018,Total,Human,62027.4,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.763204124632958e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20036410507192706
mebendazole,2019,Total,Human,65777.40000000001,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.9001257347239938e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.2159233789459084
mecillinam,2016,Total,Human,11634,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.340529627073598e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2017,Total,Human,11510,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.3502920284426143e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2018,Total,Human,4429,BWWVAEOLVKTZFQ-NTZNESFSSA-N,1.258997002614872e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2019,Total,Human,7300,BWWVAEOLVKTZFQ-NTZNESFSSA-N,2.108766516080774e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
meclozine,2016,Total,Human,62298.6,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.7888114064398083e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2017,Total,Human,72859.975,OCJYIGYOJCODJL-UHFFFAOYSA-N,2.1207836093399495e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2018,Total,Human,83020.075,OCJYIGYOJCODJL-UHFFFAOYSA-N,2.359946389294691e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2019,Total,Human,83509.225,OCJYIGYOJCODJL-UHFFFAOYSA-N,2.4123487323815825e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
medetomidine,2016,Total,Vet,80.34,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.3068433061637697e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2017,Total,Vet,76.09,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.2148020890025934e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2018,Total,Vet,69.92,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9875608584969936e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2019,Total,Vet,65.86,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9025118184805452e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medroxyprogesterone acetate,2016,Total,Human,13012.812,PSGAAPLEWMOORI-PEINSRQWSA-N,3.736434933603133e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2016,Total,Vet,4201.5999999999995,PSGAAPLEWMOORI-PEINSRQWSA-N,1.2064267905374272e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2017,Total,Human,12746.064,PSGAAPLEWMOORI-PEINSRQWSA-N,3.710081373867887e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2017,Total,Vet,3708.8,PSGAAPLEWMOORI-PEINSRQWSA-N,1.0795450108677643e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2018,Total,Human,13125.68,PSGAAPLEWMOORI-PEINSRQWSA-N,3.731133839982383e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2018,Total,Vet,1931.4,PSGAAPLEWMOORI-PEINSRQWSA-N,5.490238904606826e-10,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2019,Total,Human,14449.096,PSGAAPLEWMOORI-PEINSRQWSA-N,4.173941072936527e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2019,Total,Vet,0.1,PSGAAPLEWMOORI-PEINSRQWSA-N,2.88872125490517e-14,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
mefloquine,2016,Total,Human,8634,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.4791243596487406e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2017,Total,Human,8060,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.346077649804298e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2018,Total,Human,7916,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.250219072634754e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2019,Total,Human,7282,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.103566817821945e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
megestrol acetate,2016,Total,Human,5134.128,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.4741883009444832e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2017,Total,Human,4752.24,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.3832660112290292e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2018,Total,Human,5703.456,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.621276588066337e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2019,Total,Human,2689.824,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,7.770151760754046e-10,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
meglumine amidotrizoate,2016,Total,Human,1.51536,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.351130286816442e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2017,Total,Human,1.40118,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.078507545102713e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2018,Total,Human,1.30746,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.7166137300493133e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2019,Total,Human,1.19988,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.466118859335616e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
melatonin,2016,Total,Human,15101.247,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.33609790349461e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2017,Total,Human,16070.9346,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.677873508253918e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2018,Total,Human,16984.3194,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.827998919858573e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2019,Total,Human,18836.218200000003,DRLFMBDRBRZALE-UHFFFAOYSA-N,5.441258387637162e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
meloxicam,2016,Total,Human,14181.045,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,4.071875620196314e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2016,Total,Vet,47618.354,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.3672900320567182e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2017,Total,Human,12728.6625,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,3.705016203865025e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2017,Total,Vet,51174.7995,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.4895788255603744e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2018,Total,Human,11115.81,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,3.159803899669546e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2018,Total,Vet,51568.2015,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.465888713450886e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2019,Total,Human,4957.8225,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.432176723379709e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2019,Total,Vet,58075.633,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.6776431543917213e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
melphalan,2016,Total,Human,53.05,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.5232516478962898e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2017,Total,Human,46,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.3389525048510883e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2018,Total,Human,33.5,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,9.522781573176384e-12,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2019,Total,Human,38.4,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.1092689618835856e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
memantine,2016,Total,Human,33363.1714,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.579737193986122e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2017,Total,Human,32400.4736,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.431020714148164e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2018,Total,Human,31011.5332,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.815404683967393e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2019,Total,Human,30630.0316,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.848162332133703e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
menbutone,2019,Total,Vet,900,FHGJSJFIQNQBCK-UHFFFAOYSA-N,2.5998491294146534e-10,alimentary,choleretic veterinary bile excretion stimulator,NA,NA,NA,NA
mepivacaine,2016,Total,Human,7922.4,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.2747990302155646e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2016,Total,Vet,36,INWLQCZOYSRPNW-UHFFFAOYSA-N,1.0336863209098294e-11,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2017,Total,Human,7439.7,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.165522815291444e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2017,Total,Vet,1176,INWLQCZOYSRPNW-UHFFFAOYSA-N,3.4230611863149555e-10,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2018,Total,Human,8097.6,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.3018410766254652e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2018,Total,Vet,1750.8,INWLQCZOYSRPNW-UHFFFAOYSA-N,4.976861486064841e-10,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2019,Total,Human,7316.1,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.113417357301172e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2019,Total,Vet,1779,INWLQCZOYSRPNW-UHFFFAOYSA-N,5.139035112476298e-10,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mercaptopurine,2016,Total,Human,5904.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.6953173500644054e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2017,Total,Human,6181.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.7992174283936496e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2018,Total,Human,6047.5,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.719075270560722e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2019,Total,Human,5930.75,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.713228358252884e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
meropenem,2016,Total,Human,152350,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4.374503083072569e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2017,Total,Human,136675,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.9782898608809246e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2018,Total,Human,129585,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.683610896000185e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2019,Total,Human,124545,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.5977578869216446e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
mesna,2016,Total,Human,20386,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.85353592724105e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2017,Total,Human,18418,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.361049398771162e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2018,Total,Human,19076,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.422584516116798e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2019,Total,Human,18950,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.474126778045298e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
metamizole sodium,2016,Total,Vet,32750,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.40367416938803e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2017,Total,Vet,34150,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.940266965361884e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2018,Total,Vet,31700,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.011109727453477e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2019,Total,Vet,33100,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.561667353736114e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metformin,2016,Total,Human,69488813.456,XZWYZXLIPXDOLR-UHFFFAOYSA-N,1.9952676646033913e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.019952676646033913
metformin,2017,Total,Human,73431045.754,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1374061444815902e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021374061444815903
metformin,2018,Total,Human,74897300.814,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1290466748424115e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021290466748424115
metformin,2019,Total,Human,78024938.926,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.25392299488214e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.0225392299488214
methadone,2016,Total,Human,97993.623,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.813740767541523e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2016,Total,Vet,9.3,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.67035632901706e-12,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2017,Total,Human,96735.085,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8157322688637596e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2017,Total,Vet,44.6,USSIQXCVUWKGNF-UHFFFAOYSA-N,1.298201776442577e-11,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2018,Total,Human,95331.685,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.7099188455458378e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2018,Total,Vet,79.8,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.2684118493715688e-11,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2019,Total,Human,98344.18,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8408892306221993e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2019,Total,Vet,101.8,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.940718237493463e-11,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methenamine,2016,Total,Human,15596938,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.478428182966309e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2017,Total,Human,15766796,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.5893458690600255e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2018,Total,Human,15759884,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.479938297032757e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2019,Total,Human,13120813,VKYKSIONXSXAKP-UHFFFAOYSA-N,3.7902371394736073e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methoprene,2016,Total,Vet,3529.836,NFGXHKASABOEEW-LDRANXPESA-N,1.0135397745152971e-9,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2017,Total,Vet,2461.1454,NFGXHKASABOEEW-LDRANXPESA-N,7.163819126375508e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2018,Total,Vet,2021.0688,NFGXHKASABOEEW-LDRANXPESA-N,5.745133351272152e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2019,Total,Vet,1957.203,NFGXHKASABOEEW-LDRANXPESA-N,5.653813906264164e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoxsalen,2019,Total,Human,0.0576,QXKHYNVANLEOEG-UHFFFAOYSA-N,1.663903442825378e-14,dermatological,psoralen agent used with ultraviolet light A for psoriasis,NA,NA,NA,NA
methyl aminolevulinate,2016,Total,Human,1325.44,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.805803325518678e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2017,Total,Human,1259.2,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.6652369437141094e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2018,Total,Human,1025.92,YUUAYBAIHCDHHD-UHFFFAOYSA-N,2.9163021109113783e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2019,Total,Human,1140.48,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.294528816794249e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methylnaltrexone bromide,2016,Total,Human,129.564,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.7202370689544754e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2017,Total,Human,124.5,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.623904062042619e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2018,Total,Human,46.355999999999995,IFGIYSGOEZJNBE-KNLJMPJLSA-N,1.3177255600184014e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2019,Total,Human,97.212,IFGIYSGOEZJNBE-KNLJMPJLSA-N,2.8081837063184145e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylphenidate,2016,Total,Human,449505.8977,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.290689160057731e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2017,Total,Human,471897.4314,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3735831474039664e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2018,Total,Human,476990.1956,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3559025209688e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2019,Total,Human,494619.477,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.4288177962999792e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylprednisolone,2016,Total,Human,25117.601,VHRSUDSXCMQTMA-PJHHCJLFSA-N,7.2121446021586255e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2017,Total,Human,22609.799,VHRSUDSXCMQTMA-PJHHCJLFSA-N,6.5811841315716595e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2018,Total,Human,20784.897,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.9083592284169894e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2019,Total,Human,18925.627,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.467086097730718e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylrosaniline,2016,Total,Human,2093.2799999999997,QFVDKARCPMTZCS-UHFFFAOYSA-N,6.010541393983686e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2016,Total,Vet,710,QFVDKARCPMTZCS-UHFFFAOYSA-N,2.0386591329054967e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2017,Total,Human,1951.62,QFVDKARCPMTZCS-UHFFFAOYSA-N,5.680709755472784e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2017,Total,Vet,600,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.7464597889362018e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2018,Total,Human,713.4,QFVDKARCPMTZCS-UHFFFAOYSA-N,2.0279260818818006e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2018,Total,Vet,65,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.8477038873327316e-11,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2019,Total,Human,614.28,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.774483692463148e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
metoclopramide,2016,Total,Human,64982.585,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.865878033662785e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2016,Total,Vet,0.625,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.7945943071351206e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2017,Total,Human,64692.28,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8830410945766948e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2017,Total,Vet,1,TTWJBBZEZQICBI-UHFFFAOYSA-N,2.910766314893671e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2018,Total,Human,64784.445,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8415764748491313e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2018,Total,Vet,1.05,TTWJBBZEZQICBI-UHFFFAOYSA-N,2.9847524333836434e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2019,Total,Human,65946.56,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.905012295598791e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2019,Total,Vet,1.15,TTWJBBZEZQICBI-UHFFFAOYSA-N,3.3220294431409464e-13,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoprolol,2016,Total,Human,6866147.1280000005,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.971511767657754e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2700701051585964
metoprolol,2017,Total,Human,6845990.6295,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.992707891642631e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2729736837866618
metoprolol,2018,Total,Human,6856705.0345,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.949101622544548e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.26700022226637643
metoprolol,2019,Total,Human,6798429.0755,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.963876657036216e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2690241995940022
metronidazole,2016,Total,Human,993152.825,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.8516902493762604e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02281352199501008
metronidazole,2017,Total,Human,1004363.73,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.923468113184961e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.023387744905479686
metronidazole,2018,Total,Human,959935.85,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.7287341563616154e-07,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02182987325089292
metronidazole,2019,Total,Human,987940.2,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.853883854315265e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02283107083452212
metyrapone,2016,Total,Human,325,FJLBFSROUSIWMA-UHFFFAOYSA-N,9.331890397102626e-11,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2017,Total,Human,1712.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,4.98468731425541e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2018,Total,Human,3100,FJLBFSROUSIWMA-UHFFFAOYSA-N,8.812126231894564e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2019,Total,Human,2187.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,6.31907774510506e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
mianserin,2016,Total,Human,173771.217,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.9895813883542663e-08,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2017,Total,Human,165837.76499999998,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.8271498009925243e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2018,Total,Human,149158.389,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.240008233593657e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2019,Total,Human,156068.376,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.50838034969732e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
micafungin,2016,Total,Human,384.3,PIEUQSKUWLMALL-YABMTYFHSA-N,1.1034601475712428e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2017,Total,Human,607.1999999999999,PIEUQSKUWLMALL-YABMTYFHSA-N,1.7674173064034363e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2018,Total,Human,335.65000000000003,PIEUQSKUWLMALL-YABMTYFHSA-N,9.541258612049711e-11,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2019,Total,Human,349.85,PIEUQSKUWLMALL-YABMTYFHSA-N,1.0106191310285739e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
miconazole,2016,Total,Human,71865.6976006512,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.0635163486787636e-8,antifungal,azole antifungal,high,high,2e-7,0.10317581743393818
miconazole,2016,Total,Vet,9780,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.808181171805036e-9,antifungal,azole antifungal,high,high,2e-7,0.01404090585902518
miconazole,2017,Total,Human,75101.8795291108,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.1860402111853822e-8,antifungal,azole antifungal,high,high,2e-7,0.10930201055926911
miconazole,2017,Total,Vet,7985,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.3242469024425952e-9,antifungal,azole antifungal,high,high,2e-7,0.011621234512212976
miconazole,2018,Total,Human,75830.40361369439,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.1555712543851257e-8,antifungal,azole antifungal,high,high,2e-7,0.10777856271925629
miconazole,2018,Total,Vet,7560,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.149021752036223e-9,antifungal,azole antifungal,high,high,2e-7,0.010745108760181116
miconazole,2019,Total,Human,83889.34381461496,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.423329305373258e-8,antifungal,azole antifungal,high,high,2e-7,0.12116646526866291
miconazole,2019,Total,Vet,7545,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.179540186825951e-9,antifungal,azole antifungal,high,high,2e-7,0.010897700934129756
midazolam,2016,Total,Human,6162.6,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.769498700344143e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2017,Total,Human,6242.8,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8171331950618206e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2018,Total,Human,6157.85,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.7504435973249015e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2019,Total,Human,6539.32,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8890272676626482e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midodrine,2019,Total,Human,340.25,PTKSEFOSCHHMPD-UHFFFAOYSA-N,9.828874069814841e-11,cardiac,"antihypotensive, constricts blood vessels",NA,NA,NA,NA
midostaurin,2018,Total,Human,72.8,BMGQWWVMWDBQGC-IIFHNQTCSA-N,2.0694283538126592e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
midostaurin,2019,Total,Human,61.6,BMGQWWVMWDBQGC-IIFHNQTCSA-N,1.779452293021585e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
mifepristone,2016,Total,Human,2740.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.8697985231935e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2017,Total,Human,2626.4,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.644836649436736e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2018,Total,Human,2763.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.856436928938774e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2019,Total,Human,2751,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.946872172244123e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
miglustat,2016,Total,Human,630,UQRORFVVSGFNRO-UTINFBMNSA-N,1.8089510615922014e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2017,Total,Human,814.8,UQRORFVVSGFNRO-UTINFBMNSA-N,2.3716923933753617e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2018,Total,Human,915.6,UQRORFVVSGFNRO-UTINFBMNSA-N,2.602704121910537e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2019,Total,Human,1008,UQRORFVVSGFNRO-UTINFBMNSA-N,2.911831024944412e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
milbemycin oxime,2016,Total,Vet,3482.1718499999997,LKMMLHTWKLEARD-LEBVNCHQSA-N,9.998537245561872e-10,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2017,Total,Vet,3796.2692,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.105005250962834e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2018,Total,Vet,4060.1456,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.1541456628087514e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2019,Total,Vet,3846.8674,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.111252762318179e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milrinone,2019,Total,Human,10.1,PZRHRDRVRGEVNW-UHFFFAOYSA-N,2.9176084674542226e-12,vasodilator,inotropic vasodilator for life-threatening heart failure,low,high,NA,NA
minoxidil,2016,Total,Human,62955,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,1.807658953691064e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2017,Total,Human,85104,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,2.4771785646271093e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2018,Total,Human,105543,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.000187867396284e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2019,Total,Human,117723,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.4006893229120146e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
mirabegron,2016,Total,Human,303287.5425,PBAPPPCECJKMCM-IBGZPJMESA-N,8.708449555128015e-8,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2017,Total,Human,372761.0925000001,PBAPPPCECJKMCM-IBGZPJMESA-N,1.0850204315519639e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2018,Total,Human,436381.155,PBAPPPCECJKMCM-IBGZPJMESA-N,1.240466394541919e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2019,Total,Human,516175.395,PBAPPPCECJKMCM-IBGZPJMESA-N,1.491086834795572e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirtazapine,2016,Total,Human,319535.925,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.174997630882476e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002867186759650774
mirtazapine,2017,Total,Human,326906.742,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.515491327252358e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002973591039766362
mirtazapine,2018,Total,Human,337860.4368,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.60409296078915e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0030012790502466093
mirtazapine,2019,Total,Human,363507.1445999999,RONZAEMNMFQXRA-UHFFFAOYSA-N,1.050070814915907e-7,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0032814712966122094
misoprostol,2016,Total,Human,676.244,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.941733812214852e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2017,Total,Human,658.3222000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.916222084106694e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2018,Total,Human,621.0586000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7654344453560368e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2019,Total,Human,591.4346,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7084896999063375e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
mitomycin,2017,Total,Human,39.42,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.1474240813310847e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2018,Total,Human,54.8,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.5577565080897488e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2019,Total,Human,58.72,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.696257120880316e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitotane,2016,Total,Human,9600,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.756496855759545e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2017,Total,Human,7300,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.124859409872379e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2018,Total,Human,4750,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.3502451484354574e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2019,Total,Human,5800,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.6754583278449986e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitoxantrone,2016,Total,Human,4.75,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.3638916734226917e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2017,Total,Human,4.35,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.2661833469787465e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2018,Total,Human,3.26,KKZJGLLVHKMTCM-UHFFFAOYSA-N,9.26694565031493e-13,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2019,Total,Human,3.49,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.0081637179619046e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mivacurium chloride,2016,Total,Human,233.4205,WMSYWJSZGVOIJW-ONUALHDOSA-L,6.702321607498134e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2017,Total,Human,272.68949999999995,WMSYWJSZGVOIJW-ONUALHDOSA-L,7.937354110251972e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2018,Total,Human,285.5295,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.116522570741094e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2019,Total,Human,299.3325,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.646881550339019e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
moclobemide,2016,Total,Human,74501.91,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.1392112569070896e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2017,Total,Human,70062.95999999999,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.0393690388974263e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2018,Total,Human,61765.23,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.7557516242000038e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2019,Total,Human,56384.52,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.6287916137162566e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
modafinil,2016,Total,Human,36860.1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.0583828099269e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2017,Total,Human,41133.87,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.1973108319721531e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2018,Total,Human,44110.41,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.25389193890524e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2019,Total,Human,48698.369999999995,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.4067601649823629e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
mometasone,2016,Total,Human,14572.425,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.184254551384561e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.29887532509889725
mometasone,2017,Total,Human,15295.034,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.452026975235339e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.31800192680252426
mometasone,2018,Total,Human,15318.282,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.354407569024463e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.31102911207317596
mometasone,2019,Total,Human,16733.996,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.833984992469811e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.3452846423192722
montelukast,2016,Total,Human,90571.20506,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6006171038566978e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.01368745844135104
montelukast,2017,Total,Human,89291.39282,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5990637843039453e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013679283075283922
montelukast,2018,Total,Human,91333.7439,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5962725176720332e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013664592198273859
montelukast,2019,Total,Human,93387.5145,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6977049807891482e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.014198447267311306
morphine,2016,Total,Human,143800.62,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.1290203842320125e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2017,Total,Human,145812.63,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.244264916900542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2018,Total,Human,144049.465,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.094780868441542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2019,Total,Human,148051.625,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.2767987596074974e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
moxidectin,2016,Total,Vet,834.5274000000001,YZBLFMPOMVTDJY-LSGXYNIPSA-N,2.3962209939012376e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2017,Total,Vet,642.7746,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.8709666537492526e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2018,Total,Vet,574.6335,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6334654642178663e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2019,Total,Vet,573.168,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6557225842314866e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxonidine,2016,Total,Human,700.267344,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.0107132624240496e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2017,Total,Human,705.406072,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.053272232699059e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2018,Total,Human,674.0434680000001,WPNJAUFVNXKLIM-UHFFFAOYSA-N,1.9160503631612855e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2019,Total,Human,750.183784,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.1670718419259892e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
mycophenolic acid,2016,Total,Human,2255457,HPNSFSBZBAHARI-RUDMXATFSA-N,6.476208467500891e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,9.523835981618959
mycophenolic acid,2017,Total,Human,2364479,HPNSFSBZBAHARI-RUDMXATFSA-N,6.88244582547347e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.121243860990397
mycophenolic acid,2018,Total,Human,2429535,HPNSFSBZBAHARI-RUDMXATFSA-N,6.906248098324504e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.156247203418388
mycophenolic acid,2019,Total,Human,2551838.8,HPNSFSBZBAHARI-RUDMXATFSA-N,7.371550980651704e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.840516148017212
nabumetone,2016,Total,Human,394630,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1331212022795721e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2017,Total,Human,378785.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1025560739701565e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2018,Total,Human,335474.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,9.536269811553915e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2019,Total,Human,310164.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,8.959787836670347e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nalmefene,2016,Total,Human,468.90648,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.346395039338829e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2017,Total,Human,351.8172,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.0240576547602094e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2018,Total,Human,325.60416,WJBLNOPPDWQMCH-MBPVOVBZSA-N,9.255693417903209e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2019,Total,Human,290.92392,WJBLNOPPDWQMCH-MBPVOVBZSA-N,8.403981112643315e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
naloxegol,2016,Total,Human,1748.1625,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,5.01958795271536e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2017,Total,Human,2825.69,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,8.224923268331894e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2018,Total,Human,3741.99,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.0637060722092626e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2019,Total,Human,4433.4825,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.280709513100011e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxone,2016,Total,Human,41013.1332,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.1776309657359104e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2017,Total,Human,44180.59196,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.2859937884923013e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2018,Total,Human,47347.738,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.3459169162924874e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2019,Total,Human,49400.0052,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.4270284501366594e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naltrexone,2016,Total,Human,7338.439,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.107123336425335e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2017,Total,Human,7045.358,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.050739074276664e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2018,Total,Human,14907.313,DQCKKXVULJGBQN-XFWGSAIBSA-N,4.237584643043964e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2019,Total,Human,25436.735,DQCKKXVULJGBQN-XFWGSAIBSA-N,7.347963704989027e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
nandrolone,2018,Total,Vet,8.5,NPAGDVCDWIYMMC-IZPLOLCNSA-N,2.4162281603581873e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
nandrolone,2019,Total,Vet,18,NPAGDVCDWIYMMC-IZPLOLCNSA-N,5.1996982588293064e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
naphazoline,2016,Total,Human,28.7736,CNIIGCLFLJGOGP-UHFFFAOYSA-N,8.261910200925295e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2017,Total,Human,21.1104,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.1447441213931325e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2018,Total,Human,21.5712,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.131875399143357e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2019,Total,Human,17.814,CNIIGCLFLJGOGP-UHFFFAOYSA-N,5.145968043488071e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naproxen,2016,Total,Human,11836198.075,CMWTZPSULFXXJA-VIFPVBQESA-N,3.398587789362987e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.2265725192908658
naproxen,2017,Total,Human,12952135.85,CMWTZPSULFXXJA-VIFPVBQESA-N,3.77006407381067e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.25133760492071133
naproxen,2018,Total,Human,13554028.4,CMWTZPSULFXXJA-VIFPVBQESA-N,3.8528970713381915e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.25685980475587944
naproxen,2019,Total,Human,14678428.375,CMWTZPSULFXXJA-VIFPVBQESA-N,4.2401888035465664e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.2826792535697711
naratriptan,2016,Total,Human,313.875,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.012452610432576e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.012452610432576e-7
naratriptan,2017,Total,Human,330.645,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.624303281880175e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.624303281880174e-7
naratriptan,2018,Total,Human,414.585,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.178508178661293e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.178508178661293e-6
naratriptan,2019,Total,Human,417.045,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.2047267557519268e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.2047267557519267e-6
nebivolol,2016,Total,Human,25.200000000000003,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,7.235804246368806e-12,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2017,Total,Human,47.4,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,1.3797032332595995e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2018,Total,Human,81.6,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,2.3195790339438596e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2019,Total,Human,109.65,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,3.1674828560035196e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nelarabine,2017,Total,Human,7.5,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,2.1830747361702525e-12,antineoplastic,antimetabolite for leukaemia and lymphoma,low,high,1e-4,2.1830747361702525e-8
neomycin,2016,Total,Vet,32200,PGBHMTALBVVCIT-VCIWKGPPSA-N,9.24574987036014e-9,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2017,Total,Vet,40100,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.1672172922723617e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2018,Total,Vet,36800,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0460846623668388e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2019,Total,Vet,35300,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0197186029815252e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neostigmine,2016,Total,Human,120.3,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.45423512237368e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2017,Total,Human,118.1,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.4376150178894244e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2018,Total,Human,111.25,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.162416268704098e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2019,Total,Human,117.525,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.394969654827302e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
nepafenac,2016,Total,Human,271.246,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.788424438930766e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2017,Total,Human,299.604,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.720772310074031e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2018,Total,Human,273.159,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.764876094768023e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2019,Total,Human,301.9,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.72104946855871e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
netupitant,2016,Total,Human,1442.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,4.1424979310461407e-10,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2017,Total,Human,6062.4,WAXQNWCZJDTGBU-UHFFFAOYSA-N,1.7646229707411384e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2018,Total,Human,7616.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.165139415176495e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2019,Total,Human,8313,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.4013939792026683e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
nevirapine,2016,Total,Human,15546.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4.464031803866926e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,1.0381469311318433e-4
nevirapine,2017,Total,Human,12474.4,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.6310063318509604e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,8.444200771746419e-5
nevirapine,2018,Total,Human,10636.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.023639493658584e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.031719752694381e-5
nevirapine,2019,Total,Human,11765.6,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.398753879671227e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.904078789933086e-5
nicotine,2016,Total,Human,413358.859,SNICXCGAKADSCV-JTQLQIEISA-N,1.1868983282644304e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.4904538546547233
nicotine,2017,Total,Human,443459.232,SNICXCGAKADSCV-JTQLQIEISA-N,1.2908061945342172e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5333909894769492
nicotine,2018,Total,Human,452518.281,SNICXCGAKADSCV-JTQLQIEISA-N,1.2863381336812697e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5315446833393676
nicotine,2019,Total,Human,468355.722,SNICXCGAKADSCV-JTQLQIEISA-N,1.3529491289978573e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5590698880156435
nifedipine,2016,Total,Human,540610.2034,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.5522815894412792e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2017,Total,Human,574190.8116,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.6713352727267377e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2018,Total,Human,406169.141,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.1545850780619945e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2019,Total,Human,319523.88,HYIMSNHJOBLJNT-UHFFFAOYSA-N,9.23015423605769e-8,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nilotinib,2016,Total,Human,16940,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.864068410059031e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707955423303963
nilotinib,2017,Total,Human,16475.2,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.7955457191136206e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018444406611975463
nilotinib,2018,Total,Human,17110.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.8638388605873805e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707072540720696
nilotinib,2019,Total,Human,17972.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,5.191725388165769e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.019968174569868342
nimodipine,2016,Total,Human,1004.4,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.8839848353384235e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2017,Total,Human,1195.15,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.47880236124517e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2018,Total,Human,1105.75,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.1432285744894886e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2019,Total,Human,957.05,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.7646506770069927e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nintedanib,2016,Total,Human,5280,CPMDPSXJELVGJG-UHFFFAOYSA-N,1.5160732706677494e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,3.9896665017572354e-4
nintedanib,2017,Total,Human,9339,CPMDPSXJELVGJG-UHFFFAOYSA-N,2.718364661479198e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,7.153591214418942e-4
nintedanib,2018,Total,Human,13311,CPMDPSXJELVGJG-UHFFFAOYSA-N,3.7838132991209215e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,9.957403418739267e-4
nintedanib,2019,Total,Human,19167,CPMDPSXJELVGJG-UHFFFAOYSA-N,5.536812029276741e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,0.0014570557971780897
nitisinone,2016,Total,Human,304.62,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.746709085432006e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2017,Total,Human,293.09999999999997,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.531456068953345e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2018,Total,Human,317.58,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.027596931371212e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2019,Total,Human,343.08,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.91062488132866e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitrazepam,2016,Total,Human,25991.235,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.462995578625774e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2017,Total,Human,24605.77,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.162164646802122e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2018,Total,Human,23234.9275,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.604810132868335e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2019,Total,Human,22517.1975,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.5045907019147564e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrofurantoin,2016,Total,Human,118891.905,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.4138037740391936e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2017,Total,Human,108327.375,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.1531567413085466e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2018,Total,Human,25611.025,NXFQHRVNIOXGAQ-YCRREMRBSA-N,7.280244684780888e-9,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2019,Total,Human,516.25,NXFQHRVNIOXGAQ-YCRREMRBSA-N,1.4913023478447943e-10,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nomegestrol acetate,2016,Total,Human,763.98,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1936546540241427e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2017,Total,Human,724.92,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.110072716992719e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2018,Total,Human,763.56,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1705119695565852e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2019,Total,Human,391.02,IIVBFTNIGYRNQY-YQLZSBIMSA-N,1.1295477850930195e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
norelgestromin,2016,Total,Human,1316.304,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.7795706637747e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2017,Total,Human,1229.58,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.579020045466959e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2018,Total,Human,1179.954,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.354162450267394e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2019,Total,Human,1153.602,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.332434617101115e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norepinephrine,2016,Total,Human,563.84,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.6189824866161062e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2017,Total,Human,608.43,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.7709975489707555e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2018,Total,Human,598.5500000000001,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.701451018096933e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2019,Total,Human,625.4,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.8066062728176936e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norethisterone,2016,Total,Human,11628.66711,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.338998367228066e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.677996734456132
norethisterone,2017,Total,Human,11288.048196,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.285687044981306e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.571374089962612
norethisterone,2018,Total,Human,11405.604126,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.242181397075145e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.4843627941502895
norethisterone,2019,Total,Human,11396.149746,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.292029999535235e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.58405999907047
nortriptyline,2016,Total,Human,20790.865,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.969786875106372e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2017,Total,Human,20722.4,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.0318063883752604e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2018,Total,Human,20970.165,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.9610239059244294e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2019,Total,Human,22060.04,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.372530643205826e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
noscapine,2016,Total,Human,230103.48,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.60707832415968e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2017,Total,Human,184830.55,AKNNEGZIBPJZJG-MSOLQXFVSA-N,5.3799853890327026e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2018,Total,Human,211380.54,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.008748391761414e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2019,Total,Human,220222.27,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.361607521524653e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
nystatin,2016,Total,Human,10140,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.911549803896019e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2017,Total,Human,7980,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.3227915192851486e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2018,Total,Human,540,VQOXZBDYSJBXMA-RKEBNKJGSA-N,1.5350155371687308e-10,antifungal,topical antifungal,NA,NA,NA,NA
obeticholic acid,2017,Total,Human,5.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,1.615475304765987e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2018,Total,Human,29.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,8.399946133951109e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2019,Total,Human,73.5,ZXERDUOLZKYMJM-ZWECCWDJSA-N,2.1232101223553004e-11,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
oclacitinib,2016,Total,Vet,1577.108,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,4.528430461659608e-10,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2017,Total,Vet,6505.176,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,1.893504717325474e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2018,Total,Vet,7525.44,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.139197652598343e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2019,Total,Vet,7460.288,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.1550692513313983e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
ofloxacin,2016,Total,Human,9395,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.697634162485513e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2017,Total,Human,7144,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.079451455360038e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2018,Total,Human,6572,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.868170761161648e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2019,Total,Human,5720,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.6523485578057572e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
olanzapine,2016,Total,Human,57957.4664,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6641622281186404e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015128747528351276
olanzapine,2017,Total,Human,57756.7583,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6811642651709542e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015283311501554129
olanzapine,2018,Total,Human,57485.9054,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6341066288372564e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01485551480761142
olanzapine,2019,Total,Human,59245.3109,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.7114318885029498e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01555847171366318
olaparib,2016,Total,Human,2822.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,8.104100755933063e-10,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,2.532531486229082e-5
olaparib,2017,Total,Human,7750.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.2559603246951904e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.04987601467247e-5
olaparib,2018,Total,Human,8892.8,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.5278863275803867e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.899644773688709e-5
olaparib,2019,Total,Human,8372,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.4184374346066086e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.557616983145652e-5
olmesartan medoxomil,2016,Total,Human,20498.5319,UQGKUQLKSCSZGY-UHFFFAOYSA-N,5.8858477843788265e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2017,Total,Human,21258.5905,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.187878912951858e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2018,Total,Human,21317.3982,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.0597291572245804e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2019,Total,Human,22177.519,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.406467051636326e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olodaterol,2016,Total,Human,3.993,COUYJEVMBVSIHV-SFHVURJKSA-N,1.1465304109424858e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2017,Total,Human,7.77735,COUYJEVMBVSIHV-SFHVURJKSA-N,2.263804839913829e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2018,Total,Human,10.5654,COUYJEVMBVSIHV-SFHVURJKSA-N,3.003343177111576e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2019,Total,Human,13.5762,COUYJEVMBVSIHV-SFHVURJKSA-N,3.9217857500843574e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olopatadine,2016,Total,Human,689.9449999999999,JBIMVDZLSHOPLA-LSCVHKIXSA-N,1.9810741907781447e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2017,Total,Human,754.46,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.1960567539346784e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2018,Total,Human,789.41,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.2439937318451255e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2019,Total,Human,870.375,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.514270762238088e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olsalazine,2016,Total,Human,79768.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2904335358193255e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2017,Total,Human,76207.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2182222394225936e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2018,Total,Human,75384,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.1428816898875483e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2019,Total,Human,69604,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.0106655422641947e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
ombitasvir,2016,Total,Human,641.9,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.8431201372000538e-10,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2017,Total,Human,158.2,PIDFDZJZLOTZTM-KHVQSSSXSA-N,4.604832310161786e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2018,Total,Human,80.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,2.28831019892746e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2019,Total,Human,3.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.0110524392168097e-12,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
omeprazole,2016,Total,Human,233745.29,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.711647468058364e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.711647468058365e-4
omeprazole,2016,Total,Vet,37349.2504,SUBDBMMJDZJVOS-UHFFFAOYSA-N,1.0724280342976656e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,1.0724280342976656e-4
omeprazole,2017,Total,Human,228766.28,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.658851818075335e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.658851818075336e-4
omeprazole,2017,Total,Vet,47751.519199999995,SUBDBMMJDZJVOS-UHFFFAOYSA-N,1.3899351357235831e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,1.3899351357235832e-4
omeprazole,2018,Total,Human,219546.17,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.240866334738656e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.240866334738656e-4
omeprazole,2018,Total,Vet,63915.8387,SUBDBMMJDZJVOS-UHFFFAOYSA-N,1.81688528658649e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,1.81688528658649e-4
omeprazole,2019,Total,Human,224747.59,SUBDBMMJDZJVOS-UHFFFAOYSA-N,6.492331402217129e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,6.49233140221713e-4
omeprazole,2019,Total,Vet,75262.3956,SUBDBMMJDZJVOS-UHFFFAOYSA-N,2.1741208186480143e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,2.1741208186480145e-4
ondansetron,2016,Total,Human,10158.28,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.9167986333255283e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.114995729142276e-4
ondansetron,2017,Total,Human,9773.56,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.8448549224592172e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.890171632685055e-4
ondansetron,2018,Total,Human,9582.092,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.723825944181518e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.511956075567245e-4
ondansetron,2019,Total,Human,10485.448,FELGMEQIXOGIFQ-UHFFFAOYSA-N,3.028953650480291e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.46548015775091e-4
opium,2016,Total,Human,454.8,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.3058903854160843e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2017,Total,Human,436,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.2690941132936402e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2018,Total,Human,525.2,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.4929447409648472e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2019,Total,Human,709.5,LGFMXOTUSSVQJV-NEYUFSEYSA-N,2.0495477303552183e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
osaterone acetate,2016,Total,Vet,118.545,KKTIOMQDFOYCEN-OFUYBIASSA-N,3.4038429142293254e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2017,Total,Vet,146.73749999999998,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.271185721317099e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2018,Total,Vet,163.1175,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.6368129052614894e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2019,Total,Vet,183.09375,KKTIOMQDFOYCEN-OFUYBIASSA-N,5.289068072652936e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
oseltamivir,2016,Total,Human,3850.05,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.105484449949691e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2017,Total,Human,3546.9,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.0324197042296358e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2018,Total,Human,6644.25,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.8887087005246924e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2019,Total,Human,5278.95,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.524941506858165e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
osimertinib,2017,Total,Human,9.6,DUYJMQONPNNFPI-UHFFFAOYSA-N,2.794335662297923e-12,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,3.725780883063897e-5
osimertinib,2018,Total,Human,120,DUYJMQONPNNFPI-UHFFFAOYSA-N,3.411145638152735e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,4.548194184203647e-4
osimertinib,2019,Total,Human,208.8,DUYJMQONPNNFPI-UHFFFAOYSA-N,6.031649980241996e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,8.042199973655995e-4
oxaliplatin,2016,Total,Human,1864.3,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.353059466867208e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2017,Total,Human,1898.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.526235387141378e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2018,Total,Human,1834.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.21493102539425e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2019,Total,Human,1978.35,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.714901694641644e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxazepam,2016,Total,Human,541952.175,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5561348607911946e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2017,Total,Human,517128.355,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5052397962103758e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2018,Total,Human,502380.275,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.428076903133518e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2019,Total,Human,456991.805,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.320121940420979e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxcarbazepine,2016,Total,Human,952201.5,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.734104625832836e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021360192389319032
oxcarbazepine,2017,Total,Human,961171.05,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.79774431519098e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021857377462429533
oxcarbazepine,2018,Total,Human,958318.8,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.724137495483137e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021282324183462008
oxcarbazepine,2019,Total,Human,1066227,CTRLABGOLIVAIY-UHFFFAOYSA-N,3.0800325974537753e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.02406275466760762
oxfendazole,2016,Total,Vet,160650,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.6128252070601145e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2017,Total,Vet,149895,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.3630931677098666e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2018,Total,Vet,157455,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.4758494704611585e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2019,Total,Vet,145575,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.2052559668282024e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxybuprocaine,2016,Total,Human,449.44,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.2904999446380936e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2017,Total,Human,468.12,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.362587927328025e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2018,Total,Human,482.52,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.3716216611012146e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2019,Total,Human,531.92,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.5365686099091578e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybutynin,2016,Total,Human,369.9768,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0623332144833104e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2017,Total,Human,369.3288,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0750298301601012e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2018,Total,Human,343.6828,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.769600701067656e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2019,Total,Human,341.0924,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.853208657666163e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxyclozanide,2018,Total,Vet,748,JYWIYHUXVMAGLG-UHFFFAOYSA-N,2.1262807811152047e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxyclozanide,2019,Total,Vet,1496,JYWIYHUXVMAGLG-UHFFFAOYSA-N,4.3215269973381347e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxycodone,2016,Total,Human,329517.24381,BRUQQQPBMZOVGD-XFKAJCMBSA-N,9.461596317508505e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2017,Total,Human,358341.92017,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.0430495904451526e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2018,Total,Human,363479.17312,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.033233663289709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2019,Total,Human,376641.07752,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.08801108610241e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxymetazoline,2016,Total,Human,781.9186,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2451626691249012e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2017,Total,Human,769.4276,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2396239398294808e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2018,Total,Human,679.2178,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9307590298547475e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2019,Total,Human,681.5715,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9688700787875991e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxytetracycline,2016,Total,Human,2904.75,OWFJMIVZYSDULZ-PXOLEDIWSA-N,8.340556501841185e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2016,Total,Vet,106765,OWFJMIVZYSDULZ-PXOLEDIWSA-N,3.0655977792204984e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2017,Total,Human,2863.35,OWFJMIVZYSDULZ-PXOLEDIWSA-N,8.33454272775079e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2017,Total,Vet,88270,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.5693334261566425e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2018,Total,Human,2754,OWFJMIVZYSDULZ-PXOLEDIWSA-N,7.828579239560528e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2018,Total,Vet,96410,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.74057125811921e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2019,Total,Human,3040.65,OWFJMIVZYSDULZ-PXOLEDIWSA-N,8.783590283727406e-10,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2019,Total,Vet,75930,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.193406048849496e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
palbociclib,2016,Total,Human,92.4,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.6531282236685623e-11,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2017,Total,Human,6135.15,AHJRHEGDXFFMBM-UHFFFAOYSA-N,1.7857987956819902e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2018,Total,Human,7519.575,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.137530455167696e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2019,Total,Human,7089.6,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.0479878208775703e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palifermin,2016,Total,Human,0.075,NA,2.1535131685621443e-14,antineoplastic,"treatment for chemotherapy-caused mouth sores, ulcers",NA,NA,NA,NA
paliperidone,2016,Total,Human,1382.118,PMXMIIMHBWHSKN-UHFFFAOYSA-N,3.9685457513423646e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.5874183005369458e-6
paliperidone,2017,Total,Human,1423.691,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.1440318056172836e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.6576127222469135e-6
paliperidone,2018,Total,Human,1506.598,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.2826876634580284e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.7130750653832113e-6
paliperidone,2019,Total,Human,1561.067,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.5094874232310496e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.8037949692924198e-6
pamidronic acid,2016,Total,Human,105.6,WRUUGTRCQOWXEG-UHFFFAOYSA-N,3.032146541335499e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2017,Total,Human,41.43000000000001,WRUUGTRCQOWXEG-UHFFFAOYSA-N,1.2059304842604478e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2018,Total,Human,26.639999999999997,WRUUGTRCQOWXEG-UHFFFAOYSA-N,7.572743316699072e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2019,Total,Human,14.25,WRUUGTRCQOWXEG-UHFFFAOYSA-N,4.116427788239868e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
panobinostat,2016,Total,Human,8.55,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.455005012160845e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2017,Total,Human,9.81,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.8554617549106904e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2018,Total,Human,4.05,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.151261652876548e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2019,Total,Human,4.23,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.2219290908248873e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
pantoprazole,2016,Total,Human,1826878.9752,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.245610573950021e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.02017542528442316
pantoprazole,2017,Total,Human,1975594.656,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.750494376568748e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.022117286063725955
pantoprazole,2018,Total,Human,2154751.9728,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.125143994431435e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.023558246132428597
pantoprazole,2019,Total,Human,2363034.2632,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.826147302175019e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.02625441270067315
papaverine,2016,Total,Human,90,XQYZDYMELSJDRZ-UHFFFAOYSA-N,2.5842158022745735e-11,vasodilator,"peripheral vasodilator for chest pain, circulation issues, heart attacks, etc.",low,NA,NA,NA
paracetamol,2016,Total,Human,258960351.165,RZVAJINKPMORJF-UHFFFAOYSA-N,7.435660351590731e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,8.08223951259862
paracetamol,2017,Total,Human,268387332.29,RZVAJINKPMORJF-UHFFFAOYSA-N,7.812128061739063e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,8.491443545368547
paracetamol,2018,Total,Human,279361699.96000004,RZVAJINKPMORJF-UHFFFAOYSA-N,7.941195369045727e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,8.631734096788835
paracetamol,2019,Total,Human,296495918.355,RZVAJINKPMORJF-UHFFFAOYSA-N,8.564940613447167e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,9.309718058094747
parecoxib,2016,Total,Human,511.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.4689831160485242e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2017,Total,Human,679.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.9781567876017383e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2018,Total,Human,777.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.2104223735229722e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2019,Total,Human,964.8,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.7870382667325083e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
paritaprevir,2016,Total,Human,3851.4,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.1058720823200323e-9,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2017,Total,Human,949.2,UAUIUKWPKRJZJV-QPLHLKROSA-N,2.7628993860970716e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2018,Total,Human,483,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.3729861193564758e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2019,Total,Human,21,UAUIUKWPKRJZJV-QPLHLKROSA-N,6.066314635300858e-12,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paroxetine,2016,Total,Human,96786.6296,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.7790837517912887e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19850598227080632
paroxetine,2017,Total,Human,92756.0448,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.6999117070660822e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19285083621900587
paroxetine,2018,Total,Human,89049.5236,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.531340783397659e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.18081005595697563
paroxetine,2019,Total,Human,86480.4608,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.4981794524695342e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.17844138946210958
pazopanib,2016,Total,Human,22512,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.463985126756133e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.0399907042225835e-4
pazopanib,2017,Total,Human,22806,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.638293657746504e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.148933536091565e-4
pazopanib,2018,Total,Human,16614,CUIHSIWYWATEQL-UHFFFAOYSA-N,4.7227311360224615e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,2.9517069600140384e-4
pazopanib,2019,Total,Human,20970,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.057648471536143e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,3.7860302947100895e-4
pemetrexed,2016,Total,Human,1646.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,4.726530702360195e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,3.938775585300162e-6
pemetrexed,2017,Total,Human,1209.8,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.5214450877583614e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.934537573131968e-6
pemetrexed,2018,Total,Human,1256.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.570616696736375e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.975513913946979e-6
pemetrexed,2019,Total,Human,2052.4,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,5.928811503567371e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,4.9406762529728095e-6
penciclovir,2016,Total,Human,602.44,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.7298166310247712e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2017,Total,Human,481.24,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.4007771813794298e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2018,Total,Human,379.14,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0777514643743568e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2019,Total,Human,373.28,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0783018700310018e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
pentobarbital,2016,Total,Vet,243500,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,6.99173942059843e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2017,Total,Vet,254220,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.39975012572269e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2018,Total,Vet,286010,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,8.130181366400533e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2019,Total,Vet,260620,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.528585334533856e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentoxifylline,2016,Total,Human,149479.2,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4.2920723416817944e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2017,Total,Human,134452.4,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.9135951687660967e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2018,Total,Human,121401.6,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.450987819206359e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2019,Total,Human,116492,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.3651291642641314e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
perampanel,2016,Total,Human,565.26064,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.6230616425464876e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2017,Total,Human,644.51352,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.8760282435095475e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2018,Total,Human,695.6502,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.9774701211750648e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2019,Total,Human,782.96424,PRMWGUBFXWROHD-UHFFFAOYSA-N,2.2617654419186732e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
pergolide,2016,Total,Vet,54.68,YEHCICAEULNIGD-MZMPZRCHSA-N,1.5700546674263742e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2017,Total,Vet,63.9,YEHCICAEULNIGD-MZMPZRCHSA-N,1.859979675217055e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2018,Total,Vet,67.22,YEHCICAEULNIGD-MZMPZRCHSA-N,1.910810081638557e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2019,Total,Vet,87.72,YEHCICAEULNIGD-MZMPZRCHSA-N,2.5339862848028156e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
perindopril,2016,Total,Human,34.35,IPVQLZZIHOAWMC-QXKUPLGCSA-N,9.86309031201462e-12,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2017,Total,Human,51.45,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.4975892690127932e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2018,Total,Human,61.5,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.7482121395532767e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2019,Total,Human,84.75,IPVQLZZIHOAWMC-QXKUPLGCSA-N,2.4481912635321318e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perphenazine,2016,Total,Human,2466.96,RGCVKNLCSQQDEP-UHFFFAOYSA-N,7.08350779508809e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2017,Total,Human,2298.168,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.689430000366557e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2018,Total,Human,2226.756,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.329824180525361e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2019,Total,Human,2184.558,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.310579127173128e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
pethidine,2016,Total,Human,21194.6,XADCESSVHJOZHK-UHFFFAOYSA-N,6.0857133603209644e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2017,Total,Human,19139.9,XADCESSVHJOZHK-UHFFFAOYSA-N,5.571177619043336e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2018,Total,Human,18886.2,XADCESSVHJOZHK-UHFFFAOYSA-N,5.368631562606682e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2019,Total,Human,16755.7,XADCESSVHJOZHK-UHFFFAOYSA-N,4.840254673081457e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
phenazone,2016,Total,Human,8277984,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.376899673752898e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2017,Total,Human,7763021,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.2596340028612176e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2018,Total,Human,7343160.5,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.0873824924858714e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2019,Total,Human,6807970,VEQOALNAAJBPNY-UHFFFAOYSA-N,1.9666327641756753e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenobarbital,2016,Total,Human,94013.10499999992,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.6994461284655386e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2016,Total,Vet,1337.5,DDBREPKUVSBGFI-UHFFFAOYSA-N,3.840431817269157e-10,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2017,Total,Human,89700.9,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.6109835813564562e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2017,Total,Vet,3840,DDBREPKUVSBGFI-UHFFFAOYSA-N,1.117734264919169e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2018,Total,Human,84657.1,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.4064808116971666e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2018,Total,Vet,5742.5,DDBREPKUVSBGFI-UHFFFAOYSA-N,1.63237531892434e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2019,Total,Human,15432.46,DDBREPKUVSBGFI-UHFFFAOYSA-N,4.458007521747385e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2019,Total,Vet,13450,DDBREPKUVSBGFI-UHFFFAOYSA-N,3.8853300878474544e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenoxymethylpenicillin,2016,Total,Human,13360655.2,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.836312921842438e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2017,Total,Human,12987487.15,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.780354011133439e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2018,Total,Human,12311053.9,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.4995664843373515e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2019,Total,Human,12955160.4,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.7423847208185777e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenylbutazone,2018,Total,Vet,736,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.0921693247336774e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylbutazone,2019,Total,Vet,1024,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.958050565022895e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylpropanolamine,2016,Total,Human,231900.7625,DLNKOYKMWOXYQA-VXNVDRBHSA-N,6.658684611244698e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2017,Total,Human,276868.0875,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.058983027640334e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2018,Total,Human,262740.8425,DLNKOYKMWOXYQA-VXNVDRBHSA-N,7.468727323820415e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2019,Total,Human,279732.4,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.080689295656351e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenytoin,2016,Total,Human,34721.4,CXOFVDLJLONNDW-UHFFFAOYSA-N,9.969732284121821e-9,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2017,Total,Human,101386.1,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.9511124467844112e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2018,Total,Human,100090.875,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.8452045972928387e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2019,Total,Human,95765.575,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.7664005199071523e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
pibrentasvir,2017,Total,Human,3.36,VJYSBPDEJWLKKJ-NLIMODCCSA-N,9.78017481804273e-13,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2018,Total,Human,265.44,VJYSBPDEJWLKKJ-NLIMODCCSA-N,7.545454151593849e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2019,Total,Human,204.96,VJYSBPDEJWLKKJ-NLIMODCCSA-N,5.920723084053637e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pilocarpine,2016,Total,Human,4093.357,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.175346427083471e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2017,Total,Human,3945.289,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.1483814323720534e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2018,Total,Human,3294.01,QCHFTSOMWOSFHM-WPRPVWTQSA-N,9.36362320294291e-10,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2019,Total,Human,3521.756,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.0173371411789814e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pimecrolimus,2016,Total,Human,2820.3,KASDHRXLYQOAKZ-XDSKOBMDSA-N,8.098070919061089e-10,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2017,Total,Human,3484.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0143438454141463e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2018,Total,Human,3640.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0349415866155399e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2019,Total,Human,4461.6,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.2888318750884911e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimobendan,2016,Total,Vet,2620.3125,GLBJJMFZWDBELO-UHFFFAOYSA-N,7.523836632663991e-10,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2017,Total,Vet,3819.9125,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.1118872630841268e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2018,Total,Vet,4348.78875,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.236195981317515e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2019,Total,Vet,5381.145,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.5544627937226683e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pioglitazone,2016,Total,Human,13208.934,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.792748441555765e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2017,Total,Human,11602.8321,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.377313283404698e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2018,Total,Human,13893.6366,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.949434823847433e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2019,Total,Human,11930.8368,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.446486185296478e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
piperacillin,2016,Total,Human,1429560,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.104768380332933e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2017,Total,Human,1165680,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.393022077945254e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2018,Total,Human,1198320,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.406370034259322e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2019,Total,Human,141960,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.10082869346338e-8,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piracetam,2016,Total,Human,108088.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.1036087223210664e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2017,Total,Human,109509.6,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.187568548374798e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2018,Total,Human,103096.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.9306516635625412e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2019,Total,Human,99360,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.8702334388737772e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
pirfenidone,2016,Total,Human,41245.092,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1842913168074289e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.1172559592522914e-5
pirfenidone,2017,Total,Human,39966.696,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1633371243439557e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.0974878531546753e-5
pirfenidone,2018,Total,Human,47300.652,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.3445784395965037e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.2684702260344375e-5
pirfenidone,2019,Total,Human,60286.464,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.7415078993987538e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.6429319805648622e-5
piroxicam,2016,Total,Human,32908.44,QYSPLQLAKJAUJT-UHFFFAOYSA-N,9.449167852911632e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2017,Total,Human,28692.1,QYSPLQLAKJAUJT-UHFFFAOYSA-N,8.351599818356068e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2018,Total,Human,26629.96,QYSPLQLAKJAUJT-UHFFFAOYSA-N,7.569889324848484e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2019,Total,Human,21773.14,QYSPLQLAKJAUJT-UHFFFAOYSA-N,6.2896532304025965e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
pitolisant,2018,Total,Human,73.71000000000001,NNACHAUCXXVJSP-UHFFFAOYSA-N,2.0952962082353174e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pitolisant,2019,Total,Human,238.95,NNACHAUCXXVJSP-UHFFFAOYSA-N,6.902599438595904e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pivmecillinam,2016,Total,Human,1939166,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.568026022703973e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2017,Total,Human,1795218,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.225460082290785e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2018,Total,Human,1816464,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.163519375384559e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2019,Total,Human,1848556,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.339963008082483e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pixantrone,2018,Total,Human,0.928,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.637952626838116e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
pixantrone,2019,Total,Human,0.957,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.764506240944248e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
plerixafor,2016,Total,Human,1.584,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.548219812003249e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2017,Total,Human,1.56,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.540795451234126e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2018,Total,Human,1.152,YIQPUIGJQJDJOS-UHFFFAOYSA-N,3.274699812626625e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2019,Total,Human,1.752,YIQPUIGJQJDJOS-UHFFFAOYSA-N,5.061039638593859e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
podophyllotoxin,2016,Total,Human,253.79,YJGVMLPVUAXIQN-XVVDYKMHSA-N,7.287201427325156e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2017,Total,Human,234.99,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.840009763368636e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2018,Total,Human,241.1675,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.85547888074333e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2019,Total,Human,221.865,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.409061412195355e-11,dermatological,topical treatment for warts,low,NA,NA,NA
pomalidomide,2016,Total,Human,41.265,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.1848629453428919e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2017,Total,Human,67.977,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.9786516178752705e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2018,Total,Human,73.815,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.098280960668701e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2019,Total,Human,78.246,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.2603088331130995e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
ponatinib,2016,Total,Human,50.85,PHXJVRSECIGDHY-UHFFFAOYSA-N,1.460081928285134e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2017,Total,Human,92.25,PHXJVRSECIGDHY-UHFFFAOYSA-N,2.6851819254894103e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2018,Total,Human,119.7,PHXJVRSECIGDHY-UHFFFAOYSA-N,3.402617774057353e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2019,Total,Human,145.35,PHXJVRSECIGDHY-UHFFFAOYSA-N,4.198756344004665e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
posaconazole,2016,Total,Human,4580.1,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.3151074217775304e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.207579077506172e-4
posaconazole,2017,Total,Human,4315.2,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2560538802029162e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.0635460492754057e-4
posaconazole,2018,Total,Human,4299.6,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2222134821501252e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,2.981008493049086e-4
posaconazole,2019,Total,Human,5096.7,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.472294561987518e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.59096234631102e-4
potassium permanganate,2016,Total,Human,125805,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.6123029889461414e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2017,Total,Human,123675,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.5998902399447475e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2018,Total,Human,113475,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.2256645940781804e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2019,Total,Human,109695,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.1687827805682274e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
pradofloxacin,2016,Total,Vet,173.46,LZLXHGFNOWILIY-APPDUMDISA-N,4.980645256250528e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2017,Total,Vet,141.09,LZLXHGFNOWILIY-APPDUMDISA-N,4.1068001936834786e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2018,Total,Vet,134.535,LZLXHGFNOWILIY-APPDUMDISA-N,3.8243206535739845e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pramipexole,2016,Total,Human,1579.1929008,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.5344169434302027e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.477738490614576e-6
pramipexole,2017,Total,Human,1642.4982564,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.780928597000707e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.8298979957152965e-6
pramipexole,2018,Total,Human,1668.3206548,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.742403937217611e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.774862767453731e-6
pramipexole,2019,Total,Human,1717.1190604,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.960278326980276e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,7.086111895686109e-6
prasterone,2019,Total,Human,206.388,FMGSKLZLMKYGDP-USOAJAOKSA-N,5.961974023573682e-11,sex hormone,androgen and estrogen for various gynaecological disorders and applications,NA,NA,NA,NA
prasugrel,2016,Total,Human,3764.3088,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.080865142844582e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.688763909708326e-5
prasugrel,2017,Total,Human,3945.018,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1483025506049195e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,6.043697634762734e-5
prasugrel,2018,Total,Human,3797.7856,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.0795666486732724e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.681929729859328e-5
prasugrel,2019,Total,Human,3890.2712,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1237909102785442e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.9146890014660216e-5
pravastatin,2016,Total,Human,178725.6696,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.131841107249159e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2017,Total,Human,172430.986,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.01906305692702e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2018,Total,Human,167017.8404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.74768481478458e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2019,Total,Human,160755.9404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.6437910188574885e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
praziquantel,2016,Total,Vet,38681.070297,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.1106692567822336e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2017,Total,Vet,42742.837181,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2441441066943952e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2018,Total,Vet,44943.927322,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2775856803824488e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2019,Total,Vet,45877.980674,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.3252869790511244e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
prednisone,2016,Total,Human,409.723,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1764585012837168e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2017,Total,Human,378.1,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1005607436612966e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2018,Total,Human,3.58,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.017658448715566e-12,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
pregabalin,2016,Total,Human,1791066.915,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.1427815829713e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2017,Total,Human,1945696.37,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.663467452806891e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2018,Total,Human,1993165.606,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.66581513585246e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2019,Total,Human,1993225.119,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.757871767066187e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
prilocaine,2016,Total,Human,14261.4,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.094948360284289e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2017,Total,Human,14974.2,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.358639695248079e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2018,Total,Human,15573.6,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.426984809194619e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2019,Total,Human,15255,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.4067442743578375e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
probenecid,2016,Total,Human,389706,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1189826704902389e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2017,Total,Human,389573.5,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1339574209752294e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2018,Total,Human,368371,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.047139274893301e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2019,Total,Human,363917.75,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.0512569394622663e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
procaine,2016,Total,Vet,1895397.839720175,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.442352276668849e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2017,Total,Vet,1880531.9541237105,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.473789066144465e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2018,Total,Vet,1809090.6423749097,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.142559711466751e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2019,Total,Vet,1847522.5354660428,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.336977617117049e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
prochlorperazine,2016,Total,Human,9142.84000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.625230178407565e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2017,Total,Human,8558.645,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.4912215567133136e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2018,Total,Human,8061.03000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.291445610293198e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2019,Total,Human,7872.605,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.2741761394972713e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
progesterone,2016,Total,Human,60222.649999999994,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.7292035976094535e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2016,Total,Vet,4567.8,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.3115756601810883e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2017,Total,Human,61691,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.7956808473210542e-08,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2017,Total,Vet,5575.2,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.6228104358795187e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2018,Total,Human,64068,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.821210656209745e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2018,Total,Vet,5492.4,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.5612813585825066e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2019,Total,Human,83775.6,RJKFOVLPORLFTN-LEKSSAKUSA-N,2.4200435636243363e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2019,Total,Vet,5023.2,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.4510624607639651e-9,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
proguanil,2016,Total,Human,92181.6,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.6468571933217093e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005293714386643418
proguanil,2017,Total,Human,97745.7,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.845148909857022e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005690297819714044
proguanil,2018,Total,Human,96136.5,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.7327966886855868e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005465593377371173
proguanil,2019,Total,Human,97569,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.8184964411984258e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005636992882396851
promethazine,2016,Total,Human,59833.65,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.7180340426418446e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2017,Total,Human,56488.675,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.6442533236297622e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2018,Total,Human,54111.375,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.5381815067141412e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2019,Total,Human,54277.4,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.567922790409899e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
propentofylline,2016,Total,Vet,22908,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.577690622056214e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2017,Total,Vet,23214,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.757052923394166e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2018,Total,Vet,23299,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.6230235186100484e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2019,Total,Vet,23473,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.780695401638906e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propofol,2016,Total,Human,283568,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.14223229577107e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2016,Total,Vet,6393.1,OLBCVFGFOZPWHH-UHFFFAOYSA-N,1.8356833383912863e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2017,Total,Human,301468,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.775028994183649e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2017,Total,Vet,6341,OLBCVFGFOZPWHH-UHFFFAOYSA-N,1.8457169202740758e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2018,Total,Human,298188,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.476355796245733e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2018,Total,Vet,7119,OLBCVFGFOZPWHH-UHFFFAOYSA-N,2.02366214983411e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2019,Total,Human,324548,OLBCVFGFOZPWHH-UHFFFAOYSA-N,9.375287058369633e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2019,Total,Vet,7609,OLBCVFGFOZPWHH-UHFFFAOYSA-N,2.1980280028573444e-9,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propranolol,2016,Total,Human,80145.38,AQHHHDLHHXJYJD-UHFFFAOYSA-N,2.3012550830588952e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.10005456882864762
propranolol,2017,Total,Human,144543.47999999998,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4.2073229262150694e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.1829270837484813
propranolol,2018,Total,Human,206155.41,AQHHHDLHHXJYJD-UHFFFAOYSA-N,5.8602177300257395e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.25479207521851044
propranolol,2019,Total,Human,226062.42,AQHHHDLHHXJYJD-UHFFFAOYSA-N,6.530313175892996e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.2839266598214346
propylthiouracil,2016,Total,Human,22577.6,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482821188603823e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2017,Total,Human,19912.7,KNAHARQHSZJURB-UHFFFAOYSA-N,5.796121639858319e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2018,Total,Human,21872.3,KNAHARQHSZJURB-UHFFFAOYSA-N,6.217466728447339e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2019,Total,Human,22440,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482290496007202e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
proxymetacaine,2016,Total,Human,394.275,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.1321018727131192e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2017,Total,Human,376.725,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.096558439978318e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2018,Total,Human,375.45,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.0672621915370369e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2019,Total,Human,334.35,KCLANYCVBBTKTO-UHFFFAOYSA-N,9.658439515775437e-11,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
prucalopride,2016,Total,Human,121.4864,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.4883008293494413e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2017,Total,Human,136.16176,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.9633506438463625e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2018,Total,Human,146.34536,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.1600444702324305e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2019,Total,Human,171.09511999999998,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.9424610975455065e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
pyrantel,2016,Total,Vet,12345.304542809828,YSAUAVHXTIETRK-AATRIKPKSA-N,3.544770120380137e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2017,Total,Vet,16631.893990675977,YSAUAVHXTIETRK-AATRIKPKSA-N,4.8411556780942094e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2018,Total,Vet,32461.605806916097,YSAUAVHXTIETRK-AATRIKPKSA-N,9.227605421307946e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2019,Total,Vet,23870.71177254078,YSAUAVHXTIETRK-AATRIKPKSA-N,6.895583246705363e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrazinamide,2016,Total,Human,15432,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.431068695633469e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2017,Total,Human,16368,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.764342304217959e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2018,Total,Human,14496,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.120663930888504e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2019,Total,Human,12624,IPEHBUMCGVEMRF-UHFFFAOYSA-N,3.646721712192287e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyridostigmine,2016,Total,Human,39028.42,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.1206428855756556e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2017,Total,Human,43240.814999999995,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2586390773054892e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2018,Total,Human,43505.77,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2367043130831344e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2019,Total,Human,46642.03,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.347358234329246e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyrvinium,2016,Total,Human,1437.2,QMHSXPLYMTVAMK-UHFFFAOYSA-N,4.126705501143352e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2017,Total,Human,2412.8,QMHSXPLYMTVAMK-UHFFFAOYSA-N,7.023096964575448e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2018,Total,Human,1334,QMHSXPLYMTVAMK-UHFFFAOYSA-N,3.792056901079791e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2019,Total,Human,2815.6,QMHSXPLYMTVAMK-UHFFFAOYSA-N,8.133483565310996e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
quetiapine,2016,Total,Human,2024105.925,URKOMYMAXPYINW-UHFFFAOYSA-N,5.811918352069548e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.058119183520695485
quetiapine,2017,Total,Human,2167664.5,URKOMYMAXPYINW-UHFFFAOYSA-N,6.30956480859083e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06309564808590831
quetiapine,2018,Total,Human,2235867.525,URKOMYMAXPYINW-UHFFFAOYSA-N,6.355724796159251e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06355724796159251
quetiapine,2019,Total,Human,2349528.8000000003,URKOMYMAXPYINW-UHFFFAOYSA-N,6.78713378357184e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06787133783571841
quinagolide,2016,Total,Human,4.388625,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.260128230584139e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2017,Total,Human,3.9095775,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.1379866492466208e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2018,Total,Human,3.453975,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,9.818343129615491e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2019,Total,Human,3.0753,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,8.883684475209872e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinine,2016,Total,Human,8640.39999999999,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.480962024219244e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2017,Total,Human,7407.3,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.1560919324311883e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2018,Total,Human,7110.7,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.021302774101054e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2019,Total,Human,5907.6,LOUPRKONTZGTKE-WZBLMQSHSA-N,1.7065409685477783e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
raloxifene,2016,Total,Human,5740.56,GZUITABIAKMVPG-UHFFFAOYSA-N,1.648316207322814e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2017,Total,Human,4662,GZUITABIAKMVPG-UHFFFAOYSA-N,1.356999256003429e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2018,Total,Human,4193.28,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1919907317960915e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2019,Total,Human,3911.04,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1297904376784318e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raltegravir,2016,Total,Human,82722,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.3752388843973032e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,6.250628643150798e-5
raltegravir,2017,Total,Human,66102,CZFFBEXEKNGXKS-UHFFFAOYSA-N,1.9240747494710138e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.0633546038710884e-5
raltegravir,2018,Total,Human,77430,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.201041723018052e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.7922150605738206e-5
raltegravir,2019,Total,Human,132873,CZFFBEXEKNGXKS-UHFFFAOYSA-N,3.8383305930301476e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,1.0100869981658282e-4
raltitrexed,2016,Total,Human,0.08,IVTVGDXNLFLDRM-HNNXBMFYSA-N,2.2970807131329543e-14,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2017,Total,Human,0.012,IVTVGDXNLFLDRM-HNNXBMFYSA-N,3.4929195778724047e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2018,Total,Human,0.006,IVTVGDXNLFLDRM-HNNXBMFYSA-N,1.7055728190763676e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
ramipril,2016,Total,Human,138640.30915,HDACQVRGBOVJII-JBDAPHQKSA-N,3.98084975264069e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,3.9808497526406904e-4
ramipril,2017,Total,Human,140762.69305,HDACQVRGBOVJII-JBDAPHQKSA-N,4.097273053236573e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0972730532365734e-4
ramipril,2018,Total,Human,143805.1765,HDACQVRGBOVJII-JBDAPHQKSA-N,4.0878366713479934e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0878366713479935e-4
ramipril,2019,Total,Human,146951.5148,HDACQVRGBOVJII-JBDAPHQKSA-N,4.245019642432717e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.2450196424327174e-4
ranitidine,2016,Total,Human,1062701.285,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.051388281993883e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.04921594003215941
ranitidine,2017,Total,Human,1466133.64,VMXUWOKSQNHOCA-UKTHLTGXSA-N,4.267572412444443e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.06883181310394262
ranitidine,2018,Total,Human,1792520.525,VMXUWOKSQNHOCA-UKTHLTGXSA-N,5.095457141794167e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.08218479260958333
ranitidine,2019,Total,Human,1234937.17,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.5673892514514393e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.057538536313732895
rasagiline,2016,Total,Human,654.68592,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8798329999896302e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2017,Total,Human,657.60604,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.9141375097026192e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2018,Total,Human,636.54976,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8094699477426418e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2019,Total,Human,603.1502399999999,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.7423329181891542e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
reboxetine,2016,Total,Human,458.3568,CBQGYUDMJHNJBX-RTBURBONSA-N,1.3161032062666736e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2017,Total,Human,415.8912,CBQGYUDMJHNJBX-RTBURBONSA-N,1.2105620956207064e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2018,Total,Human,400.032,CBQGYUDMJHNJBX-RTBURBONSA-N,1.1371395099345956e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2019,Total,Human,366.5136,CBQGYUDMJHNJBX-RTBURBONSA-N,1.0587556265318115e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
regorafenib,2016,Total,Human,594.72,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.7076498021430383e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2017,Total,Human,769.4399999999999,FNHKPVJBJVTLMP-UHFFFAOYSA-N,2.239660033331785e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2018,Total,Human,584.64,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.6619101549080123e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2019,Total,Human,665.28,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.9218084764633115e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
remifentanil,2016,Total,Human,427.1749999999999,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2265693170407118e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2017,Total,Human,393.86,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.1464344207840208e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2018,Total,Human,452.21,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2854618075242068e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2019,Total,Human,475.56,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.373760279982703e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
repaglinide,2016,Total,Human,223.8552,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.427668280681501e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2017,Total,Human,209.0634,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.085347023971414e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2018,Total,Human,175.029,FAEKWTJYAYMJKF-QHCPKHFHSA-N,4.975411749168626e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2019,Total,Human,132.615,FAEKWTJYAYMJKF-QHCPKHFHSA-N,3.8308776921924916e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
retapamulin,2016,Total,Human,115.25,STZYTFJPGGDRJD-FJJJPKKESA-N,3.3092319023571617e-11,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retapamulin,2017,Total,Human,29.7,STZYTFJPGGDRJD-FJJJPKKESA-N,8.644975955234199e-12,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retigabine,2016,Total,Human,583.254,PCOBBVZJEWWZFR-UHFFFAOYSA-N,1.6747268928220602e-10,anticonvulsant,potassium channel opener for partial epilepsies,low,high,3.2e-6,5.2335215400689384e-5
ribavirin,2016,Total,Human,70760.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,2.0317908615732298e-8,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.002944624437062652
ribavirin,2017,Total,Human,31796.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,9.255305436141105e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.0013413486139334935
ribavirin,2018,Total,Human,6628.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,1.884316850515571e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,2.730893986254451e-4
ribavirin,2019,Total,Human,2826.4,IWUCXVSUMQZMFG-AFCXAGJDSA-N,8.164681754863973e-10,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,1.1832872108498512e-4
ribociclib,2018,Total,Human,7593.6,RHXHGRAEPCAFML-UHFFFAOYSA-N,2.1585729598230502e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
ribociclib,2019,Total,Human,20668.2,RHXHGRAEPCAFML-UHFFFAOYSA-N,5.970466864063105e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
rifampicin,2016,Total,Human,55719,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5998880031881885e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2017,Total,Human,54300,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.580546108987263e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2018,Total,Human,53874,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5314338342486704e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2019,Total,Human,51981,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5015861955122566e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifaximin,2016,Total,Human,48192.144,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.3837655563365753e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2017,Total,Human,66513.524,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.9360532514407172e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2018,Total,Human,87425.492,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.4851757141596402e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2019,Total,Human,102902.184,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.972557260969627e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rilpivirine,2016,Total,Human,5196,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.4919539231798536e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,7.459769615899268e-4
rilpivirine,2017,Total,Human,6089.25,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.772438378296628e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.86219189148314e-4
rilpivirine,2018,Total,Human,6192.75,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7603643458891961e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.801821729445981e-4
rilpivirine,2019,Total,Human,5976,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7262998219313296e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.631499109656648e-4
riluzole,2016,Total,Human,8909.74,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.5582989891286512e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2017,Total,Human,9853.592,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.868150367430575e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2018,Total,Human,9749.6,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.771442126144492e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2019,Total,Human,9594.872,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.7716910684494483e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
rimexolone,2016,Total,Human,231.15,QTTRZHGPGKRAFB-OOKHYKNYSA-N,6.63712758550853e-11,steroid,ophthalmic steroid for eye swelling,low,NA,NA,NA
riociguat,2016,Total,Human,32.361,WXXSNCNJFUAIDG-UHFFFAOYSA-N,9.29197861971194e-12,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,3.0973262065706466e-5
riociguat,2017,Total,Human,41.349,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.203572763545384e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.011909211817947e-5
riociguat,2018,Total,Human,52.395,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.489391464258438e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.964638214194793e-5
riociguat,2019,Total,Human,58.695,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.69553494056659e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,5.6517831352219665e-5
risedronic acid,2016,Total,Human,490.4844,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.4083528191657364e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2017,Total,Human,432.6042000000001,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.2592097330415243e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2018,Total,Human,402.9018,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.1452972647282379e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2019,Total,Human,369.0666,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.0661305318955846e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risperidone,2016,Total,Human,5740.854,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.6484006250390214e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.8420700431707266e-4
risperidone,2017,Total,Human,5595.1026,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.628603617645399e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.807937271802412e-4
risperidone,2018,Total,Human,5455.5387,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5508030866898703e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.673798425327362e-4
risperidone,2019,Total,Human,5474.955199999999,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5815619455893587e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.726830940671308e-4
ritonavir,2016,Total,Human,28187.6,NCDNCNXCDXHOMX-XGKFQTDJSA-N,8.093649038688306e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.005395766025792204
ritonavir,2017,Total,Human,17255.8,NCDNCNXCDXHOMX-XGKFQTDJSA-N,5.022760137654219e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0033485067584361457
ritonavir,2018,Total,Human,11269.3,NCDNCNXCDXHOMX-XGKFQTDJSA-N,3.203435295002884e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0021356235300019227
ritonavir,2019,Total,Human,8426,NCDNCNXCDXHOMX-XGKFQTDJSA-N,2.4340365293830966e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0016226910195887311
rivaroxaban,2016,Total,Human,169070.3082,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,4.854601801620805e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.005644885815838145
rivaroxaban,2017,Total,Human,184161.8191,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.3605201952582177e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006233163017742113
rivaroxaban,2018,Total,Human,194185.2613,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.5199517256420345e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006418548518188412
rivaroxaban,2019,Total,Human,197577.293,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.7074572577572665e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.0066365782066944955
rivastigmine,2016,Total,Human,14043.4674,XSVMFMHYUFZWBK-NSHDSACASA-N,4.032372263756424e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.064744527512848e-5
rivastigmine,2017,Total,Human,14294.810880000001,XSVMFMHYUFZWBK-NSHDSACASA-N,4.160885398727954e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.321770797455908e-5
rivastigmine,2018,Total,Human,13959.97764,XSVMFMHYUFZWBK-NSHDSACASA-N,3.968293069616309e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.936586139232617e-5
rivastigmine,2019,Total,Human,13529.56272,XSVMFMHYUFZWBK-NSHDSACASA-N,3.908313539883661e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.816627079767322e-5
rizatriptan,2016,Total,Human,13631.64,ULFRLSNUDGIQQP-UHFFFAOYSA-N,3.914122166546462e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.077210590152564e-6
rizatriptan,2017,Total,Human,14095.38,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.102835729962594e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.273787218711035e-6
rizatriptan,2018,Total,Human,14536.35,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.132133908096793e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.304306154267493e-6
rizatriptan,2019,Total,Human,15653.52,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.521865593808318e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.710276660216998e-6
robenacoxib,2016,Total,Vet,20767.56,ZEXGDYFACFXQPF-UHFFFAOYSA-N,5.963095191853927e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2017,Total,Vet,26627.086,ZEXGDYFACFXQPF-UHFFFAOYSA-N,7.750522499257684e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2018,Total,Vet,31275.343,ZEXGDYFACFXQPF-UHFFFAOYSA-N,8.890395821348391e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2019,Total,Vet,38554.181,ZEXGDYFACFXQPF-UHFFFAOYSA-N,1.1137228212016108e-8,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
rocuronium bromide,2016,Total,Human,4201,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.2062545094839426e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2017,Total,Human,5250.5,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.5282978536349215e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2018,Total,Human,5285,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.502325391469767e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2019,Total,Human,6153,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.7774301881431511e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
roflumilast,2016,Total,Human,136.6287,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.923089395380356e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.670344518309948e-4
roflumilast,2017,Total,Human,141.20925,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.1102712825139894e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.89318009823094e-4
roflumilast,2018,Total,Human,145.1148,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.125064308761721e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.910790843763954e-4
roflumilast,2019,Total,Human,136.0363,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.929709512486563e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.678225610103051e-4
romifidine,2016,Total,Vet,74.6,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.1420277649964795e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2017,Total,Vet,76.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.223825464578764e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2018,Total,Vet,49.2,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.3985697116426216e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2019,Total,Vet,51.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.4848027250212575e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
ropinirole,2016,Total,Human,6947.193105,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9947829114882182e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.116848299200341e-5
ropinirole,2017,Total,Human,6837.88758,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9903492832893796e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.1099207551396556e-5
ropinirole,2018,Total,Human,6481.99653,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.8425861824858886e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.879040910134201e-5
ropinirole,2019,Total,Human,6159.6087,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.7793392573588803e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.7802175896232505e-5
ropivacaine,2016,Total,Human,15131.475,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.344777422969184e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2017,Total,Human,16307,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.746586629697108e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2018,Total,Human,16020.725,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.554085516982873e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2019,Total,Human,15631.05,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.515374637148546e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
rosuvastatin,2016,Total,Human,102287.8436,BPRHUIZQVSMCRT-VEUZHWNKSA-N,2.9370429090190012e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.01631690505010556
rosuvastatin,2017,Total,Human,119689.1873,BPRHUIZQVSMCRT-VEUZHWNKSA-N,3.483872546498393e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.019354847480546628
rosuvastatin,2018,Total,Human,142017.5348,BPRHUIZQVSMCRT-VEUZHWNKSA-N,4.037020786451869e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.02242789325806594
rosuvastatin,2019,Total,Human,173128.051,BPRHUIZQVSMCRT-VEUZHWNKSA-N,5.0011868074400643e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.027784371152444802
rotigotine,2016,Total,Human,966.602,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.775453514344674e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002643289061280642
rotigotine,2017,Total,Human,936.432,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.725734721788509e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025959378302747704
rotigotine,2018,Total,Human,950.628,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.702275463088215e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025735956791316334
rotigotine,2019,Total,Human,893.172,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.5801249406861605e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002457261848272534
rufinamide,2016,Total,Human,43827.4,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.2584384405845405e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2017,Total,Human,38479.56,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1200500705992988e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2018,Total,Human,39283.96,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1166942400280545e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2019,Total,Human,38156,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1022204820216169e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rupatadine,2016,Total,Human,270.68,WUZYKBABMWJHDL-UHFFFAOYSA-N,7.772172592885349e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
rupatadine,2017,Total,Human,170.66,WUZYKBABMWJHDL-UHFFFAOYSA-N,4.9675137929975375e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ruxolitinib,2016,Total,Human,1009.96,HFNKQEVNSGCOJV-OAHLLOKOSA-N,2.8999495462946977e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2017,Total,Human,1403.92,HFNKQEVNSGCOJV-OAHLLOKOSA-N,4.0864830448055216e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2018,Total,Human,1772.68,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.039058041533826e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2019,Total,Human,2014.04,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.818000156229208e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
sacubitril,2016,Total,Human,10512.61008,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.018539232431885e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2017,Total,Human,33489.81272,PYNXFZCZUAOOQC-UTKZUKDTSA-N,9.748101875747356e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2018,Total,Human,67862.4016,PYNXFZCZUAOOQC-UTKZUKDTSA-N,1.9290711267700764e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2019,Total,Human,117765.8384,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.4019268048780754e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
safinamide,2016,Total,Human,77,NEMGRZFTLSKBAP-LBPRGKRZSA-N,2.2109401863904684e-11,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2017,Total,Human,1774.1,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.16399051925286e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2018,Total,Human,2206,NEMGRZFTLSKBAP-LBPRGKRZSA-N,6.270822731470778e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2019,Total,Human,1818.5,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.253139602045053e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
salbutamol,2016,Total,Human,44240.736,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.2703067675050846e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2017,Total,Human,45049.084,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.311273562240154e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2018,Total,Human,40589.565,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.1538076467022245e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2019,Total,Human,45475.561,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.3136621963943664e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salicylic acid,2016,Total,Human,6898.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.9808014124434604e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.9808014124434604e-5
salicylic acid,2017,Total,Human,8101,YGSDEFSMJLZEOE-UHFFFAOYSA-N,2.3580117916953622e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,2.358011791695362e-5
salicylic acid,2018,Total,Human,8751.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,2.4877200876911383e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,2.487720087691138e-5
salicylic acid,2019,Total,Human,5777,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.668814268958717e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.668814268958717e-5
salmeterol,2016,Total,Human,2013.138,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.780425590843811e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.627466177656278e-5
salmeterol,2017,Total,Human,1872.411,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.450150866436371e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.477341302925623e-5
salmeterol,2018,Total,Human,1761.201,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.006427590883529e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.2756489049470588e-5
salmeterol,2019,Total,Human,1623.759,GIIZNNXWQWCKIB-UHFFFAOYSA-N,4.690587136143565e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.1320850618834385e-5
sapropterin,2016,Total,Human,7272,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.088046368237855e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2017,Total,Human,10284,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.99343207823665e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2018,Total,Human,10692,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.039330763594087e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2019,Total,Human,12744,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.6813863672511494e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
saquinavir,2016,Total,Human,1860,QWAXKHKRTORLEM-UGJKXSETSA-N,5.340712658034117e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
saquinavir,2017,Total,Human,720,QWAXKHKRTORLEM-UGJKXSETSA-N,2.0957517467234422e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
sarolaner,2017,Total,Vet,21.2325,FLEFKKUZMDEUIP-QFIPXVFZSA-N,6.180284578097985e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2018,Total,Vet,339.66749999999996,FLEFKKUZMDEUIP-QFIPXVFZSA-N,9.6554609253937e-11,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2019,Total,Vet,28.5,FLEFKKUZMDEUIP-QFIPXVFZSA-N,8.232855576479736e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
saxagliptin,2016,Total,Human,2371.77395,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.810195245570204e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.168626574284425e-7
saxagliptin,2017,Total,Human,2300.15765,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.695221406564984e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.04760148059472e-7
saxagliptin,2018,Total,Human,2266.2689,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.442144394263496e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.781204625540522e-7
saxagliptin,2019,Total,Human,2118.3939,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.119449485191458e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.441525773885745e-7
scopolamine,2016,Total,Human,44.57,STECJAGHUSJQJN-USLFZFAMSA-N,1.279761092304197e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2017,Total,Human,49.73,STECJAGHUSJQJN-USLFZFAMSA-N,1.4475240883966219e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2018,Total,Human,44.759,STECJAGHUSJQJN-USLFZFAMSA-N,1.272328896817319e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2019,Total,Human,46.662,STECJAGHUSJQJN-USLFZFAMSA-N,1.3479351119638504e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
selamectin,2016,Total,Vet,3724.74,AFJYYKSVHJGXSN-XHKIUTQPSA-N,1.0695035519293551e-9,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2017,Total,Vet,3312.63,AFJYYKSVHJGXSN-XHKIUTQPSA-N,9.642291817706216e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2018,Total,Vet,3004.11,AFJYYKSVHJGXSN-XHKIUTQPSA-N,8.53954726919251e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2019,Total,Vet,2728.845,AFJYYKSVHJGXSN-XHKIUTQPSA-N,7.882872552841698e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selegiline,2016,Total,Human,8055.545,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3130296316593256e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2017,Total,Human,8197.21,MEZLKOACVSPNER-GFCCVEGCSA-N,2.386016274410954e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2018,Total,Human,8213.96,MEZLKOACVSPNER-GFCCVEGCSA-N,2.334917818830086e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2019,Total,Human,8113.04,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3436311089895843e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
sertindole,2016,Total,Human,470.36672,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.3505879007645107e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2017,Total,Human,380.9377599999999,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.1088207998790492e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2018,Total,Human,370.31064,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.0526529369979566e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2019,Total,Human,287.06552,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,8.292522691744052e-11,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertraline,2016,Total,Human,714581.3295,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.051813737449193e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2017,Total,Human,761735.099,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.217232867041395e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2018,Total,Human,779108.4285,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.2147102646048393e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2019,Total,Human,854781.554,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.469225643340672e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sevelamer,2016,Total,Human,1675254.24,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,4.810242755372756e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2017,Total,Human,1746681.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.084180566956749e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2018,Total,Human,1820013.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.173608179723959e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2019,Total,Human,1904202.72,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.500710870912238e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sildenafil,2016,Total,Human,114983.038,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.3015664865904194e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2017,Total,Human,132569.13999999998,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.85877787106423e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2018,Total,Human,147312.64800000002,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.1875408055827446e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2019,Total,Human,162538.39800000002,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.695281250408362e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
silver nitrate,2016,Total,Human,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7945943071351204e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2017,Total,Human,20,SQGYOTSLMSWVJD-UHFFFAOYSA-N,5.821532629787339e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2018,Total,Human,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7766383532045496e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2019,Total,Human,1,SQGYOTSLMSWVJD-UHFFFAOYSA-N,2.888721254905171e-13,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver sulfadiazine,2016,Total,Human,8238,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.3654188643486595e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2017,Total,Human,7642,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.224407617841742e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2018,Total,Human,7036.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.00021052357181e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2019,Total,Human,6227.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,1.7989511614921946e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
simeprevir,2016,Total,Human,63,JTZZSQYMACOLNN-VDWJNHBNSA-N,1.8089510615922013e-11,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,1.6749546866594455e-4
simeprevir,2017,Total,Human,21,JTZZSQYMACOLNN-VDWJNHBNSA-N,6.112609261276707e-12,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,5.659823390071025e-5
simvastatin,2016,Total,Human,2294448.885,RYMZZMVNJRMUDD-HGQWONQESA-N,6.58816785125364e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,3.29408392562682
simvastatin,2017,Total,Human,2024665.9194,RYMZZMVNJRMUDD-HGQWONQESA-N,5.893329357102742e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.9466646785513713
simvastatin,2018,Total,Human,1838137.0484,RYMZZMVNJRMUDD-HGQWONQESA-N,5.225127645813836e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.6125638229069184
simvastatin,2019,Total,Human,1689347.999800001,RYMZZMVNJRMUDD-HGQWONQESA-N,4.880055473953799e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.4400277369768997
sitagliptin,2016,Total,Human,667651.558,MFFMDFFZMYYVKS-SECBINFHSA-N,1.9170618962187098e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0022822165431175116
sitagliptin,2017,Total,Human,805702.4115,MFFMDFFZMYYVKS-SECBINFHSA-N,2.3452114392227986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0027919183800271413
sitagliptin,2018,Total,Human,920545.22,MFFMDFFZMYYVKS-SECBINFHSA-N,2.6167615099377914e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0031151922737354663
sitagliptin,2019,Total,Human,1017783.571,MFFMDFFZMYYVKS-SECBINFHSA-N,2.940093034440986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0035001107552868884
sodium amidotrizoate,2016,Total,Human,0.2296,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.592621646691579e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2017,Total,Human,0.2123,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.179556886519263e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2018,Total,Human,0.1981,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.63123292431714e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2019,Total,Human,0.1818,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.2516952414175994e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium phenylbutyrate,2016,Total,Human,1629.412,VPZRWNZGLKXFOE-UHFFFAOYSA-M,4.67861359868424e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2017,Total,Human,2586.248,VPZRWNZGLKXFOE-UHFFFAOYSA-M,7.527963560361124e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2018,Total,Human,4668.524,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3270846066009467e-9,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2019,Total,Human,461.168,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3321858036821078e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sofosbuvir,2016,Total,Human,23553.6,TTZHDVOVKQGIBA-IQWMDFIBSA-N,6.763065035606043e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2017,Total,Human,20339.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,5.920265823188534e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2018,Total,Human,67704,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.9245683690457733e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2019,Total,Human,56347.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.6277135429439263e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
solifenacin,2016,Total,Human,32045.152,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.20128757607674e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2017,Total,Human,31389.454,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.136736534610438e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2018,Total,Human,31586.715399999997,FBOUYBDGKBSUES-VXKWHMMOSA-N,8.978907205023485e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2019,Total,Human,33839.6869,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.775342280736606e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
sorafenib,2016,Total,Human,6899.2,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.9810024070058596e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.11652955335328585
sorafenib,2017,Total,Human,4838.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.408345173798153e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08284383375283252
sorafenib,2018,Total,Human,5174.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.4708859991714591e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08652270583361524
sorafenib,2019,Total,Human,7145.6,MLDQJTXFUGDVEO-UHFFFAOYSA-N,2.064164659905038e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.1214214505826493
sotalol,2016,Total,Human,211630.16,ZBMZVLHSJCTVON-UHFFFAOYSA-N,6.076644485665516e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2017,Total,Human,196055.88,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.706728513408357e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2018,Total,Human,176920.36,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.029175952620097e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2019,Total,Human,158257.8,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4.5716267061453147e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
spiramycin,2016,Total,Human,12807.96,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.677614736322293e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2017,Total,Human,10700.58,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.114688781382491e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2018,Total,Human,8354.5,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3748680194955852e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2019,Total,Human,8231.74,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3779202302853086e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spironolactone,2016,Total,Human,216466.675,LXMSZDCAJNLERA-ZHYRCANASA-N,6.215517802231492e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2017,Total,Human,222218.45,LXMSZDCAJNLERA-ZHYRCANASA-N,6.468259788078834e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2018,Total,Human,231659.475,LXMSZDCAJNLERA-ZHYRCANASA-N,6.585201730691689e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2019,Total,Human,243515.625,LXMSZDCAJNLERA-ZHYRCANASA-N,7.034487618390169e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
stiripentol,2016,Total,Human,12165.75,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.493213710724654e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2017,Total,Human,11735.85,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.416031685664488e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2018,Total,Human,15855,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.506976174409301e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2019,Total,Human,17010,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.913714854593695e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
streptozocin,2019,Total,Human,92,ZSJLQEPLLKMAKR-GKHCUFPYSA-N,2.6576235545127567e-11,antineoplastic,alkylating agent for pancreatic cancer,NA,NA,NA,NA
sucralfate,2016,Total,Human,383530.2,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.1012497816550309e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2017,Total,Human,422074.8,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2285611102054828e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2018,Total,Human,428604.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2183605931518314e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2019,Total,Human,487990.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.409668818413927e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sufentanil,2016,Total,Human,0.99815,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.8660388922670725e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2017,Total,Human,0.8852500000000001,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.5767558802596216e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2018,Total,Human,0.9484,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.6959421026867123e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2019,Total,Human,1.11825,GGCSSNBKKAUURC-UHFFFAOYSA-N,3.230312543297707e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sugammadex,2016,Total,Human,1915,WHRODDIHRRDWEW-VTHZAVIASA-N,5.498636957062008e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,5.498636957062008e-7
sugammadex,2017,Total,Human,2108,WHRODDIHRRDWEW-VTHZAVIASA-N,6.135895391795857e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.135895391795857e-7
sugammadex,2018,Total,Human,2350,WHRODDIHRRDWEW-VTHZAVIASA-N,6.680160208049105e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.680160208049105e-7
sugammadex,2019,Total,Human,3229,WHRODDIHRRDWEW-VTHZAVIASA-N,9.327680932088795e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,9.327680932088795e-7
sulfadiazine,2016,Total,Vet,1076297.5836,SEEPANYCNGTZFQ-UHFFFAOYSA-N,3.090428026098954e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2017,Total,Vet,1008298.9074,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.934922495004012e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2018,Total,Vet,937990.3008,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.6663512693362434e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2019,Total,Vet,963879.6822,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.784379725142381e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadoxine,2016,Total,Vet,52700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.5132019197763336e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2017,Total,Vet,50700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.4757585216510908e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2018,Total,Vet,69900,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.986992334223968e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2019,Total,Vet,104140,PJSFRIWCGOHTNF-UHFFFAOYSA-N,3.0083143148582445e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfamethoxazole,2016,Total,Human,1420137.76,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.077713823109795e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2017,Total,Human,1478592.4,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.303836951377788e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2018,Total,Human,1629399.2,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.631764978241297e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2019,Total,Human,1759706,JLKIGFTWXXRPMT-UHFFFAOYSA-N,5.083300124584158e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfanilamide,2016,Total,Vet,1250,FDDDEECHVMSUSB-UHFFFAOYSA-N,3.5891886142702405e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfasalazine,2016,Total,Human,2687662,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.717220679525427e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2017,Total,Human,2588001.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.533067589094291e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2018,Total,Human,2561204.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.280534632160131e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2019,Total,Human,2272402,NCEXYHBECQHGNR-UHFFFAOYSA-N,6.56433595708902e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfathiazole,2016,Total,Vet,10120,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.905807102113187e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2017,Total,Vet,7690,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.238379296153232e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2018,Total,Vet,6580,JNMRHUJNCSQMMB-UHFFFAOYSA-N,1.8704448582537503e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2019,Total,Vet,3000,JNMRHUJNCSQMMB-UHFFFAOYSA-N,8.66616376471551e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sumatriptan,2016,Total,Human,136688.55,KQKPFRSPSRPDEB-UHFFFAOYSA-N,3.9248078988888685e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.5699231595555475e-4
sumatriptan,2017,Total,Human,145086.492,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.2231287365968994e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.6892514946387598e-4
sumatriptan,2018,Total,Human,146788.308,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.1726358047168354e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.669054321886734e-4
sumatriptan,2019,Total,Human,153388.296,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.4309603090888574e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.772384123635543e-4
suxamethonium,2016,Total,Human,7300,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.096086150733821e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2017,Total,Human,7064,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.0561653248408886e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2018,Total,Human,6366,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.809612761040026e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2019,Total,Human,4928,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.423561834417268e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxibuzone,2016,Total,Vet,82566,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3707595770066937e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2017,Total,Vet,79515,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3144958352877022e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2018,Total,Vet,68823,ONWXNHPOAGOMTG-UHFFFAOYSA-N,1.9563773021215475e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2019,Total,Vet,71199,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.056740646279932e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
tacrolimus,2016,Total,Human,4975.231,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.4285633966851472e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2017,Total,Human,5531.2725,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.6100241671497699e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2018,Total,Human,6047.978,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.719211147861975e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2019,Total,Human,6737.598,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.9463042549606566e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tadalafil,2016,Total,Human,24370.78,WOXKDUGGOYFFRN-IIBYNOLFSA-N,6.9977060877507925e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.4578554349480816e-4
tadalafil,2017,Total,Human,26047.2452,WOXKDUGGOYFFRN-IIBYNOLFSA-N,7.581744392393584e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.5795300817486634e-4
tadalafil,2018,Total,Human,31090.7,WOXKDUGGOYFFRN-IIBYNOLFSA-N,8.837908807676271e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.841231001599223e-4
tadalafil,2019,Total,Human,36057.74,WOXKDUGGOYFFRN-IIBYNOLFSA-N,1.0416075994184435e-8,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,2.1700158321217574e-4
tafamidis,2018,Total,Human,3.6,TXEIIPDJKFWEEC-UHFFFAOYSA-N,1.0233436914458206e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafamidis,2019,Total,Human,10.8,TXEIIPDJKFWEEC-UHFFFAOYSA-N,3.1198189552975847e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafluprost,2016,Total,Human,12.05685,WSNODXPBBALQOF-VEJSHDCNSA-N,3.4619446995171325e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2017,Total,Human,14.321745,WSNODXPBBALQOF-VEJSHDCNSA-N,4.168725291649685e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2018,Total,Human,16.55181,WSNODXPBBALQOF-VEJSHDCNSA-N,4.705052873752735e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2019,Total,Human,18.6948,WSNODXPBBALQOF-VEJSHDCNSA-N,5.400406611620119e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tamoxifen,2016,Total,Human,28435.44,NKANXQFJJICGDU-QPLCGJKRSA-N,8.164812599181166e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.0800471823449134
tamoxifen,2017,Total,Human,30268.52,NKANXQFJJICGDU-QPLCGJKRSA-N,8.810458841768536e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.086377047468319
tamoxifen,2018,Total,Human,30379.12,NKANXQFJJICGDU-QPLCGJKRSA-N,8.635633556576543e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08466307408408376
tamoxifen,2019,Total,Human,31762.74,NKANXQFJJICGDU-QPLCGJKRSA-N,9.175370215202666e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08995460995296733
tamsulosin,2016,Total,Human,8000.67796,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.2972753792379887e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2017,Total,Human,8528.67572,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.4824981996427518e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2018,Total,Human,9143.26032,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.599082713255248e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2019,Total,Human,9985.11236,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.884420630694833e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tapentadol,2016,Total,Human,87252.395,KWTWDQCKEHXFFR-SMDDNHRTSA-N,2.5053224216144777e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2017,Total,Human,121340.285,KWTWDQCKEHXFFR-SMDDNHRTSA-N,3.5319321421759774e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2018,Total,Human,144810.5,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.1164142119476396e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2019,Total,Human,157934.555,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.562289059124896e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tedizolid,2016,Total,Human,154.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,4.4448511799122665e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,1.4816170599707555e-5
tedizolid,2017,Total,Human,318,XFALPSLJIHVRKE-GFCCVEGCSA-N,9.256236881361871e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,3.08541229378729e-5
tedizolid,2018,Total,Human,104.4,XFALPSLJIHVRKE-GFCCVEGCSA-N,2.96769670519288e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,9.892322350642933e-6
tedizolid,2019,Total,Human,208.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,6.031649980241996e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,2.0105499934139986e-5
teicoplanin,2016,Total,Human,83.19999999999999,BJNLLBUOHPVGFT-CAYRISATSA-N,2.388963941658272e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2017,Total,Human,62,BJNLLBUOHPVGFT-CAYRISATSA-N,1.8046751152340755e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2018,Total,Human,53.2,BJNLLBUOHPVGFT-CAYRISATSA-N,1.5122745662477126e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
telbivudine,2016,Total,Human,168,IQFYYKKMVGJFEH-CSMHCCOUSA-N,4.823869497579204e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,high,9.49e-5,5.083108005879034e-7
telmisartan,2016,Total,Human,192901.0776,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.538866811219043e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011303809818814373
telmisartan,2016,Total,Vet,236.2,RMMXLENWKUUMAY-UHFFFAOYSA-N,6.782130805525047e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.3841083276581728e-6
telmisartan,2017,Total,Human,187423.3088,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.455454538809545e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011133580691448052
telmisartan,2017,Total,Vet,248.72,RMMXLENWKUUMAY-UHFFFAOYSA-N,7.239657978403536e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.4774812200823544e-6
telmisartan,2018,Total,Human,190488.4576,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.4148655938390185e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011050746109875548
telmisartan,2018,Total,Vet,260.36,RMMXLENWKUUMAY-UHFFFAOYSA-N,7.401048986245385e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.5104181604582419e-6
telmisartan,2019,Total,Human,187408.5584,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.4137108600121697e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011048389510228919
telmisartan,2019,Total,Vet,323.14,RMMXLENWKUUMAY-UHFFFAOYSA-N,9.334613863100567e-11,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,1.9050232373674627e-6
temozolomide,2016,Total,Human,4205.3,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.2074891903672515e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,1.6099855871563355e-5
temozolomide,2017,Total,Human,5184.75,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.5091595651144955e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.0122127534859943e-5
temozolomide,2018,Total,Human,5879.1,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.671205526771979e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.228274035695972e-5
temozolomide,2019,Total,Human,5574.7,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.610375437971985e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.1471672506293138e-5
tenofovir alafenamide,2016,Total,Human,1915.35,LDEKQSIMHVQZJK-CAQYMETFSA-N,5.499641929874004e-10,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,5.499641929874004e-7
tenofovir alafenamide,2017,Total,Human,9023.4,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.6265008765811543e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.6265008765811544e-6
tenofovir alafenamide,2018,Total,Human,10650.9,LDEKQSIMHVQZJK-CAQYMETFSA-N,3.0276475897834133e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,3.0276475897834133e-6
tenofovir alafenamide,2019,Total,Human,7790.1,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.250342744783677e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.250342744783677e-6
tenofovir disoproxil,2016,Total,Human,227416.35,JFVZFKDSXNQEJW-CQSZACIVSA-N,6.529921392951168e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2017,Total,Human,165110.4,JFVZFKDSXNQEJW-CQSZACIVSA-N,4.805977905586198e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2018,Total,Human,176664.6,JFVZFKDSXNQEJW-CQSZACIVSA-N,5.0219056642166474e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2019,Total,Human,260675.1,JFVZFKDSXNQEJW-CQSZACIVSA-N,7.530177019945309e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
terazosin,2016,Total,Human,625.77914,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7968314914686584e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2017,Total,Human,613.15072,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7847384617288004e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2018,Total,Human,402.0905,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.14299104601471e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2019,Total,Human,378.028,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.0920175185492918e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terbinafine,2016,Total,Human,602958.62,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7313057710240773e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.2666146623095798
terbinafine,2017,Total,Human,615505.815,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.791593592923175e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.380365269666368
terbinafine,2018,Total,Human,638414.885,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.814771791916275e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.4240977205967456
terbinafine,2019,Total,Human,611014.7100000001,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7650511798367194e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.3302852449749425
terbutaline,2016,Total,Human,7447.31,XWTYSIMOBUGWOL-UHFFFAOYSA-N,2.138384020715272e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,8.909933419646967e-6
terbutaline,2017,Total,Human,6583.112499999999,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.916190211215545e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,7.984125880064771e-6
terbutaline,2018,Total,Human,5325.1125,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.5137278564206339e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.3071994017526415e-6
terbutaline,2019,Total,Human,5165.37,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.492131410844952e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.217214211853967e-6
teriflunomide,2016,Total,Human,5294.744,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.5203067904220535e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.067689301406845e-5
teriflunomide,2017,Total,Human,5747.896,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6730782058312064e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.576927352770688e-5
teriflunomide,2018,Total,Human,5942.72,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6892902838969187e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.630967612989729e-5
teriflunomide,2019,Total,Human,5944.68,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.717252346960967e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.72417448986989e-5
testosterone,2016,Total,Human,96412.3,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.7683354354848542e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2017,Total,Human,107058.65,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1162271213799125e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2018,Total,Human,103507.86,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.942336542946033e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2019,Total,Human,107993.53,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1196320550323916e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
tetrabenazine,2017,Total,Human,84,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.4450437045106828e-11,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2018,Total,Human,425.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,1.20981965299817e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2019,Total,Human,789.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.2809343028731223e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetracaine,2016,Total,Human,1543.9,GKCBAIGFKIBETG-UHFFFAOYSA-N,4.43307864125746e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2017,Total,Human,1059.6,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.0842479872613326e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2018,Total,Human,1220.4,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.469135114001332e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2019,Total,Human,1359.05,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.9259166214788715e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracycline,2016,Total,Human,759502,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.1807967447323814e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2017,Total,Human,695828,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.025392703359833e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2018,Total,Human,615128,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.748575995088013e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2019,Total,Human,598636,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.7292925371514117e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetryzoline,2016,Total,Human,285.6848,BYJAVTDNIXVSPW-UHFFFAOYSA-N,8.203013051440567e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2017,Total,Human,294.4928,BYJAVTDNIXVSPW-UHFFFAOYSA-N,8.571997222187185e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2018,Total,Human,277.4072,BYJAVTDNIXVSPW-UHFFFAOYSA-N,7.885636335601361e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2019,Total,Human,328.544,BYJAVTDNIXVSPW-UHFFFAOYSA-N,9.490720359715641e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
thalidomide,2016,Total,Human,2161.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,6.206712086885242e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2017,Total,Human,953.4,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.775124604619625e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2018,Total,Human,754.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.145042082125045e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2019,Total,Human,784,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.2647574638456536e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
theophylline,2016,Total,Human,358271.19,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,1.0287223007752401e-7,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2017,Total,Human,331665.26,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,9.65400066628451e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2018,Total,Human,282589.38,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,8.032946091460716e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2019,Total,Human,250207.92,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,7.227809366496124e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
thiamazole,2016,Total,Vet,855.2,PMRYVIKBURPHAH-UHFFFAOYSA-N,2.455579282339128e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2017,Total,Vet,1147.775,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.3409048070770823e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2018,Total,Vet,1379.275,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.9207565833859286e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2019,Total,Vet,1568.675,PMRYVIKBURPHAH-UHFFFAOYSA-N,4.5314648145383674e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiopental,2016,Total,Human,28305,IUJDSEJGGMCXSG-UHFFFAOYSA-N,8.127358698153533e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2017,Total,Human,26995,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.857613667055463e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2018,Total,Human,26225,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.45477453004629e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2019,Total,Human,24325,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.026814452556827e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiosulfate,2016,Total,Human,9705,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.786646040119415e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2017,Total,Human,12195,DHCDFWKWKRSZHF-UHFFFAOYSA-M,3.54967952101283e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2018,Total,Human,8400,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.3878019467069147e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2019,Total,Human,14745,DHCDFWKWKRSZHF-UHFFFAOYSA-M,4.259419490357674e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiotepa,2016,Total,Human,9.92,FOCVUCIESVLUNU-UHFFFAOYSA-N,2.848380084284863e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2017,Total,Human,12.445,FOCVUCIESVLUNU-UHFFFAOYSA-N,3.622448678885173e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2018,Total,Human,21.13,FOCVUCIESVLUNU-UHFFFAOYSA-N,6.006458944513941e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2019,Total,Human,16.064999999999998,FOCVUCIESVLUNU-UHFFFAOYSA-N,4.640730696005156e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
tiamulin,2016,Total,Vet,59790,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.7167806979777416e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2017,Total,Vet,42310,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.2315452278315118e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2018,Total,Vet,34025,UURAUHCOJAIIRQ-QGLSALSOSA-N,9.672019194845568e-9,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2019,Total,Vet,45030,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.3007911810837985e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tibolone,2016,Total,Human,4755.3492,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3654276164415276e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2017,Total,Human,4531.9197,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3191359204563027e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2018,Total,Human,4267.83,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.2131824740731155e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2019,Total,Human,4168.3635,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.204124024062091e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
ticagrelor,2016,Total,Human,387609.4764,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1129628155825037e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002099929840721705
ticagrelor,2017,Total,Human,386672.9004,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1255144533665553e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002123612176163312
ticagrelor,2018,Total,Human,385345.3596,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.0953909521516144e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0020667753814181404
ticagrelor,2019,Total,Human,400039.44,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1556024331283617e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0021803819492987957
ticlopidine,2016,Total,Human,16633.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.776061505237124e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2017,Total,Human,15354.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.469336138203486e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2018,Total,Human,13498.25,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.83704138418293e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2019,Total,Human,11178.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.229157054795745e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
tigecycline,2016,Total,Human,66,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.8950915883346872e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2017,Total,Human,43,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.2516295154042782e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2018,Total,Human,39.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.1228354392252754e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2019,Total,Human,45.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.3143681709818526e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tiludronic acid,2016,Total,Vet,131,DKJJVAGXPKPDRL-UHFFFAOYSA-N,3.761469667755212e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2017,Total,Vet,94,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.73612033600005e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2018,Total,Vet,81.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.316736412578733e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2019,Total,Vet,38.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,1.1121576831384906e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
timolol,2016,Total,Human,10924.096,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.136691278751606e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2017,Total,Human,11247.6531,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.273928976508936e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2018,Total,Human,12316.64175,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.501154898516864e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2019,Total,Human,12960.5875,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.743952458730827e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
tiotropium bromide,2016,Total,Human,128.35005,DQHNAVOVODVIMG-RGECMCKFSA-M,3.6853803048081294e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2017,Total,Human,120.37791,DQHNAVOVODVIMG-RGECMCKFSA-M,3.503919654853019e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2018,Total,Human,113.09136,DQHNAVOVODVIMG-RGECMCKFSA-M,3.2147591614730063e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2019,Total,Human,109.02105,DQHNAVOVODVIMG-RGECMCKFSA-M,3.1493142436707934e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tipiracil,2017,Total,Human,32.1004,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,9.343676301461275e-12,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2018,Total,Human,109.648,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.116877474434759e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2019,Total,Human,105.4338,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.045688590454208e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tivozanib,2019,Total,Human,0.14973,SPMVMDHWKHCIDT-UHFFFAOYSA-N,4.3252823349695124e-14,antineoplastic,vascular endothelial growth factor inhibitor for carcinomas,NA,NA,NA,NA
tobramycin,2016,Total,Human,8141.445000000001,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.3376945358165907e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.583714776110962e-4
tobramycin,2017,Total,Human,7700.825,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.2415302006891046e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.395157256253146e-4
tobramycin,2018,Total,Human,6408.112,NLVFBUXFDBBNBW-PBSUHMDJSA-N,1.82158360813285e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.5717325649663726e-4
tobramycin,2019,Total,Human,7014.999,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.0264376714438513e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.973407198909512e-4
toceranib,2016,Total,Vet,22.6,SRSGVKWWVXWSJT-ATVHPVEESA-N,6.489253014600596e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2017,Total,Vet,29.7,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.644975955234199e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2018,Total,Vet,0.3,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.527864095381839e-14,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
tofacitinib,2017,Total,Human,74.48,UJLAWZDWDVHWOW-YPMHNXCESA-N,2.1679387513328056e-11,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2018,Total,Human,1246.77,UJLAWZDWDVHWOW-YPMHNXCESA-N,3.544095039399737e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2019,Total,Human,1742.23,UJLAWZDWDVHWOW-YPMHNXCESA-N,5.032816831933436e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tolfenamic acid,2016,Total,Human,5740,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6481554116728947e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2017,Total,Human,5654,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6457472744408811e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2018,Total,Human,6188,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.7590141007407603e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2019,Total,Human,6716,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.940065194794312e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolterodine,2016,Total,Human,8240.384320000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.366103486284402e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2017,Total,Human,7516.001920000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.187732521141215e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2018,Total,Human,6333.6224,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.8004090352888715e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2019,Total,Human,5581.835840000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.6124367832399459e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
toltrazuril,2016,Total,Vet,289252.16,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.30544447460059e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2017,Total,Vet,304975,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.877109568846971e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2018,Total,Vet,292275,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.308271594925757e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2019,Total,Vet,294300,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.501506653185917e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
tolvaptan,2016,Total,Human,460.29,GYHCTFXIZSNGJT-UHFFFAOYSA-N,1.321654101809959e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,6.608270509049795e-6
tolvaptan,2017,Total,Human,1392.84,GYHCTFXIZSNGJT-UHFFFAOYSA-N,4.0542317540365004e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,2.02711587701825e-5
tolvaptan,2018,Total,Human,2364.285,GYHCTFXIZSNGJT-UHFFFAOYSA-N,6.720767054249949e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,3.360383527124974e-5
tolvaptan,2019,Total,Human,3174.18,GYHCTFXIZSNGJT-UHFFFAOYSA-N,9.169321232894894e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,4.5846606164474465e-5
topiramate,2016,Total,Human,174637.829,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.0144648597413863e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.391897698646652e-4
topiramate,2017,Total,Human,178766.903,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.2034867947026414e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.595147091078109e-4
topiramate,2018,Total,Human,179698.065,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.1081355884103056e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.492618912269146e-4
topiramate,2019,Total,Human,185006.215,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.3443138556005584e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.74657403828017e-4
topotecan,2016,Total,Human,2.498,UCFGDBYHRUNTLO-QHCPKHFHSA-N,7.17263452675765e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2017,Total,Human,0.8325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,2.4232129571489804e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2018,Total,Human,1.3325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.7877929690320994e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2019,Total,Human,1.2625,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.6470105843177783e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
torasemide,2018,Total,Vet,1.8,NGBFQHCMQULJNZ-UHFFFAOYSA-N,5.116718457229103e-13,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
torasemide,2019,Total,Vet,10.89,NGBFQHCMQULJNZ-UHFFFAOYSA-N,3.145817446591731e-12,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
trabectedin,2016,Total,Human,0.25225000000000003,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.242982623597347e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2017,Total,Human,0.289,PKVRCIRHQMSYJX-AIFWHQITSA-N,8.412114650042706e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2018,Total,Human,0.36625,PKVRCIRHQMSYJX-AIFWHQITSA-N,1.041110074977866e-13,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2019,Total,Human,0.27399999999999997,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.915096238440167e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
tramadol,2016,Total,Human,2502289.3175,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.184950662384841e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2017,Total,Human,2555566.15,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.438655864902504e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2018,Total,Human,2494378.925,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.090574824928215e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2019,Total,Human,2404390.2125,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,6.945613111934709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
trametinib,2016,Total,Human,24.42,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,7.011838876838343e-12,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2017,Total,Human,44.474999999999994,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2945633185489595e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2018,Total,Human,44.37,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2612710997069735e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2019,Total,Human,35.4,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.0226073242364304e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
travoprost,2016,Total,Human,12.95085,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.71864346920974e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2017,Total,Human,11.07165,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.2226985870292506e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2018,Total,Human,12.309325,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.4990750235295346e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2019,Total,Human,10.812275,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.1233648606379802e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
treosulfan,2019,Total,Human,1247,YCPOZVAOBBQLRI-WDSKDSINSA-N,3.602235404866747e-10,antineoplastic,"alkylating agent, pre-bone marrow transplantation",NA,NA,NA,NA
treprostinil,2016,Total,Human,34.57,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.926260031625778e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2017,Total,Human,33.79,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.835479378025712e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2018,Total,Human,34.379999999999995,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.772932253307584e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2019,Total,Human,33.21,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.593443287540072e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
tretinoin,2016,Total,Human,95.0475,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.729147238518806e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2017,Total,Human,106.53,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.1008393552562266e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2018,Total,Human,105.3975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.996051853310024e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2019,Total,Human,111.6975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.226629423697703e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
triamcinolone,2016,Total,Human,6909.47035,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.983951384868625e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.9839513848686247e-4
triamcinolone,2017,Total,Human,6813.31195,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.9831958916922507e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.9831958916922504e-4
triamcinolone,2017,Total,Vet,12.744,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.709480591700493e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.7094805917004925e-7
triamcinolone,2018,Total,Human,6618.593800000001,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.8814156142978952e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.881415614297895e-4
triamcinolone,2018,Total,Vet,9.69075,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.7547132994107178e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.7547132994107173e-7
triamcinolone,2019,Total,Human,6999.12325,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.0218516097975955e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.0218516097975954e-4
triamcinolone,2019,Total,Vet,7.83225,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.2625187048731023e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.2625187048731022e-7
tricaine mesilate,2016,Total,Vet,5447000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.5640248305544e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2017,Total,Vet,5504000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.602085779717476e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2018,Total,Vet,5756000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.636212857767262e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2019,Total,Vet,5653000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.632994125397893e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
trientine,2019,Total,Human,21.6,VILCJCGEZXAXTO-UHFFFAOYSA-N,6.239637910595169e-12,chelating agent,iron-chelating agent for copper build-up from Wilson's disease,NA,NA,NA,NA
trifluridine,2017,Total,Human,78.4,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,2.2820407908766374e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2018,Total,Human,267.8,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.612540015810854e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2019,Total,Human,257.5,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.438457231380814e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trilostane,2016,Total,Vet,3720.3,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.068228672133566e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2017,Total,Vet,3850.5,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.1207905695498074e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2018,Total,Vet,4262.1,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.2115536520308975e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2019,Total,Vet,4884.9,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.4111114458086266e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trimethoprim,2016,Total,Human,571679.532,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.641492533812592e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2016,Total,Vet,227053.5244,IEDVJHCEMCRBQM-UHFFFAOYSA-N,6.519503396851282e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2017,Total,Human,563572.4400000001,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.6404276743544342e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2017,Total,Vet,212978.4526,IEDVJHCEMCRBQM-UHFFFAOYSA-N,6.199305056262582e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2018,Total,Human,591461.06,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.681299845796828e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2018,Total,Vet,202683.0232,IEDVJHCEMCRBQM-UHFFFAOYSA-N,5.76151092096908e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2019,Total,Human,628483.9400000001,IEDVJHCEMCRBQM-UHFFFAOYSA-N,1.815514915844546e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2019,Total,Vet,214736.6218,IEDVJHCEMCRBQM-UHFFFAOYSA-N,6.203142436001932e-8,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimipramine,2016,Total,Human,77649.3,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.2295838677284336e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2017,Total,Human,74164.78,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.1587634337549975e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2018,Total,Human,70475.37,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.0033479247725008e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2019,Total,Human,35509.555,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,1.0257720628072416e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
tropicamide,2016,Total,Human,346.4,BGDKAVGWHJFAGW-UHFFFAOYSA-N,9.946359487865692e-11,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2017,Total,Human,348.65,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.014838675687678e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2018,Total,Human,356.2,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0125417302583368e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2019,Total,Human,352.45,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0181298062913271e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
ulipristal,2016,Total,Human,3879.52,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.1139463210266947e-9,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0023700985553759464
ulipristal,2017,Total,Human,3669.06,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.0679776255323767e-9,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0022722928202816525
ulipristal,2018,Total,Human,2802.09,HKDLNTKNLJPAIY-WKWWZUSTSA-N,7.965280901009499e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0016947406172360636
ulipristal,2019,Total,Human,2789.7799999999997,HKDLNTKNLJPAIY-WKWWZUSTSA-N,8.058896782509346e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0017146588898956055
umeclidinium bromide,2016,Total,Human,83.67060000000001,PEJHHXHHNGORMP-UHFFFAOYSA-M,2.4024765189532772e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,2.518319202257104e-6
umeclidinium bromide,2017,Total,Human,133.8126,PEJHHXHHNGORMP-UHFFFAOYSA-M,3.8949720858834067e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,4.082779964238372e-6
umeclidinium bromide,2018,Total,Human,184.46145,PEJHHXHHNGORMP-UHFFFAOYSA-M,5.2435405881235734e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,5.4963737821001815e-6
umeclidinium bromide,2019,Total,Human,249.24749999999997,PEJHHXHHNGORMP-UHFFFAOYSA-M,7.200065509819764e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,7.547238479894931e-6
ursodeoxycholic acid,2016,Total,Human,638521.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.8334185603756817e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2017,Total,Human,675813,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.967133715567236e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2018,Total,Human,723487.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.056600314247181e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2019,Total,Human,777307.75,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.2454254190275147e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
valaciclovir,2016,Total,Human,1190973.91,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.419703998131928e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.001709851999065964
valaciclovir,2017,Total,Human,1372743.409999999,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.9957352768202675e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0019978676384101337
valaciclovir,2018,Total,Human,1685439.98,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4.791067696787694e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.002395533848393847
valaciclovir,2019,Total,Human,1955930.05,HDOVUKNUBWVHOX-QMMMGPOBSA-N,5.650136708542733e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0028250683542713666
valganciclovir,2016,Total,Human,38610,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.108628579175792e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2017,Total,Human,45603,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3273967625809605e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2018,Total,Human,39771,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.1305389431247702e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2019,Total,Human,46013,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3291873110195162e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valproic acid,2016,Total,Human,5039748.3,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.447088577371824e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2017,Total,Human,5053161.15,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4708571259149362e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2018,Total,Human,5088836.65,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.446563578493273e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2019,Total,Human,5090799.85,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4705901731163052e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valsartan,2016,Total,Human,5444853.22112,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.563408415009324e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002791800741088079
valsartan,2017,Total,Human,5833926.01488,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6981195327694572e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.003032356308516888
valsartan,2018,Total,Human,5759581.4616,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6372309316935163e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002923626663738422
valsartan,2019,Total,Human,6585188.6816,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.9022774512098876e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.0033969240200176568
vancomycin,2016,Total,Human,70943,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0370224628973895e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2017,Total,Human,68898,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0054597756354408e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2018,Total,Human,66420.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,1.8880833238243645e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2019,Total,Human,71977.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0792293412493692e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vandetanib,2016,Total,Human,174,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.996150551064175e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.9961505510641754e-5
vandetanib,2017,Total,Human,159,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.6281184406809357e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.628118440680936e-5
vandetanib,2018,Total,Human,78,UHTHHESEBZOYNR-UHFFFAOYSA-N,2.217244664799278e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,2.2172446647992782e-5
vandetanib,2019,Total,Human,33,UHTHHESEBZOYNR-UHFFFAOYSA-N,9.532780141187063e-12,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,9.532780141187063e-6
vardenafil,2016,Total,Human,3477.78,SECKRCOLJRRGGV-UHFFFAOYSA-N,9.985926703149406e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2017,Total,Human,3440.2799999999997,SECKRCOLJRRGGV-UHFFFAOYSA-N,1.0013851137802395e-9,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2018,Total,Human,2986.24,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.488749625397685e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2019,Total,Human,2997.28,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.65830644290217e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
varenicline,2016,Total,Human,1794.48112,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.152584963541526e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2017,Total,Human,1721.50796,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.01090738078932e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2018,Total,Human,1538.3765,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.3730219065097255e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2019,Total,Human,1447.68306,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.1819528257881567e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
vecuronium,2016,Total,Human,260,BGSZAXLLHYERSY-XQIGCQGXSA-N,7.465512317682101e-11,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
vedaprofen,2016,Total,Vet,1737,VZUGVMQFWFVFBX-UHFFFAOYSA-N,4.987536498389927e-10,analgesic,veterinary NSAID,NA,NA,NA,NA
velpatasvir,2016,Total,Human,408.8,FHCUMDQMBHQXKK-CDIODLITSA-N,1.1738082444109396e-10,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2017,Total,Human,4194.4,FHCUMDQMBHQXKK-CDIODLITSA-N,1.2208918231190007e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2018,Total,Human,16290.4,FHCUMDQMBHQXKK-CDIODLITSA-N,4.630743908646943e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2019,Total,Human,10329.2,FHCUMDQMBHQXKK-CDIODLITSA-N,2.983817958616648e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
vemurafenib,2016,Total,Human,7190.4,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.064616144963899e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2017,Total,Human,4139.52,GPXBXXGIAQBQNI-UHFFFAOYSA-N,1.2049175375828647e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2018,Total,Human,3454.08,GPXBXXGIAQBQNI-UHFFFAOYSA-N,9.81864160485883e-10,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2019,Total,Human,7620.48,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.201344254857975e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
venetoclax,2017,Total,Human,1.19,LQBVNQSMGBZMKD-UHFFFAOYSA-N,3.4638119147234674e-13,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2018,Total,Human,604.59,LQBVNQSMGBZMKD-UHFFFAOYSA-N,1.7186204511423018e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2019,Total,Human,2093.9100000000003,LQBVNQSMGBZMKD-UHFFFAOYSA-N,6.048722322858486e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venlafaxine,2016,Total,Human,1370348.3595,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.934750983601042e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2017,Total,Human,1367537.226,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.980581291803933e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2018,Total,Human,1355433.264,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.852983555250604e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2019,Total,Human,1388562.3345,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4.011169529430894e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
verapamil,2016,Total,Human,768375.1111999999,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.206274560486136e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2017,Total,Human,762674.224,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.2199664404568698e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2018,Total,Human,740412.9216,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1047135899564695e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2019,Total,Human,728917.0784,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1056382574374586e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
vernakalant,2016,Total,Human,2,VBHQKCBVWWUUKN-KZNAEPCWSA-N,5.742701782832385e-13,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2017,Total,Human,6,VBHQKCBVWWUUKN-KZNAEPCWSA-N,1.7464597889362021e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2018,Total,Human,11,VBHQKCBVWWUUKN-KZNAEPCWSA-N,3.1268835016400072e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2019,Total,Human,9,VBHQKCBVWWUUKN-KZNAEPCWSA-N,2.5998491294146532e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
verteporfin,2016,Total,Human,3.315,NJLRKAMQPVVOIU-IDLGWYNRSA-N,9.51852820504468e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2017,Total,Human,3.06,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.906944923574631e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2018,Total,Human,2.85,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.101470890612746e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2019,Total,Human,2.46,NJLRKAMQPVVOIU-IDLGWYNRSA-N,7.106254287066719e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
vigabatrin,2016,Total,Human,42639.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2243296633454077e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2017,Total,Human,43862,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2767203210386615e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2018,Total,Human,39305.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.1173065406701028e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2019,Total,Human,43813.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2656498870178769e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vilanterol,2016,Total,Human,119.1465,DAFYYTQWSAWIGS-DEOSSOPVSA-N,3.4211140898411936e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2017,Total,Human,163.98558,DAFYYTQWSAWIGS-DEOSSOPVSA-N,4.7732370239230105e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2018,Total,Human,201.80028,DAFYYTQWSAWIGS-DEOSSOPVSA-N,5.736417874166672e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2019,Total,Human,248.78238,DAFYYTQWSAWIGS-DEOSSOPVSA-N,7.186629489518949e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vildagliptin,2016,Total,Human,388078.935,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1143107959520966e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.9898407070573156e-4
vildagliptin,2017,Total,Human,401346.72,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1682265131690617e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,2.0861187735161818e-4
vildagliptin,2018,Total,Human,370008.915,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0517952470665637e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8782057983331496e-4
vildagliptin,2019,Total,Human,354183.27,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0231367401808169e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8270298931800304e-4
vinblastine,2016,Total,Human,23.24,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.6730194716512315e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2017,Total,Human,22.14,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.444436621174586e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2018,Total,Human,20.97,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.960977002671905e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2019,Total,Human,18.35,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.300803502750989e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2016,Total,Human,13.13,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.770083720429461e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2017,Total,Human,12.7,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.696673219914961e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2018,Total,Human,12.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.5077947645670624e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2019,Total,Human,13.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.853554154043497e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinflunine,2016,Total,Human,59.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7127608067297588e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2017,Total,Human,61.2,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7813889847149263e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2018,Total,Human,13.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.880178163398736e-12,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2019,Total,Human,1.3,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.755337631376722e-13,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinorelbine,2016,Total,Human,578.29,GBABOYUKABKIAF-IELIFDKJSA-N,1.66047350699707e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2017,Total,Human,528.64,GBABOYUKABKIAF-IELIFDKJSA-N,1.5387475047053895e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2018,Total,Human,485.12,GBABOYUKABKIAF-IELIFDKJSA-N,1.3790124766505454e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2019,Total,Human,399.45,GBABOYUKABKIAF-IELIFDKJSA-N,1.1538997052718703e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vismodegib,2016,Total,Human,201.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,5.7886433970950434e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2017,Total,Human,340.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,9.902427003268264e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2018,Total,Human,306.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,8.71547710548024e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2019,Total,Human,361.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,1.0434061172717476e-10,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
voriconazole,2016,Total,Human,5863.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.683501741146228e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2017,Total,Human,4776.8,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.3904148532984082e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2018,Total,Human,4883.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.388080438805302e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2019,Total,Human,6599.4,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.906382704962118e-9,antifungal,azole antifungal,NA,NA,NA,NA
vortioxetine,2016,Total,Human,12130.0606,YQNWZWMKLDQSAC-UHFFFAOYSA-N,3.482966031674243e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2017,Total,Human,19275.368,YQNWZWMKLDQSAC-UHFFFAOYSA-N,5.6106091881579385e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2018,Total,Human,23910.0946,YQNWZWMKLDQSAC-UHFFFAOYSA-N,6.796734575217439e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2019,Total,Human,30263.8252,YQNWZWMKLDQSAC-UHFFFAOYSA-N,8.742375510997473e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
voxilaprevir,2017,Total,Human,8.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,2.445043704510683e-12,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2018,Total,Human,316.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.994053999262711e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2019,Total,Human,288.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.331072099146512e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
warfarin,2016,Total,Human,102193.1675,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.934324425977693e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.002667567659979721
warfarin,2017,Total,Human,86658.63,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.522430210988341e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0022931183736257647
warfarin,2018,Total,Human,72666.24,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.065626063474665e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0018778418758860593
warfarin,2019,Total,Human,61197.5,PJVWKTKQMONHTI-UHFFFAOYSA-N,1.7678251899705918e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0016071138090641745
xylazine,2016,Total,Vet,7361,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.113601391171459e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2017,Total,Vet,7566,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2022857938485508e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2018,Total,Vet,8115,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.306787237800787e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2019,Total,Vet,7709,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2269152154063958e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylometazoline,2016,Total,Human,50032.31,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.4366031791811128e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.0070768629516310974
xylometazoline,2017,Total,Human,56242.875,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6370986600277533e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008064525418855927
xylometazoline,2018,Total,Human,57843.65,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6442759532694454e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008099881543199239
xylometazoline,2019,Total,Human,61488.13,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.7762206805537227e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.00874985556923016
zanamivir,2016,Total,Human,1.5,ARAIBEBZBOPLMB-UFGQHTETSA-N,4.307026337124289e-13,antiviral,neuraminidase inhibitor for influenza,low,high,NA,NA
zidovudine,2016,Total,Human,17280,HBOMLICNUCNMMY-XLPZGREQSA-N,4.961694340367181e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2017,Total,Human,11970,HBOMLICNUCNMMY-XLPZGREQSA-N,3.484187278927723e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2018,Total,Human,8154,HBOMLICNUCNMMY-XLPZGREQSA-N,2.317873461124783e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2019,Total,Human,5940,HBOMLICNUCNMMY-XLPZGREQSA-N,1.7159004254136711e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
ziprasidone,2016,Total,Human,18900.4104,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.426971025017188e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2017,Total,Human,17402.2128,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.065377482285146e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2018,Total,Human,17195.976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.8881648771815934e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2019,Total,Human,16329.2976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.717078905479198e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
zofenopril,2016,Total,Human,3.36,IAIDUHCBNLFXEF-MNEFBYGVSA-N,9.647738995158406e-13,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2017,Total,Human,17.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,5.1345917794724335e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2018,Total,Human,38.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,1.0983888954851808e-11,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2019,Total,Human,26.88,IAIDUHCBNLFXEF-MNEFBYGVSA-N,7.764882733185099e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zoledronic acid,2016,Total,Human,111.713,XRASPMIURGNCCH-UHFFFAOYSA-N,3.207672221327771e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.0347329746218615e-6
zoledronic acid,2017,Total,Human,141.513,XRASPMIURGNCCH-UHFFFAOYSA-N,4.11911273519548e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.328746043611445e-6
zoledronic acid,2018,Total,Human,160.505,XRASPMIURGNCCH-UHFFFAOYSA-N,4.5625494220975386e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.4717901361604963e-6
zoledronic acid,2019,Total,Human,181.311,XRASPMIURGNCCH-UHFFFAOYSA-N,5.2375693944811136e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.6895385143487462e-6
zolmitriptan,2016,Total,Human,3741.645,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.074357570611294e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0743575706112941e-5
zolmitriptan,2017,Total,Human,3886.32,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.1312169344897568e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.1312169344897569e-5
zolmitriptan,2018,Total,Human,3826.47,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.087720537501858e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0877205375018581e-5
zolmitriptan,2019,Total,Human,3796.875,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.0968113514718067e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0968113514718068e-5
zolpidem,2016,Total,Human,112751.9255,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.237503417933171e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.01471592462696896
zolpidem,2017,Total,Human,111564.9205,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.247394125151903e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014760882387054104
zolpidem,2018,Total,Human,111729.2415,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.1760392899736555e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014436542227152979
zolpidem,2019,Total,Human,114395.1865,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.30455806701391e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.015020718486426861
zonisamide,2016,Total,Human,64870.078,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8626475629153796e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2017,Total,Human,65644.614,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.9107613118539744e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2018,Total,Human,63057.96,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.7924990433734136e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2019,Total,Human,65638.636,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8961172295618372e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zopiclone,2016,Total,Human,393691.9724500001,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.130427796037707e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2017,Total,Human,374501.7356,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0900870368536956e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2018,Total,Human,356499.65585,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0133935383797323e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2019,Total,Human,360740.1669,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0420777876220686e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zuclopenthixol,2016,Total,Human,16454.122,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.724555787217078e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2017,Total,Human,15475.242,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.504481312842775e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2018,Total,Human,14533.664,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.131370379998119e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2019,Total,Human,13971.81,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.0360664516496606e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
13C-urea,2016,Prescription,Total,83.45,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.3961423188868128e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2017,Prescription,Total,88.4,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.5731174223660045e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2018,Prescription,Total,186,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.28727573913674e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2019,Prescription,Total,204.6,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.910323687535979e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
4-aminosalicylic acid,2016,Prescription,Total,12390799.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.557833198371694e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2017,Prescription,Total,13384234.35,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.895837849662278e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2018,Prescription,Total,14345104.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.07776993427825e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2019,Prescription,Total,15501228.04,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.477872691628001e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
abacavir,2016,Prescription,Total,221508,MCGSCOLBFJQGHM-SCZZXKLOSA-N,6.36027193255818e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.135762845099675e-4
abacavir,2017,Prescription,Total,252378,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.346133810202347e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.311809608964705e-4
abacavir,2018,Prescription,Total,264834,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.52822786612118e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.3443264046644965e-4
abacavir,2019,Prescription,Total,248130,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.167784049796199e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.2799614374636072e-4
abiraterone,2016,Prescription,Total,107280,GZOSMCIZMLWJML-VJLLXTKPSA-N,3.0803852363112915e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,23.695271048548395
abiraterone,2017,Prescription,Total,81902,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.3839758272242136e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,18.33827559403241
abiraterone,2018,Prescription,Total,76356,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.1705119695565857e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,16.696245919666044
abiraterone,2019,Prescription,Total,71596,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.0682088696619058e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,15.909298997399274
acamprosate,2016,Prescription,Total,72615.87144,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.0850564719020765e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2017,Prescription,Total,72869.8572,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.12107125708872e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2018,Prescription,Total,74400.48504,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.114924083505365e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2019,Prescription,Total,60915.18384,AFCGFAGUEYAMAO-UHFFFAOYSA-N,1.7596698630506396e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acarbose,2016,Prescription,Total,24421.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,7.012269579472055e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2017,Prescription,Total,23097,XUFXOAAUWZOOIT-UGEKTDRHSA-N,6.722996957509911e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2018,Prescription,Total,19867.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,5.647577997166622e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2019,Prescription,Total,11034.06,XUFXOAAUWZOOIT-UGEKTDRHSA-N,3.187432364989894e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acetazolamide,2016,Prescription,Total,124689.75,BZKPWHYZMXOIDC-UHFFFAOYSA-N,3.580280248129622e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2017,Prescription,Total,156871,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.56614822583685e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2018,Prescription,Total,159839,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.5436175638057925e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2019,Prescription,Total,181725.25,BZKPWHYZMXOIDC-UHFFFAOYSA-N,5.2495359222795586e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetic acid,2016,OTC,Total,7512.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.157102357176414e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2017,OTC,Total,7935,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.309693070868127e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2018,OTC,Total,8785,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.4972428692643144e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2019,OTC,Total,8982.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.594793867218569e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetylsalicylic acid,2016,OTC,Total,1037340,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.978567133701673e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.010524972203892837
acetylsalicylic acid,2016,Prescription,Total,9996951.32,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.8704755084126283e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10143022997924482
acetylsalicylic acid,2017,OTC,Total,874785,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.5462947107742594e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.008997507811923178
acetylsalicylic acid,2017,Prescription,Total,9322959.785,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.7136957297286334e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.09589030847097645
acetylsalicylic acid,2018,OTC,Total,828605,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.3554102762512895e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.00832300450972187
acetylsalicylic acid,2018,Prescription,Total,9515922.04,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.705016329978956e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.09558361590031647
acetylsalicylic acid,2019,OTC,Total,1137295,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,3.285328239597376e-7,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.01160893370882465
acetylsalicylic acid,2019,Prescription,Total,9001627.415,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.6003192442447585e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.09188407223479712
aciclovir,2016,OTC,Total,18314.8,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.258821730610928e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.6294108653054638e-5
aciclovir,2016,Prescription,Total,415563.82,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1932295449973182e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.966147724986591e-4
aciclovir,2017,OTC,Total,18232.8,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.3071420066193314e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.6535710033096655e-5
aciclovir,2017,Prescription,Total,391196.225,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1386807942435652e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.693403971217826e-4
aciclovir,2018,OTC,Total,20978.6,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.963421657045913e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.981710828522956e-5
aciclovir,2018,Prescription,Total,394010.34,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1200222105650637e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.600111052825318e-4
aciclovir,2019,OTC,Total,20316.15,MKUXAQIIEYXACX-UHFFFAOYSA-N,5.868769432284168e-9,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,2.934384716142084e-5
aciclovir,2019,Prescription,Total,410013.645,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.184415131112643e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.922075655563215e-4
acitretin,2016,Prescription,Total,11715.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.3639311368386403e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2017,Prescription,Total,12354,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.5959607054196405e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2018,Prescription,Total,12336.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.506799847089268e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2019,Prescription,Total,12033.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.476142722090137e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
aclidinium bromide,2016,Prescription,Total,822.6033600000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.361982891017955e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2017,Prescription,Total,914.54928,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.6620392375342587e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2018,Prescription,Total,869.6434800000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.472067136291638e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2019,Prescription,Total,789.1182,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.2795425169725094e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
adapalene,2016,Prescription,Total,227444.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,6.530723361255141e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2017,Prescription,Total,245696.46,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.1516497945662e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2018,Prescription,Total,267527.88,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.60480467455207e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2019,Prescription,Total,287075.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,8.292804630938534e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adefovir dipivoxil,2016,Prescription,Total,17.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,5.082291077806661e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2017,Prescription,Total,15.3,WOZSCQDILHKSGG-UHFFFAOYSA-N,4.453472461787316e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2018,Prescription,Total,7.5,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.1319660238454594e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2019,Prescription,Total,8.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.5131874917674978e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adrenaline,2016,Prescription,Total,124.18261674,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.5657186727479435e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2017,Prescription,Total,125.5177107,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.653527242281288e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2018,Prescription,Total,118.58509049,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.3709251181242574e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2019,Prescription,Total,116.390152462,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.3621870727863275e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
afatinib,2016,Prescription,Total,264.32,ULXXDDBFHOBEHA-CWDCEQMOSA-N,7.58955467619128e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.3717358363097752e-5
afatinib,2017,Prescription,Total,294.28,ULXXDDBFHOBEHA-CWDCEQMOSA-N,8.565803111469092e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.6768134723340914e-5
afatinib,2018,Prescription,Total,200.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,5.706846652629526e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,1.783389578946727e-5
afatinib,2019,Prescription,Total,235.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,6.81044923056443e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.128265384551384e-5
aglepristone,2016,Prescription,Total,1039.2,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.9839078463597076e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2017,Prescription,Total,942.9,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.7445615583132415e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2018,Prescription,Total,1002,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.8483066078575337e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2019,Prescription,Total,873,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.5218536555322136e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
albendazole,2016,Prescription,Total,269372.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.734629679980084e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2017,Prescription,Total,296590,HXHWSAZORRCQMX-UHFFFAOYSA-N,8.633041813343138e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2018,Prescription,Total,249897.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.103639725918942e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2019,Prescription,Total,237595,HXHWSAZORRCQMX-UHFFFAOYSA-N,6.863457265591939e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
alectinib,2017,Prescription,Total,1377.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.00987167539752e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2018,Prescription,Total,5241.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,1.4899884147451146e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2019,Prescription,Total,15187.2,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.387158744249581e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alendronic acid,2016,Prescription,Total,150355.3996,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.3172311067069784e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.9247555515517984e-4
alendronic acid,2017,Prescription,Total,146830.7834,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.2739009831016874e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.885364530092443e-4
alendronic acid,2018,Prescription,Total,144256.8582,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.1006762718545634e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.727887519867785e-4
alendronic acid,2019,Prescription,Total,140754.6266,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.0660088158566066e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.696371650778733e-4
alfaxalone,2016,Prescription,Total,36.7,DUHUCHOQIDJXAT-OLVMNOGESA-N,1.0537857771497428e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2017,Prescription,Total,121.2,DUHUCHOQIDJXAT-OLVMNOGESA-N,3.5278487736511277e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2018,Prescription,Total,153.9,DUHUCHOQIDJXAT-OLVMNOGESA-N,4.3747942809308825e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2019,Prescription,Total,203.3,DUHUCHOQIDJXAT-OLVMNOGESA-N,5.872770311222212e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfentanil,2016,Prescription,Total,192.995,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.5415636528886813e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2017,Prescription,Total,186.595,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.4313444052758434e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2018,Prescription,Total,189.865,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.3971430548989084e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2019,Prescription,Total,194.61,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.621740434170953e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alimemazine,2016,Prescription,Total,175565.67,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.0411064305658113e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2017,Prescription,Total,171501.43,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.9920058540009476e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2018,Prescription,Total,171914.52,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.88687887527601e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2019,Prescription,Total,177117.34,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.1164262467026576e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
aliskiren,2016,Prescription,Total,2866.5,UXOWGYHJODZGMF-QORCZRPOSA-N,8.230727330244515e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
aliskiren,2017,Prescription,Total,1440.6,UXOWGYHJODZGMF-QORCZRPOSA-N,4.1932499532358207e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
alitretinoin,2016,Prescription,Total,2679.6,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,7.69407184863883e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2017,Prescription,Total,3087,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,8.98553561407676e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2018,Prescription,Total,3252.2999999999997,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,9.245057465803447e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2019,Prescription,Total,3581.1,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,1.0344799685940903e-9,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
allopurinol,2016,Prescription,Total,2871723.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,8.245726693031095e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2017,Prescription,Total,3206720.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.33401488590888e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2018,Prescription,Total,3212108.7,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.13080881773121e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2019,Prescription,Total,3196137.4,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.232750040977348e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
almotriptan,2016,Prescription,Total,1701.9375,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.886859757759645e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2017,Prescription,Total,1715.025,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.992036999200516e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2018,Prescription,Total,1813.0875,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.153921264345206e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2019,Prescription,Total,1760.9625,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.086929802840945e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
alprazolam,2016,Prescription,Total,1920.512000000001,VREFGVBLTWBCJP-UHFFFAOYSA-N,5.514463843175499e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2017,Prescription,Total,1699.571,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.947054016570148e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2018,Prescription,Total,1621.41,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.6090547076310224e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2019,Prescription,Total,1583.6755,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.5747970777225734e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprostadil,2016,Prescription,Total,11.99234,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.4434216149166065e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2017,Prescription,Total,12.92188,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.7612573029098216e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2018,Prescription,Total,11.87954,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.3769034211884118e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2019,Prescription,Total,12.05914,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.483549403387714e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
altrenogest,2016,Prescription,Total,44.88,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.2886622800675872e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2017,Prescription,Total,53.13,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.5464901431030068e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2018,Prescription,Total,32.34,VWAUPFMBXBWEQY-ANULTFPQSA-N,9.193037494821622e-12,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2019,Prescription,Total,1860.06,VWAUPFMBXBWEQY-ANULTFPQSA-N,5.373194857398912e-10,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
ambrisentan,2016,Prescription,Total,117.9,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.3853227009796914e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2017,Prescription,Total,130.95,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.811648489353261e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2018,Prescription,Total,126.6,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.5987586482511356e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2019,Prescription,Total,124.65,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.600791044239295e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
amfetamine,2016,Prescription,Total,2363.055,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.78516008071549e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2017,Prescription,Total,2438.82,KWTSXDURSIMDCE-UHFFFAOYSA-N,7.098835104088981e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2018,Prescription,Total,2229.57,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.337823317046829e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2019,Prescription,Total,2190,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.326299548242322e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amifampridine,2016,Prescription,Total,100,OYTKINVCDFNREN-UHFFFAOYSA-N,2.8713508914161926e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2017,Prescription,Total,132,OYTKINVCDFNREN-UHFFFAOYSA-N,3.8422115356596445e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2018,Prescription,Total,208,OYTKINVCDFNREN-UHFFFAOYSA-N,5.912652439464741e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2019,Prescription,Total,296,OYTKINVCDFNREN-UHFFFAOYSA-N,8.550614914519304e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amiloride,2016,Prescription,Total,14693.575,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4.219040967434068e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2017,Prescription,Total,12526.4375,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.6461532320620876e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2018,Prescription,Total,11403.3175,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.241531395882979e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2019,Prescription,Total,9697.7625,XSDQTOBWRPYKKA-UHFFFAOYSA-N,2.80141326587723e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiodarone,2016,Prescription,Total,292305.6,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.39311945125945e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3497133104691438
amiodarone,2017,Prescription,Total,302692.68,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.81067656708889e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3671115236287038
amiodarone,2018,Prescription,Total,314712.87,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.94609528142524e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.37275397005938504
amiodarone,2019,Prescription,Total,339226.26,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,9.799301074839877e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.40830421145166157
amisulpride,2016,Prescription,Total,77174.37,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.2159469609398305e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2017,Prescription,Total,78455.64,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.283660341254244e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2018,Prescription,Total,78187.365,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.222570742320049e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2019,Prescription,Total,83282.625,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.405802890017967e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amitriptyline,2016,Prescription,Total,389459.21,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1182740498037463e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2017,Prescription,Total,392819.36,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.14340536092609e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2018,Prescription,Total,388703.665,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1049373428322769e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2019,Prescription,Total,425743.685,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.2298548320011518e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amlodipine,2016,Prescription,Total,435018.7804,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.249091562884325e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2017,Prescription,Total,435269.7111,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.2669684129633796e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2018,Prescription,Total,468062.1878,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.330523575248497e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2019,Prescription,Total,523293.8289,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.5116500061041397e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amorolfine,2016,OTC,Total,1636.5,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.698965733802601e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2016,Prescription,Total,1200,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.4456210696994305e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2017,OTC,Total,1574.5500000000002,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.583147101115829e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2017,Prescription,Total,1230.5,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.5816979504766606e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2018,OTC,Total,1747.35,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.96705444235515e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2018,Prescription,Total,1233.75,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.507084109225781e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2019,OTC,Total,1648.05,MQHLMHIZUIDKOO-AYHJJNSGSA-N,4.760757064146465e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2019,Prescription,Total,1229.25,MQHLMHIZUIDKOO-AYHJJNSGSA-N,3.55096060259218e-10,antifungal,topical antifungal,NA,NA,NA,NA
amoxicillin,2016,Prescription,Total,2864063.95,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.223732575905482e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,10.543246892186517
amoxicillin,2017,Prescription,Total,2774019.1,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.074521353151656e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,10.351950452758533
amoxicillin,2018,Prescription,Total,2693397.9,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.656310415328947e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.81578258375506
amoxicillin,2019,Prescription,Total,2851173.4,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.236245202000241e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,10.55928872051313
amphotericin B,2016,Prescription,Total,654.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.879299158431898e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2017,Prescription,Total,449.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3083894585447048e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2018,Prescription,Total,483,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3729861193564758e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2019,Prescription,Total,492.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.4226952180407962e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
ampicillin,2016,Prescription,Total,481355,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.3821391083376416e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2017,Prescription,Total,497867.5,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.4491759482803242e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2018,Prescription,Total,107865,AVKUERGKIZMTKX-NJBDSQKTSA-N,3.06619353549454e-8,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
amsacrine,2017,Prescription,Total,4.95,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.4408293258723668e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2018,Prescription,Total,3.69,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.048927283731966e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2019,Prescription,Total,2.835,XCPGHVQEEXUHNC-UHFFFAOYSA-N,8.189524757656158e-13,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
anagrelide,2016,Prescription,Total,101.95,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9273422337988077e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2017,Prescription,Total,103.55,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.0140985190723957e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2018,Prescription,Total,103.05,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9293213167636613e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2019,Prescription,Total,107.9,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.1169302340426793e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anastrozole,2016,Prescription,Total,258.244,YBBLVLTVTVSKRW-UHFFFAOYSA-N,7.415091396028832e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,7.415091396028832e-5
anastrozole,2017,Prescription,Total,216.812,YBBLVLTVTVSKRW-UHFFFAOYSA-N,6.310890662647265e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,6.310890662647265e-5
anastrozole,2018,Prescription,Total,177.948,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.0583878668166905e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.0583878668166906e-5
anastrozole,2019,Prescription,Total,184.894,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.341072277044366e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.341072277044366e-5
anidulafungin,2016,Prescription,Total,768.5,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.2066331600533438e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2017,Prescription,Total,506.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,1.473429908599176e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2018,Prescription,Total,906.7,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.5774047917609037e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2019,Prescription,Total,1058.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,3.0568448319406516e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
antazoline,2016,OTC,Total,178.99,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.1394309605458425e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2016,Prescription,Total,178.116,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.1143353537548647e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2017,OTC,Total,183.943,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.3541508826048637e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2017,Prescription,Total,184.173,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.3608456451291186e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2018,OTC,Total,166.22199999999998,REYFJDPCWQRWAA-UHFFFAOYSA-N,4.7250620855418647e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2018,Prescription,Total,180.537,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.1319833339598365e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2019,OTC,Total,194.41,REYFJDPCWQRWAA-UHFFFAOYSA-N,5.6159629916611415e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2019,Prescription,Total,216.27,REYFJDPCWQRWAA-UHFFFAOYSA-N,6.247437457983412e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
apixaban,2016,Prescription,Total,88236.5689,QNZCBYKSOIHPEH-UHFFFAOYSA-N,2.533581507665213e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,7.037726410181147e-5
apixaban,2017,Prescription,Total,134931.107,QNZCBYKSOIHPEH-UHFFFAOYSA-N,3.9275292108691354e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.0909803363525375e-4
apixaban,2018,Prescription,Total,179092.2148,QNZCBYKSOIHPEH-UHFFFAOYSA-N,5.090913561184439e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.4141426558845663e-4
apixaban,2019,Prescription,Total,224196.9254,QNZCBYKSOIHPEH-UHFFFAOYSA-N,6.47642423687369e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.7990067324649136e-4
apomorphine,2016,Prescription,Total,621.15,VMWNQDUVQKEIOC-CYBMUJFWSA-N,1.7835396062031677e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2017,Prescription,Total,737.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.1459624656553584e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2018,Prescription,Total,817.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.3231323106502687e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2019,Prescription,Total,1014.95,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.931907637666003e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apraclonidine,2016,Prescription,Total,40.525,IEJXVRYNEISIKR-UHFFFAOYSA-N,1.163614948746412e-11,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2017,Prescription,Total,30.07,IEJXVRYNEISIKR-UHFFFAOYSA-N,8.752674308885267e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2018,Prescription,Total,23.5,IEJXVRYNEISIKR-UHFFFAOYSA-N,6.6801602080491065e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2019,Prescription,Total,26.725,IEJXVRYNEISIKR-UHFFFAOYSA-N,7.720107553734069e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apremilast,2016,Prescription,Total,342.96,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,9.847585017200974e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2017,Prescription,Total,377.28,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,1.098173915283084e-10,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2018,Prescription,Total,165.12,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,4.693736398098163e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2019,Prescription,Total,75.6,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,2.1838732687083088e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
aprepitant,2016,Prescription,Total,3657.135,ATALOFNDEOCMKK-OITMNORJSA-N,1.0500917842279361e-9,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,5.833843245710757e-4
aprepitant,2017,Prescription,Total,1379.32,ATALOFNDEOCMKK-OITMNORJSA-N,4.014878193459137e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,2.230487885255076e-4
aprepitant,2018,Prescription,Total,924.14,ATALOFNDEOCMKK-OITMNORJSA-N,2.626980108368724e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.45943339353818e-4
aprepitant,2019,Prescription,Total,867.26,ATALOFNDEOCMKK-OITMNORJSA-N,2.505272395529058e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.3918179975161435e-4
aripiprazole,2016,Prescription,Total,22934.58255,CEUORZQYGODEFX-UHFFFAOYSA-N,6.5853234049200765e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.0252311241567819
aripiprazole,2017,Prescription,Total,23956.4052,CEUORZQYGODEFX-UHFFFAOYSA-N,6.973149728210356e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026717048767089482
aripiprazole,2018,Prescription,Total,24564.66095,CEUORZQYGODEFX-UHFFFAOYSA-N,6.982803004357777e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026754034499455084
aripiprazole,2019,Prescription,Total,25654.9684,CEUORZQYGODEFX-UHFFFAOYSA-N,7.411005251100049e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.028394656134482943
arsenic trioxide,2016,Prescription,Total,4.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.205967374394801e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2017,Prescription,Total,7.5,QTLQKAJBUDWPIB-UHFFFAOYSA-N,2.1830747361702525e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2018,Prescription,Total,1.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,3.411145638152735e-13,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2019,Prescription,Total,6.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.7910071780412057e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
articaine,2016,Prescription,Total,106270.4,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0513960777115544e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2017,Prescription,Total,96838.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.8187511701472516e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2018,Prescription,Total,102442,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.9120381788636876e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2019,Prescription,Total,104114.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0075863571020085e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
asenapine,2016,Prescription,Total,118.2,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,3.39393675365394e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2017,Prescription,Total,74.1,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,2.1568778393362097e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2018,Prescription,Total,0.6,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,1.7055728190763679e-13,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
ataluren,2016,Prescription,Total,1245,OOUGLTULBSNHNF-UHFFFAOYSA-N,3.5748318598131596e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2017,Prescription,Total,1590,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.628118440680935e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2018,Prescription,Total,1593.75,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.5304278006716013e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2019,Prescription,Total,1586.25,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.582234090593327e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
atazanavir,2016,Prescription,Total,53994.45,AXRYRYVKAWYZBR-GASGPIRDSA-N,1.5503701213902704e-8,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2017,Prescription,Total,32043,AXRYRYVKAWYZBR-GASGPIRDSA-N,9.326968502813788e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2018,Prescription,Total,21825,AXRYRYVKAWYZBR-GASGPIRDSA-N,6.204021129390287e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2019,Prescription,Total,18564,AXRYRYVKAWYZBR-GASGPIRDSA-N,5.362622137605958e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atenolol,2016,Prescription,Total,501458.971,METKIMKYRPQLGS-UHFFFAOYSA-N,1.4398646633894968e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2017,Prescription,Total,451634.084,METKIMKYRPQLGS-UHFFFAOYSA-N,1.314601278365058e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2018,Prescription,Total,395443.916,METKIMKYRPQLGS-UHFFFAOYSA-N,1.124097324331197e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2019,Prescription,Total,358400.45499999996,METKIMKYRPQLGS-UHFFFAOYSA-N,1.035319012126184e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atipamezole,2016,Prescription,Total,307.6,HSWPZIDYAHLZDD-UHFFFAOYSA-N,8.83227534199621e-11,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2017,Prescription,Total,346.7,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0091626813736354e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2018,Prescription,Total,363.8,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0341456526333044e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2019,Prescription,Total,368.3,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0639160381815744e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atomoxetine,2016,Prescription,Total,40642.94568,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1670015830804793e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003646879947126498
atomoxetine,2017,Prescription,Total,40555.651,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1804802280938378e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.0036890007127932433
atomoxetine,2018,Prescription,Total,39326.5652,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1179053445459094e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003493454201705967
atomoxetine,2019,Prescription,Total,44075.1952,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.2732095318833437e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003978779787135449
atorvastatin,2016,Prescription,Total,2983202.8998,XUKUURHRXDUEBC-KAYWLYCHSA-N,8.565822305616101e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2017,Prescription,Total,3296228.5658,XUKUURHRXDUEBC-KAYWLYCHSA-N,9.594551075520914e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2018,Prescription,Total,3605848.4058,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.025006171773722e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2019,Prescription,Total,3907533.054,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.1287773787334314e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atovaquone,2016,Prescription,Total,230454,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.617142983304274e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2017,Prescription,Total,244364.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.112872274642556e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2018,Prescription,Total,240341.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.831991721713967e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2019,Prescription,Total,243922.5,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.046241102996066e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atropine,2016,Prescription,Total,508.2525,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.4593712689395084e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2017,Prescription,Total,471.785,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.3732558858721104e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2018,Prescription,Total,420.61,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.195634972386185e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2019,Prescription,Total,430.44,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.2434211769613815e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
avanafil,2017,Prescription,Total,516.8,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.5042840315370487e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2018,Prescription,Total,2318.4,WEAJZXNPAWBCOA-INIZCTEOSA-N,6.590333372911083e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2019,Prescription,Total,3580.7999999999997,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.0343933069564434e-9,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
axitinib,2016,Prescription,Total,110.544,RITAVMQDGBJQJZ-FMIVXFBMSA-N,3.174106129407116e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2017,Prescription,Total,68.152,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.9837454589263338e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2018,Prescription,Total,42.952,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.2209627287494687e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2019,Prescription,Total,38.36,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.1081134733816234e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
azacitidine,2016,Prescription,Total,668.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,1.9200723410900078e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2017,Prescription,Total,810.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.360049328115788e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2018,Prescription,Total,826.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.3499950825507217e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2019,Prescription,Total,968.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.798593151752129e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azathioprine,2016,Prescription,Total,249961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.177264580070059e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2017,Prescription,Total,246332.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.17016343263545e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2018,Prescription,Total,237961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,6.764337333223939e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2019,Prescription,Total,186067.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,5.3749714209706786e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azelaic acid,2016,Prescription,Total,138112.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.965694499907189e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2017,Prescription,Total,138474,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.0306545468858606e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2018,Prescription,Total,140379,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.990443446152023e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2019,Prescription,Total,148864.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.3002804525083084e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelastine,2016,Prescription,Total,1689.66,MBUVEWMHONZEQD-UHFFFAOYSA-N,4.851606747190284e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,4.410551588354804e-5
azelastine,2017,Prescription,Total,2350.41,MBUVEWMHONZEQD-UHFFFAOYSA-N,6.84149425418923e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,6.219540231081118e-5
azelastine,2018,Prescription,Total,2914.575,MBUVEWMHONZEQD-UHFFFAOYSA-N,8.285033165265838e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,7.531848332059854e-5
azelastine,2019,Prescription,Total,3834.09,MBUVEWMHONZEQD-UHFFFAOYSA-N,1.1075617276219363e-9,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,1.0068742978381239e-4
azithromycin,2016,Prescription,Total,169157.32,MQTOSJVFKKJCRP-BICOPXKESA-N,4.857100215715743e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2017,Prescription,Total,150059.395,MQTOSJVFKKJCRP-BICOPXKESA-N,4.3678783219932367e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2018,Prescription,Total,140032.74,MQTOSJVFKKJCRP-BICOPXKESA-N,3.980600585413133e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2019,Prescription,Total,140015.9025,MQTOSJVFKKJCRP-BICOPXKESA-N,4.0446691357648e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
aztreonam,2016,Prescription,Total,2810,WZPBZJONDBGPKJ-VEHQQRBSSA-N,8.068496004879502e-10,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2017,Prescription,Total,4266.3,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2418202329230862e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2018,Prescription,Total,4353.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2375352113081611e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2019,Prescription,Total,3906.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.1284789582287047e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
baclofen,2016,Prescription,Total,53586.095,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5386448164576278e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2017,Prescription,Total,54551.2975,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5878607919674327e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2018,Prescription,Total,53989.755,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5347243106098735e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2019,Prescription,Total,58862.845,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.7003835147568854e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
balsalazide,2016,Prescription,Total,451212.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.2955892705255842e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2017,Prescription,Total,451368.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.313828079865768e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2018,Prescription,Total,418080,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.188443140332413e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2019,Prescription,Total,389025,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.123784786189484e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
bambuterol,2016,Prescription,Total,564.13,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.6198151783746168e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2814298286966436e-6
bambuterol,2017,Prescription,Total,540.39,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.5729490089053902e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2154211393033667e-6
bambuterol,2018,Prescription,Total,375.4,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.0671200604687804e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,1.5029860006602542e-6
baricitinib,2017,Prescription,Total,16.464,XUZMWHLSFXCVMG-UHFFFAOYSA-N,4.7922856608409385e-12,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2018,Prescription,Total,39.144,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.1127157071654222e-11,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2019,Prescription,Total,349.944,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.010890670826535e-10,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
barium sulfate,2016,OTC,Total,0.582,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.671126218804224e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2017,OTC,Total,0.762,TZCXTZWJZNENPQ-UHFFFAOYSA-L,2.218003931948977e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2018,OTC,Total,0.48,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.3644582552610941e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
bazedoxifene,2019,Prescription,Total,10.08,UCJGJABZCDBEDK-UHFFFAOYSA-N,2.911831024944412e-12,sex hormone,selective estrogen receptor modulator for postmenopausal osteoporosis,NA,NA,NA,NA
beclometasone,2016,Prescription,Total,1182.338,NBMKJKDGKREAPL-DVTGEIKXSA-N,3.3949072702552384e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2017,Prescription,Total,1665.07992,NBMKJKDGKREAPL-DVTGEIKXSA-N,4.846658542741847e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2018,Prescription,Total,2285.73212,NBMKJKDGKREAPL-DVTGEIKXSA-N,6.497470959269671e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2019,Prescription,Total,2988.30912,NBMKJKDGKREAPL-DVTGEIKXSA-N,8.632392071170964e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
bedaquiline,2017,Prescription,Total,131.6,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.83056847040007e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2018,Prescription,Total,112.8,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.206476899863571e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2019,Prescription,Total,94,QUIJNHUBAXPXFS-XLJNKUFUSA-N,2.7153979796108598e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
benazepril,2016,Prescription,Total,2973.635,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.53834950799639e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2017,Prescription,Total,3536.02,XPCFTKFZXHTYIP-PMACEKPBSA-N,1.0292527904790314e-9,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2018,Prescription,Total,3202.885,XPCFTKFZXHTYIP-PMACEKPBSA-N,9.104589331045688e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2019,Prescription,Total,2978.66,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.604518453135835e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
bendamustine,2016,Prescription,Total,556.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.59683001448883e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2017,Prescription,Total,447.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3014763885468323e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2018,Prescription,Total,484.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.376184068392244e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2019,Prescription,Total,476.75,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3771978582760402e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendroflumethiazide,2016,Prescription,Total,17372.80875,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.9883429890715535e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2017,Prescription,Total,15819.7025,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.604745714863918e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2018,Prescription,Total,14377.175,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.086886482517379e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2019,Prescription,Total,12909.53,HDWIHXWEUNVBIY-UHFFFAOYSA-N,3.729203370183594e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
benzocaine,2016,Prescription,Total,1401000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.022762598874086e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2017,Prescription,Total,1830800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,5.329030969307332e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2018,Prescription,Total,1531000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.352053310009865e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2019,Prescription,Total,2376800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,6.865912678658609e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzoyl peroxide,2016,OTC,Total,229856,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.599972304973605e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2016,Prescription,Total,56707.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6282713067498374e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2017,OTC,Total,215799,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.281404599877391e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2017,Prescription,Total,57331.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6687859898232646e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2018,OTC,Total,217246,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.17548121088441e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2018,Prescription,Total,56955,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6190149985082423e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2019,OTC,Total,212620.2,OMPJBNCRMGITSC-UHFFFAOYSA-N,6.142004909621885e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2019,Prescription,Total,58629,OMPJBNCRMGITSC-UHFFFAOYSA-N,1.6936283845383524e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzydamine,2016,OTC,Total,14606.52,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.194044422248845e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2017,OTC,Total,12815.22,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,3.7302110693951665e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2018,OTC,Total,14215.2,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.0408431229557295e-09,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2019,OTC,Total,16450.41,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.752064901890456e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzyl benzoate,2016,OTC,Total,13167,SESFRYSPDFLNCH-UHFFFAOYSA-N,3.780707718727701e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2017,OTC,Total,16005,SESFRYSPDFLNCH-UHFFFAOYSA-N,4.658681486987319e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2018,OTC,Total,39666,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.1275541906913866e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2019,OTC,Total,69201,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.999023995606927e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzylpenicillin,2016,Prescription,Total,4266958.660279825,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.225193555283052e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2017,Prescription,Total,4228318.78087629,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.2307647876006975e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2018,Prescription,Total,4242239.572625091,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.2059080845132504e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2019,Prescription,Total,4234786.894533957,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.2233118912234105e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
betamethasone,2016,Prescription,Total,20510.6775,UREBDLICKHMUKA-DVTGEIKXSA-N,5.889335212317505e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011325644639072125
betamethasone,2017,Prescription,Total,21876.3715,UREBDLICKHMUKA-DVTGEIKXSA-N,6.367700525429991e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0012245577933519213
betamethasone,2018,Prescription,Total,20974.0745,UREBDLICKHMUKA-DVTGEIKXSA-N,5.962135228747126e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.001146564467066755
betamethasone,2019,Prescription,Total,21817.558,UREBDLICKHMUKA-DVTGEIKXSA-N,6.302484352472634e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0012120162216293527
betaxolol,2016,Prescription,Total,151.875,NWIUTZDMDHAVTP-UHFFFAOYSA-N,4.360864166338343e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2017,Prescription,Total,136.6375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.977198323512838e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2018,Prescription,Total,124.7625,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.546525480666922e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2019,Prescription,Total,112.375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.2462005101996854e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
bexarotene,2016,Prescription,Total,907.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.605750933960194e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2017,Prescription,Total,1027.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.9908123885532457e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2018,Prescription,Total,997.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.835514811714461e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2019,Prescription,Total,720,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.0798793035317224e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bicalutamide,2016,Prescription,Total,185064.1,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3138396850413545e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05313839685041355
bicalutamide,2017,Prescription,Total,182527.5,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3129489854175446e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05312948985417545
bicalutamide,2018,Prescription,Total,167758.4,LKJPYSCBVHEWIU-UHFFFAOYSA-N,4.7687361201956816e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.04768736120195682
bicalutamide,2019,Prescription,Total,178994.2,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.170643500447471e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.051706435004474714
bictegravir,2019,Prescription,Total,355.5,SOLUWJRYJLAZCX-LYOVBCGYSA-N,1.026940406118788e-10,antiviral,HIV therapy used as part of combination with emtricitabine and tenofovir,NA,NA,NA,NA
bilastine,2016,Prescription,Total,7,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,2.009945623991335e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2017,Prescription,Total,29.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,8.499437639489517e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2018,Prescription,Total,52.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.48384835259644e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2019,Prescription,Total,34.8,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.0052749967069991e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bimatoprost,2016,Prescription,Total,106.0422,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.0448436549773417e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2017,Prescription,Total,120.2427,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.499984007718651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2018,Prescription,Total,132.5379,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.7675506622910276e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2019,Prescription,Total,138.7122,AQOKCDNYWBIDND-FTOWTWDKSA-N,4.0070088045465694e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
binimetinib,2019,Prescription,Total,27.72,ACWZRVQXLIRSDF-UHFFFAOYSA-N,8.007535318597132e-12,antineoplastic,small molecule kinase inhibitor for melanomas,NA,NA,NA,NA
biperiden,2016,Prescription,Total,3012.098,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.64879027733293e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2017,Prescription,Total,2900.302,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.44210136461874e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2018,Prescription,Total,2793.662,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.941323288144204e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2019,Prescription,Total,2678.254,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.736729255834791e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
bisacodyl,2016,OTC,Total,48059.886,KHOITXIGCFIULA-UHFFFAOYSA-N,1.3799679650746061e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.00965012562989235
bisacodyl,2016,Prescription,Total,14159.3875,KHOITXIGCFIULA-UHFFFAOYSA-N,4.0656569920032294e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002843116777624636
bisacodyl,2017,OTC,Total,45423.313,KHOITXIGCFIULA-UHFFFAOYSA-N,1.3221664939127176e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.009245919537851172
bisacodyl,2017,Prescription,Total,14005.7375,KHOITXIGCFIULA-UHFFFAOYSA-N,4.076742893024308e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002850869155961054
bisacodyl,2018,OTC,Total,43338.509999999995,KHOITXIGCFIULA-UHFFFAOYSA-N,1.2319497445878223e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.00861503317893582
bisacodyl,2018,Prescription,Total,13918.1875,KHOITXIGCFIULA-UHFFFAOYSA-N,3.956413715134744e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002766722877716604
bisacodyl,2019,OTC,Total,40632.485,KHOITXIGCFIULA-UHFFFAOYSA-N,1.1737592305911552e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.008208106507630455
bisacodyl,2019,Prescription,Total,13469.6625,KHOITXIGCFIULA-UHFFFAOYSA-N,3.891010036014912e-9,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.002720986039171267
bisoprolol,2016,Prescription,Total,60569.89545000001,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.7391742329334313e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2017,Prescription,Total,62497.81535,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8191653567522458e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2018,Prescription,Total,64300.5406,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8278209049879405e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2019,Prescription,Total,65651.6428,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.89649295975802e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bleomycin,2016,Prescription,Total,50.55,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.4514678756108851e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2017,Prescription,Total,47.25,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.3753370837872592e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2018,Prescription,Total,42.45,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.20669276949653e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2019,Prescription,Total,39.3,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.135267453177732e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
boric acid,2016,OTC,Total,304470,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.742402059094882e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2017,OTC,Total,273870,KGBXLFKZBHKPEV-UHFFFAOYSA-N,7.971715706599294e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2018,OTC,Total,288630,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.204658046166867e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2019,OTC,Total,107190,KGBXLFKZBHKPEV-UHFFFAOYSA-N,3.096420313132852e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
bortezomib,2016,Prescription,Total,31.9165,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.164347072588489e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.036521571686331e-5
bortezomib,2017,Prescription,Total,33.929,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.875939029802732e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.1946531177339404e-5
bortezomib,2018,Prescription,Total,38.2515,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.0873453114816611e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.4163229144036915e-5
bortezomib,2019,Prescription,Total,44.9005,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.297050287058696e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.8823339712415467e-5
bosentan,2016,Prescription,Total,7290.99,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.093499063580654e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2017,Prescription,Total,7220.29,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.1016576915763616e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2018,Prescription,Total,7065.73,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.008519505822077e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2019,Prescription,Total,6926.5,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.000872777210066e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosutinib,2016,Prescription,Total,406,UBPYILGKFZZVDX-UHFFFAOYSA-N,1.1657684619149743e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2017,Prescription,Total,274.4,UBPYILGKFZZVDX-UHFFFAOYSA-N,7.9871427680682306e-11,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2018,Prescription,Total,882,UBPYILGKFZZVDX-UHFFFAOYSA-N,2.50719204404226e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2019,Prescription,Total,1461.6,UBPYILGKFZZVDX-UHFFFAOYSA-N,4.2221549861693967e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
brexpiprazole,2019,Prescription,Total,21.42,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,6.187640928006875e-12,antipsychotic,atypical antipsychotic for schizophrenia and major depressive disordered,NA,NA,NA,NA
brigatinib,2019,Prescription,Total,3.36,AILRADAXUVEEIR-UHFFFAOYSA-N,9.706103416481373e-13,antineoplastic,multikinase inhibitor for metastatic non-small cell lung cancer,NA,NA,NA,NA
brimonidine,2016,Prescription,Total,882.3695,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.53359245038346e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2017,Prescription,Total,899.191,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6173348734555536e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2018,Prescription,Total,832.37,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.3661127456909935e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2019,Prescription,Total,921.451,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6618150890536244e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brinzolamide,2016,Prescription,Total,7857.45,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.2561496061758163e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2017,Prescription,Total,7438.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.1652754001546774e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2018,Prescription,Total,8149.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.316693773258256e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2019,Prescription,Total,8000.1,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.3110058911366855e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brivaracetam,2016,Prescription,Total,2293.442,MSYKRHVOOPPJKU-BDAKNGLRSA-N,6.585276731111336e-10,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,6.585276731111335e-7
brivaracetam,2017,Prescription,Total,8006.044,MSYKRHVOOPPJKU-BDAKNGLRSA-N,2.330372319075658e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,2.330372319075658e-6
brivaracetam,2018,Prescription,Total,12378.084,MSYKRHVOOPPJKU-BDAKNGLRSA-N,3.5186206037740134e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,3.518620603774013e-6
brivaracetam,2019,Prescription,Total,16399.99,MSYKRHVOOPPJKU-BDAKNGLRSA-N,4.737499969323225e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,4.7374999693232245e-6
bromfenac,2016,Prescription,Total,48.2625,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.38578572396974e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2017,Prescription,Total,35.046,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.0201071627176356e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2018,Prescription,Total,42.057,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.19552126753158e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2019,Prescription,Total,46.0485,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.3302128070650074e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromhexine,2016,OTC,Total,73347.64,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.10606811497274e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2017,OTC,Total,69613.14,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.0262758298597715e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2018,OTC,Total,68129.81999999999,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.936672819342758e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2019,OTC,Total,67677.172,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.955004852282731e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromocriptine,2016,Prescription,Total,486.4525,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.3967758195066355e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2017,Prescription,Total,438.3275,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.2758689218915549e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2018,Prescription,Total,387.02,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.1001513207315595e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2019,Prescription,Total,357.735,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.0333966981235012e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bronopol,2016,Prescription,Total,843000,LVDKZNITIUWNER-UHFFFAOYSA-N,2.42054880146385e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2017,Prescription,Total,661500,LVDKZNITIUWNER-UHFFFAOYSA-N,1.925471917302163e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2018,Prescription,Total,1066500,LVDKZNITIUWNER-UHFFFAOYSA-N,3.031655685908243e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2019,Prescription,Total,1841000,LVDKZNITIUWNER-UHFFFAOYSA-N,5.318135830280418e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
budesonide,2016,Prescription,Total,19347.71718,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.555408497166138e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.459777322286207e-4
budesonide,2017,Prescription,Total,19341.64924,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.629902108228075e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.546397800265203e-4
budesonide,2018,Prescription,Total,19227.645,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.465691447808271e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.355455171870082e-4
budesonide,2019,OTC,Total,155.75424,VOVIALXJUBGFJZ-KWVAZRHASA-N,4.4993058362960105e-11,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,5.2317509724372215e-6
budesonide,2019,Prescription,Total,19075.08304,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.510259781672914e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.407278815898737e-4
bumetanide,2016,Prescription,Total,21770.992,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251215728621479e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2017,Prescription,Total,21814.135,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.349584934654302e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2018,Prescription,Total,22903.821,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.510689091765085e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2019,Prescription,Total,21639.479,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251042293237408e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bupivacaine,2016,Prescription,Total,26533.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.618828098529268e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2017,Prescription,Total,26503.6,LEBVLXFERQHONN-UHFFFAOYSA-N,7.714578610341587e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2018,Prescription,Total,25890.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.359816763344213e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2019,Prescription,Total,24763.25,LEBVLXFERQHONN-UHFFFAOYSA-N,7.153412661553046e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
buprenorphine,2016,Prescription,Total,19989.753480000003,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.739759647398795e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2017,Prescription,Total,20325.867759999997,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.916385119679125e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2018,Prescription,Total,20240.73956,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.753675871923292e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2019,Prescription,Total,20449.1021,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.907175587999595e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
bupropion,2016,Prescription,Total,620904.9600000001,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.7828360103807357e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.017828360103807357
bupropion,2017,Prescription,Total,650137.38,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.8923979857572258e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.018923979857572257
bupropion,2018,Prescription,Total,725158.185,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.0613501497779205e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.020613501497779203
bupropion,2019,Prescription,Total,854769.33,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.4691903316120517e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.024691903316120516
buspirone,2016,Prescription,Total,10485.42,QWCRAEMEVRGPNT-UHFFFAOYSA-N,3.0107320063873173e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2017,Prescription,Total,9892.25,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.8794028078506912e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2018,Prescription,Total,9247.26,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.628645884488688e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2019,Prescription,Total,9514.23,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.748395842505642e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
busulfan,2016,Prescription,Total,26.88,COVZYZSDYWQREU-UHFFFAOYSA-N,7.718191196126725e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2017,Prescription,Total,34.08,COVZYZSDYWQREU-UHFFFAOYSA-N,9.919891601157628e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2018,Prescription,Total,50.4,COVZYZSDYWQREU-UHFFFAOYSA-N,1.4326811680241487e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2019,Prescription,Total,42.24,COVZYZSDYWQREU-UHFFFAOYSA-N,1.220195858071944e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
butorphanol,2016,Prescription,Total,668.16,IFKLAQQSCNILHL-QHAWAJNXSA-N,1.9185218116086432e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2017,Prescription,Total,711.66,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.071475955657229e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2018,Prescription,Total,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0387280430692847e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2019,Prescription,Total,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0717908840179884e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
cabazitaxel,2016,Prescription,Total,2.88,BMQGVNUXMIRLCK-OAGWZNDDSA-N,8.269490567278635e-13,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,9.291562435144534e-7
cabazitaxel,2017,Prescription,Total,10.08,BMQGVNUXMIRLCK-OAGWZNDDSA-N,2.9340524454128196e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,3.2966881409132805e-6
cabazitaxel,2018,Prescription,Total,33.84,BMQGVNUXMIRLCK-OAGWZNDDSA-N,9.619430699590714e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.0808349100663725e-5
cabazitaxel,2019,Prescription,Total,37.8,BMQGVNUXMIRLCK-OAGWZNDDSA-N,1.0919366343541544e-11,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.2268950947799489e-5
cabergoline,2016,Prescription,Total,94.44608,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.7118783599876503e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2017,Prescription,Total,84.32452,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.4544897233557758e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2018,Prescription,Total,67.0617,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.9063102120175608e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2019,Prescription,Total,48.05075,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.3880522283913462e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabozantinib,2016,Prescription,Total,248.64,ONIQOQHATWINJY-UHFFFAOYSA-N,7.13932685641722e-11,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2017,Prescription,Total,566.04,ONIQOQHATWINJY-UHFFFAOYSA-N,1.647610164882413e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2018,Prescription,Total,891.64,ONIQOQHATWINJY-UHFFFAOYSA-N,2.5345949140020866e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2019,Prescription,Total,1194.96,ONIQOQHATWINJY-UHFFFAOYSA-N,3.4519063507614824e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
caffeine,2016,OTC,Total,1247931.265,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.583248550183888e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.00895812137545972
caffeine,2016,Prescription,Total,11808,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.3904911325842403e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,8.4762278314606e-5
caffeine,2017,OTC,Total,1190861.865,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.4663206023334533e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.008665801505833633
caffeine,2017,Prescription,Total,11290.2,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.2863133848412513e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,8.215783462103127e-5
caffeine,2018,OTC,Total,1109769.9,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.154655628115164e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007886639070287908
caffeine,2018,Prescription,Total,9306.6,RYYVLZVUVIJVGH-UHFFFAOYSA-N,2.645513999669354e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,6.613784999173384e-5
caffeine,2019,OTC,Total,1036837.5,RYYVLZVUVIJVGH-UHFFFAOYSA-N,2.99513452413274e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007487836310331849
caffeine,2019,Prescription,Total,8738.6,RYYVLZVUVIJVGH-UHFFFAOYSA-N,2.524337955811432e-9,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,6.310844889528579e-5
calcipotriol,2016,Prescription,Total,249.97125,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.177551715159199e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2017,Prescription,Total,249.35925,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.258265052071494e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2018,Prescription,Total,259.86625,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.387013543255066e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2019,Prescription,Total,271.7295,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.849507822347545e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcium folinate,2016,Prescription,Total,6309.45,KVUAALJSMIVURS-ZEDZUCNESA-L,1.8116644881845895e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2017,Prescription,Total,6863.55,KVUAALJSMIVURS-ZEDZUCNESA-L,1.997819014058845e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2018,Prescription,Total,7372.3,KVUAALJSMIVURS-ZEDZUCNESA-L,2.0956657490127843e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2019,Prescription,Total,8149.15,KVUAALJSMIVURS-ZEDZUCNESA-L,2.354062281441047e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium polystyrene sulfonate,2016,OTC,Total,2230800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.405409568571243e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2017,OTC,Total,2436600,IJBYVKWTVVYTPL-UHFFFAOYSA-M,7.092373202869917e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2018,OTC,Total,2256900,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.415512158955756e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2019,OTC,Total,1675800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,4.840919078970084e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
canagliflozin,2019,Prescription,Total,11529,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,3.330406734780171e-9,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes treatment and symptom relief,low,moderate,5.6e-5,5.9471548835360196e-5
candesartan,2016,Prescription,Total,792375.8210400001,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.275189020079842e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0022751890200798422
candesartan,2017,Prescription,Total,832738.27648,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.4239065243005956e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.002423906524300596
candesartan,2018,Prescription,Total,885051.03496,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.5158649812053066e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0025158649812053067
candesartan,2019,Prescription,Total,954982.78608,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.7586790722178533e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0027586790722178537
capecitabine,2016,Prescription,Total,223845,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.427375402890577e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2017,Prescription,Total,215490,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.27241033196437e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2018,Prescription,Total,209496,GAGWJHPBXLXJQN-UORFTKCHSA-N,5.955178055087046e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2019,Prescription,Total,253584,GAGWJHPBXLXJQN-UORFTKCHSA-N,7.325334907038727e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
captopril,2016,Prescription,Total,28587.95,FAKRSMQSSFJEIM-RQJHMYQMSA-N,8.208603571626155e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2017,Prescription,Total,26218.65,FAKRSMQSSFJEIM-RQJHMYQMSA-N,7.631636324198692e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2018,Prescription,Total,23300.325,FAKRSMQSSFJEIM-RQJHMYQMSA-N,6.623400165940928e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2019,Prescription,Total,20354.975,FAKRSMQSSFJEIM-RQJHMYQMSA-N,5.879984892556337e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
carbachol,2016,Prescription,Total,3.92,AIXAANGOTKPUOY-UHFFFAOYSA-N,1.1255695494351477e-12,ophthalmological,"lowers pressure in eye, used for post-surgery relief",low,NA,NA,NA
carbamazepine,2016,Prescription,Total,2233819.725,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.414080258641825e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.256563210345673
carbamazepine,2017,Prescription,Total,2129609.475,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.198795523708394e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.24795182094833576
carbamazepine,2018,Prescription,Total,1989509.9,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.655423347872237e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22621693391488945
carbamazepine,2019,Prescription,Total,1926617.325,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.565460416796042e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22261841667184168
carbamide,2016,OTC,Total,2357855,XSQUKJJJFZCRTK-UHFFFAOYSA-N,6.770229056080127e-7,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2017,OTC,Total,5509474,XSQUKJJJFZCRTK-UHFFFAOYSA-N,1.603679133198249e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2018,OTC,Total,8185423.5,XSQUKJJJFZCRTK-UHFFFAOYSA-N,2.3268059723714912e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2019,OTC,Total,10434144,XSQUKJJJFZCRTK-UHFFFAOYSA-N,3.0141333549541256e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbimazole,2016,Prescription,Total,18825.765,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.405537711434176e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2017,Prescription,Total,20116.76,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.855518737280038e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2018,Prescription,Total,22214.275,CFOYWRHIYXMDOT-UHFFFAOYSA-N,6.314677272581281e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2019,Prescription,Total,23105.505,CFOYWRHIYXMDOT-UHFFFAOYSA-N,6.674536339881769e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carfilzomib,2016,Prescription,Total,34.9,BLMPQMFVWMYDKT-NZTKNTHTSA-N,1.0021014611042511e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2017,Prescription,Total,105.36,BLMPQMFVWMYDKT-NZTKNTHTSA-N,3.066783389371971e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2018,Prescription,Total,313.56,BLMPQMFVWMYDKT-NZTKNTHTSA-N,8.913323552493097e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2019,Prescription,Total,334.15999999999997,BLMPQMFVWMYDKT-NZTKNTHTSA-N,9.652950945391116e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carglumic acid,2016,Prescription,Total,34,LCQLHJZYVOQKHU-VKHMYHEASA-N,9.762593030815054e-12,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2017,Prescription,Total,701,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.0404471867404627e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2018,Prescription,Total,828,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.3536904903253875e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2019,Prescription,Total,575,LCQLHJZYVOQKHU-VKHMYHEASA-N,1.661014721570473e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
cariprazine,2019,Prescription,Total,5.376,KPWSJANDNDDRMB-UHFFFAOYSA-N,1.5529765466370198e-12,antipsychotic,atypical antipsychotic for schizophrenia and bipolar I disorder,NA,NA,NA,NA
carmustine,2019,Prescription,Total,40.4,DLGOEMSEDOSKAD-UHFFFAOYSA-N,1.1670433869816887e-11,antineoplastic,"alkylating antineoplastic for brain tumours, lymphomas and multiple myeloma",NA,NA,NA,NA
carprofen,2016,Prescription,Total,107750.8,PUXBGTOOZJQSKH-UHFFFAOYSA-N,3.093903556308079e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2017,Prescription,Total,95846.4,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.7898647252382464e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2018,Prescription,Total,92620.6,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.6328529641090772e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2019,Prescription,Total,88610.1,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.5596987926927265e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carvedilol,2016,Prescription,Total,175604.29374999998,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.042215453955734e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2017,Prescription,Total,175251.63125,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.10116544872667e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2018,Prescription,Total,172444.5,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4.901944199986911e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2019,Prescription,Total,173981.75,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.025847791905976e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
caspofungin,2016,Prescription,Total,153.09,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3957510796690496e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.791502159338098e-6
caspofungin,2017,Prescription,Total,148.74,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3294738167728455e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.65894763354569e-6
caspofungin,2018,Prescription,Total,98.77,JYIKNQVWKBUSNH-OGZDCFRISA-N,2.807657122336214e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,5.615314244672427e-6
caspofungin,2019,Prescription,Total,110.72,JYIKNQVWKBUSNH-OGZDCFRISA-N,3.1983921734310044e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,6.3967843468620086e-6
cefalexin,2016,Prescription,Total,439772.75,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.2627418777330508e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2017,Prescription,Total,365434.5,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.0636944329000109e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2018,Prescription,Total,362615.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.0307778569709696e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2019,Prescription,Total,317257.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.164677613477634e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2016,Prescription,Total,706160,XIURVHNZVLADCM-IUODEOHRSA-N,2.0276331454824586e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2017,Prescription,Total,607370,XIURVHNZVLADCM-IUODEOHRSA-N,1.7679121366769685e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2018,Prescription,Total,535650,XIURVHNZVLADCM-IUODEOHRSA-N,1.522650134230427e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2019,Prescription,Total,15320,XIURVHNZVLADCM-IUODEOHRSA-N,4.425520962514721e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2017,Prescription,Total,49420,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.4385007128204518e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2018,Prescription,Total,154120,MLYYVTUWGNIJIB-BXKDBHETSA-N,4.3810480479341637e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2019,Prescription,Total,522400,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.509067983562461e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2016,Prescription,Total,921690,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.646495403109391e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2017,Prescription,Total,894152,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.602667521994805e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2018,Prescription,Total,964915,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.742887994531789e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2019,Prescription,Total,910315,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.629646289159001e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefovecin,2016,Prescription,Total,527.68,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.5151544383824963e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2017,Prescription,Total,497.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.4483973182910902e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2018,Prescription,Total,480,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.3644582552610938e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2019,Prescription,Total,401.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.1601104559699164e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
ceftaroline fosamil,2016,Prescription,Total,168,ZCCUWMICIWSJIX-NQJJCJBVSA-N,4.823869497579204e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2017,Prescription,Total,120,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.492919577872404e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2018,Prescription,Total,132,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.752260201968009e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2019,Prescription,Total,186,ZCCUWMICIWSJIX-NQJJCJBVSA-N,5.3730215341236165e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftazidime,2016,Prescription,Total,46670,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3400594610239373e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010308149700184132
ceftazidime,2017,Prescription,Total,51020,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.4850729738587506e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.011423638260451927
ceftazidime,2018,Prescription,Total,47690,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3556461290291995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010428047146378457
ceftazidime,2019,Prescription,Total,59760,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.7262998219313297e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.013279229399471766
ceftolozane,2016,Prescription,Total,320,JHFNIHVVXRKLEF-DCZLAGFPSA-N,9.188322852531816e-11,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2017,Prescription,Total,1000,JHFNIHVVXRKLEF-DCZLAGFPSA-N,2.91076631489367e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2018,Prescription,Total,1460,JHFNIHVVXRKLEF-DCZLAGFPSA-N,4.150227193085828e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2019,Prescription,Total,2470,JHFNIHVVXRKLEF-DCZLAGFPSA-N,7.135141499615771e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftriaxone,2016,Prescription,Total,85970,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.4685003613505007e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2017,Prescription,Total,91200,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6546188791830273e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2018,Prescription,Total,93290,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6518814715272387e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2019,Prescription,Total,89470,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.5845389067636563e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
cefuroxime,2016,Prescription,Total,217464.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,6.244176037640995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,8.216021102159204e-4
cefuroxime,2017,Prescription,Total,189003.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,5.501457488885845e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,7.238759853797164e-4
cefuroxime,2018,Prescription,Total,152747,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.3420188565909655e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.713182706040743e-4
cefuroxime,2019,Prescription,Total,154180.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.4538520962222035e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.860331705555531e-4
celecoxib,2016,Prescription,Total,313284,RZEKVGVHFLEQIL-UHFFFAOYSA-N,8.995482926664306e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2017,Prescription,Total,331813.5,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.658315586269709e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2018,Prescription,Total,341206.4,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.699206025581646e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2019,Prescription,Total,385292.6,RZEKVGVHFLEQIL-UHFFFAOYSA-N,1.1130029229776757e-7,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
ceritinib,2016,Prescription,Total,1822.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,5.233036999606011e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2017,Prescription,Total,2272.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,6.614716450595866e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2018,Prescription,Total,1507.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,4.2852517079293736e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2019,Prescription,Total,742.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,2.1448755317670892e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cetirizine,2016,OTC,Total,104287.25,ZKLPARSLTMPFCP-UHFFFAOYSA-N,2.9944528825084335e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2016,Prescription,Total,544487.14,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.5634136348036533e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2017,OTC,Total,112178.55,ZKLPARSLTMPFCP-UHFFFAOYSA-N,3.2652554459361536e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2017,Prescription,Total,545903.63,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.5889978973821778e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2018,OTC,Total,112028.92,ZKLPARSLTMPFCP-UHFFFAOYSA-N,3.1845580150413475e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2018,Prescription,Total,558260.25,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.5869225139512966e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2019,OTC,Total,124215.34,ZKLPARSLTMPFCP-UHFFFAOYSA-N,3.588234928432724e-8,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2019,Prescription,Total,585536.83,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.6914526863507956e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetylpyridinium,2016,OTC,Total,33935.98,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.744210642408209e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2017,OTC,Total,33221.51,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.67000522379032e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2018,OTC,Total,36098.61,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0261468003739724e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2019,OTC,Total,37280.55,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0769311717955496e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
chlorambucil,2016,Prescription,Total,51.2,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.4701316564050907e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2017,Prescription,Total,40.1,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.1672172922723618e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2018,Prescription,Total,34.95,JCKYGMPEJWAADB-UHFFFAOYSA-N,9.934961671119842e-12,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2019,Prescription,Total,35,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.0110524392168096e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chloramphenicol,2016,Prescription,Total,20504.68,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.887613119620378e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2017,Prescription,Total,20191.535,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.877283992399656e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2018,Prescription,Total,20336.5725,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.7809175481959885e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2019,Prescription,Total,20842.3125,WIIZWVCIJKGZOK-RKDXNWHRSA-N,6.020763112012572e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chlorhexidine,2016,OTC,Total,1163914.85,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.342007942080045e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.978580883428625
chlorhexidine,2016,Prescription,Total,887679.89,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.548840443443728e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.0343338612425335
chlorhexidine,2017,OTC,Total,1173260.5,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.415087141995305e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,4.065579930946792
chlorhexidine,2017,Prescription,Total,944664.93,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.749698857105387e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.2734510203635563
chlorhexidine,2018,OTC,Total,1131496.75,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.2164168361220797e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.829067662050095
chlorhexidine,2018,Prescription,Total,955012.53,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.714739021742257e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.231832168740782
chlorhexidine,2019,OTC,Total,1190193.5,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,3.438137260899977e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,4.093020548690449
chlorhexidine,2019,Prescription,Total,999258.46,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,2.886579152545808e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,3.436403753030724
chlorprothixene,2016,Prescription,Total,205340.135,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.8960357967577135e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2017,Prescription,Total,196536.425,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.720716055396262e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2018,Prescription,Total,177104.97,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.0344237159222583e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2019,Prescription,Total,163988.0150000001,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,4.737156644802082e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ciclesonide,2016,Prescription,Total,960.6624,LUKZNWIVRBCLON-GXOBDPJESA-N,2.7583988385900185e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2017,Prescription,Total,1141.9296000000002,LUKZNWIVRBCLON-GXOBDPJESA-N,3.3238902136600033e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2018,Prescription,Total,1112.1216,LUKZNWIVRBCLON-GXOBDPJESA-N,3.1613406207795335e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2019,Prescription,Total,1184.5728,LUKZNWIVRBCLON-GXOBDPJESA-N,3.421900625342532e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclopirox,2016,Prescription,Total,4128.96,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.18556929766218e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2017,Prescription,Total,4164.864,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.212294583731331e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2018,Prescription,Total,4593.6,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.3057865502848672e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2019,Prescription,Total,4581.984,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.323607457043541e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclosporin,2016,Prescription,Total,187506.8,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.383978173265977e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0026653357293395926
ciclosporin,2017,Prescription,Total,174048.57299999995,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.0661472344371195e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.002507993680414416
ciclosporin,2018,Prescription,Total,163914.435,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.6594667498376674e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0023066667078404293
ciclosporin,2019,Prescription,Total,163872.71800000002,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.7338260358568125e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0023434782355726794
cilastatin,2016,Prescription,Total,8080,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.320051520264283e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2017,Prescription,Total,8565,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.493071348706428e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2018,Prescription,Total,7635,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.1703414122746773e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2019,Prescription,Total,7800,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.253202578826033e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cimicoxib,2016,Prescription,Total,78.06400000000001,KYXDNECMRLFQMZ-UHFFFAOYSA-N,2.2414913598751367e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2017,Prescription,Total,59.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.7231736584170528e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2018,Prescription,Total,67.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.910241557365532e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2019,Prescription,Total,20.48,KYXDNECMRLFQMZ-UHFFFAOYSA-N,5.916101130045789e-12,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cinacalcet,2016,Prescription,Total,8650.3032,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.483805580434034e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.004967611160868068
cinacalcet,2017,Prescription,Total,8726.9364,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.540207250533943e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.005080414501067886
cinacalcet,2018,Prescription,Total,9831.4188,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.7947001130393992e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.0055894002260787985
cinacalcet,2019,Prescription,Total,10500.5376,VDHAWDNDOKGFTD-MRXNPFEDSA-N,3.0333126153050927e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.006066625230610185
ciprofloxacin,2016,Prescription,Total,969510.6875,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.783805376790651e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,55.676107535813024
ciprofloxacin,2017,Prescription,Total,811026.0705,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.360707366511979e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,47.21414733023958
ciprofloxacin,2018,Prescription,Total,753169.644,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.140976121599707e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,42.81952243199414
ciprofloxacin,2019,Prescription,Total,643892.9005,MYSWGUAQZAJSOK-UHFFFAOYSA-N,1.86002710755689e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,37.200542151137796
cisatracurium,2016,Prescription,Total,598.65,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7189342111463034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2017,Prescription,Total,589.05,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7145868977881162e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2018,Prescription,Total,563.75,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.6025277945905034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2019,Prescription,Total,607.8,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7557647787313624e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
citalopram,2016,Prescription,Total,141802.8492,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4.071657374557759e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2017,Prescription,Total,130996.3988,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.812999049994176e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2018,Prescription,Total,120262.5316,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.4186084175045466e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2019,Prescription,Total,112427.9148,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.2477290712742756e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
cladribine,2016,Prescription,Total,2.45,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.034809683969674e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2017,Prescription,Total,2.65,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.713530734468226e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2018,Prescription,Total,27.46,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.805838268639509e-12,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2019,Prescription,Total,73.98,PTOAARAWEBMLNO-KVQBGUIXSA-N,2.1370759843788452e-11,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
clarithromycin,2016,Prescription,Total,111591.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.2041835299947006e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2670152941662251
clarithromycin,2017,Prescription,Total,114924.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.345183633559976e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2787653027966647
clarithromycin,2018,Prescription,Total,109722.25,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.118988120798366e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2599156767331972
clarithromycin,2019,Prescription,Total,102942,AGOYDEPGAOXOCK-KCBOHYOISA-N,2.9737074342244804e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.24780895285204005
clenbuterol,2016,Prescription,Total,2.813375,STJMRWALKKWQGH-UHFFFAOYSA-N,8.078186814138032e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2017,Prescription,Total,2.4495,STJMRWALKKWQGH-UHFFFAOYSA-N,7.129922088332045e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2018,Prescription,Total,2.11225,STJMRWALKKWQGH-UHFFFAOYSA-N,6.004326978490097e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2019,Prescription,Total,1.854875,STJMRWALKKWQGH-UHFFFAOYSA-N,5.358216837692228e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clindamycin,2016,Prescription,Total,730551.664,KDLRVYVGXIQJDK-AWPVFWJPSA-N,2.097670171651983e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2017,Prescription,Total,637468.39,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.855521516421501e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2018,Prescription,Total,651510.7400000001,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.8519983491338842e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2019,Prescription,Total,646901.94,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.8687193839173894e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clobetasol,2016,Prescription,Total,9347.55,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.684009602505743e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0035786794700076573
clobetasol,2017,Prescription,Total,10366.3175,FCSHDIVRCWTZOX-DVTGEIKXSA-N,3.017392778849276e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0040231903717990345
clobetasol,2018,Prescription,Total,10203.0325,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.900335817358799e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.003867114423145065
clobetasol,2019,Prescription,Total,8940.44,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.582643905620438e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0034435252074939172
clodronic acid,2016,Prescription,Total,1824,ACSIXWWBWUQEHA-UHFFFAOYSA-N,5.237344025943134e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clodronic acid,2017,Prescription,Total,384,ACSIXWWBWUQEHA-UHFFFAOYSA-N,1.1177342649191694e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clofarabine,2016,Prescription,Total,0.46,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.320821410051449e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2018,Prescription,Total,0.4,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.1370485460509118e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2019,Prescription,Total,0.92,WDDPHFBMKLOVOX-AYQXTPAHSA-N,2.657623554512757e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clomethiazole,2016,Prescription,Total,460391.4,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.321945256790349e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2017,Prescription,Total,429892.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.2513174812553216e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2018,Prescription,Total,414868.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1793149146047161e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2019,Prescription,Total,396804.9,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1462587486805209e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomifene,2016,Prescription,Total,5009.75,GKIRPKYJQBWNGO-OCEACIFDSA-N,1.4384750128272271e-9,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomifene,2017,Prescription,Total,690.5,GKIRPKYJQBWNGO-OCEACIFDSA-N,2.009884140434079e-10,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomipramine,2016,Prescription,Total,43990.579999999994,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.2631239109691532e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2017,Prescription,Total,39469.68,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.1488701500363242e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2018,Prescription,Total,37062.145,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.0535364521444517e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2019,Prescription,Total,38705.97,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.1181075823072189e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clonazepam,2016,Prescription,Total,4984.8025,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.4313117101908662e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2017,Prescription,Total,4228.349,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.2307735836814334e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2018,Prescription,Total,3799.52775,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.080061875954398e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2019,Prescription,Total,3491.1915,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.0085079090994264e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonidine,2016,Prescription,Total,74.4451249999999,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.1375807603033958e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2017,Prescription,Total,78.385925,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.281631100517816e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2018,Prescription,Total,82.532525,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.3460871888290132e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2019,Prescription,Total,76.5191000000001,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.210423505762145e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clopidogrel,2016,Prescription,Total,583192.05,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.674549012634337e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.005401771008497861
clopidogrel,2017,Prescription,Total,654759.825,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.9058528429556747e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006147912396631208
clopidogrel,2018,Prescription,Total,751511.1,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.136261508990303e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006891166158033236
clopidogrel,2019,Prescription,Total,881861.775,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.547452853330901e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.00821758984945452
cloprostenol,2016,Prescription,Total,19.2025,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.513711549241944e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2017,Prescription,Total,19.609,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.707721666874999e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2018,Prescription,Total,19.0495,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.4150515694992115e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2019,Prescription,Total,18.258000000000003,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.274227267205861e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
clotrimazole,2016,OTC,Total,205849.5,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.910661453225775e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2017,OTC,Total,189772.8,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.5238427372305347e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2018,OTC,Total,193022.2,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4868902966387065e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2019,OTC,Total,190337,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4983053749488544e-8,antifungal,topical antifungal,NA,NA,NA,NA
cloxacillin,2016,Prescription,Total,636745,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8283183233548037e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2017,Prescription,Total,511970,LQOLIRLGBULYKD-JKIFEVAISA-N,1.4902250302361122e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2018,Prescription,Total,601620,LQOLIRLGBULYKD-JKIFEVAISA-N,1.7101778656878738e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2019,Prescription,Total,645520,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8647273444663859e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
clozapine,2016,Prescription,Total,342467.625,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.833447203249364e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2017,Prescription,Total,343189.72500000003,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.989450911476223e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2018,Prescription,Total,347240.5,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.87073264137479e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2019,Prescription,Total,345373.15,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.976867592785517e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
cobicistat,2016,Prescription,Total,27459,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,7.884442412739723e-9,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,1.6290170274255628e-5
cobicistat,2017,Prescription,Total,47232,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.3748131458505782e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,2.8405230286168972e-5
cobicistat,2018,Prescription,Total,57780,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.642466624770542e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.393526084236657e-5
cobicistat,2019,Prescription,Total,60192,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.73877909775252e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.592518797009339e-5
cobimetinib,2016,Prescription,Total,1.26,BSMCAPRUBJMWDF-KRWDZBQOSA-N,3.6179021231844026e-13,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2017,Prescription,Total,40.32,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.173620978165128e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2018,Prescription,Total,51.66,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.4684981972247523e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2019,Prescription,Total,151.2,BSMCAPRUBJMWDF-KRWDZBQOSA-N,4.3677465374166176e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
codeine,2016,Prescription,Total,1943129.045,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.579405315497444e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2017,Prescription,Total,1785329.695,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.19667753718539e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2018,Prescription,Total,1718023.555,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.883690463234922e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2019,Prescription,Total,1730315.635,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.998399552519236e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
colchicine,2016,Prescription,Total,949.577,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.7265687654183137e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2017,Prescription,Total,1010.748,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.9420512312461473e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2018,Prescription,Total,718.022,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.0410646778314195e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2019,Prescription,Total,810.6,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.3415974492261306e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colesevelam,2016,Prescription,Total,386912.25,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1109608339373449e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2017,Prescription,Total,399217.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1620288513160637e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2018,Prescription,Total,418837.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1905964260164969e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2019,Prescription,Total,418050,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.2076299206131066e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colestipol,2016,Prescription,Total,540250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.551247319087598e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2017,Prescription,Total,439250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.278554103817045e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2018,Prescription,Total,388250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.1036477450106661e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2019,Prescription,Total,358500,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.0356065698835037e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestyramine,2016,Prescription,Total,2181800,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.264713374891849e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2017,Prescription,Total,2395000,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.97128532417034e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2018,Prescription,Total,2466400,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.011041334949922e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2019,Prescription,Total,2465200,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.121275637592226e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colistin,2016,Prescription,Total,2972.2000000000003,YKQOSKADJPQZHB-QNPLFGSASA-N,8.534229119467207e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2017,Prescription,Total,2832,YKQOSKADJPQZHB-QNPLFGSASA-N,8.243290203778873e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2018,Prescription,Total,3049.2,YKQOSKADJPQZHB-QNPLFGSASA-N,8.667721066546101e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2019,Prescription,Total,3225.6,YKQOSKADJPQZHB-QNPLFGSASA-N,9.317859279822118e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
cortisone,2016,Prescription,Total,33984.45,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.7581280801789e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2017,Prescription,Total,33982.4,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.891482521924266e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2018,Prescription,Total,34960.275,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.937882464572511e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2019,Prescription,Total,37744.17,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,1.0903238612775408e-8,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
crizotinib,2016,Prescription,Total,4302,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.235255153487246e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2017,Prescription,Total,4521,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.3159574509634283e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2018,Prescription,Total,3807,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.082185953703955e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2019,Prescription,Total,2367,KTEIFNKAUNYNJU-GFCCVEGCSA-N,6.837603210360539e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cromoglicic acid,2016,OTC,Total,6337.64,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.819758826347492e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2016,Prescription,Total,29221.35,IMZMKUWMOSJXDT-UHFFFAOYSA-N,8.390474937088456e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2017,OTC,Total,6854.6,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.995213878207015e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2017,Prescription,Total,28845.37,IMZMKUWMOSJXDT-UHFFFAOYSA-N,8.396213133664442e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2018,OTC,Total,6688.5599999999995,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.9013043557935715e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2018,Prescription,Total,21649.81,IMZMKUWMOSJXDT-UHFFFAOYSA-N,6.154221245694623e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2019,OTC,Total,4095.14,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.1829717959812361e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2019,Prescription,Total,21868.2,IMZMKUWMOSJXDT-UHFFFAOYSA-N,6.317113414651725e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cyclizine,2016,OTC,Total,30906,UVKZSORBKUEBAZ-UHFFFAOYSA-N,8.874197065010884e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2017,OTC,Total,32557.85,UVKZSORBKUEBAZ-UHFFFAOYSA-N,9.476829306536088e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2018,OTC,Total,5394.9,UVKZSORBKUEBAZ-UHFFFAOYSA-N,1.5335658002725155e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2019,OTC,Total,2,UVKZSORBKUEBAZ-UHFFFAOYSA-N,5.777442509810341e-13,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclopentolate,2016,Prescription,Total,1167.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.3528764359066884e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2017,Prescription,Total,1186.1,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.4524599260953816e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2018,Prescription,Total,1249.8,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5527081821360735e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2019,Prescription,Total,1219.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5233733146078363e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclophosphamide,2016,Prescription,Total,18538.6,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.323082563560823e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2017,Prescription,Total,18727.8,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.451224939206568e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2018,Prescription,Total,17952.3,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.1031591533174464e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2019,Prescription,Total,19087.5,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.513846695300244e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyproterone acetate,2016,Prescription,Total,6064.857768,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.741433475845922e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2017,Prescription,Total,6365.400638,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.8528193757893078e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2018,Prescription,Total,7399.896064,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.103510265124766e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2019,Prescription,Total,7875.951566,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.275142869130786e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cytarabine,2016,Prescription,Total,9321.5,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.676529733433604e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2017,Prescription,Total,8311.4,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.4192543149607252e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2018,Prescription,Total,8661,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.461994364336736e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2019,Prescription,Total,5360,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,1.5483545926291714e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
dabigatran etexilate,2016,Prescription,Total,1083636.35,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.11150019954349e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.00311150019954349
dabigatran etexilate,2017,Prescription,Total,1085194.7,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.1587481778611416e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0031587481778611415
dabigatran etexilate,2018,Prescription,Total,1086955.6,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.089803211504742e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030898032115047416
dabigatran etexilate,2019,Prescription,Total,1070971.9,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.0937392909361745e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030937392909361743
dabrafenib,2016,Prescription,Total,5592.3,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.6057455590066775e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.5292814847682644e-4
dabrafenib,2017,Prescription,Total,6479.8,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8861183567248e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.796303196880762e-4
dabrafenib,2018,Prescription,Total,6400.4,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8193913785360638e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.7327536938438703e-4
dabrafenib,2019,Prescription,Total,5114.9,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.4775520346714455e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.4071924139728053e-4
dacarbazine,2016,Prescription,Total,14,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4.019891247982669e-12,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2017,Prescription,Total,36,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.0478758733617211e-11,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2019,Prescription,Total,606.5,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.7520094410999858e-10,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
daclatasvir,2016,Prescription,Total,1207.92,FKRSSPOQAMALKA-CUPIEXAXSA-N,3.468362168759447e-10,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,4.817169678832565e-6
daclatasvir,2017,Prescription,Total,168.84,FKRSSPOQAMALKA-CUPIEXAXSA-N,4.914537846066473e-11,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,6.825747008425656e-7
dacomitinib,2019,Prescription,Total,1.35,LVXJQMNHJWSHET-AATRIKPKSA-N,3.8997736941219803e-13,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,NA,NA,NA,NA
dapagliflozin,2016,Prescription,Total,30510.7733,JVHXJTBJCFBINQ-ADAARDCZSA-N,8.760713611275237e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,8.760713611275237e-5
dapagliflozin,2017,Prescription,Total,34991.5867,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0185233187104137e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0185233187104136e-4
dapagliflozin,2018,Prescription,Total,38308.9301,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0889778317742752e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0889778317742752e-4
dapagliflozin,2019,Prescription,Total,43180.9882,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.2473783842114937e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.2473783842114936e-4
dapoxetine,2016,Prescription,Total,23.4,USRHYDPUVLEVMC-FQEVSTJZSA-N,6.7189610859138906e-12,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2017,Prescription,Total,61.56,USRHYDPUVLEVMC-FQEVSTJZSA-N,1.7918677434485435e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2018,Prescription,Total,93.33,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.6530185200732896e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2019,Prescription,Total,85.86,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.480256069461579e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapsone,2016,Prescription,Total,7560,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1707412739106415e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2017,Prescription,Total,7500,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1830747361702526e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2018,Prescription,Total,7240,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.0580578683521504e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2019,Prescription,Total,8300,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.397638641571291e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
daptomycin,2016,Prescription,Total,319,DOAKLVKFURWEDJ-RWDRXURGSA-N,9.159609343617655e-11,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2017,Prescription,Total,466,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.3564171027404504e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2018,Prescription,Total,546.5,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5534925760420582e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2019,Prescription,Total,543,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5685756414135075e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
darifenacin,2016,Prescription,Total,6419.03955,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8431314933928294e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2017,Prescription,Total,6370.61775,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8543379551763703e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2018,Prescription,Total,5534.04495,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.5731194410444727e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2019,Prescription,Total,5167.35135,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.4927037676307927e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darunavir,2016,Prescription,Total,62424,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.792412080457644e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.9068213621889832e-5
darunavir,2017,Prescription,Total,57120,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.6626297190672643e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.768755020284324e-5
darunavir,2018,Prescription,Total,82536,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,2.346185969921451e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,2.4959425211930332e-5
darunavir,2019,Prescription,Total,154224,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,4.4551014681649504e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,4.73946964698399e-5
dasabuvir,2016,Prescription,Total,12446,NBRBXGKOEOGLOI-UHFFFAOYSA-N,3.573683319456593e-9,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2017,Prescription,Total,3066,NBRBXGKOEOGLOI-UHFFFAOYSA-N,8.924409521463991e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2018,Prescription,Total,1596,NBRBXGKOEOGLOI-UHFFFAOYSA-N,4.536823698743137e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2019,Prescription,Total,84,NBRBXGKOEOGLOI-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasatinib,2016,Prescription,Total,1740,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,4.996150551064175e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,2.775639195035653e-4
dasatinib,2017,Prescription,Total,2038.8,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,5.934470362805215e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.2969279793362307e-4
dasatinib,2018,Prescription,Total,2379,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,6.762596227637798e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.756997904243221e-4
dasatinib,2019,Prescription,Total,2601,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,7.513563984008349e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,4.1742022133379715e-4
daunorubicin,2016,Prescription,Total,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.504587867102085e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2017,Prescription,Total,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.525241549004283e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2018,Prescription,Total,59.8,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.699887576346113e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2019,Prescription,Total,44.2,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.2768147946680854e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
decitabine,2016,Prescription,Total,16.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,4.665945198551313e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2017,Prescription,Total,33.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.678297997021454e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2018,Prescription,Total,33.2,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.437502932222569e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2019,Prescription,Total,25.6,XAUDJQYHKZQPEU-KVQBGUIXSA-N,7.395126412557236e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
deferasirox,2016,Prescription,Total,21378,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.138373935669537e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.019182418548967302
deferasirox,2017,Prescription,Total,21690.3,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.3135394599938174e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.01972981081248068
deferasirox,2018,Prescription,Total,20962.8,BOFQWVMAQOTZIW-UHFFFAOYSA-N,5.9589303152890124e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.018621657235278165
deferasirox,2019,Prescription,Total,26090.1,BOFQWVMAQOTZIW-UHFFFAOYSA-N,7.536702641260139e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.023552195753937934
deferiprone,2016,Prescription,Total,18100,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.197145113463308e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2017,Prescription,Total,19650,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.719655808766062e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2018,Prescription,Total,20600,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.855800012162195e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2019,Prescription,Total,16450,TZXKOCQBRNJULO-UHFFFAOYSA-N,4.7519464643190056e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferoxamine,2016,Prescription,Total,6300,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.808951061592201e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2017,Prescription,Total,6655,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.9371149825617374e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2018,Prescription,Total,7530,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.1404938879408415e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2019,Prescription,Total,8240,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.38030631404186e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
degarelix,2016,Prescription,Total,642.5600000000001,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.845015228788389e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2017,Prescription,Total,624.72,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.8184139322403736e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2018,Prescription,Total,569.6,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.6191571295764982e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2019,Prescription,Total,548.0799999999999,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.5832503453884256e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
deoxycholic acid,2017,Prescription,Total,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.3286130519149364e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2018,Prescription,Total,0.56,KXGVEGMKQFWNSR-LLQZFEROSA-N,1.5918679644712765e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2019,Prescription,Total,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.310977003924136e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
dequalinium,2016,Prescription,Total,158.34,PCSWXVJAIHCTMO-UHFFFAOYSA-P,4.5464970014684004e-11,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2017,Prescription,Total,530.7,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.544743683314071e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2018,Prescription,Total,628.86,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.7876108716739408e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2019,Prescription,Total,663.18,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.9157421618280107e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
desloratadine,2016,Prescription,Total,169054.615,JAUOIFJMECXRGI-UHFFFAOYSA-N,4.854151194782713e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0013483753318840868
desloratadine,2017,Prescription,Total,195117.744,JAUOIFJMECXRGI-UHFFFAOYSA-N,5.6794215667324655e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0015776171018701292
desloratadine,2018,Prescription,Total,215869.1405,JAUOIFJMECXRGI-UHFFFAOYSA-N,6.136342308569623e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0017045395301582287
desloratadine,2019,Prescription,Total,258165.445,JAUOIFJMECXRGI-UHFFFAOYSA-N,7.457680082535517e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0020715778007043104
deslorelin,2016,Prescription,Total,55.3472,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.5892123205739028e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2017,Prescription,Total,63.8824,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.859467380345634e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2018,Prescription,Total,72.9675,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.074189744599247e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2019,Prescription,Total,80.6896,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.3308976256979624e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
desogestrel,2016,Prescription,Total,3250.642437,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.333735059155252e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4569389107982413
desogestrel,2017,Prescription,Total,3210.205131,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.344156959213623e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4607988737828235
desogestrel,2018,Prescription,Total,3032.343783,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.619805223966676e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.1925204533209914
desogestrel,2019,Prescription,Total,2996.976339,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.657429250917183e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.206455278117475
desonide,2016,Prescription,Total,3116.4700000000003,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.948478912571823e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2017,Prescription,Total,3100.3500000000004,WBGKWQHBNHJJPZ-LECWWXJVSA-N,9.024394344380591e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2018,Prescription,Total,3008.225,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.55124465611001e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2019,Prescription,Total,1222.965,WBGKWQHBNHJJPZ-LECWWXJVSA-N,3.5328049895051015e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desoximetasone,2016,Prescription,Total,4289.125,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2315582892145476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2017,Prescription,Total,4195.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2213211611504476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2018,Prescription,Total,3734.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.0616835471079744e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2019,Prescription,Total,4119.25,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.1899365029268124e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoxycortone,2016,Prescription,Total,2,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.742701782832385e-13,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2017,Prescription,Total,7,ZESRJSPZRDMNHY-YFWFAHHUSA-N,2.037536420425569e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2018,Prescription,Total,20.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.770521371208377e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2019,Prescription,Total,25.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,7.308464774910081e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
detomidine,2016,Prescription,Total,573.7252,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.647366364447933e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2017,Prescription,Total,633.9336000000001,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.8452325687592778e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2018,Prescription,Total,582.1104,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.6547194599027866e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2019,Prescription,Total,611.5088,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.7664784681215546e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
dexamethasone,2016,Prescription,Total,7152.2916000000005,UREBDLICKHMUKA-CXSFZGCWSA-N,2.0536738861328547e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2017,Prescription,Total,7864.5864,UREBDLICKHMUKA-CXSFZGCWSA-N,2.2891973173690875e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2018,Prescription,Total,8253.3534,UREBDLICKHMUKA-CXSFZGCWSA-N,2.346115870878587e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2019,Prescription,Total,10366.8578,UREBDLICKHMUKA-CXSFZGCWSA-N,2.9946962473439454e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamfetamine,2016,Prescription,Total,14420.52,KWTSXDURSIMDCE-QMMMGPOBSA-N,4.140637295668503e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2017,Prescription,Total,18878.343,KWTSXDURSIMDCE-QMMMGPOBSA-N,5.4950444885408724e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2018,Prescription,Total,21401.635,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.083674489965575e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2019,Prescription,Total,24003.256,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.933871579413006e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexchlorpheniramine,2016,Prescription,Total,173.3,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.976051094824262e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2017,Prescription,Total,176.75,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.1447794615745616e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2018,Prescription,Total,202.15,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.7463590896047954e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2019,Prescription,Total,167.85,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.8487186263583276e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexketoprofen,2016,Prescription,Total,10.5,DKYWVDODHFEZIM-NSHDSACASA-N,3.0149184359870024e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2017,Prescription,Total,15.5,DKYWVDODHFEZIM-NSHDSACASA-N,4.511687788085189e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2018,Prescription,Total,30.5,DKYWVDODHFEZIM-NSHDSACASA-N,8.669995163638201e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2019,Prescription,Total,35.5,DKYWVDODHFEZIM-NSHDSACASA-N,1.0254960454913355e-11,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexmedetomidine,2016,Prescription,Total,43.229200000000006,CUHVIMMYOGQXCV-NSHDSACASA-N,1.2412620195520887e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2017,Prescription,Total,51.3737,CUHVIMMYOGQXCV-NSHDSACASA-N,1.4953683543145293e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2018,Prescription,Total,58.011300000000006,CUHVIMMYOGQXCV-NSHDSACASA-N,1.6490416079880816e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2019,Prescription,Total,64.56960000000001,CUHVIMMYOGQXCV-NSHDSACASA-N,1.865235759407249e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexrazoxane,2017,Prescription,Total,50,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.4553831574468352e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2018,Prescription,Total,60,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.7055728190763675e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2019,Prescription,Total,95,BMKDZUISNHGIBY-ZETCQYMHSA-N,2.744285192159912e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
diatrizoic acid,2016,Prescription,Total,849520,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.439270009275884e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2017,Prescription,Total,785510,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.286436048012127e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2018,Prescription,Total,732970,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.083556181997342e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2019,Prescription,Total,672660,YVPYQUNUQOZFHG-UHFFFAOYSA-N,1.943127239324512e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diazepam,2016,Prescription,Total,110876.03,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.183639875771885e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2017,Prescription,Total,104435.425,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.0398711717160426e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2018,Prescription,Total,97114.912,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.7606092372365562e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2019,Prescription,Total,100692.862,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.9087361067663318e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
dibrompropamidine,2016,OTC,Total,4940.7,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4186483349219983e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2017,OTC,Total,5152.6875,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4998269206173676e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2018,OTC,Total,5390.475,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.5323079403184471e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2019,OTC,Total,8406,GMJFVGRUYJHMCO-UHFFFAOYSA-N,2.428259086873286e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dichlorobenzyl alcohol,2016,OTC,Total,3892.752,DBHODFSFBXJZNY-UHFFFAOYSA-N,1.1177456925262164e-9,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2017,OTC,Total,3343.536,DBHODFSFBXJZNY-UHFFFAOYSA-N,9.732251961434322e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2018,OTC,Total,2321.3088,DBHODFSFBXJZNY-UHFFFAOYSA-N,6.598601989937966e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2019,OTC,Total,722.9088,DBHODFSFBXJZNY-UHFFFAOYSA-N,2.0882820159179909e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
diclofenac,2016,OTC,Total,659978.525,DCOPUUMXTXDBNB-UHFFFAOYSA-N,1.895029926074294e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,3.790059852148588
diclofenac,2016,Prescription,Total,1478062.913,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.2440372628117643e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.48807452562353
diclofenac,2017,OTC,Total,784703.18,DCOPUUMXTXDBNB-UHFFFAOYSA-N,2.2840875835339447e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,4.568175167067889
diclofenac,2017,Prescription,Total,1463757.029,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.260654653202037e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.521309306404074
diclofenac,2018,OTC,Total,835605.09,DCOPUUMXTXDBNB-UHFFFAOYSA-N,2.375308881643103e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,4.750617763286207
diclofenac,2018,Prescription,Total,1438068.671,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.087884728704793e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.175769457409586
diclofenac,2019,OTC,Total,800363.28,DCOPUUMXTXDBNB-UHFFFAOYSA-N,2.3120264185816185e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,4.624052837163237
diclofenac,2019,Prescription,Total,1413002.575,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4.081770571638237e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,8.163541143276474
dicloxacillin,2016,Prescription,Total,2807037.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.059989627863681e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2017,Prescription,Total,2699355,YFAGHNZHGGCZAX-JKIFEVAISA-N,7.857191605939803e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2018,Prescription,Total,2868295,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.153476648487749e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2019,Prescription,Total,2968317.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.574641853556979e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dienogest,2016,Prescription,Total,1035.628,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.9736513809755686e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06758298593126293
dienogest,2017,Prescription,Total,994.407,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.89448639889447e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06578378179305615
dienogest,2018,Prescription,Total,959.019,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.7261278989629975e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06195745224915904
dienogest,2019,Prescription,Total,1100.813,AZFLJNIPTRTECV-FUMNGEBKSA-N,3.179941910775926e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.07227140706308922
digoxin,2016,Prescription,Total,582.2961875,LTMHDMANZUZIPE-PUGKRICDSA-N,1.671976677046375e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2017,Prescription,Total,531.9445625,LTMHDMANZUZIPE-PUGKRICDSA-N,1.5483663139158506e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2018,Prescription,Total,481.7478125,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3694266244158302e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2019,Prescription,Total,452.9559375,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3084634441917479e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
dihydrostreptomycin,2016,Prescription,Total,274265,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.875110522342622e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2017,Prescription,Total,252650,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.354051094578859e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2018,Prescription,Total,189635,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.3906050257591166e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2019,Prescription,Total,179655,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.189732170499885e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
diltiazem,2016,Prescription,Total,293739.3,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.434286008989685e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2017,Prescription,Total,288176.4,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.388141578673244e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2018,Prescription,Total,287198.1,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.163954550839608e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2019,Prescription,Total,263529.6,HSUGRBWQSSZJOP-RTWAWAEBSA-N,7.612635568166577e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
dimethyl fumarate,2016,Prescription,Total,169174.32,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.857588345367282e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.013128617149641303
dimethyl fumarate,2017,Prescription,Total,159363.8184,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.63870834411552e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012537049578690593
dimethyl fumarate,2018,Prescription,Total,158516.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.506014231339342e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.01217841684145768
dimethyl fumarate,2019,Prescription,Total,161051.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.6523190901913344e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012573835378895499
dimethylaminodiphenylbuten,2016,Prescription,Total,9409,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7016540537334955e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2017,Prescription,Total,10666.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.104768889781333e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2018,Prescription,Total,11326,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.2195529581431566e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2019,Prescription,Total,11148.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.220490891031029e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimeticone,2016,OTC,Total,52363,NA,1.503525467272261e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2017,OTC,Total,66244,NA,1.9282080376381627e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2018,OTC,Total,83859,NA,2.3837938505820853e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2019,OTC,Total,75511,NA,2.1813023067914432e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dinoprost,2016,Prescription,Total,8.5,PXGPLTODNUVGFL-YNNPMVKQSA-N,2.4406482577037636e-12,sex hormone,"prostaglandin for labour and abortion induction in humans, uterine infections in animals",NA,NA,NA,NA
dinoprostone,2016,Prescription,Total,0.1915,XEYBRNLFEZDVAW-ARSRFYASSA-N,5.498636957062009e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dinoprostone,2017,Prescription,Total,0.117,XEYBRNLFEZDVAW-ARSRFYASSA-N,3.4055965884255945e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dipyridamole,2016,Prescription,Total,2103356.67,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.039475049370695e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.25164479372377896
dipyridamole,2017,Prescription,Total,2164230.735,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.299569921095569e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.2624820800456487
dipyridamole,2018,Prescription,Total,1924232.88,IZEKFCXSFNUWAM-UHFFFAOYSA-N,5.469865496168396e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.22791106234034986
dipyridamole,2019,Prescription,Total,1605438.675,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4.637664823919294e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.1932360343299706
disopyramide,2016,Prescription,Total,15559,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.467534851954454e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2017,Prescription,Total,15085.5,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.391036524332846e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2018,Prescription,Total,13962.25,UVTNFZQICZKOEM-UHFFFAOYSA-N,3.968939015524835e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2019,Prescription,Total,14100,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.07309696941629e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disulfiram,2016,Prescription,Total,149374,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.289051680544024e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2017,Prescription,Total,143818,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.1862058987537786e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2018,Prescription,Total,132497.8,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.7664107711236126e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2019,Prescription,Total,104326,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.0136873363923685e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
dobutamine,2016,Prescription,Total,1156.25,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.3199994681999727e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2017,Prescription,Total,1098.75,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.19820448848942e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2018,Prescription,Total,1325,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.7664733087936447e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2019,Prescription,Total,1527.5,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4.412521716867648e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
docetaxel,2016,Prescription,Total,898.46,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.5797939219017925e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2017,Prescription,Total,908.76,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.645187996322772e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2018,Prescription,Total,867.26,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.4652918051202836e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2019,Prescription,Total,995.14,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.8746820696063313e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docusate sodium,2016,OTC,Total,30162.96,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.660844208375097e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2017,OTC,Total,28812.120000000003,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.386534835667422e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2018,OTC,Total,29620.08,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.419867224477923e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2019,OTC,Total,28856.28,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.335774937349496e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
dolutegravir,2016,Prescription,Total,17530.5,RHWKPHLQXYSBKR-BMIGLBTASA-N,5.033621680197156e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,5.298549137049638e-4
dolutegravir,2017,Prescription,Total,21798,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.344888413205222e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,6.678829908637076e-4
dolutegravir,2018,Prescription,Total,23759.85,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.754025724221938e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.109500762338881e-4
dolutegravir,2019,Prescription,Total,25429.35,RHWKPHLQXYSBKR-BMIGLBTASA-N,7.345830384342279e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.732453036149767e-4
donepezil,2016,Prescription,Total,20993.0096,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.027829682846869e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2017,Prescription,Total,21579.606,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2813190233477345e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2018,Prescription,Total,21094.7276,ADEBPBSSDYVVLD-UHFFFAOYSA-N,5.99643233673001e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2019,Prescription,Total,21592.6614,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2375179936150445e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
dopamine,2016,Prescription,Total,1146,VYFYYTLLBUKUHU-UHFFFAOYSA-N,3.2905681215629567e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2017,Prescription,Total,522,VYFYYTLLBUKUHU-UHFFFAOYSA-N,1.5194200163744958e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2018,Prescription,Total,784,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.228615150259787e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2019,Prescription,Total,749,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.1636522199239727e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
doramectin,2016,Prescription,Total,1018.5,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.9244708829073923e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2017,Prescription,Total,663,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.929838066774503e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2018,Prescription,Total,818,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.3252642766741144e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2019,Prescription,Total,692,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.998995108394378e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doravirine,2019,Prescription,Total,84,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,NNRTI antiviral for used in combination for treatment of HIV,NA,NA,NA,NA
dorzolamide,2016,Prescription,Total,20753.1,IAVUPMFITXYVAF-XPUUQOCRSA-N,5.958943218464939e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2017,Prescription,Total,21312.92,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.203692960802359e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2018,Prescription,Total,21852.98,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.211974783969913e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2019,Prescription,Total,23854.88,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.891009888921225e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
doxazosin,2016,Prescription,Total,20090.384,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.768654200729361e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2017,Prescription,Total,20391.00000000001,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.935343592699686e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2018,Prescription,Total,14713.708,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4.182550072104416e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2019,Prescription,Total,8302.724,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,2.3984255292411272e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxepin,2016,Prescription,Total,22507.01,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.462552322661317e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2017,Prescription,Total,20741.165,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.0372684413651585e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2018,Prescription,Total,18060.3,ODQWQRRAPPTVAG-GZTJUZNOSA-N,5.13385946406082e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2019,Prescription,Total,16463.375,ODQWQRRAPPTVAG-GZTJUZNOSA-N,4.755810128997441e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxorubicin,2016,Prescription,Total,599.3,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.7208005892257238e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2017,Prescription,Total,563.9200000000001,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6414393402948387e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2018,Prescription,Total,574.9,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6342230228116726e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2019,Prescription,Total,677.84,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.9580908154249206e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxycycline,2016,Prescription,Total,341623.015,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.809195486485373e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2017,Prescription,Total,317192.185,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.232723274455212e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2018,Prescription,Total,303595.08999999997,SGKRLCUYIXIAHR-AKNGSSGZSA-N,8.630058891817392e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2019,Prescription,Total,318083.255,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.188538595479213e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxylamine,2016,Prescription,Total,1619.26275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,4.6494715406495356e-10,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2017,Prescription,Total,7104.46275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.0679430858116852e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2018,Prescription,Total,9141.454,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.598569244872822e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2019,Prescription,Total,11257.61175,HCFDWZZGGLSKEP-UHFFFAOYSA-N,3.252010234169519e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
dronedarone,2016,Prescription,Total,449262,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.2899888441794218e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.32249721104485546
dronedarone,2017,Prescription,Total,519206,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.5112873352906828e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.3778218338226707
dronedarone,2018,Prescription,Total,585632.8,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.664732309399311e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4161830773498278
dronedarone,2019,Prescription,Total,675602.7999999999,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.951628168233447e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4879070420583618
droperidol,2016,Prescription,Total,35.725,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0257901059584348e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2017,Prescription,Total,37.6,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0944481344000199e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2018,Prescription,Total,37.55,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0674043226052932e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2019,Prescription,Total,36.7,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0601607005501975e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
drospirenone,2016,Prescription,Total,37983.771,METQSPRSQINEEU-HXCATZOESA-N,1.0906473472019854e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.47419449878347186
drospirenone,2017,Prescription,Total,35234.64,METQSPRSQINEEU-HXCATZOESA-N,1.025598032294051e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.4459121879539352
drospirenone,2018,Prescription,Total,34171.074,METQSPRSQINEEU-HXCATZOESA-N,9.713542502174529e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.4223279348771534
drospirenone,2019,Prescription,Total,33596.514,METQSPRSQINEEU-HXCATZOESA-N,9.705096408251912e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.421960713402257
duloxetine,2016,Prescription,Total,71834.2884,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.0626144803158793e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.04796777861199719
duloxetine,2017,Prescription,Total,78300.54119999999,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.27914577762904e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.05300339017741953
duloxetine,2018,Prescription,Total,88763.8248,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.5232194482689467e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.0586795220527662
duloxetine,2019,Prescription,Total,103103.28,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.9783663638643915e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.06926433404335794
dutasteride,2016,Prescription,Total,3128.1749999999997,JWJOTENAMICLJG-QWBYCMEYSA-N,8.982088074755847e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002138592398751392
dutasteride,2017,Prescription,Total,3410.16,JWJOTENAMICLJG-QWBYCMEYSA-N,9.926178856397798e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.0023633759181899516
dutasteride,2018,Prescription,Total,3810.36,JWJOTENAMICLJG-QWBYCMEYSA-N,1.083141074482638e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002578907320196757
dutasteride,2019,Prescription,Total,4359,JWJOTENAMICLJG-QWBYCMEYSA-N,1.2591935950131636e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.00299807998812658
dydrogesterone,2019,Prescription,Total,82.11,JGMOKGBVKVMRFX-HQZYFCCVSA-N,2.3719290224026353e-11,sex hormone,progestin for various reproductive and gynaecological disordered,NA,NA,NA,NA
ebastine,2016,OTC,Total,1712.9,MJJALKDDGIKVBE-UHFFFAOYSA-N,4.918336941906795e-10,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2016,Prescription,Total,32977.13,MJJALKDDGIKVBE-UHFFFAOYSA-N,9.468891162184769e-9,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2017,OTC,Total,1411.9,MJJALKDDGIKVBE-UHFFFAOYSA-N,4.1097109599983724e-10,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2017,Prescription,Total,36360.45,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0583677305437557e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2018,OTC,Total,92.4,MJJALKDDGIKVBE-UHFFFAOYSA-N,2.6265821413776058e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2018,Prescription,Total,38118.13000000001,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0835541073669913e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2019,Prescription,Total,42561.2,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.2294744307426991e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
econazole,2016,OTC,Total,11350.8,LEZWWPYKPKIXLL-UHFFFAOYSA-N,3.259212969828692e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.01629606484914346
econazole,2016,Prescription,Total,3740.2794,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.0739654589335624e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.0053698272946678125
econazole,2017,OTC,Total,12144.9,LEZWWPYKPKIXLL-UHFFFAOYSA-N,3.535096581775213e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.017675482908876067
econazole,2017,Prescription,Total,3978.2457,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.157974357593059e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.005789871787965295
econazole,2018,OTC,Total,12261.3,LEZWWPYKPKIXLL-UHFFFAOYSA-N,3.4854233344235103e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.017427116672117552
econazole,2018,Prescription,Total,3951.8622,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.123364792175889e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.005616823960879445
econazole,2019,OTC,Total,17028.9,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.919174537765466e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.024595872688827333
econazole,2019,Prescription,Total,4475.9286,LEZWWPYKPKIXLL-UHFFFAOYSA-N,1.292971008225794e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.00646485504112897
edoxaban,2016,Prescription,Total,130.05,HGVDHZBSSITLCT-JLJPHGGASA-N,3.734191834286759e-11,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,1.6095654458132582e-7
edoxaban,2017,Prescription,Total,5286.4800000000005,HGVDHZBSSITLCT-JLJPHGGASA-N,1.538770790835909e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,6.632632719120298e-6
edoxaban,2018,Prescription,Total,21279.33,HGVDHZBSSITLCT-JLJPHGGASA-N,6.048907809359386e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,2.6072878488618042e-5
edoxaban,2019,Prescription,Total,40912.29,HGVDHZBSSITLCT-JLJPHGGASA-N,1.1818420170984423e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,5.094146625424321e-5
efavirenz,2016,Prescription,Total,137592,XPOQHMRABVBWPR-ZDUSSCGKSA-N,3.950749118517368e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.015195188917374492
efavirenz,2017,Prescription,Total,87066,XPOQHMRABVBWPR-ZDUSSCGKSA-N,2.5342877997253232e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.00974726076817432
efavirenz,2018,Prescription,Total,62352,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.7724312735841613e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.006817043359939081
efavirenz,2019,Prescription,Total,64836,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.8729313128303163e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.0072035819724242936
eflornithine,2016,Prescription,Total,5385.45,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.5463516658177332e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2017,Prescription,Total,6365.25,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8527755285876934e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2018,Prescription,Total,6444.6,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8319557649699262e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2019,Prescription,Total,7903.95,VLCYCQAOQCDTCN-UHFFFAOYSA-N,2.283230836270772e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
elbasvir,2017,Prescription,Total,4765.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.3871547950257275e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2018,Prescription,Total,3778.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.0741129090269935e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2019,Prescription,Total,861,BVAZQCUMNICBAQ-PZHYSIFUSA-N,2.4871890004733516e-10,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
eletriptan,2016,Prescription,Total,36486.6,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0476583143474606e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2017,Prescription,Total,36664.8,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0672266478231344e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2018,Prescription,Total,37340,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.061434817738526e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2019,Prescription,Total,37276.2,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0768055124209611e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eliglustat,2016,Prescription,Total,70.56,FJZZPCZKBUKGGU-AUSIDOKSSA-N,2.0260251889832654e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2017,Prescription,Total,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.916914264336375e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2018,Prescription,Total,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.872036726218221e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2019,Prescription,Total,56.448,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.6306253739688706e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eltrombopag,2016,Prescription,Total,1215.55,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,3.490270576060953e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2017,Prescription,Total,1726.9,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.026602349189878e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2018,Prescription,Total,2057.3,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.848124934476351e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2019,Prescription,Total,2347.8,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,6.782139762266361e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eluxadoline,2017,Prescription,Total,1661.8,QFNHIDANIVGXPE-FNZWTVRRSA-N,4.8371114620903e-10,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2018,Prescription,Total,8265.6,QFNHIDANIVGXPE-FNZWTVRRSA-N,2.349597115559604e-9,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2019,Prescription,Total,316.4,QFNHIDANIVGXPE-FNZWTVRRSA-N,9.13991405051996e-11,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
elvitegravir,2016,Prescription,Total,25407,JUZYLCPPVHEVSV-LJQANCHMSA-N,7.29524120982112e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2017,Prescription,Total,43587,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.2687157136727041e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2018,Prescription,Total,47475,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.3495344930941758e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2019,Prescription,Total,33624,JUZYLCPPVHEVSV-LJQANCHMSA-N,9.713036347493145e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
emedastine,2016,Prescription,Total,31.7375,KBUZBQVCBVDWKX-UHFFFAOYSA-N,9.112949891632142e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2017,Prescription,Total,30.6275,KBUZBQVCBVDWKX-UHFFFAOYSA-N,8.914949530940588e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2018,Prescription,Total,39.182500000000005,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1138101163909964e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2019,Prescription,Total,38.427499999999995,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1100633602286842e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emodepside,2016,Prescription,Total,2393.946124,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,6.873859337149738e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2017,Prescription,Total,2639.01194,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.681547059554194e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2018,Prescription,Total,2740.303384,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.789644946288983e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2019,Prescription,Total,2591.797656,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.486980977300601e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
empagliflozin,2016,Prescription,Total,19498.119,OBWASQILIWPZMG-QZMOQZSNSA-N,5.5985941371589e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,2.3327475571495418e-5
empagliflozin,2017,Prescription,Total,44557.269,OBWASQILIWPZMG-QZMOQZSNSA-N,1.2969579768885596e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,5.403991570368998e-5
empagliflozin,2018,Prescription,Total,68882.715,OBWASQILIWPZMG-QZMOQZSNSA-N,1.958074773469733e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,8.15864488945722e-5
empagliflozin,2019,Prescription,Total,96535.977,OBWASQILIWPZMG-QZMOQZSNSA-N,2.7886552862293668e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,1.1619397025955695e-4
emtricitabine,2016,Prescription,Total,185142,XQSPYNMVSIKCOC-NTSWFWBYSA-N,5.316076467385768e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,8.714879454730768e-5
emtricitabine,2017,Prescription,Total,208338,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.064232325123176e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,9.941364467415043e-5
emtricitabine,2018,Prescription,Total,222060,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.312325003401636e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.0348073776068256e-4
emtricitabine,2019,Prescription,Total,248202,XQSPYNMVSIKCOC-NTSWFWBYSA-N,7.169863929099732e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.175387529360612e-4
enalapril,2016,Prescription,Total,318584.1288,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.147668222209313e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2017,Prescription,Total,313478.8807,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.124637663721314e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2018,Prescription,Total,305892.9873,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.695379411415875e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2019,Prescription,Total,307256.2993,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.875778024914148e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
encorafenib,2019,Prescription,Total,126.35,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,3.6498993055726825e-11,antineoplastic,small molecule BRAF inhibitor for melanomas,NA,NA,NA,NA
enoxaparin,2016,Prescription,Total,100177.6,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.876450410599348e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2017,Prescription,Total,95914.2,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.7918382247997445e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2018,Prescription,Total,90336.4,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.5679218068868392e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2019,Prescription,Total,101000.1,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.917611356175477e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enrofloxacin,2016,Prescription,Total,18469.15,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.3031410316199375e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2017,Prescription,Total,18206.94,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.299614764929015e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2018,Prescription,Total,18346.29,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.215155592482095e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2019,Prescription,Total,12959.97,SPFYMRJSYKOXGV-UHFFFAOYSA-N,3.743774080193336e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
entacapone,2016,Prescription,Total,28821,JRURYQJSLYLRLN-BJMVGYQFSA-N,8.275520404150609e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2017,Prescription,Total,31330.2,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.119489079888166e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2018,Prescription,Total,32387,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.20639781523772e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2019,Prescription,Total,33673,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.72719108164218e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entecavir,2016,Prescription,Total,52.455,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.5061671100923637e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2017,Prescription,Total,63.5925,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.8510290687987572e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2018,Prescription,Total,63.141,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.7948595561550154e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2019,Prescription,Total,57.366,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.6571438350889002e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
enzalutamide,2016,Prescription,Total,26960.64,WXCXUHSOUPDCQV-UHFFFAOYSA-N,7.741345769715105e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2017,Prescription,Total,33116.16,WXCXUHSOUPDCQV-UHFFFAOYSA-N,9.639340300662918e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2018,Prescription,Total,37022.72,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.0524157486712504e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2019,Prescription,Total,40185.6,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.160849968611172e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
ephedrine,2016,Prescription,Total,18558.75,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.328868335607026e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2017,Prescription,Total,17555.5,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.109995804111582e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2018,Prescription,Total,15878.85,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.51375582636513e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2019,Prescription,Total,15576.15,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.499515557459117e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
epinephrine,2016,Prescription,Total,271.69765,UCTWMZQNUQWSLP-VIFPVBQESA-N,7.801392895231848e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2017,Prescription,Total,291.7274,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.491502890515115e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2018,Prescription,Total,306.95865000000003,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.725672167006269e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2019,Prescription,Total,324.8584,UCTWMZQNUQWSLP-VIFPVBQESA-N,9.384253649144859e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epirubicin,2016,Prescription,Total,1315.33,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.7767739680064606e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2017,Prescription,Total,1127.27,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.281219543790187e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2018,Prescription,Total,1006.18,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8601887651637655e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2019,Prescription,Total,988.13,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8544321336094456e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
eplerenone,2016,Prescription,Total,15919.925,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.571169084002893e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2017,Prescription,Total,17031.66,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.9575182214721925e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2018,Prescription,Total,23322.025,JUKPWJGBANNWMW-VWBFHTRKSA-N,6.629568654303253e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2019,Prescription,Total,31719.375,JUKPWJGBANNWMW-VWBFHTRKSA-N,9.162843275480769e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
epoprostenol,2016,Prescription,Total,0.524,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.504587867102085e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2017,Prescription,Total,0.495,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.440829325872367e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2018,Prescription,Total,0.4785,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.3601943232134034e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2019,Prescription,Total,0.528,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.52524482258993e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
eprinomectin,2016,Prescription,Total,4106.3564,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.1790790109612587e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2017,Prescription,Total,5427.3816,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.579783953935371e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2018,Prescription,Total,5763.41,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.638319240198821e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2019,Prescription,Total,5112.176,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.4767651470016094e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprosartan,2016,Prescription,Total,462785.4,OROAFUQRIXKEMV-LDADJPATSA-N,1.3288192708243993e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2017,Prescription,Total,420487.62,OROAFUQRIXKEMV-LDADJPATSA-N,1.22394120012581e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2018,Prescription,Total,382502.232,OROAFUQRIXKEMV-LDADJPATSA-N,1.0873090168920713e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2019,Prescription,Total,333412.464,OROAFUQRIXKEMV-LDADJPATSA-N,9.631356714071049e-8,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eribulin,2016,Prescription,Total,1.826,UFNVPOGXISZXJD-JBQZKEIOSA-N,5.243086727725968e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2017,Prescription,Total,1.51976,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.423666214722804e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2018,Prescription,Total,1.41328,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.017419922907082e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2019,Prescription,Total,1.19416,UFNVPOGXISZXJD-JBQZKEIOSA-N,3.4495953737575586e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
erlotinib,2016,Prescription,Total,2868,AAKJLRGGTJKAMG-UHFFFAOYSA-N,8.23503435658164e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,5.924485148619885e-4
erlotinib,2017,Prescription,Total,3227.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,9.393770589740595e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,6.758108337942874e-4
erlotinib,2018,Prescription,Total,2084.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,5.924733580266531e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,4.2623982591845545e-4
erlotinib,2019,Prescription,Total,1297.5,AAKJLRGGTJKAMG-UHFFFAOYSA-N,3.748115828239459e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,2.696486207366517e-4
ertapenem,2016,Prescription,Total,3578,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.0273693489487138e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,7.902841145759337e-5
ertapenem,2017,Prescription,Total,4296,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2504652088783204e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.61896314521785e-5
ertapenem,2018,Prescription,Total,4515,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2834435463549666e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.872642664268974e-5
ertapenem,2019,Prescription,Total,4674,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.3501883145426768e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,1.038606395802059e-4
ertugliflozin,2018,Prescription,Total,68.39,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.9440687516105464e-11,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
ertugliflozin,2019,Prescription,Total,560.28,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.6184927446982687e-10,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
erythromycin,2016,Prescription,Total,1270675,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.6485537939502707e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2017,Prescription,Total,1150366,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.348446602598972e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2018,Prescription,Total,864442.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.457282719424038e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2019,Prescription,Total,867991.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.507385495127021e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythropoietin,2016,Prescription,Total,1012.9224,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.9084556361754294e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2017,Prescription,Total,948.5448,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.7609922520075536e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2018,Prescription,Total,1127.196,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.2041914322860087e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2019,Prescription,Total,1287.3504,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.7187964629906733e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
escitalopram,2016,Prescription,Total,396431.7842,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.1382947569483817e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2017,Prescription,Total,389371.3374,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.133368972889018e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2018,Prescription,Total,374910.2026,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0657277519149569e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2019,Prescription,Total,372772.82579999993,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0768367851395225e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
esketamine,2016,Prescription,Total,450.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.294261414305849e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2017,Prescription,Total,615.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.7908489752383303e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2018,Prescription,Total,814.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,2.314604446554887e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2019,Prescription,Total,1047.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,3.0266576948268923e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
eslicarbazepine,2016,Prescription,Total,150333.6,BMPDWHIDQYTSHX-AWEZNQCLSA-N,4.316605163698053e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2017,Prescription,Total,180806.64,BMPDWHIDQYTSHX-AWEZNQCLSA-N,5.2628587722110654e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2018,Prescription,Total,239031.12,BMPDWHIDQYTSHX-AWEZNQCLSA-N,6.794749686423025e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2019,Prescription,Total,301821.68,BMPDWHIDQYTSHX-AWEZNQCLSA-N,8.718787022071867e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
esmolol,2016,Prescription,Total,89,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5555022933604115e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2017,Prescription,Total,86,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5032590308085564e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2018,Prescription,Total,136.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,3.880178163398736e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2019,Prescription,Total,142.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4.1164277882398677e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esomeprazole,2016,Prescription,Total,1635560.512,SUBDBMMJDZJVOS-DEOSSOPVSA-N,4.696268134096325e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.004696268134096324
esomeprazole,2017,Prescription,Total,1758601.6008,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.118878300926725e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005118878300926725
esomeprazole,2018,Prescription,Total,1831296.4908,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.205682530630692e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005205682530630692
esomeprazole,2019,Prescription,Total,1967701.7156,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.684141769167089e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005684141769167089
estradiol,2016,Prescription,Total,16764.89485500001,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.8137895786403016e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.034473946600754
estradiol,2017,Prescription,Total,16335.55707,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.754898925437914e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.887247313594786
estradiol,2018,Prescription,Total,16243.17705,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.617320211987509e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.543300529968773
estradiol,2019,Prescription,Total,16651.18926,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.810064433481069e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.025161083702672
estriol,2016,OTC,Total,1073.595,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3.082667960269967e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2016,Prescription,Total,2115.3132,PROQIPRRNZUXQM-ZXXIGWHRSA-N,6.073806442444438e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,OTC,Total,1049.8425,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3.055846184943757e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,Prescription,Total,1914.1944,PROQIPRRNZUXQM-ZXXIGWHRSA-N,5.5717725796781e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,OTC,Total,1013.085,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.87981706568997e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,Prescription,Total,1698.9762,PROQIPRRNZUXQM-ZXXIGWHRSA-N,4.829546044962758e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,OTC,Total,991.86,PROQIPRRNZUXQM-ZXXIGWHRSA-N,2.8652070638902417e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,Prescription,Total,1527.568799999999,PROQIPRRNZUXQM-ZXXIGWHRSA-N,4.4127204608899825e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
ethambutol,2016,Prescription,Total,10609.5,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.046359728248009e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2017,Prescription,Total,11253,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.275485334149847e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2018,Prescription,Total,9966,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.8329564524858467e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2019,Prescription,Total,8679,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.507121177132197e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethinylestradiol,2016,Prescription,Total,2284.45398675,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.559468991253887e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.741339975011105
ethinylestradiol,2017,Prescription,Total,2211.705453,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.437757731059046e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.393593517311558
ethinylestradiol,2018,Prescription,Total,2102.425479,BFPYWIDHMRZLRN-SLHNCBLASA-N,5.976399585193354e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.075427386266725
ethinylestradiol,2019,Prescription,Total,2094.9751485,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.051799239970065e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.290854971343045
ethylmorphine,2016,Prescription,Total,168526.865,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.838997640453264e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2017,Prescription,Total,165954.01750000002,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.830533639602747e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2018,Prescription,Total,163302.13,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.642061237087925e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2019,Prescription,Total,161539.45,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.6664244272069105e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
etonogestrel,2016,Prescription,Total,3305.33,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.490762241924683e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.5150971266387714
etonogestrel,2017,Prescription,Total,3368.545,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.805047316203499e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.6314990060012957
etonogestrel,2018,Prescription,Total,3550.718,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0093346848342003e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.738276610497038
etonogestrel,2019,Prescription,Total,3539.2419999999997,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0223883591653083e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.7866235524641048
etoposide,2016,Prescription,Total,3659.2,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0506847181870131e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2017,Prescription,Total,3609.8,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0507284243503171e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2018,Prescription,Total,3554.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0103529118071891e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2019,Prescription,Total,3086.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,8.915460409013827e-10,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoricoxib,2016,Prescription,Total,393101.82,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.1287332612743277e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0015049776816991036
etoricoxib,2017,Prescription,Total,442147.1478,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.286987024042553e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0017159826987234042
etoricoxib,2018,Prescription,Total,475405.017,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.3513964584128973e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.00180186194455053
etoricoxib,2019,Prescription,Total,530281.7112,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.5318360502309253e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.002042448066974567
etravirine,2016,Prescription,Total,3480,PYGWGZALEOIKDF-UHFFFAOYSA-N,9.99230110212835e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0020392451228833366
etravirine,2017,Prescription,Total,2556,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.43991870086822e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0015183507552792286
etravirine,2018,Prescription,Total,2508,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.129294383739217e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0014549580374977995
etravirine,2019,Prescription,Total,2280,PYGWGZALEOIKDF-UHFFFAOYSA-N,6.586284461183787e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.001344139685955875
everolimus,2016,Prescription,Total,802.059,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.30299282461838e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.16449948747274143
everolimus,2017,Prescription,Total,689.892,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0081143945146237e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14343674246533028
everolimus,2018,Prescription,Total,706.9499999999999,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0095911740767302e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14354222671976644
everolimus,2019,Prescription,Total,764.208,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.2075838927685703e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.1576845637691836
exemestane,2016,Prescription,Total,7017.25,BFYIZQONLCFLEV-DAELLWKTSA-N,2.0148987042790278e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2017,Prescription,Total,6853,BFYIZQONLCFLEV-DAELLWKTSA-N,1.9947481555966323e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2018,Prescription,Total,7102.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.01897182458165e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2019,Prescription,Total,7537.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.177373645884772e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
ezetimibe,2016,Prescription,Total,125693.8396,OLNTVTPDXPETLC-XPWALMASSA-N,3.60911118380984e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.007218222367619679
ezetimibe,2017,Prescription,Total,145311.6734,OLNTVTPDXPETLC-XPWALMASSA-N,4.229683240935505e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.00845936648187101
ezetimibe,2018,Prescription,Total,181550.2022,OLNTVTPDXPETLC-XPWALMASSA-N,5.1607848361689764e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.010321569672337952
ezetimibe,2019,Prescription,Total,206958.4234,OLNTVTPDXPETLC-XPWALMASSA-N,5.978451965572435e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.01195690393114487
famotidine,2016,OTC,Total,35431.3512,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0173584185220018e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2017,OTC,Total,35443.1328,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0316667704854297e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2018,OTC,Total,32979.636,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.374861790772076e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2019,OTC,Total,32563.0032,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.406543946738508e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
fampridine,2016,Prescription,Total,10753.12,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.0875980697505288e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2017,Prescription,Total,10847.76,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.157529440005096e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2018,Prescription,Total,11444.16,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.2531413721935e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2019,Prescription,Total,11673.2,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.372062095275904e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
febantel,2016,Prescription,Total,9568.5,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.747452100451584e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2017,Prescription,Total,9452.1,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.7512854285006462e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2018,Prescription,Total,6800.0999999999995,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.933010954500201e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2019,Prescription,Total,5323.8,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.5378974216864144e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febuxostat,2017,Prescription,Total,1906.24,BQSJTQLCZDPROO-UHFFFAOYSA-N,5.54861918010291e-10,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2018,Prescription,Total,8012.48,BQSJTQLCZDPROO-UHFFFAOYSA-N,2.2776446835655022e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2019,Prescription,Total,11303.04,BQSJTQLCZDPROO-UHFFFAOYSA-N,3.2651331893043335e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
felbamate,2016,Prescription,Total,12748.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.6606278244486747e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2017,Prescription,Total,11507.4,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.3495352292007413e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2018,Prescription,Total,13672.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.886659340111226e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2019,Prescription,Total,13081.2,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.778794047966552e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felodipine,2016,Prescription,Total,33237.5734,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.543673601060114e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.19087347202120228
felodipine,2017,Prescription,Total,32285.259199999997,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.397484494697096e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.18794968989394192
felodipine,2018,Prescription,Total,32900.6745,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.352416026079829e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.1870483205215966
felodipine,2019,Prescription,Total,34789.8125,RZTAMFZIAATZDJ-UHFFFAOYSA-N,1.004980708229156e-8,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.2009961416458312
felypressin,2016,Prescription,Total,0.2567052,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.370907048511722e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2017,Prescription,Total,0.2695356,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.845551451446542e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2018,Prescription,Total,0.28032480000000004,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.968572656550318e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2019,Prescription,Total,0.27459,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.932139693844107e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
fenbendazole,2016,Prescription,Total,847857.125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.4344953116623203e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2017,Prescription,Total,907688.6125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.6420694376775737e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2018,Prescription,Total,823748.175,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.341604161739605e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2019,Prescription,Total,813966.575,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.3513225459848633e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fentanyl,2016,Prescription,Total,7638.800299999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.193367605075527e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.976006851419394e-4
fentanyl,2017,Prescription,Total,7574.263399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.2046910764851996e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9862081770136934e-4
fentanyl,2018,Prescription,Total,7407.372399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.105635504369413e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.8969689228553267e-4
fentanyl,2019,Prescription,Total,7367.357399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.128224191386289e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9173190913389991e-4
fesoterodine,2016,Prescription,Total,14490.68992,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.160785541902763e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2017,Prescription,Total,13885.55616,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.04176091340923e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2018,Prescription,Total,13299.2664,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.780477880915936e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2019,Prescription,Total,12869.67024,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.7176889965908515e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fexofenadine,2016,OTC,Total,129518.4,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.71892773294799e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,1.8594638664739947e-4
fexofenadine,2016,Prescription,Total,1047457.68,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.007618543188737e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0015038092715943686
fexofenadine,2017,OTC,Total,128352,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.7360267804923234e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,1.8680133902461616e-4
fexofenadine,2017,Prescription,Total,1152328.6800000002,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.3541595054298877e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0016770797527149437
fexofenadine,2018,OTC,Total,121611.6,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.4569573240731274e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,1.7284786620365636e-4
fexofenadine,2018,Prescription,Total,1223734.74,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.478614517172476e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.001739307258586238
fexofenadine,2019,OTC,Total,141428.4,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4.085472251272304e-8,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,2.042736125636152e-4
fexofenadine,2019,Prescription,Total,1397175.3,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4.036049985938508e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.002018024992969254
fidaxomicin,2016,Prescription,Total,212,ZVGNESXIJDCBKN-UUEYKCAUSA-N,6.087263889802327e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2017,Prescription,Total,284,ZVGNESXIJDCBKN-UUEYKCAUSA-N,8.266576334298023e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2018,Prescription,Total,276,ZVGNESXIJDCBKN-UUEYKCAUSA-N,7.845634967751289e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2019,Prescription,Total,352,ZVGNESXIJDCBKN-UUEYKCAUSA-N,1.0168298817266201e-10,antibacterial,macrolide antibiotic,NA,NA,NA,NA
finasteride,2016,Prescription,Total,24501.47,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.03523177255071e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407046354510142
finasteride,2017,Prescription,Total,24178.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.0377730483351405e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407554609667028
finasteride,2018,Prescription,Total,24142.09,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.862682083282563e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0013725364166565124
finasteride,2019,Prescription,Total,21924.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.333353805546802e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0012666707611093603
fingolimod,2016,Prescription,Total,207.1825,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.948936560608354e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.930510620989337e-5
fingolimod,2017,Prescription,Total,215.565,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.27459340670054e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.090932712660364e-5
fingolimod,2018,Prescription,Total,216.0795,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.142322032660199e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.0257744003252214e-5
fingolimod,2019,Prescription,Total,204.3895,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.904242929294403e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.9084940538396075e-5
firocoxib,2016,Prescription,Total,50877.425952,FULAPETWGIGNMT-UHFFFAOYSA-N,1.4608694236023652e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2017,Prescription,Total,64354.385976000005,FULAPETWGIGNMT-UHFFFAOYSA-N,1.8732057891460643e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2018,Prescription,Total,73775.904472,FULAPETWGIGNMT-UHFFFAOYSA-N,2.097169622836964e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2019,Prescription,Total,88211.24,FULAPETWGIGNMT-UHFFFAOYSA-N,2.5481768390954117e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
flecainide,2016,Prescription,Total,444214.9499999999,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.2754969926628992e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2017,Prescription,Total,454880.21,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.324049992579759e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2018,Prescription,Total,452896.64,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.287413665058358e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2019,Prescription,Total,460916.9,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.331460445775001e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
florfenicol,2016,Prescription,Total,17160,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.927238129670187e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2017,Prescription,Total,17930,AYIRNRDRBQJXIF-NXEZZACHSA-N,5.219004002604351e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2018,Prescription,Total,16690,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.7443350583974295e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2019,Prescription,Total,13650,AYIRNRDRBQJXIF-NXEZZACHSA-N,3.943104512945557e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
flubendazole,2016,Prescription,Total,250,CPEUVMUXAHMANV-UHFFFAOYSA-N,7.178377228540482e-11,anthelminthic,"imidazole anthelmintic for human, veterinary infections",NA,NA,NA,NA
fluconazole,2016,OTC,Total,8535.9,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.4509564074039473e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2016,Prescription,Total,75710.72,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.1739204336176176e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2017,OTC,Total,8902.5,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.5913097118340893e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2017,Prescription,Total,72238.825,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.102703384374987e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2018,OTC,Total,9445.2,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.684912731790018e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2018,Prescription,Total,71045.101,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.0195432199022546e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2019,OTC,Total,9142.05,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.640883414840581e-9,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2019,Prescription,Total,71737.762,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.0723039786872845e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fludarabine,2016,Prescription,Total,96.65,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.7751606365537495e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2017,Prescription,Total,87.45,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5454651423745147e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2018,Prescription,Total,89.9,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5555166072494243e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2019,Prescription,Total,81.4,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.351419101492809e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludrocortisone,2016,Prescription,Total,77.24,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.2178314285298668e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2017,Prescription,Total,80.97,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.356847485169405e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2018,Prescription,Total,80.31,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.282909218333718e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2019,Prescription,Total,82.49,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.382906163171275e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
flumazenil,2016,Prescription,Total,7.015,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.014252650328459e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2017,Prescription,Total,6.9399999999999995,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.020071822536207e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2018,Prescription,Total,7.92,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.2513561211808053e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2019,Prescription,Total,7.4,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.137653728629826e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flunixin,2016,Prescription,Total,19223.8,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.5198275266406615e-09,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2017,Prescription,Total,19617,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.710050279926913e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2018,Prescription,Total,16167.95,NOOCSNJCXJYGPE-UHFFFAOYSA-N,4.59593601003096e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2019,Prescription,Total,6154.15,NOOCSNJCXJYGPE-UHFFFAOYSA-N,1.7777623910874652e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
fluocinolone acetonide,2016,Prescription,Total,197.62,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.67436363161668e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2017,Prescription,Total,202.68375,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.899650320763299e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2018,Prescription,Total,184.275,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.238240520588294e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2019,Prescription,Total,228.4431875,FEBLZLNTKCEFIT-VSXGLTOVSA-N,6.599086912695372e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2016,Prescription,Total,21.3,WJOHZNCJWYWUJD-IUGZLZTKSA-N,6.1159773987164904e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2017,Prescription,Total,16.9,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.919195072170302e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2018,Prescription,Total,17.1,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.860882534367648e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2019,Prescription,Total,19,WJOHZNCJWYWUJD-IUGZLZTKSA-N,5.4885703843198235e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluorescein,2016,OTC,Total,971.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,2.7892302559216897e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,2.7892302559216894e-5
fluorescein,2016,Prescription,Total,3048,GNBHRKFJIUUOQI-UHFFFAOYSA-N,8.751877517036556e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,8.751877517036554e-5
fluorescein,2017,OTC,Total,1022.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,2.9753853270843097e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,2.9753853270843096e-5
fluorescein,2017,Prescription,Total,2868,GNBHRKFJIUUOQI-UHFFFAOYSA-N,8.348077791115045e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,8.348077791115045e-5
fluorescein,2018,OTC,Total,1034.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,2.9398390158146325e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,2.9398390158146322e-5
fluorescein,2018,Prescription,Total,2544,GNBHRKFJIUUOQI-UHFFFAOYSA-N,7.231628752883799e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,7.231628752883798e-5
fluorescein,2019,OTC,Total,1107.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,3.198969917681986e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,3.1989699176819856e-5
fluorescein,2019,Prescription,Total,1650,GNBHRKFJIUUOQI-UHFFFAOYSA-N,4.76639007059353e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,4.76639007059353e-5
fluoxetine,2016,Prescription,Total,96105.48,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.7595255566798107e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08623517364624408
fluoxetine,2017,Prescription,Total,90741.92,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.641285240847762e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08254016377649256
fluoxetine,2018,Prescription,Total,88383.38,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5124048431016308e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07851265134692596
fluoxetine,2019,Prescription,Total,87378.72,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5241276569040754e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07887898927825235
flupentixol,2016,Prescription,Total,2253.712499999999,NJMYODHXAKYRHW-DVZOWYKESA-N,6.471199395870812e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2017,Prescription,Total,2129.6025,NJMYODHXAKYRHW-DVZOWYKESA-N,6.198775221113346e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2018,Prescription,Total,1947.4855,NJMYODHXAKYRHW-DVZOWYKESA-N,5.535963890575582e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2019,Prescription,Total,1965.812,NJMYODHXAKYRHW-DVZOWYKESA-N,5.678682907547641e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flurbiprofen,2016,OTC,Total,3806.18,SYTBZMRGLBWNTM-UHFFFAOYSA-N,1.0928878335890484e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2017,OTC,Total,7265.44,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.1147998014881067e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2018,OTC,Total,8077.02,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.295990961856034e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2019,OTC,Total,10417.54,SYTBZMRGLBWNTM-UHFFFAOYSA-N,3.009336922182481e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flutamide,2016,Prescription,Total,14427,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.142497931046141e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2017,Prescription,Total,13860,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.034322112442627e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2018,Prescription,Total,11466,MKXKFYHWDHIYRV-UHFFFAOYSA-N,3.259349657254938e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2019,Prescription,Total,8505,MKXKFYHWDHIYRV-UHFFFAOYSA-N,2.456857427296847e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
fluticasone,2016,Prescription,Total,17882.717,MGNNYOODZCAHBA-GQKYHHCASA-N,5.134755539889351e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08853026792912673
fluticasone,2017,Prescription,Total,17071.5354,MGNNYOODZCAHBA-GQKYHHCASA-N,4.969125018583484e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08567456928592214
fluticasone,2018,Prescription,Total,16322.98,MGNNYOODZCAHBA-GQKYHHCASA-N,4.640005169054528e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08000008912162979
fluticasone,2019,Prescription,Total,15177.8022,MGNNYOODZCAHBA-GQKYHHCASA-N,4.384443981788646e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.07559386175497665
fluticasone furoate,2016,Prescription,Total,1262.8347,XTULMSXFIHGYFS-VLSRWLAYSA-N,3.6260415415563003e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.006251795761303965
fluticasone furoate,2017,Prescription,Total,1501.49244,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.3704936164195046e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.0075353338214129385
fluticasone furoate,2018,Prescription,Total,1645.16016,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.676567419872213e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.008063047275641746
fluticasone furoate,2019,Prescription,Total,1907.83512,XTULMSXFIHGYFS-VLSRWLAYSA-N,5.511203861998557e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.009502075624135442
fluvastatin,2016,Prescription,Total,146666.31,FJLGEFLZQAZZCD-MCBHFWOFSA-N,4.2113043995922366e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0022164759997853876
fluvastatin,2017,Prescription,Total,135773.68839999998,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.9520547864358945e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.00208002883496626
fluvastatin,2018,Prescription,Total,133801.1248,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8034593603454146e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020018207159712706
fluvastatin,2019,Prescription,Total,133494.1104,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8562727411713746e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020296172321954604
fluvoxamine,2016,Prescription,Total,18077.03999999999,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.190552491816614e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2017,Prescription,Total,17547.885000000002,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.107779255562791e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2018,Prescription,Total,16008.705,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.55066868610199e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2019,Prescription,Total,15773.355,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.556482584966474e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fomepizole,2016,Prescription,Total,3.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.0049728119956673e-12,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2017,Prescription,Total,62,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.8046751152340755e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2018,Prescription,Total,126.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.5959160268860076e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2019,Prescription,Total,132.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.827555662749351e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
formoterol,2016,Prescription,Total,396.45546,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.1383627384778168e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.211024189870018e-6
formoterol,2017,Prescription,Total,409.81806,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.192884604283073e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.2690261747692265e-6
formoterol,2018,Prescription,Total,431.31168,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.22605579659694e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3043146772307874e-6
formoterol,2019,Prescription,Total,453.85374,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.311056945356205e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3947414312300055e-6
fosfomycin,2017,Prescription,Total,1240,YMDXZJFXQJVXBF-STHAYSLISA-N,3.609350230468151e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2018,Prescription,Total,1320,YMDXZJFXQJVXBF-STHAYSLISA-N,3.7522602019680086e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2019,Prescription,Total,500,YMDXZJFXQJVXBF-STHAYSLISA-N,1.4443606274525851e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosphenytoin,2016,Prescription,Total,1890,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.426853184776604e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2017,Prescription,Total,2225,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.476455050638416e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2018,Prescription,Total,1840,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.230423311834193e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2019,Prescription,Total,2205,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.3696303670659e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
frovatriptan,2016,Prescription,Total,14.49,XPSQPHWEGNHMSK-SECBINFHSA-N,4.160587441662063e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2017,Prescription,Total,13.265,XPSQPHWEGNHMSK-SECBINFHSA-N,3.8611315167064535e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2018,Prescription,Total,11.145,XPSQPHWEGNHMSK-SECBINFHSA-N,3.1681015114343525e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2019,Prescription,Total,12.255,XPSQPHWEGNHMSK-SECBINFHSA-N,3.540127897886287e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
fulvestrant,2016,Prescription,Total,3410,VWUXBMIQPBEWFH-WCCTWKNTSA-N,9.791306539729215e-10,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,1.7177730771454764
fulvestrant,2017,Prescription,Total,4920,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4320970269276854e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.512450924434536
fulvestrant,2018,Prescription,Total,5496.25,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.5623757678080807e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.7410101189615452
fulvestrant,2019,Prescription,Total,5082.5,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4681925778055527e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.575776452290443
furosemide,2016,Prescription,Total,910025.21,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.6130016979447076e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001840142040806132
furosemide,2017,Prescription,Total,856420.09,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.492838749370205e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0017555202460353555
furosemide,2018,Prescription,Total,839546.43,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.386512618934334e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0016806426893903762
furosemide,2019,Prescription,Total,875445.1799999999,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.5289170989702826e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0017809275344861143
fusidic acid,2016,Prescription,Total,45815.85,IECPWNUMDGFDKC-MZJAQBGESA-N,1.3155338173849057e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.003059380970662571
fusidic acid,2017,Prescription,Total,43044.05,IECPWNUMDGFDKC-MZJAQBGESA-N,1.2529117079659889e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.002913748158060439
fusidic acid,2018,Prescription,Total,39512.2,IECPWNUMDGFDKC-MZJAQBGESA-N,1.123182239031821e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0026120517186786533
fusidic acid,2019,Prescription,Total,33726.25,IECPWNUMDGFDKC-MZJAQBGESA-N,9.74257352232455e-9,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.002265714772633616
gabapentin,2016,Prescription,Total,9489062.7,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.724642864234914e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2017,Prescription,Total,10268756.8,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.988995138927531e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2018,Prescription,Total,11241014.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.195394798340554e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2019,Prescription,Total,12516304.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.615611484201523e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gadobenic acid,2016,Prescription,Total,27758.74,MXZROTBGJUUXID-UHFFFAOYSA-K,7.970508284359032e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.245916622144574e-5
gadobenic acid,2017,Prescription,Total,9260.15,MXZROTBGJUUXID-UHFFFAOYSA-K,2.6954132690862613e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.4503756991693283e-5
gadobenic acid,2018,Prescription,Total,1103.87,MXZROTBGJUUXID-UHFFFAOYSA-K,3.1378844463230494e-10,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.852622223930045e-6
gadobenic acid,2019,Prescription,Total,295.59000000000003,MXZROTBGJUUXID-UHFFFAOYSA-K,8.538771157374194e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.76251923397654e-7
gadobutrol,2016,Prescription,Total,24717.93,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,7.097385033946305e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,7.097385033946304e-5
gadobutrol,2017,Prescription,Total,27529.878,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,8.013304153553233e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,8.013304153553232e-5
gadobutrol,2018,Prescription,Total,33539.282999999996,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,9.533948242685014e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,9.533948242685014e-5
gadobutrol,2019,Prescription,Total,35852.337,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,1.0356740792992308e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.0356740792992307e-4
gadodiamide,2016,Prescription,Total,54.43456,HZHFFEYYPYZMNU-UHFFFAOYSA-K,1.563007223798482e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2017,Prescription,Total,11.966728,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.4832348761894896e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2018,Prescription,Total,1.079816,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.0695080320062783e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadopentetic acid,2016,Prescription,Total,4.7376,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3603311983173353e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.801655991586676e-9
gadopentetic acid,2017,Prescription,Total,4.7752,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3899491306880253e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.949745653440126e-9
gadopentetic acid,2018,Prescription,Total,2.5192,IZOOGPBRAOKZFK-UHFFFAOYSA-K,7.161131743028642e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,3.580565871514321e-9
gadoteric acid,2016,Prescription,Total,108961.9125,GFSTXYOTEVLASN-UHFFFAOYSA-K,3.1286788458728824e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2017,Prescription,Total,142024.05,GFSTXYOTEVLASN-UHFFFAOYSA-K,4.133988206447743e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2018,Prescription,Total,319547.13,GFSTXYOTEVLASN-UHFFFAOYSA-K,9.083514989031043e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2019,Prescription,Total,385126.77,GFSTXYOTEVLASN-UHFFFAOYSA-K,1.112523886331975e-7,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteridol,2016,Prescription,Total,42593.25,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.2230016635581276e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2017,Prescription,Total,58862.475,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.7133490944127083e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2018,Prescription,Total,30038.715,DPNNNPAKRZOSMO-UHFFFAOYSA-K,8.538869303996928e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2019,Prescription,Total,6940.6050000000005,DPNNNPAKRZOSMO-UHFFFAOYSA-K,2.00494731854011e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoxetic acid,2016,Prescription,Total,6676.624,PCZHWPSNPWAQNF-LMOVPXPDSA-K,1.917093027405074e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.917093027405074e-5
gadoxetic acid,2017,Prescription,Total,6966.912,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.027905276842849e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.027905276842849e-5
gadoxetic acid,2018,Prescription,Total,7266.2715,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.0655258610715444e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.0655258610715445e-5
gadoxetic acid,2019,Prescription,Total,8001.063,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.3112840749935326e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.3112840749935324e-5
galantamine,2016,Prescription,Total,1093.11776,ASUTZQLVASHGKV-JDFRZJQESA-N,3.138724654598872e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,7.133465124088344e-4
galantamine,2017,Prescription,Total,925.65984,ASUTZQLVASHGKV-JDFRZJQESA-N,2.6943794813218644e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,6.123589730276964e-4
galantamine,2018,Prescription,Total,764.51872,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1732372475117604e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.939175562526728e-4
galantamine,2019,Prescription,Total,746.7734399999999,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1572203087266508e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.902773428924206e-4
gamithromycin,2016,Prescription,Total,1867.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,5.36224778971974e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2017,Prescription,Total,4732.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.3775201585234294e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2018,Prescription,Total,3067.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,8.719741037527928e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2019,Prescription,Total,4057.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.1720986491777726e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
ganciclovir,2016,Prescription,Total,2415,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.934312402770105e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2017,Prescription,Total,2742.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,7.982776618595891e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2018,Prescription,Total,1800,IRSCQMHQWWYFCW-UHFFFAOYSA-N,5.116718457229103e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2019,Prescription,Total,2387.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.896821996086095e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
gefitinib,2016,Prescription,Total,2130,XGALLCVXEZPNRQ-UHFFFAOYSA-N,6.115977398716491e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.9112429370989035e-4
gefitinib,2017,Prescription,Total,1815,XGALLCVXEZPNRQ-UHFFFAOYSA-N,5.283040861532012e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.6509502692287536e-4
gefitinib,2018,Prescription,Total,4035,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.1469977208288571e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,3.5843678775901786e-4
gefitinib,2019,Prescription,Total,4710,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.360587711060335e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,4.251836597063547e-4
gemcitabine,2016,Prescription,Total,12382.2742,SDUQYLNIPVEERB-QPPQHZFASA-N,3.555385406192972e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,6.584047048505503e-4
gemcitabine,2017,Prescription,Total,14020.49296,SDUQYLNIPVEERB-QPPQHZFASA-N,4.081037862617184e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.557477523365156e-4
gemcitabine,2018,Prescription,Total,14185.31396,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0323476533734255e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.467310469210047e-4
gemcitabine,2019,Prescription,Total,14058.91928,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0612298945132105e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.52079610095039e-4
gentamicin,2016,Prescription,Total,26079.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,7.488253416742118e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2017,Prescription,Total,32411.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,9.434142918528172e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2018,Prescription,Total,35897.6,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.0204328471679302e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2019,Prescription,Total,39705.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.1469725517026077e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
glecaprevir,2017,Prescription,Total,8.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,2.445043704510683e-12,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2018,Prescription,Total,663.6,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.8863635378984627e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2019,Prescription,Total,512.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.4801807710134094e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glibenclamide,2016,Prescription,Total,1259.04625,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.6151635722717145e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,6.342392232055639e-6
glibenclamide,2017,Prescription,Total,1163.73775,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.387368642070151e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,5.942752003631843e-6
glibenclamide,2018,Prescription,Total,968.8315,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.7540211211083096e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.831616001944402e-6
glibenclamide,2019,Prescription,Total,841.27225,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.4302010297368963e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.263510578485783e-6
glimepiride,2016,Prescription,Total,26242.2288,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.535064705762769e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0024306660341170223
glimepiride,2017,Prescription,Total,24436.9377,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.1130215096315215e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0022945230676230713
glimepiride,2018,Prescription,Total,21204.7452,WIGIZIANZCJQQY-UHFFFAOYSA-N,6.027706174760012e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0019444213466967783
glimepiride,2019,Prescription,Total,19094.0382,WIGIZIANZCJQQY-UHFFFAOYSA-N,5.515735399031126e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0017792694835584279
glipizide,2016,Prescription,Total,7067.205,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,2.0292425376570974e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2017,Prescription,Total,6028.63,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.7547933128957426e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2018,Prescription,Total,5159.665,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.4666973965899443e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2019,Prescription,Total,4390.65,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.2683363977849384e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glycerol phenylbutyrate,2019,Prescription,Total,0.006215,ZSDBFLMJVAGKOU-UHFFFAOYSA-N,1.7953402599235634e-15,metabolic,treatment for hyperammonaemia from inborn urea cycle disorders,NA,NA,NA,NA
glyceryl trinitrate,2016,Prescription,Total,14910.57,SNIOPGDIGTZGOP-UHFFFAOYSA-N,4.2813478461023535e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.010703369615255883
glyceryl trinitrate,2017,Prescription,Total,12876.8725,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.748156671418064e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.00937039167854516
glyceryl trinitrate,2018,Prescription,Total,11425.0175,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.2476998842453053e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008119249710613263
glyceryl trinitrate,2019,Prescription,Total,11939.82375,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.449082264644655e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008622705661611638
glycopyrronium bromide,2016,Prescription,Total,160.46486,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.607509188019745e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.3962149054605287e-6
glycopyrronium bromide,2017,Prescription,Total,162.98399,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.7440830795896675e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.43760093320899e-6
glycopyrronium bromide,2018,Prescription,Total,180.48884,ANGKOCUUWGHLCE-UHFFFAOYSA-N,5.1306143275103894e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.5547316143970876e-6
glycopyrronium bromide,2019,Prescription,Total,210.60877,ANGKOCUUWGHLCE-UHFFFAOYSA-N,6.083900303684343e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.843606152631619e-6
grapiprant,2019,Prescription,Total,5966.4,HZVLFTCYCLXTGV-UHFFFAOYSA-N,1.7235266495266206e-9,analgesic,analgesic and anti-inflammatory small molecule used for pain relief in dogs,NA,NA,NA,NA
grazoprevir,2017,Prescription,Total,9531.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.774309590051455e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2018,Prescription,Total,7557.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.148225818053987e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2019,Prescription,Total,1722,OBMNJSNZOWALQB-NCQNOWPTSA-N,4.974378000946702e-10,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
guanfacine,2016,Prescription,Total,30.436,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.739243573114325e-12,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2017,Prescription,Total,224.224,INJOMKTZOLKMBF-UHFFFAOYSA-N,6.526636661907183e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2018,Prescription,Total,310.576,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.8284997309577e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2019,Prescription,Total,411.46,INJOMKTZOLKMBF-UHFFFAOYSA-N,1.1885932475432814e-10,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
haloperidol,2016,Prescription,Total,2485.3250000000003,LNEPOXFFQSENCJ-UHFFFAOYSA-N,7.13624015420895e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,5.097314395863536e-4
haloperidol,2017,Prescription,Total,2278.565,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.632370248295694e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.73740732021121e-4
haloperidol,2018,Prescription,Total,2117.817,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.020151851629759e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.300108465449828e-4
haloperidol,2019,Prescription,Total,2022.669,LNEPOXFFQSENCJ-UHFFFAOYSA-N,5.842926931937785e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.173519237098418e-4
hexaminolevulinate,2016,Prescription,Total,146.965,RYQOILLJDKPETL-UHFFFAOYSA-N,4.219880837569808e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2017,Prescription,Total,159.545,RYQOILLJDKPETL-UHFFFAOYSA-N,4.6439821170971056e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2018,Prescription,Total,152.915,RYQOILLJDKPETL-UHFFFAOYSA-N,4.346794460484379e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2019,Prescription,Total,157.165,RYQOILLJDKPETL-UHFFFAOYSA-N,4.540058760271711e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hyaluronic acid,2016,Prescription,Total,83.367,KIUKXJAPPMFGSW-MNSSHETKSA-N,2.3937590976469373e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2017,Prescription,Total,122.815,KIUKXJAPPMFGSW-MNSSHETKSA-N,3.574857649636661e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2018,Prescription,Total,144.586,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.110032526982928e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2019,Prescription,Total,154.713,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.469227315101436e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hydralazine,2016,Prescription,Total,6614.35,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992119768638694e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2017,Prescription,Total,6524.85,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992313589733966e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2018,Prescription,Total,6598.325,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.875653961905345e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2019,Prescription,Total,7004.025,RPTUSVTUFVMDQK-UHFFFAOYSA-N,2.0232675887387187e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydrochlorothiazide,2016,Prescription,Total,1370138.17798,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.9341474787062307e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.9341474787062304e-4
hydrochlorothiazide,2017,Prescription,Total,1344980.24186,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.91492318220363e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.91492318220363e-4
hydrochlorothiazide,2018,Prescription,Total,1305368.66112,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.710668845467304e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.710668845467304e-4
hydrochlorothiazide,2019,Prescription,Total,1274101.87638,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.680525171213466e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.680525171213466e-4
hydrocodone,2016,Prescription,Total,133.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.8289464137034926e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2017,Prescription,Total,112.25,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.267335188468145e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2018,Prescription,Total,67.65,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.9230333535086045e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2019,Prescription,Total,55.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.5989072145900118e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocortisone,2016,OTC,Total,68937.65,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.9794418277963747e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2016,Prescription,Total,100858.5087,JYGXADMDTFJGBT-VWUMJDOOSA-N,2.8960016886265284e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,OTC,Total,67050.5,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.9516833679677804e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,Prescription,Total,105739.17748,JYGXADMDTFJGBT-VWUMJDOOSA-N,3.0778203597334736e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,OTC,Total,66646.68000000001,JYGXADMDTFJGBT-VWUMJDOOSA-N,1.8945127648280097e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,Prescription,Total,106168.67347,JYGXADMDTFJGBT-VWUMJDOOSA-N,3.017973395130437e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,OTC,Total,69407.56,JYGXADMDTFJGBT-VWUMJDOOSA-N,2.0049909382310592e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,Prescription,Total,115952.74797,JYGXADMDTFJGBT-VWUMJDOOSA-N,3.3495516762560134e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone aceponate,2016,Prescription,Total,211.844832,MFBMYAOAMQLLPK-FZNHGJLXSA-N,6.082808472051136e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2017,Prescription,Total,240.605664,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.003468619438246e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2018,Prescription,Total,256.53952,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.29244720551497e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2019,Prescription,Total,275.802176,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.967156079602967e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydromorphone,2016,Prescription,Total,2001.73168,WVLOADHCBXTIJK-YNHQPCIGSA-N,5.747674043744033e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2017,Prescription,Total,1683.50176,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.900280214072207e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2018,Prescription,Total,1407.76,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.001728652971579e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2019,Prescription,Total,1406.8,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.0638530614005936e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydroxycarbamide,2016,Prescription,Total,451650,VSNHCAURESNICA-UHFFFAOYSA-N,1.2968456301081234e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2017,Prescription,Total,473350,VSNHCAURESNICA-UHFFFAOYSA-N,1.377811235154919e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2018,Prescription,Total,509900,VSNHCAURESNICA-UHFFFAOYSA-N,1.4494526340783996e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2019,Prescription,Total,547400,VSNHCAURESNICA-UHFFFAOYSA-N,1.5812860149350906e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxychloroquine,2016,Prescription,Total,573923.8,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.647936614734969e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2017,Prescription,Total,572213.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.6655800718040404e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2018,Prescription,Total,566380.4,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.610005025829335e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2019,Prescription,Total,565996.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.63500640862406e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxyzine,2016,Prescription,Total,167392.595,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.806428768697197e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2017,Prescription,Total,150496.77,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.380609286163002e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2018,Prescription,Total,147143.27,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1827260303669184e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2019,Prescription,Total,143352.105,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1410427264889787e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hyoscyamine,2016,Prescription,Total,150.3642,RKUNBYITZUJHSG-VFSICIBPSA-N,4.3174837970708273e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2017,Prescription,Total,161.3546,RKUNBYITZUJHSG-VFSICIBPSA-N,4.6966553443314215e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2018,Prescription,Total,166.2378,RKUNBYITZUJHSG-VFSICIBPSA-N,4.7255112197175556e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2019,Prescription,Total,182.076,RKUNBYITZUJHSG-VFSICIBPSA-N,5.259668112081138e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
ibandronic acid,2016,Prescription,Total,369.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0621126947348496e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2017,Prescription,Total,351.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0242986662110824e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2018,Prescription,Total,306.45,MPBVHIBUJCELCL-UHFFFAOYSA-N,8.711213173432547e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2019,Prescription,Total,258.75,MPBVHIBUJCELCL-UHFFFAOYSA-N,7.474566247067129e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibrutinib,2016,Prescription,Total,10386.6,XYFPWWZEPKGCCK-GOSISDBHSA-N,2.982357316878343e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0019241014947602212
ibrutinib,2017,Prescription,Total,14044.8,XYFPWWZEPKGCCK-GOSISDBHSA-N,4.0881130739418615e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.002637492305768943
ibrutinib,2018,Prescription,Total,19324.199999999997,XYFPWWZEPKGCCK-GOSISDBHSA-N,5.493138378399256e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0035439602441285525
ibrutinib,2019,Prescription,Total,22408.4,XYFPWWZEPKGCCK-GOSISDBHSA-N,6.473162136841701e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0041762336366720654
ibuprofen,2016,OTC,Total,21759223,HEFNNWSXXWATRW-UHFFFAOYSA-N,6.247836435757372e-6,analgesic,NSAID for many minor pains,low,low,1e-6,6.247836435757372
ibuprofen,2016,Prescription,Total,17459917.08,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.01335484717108e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.0133548471710805
ibuprofen,2017,OTC,Total,21844919.85,HEFNNWSXXWATRW-UHFFFAOYSA-N,6.358545685093209e-6,analgesic,NSAID for many minor pains,low,low,1e-6,6.358545685093209
ibuprofen,2017,Prescription,Total,18112489.64,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.272122472297258e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.272122472297258
ibuprofen,2018,OTC,Total,20575823.65,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.848927591258115e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.848927591258116
ibuprofen,2018,Prescription,Total,17436985.8,HEFNNWSXXWATRW-UHFFFAOYSA-N,4.956674837850099e-6,analgesic,NSAID for many minor pains,low,low,1e-6,4.956674837850099
ibuprofen,2019,OTC,Total,20877430.85,HEFNNWSXXWATRW-UHFFFAOYSA-N,6.030907824420792e-6,analgesic,NSAID for many minor pains,low,low,1e-6,6.030907824420792
ibuprofen,2019,Prescription,Total,17736528.2,HEFNNWSXXWATRW-UHFFFAOYSA-N,5.123588599956494e-6,analgesic,NSAID for many minor pains,low,low,1e-6,5.123588599956495
ibutilide,2016,Prescription,Total,0.33408,ALOBUEHUHMBRLE-UHFFFAOYSA-N,9.592609058043216e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2017,Prescription,Total,0.2262,ALOBUEHUHMBRLE-UHFFFAOYSA-N,6.584153404289482e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2018,Prescription,Total,0.20532,ALOBUEHUHMBRLE-UHFFFAOYSA-N,5.83647018687933e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2019,Prescription,Total,0.15399,ALOBUEHUHMBRLE-UHFFFAOYSA-N,4.4483418604284714e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
icatibant,2016,Prescription,Total,43.26,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.2421463956266448e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2017,Prescription,Total,47.28,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3762103136817271e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2018,Prescription,Total,46.11,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3107327114601884e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2019,Prescription,Total,48.03,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3874528187309534e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
idarubicin,2016,Prescription,Total,5.855,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.681175946924181e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2017,Prescription,Total,5.95,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.7319059573617337e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2018,Prescription,Total,5.125,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.4568434496277306e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2019,Prescription,Total,4.675,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.3504771866681672e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idebenone,2017,Prescription,Total,2430,JGPMMRGNQUBGND-UHFFFAOYSA-N,7.073162145191619e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2018,Prescription,Total,1890,JGPMMRGNQUBGND-UHFFFAOYSA-N,5.372554380090558e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2019,Prescription,Total,2376,JGPMMRGNQUBGND-UHFFFAOYSA-N,6.863601701654684e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idelalisib,2016,Prescription,Total,1251,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.5920599651616565e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2017,Prescription,Total,978,IFSDAJWBUCMOAH-HNNXBMFYSA-N,2.8467294559660096e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2018,Prescription,Total,1401,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9825125325433184e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2019,Prescription,Total,1368,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9517706767102734e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
ifosfamide,2016,Prescription,Total,11382,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.26817158460991e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2017,Prescription,Total,10942.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.1851060400723987e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2018,Prescription,Total,10785.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.065909273358027e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2019,Prescription,Total,11104.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.207780517509446e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
iloprost,2016,Prescription,Total,0.22312,HIFJCPQKFCZDDL-ACWOEMLNSA-N,6.406558108927811e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2017,Prescription,Total,0.10449,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0414597224323963e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2018,Prescription,Total,0.10188,HIFJCPQKFCZDDL-ACWOEMLNSA-N,2.8960626467916725e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2019,Prescription,Total,0.10397,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0034034887249056e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
imatinib,2016,Prescription,Total,62640,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.7986141983831033e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.873556456649066e-4
imatinib,2017,Prescription,Total,62232,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8114280930846287e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8869042636298215e-4
imatinib,2018,Prescription,Total,63588,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8075660736571344e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8828813267261817e-4
imatinib,2019,Prescription,Total,68550,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.9802184202374945e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,2.0627275210807235e-4
imepitoin,2016,Prescription,Total,57400,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6481554116728947e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2017,Prescription,Total,60530,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.7618868504051385e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2018,Prescription,Total,57240,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6271164693988546e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2019,Prescription,Total,63500,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.8343379968647833e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imidacloprid,2016,Prescription,Total,1438919.32,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.1316422721579817e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2017,Prescription,Total,1373892.38,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.9990796599930937e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2018,Prescription,Total,1254248.23,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.565352815771074e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2019,Prescription,Total,1391246.68,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.018923855332252e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imipenem,2016,Prescription,Total,8080,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.320051520264283e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2017,Prescription,Total,8565,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.493071348706428e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2018,Prescription,Total,7635,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.1703414122746773e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2019,Prescription,Total,7800,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.253202578826033e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imiquimod,2016,Prescription,Total,2332.6499999999996,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.697856656861981e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2017,Prescription,Total,2716.05,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.905786849566952e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2018,Prescription,Total,2518.2375,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.158395719964706e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2019,Prescription,Total,2211.3,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.387829310971804e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
indacaterol,2016,Prescription,Total,462.6642000000001,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.3284712630963598e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.3284712630963596e-6
indacaterol,2017,Prescription,Total,419.40825,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.2207994062885028e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.2207994062885028e-6
indacaterol,2018,Prescription,Total,377.676,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.0735898666958103e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.0735898666958103e-6
indacaterol,2019,Prescription,Total,330.53625,QZZUEBNBZAPZLX-QFIPXVFZSA-N,9.548270908916491e-11,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,9.54827090891649e-7
ingenol mebutate,2016,Prescription,Total,1.582302,VDJHFHXMUKFKET-WDUFCVPESA-N,4.543344258189625e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2017,Prescription,Total,1.6694165,VDJHFHXMUKFKET-WDUFCVPESA-N,4.859281313727689e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2018,Prescription,Total,1.4774685,VDJHFHXMUKFKET-WDUFCVPESA-N,4.199883524402553e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2019,Prescription,Total,1.5530915,VDJHFHXMUKFKET-WDUFCVPESA-N,4.4864484268625544e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
iodixanol,2016,Prescription,Total,1870054,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.369581219896417e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.369581219896416e-4
iodixanol,2017,Prescription,Total,1640141,NBQNWMBBSKPBAY-UHFFFAOYSA-N,4.77406717447602e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,4.774067174476019e-4
iodixanol,2018,Prescription,Total,1766954,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.022781191597107e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.022781191597106e-4
iodixanol,2019,Prescription,Total,1825304,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.272794461463427e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.272794461463427e-4
iohexol,2016,Prescription,Total,11716927,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.3643408786108454e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2017,Prescription,Total,12923588,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.761754461796406e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2018,Prescription,Total,15893883,NTHXOOBQLCIOLC-UHFFFAOYSA-N,4.518029139063326e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2019,Prescription,Total,17866262,NTHXOOBQLCIOLC-UHFFFAOYSA-N,5.161065078510456e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iomeprol,2016,Prescription,Total,3157700,NJKDOADNQSYQEV-UHFFFAOYSA-N,9.066864709824912e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,9.066864709824912e-4
iomeprol,2017,Prescription,Total,3951115,NJKDOADNQSYQEV-UHFFFAOYSA-N,1.1500772448271104e-6,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,0.0011500772448271104
iomeprol,2018,Prescription,Total,1280985,NJKDOADNQSYQEV-UHFFFAOYSA-N,3.641355329407568e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,3.6413553294075676e-4
iomeprol,2019,Prescription,Total,715315,NJKDOADNQSYQEV-UHFFFAOYSA-N,2.066345644452492e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,2.066345644452492e-4
ipratropium bromide,2016,Prescription,Total,3013.797,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.653668702497446e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2017,Prescription,Total,3072.089,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.94213317755538e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2018,Prescription,Total,2951.438,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.389820716648526e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2019,Prescription,Total,2945.5260000000003,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.508803563075807e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
irbesartan,2016,Prescription,Total,3025751.303,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.687993701072755e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012340900143569256
irbesartan,2017,Prescription,Total,2907397.66675,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.462755192376352e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012020959080080045
irbesartan,2018,Prescription,Total,2783303.261,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.911877315347028e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0011238462095663393
irbesartan,2019,Prescription,Total,2669838.14,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.712418182174487e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0010955139463316034
irinotecan,2016,Prescription,Total,3416.08,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.808764353149027e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2017,Prescription,Total,3671.28,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.068623815654283e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2018,Prescription,Total,3442.8199999999997,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.786633688287496e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2019,Prescription,Total,3573.76,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.03235964719299e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
isavuconazole,2017,Prescription,Total,89.2,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.596403552885154e-11,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2018,Prescription,Total,355.6,DDFOUSQFMYRUQK-RCDICMHDSA-N,1.0108361574392606e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2019,Prescription,Total,774.4,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.2370257397985638e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isoniazid,2016,Prescription,Total,6652,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.910022612970051e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2017,Prescription,Total,5565,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.6198414542383272e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2018,Prescription,Total,5374.5,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.527766852687656e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2019,Prescription,Total,5328,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.5391106846134748e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoprenaline,2016,Prescription,Total,6.9,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.981232115077173e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2017,Prescription,Total,8.89,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.587671253940473e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2018,Prescription,Total,8.21,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.3337921407694967e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2019,Prescription,Total,6.6,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.9065560282374125e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isosorbide dinitrate,2016,Prescription,Total,8179.22,MOYKHGMNXAOIAT-JGWLITMVSA-N,2.348541063808915e-9,cardiac,nitrate for angina,NA,NA,NA,NA
isosorbide mononitrate,2016,Prescription,Total,384007.5385,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.1026203879825129e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2017,Prescription,Total,375319.61719999986,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0924676990645467e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2018,Prescription,Total,355909.5727,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0117161554103408e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2019,Prescription,Total,330703.8683,YWXYYJSYQOXTPL-SLPGGIOYSA-N,9.553112934375701e-8,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isotretinoin,2016,Prescription,Total,66031.8,SHGAZHPCJJPHSC-XFYACQKRSA-N,1.8960046779181575e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2017,Prescription,Total,71597.4,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.0840330015396805e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2018,Prescription,Total,80914.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.300084336621817e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2019,Prescription,Total,88999.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.5709388070955626e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isradipine,2016,Prescription,Total,665.265,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.9102092507779935e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2017,Prescription,Total,629.785,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.83315696362531e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2018,Prescription,Total,212.305,HMJIYCCIJYRONP-UHFFFAOYSA-N,6.03502728923347e-11,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
itraconazole,2016,Prescription,Total,1122.58,VHVPQPYKVGDNFY-ZPGVKDDISA-N,3.223321083685989e-10,antifungal,azole antifungal,high,high,0.001,3.2233210836859885e-7
itraconazole,2017,Prescription,Total,935.1,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.721857581057071e-10,antifungal,azole antifungal,high,high,0.001,2.721857581057071e-7
itraconazole,2018,Prescription,Total,936.36,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.661716941450579e-10,antifungal,azole antifungal,high,high,0.001,2.661716941450579e-7
itraconazole,2019,Prescription,Total,962.96,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.7817230196234827e-10,antifungal,azole antifungal,high,high,0.001,2.7817230196234827e-7
ivabradine,2016,Prescription,Total,252.77,ACRHBAYQBXXRTO-OAQYLSRUSA-N,7.257913648232709e-11,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2017,Prescription,Total,358.8172,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.0444330189644651e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2018,Prescription,Total,415.38,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.1807680626465693e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2019,Prescription,Total,567,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.6379049515312314e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivacaftor,2016,Prescription,Total,1848,PURKAOJPTOLRMP-UHFFFAOYSA-N,5.306256447337124e-10,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2017,Prescription,Total,4300.8,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.2518623767094694e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2018,Prescription,Total,5390,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.5321729158036032e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2019,Prescription,Total,6815.2,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.9687213096429715e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivermectin,2016,Prescription,Total,24269.320855,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.9685736071069844e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2017,Prescription,Total,25257.930293,AZSNMRSAGSSBNP-XPNPUAGNSA-N,7.351993268079681e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2018,Prescription,Total,26355.307825000004,AZSNMRSAGSSBNP-XPNPUAGNSA-N,7.491816110785118e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2019,Prescription,Total,27449.464439,AZSNMRSAGSSBNP-XPNPUAGNSA-N,7.929385136070292e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ixazomib,2017,Prescription,Total,0.012,MXAYKZJJDUDWDS-LBPRGKRZSA-N,3.4929195778724047e-15,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2018,Prescription,Total,0.24,MXAYKZJJDUDWDS-LBPRGKRZSA-N,6.822291276305471e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2019,Prescription,Total,0.192,MXAYKZJJDUDWDS-LBPRGKRZSA-N,5.546344809417927e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ketamine,2016,Prescription,Total,9954.5,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.858286244860249e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2017,Prescription,Total,11197.3,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.259272365775889e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2018,Prescription,Total,12654.7,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.597252058927618e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2019,Prescription,Total,11764.2,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.3983494586955403e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketobemidone,2016,Prescription,Total,11949.92,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.4312413444352184e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2017,Prescription,Total,9811.485,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.8558940037084523e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2018,Prescription,Total,9591.935,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7266239363912132e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2019,Prescription,Total,9099.27,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.628525465312097e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketoconazole,2016,OTC,Total,163146,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.6844941253098624e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2016,Prescription,Total,12786.4,XMAYWYJOQHXEEK-OZXSUGGESA-N,3.6714241038004005e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,OTC,Total,163381.2,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.7556449344690575e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,Prescription,Total,13614.6,XMAYWYJOQHXEEK-OZXSUGGESA-N,3.962891907075136e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,OTC,Total,176262,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.0104612706006455e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,Prescription,Total,15216.2,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.325389521604971e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,OTC,Total,205199.52,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.9276421492033875e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,Prescription,Total,17099,XMAYWYJOQHXEEK-OZXSUGGESA-N,4.939424473762351e-9,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoprofen,2016,Prescription,Total,314173.89999999997,DKYWVDODHFEZIM-UHFFFAOYSA-N,9.021035078247016e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2017,Prescription,Total,301153.8,DKYWVDODHFEZIM-UHFFFAOYSA-N,8.765883366422253e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2018,Prescription,Total,286970.2,DKYWVDODHFEZIM-UHFFFAOYSA-N,8.157476216748484e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2019,Prescription,Total,279874.7,DKYWVDODHFEZIM-UHFFFAOYSA-N,8.084799946002082e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketorolac,2016,Prescription,Total,1791.15,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.143020149160112e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2017,Prescription,Total,1966.53,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.724109281227848e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2018,Prescription,Total,2210.76,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.284353609168783e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2019,Prescription,Total,2277.54,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.579178206896721e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketotifen,2016,OTC,Total,50.216,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,1.4418775636335551e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2016,Prescription,Total,109.956,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,3.157222586165589e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2017,OTC,Total,57.8945,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,1.685173604176116e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2017,Prescription,Total,118.14,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,3.438779324415382e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2018,OTC,Total,54.67325,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,1.55415348550945e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2018,Prescription,Total,125.97,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,3.580850133650834e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2019,OTC,Total,79.99925,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,2.3109553385147247e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2019,Prescription,Total,170.256,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4.9182212597513465e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
labetalol,2016,Prescription,Total,207503.95,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.9581665180488116e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2017,Prescription,Total,207948.35,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.052890524177192e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2018,Prescription,Total,206306.84999999992,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.864522595821087e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2019,Prescription,Total,213303.15,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.161733431432258e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
lacosamide,2016,Prescription,Total,59488.407,VPPJLAIAVCUEMN-GFCCVEGCSA-N,1.7081209046837927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,1.7081209046837927e-5
lacosamide,2017,Prescription,Total,69342.464,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.01839708402927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.01839708402927e-5
lacosamide,2018,Prescription,Total,74852.92,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.1277850963416305e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.1277850963416306e-5
lacosamide,2019,Prescription,Total,92119.712,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.6610817005014293e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.6610817005014292e-5
lamivudine,2016,Prescription,Total,118844.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.4124397387982256e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.4124397387982256e-5
lamivudine,2017,Prescription,Total,130937.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.8112817327975845e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.8112817327975845e-5
lamivudine,2018,Prescription,Total,137233.2,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.90102026324785e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.90102026324785e-5
lamivudine,2019,Prescription,Total,140562,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4.0604443703198054e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,4.060444370319805e-5
lamotrigine,2016,Prescription,Total,2377299.3282,PYZRQGJRPPTADH-UHFFFAOYSA-N,6.826060545190186e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004550707030126791
lamotrigine,2017,Prescription,Total,2487666.8492,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.241016867329032e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004827344578219355
lamotrigine,2018,Prescription,Total,2516154.5068,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.152474558990972e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004768316372660649
lamotrigine,2019,Prescription,Total,2623016.7694,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.577164293738475e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.005051442862492317
lansoprazole,2016,Prescription,Total,292300.8531,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.392983151103988e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2017,Prescription,Total,283156.6404,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.2420281071478007e-08,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2018,Prescription,Total,267404.1549,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.601287638425445e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2019,Prescription,Total,261259.5957,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.547061471465214e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lapatinib,2016,Prescription,Total,4305,BCFGMOOMADDAQU-UHFFFAOYSA-N,1.236116558754671e-9,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.01236116558754671
lapatinib,2017,Prescription,Total,2373,BCFGMOOMADDAQU-UHFFFAOYSA-N,6.907248465242679e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.006907248465242679
lapatinib,2018,Prescription,Total,1323,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.76078806606339e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.00376078806606339
lapatinib,2019,Prescription,Total,1155,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.3364730494154715e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.0033364730494154717
latanoprost,2016,Prescription,Total,54.728325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.571442247744651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2017,Prescription,Total,55.9576,GGXICVAJURFBLW-CEYXHVGTSA-N,1.6287949714229405e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2018,Prescription,Total,57.58145,GGXICVAJURFBLW-CEYXHVGTSA-N,1.636822600050082e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2019,Prescription,Total,60.533325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.7486390255758248e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
ledipasvir,2016,Prescription,Total,1960.56,VRTWBAAJJOHBQU-KMWAZVGDSA-N,5.62945570367493e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2017,Prescription,Total,216.72,VRTWBAAJJOHBQU-KMWAZVGDSA-N,6.308212757637562e-11,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2018,Prescription,Total,549.36,VRTWBAAJJOHBQU-KMWAZVGDSA-N,1.5616224731463223e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2019,Prescription,Total,3354.12,VRTWBAAJJOHBQU-KMWAZVGDSA-N,9.68911773550253e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
leflunomide,2016,Prescription,Total,10861.2,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.118631630184955e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011812998599185435
leflunomide,2017,Prescription,Total,10776.8,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.13687464223461e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.001188210091755534
leflunomide,2018,Prescription,Total,10363,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.945808520681399e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011158365608641661
leflunomide,2019,Prescription,Total,8645,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.4972995248655198e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,9.459467897217878e-4
lenalidomide,2016,Prescription,Total,1184.7675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,3.4018832172459336e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2017,Prescription,Total,1734.9675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.050084956435282e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2018,Prescription,Total,2057.9475,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.84996553181027e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2019,Prescription,Total,2054.115,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.933765660519534e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenvatinib,2016,Prescription,Total,13.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,3.824639387366369e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2017,Prescription,Total,14.94,WOSKHXYHFSIKNG-UHFFFAOYSA-N,4.348684874451143e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2018,Prescription,Total,43.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.2314235753731374e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2019,Prescription,Total,48.84,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.4108514608956851e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lercanidipine,2016,Prescription,Total,207515.2234,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,5.9584902169202033e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2017,Prescription,Total,213714.6424,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.220733820974667e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2018,Prescription,Total,231386.8572,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.57745223886375e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2019,Prescription,Total,259667.2152,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,7.50106203750275e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lesinurad,2018,Prescription,Total,126,FGQFOYHRJSUHMR-UHFFFAOYSA-N,3.5817029200603715e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
lesinurad,2019,Prescription,Total,264,FGQFOYHRJSUHMR-UHFFFAOYSA-N,7.626224112949649e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
letermovir,2019,Prescription,Total,376.32,FWYSMLBETOMXAG-QHCPKHFHSA-N,1.0870835826459135e-10,antiviral,antiviral for prevention of cytomegalovirus infection after bone marrow transplants,NA,NA,NA,NA
letrozole,2016,Prescription,Total,6260.475,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.797602047193879e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.035952040943877585
letrozole,2017,Prescription,Total,6850.075,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.9938967564495253e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.03987793512899051
letrozole,2018,Prescription,Total,7181.225,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.041350361278614e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.04082700722557229
letrozole,2019,Prescription,Total,7892.875,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.2800315774809646e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.0456006315496193
leuprorelin,2016,Prescription,Total,138.3825,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.973447147314013e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2017,Prescription,Total,121.35875,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.532469615176022e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2018,Prescription,Total,106.8375,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.036985600967857e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2019,Prescription,Total,100.965,GFIJNRVAKGFPGQ-LIJARHBVSA-N,2.9165974150150054e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
levetiracetam,2016,Prescription,Total,4353771.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.2501205677547414e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2017,Prescription,Total,4592883,HPHUVLMMVZITSG-LURJTMIESA-N,1.3368809124647785e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2018,Prescription,Total,4874655.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.38567998719352e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2019,Prescription,Total,5139031.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.48452295236772e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levocabastine,2016,OTC,Total,805.044,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.3115638070292574e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.311563807029257e-5
levocabastine,2016,Prescription,Total,850.47,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.4419977926227287e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.4419977926227286e-5
levocabastine,2017,OTC,Total,936.232,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.7251525685255304e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.7251525685255302e-5
levocabastine,2017,Prescription,Total,962.88,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.8027186692848174e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.802718669284817e-5
levocabastine,2018,OTC,Total,884.898,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.515429960758399e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.515429960758399e-5
levocabastine,2018,Prescription,Total,1005.12,ZCGOMHNNNFPNMX-YHYDXASRSA-N,2.8571755865167307e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,2.8571755865167306e-5
levocabastine,2019,OTC,Total,1064.4955,ZCGOMHNNNFPNMX-YHYDXASRSA-N,3.0750307766009066e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,3.0750307766009064e-5
levocabastine,2019,Prescription,Total,1171.314,ZCGOMHNNNFPNMX-YHYDXASRSA-N,3.3835996479679947e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,3.3835996479679944e-5
levocetirizine,2016,Prescription,Total,710.082,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0388945836785928e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2017,Prescription,Total,766.039499999999,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.2297619724779864e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2018,Prescription,Total,713.385,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0278834425613237e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2019,Prescription,Total,715.95,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0681799824493566e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levofloxacin,2017,Prescription,Total,40.32,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.173620978165128e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,1.5859742948177405e-6
levofloxacin,2018,Prescription,Total,53.76,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.5281932458924248e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,2.0651260079627363e-6
levofloxacin,2019,Prescription,Total,134.4,GSDSWSVVBLHKDQ-JTQLQIEISA-N,3.882441366592549e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,5.246542387287228e-6
levomepromazine,2016,Prescription,Total,102377.38,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.939613813238543e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2017,Prescription,Total,92423.555,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.6902337059672243e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2018,Prescription,Total,85520.88999999998,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.4310350907869983e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2019,Prescription,Total,74070.30500000001,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.1396846441080873e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomethadone,2016,Prescription,Total,169.915,USSIQXCVUWKGNF-QGZVFWFLSA-N,4.878855867149824e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2017,Prescription,Total,310.805,USSIQXCVUWKGNF-QGZVFWFLSA-N,9.046807245005271e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2018,Prescription,Total,449.595,USSIQXCVUWKGNF-QGZVFWFLSA-N,1.2780283526543988e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2019,Prescription,Total,765.625,USSIQXCVUWKGNF-QGZVFWFLSA-N,2.211677210786771e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levonorgestrel,2016,OTC,Total,44.3625,WWYNJERNGUHSAO-XUDSTZEESA-N,1.2738030392045083e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.2738030392045083
levonorgestrel,2016,Prescription,Total,7241.0969,WWYNJERNGUHSAO-XUDSTZEESA-N,2.0791730038646032e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,207.91730038646034
levonorgestrel,2017,OTC,Total,51.6075,WWYNJERNGUHSAO-XUDSTZEESA-N,1.5021737259587508e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.5021737259587509
levonorgestrel,2017,Prescription,Total,7390.17125,WWYNJERNGUHSAO-XUDSTZEESA-N,2.151106153579565e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,215.1106153579565
levonorgestrel,2018,OTC,Total,57.8685,WWYNJERNGUHSAO-XUDSTZEESA-N,1.6449823446786796e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.6449823446786798
levonorgestrel,2018,Prescription,Total,7236.39905,WWYNJERNGUHSAO-XUDSTZEESA-N,2.057034254611674e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,205.70342546116743
levonorgestrel,2019,OTC,Total,56.646,WWYNJERNGUHSAO-XUDSTZEESA-N,1.636345042053583e-11,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,1.636345042053583
levonorgestrel,2019,Prescription,Total,7322.5549,WWYNJERNGUHSAO-XUDSTZEESA-N,2.1152819979840003e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,211.52819979840004
levosimendan,2016,Prescription,Total,15.0375,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.3177939029671e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2017,Prescription,Total,15.15,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.4098109670639096e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2018,Prescription,Total,14.4875,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.118247702728146e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2019,Prescription,Total,16.3625,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.7266701533385855e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levothyroxine sodium,2016,Prescription,Total,7388.251575,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.121426274588334e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2017,Prescription,Total,7133.40885,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.0763686190944395e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2018,Prescription,Total,7579.60385,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.1545943843210982e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2019,Prescription,Total,7705.6711,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.22595358898785e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
lidocaine,2016,OTC,Total,92747.5,NNJVILVZKWQKPM-UHFFFAOYSA-N,2.6631061680162333e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2016,Prescription,Total,545413.74,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.5660742285396394e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,OTC,Total,59894,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.7433743766424147e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,Prescription,Total,567110.064,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.6507248711283938e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,OTC,Total,59996,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.7054591142217624e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,Prescription,Total,561980.8,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.5974986288713208e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,OTC,Total,56952,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.6451845290935926e-8,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,Prescription,Total,593433.23,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.7142631848680286e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
linagliptin,2016,Prescription,Total,10846.965,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.1145442621910243e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,9.73295081934695e-6
linagliptin,2017,Prescription,Total,12320.0925,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.586091024537414e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.1206534451679418e-5
linagliptin,2018,Prescription,Total,12987.468,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.6918454015706853e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.153701687990839e-5
linagliptin,2019,Prescription,Total,13415.778,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.875444305968918e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.2110763456152868e-5
linezolid,2016,Prescription,Total,22374,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.4243604844545905e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2017,Prescription,Total,21606,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.2890016999592645e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2018,Prescription,Total,22014,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.257746673191193e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2019,Prescription,Total,23940,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.915598684242978e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
liothyronine sodium,2016,Prescription,Total,40.16572,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.153298759263732e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2017,Prescription,Total,45.3151,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3190166663603817e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2018,Prescription,Total,46.2898,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3158437446746874e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2019,Prescription,Total,58.48984,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.6896084400400264e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
lipegfilgrastim,2016,Prescription,Total,20.958,GAQMWPRWVIGRRV-IVDGIBIRSA-N,6.017777198230056e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2017,Prescription,Total,7.524,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.1900605753259976e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2018,Prescription,Total,71.616,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.0357717168495523e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2019,Prescription,Total,38.256,GAQMWPRWVIGRRV-IVDGIBIRSA-N,1.1051092032765219e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lisdexamfetamine,2016,Prescription,Total,45990.978,VOBHXZCDAVEXEY-JSGCOSHPSA-N,1.320562356774025e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2017,Prescription,Total,74352.40800000001,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.1642248463763068e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2018,Prescription,Total,105380.181,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.995559539715798e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2019,Prescription,Total,157686.582,VOBHXZCDAVEXEY-JSGCOSHPSA-N,4.5551258103674713e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisinopril,2016,Prescription,Total,151188.9495,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.3411652491910275e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.61763770765919e-4
lisinopril,2017,Prescription,Total,144476.25209999998,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.2053660791476584e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.504471732623049e-4
lisinopril,2018,Prescription,Total,137568.0606,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.9105390822068435e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.258782568505703e-4
lisinopril,2019,Prescription,Total,132054.1359,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.814675891724659e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.178896576437216e-4
loperamide,2016,OTC,Total,10560.304,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.032233830402598e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.064467660805196e-5
loperamide,2016,Prescription,Total,17681.255999999998,RDOIQAHITMMDAJ-UHFFFAOYSA-N,5.07690901769579e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.0153818035391579e-4
loperamide,2017,OTC,Total,10889.86,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.169783766190798e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.339567532381595e-5
loperamide,2017,Prescription,Total,19023.837,RDOIQAHITMMDAJ-UHFFFAOYSA-N,5.537394391962785e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.1074788783925569e-4
loperamide,2018,OTC,Total,10890.152,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.095657874468357e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.191315748936714e-5
loperamide,2018,Prescription,Total,20381.942,RDOIQAHITMMDAJ-UHFFFAOYSA-N,5.793814379198503e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.1587628758397005e-4
loperamide,2019,OTC,Total,11464.092,RDOIQAHITMMDAJ-UHFFFAOYSA-N,3.311656622858832e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,6.623313245717664e-5
loperamide,2019,Prescription,Total,21066.849,RDOIQAHITMMDAJ-UHFFFAOYSA-N,6.085625448017774e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.2171250896035547e-4
lopinavir,2016,Prescription,Total,27612,KJHKTHWMRKYKJE-SUGCFTRWSA-N,7.928374081378391e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2017,Prescription,Total,17604,KJHKTHWMRKYKJE-SUGCFTRWSA-N,5.124113020738817e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2018,Prescription,Total,11149.2,KJHKTHWMRKYKJE-SUGCFTRWSA-N,3.1692954124077063e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2019,Prescription,Total,9900,KJHKTHWMRKYKJE-SUGCFTRWSA-N,2.8598340423561183e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
loratadine,2016,OTC,Total,268.8,JCCNYMKQOSZNPW-UHFFFAOYSA-N,7.718191196126726e-11,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2016,Prescription,Total,115171.43,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.306975881961776e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2017,OTC,Total,540.32,JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.5727452552633478e-10,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2017,Prescription,Total,113953.49,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.3169198015657266e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2018,OTC,Total,570.64,JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.6221134557962303e-10,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2018,Prescription,Total,110787.4,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.149266302269019e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2019,OTC,Total,438.06,JCCNYMKQOSZNPW-UHFFFAOYSA-N,1.265433232923759e-10,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2019,Prescription,Total,113677.5,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.2838261045448254e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
losartan,2016,Prescription,Total,3027866.1195,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.694066081315213e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.694066081315212e-4
losartan,2017,Prescription,Total,3039786.7165,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.848108778849434e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.848108778849434e-4
losartan,2018,Prescription,Total,3032960.4255,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.621558105111824e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.621558105111823e-4
losartan,2019,Prescription,Total,3082248.4125,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.903756502086469e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.903756502086469e-4
lovastatin,2016,Prescription,Total,7570.83319999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.1738518657583276e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2017,Prescription,Total,7141.514799999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.0787280717154603e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2018,Prescription,Total,7115.6232,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.022702253451534e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2019,Prescription,Total,6928.0512,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.001320875651127e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
loxapine,2016,Prescription,Total,0.4732,XJGVXQDUIWGIRW-UHFFFAOYSA-N,1.3587232418181425e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2017,Prescription,Total,1.4651,XJGVXQDUIWGIRW-UHFFFAOYSA-N,4.2645637279507163e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2018,Prescription,Total,0.3003,XJGVXQDUIWGIRW-UHFFFAOYSA-N,8.53639195947722e-14,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
lumacaftor,2016,Prescription,Total,1344,UFSKUSARDNFIRC-UHFFFAOYSA-N,3.8590955980633625e-10,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2017,Prescription,Total,5040,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.4670262227064096e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2018,Prescription,Total,6608,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.8784041980761063e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2019,Prescription,Total,8512,UFSKUSARDNFIRC-UHFFFAOYSA-N,2.458879532175281e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lurasidone,2016,Prescription,Total,4085.01016,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.1729497564360203e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2017,Prescription,Total,5081.82864,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.479201562337391e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2018,Prescription,Total,6887.00166,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.9577138060383033e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2019,Prescription,Total,9104.99996,PQXKDMSYBGKCJA-CVTJIBDQSA-N,2.630180691036272e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lymecycline,2016,Prescription,Total,1073133.9,PZTCVADFMACKLU-UEPZRUIBSA-N,3.081343980373935e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2017,Prescription,Total,1097286.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.193944873064205e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2018,Prescription,Total,1083620.4,PZTCVADFMACKLU-UEPZRUIBSA-N,3.080322500727768e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2019,Prescription,Total,1146855.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.312946148027023e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
macitentan,2016,Prescription,Total,356.7,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.0242108629681559e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2017,Prescription,Total,436.8,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.2714227263455548e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2018,Prescription,Total,479.1,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.3618998960324794e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2019,Prescription,Total,525.6,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.5183118915781576e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macrogol,2016,OTC,Total,20729440.74266,LYCAIKOWRPUZTN-UHFFFAOYSA-N,5.952149815499594e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.006265420858420625
macrogol,2016,Prescription,Total,68677249.2,LYCAIKOWRPUZTN-UHFFFAOYSA-N,1.9719648071043203e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.020757524285308634
macrogol,2017,OTC,Total,23530761.3096,LYCAIKOWRPUZTN-UHFFFAOYSA-N,6.849254738378695e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.00720974182987231
macrogol,2017,Prescription,Total,83741585.91,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.437521874226024e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.025658124991852882
macrogol,2018,OTC,Total,25538652.30416,LYCAIKOWRPUZTN-UHFFFAOYSA-N,7.259671867636223e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.007641759860669709
macrogol,2018,Prescription,Total,93882515.82,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.6687244528183177e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.028091836345455975
macrogol,2019,OTC,Total,33252746.68248,LYCAIKOWRPUZTN-UHFFFAOYSA-N,9.605791612565738e-6,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.01011135959217446
macrogol,2019,Prescription,Total,99923381.43,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.886507957988376e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.03038429429461448
malathion,2016,OTC,Total,8060.525,JXSJBGJIGXNWCI-UHFFFAOYSA-N,2.3144595644032507e-9,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
malathion,2017,OTC,Total,2174.975,JXSJBGJIGXNWCI-UHFFFAOYSA-N,6.33084396573586e-10,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
maraviroc,2016,Prescription,Total,855,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.4550050121608447e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.668483708870483e-7
maraviroc,2017,Prescription,Total,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1481455403915282e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3349408047734003e-7
maraviroc,2018,Prescription,Total,954,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.7118607823314245e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.9476747634037224e-7
maraviroc,2019,Prescription,Total,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1318762861200159e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3172568327391477e-7
maropitant,2016,Prescription,Total,756.792,OMPCVMLFFSQFIX-CONSDPRKSA-N,2.173015383816643e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2017,Prescription,Total,1060.856,OMPCVMLFFSQFIX-CONSDPRKSA-N,3.0879039097528395e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2018,Prescription,Total,1442.464,OMPCVMLFFSQFIX-CONSDPRKSA-N,4.100378984826955e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2019,Prescription,Total,1906.536,OMPCVMLFFSQFIX-CONSDPRKSA-N,5.507451066441885e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
mavacoxib,2016,Prescription,Total,159.82,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.588992994661359e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2017,Prescription,Total,170.18,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.953542114686048e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2018,Prescription,Total,114.23,TTZNQDOUNXBMJV-UHFFFAOYSA-N,3.2471263853848907e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2019,Prescription,Total,61.95,TTZNQDOUNXBMJV-UHFFFAOYSA-N,1.7895628174137533e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mebendazole,2016,OTC,Total,61423.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.7636756007363508e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20041768190185807
mebendazole,2017,OTC,Total,63877.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.859316020497259e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.21128591142014308
mebendazole,2018,OTC,Total,62027.4,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.763204124632958e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20036410507192706
mebendazole,2019,OTC,Total,65777.40000000001,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.9001257347239938e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.2159233789459084
mecillinam,2016,Prescription,Total,11634,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.340529627073598e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2017,Prescription,Total,11510,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.3502920284426143e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2018,Prescription,Total,4429,BWWVAEOLVKTZFQ-NTZNESFSSA-N,1.258997002614872e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2019,Prescription,Total,7300,BWWVAEOLVKTZFQ-NTZNESFSSA-N,2.108766516080774e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
meclozine,2016,OTC,Total,49589.25,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.4238813719216044e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2016,Prescription,Total,12709.35,OCJYIGYOJCODJL-UHFFFAOYSA-N,3.649300345182039e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2017,OTC,Total,51284.5,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.4927719507616442e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2017,Prescription,Total,21575.475,OCJYIGYOJCODJL-UHFFFAOYSA-N,6.28011658578305e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2018,OTC,Total,55553.25,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.5791685535225702e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2018,Prescription,Total,27466.825,OCJYIGYOJCODJL-UHFFFAOYSA-N,7.807778357721209e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2019,OTC,Total,57038.75,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.647690494782223e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2019,Prescription,Total,26470.475,OCJYIGYOJCODJL-UHFFFAOYSA-N,7.646582375993594e-9,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
medetomidine,2016,Prescription,Total,80.34,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.3068433061637697e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2017,Prescription,Total,76.09,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.2148020890025934e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2018,Prescription,Total,69.92,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9875608584969936e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2019,Prescription,Total,65.86,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9025118184805452e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medroxyprogesterone acetate,2016,Prescription,Total,17214.412,PSGAAPLEWMOORI-PEINSRQWSA-N,4.94286172414056e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2017,Prescription,Total,16454.864,PSGAAPLEWMOORI-PEINSRQWSA-N,4.789626384735652e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2018,Prescription,Total,15057.08,PSGAAPLEWMOORI-PEINSRQWSA-N,4.2801577304430655e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2019,Prescription,Total,14449.196,PSGAAPLEWMOORI-PEINSRQWSA-N,4.173969960149077e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
mefloquine,2016,Prescription,Total,8634,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.4791243596487406e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2017,Prescription,Total,8060,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.346077649804298e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2018,Prescription,Total,7916,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.250219072634754e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2019,Prescription,Total,7282,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.103566817821945e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
megestrol acetate,2016,Prescription,Total,5134.128,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.4741883009444832e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2017,Prescription,Total,4752.24,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.3832660112290292e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2018,Prescription,Total,5703.456,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.621276588066337e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2019,Prescription,Total,2689.824,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,7.770151760754046e-10,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
meglumine amidotrizoate,2016,Prescription,Total,1.51536,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.351130286816442e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2017,Prescription,Total,1.40118,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.078507545102713e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2018,Prescription,Total,1.30746,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.7166137300493133e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2019,Prescription,Total,1.19988,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.466118859335616e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
melatonin,2016,Prescription,Total,15101.247,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.33609790349461e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2017,Prescription,Total,16070.9346,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.677873508253918e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2018,Prescription,Total,16984.3194,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.827998919858573e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2019,Prescription,Total,18836.218200000003,DRLFMBDRBRZALE-UHFFFAOYSA-N,5.441258387637162e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
meloxicam,2016,Prescription,Total,61799.399,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.7744775940763494e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2017,Prescription,Total,63903.462,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.8600804459468773e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2018,Prescription,Total,62684.0115,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.7818691034178408e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2019,Prescription,Total,63033.4555,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.8208608267296922e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
melphalan,2016,Prescription,Total,53.05,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.5232516478962898e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2017,Prescription,Total,46,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.3389525048510883e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2018,Prescription,Total,33.5,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,9.522781573176384e-12,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2019,Prescription,Total,38.4,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.1092689618835856e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
memantine,2016,Prescription,Total,33363.1714,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.579737193986122e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2017,Prescription,Total,32400.4736,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.431020714148164e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2018,Prescription,Total,31011.5332,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.815404683967393e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2019,Prescription,Total,30630.0316,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.848162332133703e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
menbutone,2019,Prescription,Total,900,FHGJSJFIQNQBCK-UHFFFAOYSA-N,2.5998491294146534e-10,alimentary,choleretic veterinary bile excretion stimulator,NA,NA,NA,NA
mepivacaine,2016,Prescription,Total,7958.4,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.285135893424663e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2017,Prescription,Total,8615.7,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.5078289339229392e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2018,Prescription,Total,9848.4,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.7995272252319502e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2019,Prescription,Total,9095.1,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.6273208685488013e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mercaptopurine,2016,Prescription,Total,5904.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.6953173500644054e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2017,Prescription,Total,6181.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.7992174283936496e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2018,Prescription,Total,6047.5,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.719075270560722e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2019,Prescription,Total,5930.75,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.713228358252884e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
meropenem,2016,Prescription,Total,152350,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4.374503083072569e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2017,Prescription,Total,136675,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.9782898608809246e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2018,Prescription,Total,129585,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.683610896000185e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2019,Prescription,Total,124545,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.5977578869216446e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
mesna,2016,Prescription,Total,20386,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.85353592724105e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2017,Prescription,Total,18418,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.361049398771162e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2018,Prescription,Total,19076,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.422584516116798e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2019,Prescription,Total,18950,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.474126778045298e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
metamizole sodium,2016,Prescription,Total,32750,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.40367416938803e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2017,Prescription,Total,34150,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.940266965361884e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2018,Prescription,Total,31700,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.011109727453477e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2019,Prescription,Total,33100,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.561667353736114e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metformin,2016,Prescription,Total,69488813.456,XZWYZXLIPXDOLR-UHFFFAOYSA-N,1.9952676646033913e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.019952676646033913
metformin,2017,Prescription,Total,73431045.754,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1374061444815902e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021374061444815903
metformin,2018,Prescription,Total,74897300.814,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1290466748424115e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021290466748424115
metformin,2019,Prescription,Total,78024938.926,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.25392299488214e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.0225392299488214
methadone,2016,Prescription,Total,98002.923,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8140078031744248e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2017,Prescription,Total,96779.685,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8170304706402024e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2018,Prescription,Total,95411.485,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.7121872573952098e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2019,Prescription,Total,98445.98,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8438299488596932e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methenamine,2016,Prescription,Total,15596938,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.478428182966309e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2017,Prescription,Total,15766796,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.5893458690600255e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2018,Prescription,Total,15759884,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.479938297032757e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2019,Prescription,Total,13120813,VKYKSIONXSXAKP-UHFFFAOYSA-N,3.7902371394736073e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methoprene,2016,Prescription,Total,3529.836,NFGXHKASABOEEW-LDRANXPESA-N,1.0135397745152971e-9,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2017,Prescription,Total,2461.1454,NFGXHKASABOEEW-LDRANXPESA-N,7.163819126375508e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2018,Prescription,Total,2021.0688,NFGXHKASABOEEW-LDRANXPESA-N,5.745133351272152e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2019,Prescription,Total,1957.203,NFGXHKASABOEEW-LDRANXPESA-N,5.653813906264164e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoxsalen,2019,Prescription,Total,0.0576,QXKHYNVANLEOEG-UHFFFAOYSA-N,1.663903442825378e-14,dermatological,psoralen agent used with ultraviolet light A for psoriasis,NA,NA,NA,NA
methyl aminolevulinate,2016,Prescription,Total,1325.44,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.805803325518678e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2017,Prescription,Total,1259.2,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.6652369437141094e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2018,Prescription,Total,1025.92,YUUAYBAIHCDHHD-UHFFFAOYSA-N,2.9163021109113783e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2019,Prescription,Total,1140.48,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.294528816794249e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methylnaltrexone bromide,2016,Prescription,Total,129.564,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.7202370689544754e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2017,Prescription,Total,124.5,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.623904062042619e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2018,Prescription,Total,46.355999999999995,IFGIYSGOEZJNBE-KNLJMPJLSA-N,1.3177255600184014e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2019,Prescription,Total,97.212,IFGIYSGOEZJNBE-KNLJMPJLSA-N,2.8081837063184145e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylphenidate,2016,Prescription,Total,449505.8977,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.290689160057731e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2017,Prescription,Total,471897.4314,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3735831474039664e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2018,Prescription,Total,476990.1956,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3559025209688e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2019,Prescription,Total,494619.477,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.4288177962999792e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylprednisolone,2016,Prescription,Total,25117.601,VHRSUDSXCMQTMA-PJHHCJLFSA-N,7.2121446021586255e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2017,Prescription,Total,22609.799,VHRSUDSXCMQTMA-PJHHCJLFSA-N,6.5811841315716595e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2018,Prescription,Total,20784.897,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.9083592284169894e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2019,Prescription,Total,18925.627,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.467086097730718e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylrosaniline,2016,OTC,Total,2803.2799999999997,QFVDKARCPMTZCS-UHFFFAOYSA-N,8.049200526889184e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2017,OTC,Total,2551.62,QFVDKARCPMTZCS-UHFFFAOYSA-N,7.427169544408987e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2018,OTC,Total,778.4,QFVDKARCPMTZCS-UHFFFAOYSA-N,2.2126964706150738e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2019,OTC,Total,614.28,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.774483692463148e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
metoclopramide,2016,Prescription,Total,64983.21,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8658959796058563e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2017,Prescription,Total,64693.28,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8830702022398436e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2018,Prescription,Total,64785.495,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8416063223734652e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2019,Prescription,Total,65947.70999999999,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.9050455158932224e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoprolol,2016,Prescription,Total,6866147.1280000005,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.971511767657754e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2700701051585964
metoprolol,2017,Prescription,Total,6845990.6295,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.992707891642631e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2729736837866618
metoprolol,2018,Prescription,Total,6856705.0345,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.949101622544548e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.26700022226637643
metoprolol,2019,Prescription,Total,6798429.0755,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.963876657036216e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2690241995940022
metronidazole,2016,OTC,Total,2750.675,VAOCPAMSLUNLGC-UHFFFAOYSA-N,7.898153113246235e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,6.318522490596988e-5
metronidazole,2016,Prescription,Total,990402.15,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.843792096263014e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.022750336770104112
metronidazole,2017,OTC,Total,2604.625,VAOCPAMSLUNLGC-UHFFFAOYSA-N,7.581454712929925e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,6.06516377034394e-5
metronidazole,2017,Prescription,Total,1001759.105,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.915886658472031e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.023327093267776246
metronidazole,2018,OTC,Total,2358.725,VAOCPAMSLUNLGC-UHFFFAOYSA-N,6.704962079459842e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,5.363969663567873e-5
metronidazole,2018,Prescription,Total,957577.125,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.722029194282155e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02177623355425724
metronidazole,2019,OTC,Total,1378.425,VAOCPAMSLUNLGC-UHFFFAOYSA-N,3.981885595792659e-10,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,3.185508476634127e-5
metronidazole,2019,Prescription,Total,986561.775,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.8499019687194724e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02279921574975578
metyrapone,2016,Prescription,Total,325,FJLBFSROUSIWMA-UHFFFAOYSA-N,9.331890397102626e-11,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2017,Prescription,Total,1712.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,4.98468731425541e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2018,Prescription,Total,3100,FJLBFSROUSIWMA-UHFFFAOYSA-N,8.812126231894564e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2019,Prescription,Total,2187.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,6.31907774510506e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
mianserin,2016,Prescription,Total,173771.217,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.9895813883542663e-08,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2017,Prescription,Total,165837.76499999998,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.8271498009925243e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2018,Prescription,Total,149158.389,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.240008233593657e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2019,Prescription,Total,156068.376,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.50838034969732e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
micafungin,2016,Prescription,Total,384.3,PIEUQSKUWLMALL-YABMTYFHSA-N,1.1034601475712428e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2017,Prescription,Total,607.1999999999999,PIEUQSKUWLMALL-YABMTYFHSA-N,1.7674173064034363e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2018,Prescription,Total,335.65000000000003,PIEUQSKUWLMALL-YABMTYFHSA-N,9.541258612049711e-11,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2019,Prescription,Total,349.85,PIEUQSKUWLMALL-YABMTYFHSA-N,1.0106191310285739e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
miconazole,2016,OTC,Total,19218.4091573575,BYBLEWFAAKGYCD-UHFFFAOYSA-N,5.518279626557957e-9,antifungal,azole antifungal,high,high,2e-7,0.027591398132789786
miconazole,2016,Prescription,Total,62427.2884432937,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.7925065032034714e-8,antifungal,azole antifungal,high,high,2e-7,0.08962532516017357
miconazole,2017,OTC,Total,19801.9677668942,BYBLEWFAAKGYCD-UHFFFAOYSA-N,5.763890074448586e-9,antifungal,azole antifungal,high,high,2e-7,0.02881945037224293
miconazole,2017,Prescription,Total,63284.911762216594,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.8420758939847832e-8,antifungal,azole antifungal,high,high,2e-7,0.09210379469923917
miconazole,2018,OTC,Total,20029.346744051298,BYBLEWFAAKGYCD-UHFFFAOYSA-N,5.693584898418272e-9,antifungal,azole antifungal,high,high,2e-7,0.028467924492091363
miconazole,2018,Prescription,Total,63361.0568696431,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.8011149397469204e-8,antifungal,azole antifungal,high,high,2e-7,0.09005574698734603
miconazole,2019,OTC,Total,23891.87675259866,BYBLEWFAAKGYCD-UHFFFAOYSA-N,6.9016972194806475e-9,antifungal,azole antifungal,high,high,2e-7,0.034508486097403236
miconazole,2019,Prescription,Total,67542.4670620163,BYBLEWFAAKGYCD-UHFFFAOYSA-N,1.9511136021077884e-8,antifungal,azole antifungal,high,high,2e-7,0.09755568010538943
midazolam,2016,Prescription,Total,6162.6,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.769498700344143e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2017,Prescription,Total,6242.8,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8171331950618206e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2018,Prescription,Total,6157.85,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.7504435973249015e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2019,Prescription,Total,6539.32,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8890272676626482e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midodrine,2019,Prescription,Total,340.25,PTKSEFOSCHHMPD-UHFFFAOYSA-N,9.828874069814841e-11,cardiac,"antihypotensive, constricts blood vessels",NA,NA,NA,NA
midostaurin,2018,Prescription,Total,72.8,BMGQWWVMWDBQGC-IIFHNQTCSA-N,2.0694283538126592e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
midostaurin,2019,Prescription,Total,61.6,BMGQWWVMWDBQGC-IIFHNQTCSA-N,1.779452293021585e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
mifepristone,2016,Prescription,Total,2740.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.8697985231935e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2017,Prescription,Total,2626.4,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.644836649436736e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2018,Prescription,Total,2763.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.856436928938774e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2019,Prescription,Total,2751,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.946872172244123e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
miglustat,2016,Prescription,Total,630,UQRORFVVSGFNRO-UTINFBMNSA-N,1.8089510615922014e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2017,Prescription,Total,814.8,UQRORFVVSGFNRO-UTINFBMNSA-N,2.3716923933753617e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2018,Prescription,Total,915.6,UQRORFVVSGFNRO-UTINFBMNSA-N,2.602704121910537e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2019,Prescription,Total,1008,UQRORFVVSGFNRO-UTINFBMNSA-N,2.911831024944412e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
milbemycin oxime,2016,Prescription,Total,3482.1718499999997,LKMMLHTWKLEARD-LEBVNCHQSA-N,9.998537245561872e-10,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2017,Prescription,Total,3796.2692,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.105005250962834e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2018,Prescription,Total,4060.1456,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.1541456628087514e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2019,Prescription,Total,3846.8674,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.111252762318179e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milrinone,2019,Prescription,Total,10.1,PZRHRDRVRGEVNW-UHFFFAOYSA-N,2.9176084674542226e-12,vasodilator,inotropic vasodilator for life-threatening heart failure,low,high,NA,NA
minoxidil,2016,OTC,Total,62955,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,1.807658953691064e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2017,OTC,Total,85104,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,2.4771785646271093e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2018,OTC,Total,105543,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.000187867396284e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2019,OTC,Total,117723,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.4006893229120146e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
mirabegron,2016,Prescription,Total,303287.5425,PBAPPPCECJKMCM-IBGZPJMESA-N,8.708449555128015e-8,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2017,Prescription,Total,372761.0925000001,PBAPPPCECJKMCM-IBGZPJMESA-N,1.0850204315519639e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2018,Prescription,Total,436381.155,PBAPPPCECJKMCM-IBGZPJMESA-N,1.240466394541919e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2019,Prescription,Total,516175.395,PBAPPPCECJKMCM-IBGZPJMESA-N,1.491086834795572e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirtazapine,2016,Prescription,Total,319535.925,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.174997630882476e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002867186759650774
mirtazapine,2017,Prescription,Total,326906.742,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.515491327252358e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002973591039766362
mirtazapine,2018,Prescription,Total,337860.4368,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.60409296078915e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0030012790502466093
mirtazapine,2019,Prescription,Total,363507.1445999999,RONZAEMNMFQXRA-UHFFFAOYSA-N,1.050070814915907e-7,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0032814712966122094
misoprostol,2016,Prescription,Total,676.244,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.941733812214852e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2017,Prescription,Total,658.3222000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.916222084106694e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2018,Prescription,Total,621.0586000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7654344453560368e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2019,Prescription,Total,591.4346,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7084896999063375e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
mitomycin,2017,Prescription,Total,39.42,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.1474240813310847e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2018,Prescription,Total,54.8,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.5577565080897488e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2019,Prescription,Total,58.72,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.696257120880316e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitotane,2016,Prescription,Total,9600,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.756496855759545e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2017,Prescription,Total,7300,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.124859409872379e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2018,Prescription,Total,4750,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.3502451484354574e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2019,Prescription,Total,5800,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.6754583278449986e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitoxantrone,2016,Prescription,Total,4.75,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.3638916734226917e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2017,Prescription,Total,4.35,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.2661833469787465e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2018,Prescription,Total,3.26,KKZJGLLVHKMTCM-UHFFFAOYSA-N,9.26694565031493e-13,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2019,Prescription,Total,3.49,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.0081637179619046e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mivacurium chloride,2016,Prescription,Total,233.4205,WMSYWJSZGVOIJW-ONUALHDOSA-L,6.702321607498134e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2017,Prescription,Total,272.68949999999995,WMSYWJSZGVOIJW-ONUALHDOSA-L,7.937354110251972e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2018,Prescription,Total,285.5295,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.116522570741094e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2019,Prescription,Total,299.3325,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.646881550339019e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
moclobemide,2016,Prescription,Total,74501.91,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.1392112569070896e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2017,Prescription,Total,70062.95999999999,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.0393690388974263e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2018,Prescription,Total,61765.23,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.7557516242000038e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2019,Prescription,Total,56384.52,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.6287916137162566e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
modafinil,2016,Prescription,Total,36860.1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.0583828099269e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2017,Prescription,Total,41133.87,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.1973108319721531e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2018,Prescription,Total,44110.41,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.25389193890524e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2019,Prescription,Total,48698.369999999995,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.4067601649823629e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
mometasone,2016,OTC,Total,174.696,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.016135153268432e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.0035829536809060232
mometasone,2016,Prescription,Total,14397.729,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.134093199851877e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.2952923714179912
mometasone,2017,OTC,Total,192.582,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.605611984548528e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.004004008560391806
mometasone,2017,Prescription,Total,15102.452,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.395970855389853e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.3139979182421324
mometasone,2018,OTC,Total,182.529,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.188608351553172e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.00370614882253798
mometasone,2018,Prescription,Total,15135.753,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.3025214855089324e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.307322963250638
mometasone,2019,OTC,Total,178.983,QLIIKPVHVRXHRI-CXSFZGCWSA-N,5.1703199636669206e-11,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.003693085688333515
mometasone,2019,Prescription,Total,16555.013,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.782281792833141e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.34159155663093865
montelukast,2016,Prescription,Total,90571.20506,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6006171038566978e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.01368745844135104
montelukast,2017,Prescription,Total,89291.39282,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5990637843039453e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013679283075283922
montelukast,2018,Prescription,Total,91333.7439,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5962725176720332e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013664592198273859
montelukast,2019,Prescription,Total,93387.5145,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6977049807891482e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.014198447267311306
morphine,2016,Prescription,Total,143800.62,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.1290203842320125e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2017,Prescription,Total,145812.63,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.244264916900542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2018,Prescription,Total,144049.465,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.094780868441542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2019,Prescription,Total,148051.625,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.2767987596074974e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
moxidectin,2016,Prescription,Total,834.5274000000001,YZBLFMPOMVTDJY-LSGXYNIPSA-N,2.3962209939012376e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2017,Prescription,Total,642.7746,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.8709666537492526e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2018,Prescription,Total,574.6335,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6334654642178663e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2019,Prescription,Total,573.168,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6557225842314866e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxonidine,2016,Prescription,Total,700.267344,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.0107132624240496e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2017,Prescription,Total,705.406072,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.053272232699059e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2018,Prescription,Total,674.0434680000001,WPNJAUFVNXKLIM-UHFFFAOYSA-N,1.9160503631612855e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2019,Prescription,Total,750.183784,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.1670718419259892e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
mycophenolic acid,2016,Prescription,Total,2255457,HPNSFSBZBAHARI-RUDMXATFSA-N,6.476208467500891e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,9.523835981618959
mycophenolic acid,2017,Prescription,Total,2364479,HPNSFSBZBAHARI-RUDMXATFSA-N,6.88244582547347e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.121243860990397
mycophenolic acid,2018,Prescription,Total,2429535,HPNSFSBZBAHARI-RUDMXATFSA-N,6.906248098324504e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.156247203418388
mycophenolic acid,2019,Prescription,Total,2551838.8,HPNSFSBZBAHARI-RUDMXATFSA-N,7.371550980651704e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.840516148017212
nabumetone,2016,Prescription,Total,394630,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1331212022795721e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2017,Prescription,Total,378785.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1025560739701565e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2018,Prescription,Total,335474.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,9.536269811553915e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2019,Prescription,Total,310164.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,8.959787836670347e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nalmefene,2016,Prescription,Total,468.90648,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.346395039338829e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2017,Prescription,Total,351.8172,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.0240576547602094e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2018,Prescription,Total,325.60416,WJBLNOPPDWQMCH-MBPVOVBZSA-N,9.255693417903209e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2019,Prescription,Total,290.92392,WJBLNOPPDWQMCH-MBPVOVBZSA-N,8.403981112643315e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
naloxegol,2016,Prescription,Total,1748.1625,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,5.01958795271536e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2017,Prescription,Total,2825.69,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,8.224923268331894e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2018,Prescription,Total,3741.99,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.0637060722092626e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2019,Prescription,Total,4433.4825,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.280709513100011e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxone,2016,Prescription,Total,41013.1332,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.1776309657359104e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2017,Prescription,Total,44180.59196,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.2859937884923013e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2018,Prescription,Total,47347.738,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.3459169162924874e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2019,Prescription,Total,49400.0052,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.4270284501366594e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naltrexone,2016,Prescription,Total,7338.439,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.107123336425335e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2017,Prescription,Total,7045.358,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.050739074276664e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2018,Prescription,Total,14907.313,DQCKKXVULJGBQN-XFWGSAIBSA-N,4.237584643043964e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2019,Prescription,Total,25436.735,DQCKKXVULJGBQN-XFWGSAIBSA-N,7.347963704989027e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
nandrolone,2018,Prescription,Total,8.5,NPAGDVCDWIYMMC-IZPLOLCNSA-N,2.4162281603581873e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
nandrolone,2019,Prescription,Total,18,NPAGDVCDWIYMMC-IZPLOLCNSA-N,5.1996982588293064e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
naphazoline,2016,OTC,Total,28.7736,CNIIGCLFLJGOGP-UHFFFAOYSA-N,8.261910200925295e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2017,OTC,Total,21.1104,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.1447441213931325e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2018,OTC,Total,21.5712,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.131875399143357e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2019,OTC,Total,17.814,CNIIGCLFLJGOGP-UHFFFAOYSA-N,5.145968043488071e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naproxen,2016,OTC,Total,803170,CMWTZPSULFXXJA-VIFPVBQESA-N,2.3061828954587438e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.015374552636391625
naproxen,2016,Prescription,Total,11033028.075,CMWTZPSULFXXJA-VIFPVBQESA-N,3.1679694998171128e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.21119796665447418
naproxen,2017,OTC,Total,793955,CMWTZPSULFXXJA-VIFPVBQESA-N,2.311017469541404e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.015406783130276026
naproxen,2017,Prescription,Total,12158180.85,CMWTZPSULFXXJA-VIFPVBQESA-N,3.5389623268565293e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.23593082179043529
naproxen,2018,OTC,Total,757045,CMWTZPSULFXXJA-VIFPVBQESA-N,2.151992291362781e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.014346615275751873
naproxen,2018,Prescription,Total,12796983.4,CMWTZPSULFXXJA-VIFPVBQESA-N,3.637697842201913e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.24251318948012754
naproxen,2019,OTC,Total,885185,CMWTZPSULFXXJA-VIFPVBQESA-N,2.557052724023234e-7,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.017047018160154893
naproxen,2019,Prescription,Total,13793243.375,CMWTZPSULFXXJA-VIFPVBQESA-N,3.984483531144243e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.2656322354096162
naratriptan,2016,Prescription,Total,313.875,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.012452610432576e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.012452610432576e-7
naratriptan,2017,Prescription,Total,330.645,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.624303281880175e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.624303281880174e-7
naratriptan,2018,Prescription,Total,414.585,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.178508178661293e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.178508178661293e-6
naratriptan,2019,Prescription,Total,417.045,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.2047267557519268e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.2047267557519267e-6
nebivolol,2016,Prescription,Total,25.200000000000003,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,7.235804246368806e-12,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2017,Prescription,Total,47.4,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,1.3797032332595995e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2018,Prescription,Total,81.6,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,2.3195790339438596e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2019,Prescription,Total,109.65,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,3.1674828560035196e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nelarabine,2017,Prescription,Total,7.5,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,2.1830747361702525e-12,antineoplastic,antimetabolite for leukaemia and lymphoma,low,high,1e-4,2.1830747361702525e-8
neomycin,2016,Prescription,Total,32200,PGBHMTALBVVCIT-VCIWKGPPSA-N,9.24574987036014e-9,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2017,Prescription,Total,40100,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.1672172922723617e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2018,Prescription,Total,36800,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0460846623668388e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2019,Prescription,Total,35300,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0197186029815252e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neostigmine,2016,Prescription,Total,120.3,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.45423512237368e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2017,Prescription,Total,118.1,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.4376150178894244e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2018,Prescription,Total,111.25,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.162416268704098e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2019,Prescription,Total,117.525,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.394969654827302e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
nepafenac,2016,Prescription,Total,271.246,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.788424438930766e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2017,Prescription,Total,299.604,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.720772310074031e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2018,Prescription,Total,273.159,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.764876094768023e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2019,Prescription,Total,301.9,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.72104946855871e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
netupitant,2016,Prescription,Total,1442.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,4.1424979310461407e-10,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2017,Prescription,Total,6062.4,WAXQNWCZJDTGBU-UHFFFAOYSA-N,1.7646229707411384e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2018,Prescription,Total,7616.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.165139415176495e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2019,Prescription,Total,8313,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.4013939792026683e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
nevirapine,2016,Prescription,Total,15546.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4.464031803866926e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,1.0381469311318433e-4
nevirapine,2017,Prescription,Total,12474.4,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.6310063318509604e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,8.444200771746419e-5
nevirapine,2018,Prescription,Total,10636.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.023639493658584e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.031719752694381e-5
nevirapine,2019,Prescription,Total,11765.6,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.398753879671227e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.904078789933086e-5
nicotine,2016,OTC,Total,413358.859,SNICXCGAKADSCV-JTQLQIEISA-N,1.1868983282644304e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.4904538546547233
nicotine,2017,OTC,Total,443459.232,SNICXCGAKADSCV-JTQLQIEISA-N,1.2908061945342172e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5333909894769492
nicotine,2018,OTC,Total,452518.281,SNICXCGAKADSCV-JTQLQIEISA-N,1.2863381336812697e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5315446833393676
nicotine,2019,OTC,Total,468355.722,SNICXCGAKADSCV-JTQLQIEISA-N,1.3529491289978573e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5590698880156435
nifedipine,2016,Prescription,Total,540610.2034,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.5522815894412792e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2017,Prescription,Total,574190.8116,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.6713352727267377e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2018,Prescription,Total,406169.141,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.1545850780619945e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2019,Prescription,Total,319523.88,HYIMSNHJOBLJNT-UHFFFAOYSA-N,9.23015423605769e-8,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nilotinib,2016,Prescription,Total,16940,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.864068410059031e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707955423303963
nilotinib,2017,Prescription,Total,16475.2,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.7955457191136206e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018444406611975463
nilotinib,2018,Prescription,Total,17110.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.8638388605873805e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707072540720696
nilotinib,2019,Prescription,Total,17972.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,5.191725388165769e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.019968174569868342
nimodipine,2016,Prescription,Total,1004.4,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.8839848353384235e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2017,Prescription,Total,1195.15,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.47880236124517e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2018,Prescription,Total,1105.75,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.1432285744894886e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2019,Prescription,Total,957.05,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.7646506770069927e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nintedanib,2016,Prescription,Total,5280,CPMDPSXJELVGJG-UHFFFAOYSA-N,1.5160732706677494e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,3.9896665017572354e-4
nintedanib,2017,Prescription,Total,9339,CPMDPSXJELVGJG-UHFFFAOYSA-N,2.718364661479198e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,7.153591214418942e-4
nintedanib,2018,Prescription,Total,13311,CPMDPSXJELVGJG-UHFFFAOYSA-N,3.7838132991209215e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,9.957403418739267e-4
nintedanib,2019,Prescription,Total,19167,CPMDPSXJELVGJG-UHFFFAOYSA-N,5.536812029276741e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,0.0014570557971780897
nitisinone,2016,Prescription,Total,304.62,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.746709085432006e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2017,Prescription,Total,293.09999999999997,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.531456068953345e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2018,Prescription,Total,317.58,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.027596931371212e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2019,Prescription,Total,343.08,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.91062488132866e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitrazepam,2016,Prescription,Total,25991.235,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.462995578625774e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2017,Prescription,Total,24605.77,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.162164646802122e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2018,Prescription,Total,23234.9275,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.604810132868335e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2019,Prescription,Total,22517.1975,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.5045907019147564e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrofurantoin,2016,Prescription,Total,118891.905,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.4138037740391936e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2017,Prescription,Total,108327.375,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.1531567413085466e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2018,Prescription,Total,25611.025,NXFQHRVNIOXGAQ-YCRREMRBSA-N,7.280244684780888e-9,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2019,Prescription,Total,516.25,NXFQHRVNIOXGAQ-YCRREMRBSA-N,1.4913023478447943e-10,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nomegestrol acetate,2016,Prescription,Total,763.98,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1936546540241427e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2017,Prescription,Total,724.92,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.110072716992719e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2018,Prescription,Total,763.56,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1705119695565852e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2019,Prescription,Total,391.02,IIVBFTNIGYRNQY-YQLZSBIMSA-N,1.1295477850930195e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
norelgestromin,2016,Prescription,Total,1316.304,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.7795706637747e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2017,Prescription,Total,1229.58,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.579020045466959e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2018,Prescription,Total,1179.954,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.354162450267394e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2019,Prescription,Total,1153.602,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.332434617101115e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norepinephrine,2016,Prescription,Total,563.84,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.6189824866161062e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2017,Prescription,Total,608.43,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.7709975489707555e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2018,Prescription,Total,598.5500000000001,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.701451018096933e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2019,Prescription,Total,625.4,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.8066062728176936e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norethisterone,2016,Prescription,Total,11628.66711,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.338998367228066e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.677996734456132
norethisterone,2017,Prescription,Total,11288.048196,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.285687044981306e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.571374089962612
norethisterone,2018,Prescription,Total,11405.604126,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.242181397075145e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.4843627941502895
norethisterone,2019,Prescription,Total,11396.149746,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.292029999535235e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.58405999907047
nortriptyline,2016,Prescription,Total,20790.865,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.969786875106372e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2017,Prescription,Total,20722.4,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.0318063883752604e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2018,Prescription,Total,20970.165,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.9610239059244294e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2019,Prescription,Total,22060.04,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.372530643205826e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
noscapine,2016,OTC,Total,230103.48,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.60707832415968e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2017,OTC,Total,184830.55,AKNNEGZIBPJZJG-MSOLQXFVSA-N,5.3799853890327026e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2018,OTC,Total,211380.54,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.008748391761414e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2019,OTC,Total,220222.27,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.361607521524653e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
nystatin,2016,Prescription,Total,10140,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.911549803896019e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2017,Prescription,Total,7980,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.3227915192851486e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2018,Prescription,Total,540,VQOXZBDYSJBXMA-RKEBNKJGSA-N,1.5350155371687308e-10,antifungal,topical antifungal,NA,NA,NA,NA
obeticholic acid,2017,Prescription,Total,5.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,1.615475304765987e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2018,Prescription,Total,29.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,8.399946133951109e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2019,Prescription,Total,73.5,ZXERDUOLZKYMJM-ZWECCWDJSA-N,2.1232101223553004e-11,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
oclacitinib,2016,Prescription,Total,1577.108,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,4.528430461659608e-10,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2017,Prescription,Total,6505.176,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,1.893504717325474e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2018,Prescription,Total,7525.44,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.139197652598343e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2019,Prescription,Total,7460.288,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.1550692513313983e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
ofloxacin,2016,Prescription,Total,9395,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.697634162485513e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2017,Prescription,Total,7144,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.079451455360038e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2018,Prescription,Total,6572,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.868170761161648e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2019,Prescription,Total,5720,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.6523485578057572e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
olanzapine,2016,Prescription,Total,57957.4664,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6641622281186404e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015128747528351276
olanzapine,2017,Prescription,Total,57756.7583,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6811642651709542e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015283311501554129
olanzapine,2018,Prescription,Total,57485.9054,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6341066288372564e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01485551480761142
olanzapine,2019,Prescription,Total,59245.3109,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.7114318885029498e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01555847171366318
olaparib,2016,Prescription,Total,2822.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,8.104100755933063e-10,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,2.532531486229082e-5
olaparib,2017,Prescription,Total,7750.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.2559603246951904e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.04987601467247e-5
olaparib,2018,Prescription,Total,8892.8,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.5278863275803867e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.899644773688709e-5
olaparib,2019,Prescription,Total,8372,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.4184374346066086e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.557616983145652e-5
olmesartan medoxomil,2016,Prescription,Total,20498.5319,UQGKUQLKSCSZGY-UHFFFAOYSA-N,5.8858477843788265e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2017,Prescription,Total,21258.5905,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.187878912951858e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2018,Prescription,Total,21317.3982,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.0597291572245804e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2019,Prescription,Total,22177.519,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.406467051636326e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olodaterol,2016,Prescription,Total,3.993,COUYJEVMBVSIHV-SFHVURJKSA-N,1.1465304109424858e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2017,Prescription,Total,7.77735,COUYJEVMBVSIHV-SFHVURJKSA-N,2.263804839913829e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2018,Prescription,Total,10.5654,COUYJEVMBVSIHV-SFHVURJKSA-N,3.003343177111576e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2019,Prescription,Total,13.5762,COUYJEVMBVSIHV-SFHVURJKSA-N,3.9217857500843574e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olopatadine,2016,Prescription,Total,689.9449999999999,JBIMVDZLSHOPLA-LSCVHKIXSA-N,1.9810741907781447e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2017,Prescription,Total,754.46,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.1960567539346784e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2018,Prescription,Total,789.41,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.2439937318451255e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2019,Prescription,Total,870.375,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.514270762238088e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olsalazine,2016,Prescription,Total,79768.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2904335358193255e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2017,Prescription,Total,76207.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2182222394225936e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2018,Prescription,Total,75384,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.1428816898875483e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2019,Prescription,Total,69604,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.0106655422641947e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
ombitasvir,2016,Prescription,Total,641.9,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.8431201372000538e-10,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2017,Prescription,Total,158.2,PIDFDZJZLOTZTM-KHVQSSSXSA-N,4.604832310161786e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2018,Prescription,Total,80.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,2.28831019892746e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2019,Prescription,Total,3.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.0110524392168097e-12,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
omeprazole,2016,Prescription,Total,271094.5404,SUBDBMMJDZJVOS-UHFFFAOYSA-N,7.78407550235603e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,7.784075502356031e-4
omeprazole,2017,Prescription,Total,276517.7992,SUBDBMMJDZJVOS-UHFFFAOYSA-N,8.048786953798919e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,8.04878695379892e-4
omeprazole,2018,Prescription,Total,283462.0087,SUBDBMMJDZJVOS-UHFFFAOYSA-N,8.057751621325149e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,8.05775162132515e-4
omeprazole,2019,Prescription,Total,300009.9856,SUBDBMMJDZJVOS-UHFFFAOYSA-N,8.666452220865141e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,8.666452220865142e-4
ondansetron,2016,Prescription,Total,10158.28,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.9167986333255283e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.114995729142276e-4
ondansetron,2017,Prescription,Total,9773.56,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.8448549224592172e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.890171632685055e-4
ondansetron,2018,Prescription,Total,9582.092,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.723825944181518e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.511956075567245e-4
ondansetron,2019,Prescription,Total,10485.448,FELGMEQIXOGIFQ-UHFFFAOYSA-N,3.028953650480291e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.46548015775091e-4
opium,2016,Prescription,Total,454.8,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.3058903854160843e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2017,Prescription,Total,436,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.2690941132936402e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2018,Prescription,Total,525.2,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.4929447409648472e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2019,Prescription,Total,709.5,LGFMXOTUSSVQJV-NEYUFSEYSA-N,2.0495477303552183e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
osaterone acetate,2016,Prescription,Total,118.545,KKTIOMQDFOYCEN-OFUYBIASSA-N,3.4038429142293254e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2017,Prescription,Total,146.73749999999998,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.271185721317099e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2018,Prescription,Total,163.1175,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.6368129052614894e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2019,Prescription,Total,183.09375,KKTIOMQDFOYCEN-OFUYBIASSA-N,5.289068072652936e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
oseltamivir,2016,Prescription,Total,3850.05,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.105484449949691e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2017,Prescription,Total,3546.9,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.0324197042296358e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2018,Prescription,Total,6644.25,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.8887087005246924e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2019,Prescription,Total,5278.95,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.524941506858165e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
osimertinib,2017,Prescription,Total,9.6,DUYJMQONPNNFPI-UHFFFAOYSA-N,2.794335662297923e-12,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,3.725780883063897e-5
osimertinib,2018,Prescription,Total,120,DUYJMQONPNNFPI-UHFFFAOYSA-N,3.411145638152735e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,4.548194184203647e-4
osimertinib,2019,Prescription,Total,208.8,DUYJMQONPNNFPI-UHFFFAOYSA-N,6.031649980241996e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,8.042199973655995e-4
oxaliplatin,2016,Prescription,Total,1864.3,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.353059466867208e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2017,Prescription,Total,1898.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.526235387141378e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2018,Prescription,Total,1834.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.21493102539425e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2019,Prescription,Total,1978.35,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.714901694641644e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxazepam,2016,Prescription,Total,541952.175,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5561348607911946e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2017,Prescription,Total,517128.355,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5052397962103758e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2018,Prescription,Total,502380.275,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.428076903133518e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2019,Prescription,Total,456991.805,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.320121940420979e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxcarbazepine,2016,Prescription,Total,952201.5,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.734104625832836e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021360192389319032
oxcarbazepine,2017,Prescription,Total,961171.05,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.79774431519098e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021857377462429533
oxcarbazepine,2018,Prescription,Total,958318.8,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.724137495483137e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021282324183462008
oxcarbazepine,2019,Prescription,Total,1066227,CTRLABGOLIVAIY-UHFFFAOYSA-N,3.0800325974537753e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.02406275466760762
oxfendazole,2016,Prescription,Total,160650,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.6128252070601145e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2017,Prescription,Total,149895,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.3630931677098666e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2018,Prescription,Total,157455,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.4758494704611585e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2019,Prescription,Total,145575,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.2052559668282024e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxybuprocaine,2016,Prescription,Total,449.44,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.2904999446380936e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2017,Prescription,Total,468.12,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.362587927328025e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2018,Prescription,Total,482.52,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.3716216611012146e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2019,Prescription,Total,531.92,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.5365686099091578e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybutynin,2016,Prescription,Total,369.9768,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0623332144833104e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2017,Prescription,Total,369.3288,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0750298301601012e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2018,Prescription,Total,343.6828,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.769600701067656e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2019,Prescription,Total,341.0924,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.853208657666163e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxyclozanide,2018,Prescription,Total,748,JYWIYHUXVMAGLG-UHFFFAOYSA-N,2.1262807811152047e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxyclozanide,2019,Prescription,Total,1496,JYWIYHUXVMAGLG-UHFFFAOYSA-N,4.3215269973381347e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxycodone,2016,Prescription,Total,329517.24381,BRUQQQPBMZOVGD-XFKAJCMBSA-N,9.461596317508505e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2017,Prescription,Total,358341.92017,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.0430495904451526e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2018,Prescription,Total,363479.17312,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.033233663289709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2019,Prescription,Total,376641.07752,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.08801108610241e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxymetazoline,2016,OTC,Total,781.9186,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2451626691249012e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2017,OTC,Total,769.4276,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2396239398294808e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2018,OTC,Total,679.2178,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9307590298547475e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2019,OTC,Total,681.5715,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9688700787875991e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxytetracycline,2016,Prescription,Total,109669.75,OWFJMIVZYSDULZ-PXOLEDIWSA-N,3.14900334423891e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2017,Prescription,Total,91133.35,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.6526788534341512e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2018,Prescription,Total,99164,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.8188570505148153e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2019,Prescription,Total,78970.65,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.2812419516867697e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
palbociclib,2016,Prescription,Total,92.4,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.6531282236685623e-11,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2017,Prescription,Total,6135.15,AHJRHEGDXFFMBM-UHFFFAOYSA-N,1.7857987956819902e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2018,Prescription,Total,7519.575,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.137530455167696e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2019,Prescription,Total,7089.6,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.0479878208775703e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palifermin,2016,Prescription,Total,0.075,NA,2.1535131685621443e-14,antineoplastic,"treatment for chemotherapy-caused mouth sores, ulcers",NA,NA,NA,NA
paliperidone,2016,Prescription,Total,1382.118,PMXMIIMHBWHSKN-UHFFFAOYSA-N,3.9685457513423646e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.5874183005369458e-6
paliperidone,2017,Prescription,Total,1423.691,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.1440318056172836e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.6576127222469135e-6
paliperidone,2018,Prescription,Total,1506.598,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.2826876634580284e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.7130750653832113e-6
paliperidone,2019,Prescription,Total,1561.067,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.5094874232310496e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.8037949692924198e-6
pamidronic acid,2016,Prescription,Total,105.6,WRUUGTRCQOWXEG-UHFFFAOYSA-N,3.032146541335499e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2017,Prescription,Total,41.43000000000001,WRUUGTRCQOWXEG-UHFFFAOYSA-N,1.2059304842604478e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2018,Prescription,Total,26.639999999999997,WRUUGTRCQOWXEG-UHFFFAOYSA-N,7.572743316699072e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2019,Prescription,Total,14.25,WRUUGTRCQOWXEG-UHFFFAOYSA-N,4.116427788239868e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
panobinostat,2016,Prescription,Total,8.55,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.455005012160845e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2017,Prescription,Total,9.81,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.8554617549106904e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2018,Prescription,Total,4.05,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.151261652876548e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2019,Prescription,Total,4.23,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.2219290908248873e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
pantoprazole,2016,OTC,Total,25919.18,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.442306059777676e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,2.8624254076067986e-4
pantoprazole,2016,Prescription,Total,1800959.7952,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.171187513352244e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.01988918274366248
pantoprazole,2017,OTC,Total,26950.56,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.844678221552075e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,3.017183931366183e-4
pantoprazole,2017,Prescription,Total,1948644.096,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.672047594353227e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.021815567670589335
pantoprazole,2018,OTC,Total,26676.44,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.583101828953595e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,2.9165776265206137e-4
pantoprazole,2018,Prescription,Total,2128075.5328,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.049312976141899e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.023266588369776537
pantoprazole,2019,OTC,Total,25204.34,IQPSEEYGBUAQFF-UHFFFAOYSA-N,7.280831267385658e-9,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,2.800319718225253e-4
pantoprazole,2019,Prescription,Total,2337829.9232,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.753338989501163e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.025974380728850627
papaverine,2016,Prescription,Total,90,XQYZDYMELSJDRZ-UHFFFAOYSA-N,2.5842158022745735e-11,vasodilator,"peripheral vasodilator for chest pain, circulation issues, heart attacks, etc.",low,NA,NA,NA
paracetamol,2016,OTC,Total,88627560.68,RZVAJINKPMORJF-UHFFFAOYSA-N,2.5448082536256073e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.7660959278539208
paracetamol,2016,Prescription,Total,170332790.485,RZVAJINKPMORJF-UHFFFAOYSA-N,4.890852097965124e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,5.3161435847447
paracetamol,2017,OTC,Total,87693173.74,RZVAJINKPMORJF-UHFFFAOYSA-N,2.5525433616851017e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.7745036540055454
paracetamol,2017,Prescription,Total,180694158.55,RZVAJINKPMORJF-UHFFFAOYSA-N,5.259584700053961e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,5.716939891363001
paracetamol,2018,OTC,Total,88368184.41,RZVAJINKPMORJF-UHFFFAOYSA-N,2.5119728900137335e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.730405315232319
paracetamol,2018,Prescription,Total,190993515.55,RZVAJINKPMORJF-UHFFFAOYSA-N,5.4292224790319925e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,5.901328781556513
paracetamol,2019,OTC,Total,90825833.23,RZVAJINKPMORJF-UHFFFAOYSA-N,2.6237051494597333e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,2.8518534233257973
paracetamol,2019,Prescription,Total,205670085.125,RZVAJINKPMORJF-UHFFFAOYSA-N,5.941235463987432e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,6.4578646347689475
parecoxib,2016,Prescription,Total,511.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.4689831160485242e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2017,Prescription,Total,679.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.9781567876017383e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2018,Prescription,Total,777.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.2104223735229722e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2019,Prescription,Total,964.8,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.7870382667325083e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
paritaprevir,2016,Prescription,Total,3851.4,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.1058720823200323e-9,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2017,Prescription,Total,949.2,UAUIUKWPKRJZJV-QPLHLKROSA-N,2.7628993860970716e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2018,Prescription,Total,483,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.3729861193564758e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2019,Prescription,Total,21,UAUIUKWPKRJZJV-QPLHLKROSA-N,6.066314635300858e-12,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paroxetine,2016,Prescription,Total,96786.6296,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.7790837517912887e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19850598227080632
paroxetine,2017,Prescription,Total,92756.0448,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.6999117070660822e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19285083621900587
paroxetine,2018,Prescription,Total,89049.5236,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.531340783397659e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.18081005595697563
paroxetine,2019,Prescription,Total,86480.4608,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.4981794524695342e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.17844138946210958
pazopanib,2016,Prescription,Total,22512,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.463985126756133e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.0399907042225835e-4
pazopanib,2017,Prescription,Total,22806,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.638293657746504e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.148933536091565e-4
pazopanib,2018,Prescription,Total,16614,CUIHSIWYWATEQL-UHFFFAOYSA-N,4.7227311360224615e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,2.9517069600140384e-4
pazopanib,2019,Prescription,Total,20970,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.057648471536143e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,3.7860302947100895e-4
pemetrexed,2016,Prescription,Total,1646.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,4.726530702360195e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,3.938775585300162e-6
pemetrexed,2017,Prescription,Total,1209.8,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.5214450877583614e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.934537573131968e-6
pemetrexed,2018,Prescription,Total,1256.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.570616696736375e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.975513913946979e-6
pemetrexed,2019,Prescription,Total,2052.4,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,5.928811503567371e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,4.9406762529728095e-6
penciclovir,2016,OTC,Total,602.44,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.7298166310247712e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2017,OTC,Total,481.24,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.4007771813794298e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2018,OTC,Total,379.14,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0777514643743568e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2019,OTC,Total,373.28,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0783018700310018e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
pentobarbital,2016,Prescription,Total,243500,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,6.99173942059843e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2017,Prescription,Total,254220,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.39975012572269e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2018,Prescription,Total,286010,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,8.130181366400533e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2019,Prescription,Total,260620,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.528585334533856e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentoxifylline,2016,Prescription,Total,149479.2,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4.2920723416817944e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2017,Prescription,Total,134452.4,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.9135951687660967e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2018,Prescription,Total,121401.6,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.450987819206359e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2019,Prescription,Total,116492,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.3651291642641314e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
perampanel,2016,Prescription,Total,565.26064,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.6230616425464876e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2017,Prescription,Total,644.51352,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.8760282435095475e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2018,Prescription,Total,695.6502,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.9774701211750648e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2019,Prescription,Total,782.96424,PRMWGUBFXWROHD-UHFFFAOYSA-N,2.2617654419186732e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
pergolide,2016,Prescription,Total,54.68,YEHCICAEULNIGD-MZMPZRCHSA-N,1.5700546674263742e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2017,Prescription,Total,63.9,YEHCICAEULNIGD-MZMPZRCHSA-N,1.859979675217055e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2018,Prescription,Total,67.22,YEHCICAEULNIGD-MZMPZRCHSA-N,1.910810081638557e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2019,Prescription,Total,87.72,YEHCICAEULNIGD-MZMPZRCHSA-N,2.5339862848028156e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
perindopril,2016,Prescription,Total,34.35,IPVQLZZIHOAWMC-QXKUPLGCSA-N,9.86309031201462e-12,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2017,Prescription,Total,51.45,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.4975892690127932e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2018,Prescription,Total,61.5,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.7482121395532767e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2019,Prescription,Total,84.75,IPVQLZZIHOAWMC-QXKUPLGCSA-N,2.4481912635321318e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perphenazine,2016,Prescription,Total,2466.96,RGCVKNLCSQQDEP-UHFFFAOYSA-N,7.08350779508809e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2017,Prescription,Total,2298.168,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.689430000366557e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2018,Prescription,Total,2226.756,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.329824180525361e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2019,Prescription,Total,2184.558,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.310579127173128e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
pethidine,2016,Prescription,Total,21194.6,XADCESSVHJOZHK-UHFFFAOYSA-N,6.0857133603209644e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2017,Prescription,Total,19139.9,XADCESSVHJOZHK-UHFFFAOYSA-N,5.571177619043336e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2018,Prescription,Total,18886.2,XADCESSVHJOZHK-UHFFFAOYSA-N,5.368631562606682e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2019,Prescription,Total,16755.7,XADCESSVHJOZHK-UHFFFAOYSA-N,4.840254673081457e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
phenazone,2016,OTC,Total,8277984,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.376899673752898e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2017,OTC,Total,7763021,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.2596340028612176e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2018,OTC,Total,7343160.5,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.0873824924858714e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2019,OTC,Total,6807970,VEQOALNAAJBPNY-UHFFFAOYSA-N,1.9666327641756753e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenobarbital,2016,Prescription,Total,95350.60499999992,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.73785044663823e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2017,Prescription,Total,93540.9,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.7227570078483733e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2018,Prescription,Total,90399.6,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.5697183435896e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2019,Prescription,Total,28882.46,DDBREPKUVSBGFI-UHFFFAOYSA-N,8.343337609594841e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenoxymethylpenicillin,2016,Prescription,Total,13360655.2,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.836312921842438e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2017,Prescription,Total,12987487.15,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.780354011133439e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2018,Prescription,Total,12311053.9,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.4995664843373515e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2019,Prescription,Total,12955160.4,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.7423847208185777e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenylbutazone,2018,Prescription,Total,736,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.0921693247336774e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylbutazone,2019,Prescription,Total,1024,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.958050565022895e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylpropanolamine,2016,Prescription,Total,231900.7625,DLNKOYKMWOXYQA-VXNVDRBHSA-N,6.658684611244698e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2017,Prescription,Total,276868.0875,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.058983027640334e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2018,Prescription,Total,262740.8425,DLNKOYKMWOXYQA-VXNVDRBHSA-N,7.468727323820415e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2019,Prescription,Total,279732.4,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.080689295656351e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenytoin,2016,Prescription,Total,34721.4,CXOFVDLJLONNDW-UHFFFAOYSA-N,9.969732284121821e-9,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2017,Prescription,Total,101386.1,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.9511124467844112e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2018,Prescription,Total,100090.875,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.8452045972928387e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2019,Prescription,Total,95765.575,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.7664005199071523e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
pibrentasvir,2017,Prescription,Total,3.36,VJYSBPDEJWLKKJ-NLIMODCCSA-N,9.78017481804273e-13,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2018,Prescription,Total,265.44,VJYSBPDEJWLKKJ-NLIMODCCSA-N,7.545454151593849e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2019,Prescription,Total,204.96,VJYSBPDEJWLKKJ-NLIMODCCSA-N,5.920723084053637e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pilocarpine,2016,Prescription,Total,4093.357,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.175346427083471e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2017,Prescription,Total,3945.289,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.1483814323720534e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2018,Prescription,Total,3294.01,QCHFTSOMWOSFHM-WPRPVWTQSA-N,9.36362320294291e-10,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2019,Prescription,Total,3521.756,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.0173371411789814e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pimecrolimus,2016,Prescription,Total,2820.3,KASDHRXLYQOAKZ-XDSKOBMDSA-N,8.098070919061089e-10,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2017,Prescription,Total,3484.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0143438454141463e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2018,Prescription,Total,3640.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0349415866155399e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2019,Prescription,Total,4461.6,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.2888318750884911e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimobendan,2016,Prescription,Total,2620.3125,GLBJJMFZWDBELO-UHFFFAOYSA-N,7.523836632663991e-10,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2017,Prescription,Total,3819.9125,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.1118872630841268e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2018,Prescription,Total,4348.78875,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.236195981317515e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2019,Prescription,Total,5381.145,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.5544627937226683e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pioglitazone,2016,Prescription,Total,13208.934,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.792748441555765e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2017,Prescription,Total,11602.8321,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.377313283404698e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2018,Prescription,Total,13893.6366,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.949434823847433e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2019,Prescription,Total,11930.8368,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.446486185296478e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
piperacillin,2016,Prescription,Total,1429560,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.104768380332933e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2017,Prescription,Total,1165680,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.393022077945254e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2018,Prescription,Total,1198320,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.406370034259322e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2019,Prescription,Total,141960,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.10082869346338e-8,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piracetam,2016,Prescription,Total,108088.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.1036087223210664e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2017,Prescription,Total,109509.6,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.187568548374798e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2018,Prescription,Total,103096.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.9306516635625412e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2019,Prescription,Total,99360,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.8702334388737772e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
pirfenidone,2016,Prescription,Total,41245.092,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1842913168074289e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.1172559592522914e-5
pirfenidone,2017,Prescription,Total,39966.696,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1633371243439557e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.0974878531546753e-5
pirfenidone,2018,Prescription,Total,47300.652,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.3445784395965037e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.2684702260344375e-5
pirfenidone,2019,Prescription,Total,60286.464,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.7415078993987538e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.6429319805648622e-5
piroxicam,2016,Prescription,Total,32908.44,QYSPLQLAKJAUJT-UHFFFAOYSA-N,9.449167852911632e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2017,Prescription,Total,28692.1,QYSPLQLAKJAUJT-UHFFFAOYSA-N,8.351599818356068e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2018,Prescription,Total,26629.96,QYSPLQLAKJAUJT-UHFFFAOYSA-N,7.569889324848484e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2019,Prescription,Total,21773.14,QYSPLQLAKJAUJT-UHFFFAOYSA-N,6.2896532304025965e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
pitolisant,2018,Prescription,Total,73.71000000000001,NNACHAUCXXVJSP-UHFFFAOYSA-N,2.0952962082353174e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pitolisant,2019,Prescription,Total,238.95,NNACHAUCXXVJSP-UHFFFAOYSA-N,6.902599438595904e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pivmecillinam,2016,Prescription,Total,1939166,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.568026022703973e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2017,Prescription,Total,1795218,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.225460082290785e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2018,Prescription,Total,1816464,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.163519375384559e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2019,Prescription,Total,1848556,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.339963008082483e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pixantrone,2018,Prescription,Total,0.928,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.637952626838116e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
pixantrone,2019,Prescription,Total,0.957,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.764506240944248e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
plerixafor,2016,Prescription,Total,1.584,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.548219812003249e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2017,Prescription,Total,1.56,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.540795451234126e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2018,Prescription,Total,1.152,YIQPUIGJQJDJOS-UHFFFAOYSA-N,3.274699812626625e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2019,Prescription,Total,1.752,YIQPUIGJQJDJOS-UHFFFAOYSA-N,5.061039638593859e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
podophyllotoxin,2016,Prescription,Total,253.79,YJGVMLPVUAXIQN-XVVDYKMHSA-N,7.287201427325156e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2017,Prescription,Total,234.99,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.840009763368636e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2018,Prescription,Total,241.1675,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.85547888074333e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2019,Prescription,Total,221.865,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.409061412195355e-11,dermatological,topical treatment for warts,low,NA,NA,NA
pomalidomide,2016,Prescription,Total,41.265,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.1848629453428919e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2017,Prescription,Total,67.977,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.9786516178752705e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2018,Prescription,Total,73.815,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.098280960668701e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2019,Prescription,Total,78.246,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.2603088331130995e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
ponatinib,2016,Prescription,Total,50.85,PHXJVRSECIGDHY-UHFFFAOYSA-N,1.460081928285134e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2017,Prescription,Total,92.25,PHXJVRSECIGDHY-UHFFFAOYSA-N,2.6851819254894103e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2018,Prescription,Total,119.7,PHXJVRSECIGDHY-UHFFFAOYSA-N,3.402617774057353e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2019,Prescription,Total,145.35,PHXJVRSECIGDHY-UHFFFAOYSA-N,4.198756344004665e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
posaconazole,2016,Prescription,Total,4580.1,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.3151074217775304e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.207579077506172e-4
posaconazole,2017,Prescription,Total,4315.2,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2560538802029162e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.0635460492754057e-4
posaconazole,2018,Prescription,Total,4299.6,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2222134821501252e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,2.981008493049086e-4
posaconazole,2019,Prescription,Total,5096.7,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.472294561987518e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.59096234631102e-4
potassium permanganate,2016,OTC,Total,125805,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.6123029889461414e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2017,OTC,Total,123675,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.5998902399447475e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2018,OTC,Total,113475,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.2256645940781804e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2019,OTC,Total,109695,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.1687827805682274e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
pradofloxacin,2016,Prescription,Total,173.46,LZLXHGFNOWILIY-APPDUMDISA-N,4.980645256250528e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2017,Prescription,Total,141.09,LZLXHGFNOWILIY-APPDUMDISA-N,4.1068001936834786e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2018,Prescription,Total,134.535,LZLXHGFNOWILIY-APPDUMDISA-N,3.8243206535739845e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pramipexole,2016,Prescription,Total,1579.1929008,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.5344169434302027e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.477738490614576e-6
pramipexole,2017,Prescription,Total,1642.4982564,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.780928597000707e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.8298979957152965e-6
pramipexole,2018,Prescription,Total,1668.3206548,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.742403937217611e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.774862767453731e-6
pramipexole,2019,Prescription,Total,1717.1190604,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.960278326980276e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,7.086111895686109e-6
prasterone,2019,Prescription,Total,206.388,FMGSKLZLMKYGDP-USOAJAOKSA-N,5.961974023573682e-11,sex hormone,androgen and estrogen for various gynaecological disorders and applications,NA,NA,NA,NA
prasugrel,2016,Prescription,Total,3764.3088,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.080865142844582e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.688763909708326e-5
prasugrel,2017,Prescription,Total,3945.018,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1483025506049195e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,6.043697634762734e-5
prasugrel,2018,Prescription,Total,3797.7856,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.0795666486732724e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.681929729859328e-5
prasugrel,2019,Prescription,Total,3890.2712,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1237909102785442e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.9146890014660216e-5
pravastatin,2016,Prescription,Total,178725.6696,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.131841107249159e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2017,Prescription,Total,172430.986,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.01906305692702e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2018,Prescription,Total,167017.8404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.74768481478458e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2019,Prescription,Total,160755.9404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.6437910188574885e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
praziquantel,2016,Prescription,Total,38681.070297,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.1106692567822336e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2017,Prescription,Total,42742.837181,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2441441066943952e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2018,Prescription,Total,44943.927322,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2775856803824488e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2019,Prescription,Total,45877.980674,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.3252869790511244e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
prednisone,2016,Prescription,Total,409.723,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1764585012837168e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2017,Prescription,Total,378.1,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1005607436612966e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2018,Prescription,Total,3.58,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.017658448715566e-12,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
pregabalin,2016,Prescription,Total,1791066.915,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.1427815829713e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2017,Prescription,Total,1945696.37,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.663467452806891e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2018,Prescription,Total,1993165.606,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.66581513585246e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2019,Prescription,Total,1993225.119,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.757871767066187e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
prilocaine,2016,Prescription,Total,14261.4,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.094948360284289e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2017,Prescription,Total,14974.2,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.358639695248079e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2018,Prescription,Total,15573.6,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.426984809194619e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2019,Prescription,Total,15255,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.4067442743578375e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
probenecid,2016,Prescription,Total,389706,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1189826704902389e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2017,Prescription,Total,389573.5,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1339574209752294e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2018,Prescription,Total,368371,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.047139274893301e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2019,Prescription,Total,363917.75,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.0512569394622663e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
procaine,2016,Prescription,Total,1895397.839720175,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.442352276668849e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2017,Prescription,Total,1880531.9541237105,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.473789066144465e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2018,Prescription,Total,1809090.6423749097,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.142559711466751e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2019,Prescription,Total,1847522.5354660428,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.336977617117049e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
prochlorperazine,2016,Prescription,Total,9142.84000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.625230178407565e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2017,Prescription,Total,8558.645,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.4912215567133136e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2018,Prescription,Total,8061.03000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.291445610293198e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2019,Prescription,Total,7872.605,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.2741761394972713e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
progesterone,2016,Prescription,Total,64790.45,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.8603611636275623e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2017,Prescription,Total,67266.2,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.9579618909090063e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2018,Prescription,Total,69560.4,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.9773387920679963e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2019,Prescription,Total,88798.8,RJKFOVLPORLFTN-LEKSSAKUSA-N,2.5651498097007324e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
proguanil,2016,Prescription,Total,92181.6,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.6468571933217093e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005293714386643418
proguanil,2017,Prescription,Total,97745.7,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.845148909857022e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005690297819714044
proguanil,2018,Prescription,Total,96136.5,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.7327966886855868e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005465593377371173
proguanil,2019,Prescription,Total,97569,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.8184964411984258e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005636992882396851
promethazine,2016,Prescription,Total,59833.65,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.7180340426418446e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2017,Prescription,Total,56488.675,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.6442533236297622e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2018,Prescription,Total,54111.375,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.5381815067141412e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2019,Prescription,Total,54277.4,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.567922790409899e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
propentofylline,2016,Prescription,Total,22908,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.577690622056214e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2017,Prescription,Total,23214,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.757052923394166e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2018,Prescription,Total,23299,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.6230235186100484e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2019,Prescription,Total,23473,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.780695401638906e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propofol,2016,Prescription,Total,289961.1,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.325800629610196e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2017,Prescription,Total,307809,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.959600686211058e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2018,Prescription,Total,305307,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.678722011229142e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2019,Prescription,Total,332157,OLBCVFGFOZPWHH-UHFFFAOYSA-N,9.595089858655366e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propranolol,2016,Prescription,Total,80145.38,AQHHHDLHHXJYJD-UHFFFAOYSA-N,2.3012550830588952e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.10005456882864762
propranolol,2017,Prescription,Total,144543.47999999998,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4.2073229262150694e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.1829270837484813
propranolol,2018,Prescription,Total,206155.41,AQHHHDLHHXJYJD-UHFFFAOYSA-N,5.8602177300257395e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.25479207521851044
propranolol,2019,Prescription,Total,226062.42,AQHHHDLHHXJYJD-UHFFFAOYSA-N,6.530313175892996e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.2839266598214346
propylthiouracil,2016,Prescription,Total,22577.6,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482821188603823e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2017,Prescription,Total,19912.7,KNAHARQHSZJURB-UHFFFAOYSA-N,5.796121639858319e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2018,Prescription,Total,21872.3,KNAHARQHSZJURB-UHFFFAOYSA-N,6.217466728447339e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2019,Prescription,Total,22440,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482290496007202e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
proxymetacaine,2016,Prescription,Total,394.275,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.1321018727131192e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2017,Prescription,Total,376.725,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.096558439978318e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2018,Prescription,Total,375.45,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.0672621915370369e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2019,Prescription,Total,334.35,KCLANYCVBBTKTO-UHFFFAOYSA-N,9.658439515775437e-11,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
prucalopride,2016,Prescription,Total,121.4864,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.4883008293494413e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2017,Prescription,Total,136.16176,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.9633506438463625e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2018,Prescription,Total,146.34536,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.1600444702324305e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2019,Prescription,Total,171.09511999999998,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.9424610975455065e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
pyrantel,2016,Prescription,Total,12345.304542809828,YSAUAVHXTIETRK-AATRIKPKSA-N,3.544770120380137e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2017,Prescription,Total,16631.893990675977,YSAUAVHXTIETRK-AATRIKPKSA-N,4.8411556780942094e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2018,Prescription,Total,32461.605806916097,YSAUAVHXTIETRK-AATRIKPKSA-N,9.227605421307946e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2019,Prescription,Total,23870.71177254078,YSAUAVHXTIETRK-AATRIKPKSA-N,6.895583246705363e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrazinamide,2016,Prescription,Total,15432,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.431068695633469e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2017,Prescription,Total,16368,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.764342304217959e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2018,Prescription,Total,14496,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.120663930888504e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2019,Prescription,Total,12624,IPEHBUMCGVEMRF-UHFFFAOYSA-N,3.646721712192287e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyridostigmine,2016,Prescription,Total,39028.42,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.1206428855756556e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2017,Prescription,Total,43240.814999999995,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2586390773054892e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2018,Prescription,Total,43505.77,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2367043130831344e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2019,Prescription,Total,46642.03,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.347358234329246e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyrvinium,2016,OTC,Total,1437.2,QMHSXPLYMTVAMK-UHFFFAOYSA-N,4.126705501143352e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2017,OTC,Total,2412.8,QMHSXPLYMTVAMK-UHFFFAOYSA-N,7.023096964575448e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2018,OTC,Total,1334,QMHSXPLYMTVAMK-UHFFFAOYSA-N,3.792056901079791e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2019,OTC,Total,2815.6,QMHSXPLYMTVAMK-UHFFFAOYSA-N,8.133483565310996e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
quetiapine,2016,Prescription,Total,2024105.925,URKOMYMAXPYINW-UHFFFAOYSA-N,5.811918352069548e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.058119183520695485
quetiapine,2017,Prescription,Total,2167664.5,URKOMYMAXPYINW-UHFFFAOYSA-N,6.30956480859083e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06309564808590831
quetiapine,2018,Prescription,Total,2235867.525,URKOMYMAXPYINW-UHFFFAOYSA-N,6.355724796159251e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06355724796159251
quetiapine,2019,Prescription,Total,2349528.8000000003,URKOMYMAXPYINW-UHFFFAOYSA-N,6.78713378357184e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06787133783571841
quinagolide,2016,Prescription,Total,4.388625,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.260128230584139e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2017,Prescription,Total,3.9095775,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.1379866492466208e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2018,Prescription,Total,3.453975,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,9.818343129615491e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2019,Prescription,Total,3.0753,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,8.883684475209872e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinine,2016,Prescription,Total,8640.39999999999,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.480962024219244e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2017,Prescription,Total,7407.3,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.1560919324311883e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2018,Prescription,Total,7110.7,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.021302774101054e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2019,Prescription,Total,5907.6,LOUPRKONTZGTKE-WZBLMQSHSA-N,1.7065409685477783e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
raloxifene,2016,Prescription,Total,5740.56,GZUITABIAKMVPG-UHFFFAOYSA-N,1.648316207322814e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2017,Prescription,Total,4662,GZUITABIAKMVPG-UHFFFAOYSA-N,1.356999256003429e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2018,Prescription,Total,4193.28,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1919907317960915e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2019,Prescription,Total,3911.04,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1297904376784318e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raltegravir,2016,Prescription,Total,82722,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.3752388843973032e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,6.250628643150798e-5
raltegravir,2017,Prescription,Total,66102,CZFFBEXEKNGXKS-UHFFFAOYSA-N,1.9240747494710138e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.0633546038710884e-5
raltegravir,2018,Prescription,Total,77430,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.201041723018052e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.7922150605738206e-5
raltegravir,2019,Prescription,Total,132873,CZFFBEXEKNGXKS-UHFFFAOYSA-N,3.8383305930301476e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,1.0100869981658282e-4
raltitrexed,2016,Prescription,Total,0.08,IVTVGDXNLFLDRM-HNNXBMFYSA-N,2.2970807131329543e-14,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2017,Prescription,Total,0.012,IVTVGDXNLFLDRM-HNNXBMFYSA-N,3.4929195778724047e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2018,Prescription,Total,0.006,IVTVGDXNLFLDRM-HNNXBMFYSA-N,1.7055728190763676e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
ramipril,2016,Prescription,Total,138640.30915,HDACQVRGBOVJII-JBDAPHQKSA-N,3.98084975264069e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,3.9808497526406904e-4
ramipril,2017,Prescription,Total,140762.69305,HDACQVRGBOVJII-JBDAPHQKSA-N,4.097273053236573e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0972730532365734e-4
ramipril,2018,Prescription,Total,143805.1765,HDACQVRGBOVJII-JBDAPHQKSA-N,4.0878366713479934e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0878366713479935e-4
ramipril,2019,Prescription,Total,146951.5148,HDACQVRGBOVJII-JBDAPHQKSA-N,4.245019642432717e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.2450196424327174e-4
ranitidine,2016,OTC,Total,32202.9,VMXUWOKSQNHOCA-UKTHLTGXSA-N,9.246582562118653e-9,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.0014913842842126858
ranitidine,2016,Prescription,Total,1030498.385,VMXUWOKSQNHOCA-UKTHLTGXSA-N,2.958922456372697e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.04772455574794673
ranitidine,2017,Prescription,Total,1466133.64,VMXUWOKSQNHOCA-UKTHLTGXSA-N,4.267572412444443e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.06883181310394262
ranitidine,2018,OTC,Total,13401.75,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.809610088009452e-9,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,6.144532400015245e-4
ranitidine,2018,Prescription,Total,1779118.775,VMXUWOKSQNHOCA-UKTHLTGXSA-N,5.057361040914072e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.08157033936958182
ranitidine,2019,OTC,Total,18132,VMXUWOKSQNHOCA-UKTHLTGXSA-N,5.2378293793940555e-9,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,8.448111902248477e-4
ranitidine,2019,Prescription,Total,1216805.17,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.515010957657499e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.05669372512350805
rasagiline,2016,Prescription,Total,654.68592,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8798329999896302e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2017,Prescription,Total,657.60604,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.9141375097026192e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2018,Prescription,Total,636.54976,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8094699477426418e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2019,Prescription,Total,603.1502399999999,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.7423329181891542e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
reboxetine,2016,Prescription,Total,458.3568,CBQGYUDMJHNJBX-RTBURBONSA-N,1.3161032062666736e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2017,Prescription,Total,415.8912,CBQGYUDMJHNJBX-RTBURBONSA-N,1.2105620956207064e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2018,Prescription,Total,400.032,CBQGYUDMJHNJBX-RTBURBONSA-N,1.1371395099345956e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2019,Prescription,Total,366.5136,CBQGYUDMJHNJBX-RTBURBONSA-N,1.0587556265318115e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
regorafenib,2016,Prescription,Total,594.72,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.7076498021430383e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2017,Prescription,Total,769.4399999999999,FNHKPVJBJVTLMP-UHFFFAOYSA-N,2.239660033331785e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2018,Prescription,Total,584.64,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.6619101549080123e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2019,Prescription,Total,665.28,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.9218084764633115e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
remifentanil,2016,Prescription,Total,427.1749999999999,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2265693170407118e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2017,Prescription,Total,393.86,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.1464344207840208e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2018,Prescription,Total,452.21,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2854618075242068e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2019,Prescription,Total,475.56,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.373760279982703e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
repaglinide,2016,Prescription,Total,223.8552,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.427668280681501e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2017,Prescription,Total,209.0634,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.085347023971414e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2018,Prescription,Total,175.029,FAEKWTJYAYMJKF-QHCPKHFHSA-N,4.975411749168626e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2019,Prescription,Total,132.615,FAEKWTJYAYMJKF-QHCPKHFHSA-N,3.8308776921924916e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
retapamulin,2016,Prescription,Total,115.25,STZYTFJPGGDRJD-FJJJPKKESA-N,3.3092319023571617e-11,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retapamulin,2017,Prescription,Total,29.7,STZYTFJPGGDRJD-FJJJPKKESA-N,8.644975955234199e-12,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retigabine,2016,Prescription,Total,583.254,PCOBBVZJEWWZFR-UHFFFAOYSA-N,1.6747268928220602e-10,anticonvulsant,potassium channel opener for partial epilepsies,low,high,3.2e-6,5.2335215400689384e-5
ribavirin,2016,Prescription,Total,70760.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,2.0317908615732298e-8,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.002944624437062652
ribavirin,2017,Prescription,Total,31796.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,9.255305436141105e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.0013413486139334935
ribavirin,2018,Prescription,Total,6628.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,1.884316850515571e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,2.730893986254451e-4
ribavirin,2019,Prescription,Total,2826.4,IWUCXVSUMQZMFG-AFCXAGJDSA-N,8.164681754863973e-10,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,1.1832872108498512e-4
ribociclib,2018,Prescription,Total,7593.6,RHXHGRAEPCAFML-UHFFFAOYSA-N,2.1585729598230502e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
ribociclib,2019,Prescription,Total,20668.2,RHXHGRAEPCAFML-UHFFFAOYSA-N,5.970466864063105e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
rifampicin,2016,Prescription,Total,55719,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5998880031881885e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2017,Prescription,Total,54300,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.580546108987263e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2018,Prescription,Total,53874,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5314338342486704e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2019,Prescription,Total,51981,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5015861955122566e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifaximin,2016,Prescription,Total,48192.144,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.3837655563365753e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2017,Prescription,Total,66513.524,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.9360532514407172e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2018,Prescription,Total,87425.492,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.4851757141596402e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2019,Prescription,Total,102902.184,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.972557260969627e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rilpivirine,2016,Prescription,Total,5196,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.4919539231798536e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,7.459769615899268e-4
rilpivirine,2017,Prescription,Total,6089.25,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.772438378296628e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.86219189148314e-4
rilpivirine,2018,Prescription,Total,6192.75,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7603643458891961e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.801821729445981e-4
rilpivirine,2019,Prescription,Total,5976,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7262998219313296e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.631499109656648e-4
riluzole,2016,Prescription,Total,8909.74,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.5582989891286512e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2017,Prescription,Total,9853.592,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.868150367430575e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2018,Prescription,Total,9749.6,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.771442126144492e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2019,Prescription,Total,9594.872,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.7716910684494483e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
rimexolone,2016,Prescription,Total,231.15,QTTRZHGPGKRAFB-OOKHYKNYSA-N,6.63712758550853e-11,steroid,ophthalmic steroid for eye swelling,low,NA,NA,NA
riociguat,2016,Prescription,Total,32.361,WXXSNCNJFUAIDG-UHFFFAOYSA-N,9.29197861971194e-12,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,3.0973262065706466e-5
riociguat,2017,Prescription,Total,41.349,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.203572763545384e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.011909211817947e-5
riociguat,2018,Prescription,Total,52.395,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.489391464258438e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.964638214194793e-5
riociguat,2019,Prescription,Total,58.695,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.69553494056659e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,5.6517831352219665e-5
risedronic acid,2016,Prescription,Total,490.4844,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.4083528191657364e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2017,Prescription,Total,432.6042000000001,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.2592097330415243e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2018,Prescription,Total,402.9018,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.1452972647282379e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2019,Prescription,Total,369.0666,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.0661305318955846e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risperidone,2016,Prescription,Total,5740.854,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.6484006250390214e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.8420700431707266e-4
risperidone,2017,Prescription,Total,5595.1026,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.628603617645399e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.807937271802412e-4
risperidone,2018,Prescription,Total,5455.5387,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5508030866898703e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.673798425327362e-4
risperidone,2019,Prescription,Total,5474.955199999999,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5815619455893587e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.726830940671308e-4
ritonavir,2016,Prescription,Total,28187.6,NCDNCNXCDXHOMX-XGKFQTDJSA-N,8.093649038688306e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.005395766025792204
ritonavir,2017,Prescription,Total,17255.8,NCDNCNXCDXHOMX-XGKFQTDJSA-N,5.022760137654219e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0033485067584361457
ritonavir,2018,Prescription,Total,11269.3,NCDNCNXCDXHOMX-XGKFQTDJSA-N,3.203435295002884e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0021356235300019227
ritonavir,2019,Prescription,Total,8426,NCDNCNXCDXHOMX-XGKFQTDJSA-N,2.4340365293830966e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0016226910195887311
rivaroxaban,2016,Prescription,Total,169070.3082,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,4.854601801620805e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.005644885815838145
rivaroxaban,2017,Prescription,Total,184161.8191,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.3605201952582177e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006233163017742113
rivaroxaban,2018,Prescription,Total,194185.2613,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.5199517256420345e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006418548518188412
rivaroxaban,2019,Prescription,Total,197577.293,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.7074572577572665e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.0066365782066944955
rivastigmine,2016,Prescription,Total,14043.4674,XSVMFMHYUFZWBK-NSHDSACASA-N,4.032372263756424e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.064744527512848e-5
rivastigmine,2017,Prescription,Total,14294.810880000001,XSVMFMHYUFZWBK-NSHDSACASA-N,4.160885398727954e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.321770797455908e-5
rivastigmine,2018,Prescription,Total,13959.97764,XSVMFMHYUFZWBK-NSHDSACASA-N,3.968293069616309e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.936586139232617e-5
rivastigmine,2019,Prescription,Total,13529.56272,XSVMFMHYUFZWBK-NSHDSACASA-N,3.908313539883661e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.816627079767322e-5
rizatriptan,2016,Prescription,Total,13631.64,ULFRLSNUDGIQQP-UHFFFAOYSA-N,3.914122166546462e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.077210590152564e-6
rizatriptan,2017,Prescription,Total,14095.38,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.102835729962594e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.273787218711035e-6
rizatriptan,2018,Prescription,Total,14536.35,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.132133908096793e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.304306154267493e-6
rizatriptan,2019,Prescription,Total,15653.52,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.521865593808318e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.710276660216998e-6
robenacoxib,2016,Prescription,Total,20767.56,ZEXGDYFACFXQPF-UHFFFAOYSA-N,5.963095191853927e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2017,Prescription,Total,26627.086,ZEXGDYFACFXQPF-UHFFFAOYSA-N,7.750522499257684e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2018,Prescription,Total,31275.343,ZEXGDYFACFXQPF-UHFFFAOYSA-N,8.890395821348391e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2019,Prescription,Total,38554.181,ZEXGDYFACFXQPF-UHFFFAOYSA-N,1.1137228212016108e-8,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
rocuronium bromide,2016,Prescription,Total,4201,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.2062545094839426e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2017,Prescription,Total,5250.5,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.5282978536349215e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2018,Prescription,Total,5285,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.502325391469767e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2019,Prescription,Total,6153,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.7774301881431511e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
roflumilast,2016,Prescription,Total,136.6287,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.923089395380356e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.670344518309948e-4
roflumilast,2017,Prescription,Total,141.20925,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.1102712825139894e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.89318009823094e-4
roflumilast,2018,Prescription,Total,145.1148,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.125064308761721e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.910790843763954e-4
roflumilast,2019,Prescription,Total,136.0363,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.929709512486563e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.678225610103051e-4
romifidine,2016,Prescription,Total,74.6,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.1420277649964795e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2017,Prescription,Total,76.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.223825464578764e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2018,Prescription,Total,49.2,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.3985697116426216e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2019,Prescription,Total,51.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.4848027250212575e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
ropinirole,2016,Prescription,Total,6947.193105,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9947829114882182e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.116848299200341e-5
ropinirole,2017,Prescription,Total,6837.88758,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9903492832893796e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.1099207551396556e-5
ropinirole,2018,Prescription,Total,6481.99653,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.8425861824858886e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.879040910134201e-5
ropinirole,2019,Prescription,Total,6159.6087,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.7793392573588803e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.7802175896232505e-5
ropivacaine,2016,Prescription,Total,15131.475,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.344777422969184e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2017,Prescription,Total,16307,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.746586629697108e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2018,Prescription,Total,16020.725,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.554085516982873e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2019,Prescription,Total,15631.05,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.515374637148546e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
rosuvastatin,2016,Prescription,Total,102287.8436,BPRHUIZQVSMCRT-VEUZHWNKSA-N,2.9370429090190012e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.01631690505010556
rosuvastatin,2017,Prescription,Total,119689.1873,BPRHUIZQVSMCRT-VEUZHWNKSA-N,3.483872546498393e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.019354847480546628
rosuvastatin,2018,Prescription,Total,142017.5348,BPRHUIZQVSMCRT-VEUZHWNKSA-N,4.037020786451869e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.02242789325806594
rosuvastatin,2019,Prescription,Total,173128.051,BPRHUIZQVSMCRT-VEUZHWNKSA-N,5.0011868074400643e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.027784371152444802
rotigotine,2016,Prescription,Total,966.602,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.775453514344674e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002643289061280642
rotigotine,2017,Prescription,Total,936.432,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.725734721788509e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025959378302747704
rotigotine,2018,Prescription,Total,950.628,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.702275463088215e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025735956791316334
rotigotine,2019,Prescription,Total,893.172,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.5801249406861605e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002457261848272534
rufinamide,2016,Prescription,Total,43827.4,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.2584384405845405e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2017,Prescription,Total,38479.56,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1200500705992988e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2018,Prescription,Total,39283.96,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1166942400280545e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2019,Prescription,Total,38156,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1022204820216169e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rupatadine,2016,Prescription,Total,270.68,WUZYKBABMWJHDL-UHFFFAOYSA-N,7.772172592885349e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
rupatadine,2017,Prescription,Total,170.66,WUZYKBABMWJHDL-UHFFFAOYSA-N,4.9675137929975375e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ruxolitinib,2016,Prescription,Total,1009.96,HFNKQEVNSGCOJV-OAHLLOKOSA-N,2.8999495462946977e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2017,Prescription,Total,1403.92,HFNKQEVNSGCOJV-OAHLLOKOSA-N,4.0864830448055216e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2018,Prescription,Total,1772.68,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.039058041533826e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2019,Prescription,Total,2014.04,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.818000156229208e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
sacubitril,2016,Prescription,Total,10512.61008,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.018539232431885e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2017,Prescription,Total,33489.81272,PYNXFZCZUAOOQC-UTKZUKDTSA-N,9.748101875747356e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2018,Prescription,Total,67862.4016,PYNXFZCZUAOOQC-UTKZUKDTSA-N,1.9290711267700764e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2019,Prescription,Total,117765.8384,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.4019268048780754e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
safinamide,2016,Prescription,Total,77,NEMGRZFTLSKBAP-LBPRGKRZSA-N,2.2109401863904684e-11,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2017,Prescription,Total,1774.1,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.16399051925286e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2018,Prescription,Total,2206,NEMGRZFTLSKBAP-LBPRGKRZSA-N,6.270822731470778e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2019,Prescription,Total,1818.5,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.253139602045053e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
salbutamol,2016,Prescription,Total,44240.736,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.2703067675050846e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2017,Prescription,Total,45049.084,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.311273562240154e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2018,Prescription,Total,40589.565,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.1538076467022245e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2019,Prescription,Total,45475.561,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.3136621963943664e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salicylic acid,2016,OTC,Total,6766,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.942756013132196e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.942756013132196e-5
salicylic acid,2016,Prescription,Total,132.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3.804539931126455e-11,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,3.8045399311264546e-7
salicylic acid,2017,OTC,Total,6086,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.7714923792442875e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.7714923792442875e-5
salicylic acid,2017,Prescription,Total,2015,YGSDEFSMJLZEOE-UHFFFAOYSA-N,5.865194124510744e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,5.8651941245107436e-6
salicylic acid,2018,OTC,Total,6414,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.823257343592637e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.823257343592637e-5
salicylic acid,2018,Prescription,Total,2337.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,6.644627440985016e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,6.644627440985016e-6
salicylic acid,2019,OTC,Total,2382,YGSDEFSMJLZEOE-UHFFFAOYSA-N,6.880934029184116e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,6.8809340291841155e-6
salicylic acid,2019,Prescription,Total,3395,YGSDEFSMJLZEOE-UHFFFAOYSA-N,9.80720866040305e-10,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,9.8072086604030508e-06
salmeterol,2016,Prescription,Total,2013.138,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.780425590843811e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.627466177656278e-5
salmeterol,2017,Prescription,Total,1872.411,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.450150866436371e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.477341302925623e-5
salmeterol,2018,Prescription,Total,1761.201,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.006427590883529e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.2756489049470588e-5
salmeterol,2019,Prescription,Total,1623.759,GIIZNNXWQWCKIB-UHFFFAOYSA-N,4.690587136143565e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.1320850618834385e-5
sapropterin,2016,Prescription,Total,7272,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.088046368237855e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2017,Prescription,Total,10284,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.99343207823665e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2018,Prescription,Total,10692,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.039330763594087e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2019,Prescription,Total,12744,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.6813863672511494e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
saquinavir,2016,Prescription,Total,1860,QWAXKHKRTORLEM-UGJKXSETSA-N,5.340712658034117e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
saquinavir,2017,Prescription,Total,720,QWAXKHKRTORLEM-UGJKXSETSA-N,2.0957517467234422e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
sarolaner,2017,Prescription,Total,21.2325,FLEFKKUZMDEUIP-QFIPXVFZSA-N,6.180284578097985e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2018,Prescription,Total,339.66749999999996,FLEFKKUZMDEUIP-QFIPXVFZSA-N,9.6554609253937e-11,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2019,Prescription,Total,28.5,FLEFKKUZMDEUIP-QFIPXVFZSA-N,8.232855576479736e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
saxagliptin,2016,Prescription,Total,2371.77395,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.810195245570204e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.168626574284425e-7
saxagliptin,2017,Prescription,Total,2300.15765,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.695221406564984e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.04760148059472e-7
saxagliptin,2018,Prescription,Total,2266.2689,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.442144394263496e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.781204625540522e-7
saxagliptin,2019,Prescription,Total,2118.3939,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.119449485191458e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.441525773885745e-7
scopolamine,2016,Prescription,Total,44.57,STECJAGHUSJQJN-USLFZFAMSA-N,1.279761092304197e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2017,Prescription,Total,49.73,STECJAGHUSJQJN-USLFZFAMSA-N,1.4475240883966219e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2018,Prescription,Total,44.759,STECJAGHUSJQJN-USLFZFAMSA-N,1.272328896817319e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2019,Prescription,Total,46.662,STECJAGHUSJQJN-USLFZFAMSA-N,1.3479351119638504e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
selamectin,2016,Prescription,Total,3724.74,AFJYYKSVHJGXSN-XHKIUTQPSA-N,1.0695035519293551e-9,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2017,Prescription,Total,3312.63,AFJYYKSVHJGXSN-XHKIUTQPSA-N,9.642291817706216e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2018,Prescription,Total,3004.11,AFJYYKSVHJGXSN-XHKIUTQPSA-N,8.53954726919251e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2019,Prescription,Total,2728.845,AFJYYKSVHJGXSN-XHKIUTQPSA-N,7.882872552841698e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selegiline,2016,Prescription,Total,8055.545,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3130296316593256e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2017,Prescription,Total,8197.21,MEZLKOACVSPNER-GFCCVEGCSA-N,2.386016274410954e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2018,Prescription,Total,8213.96,MEZLKOACVSPNER-GFCCVEGCSA-N,2.334917818830086e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2019,Prescription,Total,8113.04,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3436311089895843e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
sertindole,2016,Prescription,Total,470.36672,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.3505879007645107e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2017,Prescription,Total,380.9377599999999,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.1088207998790492e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2018,Prescription,Total,370.31064,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.0526529369979566e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2019,Prescription,Total,287.06552,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,8.292522691744052e-11,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertraline,2016,Prescription,Total,714581.3295,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.051813737449193e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2017,Prescription,Total,761735.099,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.217232867041395e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2018,Prescription,Total,779108.4285,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.2147102646048393e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2019,Prescription,Total,854781.554,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.469225643340672e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sevelamer,2016,Prescription,Total,1675254.24,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,4.810242755372756e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2017,Prescription,Total,1746681.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.084180566956749e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2018,Prescription,Total,1820013.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.173608179723959e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2019,Prescription,Total,1904202.72,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.500710870912238e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sildenafil,2016,Prescription,Total,114983.038,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.3015664865904194e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2017,Prescription,Total,132569.13999999998,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.85877787106423e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2018,Prescription,Total,147312.64800000002,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.1875408055827446e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2019,OTC,Total,8860.2,BNRNXUUZRGQAQC-UHFFFAOYSA-N,2.559464806271079e-9,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2019,Prescription,Total,153678.198,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.4393347697812537e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
silver nitrate,2016,Prescription,Total,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7945943071351204e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2017,Prescription,Total,20,SQGYOTSLMSWVJD-UHFFFAOYSA-N,5.821532629787339e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2018,Prescription,Total,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7766383532045496e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2019,Prescription,Total,1,SQGYOTSLMSWVJD-UHFFFAOYSA-N,2.888721254905171e-13,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver sulfadiazine,2016,Prescription,Total,8238,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.3654188643486595e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2017,Prescription,Total,7642,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.224407617841742e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2018,Prescription,Total,7036.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.00021052357181e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2019,Prescription,Total,6227.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,1.7989511614921946e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
simeprevir,2016,Prescription,Total,63,JTZZSQYMACOLNN-VDWJNHBNSA-N,1.8089510615922013e-11,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,1.6749546866594455e-4
simeprevir,2017,Prescription,Total,21,JTZZSQYMACOLNN-VDWJNHBNSA-N,6.112609261276707e-12,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,5.659823390071025e-5
simvastatin,2016,Prescription,Total,2294448.885,RYMZZMVNJRMUDD-HGQWONQESA-N,6.58816785125364e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,3.29408392562682
simvastatin,2017,Prescription,Total,2024665.9194,RYMZZMVNJRMUDD-HGQWONQESA-N,5.893329357102742e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.9466646785513713
simvastatin,2018,Prescription,Total,1838137.0484,RYMZZMVNJRMUDD-HGQWONQESA-N,5.225127645813836e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.6125638229069184
simvastatin,2019,Prescription,Total,1689347.999800001,RYMZZMVNJRMUDD-HGQWONQESA-N,4.880055473953799e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.4400277369768997
sitagliptin,2016,Prescription,Total,667651.558,MFFMDFFZMYYVKS-SECBINFHSA-N,1.9170618962187098e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0022822165431175116
sitagliptin,2017,Prescription,Total,805702.4115,MFFMDFFZMYYVKS-SECBINFHSA-N,2.3452114392227986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0027919183800271413
sitagliptin,2018,Prescription,Total,920545.22,MFFMDFFZMYYVKS-SECBINFHSA-N,2.6167615099377914e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0031151922737354663
sitagliptin,2019,Prescription,Total,1017783.571,MFFMDFFZMYYVKS-SECBINFHSA-N,2.940093034440986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0035001107552868884
sodium amidotrizoate,2016,Prescription,Total,0.2296,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.592621646691579e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2017,Prescription,Total,0.2123,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.179556886519263e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2018,Prescription,Total,0.1981,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.63123292431714e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2019,Prescription,Total,0.1818,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.2516952414175994e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium phenylbutyrate,2016,Prescription,Total,1629.412,VPZRWNZGLKXFOE-UHFFFAOYSA-M,4.67861359868424e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2017,Prescription,Total,2586.248,VPZRWNZGLKXFOE-UHFFFAOYSA-M,7.527963560361124e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2018,Prescription,Total,4668.524,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3270846066009467e-9,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2019,Prescription,Total,461.168,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3321858036821078e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sofosbuvir,2016,Prescription,Total,23553.6,TTZHDVOVKQGIBA-IQWMDFIBSA-N,6.763065035606043e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2017,Prescription,Total,20339.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,5.920265823188534e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2018,Prescription,Total,67704,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.9245683690457733e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2019,Prescription,Total,56347.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.6277135429439263e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
solifenacin,2016,Prescription,Total,32045.152,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.20128757607674e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2017,Prescription,Total,31389.454,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.136736534610438e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2018,Prescription,Total,31586.715399999997,FBOUYBDGKBSUES-VXKWHMMOSA-N,8.978907205023485e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2019,Prescription,Total,33839.6869,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.775342280736606e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
sorafenib,2016,Prescription,Total,6899.2,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.9810024070058596e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.11652955335328585
sorafenib,2017,Prescription,Total,4838.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.408345173798153e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08284383375283252
sorafenib,2018,Prescription,Total,5174.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.4708859991714591e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08652270583361524
sorafenib,2019,Prescription,Total,7145.6,MLDQJTXFUGDVEO-UHFFFAOYSA-N,2.064164659905038e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.1214214505826493
sotalol,2016,Prescription,Total,211630.16,ZBMZVLHSJCTVON-UHFFFAOYSA-N,6.076644485665516e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2017,Prescription,Total,196055.88,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.706728513408357e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2018,Prescription,Total,176920.36,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.029175952620097e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2019,Prescription,Total,158257.8,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4.5716267061453147e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
spiramycin,2016,Prescription,Total,12807.96,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.677614736322293e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2017,Prescription,Total,10700.58,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.114688781382491e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2018,Prescription,Total,8354.5,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3748680194955852e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2019,Prescription,Total,8231.74,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3779202302853086e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spironolactone,2016,Prescription,Total,216466.675,LXMSZDCAJNLERA-ZHYRCANASA-N,6.215517802231492e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2017,Prescription,Total,222218.45,LXMSZDCAJNLERA-ZHYRCANASA-N,6.468259788078834e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2018,Prescription,Total,231659.475,LXMSZDCAJNLERA-ZHYRCANASA-N,6.585201730691689e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2019,Prescription,Total,243515.625,LXMSZDCAJNLERA-ZHYRCANASA-N,7.034487618390169e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
stiripentol,2016,Prescription,Total,12165.75,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.493213710724654e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2017,Prescription,Total,11735.85,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.416031685664488e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2018,Prescription,Total,15855,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.506976174409301e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2019,Prescription,Total,17010,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.913714854593695e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
streptozocin,2019,Prescription,Total,92,ZSJLQEPLLKMAKR-GKHCUFPYSA-N,2.6576235545127567e-11,antineoplastic,alkylating agent for pancreatic cancer,NA,NA,NA,NA
sucralfate,2016,Prescription,Total,383530.2,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.1012497816550309e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2017,Prescription,Total,422074.8,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2285611102054828e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2018,Prescription,Total,428604.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2183605931518314e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2019,Prescription,Total,487990.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.409668818413927e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sufentanil,2016,Prescription,Total,0.99815,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.8660388922670725e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2017,Prescription,Total,0.8852500000000001,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.5767558802596216e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2018,Prescription,Total,0.9484,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.6959421026867123e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2019,Prescription,Total,1.11825,GGCSSNBKKAUURC-UHFFFAOYSA-N,3.230312543297707e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sugammadex,2016,Prescription,Total,1915,WHRODDIHRRDWEW-VTHZAVIASA-N,5.498636957062008e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,5.498636957062008e-7
sugammadex,2017,Prescription,Total,2108,WHRODDIHRRDWEW-VTHZAVIASA-N,6.135895391795857e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.135895391795857e-7
sugammadex,2018,Prescription,Total,2350,WHRODDIHRRDWEW-VTHZAVIASA-N,6.680160208049105e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.680160208049105e-7
sugammadex,2019,Prescription,Total,3229,WHRODDIHRRDWEW-VTHZAVIASA-N,9.327680932088795e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,9.327680932088795e-7
sulfadiazine,2016,Prescription,Total,1076297.5836,SEEPANYCNGTZFQ-UHFFFAOYSA-N,3.090428026098954e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2017,Prescription,Total,1008298.9074,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.934922495004012e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2018,Prescription,Total,937990.3008,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.6663512693362434e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2019,Prescription,Total,963879.6822,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.784379725142381e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadoxine,2016,Prescription,Total,52700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.5132019197763336e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2017,Prescription,Total,50700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.4757585216510908e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2018,Prescription,Total,69900,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.986992334223968e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2019,Prescription,Total,104140,PJSFRIWCGOHTNF-UHFFFAOYSA-N,3.0083143148582445e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfamethoxazole,2016,Prescription,Total,1420137.76,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.077713823109795e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2017,Prescription,Total,1478592.4,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.303836951377788e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2018,Prescription,Total,1629399.2,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.631764978241297e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2019,Prescription,Total,1759706,JLKIGFTWXXRPMT-UHFFFAOYSA-N,5.083300124584158e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfanilamide,2016,Prescription,Total,1250,FDDDEECHVMSUSB-UHFFFAOYSA-N,3.5891886142702405e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfasalazine,2016,Prescription,Total,2687662,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.717220679525427e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2017,Prescription,Total,2588001.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.533067589094291e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2018,Prescription,Total,2561204.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.280534632160131e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2019,Prescription,Total,2272402,NCEXYHBECQHGNR-UHFFFAOYSA-N,6.56433595708902e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfathiazole,2016,Prescription,Total,10120,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.905807102113187e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2017,Prescription,Total,7690,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.238379296153232e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2018,Prescription,Total,6580,JNMRHUJNCSQMMB-UHFFFAOYSA-N,1.8704448582537503e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2019,Prescription,Total,3000,JNMRHUJNCSQMMB-UHFFFAOYSA-N,8.66616376471551e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sumatriptan,2016,Prescription,Total,136688.55,KQKPFRSPSRPDEB-UHFFFAOYSA-N,3.9248078988888685e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.5699231595555475e-4
sumatriptan,2017,Prescription,Total,145086.492,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.2231287365968994e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.6892514946387598e-4
sumatriptan,2018,Prescription,Total,146788.308,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.1726358047168354e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.669054321886734e-4
sumatriptan,2019,Prescription,Total,153388.296,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.4309603090888574e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.772384123635543e-4
suxamethonium,2016,Prescription,Total,7300,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.096086150733821e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2017,Prescription,Total,7064,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.0561653248408886e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2018,Prescription,Total,6366,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.809612761040026e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2019,Prescription,Total,4928,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.423561834417268e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxibuzone,2016,Prescription,Total,82566,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3707595770066937e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2017,Prescription,Total,79515,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3144958352877022e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2018,Prescription,Total,68823,ONWXNHPOAGOMTG-UHFFFAOYSA-N,1.9563773021215475e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2019,Prescription,Total,71199,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.056740646279932e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
tacrolimus,2016,Prescription,Total,4975.231,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.4285633966851472e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2017,Prescription,Total,5531.2725,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.6100241671497699e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2018,Prescription,Total,6047.978,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.719211147861975e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2019,Prescription,Total,6737.598,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.9463042549606566e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tadalafil,2016,Prescription,Total,24370.78,WOXKDUGGOYFFRN-IIBYNOLFSA-N,6.9977060877507925e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.4578554349480816e-4
tadalafil,2017,Prescription,Total,26047.2452,WOXKDUGGOYFFRN-IIBYNOLFSA-N,7.581744392393584e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.5795300817486634e-4
tadalafil,2018,Prescription,Total,31090.7,WOXKDUGGOYFFRN-IIBYNOLFSA-N,8.837908807676271e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.841231001599223e-4
tadalafil,2019,Prescription,Total,36057.74,WOXKDUGGOYFFRN-IIBYNOLFSA-N,1.0416075994184435e-8,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,2.1700158321217574e-4
tafamidis,2018,Prescription,Total,3.6,TXEIIPDJKFWEEC-UHFFFAOYSA-N,1.0233436914458206e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafamidis,2019,Prescription,Total,10.8,TXEIIPDJKFWEEC-UHFFFAOYSA-N,3.1198189552975847e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafluprost,2016,Prescription,Total,12.05685,WSNODXPBBALQOF-VEJSHDCNSA-N,3.4619446995171325e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2017,Prescription,Total,14.321745,WSNODXPBBALQOF-VEJSHDCNSA-N,4.168725291649685e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2018,Prescription,Total,16.55181,WSNODXPBBALQOF-VEJSHDCNSA-N,4.705052873752735e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2019,Prescription,Total,18.6948,WSNODXPBBALQOF-VEJSHDCNSA-N,5.400406611620119e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tamoxifen,2016,Prescription,Total,28435.44,NKANXQFJJICGDU-QPLCGJKRSA-N,8.164812599181166e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.0800471823449134
tamoxifen,2017,Prescription,Total,30268.52,NKANXQFJJICGDU-QPLCGJKRSA-N,8.810458841768536e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.086377047468319
tamoxifen,2018,Prescription,Total,30379.12,NKANXQFJJICGDU-QPLCGJKRSA-N,8.635633556576543e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08466307408408376
tamoxifen,2019,Prescription,Total,31762.74,NKANXQFJJICGDU-QPLCGJKRSA-N,9.175370215202666e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08995460995296733
tamsulosin,2016,Prescription,Total,8000.67796,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.2972753792379887e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2017,Prescription,Total,8528.67572,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.4824981996427518e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2018,Prescription,Total,9143.26032,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.599082713255248e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2019,Prescription,Total,9985.11236,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.884420630694833e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tapentadol,2016,Prescription,Total,87252.395,KWTWDQCKEHXFFR-SMDDNHRTSA-N,2.5053224216144777e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2017,Prescription,Total,121340.285,KWTWDQCKEHXFFR-SMDDNHRTSA-N,3.5319321421759774e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2018,Prescription,Total,144810.5,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.1164142119476396e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2019,Prescription,Total,157934.555,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.562289059124896e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tedizolid,2016,Prescription,Total,154.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,4.4448511799122665e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,1.4816170599707555e-5
tedizolid,2017,Prescription,Total,318,XFALPSLJIHVRKE-GFCCVEGCSA-N,9.256236881361871e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,3.08541229378729e-5
tedizolid,2018,Prescription,Total,104.4,XFALPSLJIHVRKE-GFCCVEGCSA-N,2.96769670519288e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,9.892322350642933e-6
tedizolid,2019,Prescription,Total,208.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,6.031649980241996e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,2.0105499934139986e-5
teicoplanin,2016,Prescription,Total,83.19999999999999,BJNLLBUOHPVGFT-CAYRISATSA-N,2.388963941658272e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2017,Prescription,Total,62,BJNLLBUOHPVGFT-CAYRISATSA-N,1.8046751152340755e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2018,Prescription,Total,53.2,BJNLLBUOHPVGFT-CAYRISATSA-N,1.5122745662477126e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
telbivudine,2016,Prescription,Total,168,IQFYYKKMVGJFEH-CSMHCCOUSA-N,4.823869497579204e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,high,9.49e-5,5.083108005879034e-7
telmisartan,2016,Prescription,Total,193137.27760000003,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.545648942024567e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011317650902090955
telmisartan,2017,Prescription,Total,187672.0288,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.462694196787947e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011148355503648871
telmisartan,2018,Prescription,Total,190748.8176,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.422266642825263e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.001106585029148013
telmisartan,2019,Prescription,Total,187731.6984,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.4230454738752705e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011067439742602594
temozolomide,2016,Prescription,Total,4205.3,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.2074891903672515e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,1.6099855871563355e-5
temozolomide,2017,Prescription,Total,5184.75,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.5091595651144955e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.0122127534859943e-5
temozolomide,2018,Prescription,Total,5879.1,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.671205526771979e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.228274035695972e-5
temozolomide,2019,Prescription,Total,5574.7,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.610375437971985e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.1471672506293138e-5
tenofovir alafenamide,2016,Prescription,Total,1915.35,LDEKQSIMHVQZJK-CAQYMETFSA-N,5.499641929874004e-10,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,5.499641929874004e-7
tenofovir alafenamide,2017,Prescription,Total,9023.4,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.6265008765811543e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.6265008765811544e-6
tenofovir alafenamide,2018,Prescription,Total,10650.9,LDEKQSIMHVQZJK-CAQYMETFSA-N,3.0276475897834133e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,3.0276475897834133e-6
tenofovir alafenamide,2019,Prescription,Total,7790.1,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.250342744783677e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.250342744783677e-6
tenofovir disoproxil,2016,Prescription,Total,227416.35,JFVZFKDSXNQEJW-CQSZACIVSA-N,6.529921392951168e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2017,Prescription,Total,165110.4,JFVZFKDSXNQEJW-CQSZACIVSA-N,4.805977905586198e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2018,Prescription,Total,176664.6,JFVZFKDSXNQEJW-CQSZACIVSA-N,5.0219056642166474e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2019,Prescription,Total,260675.1,JFVZFKDSXNQEJW-CQSZACIVSA-N,7.530177019945309e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
terazosin,2016,Prescription,Total,625.77914,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7968314914686584e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2017,Prescription,Total,613.15072,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7847384617288004e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2018,Prescription,Total,402.0905,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.14299104601471e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2019,Prescription,Total,378.028,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.0920175185492918e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terbinafine,2016,OTC,Total,12387.92,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.557006513479248e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.06711333044300469
terbinafine,2016,Prescription,Total,590570.7,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.6957357058892846e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.199501331866575
terbinafine,2017,OTC,Total,11978.89,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.486774950181663e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.0657882066072012
terbinafine,2017,Prescription,Total,603526.9249999999,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.756725843421358e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.314577063059166
terbinafine,2018,OTC,Total,13448.63,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.822936296969168e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.07213087352772016
terbinafine,2018,Prescription,Total,624966.255,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7765424289465834e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.3519668470690256
terbinafine,2019,OTC,Total,12555.31,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,3.626879085892344e-9,antifungal,topical allylamine antifungal,high,low,5.3e-8,0.06843168086589328
terbinafine,2019,Prescription,Total,598459.4,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7287823889777958e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.2618535641090487
terbutaline,2016,Prescription,Total,7447.31,XWTYSIMOBUGWOL-UHFFFAOYSA-N,2.138384020715272e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,8.909933419646967e-6
terbutaline,2017,Prescription,Total,6583.112499999999,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.916190211215545e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,7.984125880064771e-6
terbutaline,2018,Prescription,Total,5325.1125,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.5137278564206339e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.3071994017526415e-6
terbutaline,2019,Prescription,Total,5165.37,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.492131410844952e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.217214211853967e-6
teriflunomide,2016,Prescription,Total,5294.744,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.5203067904220535e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.067689301406845e-5
teriflunomide,2017,Prescription,Total,5747.896,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6730782058312064e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.576927352770688e-5
teriflunomide,2018,Prescription,Total,5942.72,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6892902838969187e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.630967612989729e-5
teriflunomide,2019,Prescription,Total,5944.68,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.717252346960967e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.72417448986989e-5
testosterone,2016,Prescription,Total,96412.3,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.7683354354848542e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2017,Prescription,Total,107058.65,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1162271213799125e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2018,Prescription,Total,103507.86,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.942336542946033e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2019,Prescription,Total,107993.53,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1196320550323916e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
tetrabenazine,2017,Prescription,Total,84,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.4450437045106828e-11,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2018,Prescription,Total,425.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,1.20981965299817e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2019,Prescription,Total,789.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.2809343028731223e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetracaine,2016,Prescription,Total,1543.9,GKCBAIGFKIBETG-UHFFFAOYSA-N,4.43307864125746e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2017,Prescription,Total,1059.6,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.0842479872613326e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2018,Prescription,Total,1220.4,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.469135114001332e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2019,Prescription,Total,1359.05,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.9259166214788715e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracycline,2016,Prescription,Total,759502,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.1807967447323814e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2017,Prescription,Total,695828,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.025392703359833e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2018,Prescription,Total,615128,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.748575995088013e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2019,Prescription,Total,598636,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.7292925371514117e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetryzoline,2016,OTC,Total,143.192,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.111544768436675e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2016,Prescription,Total,142.4928,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.091468283003892e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2017,OTC,Total,147.1544,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.2833207060838907e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2017,Prescription,Total,147.3384,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.2886765161032956e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2018,OTC,Total,132.9776,BYJAVTDNIXVSPW-UHFFFAOYSA-N,3.7800496684334925e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2018,Prescription,Total,144.4296,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.1055866671678687e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2019,OTC,Total,155.528,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.492770393328913e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2019,Prescription,Total,173.016,BYJAVTDNIXVSPW-UHFFFAOYSA-N,4.9979499663867294e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
thalidomide,2016,Prescription,Total,2161.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,6.206712086885242e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2017,Prescription,Total,953.4,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.775124604619625e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2018,Prescription,Total,754.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.145042082125045e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2019,Prescription,Total,784,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.2647574638456536e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
theophylline,2016,Prescription,Total,358271.19,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,1.0287223007752401e-7,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2017,Prescription,Total,331665.26,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,9.65400066628451e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2018,Prescription,Total,282589.38,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,8.032946091460716e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2019,Prescription,Total,250207.92,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,7.227809366496124e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
thiamazole,2016,Prescription,Total,855.2,PMRYVIKBURPHAH-UHFFFAOYSA-N,2.455579282339128e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2017,Prescription,Total,1147.775,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.3409048070770823e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2018,Prescription,Total,1379.275,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.9207565833859286e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2019,Prescription,Total,1568.675,PMRYVIKBURPHAH-UHFFFAOYSA-N,4.5314648145383674e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiopental,2016,Prescription,Total,28305,IUJDSEJGGMCXSG-UHFFFAOYSA-N,8.127358698153533e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2017,Prescription,Total,26995,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.857613667055463e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2018,Prescription,Total,26225,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.45477453004629e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2019,Prescription,Total,24325,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.026814452556827e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiosulfate,2016,Prescription,Total,9705,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.786646040119415e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2017,Prescription,Total,12195,DHCDFWKWKRSZHF-UHFFFAOYSA-M,3.54967952101283e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2018,Prescription,Total,8400,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.3878019467069147e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2019,Prescription,Total,14745,DHCDFWKWKRSZHF-UHFFFAOYSA-M,4.259419490357674e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiotepa,2016,Prescription,Total,9.92,FOCVUCIESVLUNU-UHFFFAOYSA-N,2.848380084284863e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2017,Prescription,Total,12.445,FOCVUCIESVLUNU-UHFFFAOYSA-N,3.622448678885173e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2018,Prescription,Total,21.13,FOCVUCIESVLUNU-UHFFFAOYSA-N,6.006458944513941e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2019,Prescription,Total,16.064999999999998,FOCVUCIESVLUNU-UHFFFAOYSA-N,4.640730696005156e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
tiamulin,2016,Prescription,Total,59790,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.7167806979777416e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2017,Prescription,Total,42310,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.2315452278315118e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2018,Prescription,Total,34025,UURAUHCOJAIIRQ-QGLSALSOSA-N,9.672019194845568e-9,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2019,Prescription,Total,45030,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.3007911810837985e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tibolone,2016,Prescription,Total,4755.3492,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3654276164415276e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2017,Prescription,Total,4531.9197,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3191359204563027e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2018,Prescription,Total,4267.83,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.2131824740731155e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2019,Prescription,Total,4168.3635,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.204124024062091e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
ticagrelor,2016,Prescription,Total,387609.4764,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1129628155825037e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002099929840721705
ticagrelor,2017,Prescription,Total,386672.9004,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1255144533665553e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002123612176163312
ticagrelor,2018,Prescription,Total,385345.3596,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.0953909521516144e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0020667753814181404
ticagrelor,2019,Prescription,Total,400039.44,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1556024331283617e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0021803819492987957
ticlopidine,2016,Prescription,Total,16633.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.776061505237124e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2017,Prescription,Total,15354.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.469336138203486e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2018,Prescription,Total,13498.25,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.83704138418293e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2019,Prescription,Total,11178.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.229157054795745e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
tigecycline,2016,Prescription,Total,66,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.8950915883346872e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2017,Prescription,Total,43,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.2516295154042782e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2018,Prescription,Total,39.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.1228354392252754e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2019,Prescription,Total,45.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.3143681709818526e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tiludronic acid,2016,Prescription,Total,131,DKJJVAGXPKPDRL-UHFFFAOYSA-N,3.761469667755212e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2017,Prescription,Total,94,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.73612033600005e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2018,Prescription,Total,81.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.316736412578733e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2019,Prescription,Total,38.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,1.1121576831384906e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
timolol,2016,Prescription,Total,10924.096,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.136691278751606e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2017,Prescription,Total,11247.6531,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.273928976508936e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2018,Prescription,Total,12316.64175,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.501154898516864e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2019,Prescription,Total,12960.5875,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.743952458730827e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
tiotropium bromide,2016,Prescription,Total,128.35005,DQHNAVOVODVIMG-RGECMCKFSA-M,3.6853803048081294e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2017,Prescription,Total,120.37791,DQHNAVOVODVIMG-RGECMCKFSA-M,3.503919654853019e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2018,Prescription,Total,113.09136,DQHNAVOVODVIMG-RGECMCKFSA-M,3.2147591614730063e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2019,Prescription,Total,109.02105,DQHNAVOVODVIMG-RGECMCKFSA-M,3.1493142436707934e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tipiracil,2017,Prescription,Total,32.1004,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,9.343676301461275e-12,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2018,Prescription,Total,109.648,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.116877474434759e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2019,Prescription,Total,105.4338,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.045688590454208e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tivozanib,2019,Prescription,Total,0.14973,SPMVMDHWKHCIDT-UHFFFAOYSA-N,4.3252823349695124e-14,antineoplastic,vascular endothelial growth factor inhibitor for carcinomas,NA,NA,NA,NA
tobramycin,2016,Prescription,Total,8141.445000000001,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.3376945358165907e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.583714776110962e-4
tobramycin,2017,Prescription,Total,7700.825,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.2415302006891046e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.395157256253146e-4
tobramycin,2018,Prescription,Total,6408.112,NLVFBUXFDBBNBW-PBSUHMDJSA-N,1.82158360813285e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.5717325649663726e-4
tobramycin,2019,Prescription,Total,7014.999,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.0264376714438513e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.973407198909512e-4
toceranib,2016,Prescription,Total,22.6,SRSGVKWWVXWSJT-ATVHPVEESA-N,6.489253014600596e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2017,Prescription,Total,29.7,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.644975955234199e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2018,Prescription,Total,0.3,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.527864095381839e-14,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
tofacitinib,2017,Prescription,Total,74.48,UJLAWZDWDVHWOW-YPMHNXCESA-N,2.1679387513328056e-11,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2018,Prescription,Total,1246.77,UJLAWZDWDVHWOW-YPMHNXCESA-N,3.544095039399737e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2019,Prescription,Total,1742.23,UJLAWZDWDVHWOW-YPMHNXCESA-N,5.032816831933436e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tolfenamic acid,2016,Prescription,Total,5740,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6481554116728947e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2017,Prescription,Total,5654,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6457472744408811e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2018,Prescription,Total,6188,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.7590141007407603e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2019,Prescription,Total,6716,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.940065194794312e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolterodine,2016,Prescription,Total,8240.384320000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.366103486284402e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2017,Prescription,Total,7516.001920000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.187732521141215e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2018,Prescription,Total,6333.6224,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.8004090352888715e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2019,Prescription,Total,5581.835840000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.6124367832399459e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
toltrazuril,2016,Prescription,Total,289252.16,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.30544447460059e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2017,Prescription,Total,304975,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.877109568846971e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2018,Prescription,Total,292275,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.308271594925757e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2019,Prescription,Total,294300,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.501506653185917e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
tolvaptan,2016,Prescription,Total,460.29,GYHCTFXIZSNGJT-UHFFFAOYSA-N,1.321654101809959e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,6.608270509049795e-6
tolvaptan,2017,Prescription,Total,1392.84,GYHCTFXIZSNGJT-UHFFFAOYSA-N,4.0542317540365004e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,2.02711587701825e-5
tolvaptan,2018,Prescription,Total,2364.285,GYHCTFXIZSNGJT-UHFFFAOYSA-N,6.720767054249949e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,3.360383527124974e-5
tolvaptan,2019,Prescription,Total,3174.18,GYHCTFXIZSNGJT-UHFFFAOYSA-N,9.169321232894894e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,4.5846606164474465e-5
topiramate,2016,Prescription,Total,174637.829,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.0144648597413863e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.391897698646652e-4
topiramate,2017,Prescription,Total,178766.903,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.2034867947026414e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.595147091078109e-4
topiramate,2018,Prescription,Total,179698.065,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.1081355884103056e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.492618912269146e-4
topiramate,2019,Prescription,Total,185006.215,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.3443138556005584e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.74657403828017e-4
topotecan,2016,Prescription,Total,2.498,UCFGDBYHRUNTLO-QHCPKHFHSA-N,7.17263452675765e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2017,Prescription,Total,0.8325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,2.4232129571489804e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2018,Prescription,Total,1.3325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.7877929690320994e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2019,Prescription,Total,1.2625,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.6470105843177783e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
torasemide,2018,Prescription,Total,1.8,NGBFQHCMQULJNZ-UHFFFAOYSA-N,5.116718457229103e-13,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
torasemide,2019,Prescription,Total,10.89,NGBFQHCMQULJNZ-UHFFFAOYSA-N,3.145817446591731e-12,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
trabectedin,2016,Prescription,Total,0.25225000000000003,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.242982623597347e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2017,Prescription,Total,0.289,PKVRCIRHQMSYJX-AIFWHQITSA-N,8.412114650042706e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2018,Prescription,Total,0.36625,PKVRCIRHQMSYJX-AIFWHQITSA-N,1.041110074977866e-13,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2019,Prescription,Total,0.27399999999999997,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.915096238440167e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
tramadol,2016,Prescription,Total,2502289.3175,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.184950662384841e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2017,Prescription,Total,2555566.15,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.438655864902504e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2018,Prescription,Total,2494378.925,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.090574824928215e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2019,Prescription,Total,2404390.2125,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,6.945613111934709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
trametinib,2016,Prescription,Total,24.42,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,7.011838876838343e-12,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2017,Prescription,Total,44.474999999999994,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2945633185489595e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2018,Prescription,Total,44.37,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2612710997069735e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2019,Prescription,Total,35.4,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.0226073242364304e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
travoprost,2016,Prescription,Total,12.95085,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.71864346920974e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2017,Prescription,Total,11.07165,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.2226985870292506e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2018,Prescription,Total,12.309325,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.4990750235295346e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2019,Prescription,Total,10.812275,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.1233648606379802e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
treosulfan,2019,Prescription,Total,1247,YCPOZVAOBBQLRI-WDSKDSINSA-N,3.602235404866747e-10,antineoplastic,"alkylating agent, pre-bone marrow transplantation",NA,NA,NA,NA
treprostinil,2016,Prescription,Total,34.57,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.926260031625778e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2017,Prescription,Total,33.79,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.835479378025712e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2018,Prescription,Total,34.379999999999995,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.772932253307584e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2019,Prescription,Total,33.21,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.593443287540072e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
tretinoin,2016,Prescription,Total,95.0475,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.729147238518806e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2017,Prescription,Total,106.53,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.1008393552562266e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2018,Prescription,Total,105.3975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.996051853310024e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2019,Prescription,Total,111.6975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.226629423697703e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
triamcinolone,2016,OTC,Total,12.85845,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.692112186973054e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.692112186973054e-7
triamcinolone,2016,Prescription,Total,6896.6119,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.9802592726816523e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.9802592726816522e-4
triamcinolone,2017,OTC,Total,12.4476,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.623205478127045e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.6232054781270445e-7
triamcinolone,2017,Prescription,Total,6813.6083499999995,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.983282166805824e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.983282166805824e-4
triamcinolone,2018,OTC,Total,10.8075,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.072163040361307e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.072163040361307e-7
triamcinolone,2018,Prescription,Total,6617.47705,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.8810981645569443e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.8810981645569442e-4
triamcinolone,2019,OTC,Total,13.00695,GFNANZIMVAIWHM-OBYCQNJPSA-N,3.757345292648881e-12,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,3.75734529264888e-7
triamcinolone,2019,Prescription,Total,6993.94855,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.0203567832098193e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.0203567832098192e-4
tricaine mesilate,2016,Prescription,Total,5447000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.5640248305544e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2017,Prescription,Total,5504000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.602085779717476e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2018,Prescription,Total,5756000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.636212857767262e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2019,Prescription,Total,5653000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.632994125397893e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
trientine,2019,Prescription,Total,21.6,VILCJCGEZXAXTO-UHFFFAOYSA-N,6.239637910595169e-12,chelating agent,iron-chelating agent for copper build-up from Wilson's disease,NA,NA,NA,NA
trifluridine,2017,Prescription,Total,78.4,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,2.2820407908766374e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2018,Prescription,Total,267.8,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.612540015810854e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2019,Prescription,Total,257.5,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.438457231380814e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trilostane,2016,Prescription,Total,3720.3,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.068228672133566e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2017,Prescription,Total,3850.5,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.1207905695498074e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2018,Prescription,Total,4262.1,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.2115536520308975e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2019,Prescription,Total,4884.9,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.4111114458086266e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trimethoprim,2016,Prescription,Total,798733.0564,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.29344287349772e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2017,Prescription,Total,776550.8926000001,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.260358179980693e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2018,Prescription,Total,794144.0832,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.2574509378937357e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2019,Prescription,Total,843220.5618,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.435829159444739e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimipramine,2016,Prescription,Total,77649.3,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.2295838677284336e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2017,Prescription,Total,74164.78,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.1587634337549975e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2018,Prescription,Total,70475.37,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.0033479247725008e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2019,Prescription,Total,35509.555,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,1.0257720628072416e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
tropicamide,2016,Prescription,Total,346.4,BGDKAVGWHJFAGW-UHFFFAOYSA-N,9.946359487865692e-11,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2017,Prescription,Total,348.65,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.014838675687678e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2018,Prescription,Total,356.2,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0125417302583368e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2019,Prescription,Total,352.45,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0181298062913271e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
ulipristal,2016,OTC,Total,2977.5,HKDLNTKNLJPAIY-WKWWZUSTSA-N,8.549447279191714e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0018190313359982369
ulipristal,2016,Prescription,Total,902.02,HKDLNTKNLJPAIY-WKWWZUSTSA-N,2.5900159310752337e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,5.510672193777093e-4
ulipristal,2017,OTC,Total,2643,HKDLNTKNLJPAIY-WKWWZUSTSA-N,7.69315537026397e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0016368415681412703
ulipristal,2017,Prescription,Total,1026.06,HKDLNTKNLJPAIY-WKWWZUSTSA-N,2.9866208850597986e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,6.354512521403827e-4
ulipristal,2018,OTC,Total,2374.53,HKDLNTKNLJPAIY-WKWWZUSTSA-N,6.749889710135678e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0014361467468373783
ulipristal,2018,Prescription,Total,427.56,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.2153911908738195e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,2.5859387039868503e-4
ulipristal,2019,OTC,Total,2310,HKDLNTKNLJPAIY-WKWWZUSTSA-N,6.672946098830943e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0014197757657087114
ulipristal,2019,Prescription,Total,479.78,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.3859506836784023e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,2.948831241868941e-4
umeclidinium bromide,2016,Prescription,Total,83.67060000000001,PEJHHXHHNGORMP-UHFFFAOYSA-M,2.4024765189532772e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,2.518319202257104e-6
umeclidinium bromide,2017,Prescription,Total,133.8126,PEJHHXHHNGORMP-UHFFFAOYSA-M,3.8949720858834067e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,4.082779964238372e-6
umeclidinium bromide,2018,Prescription,Total,184.46145,PEJHHXHHNGORMP-UHFFFAOYSA-M,5.2435405881235734e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,5.4963737821001815e-6
umeclidinium bromide,2019,Prescription,Total,249.24749999999997,PEJHHXHHNGORMP-UHFFFAOYSA-M,7.200065509819764e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,7.547238479894931e-6
ursodeoxycholic acid,2016,Prescription,Total,638521.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.8334185603756817e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2017,Prescription,Total,675813,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.967133715567236e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2018,Prescription,Total,723487.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.056600314247181e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2019,Prescription,Total,777307.75,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.2454254190275147e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
valaciclovir,2016,Prescription,Total,1190973.91,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.419703998131928e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.001709851999065964
valaciclovir,2017,Prescription,Total,1372743.409999999,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.9957352768202675e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0019978676384101337
valaciclovir,2018,Prescription,Total,1685439.98,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4.791067696787694e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.002395533848393847
valaciclovir,2019,Prescription,Total,1955930.05,HDOVUKNUBWVHOX-QMMMGPOBSA-N,5.650136708542733e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0028250683542713666
valganciclovir,2016,Prescription,Total,38610,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.108628579175792e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2017,Prescription,Total,45603,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3273967625809605e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2018,Prescription,Total,39771,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.1305389431247702e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2019,Prescription,Total,46013,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3291873110195162e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valproic acid,2016,Prescription,Total,5039748.3,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.447088577371824e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2017,Prescription,Total,5053161.15,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4708571259149362e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2018,Prescription,Total,5088836.65,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.446563578493273e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2019,Prescription,Total,5090799.85,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4705901731163052e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valsartan,2016,Prescription,Total,5444853.22112,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.563408415009324e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002791800741088079
valsartan,2017,Prescription,Total,5833926.01488,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6981195327694572e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.003032356308516888
valsartan,2018,Prescription,Total,5759581.4616,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6372309316935163e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002923626663738422
valsartan,2019,Prescription,Total,6585188.6816,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.9022774512098876e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.0033969240200176568
vancomycin,2016,Prescription,Total,70943,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0370224628973895e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2017,Prescription,Total,68898,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0054597756354408e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2018,Prescription,Total,66420.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,1.8880833238243645e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2019,Prescription,Total,71977.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0792293412493692e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vandetanib,2016,Prescription,Total,174,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.996150551064175e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.9961505510641754e-5
vandetanib,2017,Prescription,Total,159,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.6281184406809357e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.628118440680936e-5
vandetanib,2018,Prescription,Total,78,UHTHHESEBZOYNR-UHFFFAOYSA-N,2.217244664799278e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,2.2172446647992782e-5
vandetanib,2019,Prescription,Total,33,UHTHHESEBZOYNR-UHFFFAOYSA-N,9.532780141187063e-12,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,9.532780141187063e-6
vardenafil,2016,Prescription,Total,3477.78,SECKRCOLJRRGGV-UHFFFAOYSA-N,9.985926703149406e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2017,Prescription,Total,3440.2799999999997,SECKRCOLJRRGGV-UHFFFAOYSA-N,1.0013851137802395e-9,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2018,Prescription,Total,2986.24,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.488749625397685e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2019,Prescription,Total,2997.28,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.65830644290217e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
varenicline,2016,Prescription,Total,1794.48112,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.152584963541526e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2017,Prescription,Total,1721.50796,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.01090738078932e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2018,Prescription,Total,1538.3765,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.3730219065097255e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2019,Prescription,Total,1447.68306,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.1819528257881567e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
vecuronium,2016,Prescription,Total,260,BGSZAXLLHYERSY-XQIGCQGXSA-N,7.465512317682101e-11,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
vedaprofen,2016,Prescription,Total,1737,VZUGVMQFWFVFBX-UHFFFAOYSA-N,4.987536498389927e-10,analgesic,veterinary NSAID,NA,NA,NA,NA
velpatasvir,2016,Prescription,Total,408.8,FHCUMDQMBHQXKK-CDIODLITSA-N,1.1738082444109396e-10,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2017,Prescription,Total,4194.4,FHCUMDQMBHQXKK-CDIODLITSA-N,1.2208918231190007e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2018,Prescription,Total,16290.4,FHCUMDQMBHQXKK-CDIODLITSA-N,4.630743908646943e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2019,Prescription,Total,10329.2,FHCUMDQMBHQXKK-CDIODLITSA-N,2.983817958616648e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
vemurafenib,2016,Prescription,Total,7190.4,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.064616144963899e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2017,Prescription,Total,4139.52,GPXBXXGIAQBQNI-UHFFFAOYSA-N,1.2049175375828647e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2018,Prescription,Total,3454.08,GPXBXXGIAQBQNI-UHFFFAOYSA-N,9.81864160485883e-10,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2019,Prescription,Total,7620.48,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.201344254857975e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
venetoclax,2017,Prescription,Total,1.19,LQBVNQSMGBZMKD-UHFFFAOYSA-N,3.4638119147234674e-13,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2018,Prescription,Total,604.59,LQBVNQSMGBZMKD-UHFFFAOYSA-N,1.7186204511423018e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2019,Prescription,Total,2093.9100000000003,LQBVNQSMGBZMKD-UHFFFAOYSA-N,6.048722322858486e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venlafaxine,2016,Prescription,Total,1370348.3595,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.934750983601042e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2017,Prescription,Total,1367537.226,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.980581291803933e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2018,Prescription,Total,1355433.264,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.852983555250604e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2019,Prescription,Total,1388562.3345,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4.011169529430894e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
verapamil,2016,Prescription,Total,768375.1111999999,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.206274560486136e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2017,Prescription,Total,762674.224,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.2199664404568698e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2018,Prescription,Total,740412.9216,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1047135899564695e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2019,Prescription,Total,728917.0784,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1056382574374586e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
vernakalant,2016,Prescription,Total,2,VBHQKCBVWWUUKN-KZNAEPCWSA-N,5.742701782832385e-13,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2017,Prescription,Total,6,VBHQKCBVWWUUKN-KZNAEPCWSA-N,1.7464597889362021e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2018,Prescription,Total,11,VBHQKCBVWWUUKN-KZNAEPCWSA-N,3.1268835016400072e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2019,Prescription,Total,9,VBHQKCBVWWUUKN-KZNAEPCWSA-N,2.5998491294146532e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
verteporfin,2016,Prescription,Total,3.315,NJLRKAMQPVVOIU-IDLGWYNRSA-N,9.51852820504468e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2017,Prescription,Total,3.06,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.906944923574631e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2018,Prescription,Total,2.85,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.101470890612746e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2019,Prescription,Total,2.46,NJLRKAMQPVVOIU-IDLGWYNRSA-N,7.106254287066719e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
vigabatrin,2016,Prescription,Total,42639.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2243296633454077e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2017,Prescription,Total,43862,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2767203210386615e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2018,Prescription,Total,39305.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.1173065406701028e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2019,Prescription,Total,43813.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2656498870178769e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vilanterol,2016,Prescription,Total,119.1465,DAFYYTQWSAWIGS-DEOSSOPVSA-N,3.4211140898411936e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2017,Prescription,Total,163.98558,DAFYYTQWSAWIGS-DEOSSOPVSA-N,4.7732370239230105e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2018,Prescription,Total,201.80028,DAFYYTQWSAWIGS-DEOSSOPVSA-N,5.736417874166672e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2019,Prescription,Total,248.78238,DAFYYTQWSAWIGS-DEOSSOPVSA-N,7.186629489518949e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vildagliptin,2016,Prescription,Total,388078.935,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1143107959520966e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.9898407070573156e-4
vildagliptin,2017,Prescription,Total,401346.72,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1682265131690617e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,2.0861187735161818e-4
vildagliptin,2018,Prescription,Total,370008.915,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0517952470665637e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8782057983331496e-4
vildagliptin,2019,Prescription,Total,354183.27,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0231367401808169e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8270298931800304e-4
vinblastine,2016,Prescription,Total,23.24,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.6730194716512315e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2017,Prescription,Total,22.14,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.444436621174586e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2018,Prescription,Total,20.97,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.960977002671905e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2019,Prescription,Total,18.35,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.300803502750989e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2016,Prescription,Total,13.13,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.770083720429461e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2017,Prescription,Total,12.7,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.696673219914961e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2018,Prescription,Total,12.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.5077947645670624e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2019,Prescription,Total,13.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.853554154043497e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinflunine,2016,Prescription,Total,59.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7127608067297588e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2017,Prescription,Total,61.2,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7813889847149263e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2018,Prescription,Total,13.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.880178163398736e-12,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2019,Prescription,Total,1.3,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.755337631376722e-13,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinorelbine,2016,Prescription,Total,578.29,GBABOYUKABKIAF-IELIFDKJSA-N,1.66047350699707e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2017,Prescription,Total,528.64,GBABOYUKABKIAF-IELIFDKJSA-N,1.5387475047053895e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2018,Prescription,Total,485.12,GBABOYUKABKIAF-IELIFDKJSA-N,1.3790124766505454e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2019,Prescription,Total,399.45,GBABOYUKABKIAF-IELIFDKJSA-N,1.1538997052718703e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vismodegib,2016,Prescription,Total,201.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,5.7886433970950434e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2017,Prescription,Total,340.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,9.902427003268264e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2018,Prescription,Total,306.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,8.71547710548024e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2019,Prescription,Total,361.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,1.0434061172717476e-10,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
voriconazole,2016,Prescription,Total,5863.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.683501741146228e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2017,Prescription,Total,4776.8,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.3904148532984082e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2018,Prescription,Total,4883.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.388080438805302e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2019,Prescription,Total,6599.4,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.906382704962118e-9,antifungal,azole antifungal,NA,NA,NA,NA
vortioxetine,2016,Prescription,Total,12130.0606,YQNWZWMKLDQSAC-UHFFFAOYSA-N,3.482966031674243e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2017,Prescription,Total,19275.368,YQNWZWMKLDQSAC-UHFFFAOYSA-N,5.6106091881579385e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2018,Prescription,Total,23910.0946,YQNWZWMKLDQSAC-UHFFFAOYSA-N,6.796734575217439e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2019,Prescription,Total,30263.8252,YQNWZWMKLDQSAC-UHFFFAOYSA-N,8.742375510997473e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
voxilaprevir,2017,Prescription,Total,8.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,2.445043704510683e-12,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2018,Prescription,Total,316.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.994053999262711e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2019,Prescription,Total,288.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.331072099146512e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
warfarin,2016,Prescription,Total,102193.1675,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.934324425977693e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.002667567659979721
warfarin,2017,Prescription,Total,86658.63,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.522430210988341e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0022931183736257647
warfarin,2018,Prescription,Total,72666.24,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.065626063474665e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0018778418758860593
warfarin,2019,Prescription,Total,61197.5,PJVWKTKQMONHTI-UHFFFAOYSA-N,1.7678251899705918e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0016071138090641745
xylazine,2016,Prescription,Total,7361,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.113601391171459e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2017,Prescription,Total,7566,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2022857938485508e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2018,Prescription,Total,8115,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.306787237800787e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2019,Prescription,Total,7709,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2269152154063958e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylometazoline,2016,OTC,Total,50032.31,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.4366031791811128e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.0070768629516310974
xylometazoline,2017,OTC,Total,56242.875,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6370986600277533e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008064525418855927
xylometazoline,2018,OTC,Total,57843.65,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6442759532694454e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008099881543199239
xylometazoline,2019,OTC,Total,61488.13,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.7762206805537227e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.00874985556923016
zanamivir,2016,Prescription,Total,1.5,ARAIBEBZBOPLMB-UFGQHTETSA-N,4.307026337124289e-13,antiviral,neuraminidase inhibitor for influenza,low,high,NA,NA
zidovudine,2016,Prescription,Total,17280,HBOMLICNUCNMMY-XLPZGREQSA-N,4.961694340367181e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2017,Prescription,Total,11970,HBOMLICNUCNMMY-XLPZGREQSA-N,3.484187278927723e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2018,Prescription,Total,8154,HBOMLICNUCNMMY-XLPZGREQSA-N,2.317873461124783e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2019,Prescription,Total,5940,HBOMLICNUCNMMY-XLPZGREQSA-N,1.7159004254136711e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
ziprasidone,2016,Prescription,Total,18900.4104,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.426971025017188e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2017,Prescription,Total,17402.2128,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.065377482285146e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2018,Prescription,Total,17195.976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.8881648771815934e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2019,Prescription,Total,16329.2976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.717078905479198e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
zofenopril,2016,Prescription,Total,3.36,IAIDUHCBNLFXEF-MNEFBYGVSA-N,9.647738995158406e-13,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2017,Prescription,Total,17.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,5.1345917794724335e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2018,Prescription,Total,38.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,1.0983888954851808e-11,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2019,Prescription,Total,26.88,IAIDUHCBNLFXEF-MNEFBYGVSA-N,7.764882733185099e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zoledronic acid,2016,Prescription,Total,111.713,XRASPMIURGNCCH-UHFFFAOYSA-N,3.207672221327771e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.0347329746218615e-6
zoledronic acid,2017,Prescription,Total,141.513,XRASPMIURGNCCH-UHFFFAOYSA-N,4.11911273519548e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.328746043611445e-6
zoledronic acid,2018,Prescription,Total,160.505,XRASPMIURGNCCH-UHFFFAOYSA-N,4.5625494220975386e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.4717901361604963e-6
zoledronic acid,2019,Prescription,Total,181.311,XRASPMIURGNCCH-UHFFFAOYSA-N,5.2375693944811136e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.6895385143487462e-6
zolmitriptan,2016,Prescription,Total,3741.645,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.074357570611294e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0743575706112941e-5
zolmitriptan,2017,Prescription,Total,3886.32,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.1312169344897568e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.1312169344897569e-5
zolmitriptan,2018,Prescription,Total,3826.47,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.087720537501858e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0877205375018581e-5
zolmitriptan,2019,Prescription,Total,3796.875,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.0968113514718067e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0968113514718068e-5
zolpidem,2016,Prescription,Total,112751.9255,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.237503417933171e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.01471592462696896
zolpidem,2017,Prescription,Total,111564.9205,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.247394125151903e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014760882387054104
zolpidem,2018,Prescription,Total,111729.2415,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.1760392899736555e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014436542227152979
zolpidem,2019,Prescription,Total,114395.1865,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.30455806701391e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.015020718486426861
zonisamide,2016,Prescription,Total,64870.078,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8626475629153796e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2017,Prescription,Total,65644.614,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.9107613118539744e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2018,Prescription,Total,63057.96,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.7924990433734136e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2019,Prescription,Total,65638.636,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8961172295618372e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zopiclone,2016,Prescription,Total,393691.9724500001,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.130427796037707e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2017,Prescription,Total,374501.7356,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0900870368536956e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2018,Prescription,Total,356499.65585,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0133935383797323e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2019,Prescription,Total,360740.1669,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0420777876220686e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zuclopenthixol,2016,Prescription,Total,16454.122,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.724555787217078e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2017,Prescription,Total,15475.242,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.504481312842775e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2018,Prescription,Total,14533.664,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.131370379998119e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2019,Prescription,Total,13971.81,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.0360664516496606e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
13C-urea,2016,Total,Total,83.45,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.3961423188868128e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2017,Total,Total,88.4,XSQUKJJJFZCRTK-OUBTZVSYSA-N,2.5731174223660045e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2018,Total,Total,186,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.28727573913674e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
13C-urea,2019,Total,Total,204.6,XSQUKJJJFZCRTK-OUBTZVSYSA-N,5.910323687535979e-11,diagnostic agent,labelled urea used to detect H. pylori infection,NA,NA,NA,NA
4-aminosalicylic acid,2016,Total,Total,12390799.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.557833198371694e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2017,Total,Total,13384234.35,WUBBRNOQWQTFEX-UHFFFAOYSA-N,3.895837849662278e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2018,Total,Total,14345104.08,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.07776993427825e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
4-aminosalicylic acid,2019,Total,Total,15501228.04,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4.477872691628001e-6,antibacterial,antibacterial for tuberculosis,NA,NA,NA,NA
abacavir,2016,Total,Total,221508,MCGSCOLBFJQGHM-SCZZXKLOSA-N,6.36027193255818e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.135762845099675e-4
abacavir,2017,Total,Total,252378,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.346133810202347e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.311809608964705e-4
abacavir,2018,Total,Total,264834,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.52822786612118e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.3443264046644965e-4
abacavir,2019,Total,Total,248130,MCGSCOLBFJQGHM-SCZZXKLOSA-N,7.167784049796199e-8,antiviral,oral HIV reverse-transcriptase inhibitor,low,moderate,5.6e-4,1.2799614374636072e-4
abiraterone,2016,Total,Total,107280,GZOSMCIZMLWJML-VJLLXTKPSA-N,3.0803852363112915e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,23.695271048548395
abiraterone,2017,Total,Total,81902,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.3839758272242136e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,18.33827559403241
abiraterone,2018,Total,Total,76356,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.1705119695565857e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,16.696245919666044
abiraterone,2019,Total,Total,71596,GZOSMCIZMLWJML-VJLLXTKPSA-N,2.0682088696619058e-8,antineoplastic,androgen-supressing prostate cancer treatment,high,low,1.3e-9,15.909298997399274
acamprosate,2016,Total,Total,72615.87144,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.0850564719020765e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2017,Total,Total,72869.8572,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.12107125708872e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2018,Total,Total,74400.48504,AFCGFAGUEYAMAO-UHFFFAOYSA-N,2.114924083505365e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acamprosate,2019,Total,Total,60915.18384,AFCGFAGUEYAMAO-UHFFFAOYSA-N,1.7596698630506396e-8,other nervous system,treatment for alcohol withdrawal,NA,NA,NA,NA
acarbose,2016,Total,Total,24421.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,7.012269579472055e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2017,Total,Total,23097,XUFXOAAUWZOOIT-UGEKTDRHSA-N,6.722996957509911e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2018,Total,Total,19867.5,XUFXOAAUWZOOIT-UGEKTDRHSA-N,5.647577997166622e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acarbose,2019,Total,Total,11034.06,XUFXOAAUWZOOIT-UGEKTDRHSA-N,3.187432364989894e-9,anti-diabetic,starch enzyme-inhibiting type 2 diabetes drug,NA,NA,NA,NA
acetazolamide,2016,Total,Total,124689.75,BZKPWHYZMXOIDC-UHFFFAOYSA-N,3.580280248129622e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2017,Total,Total,156871,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.56614822583685e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2018,Total,Total,159839,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4.5436175638057925e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetazolamide,2019,Total,Total,181725.25,BZKPWHYZMXOIDC-UHFFFAOYSA-N,5.2495359222795586e-8,ophthalmological,"reduces body fluid pressure, wide applications",NA,NA,NA,NA
acetic acid,2016,Total,Total,7512.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.157102357176414e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2017,Total,Total,7935,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.309693070868127e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2018,Total,Total,8785,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.4972428692643144e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetic acid,2019,Total,Total,8982.5,QTBSBXVTEAMEQO-UHFFFAOYSA-N,2.594793867218569e-9,antibiotic,"acid used as an topical antiseptic, other diverse applications",NA,NA,NA,NA
acetylsalicylic acid,2016,Total,Total,11034291.32,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,3.168332221782796e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.11195520218313768
acetylsalicylic acid,2017,Total,Total,10197744.785,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.9683252008060594e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10488781628289963
acetylsalicylic acid,2018,Total,Total,10344527.04,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.940557357604085e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10390662041003834
acetylsalicylic acid,2019,Total,Total,10138922.415,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2.928852068204496e-6,analgesic,"aka aspirin, analgesic, anti-inflammatory and antiplatet agent for fevers, pain and heart conditions",low,low,2.83e-5,0.10349300594362176
aciclovir,2016,Total,Total,433878.62,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.2458177623034278e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,6.229088811517139e-4
aciclovir,2017,Total,Total,409429.025,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1917522143097584e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.958761071548792e-4
aciclovir,2018,Total,Total,414988.94,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.1796564271355229e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,5.898282135677614e-4
aciclovir,2019,Total,Total,430329.795,MKUXAQIIEYXACX-UHFFFAOYSA-N,1.243102825435485e-7,antiviral,topical and systemic HSV and varicella zoster treatment,low,high,2e-4,6.215514127177425e-4
acitretin,2016,Total,Total,11715.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.3639311368386403e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2017,Total,Total,12354,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.5959607054196405e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2018,Total,Total,12336.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.506799847089268e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
acitretin,2019,Total,Total,12033.5,IHUNBGSDBOWDMA-AQFIFDHZSA-N,3.476142722090137e-9,antipsoriatic,"teratogenic antipsoriatic retinoid, inhibits cell reproduction",NA,NA,NA,NA
aclidinium bromide,2016,Total,Total,822.6033600000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.361982891017955e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2017,Total,Total,914.54928,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.6620392375342587e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2018,Total,Total,869.6434800000001,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.472067136291638e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
aclidinium bromide,2019,Total,Total,789.1182,XLAKJQPTOJHYDR-QTQXQZBYSA-M,2.2795425169725094e-10,respiratory,muscarinic antagonist used to treat COPD,low,NA,NA,NA
adapalene,2016,Total,Total,227444.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,6.530723361255141e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2017,Total,Total,245696.46,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.1516497945662e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2018,Total,Total,267527.88,LZCDAPDGXCYOEH-UHFFFAOYSA-N,7.60480467455207e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adapalene,2019,Total,Total,287075.28,LZCDAPDGXCYOEH-UHFFFAOYSA-N,8.292804630938534e-8,anti-acne,"anti-acne retinoid, inhibits cell reproduction",NA,NA,NA,NA
adefovir dipivoxil,2016,Total,Total,17.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,5.082291077806661e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2017,Total,Total,15.3,WOZSCQDILHKSGG-UHFFFAOYSA-N,4.453472461787316e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2018,Total,Total,7.5,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.1319660238454594e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adefovir dipivoxil,2019,Total,Total,8.7,WOZSCQDILHKSGG-UHFFFAOYSA-N,2.5131874917674978e-12,antiviral,"prodrug of adefovir, a nucleotide analogue reverse-transcriptase inhibitor for hepatitis B",NA,NA,NA,NA
adrenaline,2016,Total,Total,124.18261674,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.5657186727479435e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2017,Total,Total,125.5177107,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.653527242281288e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2018,Total,Total,118.58509049,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.3709251181242574e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
adrenaline,2019,Total,Total,116.390152462,UCTWMZQNUQWSLP-VIFPVBQESA-N,3.3621870727863275e-11,other hormone,"natural hormone used as a medication for cardiac arrest, anaphylaxis, etc.",NA,NA,NA,NA
afatinib,2016,Total,Total,264.32,ULXXDDBFHOBEHA-CWDCEQMOSA-N,7.58955467619128e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.3717358363097752e-5
afatinib,2017,Total,Total,294.28,ULXXDDBFHOBEHA-CWDCEQMOSA-N,8.565803111469092e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.6768134723340914e-5
afatinib,2018,Total,Total,200.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,5.706846652629526e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,1.783389578946727e-5
afatinib,2019,Total,Total,235.76,ULXXDDBFHOBEHA-CWDCEQMOSA-N,6.81044923056443e-11,antineoplastic,tyrosine kinase inhibitor for lung carcinomas,low,low,3.2e-6,2.128265384551384e-5
aglepristone,2016,Total,Total,1039.2,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.9839078463597076e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2017,Total,Total,942.9,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.7445615583132415e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2018,Total,Total,1002,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.8483066078575337e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
aglepristone,2019,Total,Total,873,RTCKAOKDXNYXEH-FWSJOHTJSA-N,2.5218536555322136e-10,sex hormone,antiprogestogen used as abortifacient in animals,NA,NA,NA,NA
albendazole,2016,Total,Total,269372.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.734629679980084e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2017,Total,Total,296590,HXHWSAZORRCQMX-UHFFFAOYSA-N,8.633041813343138e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2018,Total,Total,249897.5,HXHWSAZORRCQMX-UHFFFAOYSA-N,7.103639725918942e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
albendazole,2019,Total,Total,237595,HXHWSAZORRCQMX-UHFFFAOYSA-N,6.863457265591939e-8,anthelminthic,broad-spectrum human and veterinary benzimidazole antihelminthic,NA,NA,NA,NA
alectinib,2017,Total,Total,1377.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.00987167539752e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2018,Total,Total,5241.6,KDGFLJKFZUIJMX-UHFFFAOYSA-N,1.4899884147451146e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alectinib,2019,Total,Total,15187.2,KDGFLJKFZUIJMX-UHFFFAOYSA-N,4.387158744249581e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
alendronic acid,2016,Total,Total,150355.3996,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.3172311067069784e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.9247555515517984e-4
alendronic acid,2017,Total,Total,146830.7834,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.2739009831016874e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.885364530092443e-4
alendronic acid,2018,Total,Total,144256.8582,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.1006762718545634e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.727887519867785e-4
alendronic acid,2019,Total,Total,140754.6266,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4.0660088158566066e-8,other musculoskeletal,"bisphosphonate treatment for osteoporosis, Paget's disease",low,moderate,1.1e-4,3.696371650778733e-4
alfaxalone,2016,Total,Total,36.7,DUHUCHOQIDJXAT-OLVMNOGESA-N,1.0537857771497428e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2017,Total,Total,121.2,DUHUCHOQIDJXAT-OLVMNOGESA-N,3.5278487736511277e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2018,Total,Total,153.9,DUHUCHOQIDJXAT-OLVMNOGESA-N,4.3747942809308825e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfaxalone,2019,Total,Total,203.3,DUHUCHOQIDJXAT-OLVMNOGESA-N,5.872770311222212e-11,anaesthetic,GABA agonist veterinary sedative and anaesthetic,NA,NA,NA,NA
alfentanil,2016,Total,Total,192.995,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.5415636528886813e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2017,Total,Total,186.595,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.4313444052758434e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2018,Total,Total,189.865,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.3971430548989084e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alfentanil,2019,Total,Total,194.61,IDBPHNDTYPBSNI-UHFFFAOYSA-N,5.621740434170953e-11,anaesthetic,opioid anaesthetic,low,NA,NA,NA
alimemazine,2016,Total,Total,175565.67,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.0411064305658113e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2017,Total,Total,171501.43,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.9920058540009476e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2018,Total,Total,171914.52,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,4.88687887527601e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
alimemazine,2019,Total,Total,177117.34,ZZHLYYDVIOPZBE-UHFFFAOYSA-N,5.1164262467026576e-8,antihistamine,"antihistamine, motion sickness and anti-anxiety drug",low,high,NA,NA
aliskiren,2016,Total,Total,2866.5,UXOWGYHJODZGMF-QORCZRPOSA-N,8.230727330244515e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
aliskiren,2017,Total,Total,1440.6,UXOWGYHJODZGMF-QORCZRPOSA-N,4.1932499532358207e-10,antihypertensive,renin-inhibiting treatment for high blood pressure,NA,NA,NA,NA
alitretinoin,2016,Total,Total,2679.6,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,7.69407184863883e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2017,Total,Total,3087,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,8.98553561407676e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2018,Total,Total,3252.2999999999997,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,9.245057465803447e-10,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
alitretinoin,2019,Total,Total,3581.1,SHGAZHPCJJPHSC-ZVCIMWCZSA-N,1.0344799685940903e-9,antineoplastic,antineoplastic retinoid and eczema treatment,NA,NA,NA,NA
allopurinol,2016,Total,Total,2871723.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,8.245726693031095e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2017,Total,Total,3206720.8,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.33401488590888e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2018,Total,Total,3212108.7,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.13080881773121e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
allopurinol,2019,Total,Total,3196137.4,OFCNXPDARWKPPY-UHFFFAOYSA-N,9.232750040977348e-7,antigout,"antigout medication, inhibits purine metabolism",low,NA,NA,NA
almotriptan,2016,Total,Total,1701.9375,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.886859757759645e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2017,Total,Total,1715.025,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,4.992036999200516e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2018,Total,Total,1813.0875,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.153921264345206e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
almotriptan,2019,Total,Total,1760.9625,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,5.086929802840945e-10,analgesic,triptan antimigraine medication,low,NA,NA,NA
alprazolam,2016,Total,Total,1920.512000000001,VREFGVBLTWBCJP-UHFFFAOYSA-N,5.514463843175499e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2017,Total,Total,1699.571,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.947054016570148e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2018,Total,Total,1621.41,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.6090547076310224e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprazolam,2019,Total,Total,1583.6755,VREFGVBLTWBCJP-UHFFFAOYSA-N,4.5747970777225734e-10,anti-anxiety,"benzodiazepine used for anxiety, panic and depression, aka Xanax",NA,NA,NA,NA
alprostadil,2016,Total,Total,11.99234,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.4434216149166065e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2017,Total,Total,12.92188,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.7612573029098216e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2018,Total,Total,11.87954,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.3769034211884118e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
alprostadil,2019,Total,Total,12.05914,GMVPRGQOIOIIMI-DWKJAMRDSA-N,3.483549403387714e-12,vasodilator,prostaglandin vasodilator for erectile dysfunction and neonatal heart issues,low,NA,NA,NA
altrenogest,2016,Total,Total,44.88,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.2886622800675872e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2017,Total,Total,53.13,VWAUPFMBXBWEQY-ANULTFPQSA-N,1.5464901431030068e-11,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2018,Total,Total,32.34,VWAUPFMBXBWEQY-ANULTFPQSA-N,9.193037494821622e-12,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
altrenogest,2019,Total,Total,1860.06,VWAUPFMBXBWEQY-ANULTFPQSA-N,5.373194857398912e-10,sex hormone,"veterinary birth control, progestin",NA,NA,NA,NA
ambrisentan,2016,Total,Total,117.9,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.3853227009796914e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2017,Total,Total,130.95,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.811648489353261e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2018,Total,Total,126.6,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.5987586482511356e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
ambrisentan,2019,Total,Total,124.65,OUJTZYPIHDYQMC-LJQANCHMSA-N,3.600791044239295e-11,antihypertensive,endothelin receptor antagonist for pulmonary hypertension,low,NA,NA,NA
amfetamine,2016,Total,Total,2363.055,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.78516008071549e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2017,Total,Total,2438.82,KWTSXDURSIMDCE-UHFFFAOYSA-N,7.098835104088981e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2018,Total,Total,2229.57,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.337823317046829e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amfetamine,2019,Total,Total,2190,KWTSXDURSIMDCE-UHFFFAOYSA-N,6.326299548242322e-10,stimulant,CNS stimulant for ADHD,NA,NA,NA,NA
amifampridine,2016,Total,Total,100,OYTKINVCDFNREN-UHFFFAOYSA-N,2.8713508914161926e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2017,Total,Total,132,OYTKINVCDFNREN-UHFFFAOYSA-N,3.8422115356596445e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2018,Total,Total,208,OYTKINVCDFNREN-UHFFFAOYSA-N,5.912652439464741e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amifampridine,2019,Total,Total,296,OYTKINVCDFNREN-UHFFFAOYSA-N,8.550614914519304e-11,other nervous system,cholinergic muscle stimulant used to treat some rare diseases,NA,NA,NA,NA
amiloride,2016,Total,Total,14693.575,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4.219040967434068e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2017,Total,Total,12526.4375,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.6461532320620876e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2018,Total,Total,11403.3175,XSDQTOBWRPYKKA-UHFFFAOYSA-N,3.241531395882979e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiloride,2019,Total,Total,9697.7625,XSDQTOBWRPYKKA-UHFFFAOYSA-N,2.80141326587723e-9,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure",low,NA,NA,NA
amiodarone,2016,Total,Total,292305.6,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.39311945125945e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3497133104691438
amiodarone,2017,Total,Total,302692.68,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.81067656708889e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.3671115236287038
amiodarone,2018,Total,Total,314712.87,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,8.94609528142524e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.37275397005938504
amiodarone,2019,Total,Total,339226.26,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,9.799301074839877e-8,cardiac,Group III antiarrhythmic for ventricular tachycardia or fibrillation,high,high,2.4e-7,0.40830421145166157
amisulpride,2016,Total,Total,77174.37,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.2159469609398305e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2017,Total,Total,78455.64,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.283660341254244e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2018,Total,Total,78187.365,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.222570742320049e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amisulpride,2019,Total,Total,83282.625,NTJOBXMMWNYJFB-UHFFFAOYSA-N,2.405802890017967e-8,antipsychotic,"atypical benzamide antipsychotic, antiemetic",NA,NA,NA,NA
amitriptyline,2016,Total,Total,389459.21,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1182740498037463e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2017,Total,Total,392819.36,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.14340536092609e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2018,Total,Total,388703.665,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.1049373428322769e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amitriptyline,2019,Total,Total,425743.685,KRMDCWKBEZIMAB-UHFFFAOYSA-N,1.2298548320011518e-7,antidepressant,"tricyclic antidepressant with sedative effects, also for pain syndromes",high,NA,NA,NA
amlodipine,2016,Total,Total,435018.7804,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.249091562884325e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2017,Total,Total,435269.7111,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.2669684129633796e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2018,Total,Total,468062.1878,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.330523575248497e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amlodipine,2019,Total,Total,523293.8289,HTIQEAQVCYTUBX-UHFFFAOYSA-N,1.5116500061041397e-7,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, artery disease, hypertension",NA,NA,NA,NA
amorolfine,2016,Total,Total,2836.5,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.144586803502031e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2017,Total,Total,2805.05,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.16484505159249e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2018,Total,Total,2981.1,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.474138551580931e-10,antifungal,topical antifungal,NA,NA,NA,NA
amorolfine,2019,Total,Total,2877.3,MQHLMHIZUIDKOO-AYHJJNSGSA-N,8.311717666738646e-10,antifungal,topical antifungal,NA,NA,NA,NA
amoxicillin,2016,Total,Total,2864063.95,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.223732575905482e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,10.543246892186517
amoxicillin,2017,Total,Total,2774019.1,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.074521353151656e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,10.351950452758533
amoxicillin,2018,Total,Total,2693397.9,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,7.656310415328947e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,9.81578258375506
amoxicillin,2019,Total,Total,2851173.4,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,8.236245202000241e-7,antibacterial,systemic penicillin antibiotic,low,high,7.8e-8,10.55928872051313
amphotericin B,2016,Total,Total,654.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.879299158431898e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2017,Total,Total,449.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3083894585447048e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2018,Total,Total,483,APKFDSVGJQXUKY-INPOYWNPSA-N,1.3729861193564758e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
amphotericin B,2019,Total,Total,492.5,APKFDSVGJQXUKY-INPOYWNPSA-N,1.4226952180407962e-10,antifungal,polyene antifungal for systemic fungal and protozoal infections with severe side effects,NA,NA,NA,NA
ampicillin,2016,Total,Total,481355,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.3821391083376416e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2017,Total,Total,497867.5,AVKUERGKIZMTKX-NJBDSQKTSA-N,1.4491759482803242e-7,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
ampicillin,2018,Total,Total,107865,AVKUERGKIZMTKX-NJBDSQKTSA-N,3.06619353549454e-8,antibacterial,systemic penicillin antibiotic,NA,NA,NA,NA
amsacrine,2017,Total,Total,4.95,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.4408293258723668e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2018,Total,Total,3.69,XCPGHVQEEXUHNC-UHFFFAOYSA-N,1.048927283731966e-12,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
amsacrine,2019,Total,Total,2.835,XCPGHVQEEXUHNC-UHFFFAOYSA-N,8.189524757656158e-13,antineoplastic,"adult leukaemia therapy, inhibits DNA replication and transcription",NA,NA,NA,NA
anagrelide,2016,Total,Total,101.95,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9273422337988077e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2017,Total,Total,103.55,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.0140985190723957e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2018,Total,Total,103.05,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,2.9293213167636613e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anagrelide,2019,Total,Total,107.9,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,3.1169302340426793e-11,antineoplastic,treats overproduction of platelets,NA,NA,NA,NA
anastrozole,2016,Total,Total,258.244,YBBLVLTVTVSKRW-UHFFFAOYSA-N,7.415091396028832e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,7.415091396028832e-5
anastrozole,2017,Total,Total,216.812,YBBLVLTVTVSKRW-UHFFFAOYSA-N,6.310890662647265e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,6.310890662647265e-5
anastrozole,2018,Total,Total,177.948,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.0583878668166905e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.0583878668166906e-5
anastrozole,2019,Total,Total,184.894,YBBLVLTVTVSKRW-UHFFFAOYSA-N,5.341072277044366e-11,sex hormone,estrogen agonist for breast cancer,low,high,1e-6,5.341072277044366e-5
anidulafungin,2016,Total,Total,768.5,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.2066331600533438e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2017,Total,Total,506.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,1.473429908599176e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2018,Total,Total,906.7,JHVAMHSQVVQIOT-MFAJLEFUSA-N,2.5774047917609037e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
anidulafungin,2019,Total,Total,1058.2,JHVAMHSQVVQIOT-MFAJLEFUSA-N,3.0568448319406516e-10,antifungal,echinocandin injected for candida blood and stomach infections,NA,NA,NA,NA
antazoline,2016,Total,Total,357.106,REYFJDPCWQRWAA-UHFFFAOYSA-N,1.0253766314300707e-10,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2017,Total,Total,368.116,REYFJDPCWQRWAA-UHFFFAOYSA-N,1.0714996527733983e-10,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2018,Total,Total,346.759,REYFJDPCWQRWAA-UHFFFAOYSA-N,9.857045419501701e-11,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
antazoline,2019,Total,Total,410.6799999999999,REYFJDPCWQRWAA-UHFFFAOYSA-N,1.1863400449644552e-10,antihistamine,"antihistamine for nasal congestion, allergic conjunctivitis and eye drops",NA,NA,NA,NA
apixaban,2016,Total,Total,88236.5689,QNZCBYKSOIHPEH-UHFFFAOYSA-N,2.533581507665213e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,7.037726410181147e-5
apixaban,2017,Total,Total,134931.107,QNZCBYKSOIHPEH-UHFFFAOYSA-N,3.9275292108691354e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.0909803363525375e-4
apixaban,2018,Total,Total,179092.2148,QNZCBYKSOIHPEH-UHFFFAOYSA-N,5.090913561184439e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.4141426558845663e-4
apixaban,2019,Total,Total,224196.9254,QNZCBYKSOIHPEH-UHFFFAOYSA-N,6.47642423687369e-8,anticoagulant,"inhibits clotting, used for atrial fibrillation, DVT",low,moderate,3.6e-4,1.7990067324649136e-4
apomorphine,2016,Total,Total,621.15,VMWNQDUVQKEIOC-CYBMUJFWSA-N,1.7835396062031677e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2017,Total,Total,737.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.1459624656553584e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2018,Total,Total,817.25,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.3231323106502687e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apomorphine,2019,Total,Total,1014.95,VMWNQDUVQKEIOC-CYBMUJFWSA-N,2.931907637666003e-10,dopaminergic,"dopaminergic for Parkinson's, erectile dysfunction, substance abuse, canine emesis",NA,NA,NA,NA
apraclonidine,2016,Total,Total,40.525,IEJXVRYNEISIKR-UHFFFAOYSA-N,1.163614948746412e-11,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2017,Total,Total,30.07,IEJXVRYNEISIKR-UHFFFAOYSA-N,8.752674308885267e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2018,Total,Total,23.5,IEJXVRYNEISIKR-UHFFFAOYSA-N,6.6801602080491065e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apraclonidine,2019,Total,Total,26.725,IEJXVRYNEISIKR-UHFFFAOYSA-N,7.720107553734069e-12,ophthalmological,reduces pressure in eye,low,NA,NA,NA
apremilast,2016,Total,Total,342.96,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,9.847585017200974e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2017,Total,Total,377.28,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,1.098173915283084e-10,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2018,Total,Total,165.12,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,4.693736398098163e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
apremilast,2019,Total,Total,75.6,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,2.1838732687083088e-11,immunosuppressant,supresses immune system to reduce inflammation for psoriasis and psoriatic arthritis,NA,NA,NA,NA
aprepitant,2016,Total,Total,3657.135,ATALOFNDEOCMKK-OITMNORJSA-N,1.0500917842279361e-9,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,5.833843245710757e-4
aprepitant,2017,Total,Total,1379.32,ATALOFNDEOCMKK-OITMNORJSA-N,4.014878193459137e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,2.230487885255076e-4
aprepitant,2018,Total,Total,924.14,ATALOFNDEOCMKK-OITMNORJSA-N,2.626980108368724e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.45943339353818e-4
aprepitant,2019,Total,Total,867.26,ATALOFNDEOCMKK-OITMNORJSA-N,2.505272395529058e-10,antiemetic,used to prevent nausea and vomiting from chemotherapy,low,high,1.8e-6,1.3918179975161435e-4
aripiprazole,2016,Total,Total,22934.58255,CEUORZQYGODEFX-UHFFFAOYSA-N,6.5853234049200765e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.0252311241567819
aripiprazole,2017,Total,Total,23956.4052,CEUORZQYGODEFX-UHFFFAOYSA-N,6.973149728210356e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026717048767089482
aripiprazole,2018,Total,Total,24564.66095,CEUORZQYGODEFX-UHFFFAOYSA-N,6.982803004357777e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.026754034499455084
aripiprazole,2019,Total,Total,25654.9684,CEUORZQYGODEFX-UHFFFAOYSA-N,7.411005251100049e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar, other mental disorders",low,moderate,2.61e-7,0.028394656134482943
arsenic trioxide,2016,Total,Total,4.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.205967374394801e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2017,Total,Total,7.5,QTLQKAJBUDWPIB-UHFFFAOYSA-N,2.1830747361702525e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2018,Total,Total,1.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,3.411145638152735e-13,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
arsenic trioxide,2019,Total,Total,6.2,QTLQKAJBUDWPIB-UHFFFAOYSA-N,1.7910071780412057e-12,antineoplastic,inorganic antineoplastic for acute promyelocytic leukaemia,NA,NA,NA,NA
articaine,2016,Total,Total,106270.4,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0513960777115544e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2017,Total,Total,96838.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.8187511701472516e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2018,Total,Total,102442,QTGIAADRBBLJGA-UHFFFAOYSA-N,2.9120381788636876e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
articaine,2019,Total,Total,104114.8,QTGIAADRBBLJGA-UHFFFAOYSA-N,3.0075863571020085e-8,anaesthetic,amide-type local anaesthetic used for dental pain management,NA,NA,NA,NA
asenapine,2016,Total,Total,118.2,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,3.39393675365394e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2017,Total,Total,74.1,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,2.1568778393362097e-11,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
asenapine,2018,Total,Total,0.6,VSWBSWWIRNCQIJ-GJZGRUSLSA-N,1.7055728190763679e-13,antipsychotic,atypical antipsychotic for schizophrenia and bipolar disorder,NA,NA,NA,NA
ataluren,2016,Total,Total,1245,OOUGLTULBSNHNF-UHFFFAOYSA-N,3.5748318598131596e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2017,Total,Total,1590,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.628118440680935e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2018,Total,Total,1593.75,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.5304278006716013e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
ataluren,2019,Total,Total,1586.25,OOUGLTULBSNHNF-UHFFFAOYSA-N,4.582234090593327e-10,other musculoskeletal,protein restoration therapy for Duchenne muscular dystrophy,NA,NA,NA,NA
atazanavir,2016,Total,Total,53994.45,AXRYRYVKAWYZBR-GASGPIRDSA-N,1.5503701213902704e-8,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2017,Total,Total,32043,AXRYRYVKAWYZBR-GASGPIRDSA-N,9.326968502813788e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2018,Total,Total,21825,AXRYRYVKAWYZBR-GASGPIRDSA-N,6.204021129390287e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atazanavir,2019,Total,Total,18564,AXRYRYVKAWYZBR-GASGPIRDSA-N,5.362622137605958e-9,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
atenolol,2016,Total,Total,501458.971,METKIMKYRPQLGS-UHFFFAOYSA-N,1.4398646633894968e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2017,Total,Total,451634.084,METKIMKYRPQLGS-UHFFFAOYSA-N,1.314601278365058e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2018,Total,Total,395443.916,METKIMKYRPQLGS-UHFFFAOYSA-N,1.124097324331197e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atenolol,2019,Total,Total,358400.45499999996,METKIMKYRPQLGS-UHFFFAOYSA-N,1.035319012126184e-7,beta blocker,beta blocker used for angina and hypertension,low,NA,NA,NA
atipamezole,2016,Total,Total,307.6,HSWPZIDYAHLZDD-UHFFFAOYSA-N,8.83227534199621e-11,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2017,Total,Total,346.7,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0091626813736354e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2018,Total,Total,363.8,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0341456526333044e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atipamezole,2019,Total,Total,368.3,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1.0639160381815744e-10,other,used for reversal of veterinary sedation,NA,NA,NA,NA
atomoxetine,2016,Total,Total,40642.94568,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1670015830804793e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003646879947126498
atomoxetine,2017,Total,Total,40555.651,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1804802280938378e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.0036890007127932433
atomoxetine,2018,Total,Total,39326.5652,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.1179053445459094e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003493454201705967
atomoxetine,2019,Total,Total,44075.1952,VHGCDTVCOLNTBX-QGZVFWFLSA-N,1.2732095318833437e-8,other nervous system,norepinephrine reuptake inhibitor for ADHD,low,high,3.2e-6,0.003978779787135449
atorvastatin,2016,Total,Total,2983202.8998,XUKUURHRXDUEBC-KAYWLYCHSA-N,8.565822305616101e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2017,Total,Total,3296228.5658,XUKUURHRXDUEBC-KAYWLYCHSA-N,9.594551075520914e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2018,Total,Total,3605848.4058,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.025006171773722e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atorvastatin,2019,Total,Total,3907533.054,XUKUURHRXDUEBC-KAYWLYCHSA-N,1.1287773787334314e-6,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
atovaquone,2016,Total,Total,230454,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.617142983304274e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2017,Total,Total,244364.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.112872274642556e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2018,Total,Total,240341.25,BSJMWHQBCZFXBR-UHFFFAOYSA-N,6.831991721713967e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atovaquone,2019,Total,Total,243922.5,BSJMWHQBCZFXBR-UHFFFAOYSA-N,7.046241102996066e-8,antibiotic,"quinone antibiotic for fungal pneumonia, toxoplasmosis, malaria, babesia",high,NA,NA,NA
atropine,2016,Total,Total,508.2525,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.4593712689395084e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2017,Total,Total,471.785,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.3732558858721104e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2018,Total,Total,420.61,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.195634972386185e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
atropine,2019,Total,Total,430.44,RKUNBYITZUJHSG-PJPHBNEVSA-N,1.2434211769613815e-10,other,"anticholinergic for reducing saliva during surgery, eye disorders; antidote",low,NA,NA,NA
avanafil,2017,Total,Total,516.8,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.5042840315370487e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2018,Total,Total,2318.4,WEAJZXNPAWBCOA-INIZCTEOSA-N,6.590333372911083e-10,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
avanafil,2019,Total,Total,3580.7999999999997,WEAJZXNPAWBCOA-INIZCTEOSA-N,1.0343933069564434e-9,vasodilator,PDE5 inhibitor for erectile dysfunction,NA,NA,NA,NA
axitinib,2016,Total,Total,110.544,RITAVMQDGBJQJZ-FMIVXFBMSA-N,3.174106129407116e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2017,Total,Total,68.152,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.9837454589263338e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2018,Total,Total,42.952,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.2209627287494687e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
axitinib,2019,Total,Total,38.36,RITAVMQDGBJQJZ-FMIVXFBMSA-N,1.1081134733816234e-11,antineoplastic,small molecule tyrosine kinase inhibitor for renal cell carcinoma,NA,NA,NA,NA
azacitidine,2016,Total,Total,668.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,1.9200723410900078e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2017,Total,Total,810.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.360049328115788e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2018,Total,Total,826.7,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.3499950825507217e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azacitidine,2019,Total,Total,968.8,NMUSYJAQQFHJEW-KVTDHHQDSA-N,2.798593151752129e-10,antineoplastic,nucleoside analogue used for myeloid leukaemia,NA,NA,NA,NA
azathioprine,2016,Total,Total,249961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.177264580070059e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2017,Total,Total,246332.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,7.17016343263545e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2018,Total,Total,237961.25,LMEKQMALGUDUQG-UHFFFAOYSA-N,6.764337333223939e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azathioprine,2019,Total,Total,186067.5,LMEKQMALGUDUQG-UHFFFAOYSA-N,5.3749714209706786e-8,immunosuppressant,immunosuppressant for organ transplants and rheumatoid arthritis,NA,NA,NA,NA
azelaic acid,2016,Total,Total,138112.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.965694499907189e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2017,Total,Total,138474,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.0306545468858606e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2018,Total,Total,140379,BDJRBEYXGGNYIS-UHFFFAOYSA-N,3.990443446152023e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelaic acid,2019,Total,Total,148864.5,BDJRBEYXGGNYIS-UHFFFAOYSA-N,4.3002804525083084e-8,dermatological,"facial antiseptic and keratin inhibitor used for acne, rosacea",NA,NA,NA,NA
azelastine,2016,Total,Total,1689.66,MBUVEWMHONZEQD-UHFFFAOYSA-N,4.851606747190284e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,4.410551588354804e-5
azelastine,2017,Total,Total,2350.41,MBUVEWMHONZEQD-UHFFFAOYSA-N,6.84149425418923e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,6.219540231081118e-5
azelastine,2018,Total,Total,2914.575,MBUVEWMHONZEQD-UHFFFAOYSA-N,8.285033165265838e-10,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,7.531848332059854e-5
azelastine,2019,Total,Total,3834.09,MBUVEWMHONZEQD-UHFFFAOYSA-N,1.1075617276219363e-9,antihistamine,"nasal spray antihistamine for rhinitis, eye drops for conjunctivitis",low,high,1.1e-5,1.0068742978381239e-4
azithromycin,2016,Total,Total,169157.32,MQTOSJVFKKJCRP-BICOPXKESA-N,4.857100215715743e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2017,Total,Total,150059.395,MQTOSJVFKKJCRP-BICOPXKESA-N,4.3678783219932367e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2018,Total,Total,140032.74,MQTOSJVFKKJCRP-BICOPXKESA-N,3.980600585413133e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
azithromycin,2019,Total,Total,140015.9025,MQTOSJVFKKJCRP-BICOPXKESA-N,4.0446691357648e-8,antibacterial,broad-spectrum macrolide antibacterial,NA,NA,NA,NA
aztreonam,2016,Total,Total,2810,WZPBZJONDBGPKJ-VEHQQRBSSA-N,8.068496004879502e-10,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2017,Total,Total,4266.3,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2418202329230862e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2018,Total,Total,4353.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.2375352113081611e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
aztreonam,2019,Total,Total,3906.5,WZPBZJONDBGPKJ-VEHQQRBSSA-N,1.1284789582287047e-9,antibacterial,penicillin-like antibacterial for gram-negative infections,NA,NA,NA,NA
baclofen,2016,Total,Total,53586.095,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5386448164576278e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2017,Total,Total,54551.2975,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5878607919674327e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2018,Total,Total,53989.755,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.5347243106098735e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
baclofen,2019,Total,Total,58862.845,KPYSYYIEGFHWSV-UHFFFAOYSA-N,1.7003835147568854e-8,muscle relaxant,muscle relaxant and antispasmodic for spinal cord disorders and multiple sclerosis,low,high,NA,NA
balsalazide,2016,Total,Total,451212.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.2955892705255842e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2017,Total,Total,451368.45,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.313828079865768e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2018,Total,Total,418080,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.188443140332413e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
balsalazide,2019,Total,Total,389025,IPOKCKJONYRRHP-UHFFFAOYSA-N,1.123784786189484e-7,alimentary,anti-inflammatory treatment for ulcerative colitis,NA,NA,NA,NA
bambuterol,2016,Total,Total,564.13,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.6198151783746168e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2814298286966436e-6
bambuterol,2017,Total,Total,540.39,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.5729490089053902e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,2.2154211393033667e-6
bambuterol,2018,Total,Total,375.4,ANZXOIAKUNOVQU-UHFFFAOYSA-N,1.0671200604687804e-10,respiratory,long-acting adrenoceptor agonist for chronic asthma,low,high,7.099999999999999e-5,1.5029860006602542e-6
baricitinib,2017,Total,Total,16.464,XUZMWHLSFXCVMG-UHFFFAOYSA-N,4.7922856608409385e-12,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2018,Total,Total,39.144,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.1127157071654222e-11,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
baricitinib,2019,Total,Total,349.944,XUZMWHLSFXCVMG-UHFFFAOYSA-N,1.010890670826535e-10,immunosuppressant,Janus kinase inhibitor for rheumatoid arthritis,NA,NA,NA,NA
barium sulfate,2016,Total,Total,0.582,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.671126218804224e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2017,Total,Total,0.762,TZCXTZWJZNENPQ-UHFFFAOYSA-L,2.218003931948977e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
barium sulfate,2018,Total,Total,0.48,TZCXTZWJZNENPQ-UHFFFAOYSA-L,1.3644582552610941e-13,diagnostic agent,radiocontrast agent used for x-ray imaging,NA,NA,NA,NA
bazedoxifene,2019,Total,Total,10.08,UCJGJABZCDBEDK-UHFFFAOYSA-N,2.911831024944412e-12,sex hormone,selective estrogen receptor modulator for postmenopausal osteoporosis,NA,NA,NA,NA
beclometasone,2016,Total,Total,1182.338,NBMKJKDGKREAPL-DVTGEIKXSA-N,3.3949072702552384e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2017,Total,Total,1665.07992,NBMKJKDGKREAPL-DVTGEIKXSA-N,4.846658542741847e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2018,Total,Total,2285.73212,NBMKJKDGKREAPL-DVTGEIKXSA-N,6.497470959269671e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
beclometasone,2019,Total,Total,2988.30912,NBMKJKDGKREAPL-DVTGEIKXSA-N,8.632392071170964e-10,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, etc.",low,high,NA,NA
bedaquiline,2017,Total,Total,131.6,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.83056847040007e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2018,Total,Total,112.8,QUIJNHUBAXPXFS-XLJNKUFUSA-N,3.206476899863571e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
bedaquiline,2019,Total,Total,94,QUIJNHUBAXPXFS-XLJNKUFUSA-N,2.7153979796108598e-11,antibacterial,ATP synthase-inhibiting antibacterial for drug-resistant tuberculosis,NA,NA,NA,NA
benazepril,2016,Total,Total,2973.635,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.53834950799639e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2017,Total,Total,3536.02,XPCFTKFZXHTYIP-PMACEKPBSA-N,1.0292527904790314e-9,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2018,Total,Total,3202.885,XPCFTKFZXHTYIP-PMACEKPBSA-N,9.104589331045688e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
benazepril,2019,Total,Total,2978.66,XPCFTKFZXHTYIP-PMACEKPBSA-N,8.604518453135835e-10,antihypertensive,"ACE inhibitor for hypertension, prevention of strokes and heart attacks",NA,NA,NA,NA
bendamustine,2016,Total,Total,556.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.59683001448883e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2017,Total,Total,447.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3014763885468323e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2018,Total,Total,484.125,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.376184068392244e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendamustine,2019,Total,Total,476.75,YTKUWDBFDASYHO-UHFFFAOYSA-N,1.3771978582760402e-10,antineoplastic,alkylating antineoplastic for chronic lymphocytic leukaemia,NA,NA,NA,NA
bendroflumethiazide,2016,Total,Total,17372.80875,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.9883429890715535e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2017,Total,Total,15819.7025,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.604745714863918e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2018,Total,Total,14377.175,HDWIHXWEUNVBIY-UHFFFAOYSA-N,4.086886482517379e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
bendroflumethiazide,2019,Total,Total,12909.53,HDWIHXWEUNVBIY-UHFFFAOYSA-N,3.729203370183594e-9,diuretic,thiazide diuretic for hypertension,NA,NA,NA,NA
benzocaine,2016,Total,Total,1401000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.022762598874086e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2017,Total,Total,1830800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,5.329030969307332e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2018,Total,Total,1531000,BLFLLBZGZJTVJG-UHFFFAOYSA-N,4.352053310009865e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzocaine,2019,Total,Total,2376800,BLFLLBZGZJTVJG-UHFFFAOYSA-N,6.865912678658609e-7,anaesthetic,topic anaesthetic and cough medicine,NA,NA,NA,NA
benzoyl peroxide,2016,Total,Total,286563.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,8.228243611723443e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2017,Total,Total,273130.5,OMPJBNCRMGITSC-UHFFFAOYSA-N,7.950190589700657e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2018,Total,Total,274201,OMPJBNCRMGITSC-UHFFFAOYSA-N,7.794496209392651e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzoyl peroxide,2019,Total,Total,271249.2,OMPJBNCRMGITSC-UHFFFAOYSA-N,7.835633294160235e-8,dermatological,facial antiseptic and sebostatic for acne,NA,NA,NA,NA
benzydamine,2016,Total,Total,14606.52,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.194044422248845e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2017,Total,Total,12815.22,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,3.7302110693951665e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2018,Total,Total,14215.2,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.0408431229557295e-09,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzydamine,2019,Total,Total,16450.41,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,4.752064901890456e-9,analgesic,NSAID for mouth and throat inflammation,NA,NA,NA,NA
benzyl benzoate,2016,Total,Total,13167,SESFRYSPDFLNCH-UHFFFAOYSA-N,3.780707718727701e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2017,Total,Total,16005,SESFRYSPDFLNCH-UHFFFAOYSA-N,4.658681486987319e-9,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2018,Total,Total,39666,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.1275541906913866e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzyl benzoate,2019,Total,Total,69201,SESFRYSPDFLNCH-UHFFFAOYSA-N,1.999023995606927e-8,antiparasitic,"topical insecticide, acaricide and vasodilator, used for scabies and lice",NA,NA,NA,NA
benzylpenicillin,2016,Total,Total,4266958.660279825,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.225193555283052e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2017,Total,Total,4228318.78087629,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.2307647876006975e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2018,Total,Total,4242239.572625091,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.2059080845132504e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
benzylpenicillin,2019,Total,Total,4234786.894533957,JGSARLDLIJGVTE-MBNYWOFBSA-N,1.2233118912234105e-6,antibacterial,penicillin antibacterial (also Penicillin G),low,high,NA,NA
betamethasone,2016,Total,Total,20510.6775,UREBDLICKHMUKA-DVTGEIKXSA-N,5.889335212317505e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0011325644639072125
betamethasone,2017,Total,Total,21876.3715,UREBDLICKHMUKA-DVTGEIKXSA-N,6.367700525429991e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0012245577933519213
betamethasone,2018,Total,Total,20974.0745,UREBDLICKHMUKA-DVTGEIKXSA-N,5.962135228747126e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.001146564467066755
betamethasone,2019,Total,Total,21817.558,UREBDLICKHMUKA-DVTGEIKXSA-N,6.302484352472634e-9,steroid,"steroid medication used for chronic asthma, skin diseases, ulcerative colitis, lupus, etc.",low,high,5.2e-6,0.0012120162216293527
betaxolol,2016,Total,Total,151.875,NWIUTZDMDHAVTP-UHFFFAOYSA-N,4.360864166338343e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2017,Total,Total,136.6375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.977198323512838e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2018,Total,Total,124.7625,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.546525480666922e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
betaxolol,2019,Total,Total,112.375,NWIUTZDMDHAVTP-UHFFFAOYSA-N,3.2462005101996854e-11,beta blocker,beta blocker used for hypertension and glaucoma,low,NA,NA,NA
bexarotene,2016,Total,Total,907.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.605750933960194e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2017,Total,Total,1027.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.9908123885532457e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2018,Total,Total,997.5,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.835514811714461e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bexarotene,2019,Total,Total,720,"NAVMQTYZDKMPEU-UHFFFAOYSA-N",2.0798793035317224e-10,antineoplastic,retinoid antineoplastic for skin T-cell lymphoma,NA,NA,NA,NA
bicalutamide,2016,Total,Total,185064.1,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3138396850413545e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05313839685041355
bicalutamide,2017,Total,Total,182527.5,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.3129489854175446e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.05312948985417545
bicalutamide,2018,Total,Total,167758.4,LKJPYSCBVHEWIU-UHFFFAOYSA-N,4.7687361201956816e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.04768736120195682
bicalutamide,2019,Total,Total,178994.2,LKJPYSCBVHEWIU-UHFFFAOYSA-N,5.170643500447471e-8,other hormone,"antiandrogen used for prostate cancer, feminising hormone therapy, hormone disorders",low,high,1e-6,0.051706435004474714
bictegravir,2019,Total,Total,355.5,SOLUWJRYJLAZCX-LYOVBCGYSA-N,1.026940406118788e-10,antiviral,HIV therapy used as part of combination with emtricitabine and tenofovir,NA,NA,NA,NA
bilastine,2016,Total,Total,7,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,2.009945623991335e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2017,Total,Total,29.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,8.499437639489517e-12,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2018,Total,Total,52.2,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.48384835259644e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bilastine,2019,Total,Total,34.8,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,1.0052749967069991e-11,antihistamine,antihistamine used for allergic rhinoconjunctivitis and hives,NA,NA,NA,NA
bimatoprost,2016,Total,Total,106.0422,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.0448436549773417e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2017,Total,Total,120.2427,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.499984007718651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2018,Total,Total,132.5379,AQOKCDNYWBIDND-FTOWTWDKSA-N,3.7675506622910276e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
bimatoprost,2019,Total,Total,138.7122,AQOKCDNYWBIDND-FTOWTWDKSA-N,4.0070088045465694e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
binimetinib,2019,Total,Total,27.72,ACWZRVQXLIRSDF-UHFFFAOYSA-N,8.007535318597132e-12,antineoplastic,small molecule kinase inhibitor for melanomas,NA,NA,NA,NA
biperiden,2016,Total,Total,3012.098,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.64879027733293e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2017,Total,Total,2900.302,YSXKPIUOCJLQIE-UHFFFAOYSA-N,8.44210136461874e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2018,Total,Total,2793.662,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.941323288144204e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
biperiden,2019,Total,Total,2678.254,YSXKPIUOCJLQIE-UHFFFAOYSA-N,7.736729255834791e-10,dopaminergic,anticholinergic antiparkinson agent,NA,NA,NA,NA
bisacodyl,2016,Total,Total,62219.2735,KHOITXIGCFIULA-UHFFFAOYSA-N,1.7865336642749293e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.012493242407516987
bisacodyl,2017,Total,Total,59429.0505,KHOITXIGCFIULA-UHFFFAOYSA-N,1.7298407832151483e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.012096788693812225
bisacodyl,2018,Total,Total,57256.697499999995,KHOITXIGCFIULA-UHFFFAOYSA-N,1.6275911161012967e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.011381756056652424
bisacodyl,2019,Total,Total,54102.1475,KHOITXIGCFIULA-UHFFFAOYSA-N,1.5628602341926464e-8,laxative,laxative used for constipation and pre-surgery preparation,low,high,1.43e-6,0.010929092546801723
bisoprolol,2016,Total,Total,60569.89545000001,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.7391742329334313e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2017,Total,Total,62497.81535,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8191653567522458e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2018,Total,Total,64300.5406,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.8278209049879405e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bisoprolol,2019,Total,Total,65651.6428,VHYCDWMUTMEGQY-UHFFFAOYSA-N,1.89649295975802e-8,beta blocker,beta blocker used for hypertension,NA,NA,NA,NA
bleomycin,2016,Total,Total,50.55,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.4514678756108851e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2017,Total,Total,47.25,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.3753370837872592e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2018,Total,Total,42.45,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.20669276949653e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
bleomycin,2019,Total,Total,39.3,OYVAGSVQBOHSSS-WXFSZRTFSA-O,1.135267453177732e-11,antineoplastic,"treatment for carcinomas, testicular cancer, lymphoma, etc.",NA,NA,NA,NA
boric acid,2016,Total,Total,304470,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.742402059094882e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2017,Total,Total,273870,KGBXLFKZBHKPEV-UHFFFAOYSA-N,7.971715706599294e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2018,Total,Total,288630,KGBXLFKZBHKPEV-UHFFFAOYSA-N,8.204658046166867e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
boric acid,2019,Total,Total,107190,KGBXLFKZBHKPEV-UHFFFAOYSA-N,3.096420313132852e-8,antiseptic,antiseptic for a broad range of infections,NA,NA,NA,NA
bortezomib,2016,Total,Total,31.9165,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.164347072588489e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.036521571686331e-5
bortezomib,2017,Total,Total,33.929,GXJABQQUPOEUTA-RDJZCZTQSA-N,9.875939029802732e-12,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.1946531177339404e-5
bortezomib,2018,Total,Total,38.2515,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.0873453114816611e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.4163229144036915e-5
bortezomib,2019,Total,Total,44.9005,GXJABQQUPOEUTA-RDJZCZTQSA-N,1.297050287058696e-11,antineoplastic,proteasome inhibitor for multiple myeloma and mantle cell lymphoma,low,NA,4.5e-7,2.8823339712415467e-5
bosentan,2016,Total,Total,7290.99,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.093499063580654e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2017,Total,Total,7220.29,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.1016576915763616e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2018,Total,Total,7065.73,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.008519505822077e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosentan,2019,Total,Total,6926.5,GJPICJJJRGTNOD-UHFFFAOYSA-N,2.000872777210066e-9,antihypertensive,endothelin receptor antagonist for pulmonary artery hypertension,NA,NA,NA,NA
bosutinib,2016,Total,Total,406,UBPYILGKFZZVDX-UHFFFAOYSA-N,1.1657684619149743e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2017,Total,Total,274.4,UBPYILGKFZZVDX-UHFFFAOYSA-N,7.9871427680682306e-11,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2018,Total,Total,882,UBPYILGKFZZVDX-UHFFFAOYSA-N,2.50719204404226e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
bosutinib,2019,Total,Total,1461.6,UBPYILGKFZZVDX-UHFFFAOYSA-N,4.2221549861693967e-10,antineoplastic,tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
brexpiprazole,2019,Total,Total,21.42,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,6.187640928006875e-12,antipsychotic,atypical antipsychotic for schizophrenia and major depressive disordered,NA,NA,NA,NA
brigatinib,2019,Total,Total,3.36,AILRADAXUVEEIR-UHFFFAOYSA-N,9.706103416481373e-13,antineoplastic,multikinase inhibitor for metastatic non-small cell lung cancer,NA,NA,NA,NA
brimonidine,2016,Total,Total,882.3695,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.53359245038346e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2017,Total,Total,899.191,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6173348734555536e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2018,Total,Total,832.37,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.3661127456909935e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brimonidine,2019,Total,Total,921.451,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2.6618150890536244e-10,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
brinzolamide,2016,Total,Total,7857.45,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.2561496061758163e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2017,Total,Total,7438.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.1652754001546774e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2018,Total,Total,8149.85,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.316693773258256e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brinzolamide,2019,Total,Total,8000.1,HCRKCZRJWPKOAR-JTQLQIEISA-N,2.3110058911366855e-9,ophthalmological,treatment for glaucoma or other causes of high eye pressure,low,NA,NA,NA
brivaracetam,2016,Total,Total,2293.442,MSYKRHVOOPPJKU-BDAKNGLRSA-N,6.585276731111336e-10,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,6.585276731111335e-7
brivaracetam,2017,Total,Total,8006.044,MSYKRHVOOPPJKU-BDAKNGLRSA-N,2.330372319075658e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,2.330372319075658e-6
brivaracetam,2018,Total,Total,12378.084,MSYKRHVOOPPJKU-BDAKNGLRSA-N,3.5186206037740134e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,3.518620603774013e-6
brivaracetam,2019,Total,Total,16399.99,MSYKRHVOOPPJKU-BDAKNGLRSA-N,4.737499969323225e-9,anticonvulsant,pyrrolidine anticonvulsant for partial onset seizures,low,high,0.001,4.7374999693232245e-6
bromfenac,2016,Total,Total,48.2625,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.38578572396974e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2017,Total,Total,35.046,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.0201071627176356e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2018,Total,Total,42.057,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.19552126753158e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromfenac,2019,Total,Total,46.0485,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,1.3302128070650074e-11,analgesic,NSAID for eye inflammation for cataract surgery,low,NA,NA,NA
bromhexine,2016,Total,Total,73347.64,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.10606811497274e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2017,Total,Total,69613.14,OJGDCBLYJGHCIH-UHFFFAOYSA-N,2.0262758298597715e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2018,Total,Total,68129.81999999999,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.936672819342758e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromhexine,2019,Total,Total,67677.172,OJGDCBLYJGHCIH-UHFFFAOYSA-N,1.955004852282731e-8,respiratory,expectorant for mucus respiratory disorders,NA,NA,NA,NA
bromocriptine,2016,Total,Total,486.4525,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.3967758195066355e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2017,Total,Total,438.3275,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.2758689218915549e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2018,Total,Total,387.02,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.1001513207315595e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bromocriptine,2019,Total,Total,357.735,OZVBMTJYIDMWIL-AYFBDAFISA-N,1.0333966981235012e-10,dopaminergic,"dopaminergic for tumours, Parkinson's, hyperprolactinaemia, type 2 diabetes, etc.",low,NA,NA,NA
bronopol,2016,Total,Total,843000,LVDKZNITIUWNER-UHFFFAOYSA-N,2.42054880146385e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2017,Total,Total,661500,LVDKZNITIUWNER-UHFFFAOYSA-N,1.925471917302163e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2018,Total,Total,1066500,LVDKZNITIUWNER-UHFFFAOYSA-N,3.031655685908243e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
bronopol,2019,Total,Total,1841000,LVDKZNITIUWNER-UHFFFAOYSA-N,5.318135830280418e-7,antibiotic,veterinary antibacterial and antifungal,NA,NA,NA,NA
budesonide,2016,Total,Total,19347.71718,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.555408497166138e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.459777322286207e-4
budesonide,2017,Total,Total,19341.64924,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.629902108228075e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.546397800265203e-4
budesonide,2018,Total,Total,19227.645,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.465691447808271e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.355455171870082e-4
budesonide,2019,Total,Total,19230.83728,VOVIALXJUBGFJZ-KWVAZRHASA-N,5.5552528400358745e-9,steroid,"steroid used for inflammation reducing in Crohn's, ulcerative colitis",low,high,8.6e-6,6.459596325623109e-4
bumetanide,2016,Total,Total,21770.992,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251215728621479e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2017,Total,Total,21814.135,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.349584934654302e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2018,Total,Total,22903.821,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.510689091765085e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bumetanide,2019,Total,Total,21639.479,MAEIEVLCKWDQJH-UHFFFAOYSA-N,6.251042293237408e-9,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease",low,NA,NA,NA
bupivacaine,2016,Total,Total,26533.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.618828098529268e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2017,Total,Total,26503.6,LEBVLXFERQHONN-UHFFFAOYSA-N,7.714578610341587e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2018,Total,Total,25890.95,LEBVLXFERQHONN-UHFFFAOYSA-N,7.359816763344213e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
bupivacaine,2019,Total,Total,24763.25,LEBVLXFERQHONN-UHFFFAOYSA-N,7.153412661553046e-9,anaesthetic,"anaesthetic for labour, surgery",NA,NA,NA,NA
buprenorphine,2016,Total,Total,19989.753480000003,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.739759647398795e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2017,Total,Total,20325.867759999997,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.916385119679125e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2018,Total,Total,20240.73956,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.753675871923292e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
buprenorphine,2019,Total,Total,20449.1021,RMRJXGBAOAMLHD-IHFGGWKQSA-N,5.907175587999595e-9,analgesic,opioid analgesic used for pain and addiction treatment,NA,NA,NA,NA
bupropion,2016,Total,Total,620904.9600000001,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.7828360103807357e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.017828360103807357
bupropion,2017,Total,Total,650137.38,SNPPWIUOZRMYNY-UHFFFAOYSA-N,1.8923979857572258e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.018923979857572257
bupropion,2018,Total,Total,725158.185,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.0613501497779205e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.020613501497779203
bupropion,2019,Total,Total,854769.33,SNPPWIUOZRMYNY-UHFFFAOYSA-N,2.4691903316120517e-7,antidepressant,"antidepressant for depression, smoking cessation",low,high,1e-5,0.024691903316120516
buspirone,2016,Total,Total,10485.42,QWCRAEMEVRGPNT-UHFFFAOYSA-N,3.0107320063873173e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2017,Total,Total,9892.25,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.8794028078506912e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2018,Total,Total,9247.26,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.628645884488688e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
buspirone,2019,Total,Total,9514.23,QWCRAEMEVRGPNT-UHFFFAOYSA-N,2.748395842505642e-9,anti-anxiety,anti-anxiety medication,NA,NA,NA,NA
busulfan,2016,Total,Total,26.88,COVZYZSDYWQREU-UHFFFAOYSA-N,7.718191196126725e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2017,Total,Total,34.08,COVZYZSDYWQREU-UHFFFAOYSA-N,9.919891601157628e-12,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2018,Total,Total,50.4,COVZYZSDYWQREU-UHFFFAOYSA-N,1.4326811680241487e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
busulfan,2019,Total,Total,42.24,COVZYZSDYWQREU-UHFFFAOYSA-N,1.220195858071944e-11,antineoplastic,"antineoplastic treatment for leukaemia symptoms, stem cell transplants",NA,NA,NA,NA
butorphanol,2016,Total,Total,668.16,IFKLAQQSCNILHL-QHAWAJNXSA-N,1.9185218116086432e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2017,Total,Total,711.66,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.071475955657229e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2018,Total,Total,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0387280430692847e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
butorphanol,2019,Total,Total,717.2,IFKLAQQSCNILHL-QHAWAJNXSA-N,2.0717908840179884e-10,analgesic,opioid analgesic for migraines and pain management in humans and animals,NA,NA,NA,NA
cabazitaxel,2016,Total,Total,2.88,BMQGVNUXMIRLCK-OAGWZNDDSA-N,8.269490567278635e-13,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,9.291562435144534e-7
cabazitaxel,2017,Total,Total,10.08,BMQGVNUXMIRLCK-OAGWZNDDSA-N,2.9340524454128196e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,3.2966881409132805e-6
cabazitaxel,2018,Total,Total,33.84,BMQGVNUXMIRLCK-OAGWZNDDSA-N,9.619430699590714e-12,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.0808349100663725e-5
cabazitaxel,2019,Total,Total,37.8,BMQGVNUXMIRLCK-OAGWZNDDSA-N,1.0919366343541544e-11,antineoplastic,mitotic inhibitor used with prednisone for metastatic prostate cancer,low,high,8.9e-7,1.2268950947799489e-5
cabergoline,2016,Total,Total,94.44608,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.7118783599876503e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2017,Total,Total,84.32452,KORNTPPJEAJQIU-KJXAQDMKSA-N,2.4544897233557758e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2018,Total,Total,67.0617,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.9063102120175608e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabergoline,2019,Total,Total,48.05075,KORNTPPJEAJQIU-KJXAQDMKSA-N,1.3880522283913462e-11,dopaminergic,"dopaminergic prolactin inhibitor for hyperprolactinemia, Parkinson's, etc.",NA,NA,NA,NA
cabozantinib,2016,Total,Total,248.64,ONIQOQHATWINJY-UHFFFAOYSA-N,7.13932685641722e-11,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2017,Total,Total,566.04,ONIQOQHATWINJY-UHFFFAOYSA-N,1.647610164882413e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2018,Total,Total,891.64,ONIQOQHATWINJY-UHFFFAOYSA-N,2.5345949140020866e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
cabozantinib,2019,Total,Total,1194.96,ONIQOQHATWINJY-UHFFFAOYSA-N,3.4519063507614824e-10,antineoplastic,"multikinase inhibitor for kidney, liver, thyroid cancer",NA,NA,NA,NA
caffeine,2016,Total,Total,1259739.265,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.6171534615097297e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.009042883653774324
caffeine,2017,Total,Total,1202152.065,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.499183736181866e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.008747959340454664
caffeine,2018,Total,Total,1119076.5,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.181110768111858e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007952776920279644
caffeine,2019,Total,Total,1045576.1,RYYVLZVUVIJVGH-UHFFFAOYSA-N,3.020377903690854e-7,stimulant,"ubiquitous stimulant, adjuvant in many over-the-counter formulations",low,NA,4e-5,0.007550944759227135
calcipotriol,2016,Total,Total,249.97125,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.177551715159199e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2017,Total,Total,249.35925,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.258265052071494e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2018,Total,Total,259.86625,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.387013543255066e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcipotriol,2019,Total,Total,271.7295,LWQQLNNNIPYSNX-UROSTWAQSA-N,7.849507822347545e-11,antipsoriatic,synthetic vitamin D used for treatment of psoriasis,high,high,NA,NA
calcium folinate,2016,Total,Total,6309.45,KVUAALJSMIVURS-ZEDZUCNESA-L,1.8116644881845895e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2017,Total,Total,6863.55,KVUAALJSMIVURS-ZEDZUCNESA-L,1.997819014058845e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2018,Total,Total,7372.3,KVUAALJSMIVURS-ZEDZUCNESA-L,2.0956657490127843e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium folinate,2019,Total,Total,8149.15,KVUAALJSMIVURS-ZEDZUCNESA-L,2.354062281441047e-9,other,"prodrug of folinic acid, used to mitigate chemotherapy toxicity, folate deficiency, methanol poisoning, etc.",NA,NA,NA,NA
calcium polystyrene sulfonate,2016,Total,Total,2230800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.405409568571243e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2017,Total,Total,2436600,IJBYVKWTVVYTPL-UHFFFAOYSA-M,7.092373202869917e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2018,Total,Total,2256900,IJBYVKWTVVYTPL-UHFFFAOYSA-M,6.415512158955756e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
calcium polystyrene sulfonate,2019,Total,Total,1675800,IJBYVKWTVVYTPL-UHFFFAOYSA-M,4.840919078970084e-7,metabolic,potassium binder for treatment of hyperkalaemia,NA,NA,NA,NA
canagliflozin,2019,Total,Total,11529,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,3.330406734780171e-9,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes treatment and symptom relief,low,moderate,5.6e-5,5.9471548835360196e-5
candesartan,2016,Total,Total,792375.8210400001,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.275189020079842e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0022751890200798422
candesartan,2017,Total,Total,832738.27648,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.4239065243005956e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.002423906524300596
candesartan,2018,Total,Total,885051.03496,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.5158649812053066e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0025158649812053067
candesartan,2019,Total,Total,954982.78608,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2.7586790722178533e-7,antihypertensive,angiotensin II receptor blocker for hypertension and some types of heart failure,low,high,9.999999999999999e-5,0.0027586790722178537
capecitabine,2016,Total,Total,223845,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.427375402890577e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2017,Total,Total,215490,GAGWJHPBXLXJQN-UORFTKCHSA-N,6.27241033196437e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2018,Total,Total,209496,GAGWJHPBXLXJQN-UORFTKCHSA-N,5.955178055087046e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
capecitabine,2019,Total,Total,253584,GAGWJHPBXLXJQN-UORFTKCHSA-N,7.325334907038727e-8,antineoplastic,"antimetabolite for chemotherapy of colon, breast, colorectal cancer",NA,NA,NA,NA
captopril,2016,Total,Total,28587.95,FAKRSMQSSFJEIM-RQJHMYQMSA-N,8.208603571626155e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2017,Total,Total,26218.65,FAKRSMQSSFJEIM-RQJHMYQMSA-N,7.631636324198692e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2018,Total,Total,23300.325,FAKRSMQSSFJEIM-RQJHMYQMSA-N,6.623400165940928e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
captopril,2019,Total,Total,20354.975,FAKRSMQSSFJEIM-RQJHMYQMSA-N,5.879984892556337e-9,antihypertensive,"ACE inhibitor for hypertension, prevention and treatment of strokes, hear failure",NA,NA,NA,NA
carbachol,2016,Total,Total,3.92,AIXAANGOTKPUOY-UHFFFAOYSA-N,1.1255695494351477e-12,ophthalmological,"lowers pressure in eye, used for post-surgery relief",low,NA,NA,NA
carbamazepine,2016,Total,Total,2233819.725,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.414080258641825e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.256563210345673
carbamazepine,2017,Total,Total,2129609.475,FFGPTBGBLSHEPO-UHFFFAOYSA-N,6.198795523708394e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.24795182094833576
carbamazepine,2018,Total,Total,1989509.9,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.655423347872237e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22621693391488945
carbamazepine,2019,Total,Total,1926617.325,FFGPTBGBLSHEPO-UHFFFAOYSA-N,5.565460416796042e-7,anticonvulsant,dibenzazepine anticonvulsant used for seizure/nerve pain conditions and bipolar disorder,low,high,2.5e-6,0.22261841667184168
carbamide,2016,Total,Total,2357855,XSQUKJJJFZCRTK-UHFFFAOYSA-N,6.770229056080127e-7,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2017,Total,Total,5509474,XSQUKJJJFZCRTK-UHFFFAOYSA-N,1.603679133198249e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2018,Total,Total,8185423.5,XSQUKJJJFZCRTK-UHFFFAOYSA-N,2.3268059723714912e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbamide,2019,Total,Total,10434144,XSQUKJJJFZCRTK-UHFFFAOYSA-N,3.0141333549541256e-6,dermatological,"aka urea, used as a topical emollient",NA,NA,NA,NA
carbimazole,2016,Total,Total,18825.765,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.405537711434176e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2017,Total,Total,20116.76,CFOYWRHIYXMDOT-UHFFFAOYSA-N,5.855518737280038e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2018,Total,Total,22214.275,CFOYWRHIYXMDOT-UHFFFAOYSA-N,6.314677272581281e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carbimazole,2019,Total,Total,23105.505,CFOYWRHIYXMDOT-UHFFFAOYSA-N,6.674536339881769e-9,antithyroid,"imidazole derivative inhibiting thyroid hormone production, for hyperthyroidism",NA,NA,NA,NA
carfilzomib,2016,Total,Total,34.9,BLMPQMFVWMYDKT-NZTKNTHTSA-N,1.0021014611042511e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2017,Total,Total,105.36,BLMPQMFVWMYDKT-NZTKNTHTSA-N,3.066783389371971e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2018,Total,Total,313.56,BLMPQMFVWMYDKT-NZTKNTHTSA-N,8.913323552493097e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carfilzomib,2019,Total,Total,334.15999999999997,BLMPQMFVWMYDKT-NZTKNTHTSA-N,9.652950945391116e-11,antineoplastic,proteasome inhibitor for multiple myeloma,high,NA,NA,NA
carglumic acid,2016,Total,Total,34,LCQLHJZYVOQKHU-VKHMYHEASA-N,9.762593030815054e-12,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2017,Total,Total,701,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.0404471867404627e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2018,Total,Total,828,LCQLHJZYVOQKHU-VKHMYHEASA-N,2.3536904903253875e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
carglumic acid,2019,Total,Total,575,LCQLHJZYVOQKHU-VKHMYHEASA-N,1.661014721570473e-10,metabolic,carbamoyl phosphate synthetase inhibitor for hyperammonaemia,NA,NA,NA,NA
cariprazine,2019,Total,Total,5.376,KPWSJANDNDDRMB-UHFFFAOYSA-N,1.5529765466370198e-12,antipsychotic,atypical antipsychotic for schizophrenia and bipolar I disorder,NA,NA,NA,NA
carmustine,2019,Total,Total,40.4,DLGOEMSEDOSKAD-UHFFFAOYSA-N,1.1670433869816887e-11,antineoplastic,"alkylating antineoplastic for brain tumours, lymphomas and multiple myeloma",NA,NA,NA,NA
carprofen,2016,Total,Total,107750.8,PUXBGTOOZJQSKH-UHFFFAOYSA-N,3.093903556308079e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2017,Total,Total,95846.4,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.7898647252382464e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2018,Total,Total,92620.6,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.6328529641090772e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carprofen,2019,Total,Total,88610.1,PUXBGTOOZJQSKH-UHFFFAOYSA-N,2.5596987926927265e-8,analgesic,NSAID veterinary analgesic for joint and post-operative paint,NA,NA,NA,NA
carvedilol,2016,Total,Total,175604.29374999998,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.042215453955734e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2017,Total,Total,175251.63125,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.10116544872667e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2018,Total,Total,172444.5,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4.901944199986911e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
carvedilol,2019,Total,Total,173981.75,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5.025847791905976e-8,beta blocker,non-cardioselective beta blocker for heart failure and hypertension,NA,NA,NA,NA
caspofungin,2016,Total,Total,153.09,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3957510796690496e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.791502159338098e-6
caspofungin,2017,Total,Total,148.74,JYIKNQVWKBUSNH-OGZDCFRISA-N,4.3294738167728455e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,8.65894763354569e-6
caspofungin,2018,Total,Total,98.77,JYIKNQVWKBUSNH-OGZDCFRISA-N,2.807657122336214e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,5.615314244672427e-6
caspofungin,2019,Total,Total,110.72,JYIKNQVWKBUSNH-OGZDCFRISA-N,3.1983921734310044e-11,antifungal,echinocandin antifungal for internal infections,low,moderate,5e-6,6.3967843468620086e-6
cefalexin,2016,Total,Total,439772.75,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.2627418777330508e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2017,Total,Total,365434.5,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.0636944329000109e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2018,Total,Total,362615.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,1.0307778569709696e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalexin,2019,Total,Total,317257.25,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,9.164677613477634e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2016,Total,Total,706160,XIURVHNZVLADCM-IUODEOHRSA-N,2.0276331454824586e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2017,Total,Total,607370,XIURVHNZVLADCM-IUODEOHRSA-N,1.7679121366769685e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2018,Total,Total,535650,XIURVHNZVLADCM-IUODEOHRSA-N,1.522650134230427e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefalotin,2019,Total,Total,15320,XIURVHNZVLADCM-IUODEOHRSA-N,4.425520962514721e-9,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2017,Total,Total,49420,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.4385007128204518e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2018,Total,Total,154120,MLYYVTUWGNIJIB-BXKDBHETSA-N,4.3810480479341637e-8,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefazolin,2019,Total,Total,522400,MLYYVTUWGNIJIB-BXKDBHETSA-N,1.509067983562461e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2016,Total,Total,921690,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.646495403109391e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2017,Total,Total,894152,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.602667521994805e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2018,Total,Total,964915,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.742887994531789e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefotaxime,2019,Total,Total,910315,GPRBEKHLDVQUJE-QSWIMTSFSA-N,2.629646289159001e-7,antibacterial,beta-lactam cephalosporin antibiotic,NA,NA,NA,NA
cefovecin,2016,Total,Total,527.68,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.5151544383824963e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2017,Total,Total,497.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.4483973182910902e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2018,Total,Total,480,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.3644582552610938e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
cefovecin,2019,Total,Total,401.6,ZJGQFXVQDVCVOK-QFKLAVHZSA-N,1.1601104559699164e-10,antibacterial,beta-lactam cephalosporin antibiotic for cats and dogs,NA,NA,NA,NA
ceftaroline fosamil,2016,Total,Total,168,ZCCUWMICIWSJIX-NQJJCJBVSA-N,4.823869497579204e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2017,Total,Total,120,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.492919577872404e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2018,Total,Total,132,ZCCUWMICIWSJIX-NQJJCJBVSA-N,3.752260201968009e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftaroline fosamil,2019,Total,Total,186,ZCCUWMICIWSJIX-NQJJCJBVSA-N,5.3730215341236165e-11,antibacterial,"beta-lactam cephalosporin antibiotic, prodrug of ceftaroline, for MRSA, etc.",NA,NA,NA,NA
ceftazidime,2016,Total,Total,46670,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3400594610239373e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010308149700184132
ceftazidime,2017,Total,Total,51020,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.4850729738587506e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.011423638260451927
ceftazidime,2018,Total,Total,47690,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.3556461290291995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.010428047146378457
ceftazidime,2019,Total,Total,59760,ORFOPKXBNMVMKC-DWVKKRMSSA-N,1.7262998219313297e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,1.3e-6,0.013279229399471766
ceftolozane,2016,Total,Total,320,JHFNIHVVXRKLEF-DCZLAGFPSA-N,9.188322852531816e-11,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2017,Total,Total,1000,JHFNIHVVXRKLEF-DCZLAGFPSA-N,2.91076631489367e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2018,Total,Total,1460,JHFNIHVVXRKLEF-DCZLAGFPSA-N,4.150227193085828e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftolozane,2019,Total,Total,2470,JHFNIHVVXRKLEF-DCZLAGFPSA-N,7.135141499615771e-10,antibacterial,beta-lactam cephalosporin antibiotic used in combination with tazobactam,NA,NA,NA,NA
ceftriaxone,2016,Total,Total,85970,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.4685003613505007e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2017,Total,Total,91200,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6546188791830273e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2018,Total,Total,93290,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.6518814715272387e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
ceftriaxone,2019,Total,Total,89470,VAAUVRVFOQPIGI-SPQHTLEESA-N,2.5845389067636563e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,NA,NA,NA
cefuroxime,2016,Total,Total,217464.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,6.244176037640995e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,8.216021102159204e-4
cefuroxime,2017,Total,Total,189003.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,5.501457488885845e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,7.238759853797164e-4
cefuroxime,2018,Total,Total,152747,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.3420188565909655e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.713182706040743e-4
cefuroxime,2019,Total,Total,154180.75,JFPVXVDWJQMJEE-IZRZKJBUSA-N,4.4538520962222035e-8,antibacterial,beta-lactam cephalosporin antibiotic,low,high,7.6e-5,5.860331705555531e-4
celecoxib,2016,Total,Total,313284,RZEKVGVHFLEQIL-UHFFFAOYSA-N,8.995482926664306e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2017,Total,Total,331813.5,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.658315586269709e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2018,Total,Total,341206.4,RZEKVGVHFLEQIL-UHFFFAOYSA-N,9.699206025581646e-8,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
celecoxib,2019,Total,Total,385292.6,RZEKVGVHFLEQIL-UHFFFAOYSA-N,1.1130029229776757e-7,analgesic,"NSAID for arthritis, ankylosing spondylitis, menstrual pain",NA,NA,NA,NA
ceritinib,2016,Total,Total,1822.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,5.233036999606011e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2017,Total,Total,2272.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,6.614716450595866e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2018,Total,Total,1507.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,4.2852517079293736e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
ceritinib,2019,Total,Total,742.5,VERWOWGGCGHDQE-UHFFFAOYSA-N,2.1448755317670892e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cetirizine,2016,Total,Total,648774.39,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.862858923054497e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2017,Total,Total,658082.18,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.915523441975793e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2018,Total,Total,670289.17,ZKLPARSLTMPFCP-UHFFFAOYSA-N,1.9053783154554314e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetirizine,2019,Total,Total,709752.1699999999,ZKLPARSLTMPFCP-UHFFFAOYSA-N,2.0502761791940677e-7,antihistamine,antihistamine for colds and allergic reactions,NA,NA,NA,NA
cetylpyridinium,2016,Total,Total,33935.98,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.744210642408209e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2017,Total,Total,33221.51,NEUSVAOJNUQRTM-UHFFFAOYSA-N,9.67000522379032e-9,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2018,Total,Total,36098.61,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0261468003739724e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
cetylpyridinium,2019,Total,Total,37280.55,NEUSVAOJNUQRTM-UHFFFAOYSA-N,1.0769311717955496e-8,antiseptic,ammonium compound used in mouth products for plaque and gingivitis,NA,NA,NA,NA
chlorambucil,2016,Total,Total,51.2,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.4701316564050907e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2017,Total,Total,40.1,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.1672172922723618e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2018,Total,Total,34.95,JCKYGMPEJWAADB-UHFFFAOYSA-N,9.934961671119842e-12,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chlorambucil,2019,Total,Total,35,JCKYGMPEJWAADB-UHFFFAOYSA-N,1.0110524392168096e-11,antineoplastic,alkylating antineoplastic for lymphomas and leukaemia,NA,NA,NA,NA
chloramphenicol,2016,Total,Total,20504.68,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.887613119620378e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2017,Total,Total,20191.535,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.877283992399656e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2018,Total,Total,20336.5725,WIIZWVCIJKGZOK-RKDXNWHRSA-N,5.7809175481959885e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chloramphenicol,2019,Total,Total,20842.3125,WIIZWVCIJKGZOK-RKDXNWHRSA-N,6.020763112012572e-9,antibacterial,broad-spectrum amphenicol antibiotic with serious side effects,NA,NA,NA,NA
chlorhexidine,2016,Total,Total,2051594.74,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,5.890848385523772e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,7.012914744671158
chlorhexidine,2017,Total,Total,2117925.43,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,6.164785999100693e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,7.339030951310349
chlorhexidine,2018,Total,Total,2086509.28,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,5.931155857864336e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,7.060899830790877
chlorhexidine,2019,Total,Total,2189451.96,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,6.324716413445785e-7,antiseptic,antiseptic used for cleaning skin,low,high,8.4e-8,7.529424301721173
chlorprothixene,2016,Total,Total,205340.135,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.8960357967577135e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2017,Total,Total,196536.425,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.720716055396262e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2018,Total,Total,177104.97,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,5.0344237159222583e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
chlorprothixene,2019,Total,Total,163988.0150000001,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,4.737156644802082e-8,antipsychotic,"typical thioxanthene-derived antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ciclesonide,2016,Total,Total,960.6624,LUKZNWIVRBCLON-GXOBDPJESA-N,2.7583988385900185e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2017,Total,Total,1141.9296000000002,LUKZNWIVRBCLON-GXOBDPJESA-N,3.3238902136600033e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2018,Total,Total,1112.1216,LUKZNWIVRBCLON-GXOBDPJESA-N,3.1613406207795335e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclesonide,2019,Total,Total,1184.5728,LUKZNWIVRBCLON-GXOBDPJESA-N,3.421900625342532e-10,steroid,steroid taken nasal for nasal allergy symptoms,NA,NA,NA,NA
ciclopirox,2016,Total,Total,4128.96,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.18556929766218e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2017,Total,Total,4164.864,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.212294583731331e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2018,Total,Total,4593.6,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.3057865502848672e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclopirox,2019,Total,Total,4581.984,SCKYRAXSEDYPSA-UHFFFAOYSA-N,1.323607457043541e-9,antifungal,topical antifungal for superficial skin infections,NA,NA,NA,NA
ciclosporin,2016,Total,Total,187506.8,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.383978173265977e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0026653357293395926
ciclosporin,2017,Total,Total,174048.57299999995,PMATZTZNYRCHOR-CGLBZJNRSA-N,5.0661472344371195e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.002507993680414416
ciclosporin,2018,Total,Total,163914.435,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.6594667498376674e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0023066667078404293
ciclosporin,2019,Total,Total,163872.71800000002,PMATZTZNYRCHOR-CGLBZJNRSA-N,4.7338260358568125e-8,immunosuppressant,"immunosuppressant for organ transplants, dry eyes, various immune disorders",NA,low,2.02e-5,0.0023434782355726794
cilastatin,2016,Total,Total,8080,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.320051520264283e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2017,Total,Total,8565,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.493071348706428e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2018,Total,Total,7635,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.1703414122746773e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cilastatin,2019,Total,Total,7800,DHSUYTOATWAVLW-WFVMDLQDSA-N,2.253202578826033e-9,antibiotic,degradation inhibitor used with antibiotic imipenem to prolong effects,NA,NA,NA,NA
cimicoxib,2016,Total,Total,78.06400000000001,KYXDNECMRLFQMZ-UHFFFAOYSA-N,2.2414913598751367e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2017,Total,Total,59.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.7231736584170528e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2018,Total,Total,67.2,KYXDNECMRLFQMZ-UHFFFAOYSA-N,1.910241557365532e-11,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cimicoxib,2019,Total,Total,20.48,KYXDNECMRLFQMZ-UHFFFAOYSA-N,5.916101130045789e-12,analgesic,coxib NSAID used for arthritis and pain management in dogs,NA,NA,NA,NA
cinacalcet,2016,Total,Total,8650.3032,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.483805580434034e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.004967611160868068
cinacalcet,2017,Total,Total,8726.9364,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.540207250533943e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.005080414501067886
cinacalcet,2018,Total,Total,9831.4188,VDHAWDNDOKGFTD-MRXNPFEDSA-N,2.7947001130393992e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.0055894002260787985
cinacalcet,2019,Total,Total,10500.5376,VDHAWDNDOKGFTD-MRXNPFEDSA-N,3.0333126153050927e-9,antithyroid,calcimimetic for hyperparathyroidism and hypercalcemia,low,high,5e-7,0.006066625230610185
ciprofloxacin,2016,Total,Total,969510.6875,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.783805376790651e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,55.676107535813024
ciprofloxacin,2017,Total,Total,811026.0705,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.360707366511979e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,47.21414733023958
ciprofloxacin,2018,Total,Total,753169.644,MYSWGUAQZAJSOK-UHFFFAOYSA-N,2.140976121599707e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,42.81952243199414
ciprofloxacin,2019,Total,Total,643892.9005,MYSWGUAQZAJSOK-UHFFFAOYSA-N,1.86002710755689e-7,antibacterial,quinolone antibiotic with serious side effects,low,high,5e-9,37.200542151137796
cisatracurium,2016,Total,Total,598.65,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7189342111463034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2017,Total,Total,589.05,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7145868977881162e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2018,Total,Total,563.75,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.6025277945905034e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
cisatracurium,2019,Total,Total,607.8,YXSLJKQTIDHPOT-LJCJQEJUSA-N,1.7557647787313624e-10,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
citalopram,2016,Total,Total,141802.8492,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4.071657374557759e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2017,Total,Total,130996.3988,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.812999049994176e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2018,Total,Total,120262.5316,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.4186084175045466e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
citalopram,2019,Total,Total,112427.9148,WSEQXVZVJXJVFP-UHFFFAOYSA-N,3.2477290712742756e-8,antidepressant,SSRI for depression,NA,NA,NA,NA
cladribine,2016,Total,Total,2.45,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.034809683969674e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2017,Total,Total,2.65,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.713530734468226e-13,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2018,Total,Total,27.46,PTOAARAWEBMLNO-KVQBGUIXSA-N,7.805838268639509e-12,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
cladribine,2019,Total,Total,73.98,PTOAARAWEBMLNO-KVQBGUIXSA-N,2.1370759843788452e-11,antineoplastic,antimetabolite and immunosuppressant for multiple sclerosis and leukaemia,NA,NA,NA,NA
clarithromycin,2016,Total,Total,111591.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.2041835299947006e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2670152941662251
clarithromycin,2017,Total,Total,114924.5,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.345183633559976e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2787653027966647
clarithromycin,2018,Total,Total,109722.25,AGOYDEPGAOXOCK-KCBOHYOISA-N,3.118988120798366e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.2599156767331972
clarithromycin,2019,Total,Total,102942,AGOYDEPGAOXOCK-KCBOHYOISA-N,2.9737074342244804e-8,antibacterial,macrolide antibiotic,low,high,1.2e-7,0.24780895285204005
clenbuterol,2016,Total,Total,2.813375,STJMRWALKKWQGH-UHFFFAOYSA-N,8.078186814138032e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2017,Total,Total,2.4495,STJMRWALKKWQGH-UHFFFAOYSA-N,7.129922088332045e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2018,Total,Total,2.11225,STJMRWALKKWQGH-UHFFFAOYSA-N,6.004326978490097e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clenbuterol,2019,Total,Total,1.854875,STJMRWALKKWQGH-UHFFFAOYSA-N,5.358216837692228e-13,respiratory,sympathomimetic amine decongestant and bronchodilator for obstructive airway disorders,NA,NA,NA,NA
clindamycin,2016,Total,Total,730551.664,KDLRVYVGXIQJDK-AWPVFWJPSA-N,2.097670171651983e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2017,Total,Total,637468.39,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.855521516421501e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2018,Total,Total,651510.7400000001,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.8519983491338842e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clindamycin,2019,Total,Total,646901.94,KDLRVYVGXIQJDK-AWPVFWJPSA-N,1.8687193839173894e-7,antibacterial,lincomycin antibiotic,low,high,NA,NA
clobetasol,2016,Total,Total,9347.55,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.684009602505743e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0035786794700076573
clobetasol,2017,Total,Total,10366.3175,FCSHDIVRCWTZOX-DVTGEIKXSA-N,3.017392778849276e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0040231903717990345
clobetasol,2018,Total,Total,10203.0325,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.900335817358799e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.003867114423145065
clobetasol,2019,Total,Total,8940.44,FCSHDIVRCWTZOX-DVTGEIKXSA-N,2.582643905620438e-9,steroid,"corticosteroid used topically for psoriasis, skin conditions",low,high,7.5e-7,0.0034435252074939172
clodronic acid,2016,Total,Total,1824,ACSIXWWBWUQEHA-UHFFFAOYSA-N,5.237344025943134e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clodronic acid,2017,Total,Total,384,ACSIXWWBWUQEHA-UHFFFAOYSA-N,1.1177342649191694e-10,other musculoskeletal,"analgesic bisphosphonate treatment for osteoporosis, thyroid disorder, hypercalcemia, myeloma and pain",NA,NA,NA,NA
clofarabine,2016,Total,Total,0.46,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.320821410051449e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2018,Total,Total,0.4,WDDPHFBMKLOVOX-AYQXTPAHSA-N,1.1370485460509118e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clofarabine,2019,Total,Total,0.92,WDDPHFBMKLOVOX-AYQXTPAHSA-N,2.657623554512757e-13,antineoplastic,antimetabolite for leukaemia,low,NA,NA,NA
clomethiazole,2016,Total,Total,460391.4,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.321945256790349e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2017,Total,Total,429892.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.2513174812553216e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2018,Total,Total,414868.8,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1793149146047161e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomethiazole,2019,Total,Total,396804.9,PCLITLDOTJTVDJ-UHFFFAOYSA-N,1.1462587486805209e-7,sedative,"toxic sedative and muscle relaxant used for Parkinson's, age-associated restlessness, etc.",NA,NA,NA,NA
clomifene,2016,Total,Total,5009.75,GKIRPKYJQBWNGO-OCEACIFDSA-N,1.4384750128272271e-9,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomifene,2017,Total,Total,690.5,GKIRPKYJQBWNGO-OCEACIFDSA-N,2.009884140434079e-10,sex hormone,selective estrogen receptor modulator for infertility,NA,NA,NA,NA
clomipramine,2016,Total,Total,43990.579999999994,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.2631239109691532e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2017,Total,Total,39469.68,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.1488701500363242e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2018,Total,Total,37062.145,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.0535364521444517e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clomipramine,2019,Total,Total,38705.97,GDLIGKIOYRNHDA-UHFFFAOYSA-N,1.1181075823072189e-8,antidepressant,tricyclic antidepressant for OCD,low,high,NA,NA
clonazepam,2016,Total,Total,4984.8025,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.4313117101908662e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2017,Total,Total,4228.349,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.2307735836814334e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2018,Total,Total,3799.52775,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.080061875954398e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonazepam,2019,Total,Total,3491.1915,DGBIGWXXNGSACT-UHFFFAOYSA-N,1.0085079090994264e-9,anticonvulsant,benzodiazepine for seizure and panic disorders,NA,NA,NA,NA
clonidine,2016,Total,Total,74.4451249999999,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.1375807603033958e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2017,Total,Total,78.385925,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.281631100517816e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2018,Total,Total,82.532525,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.3460871888290132e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clonidine,2019,Total,Total,76.5191000000001,GJSURZIOUXUGAL-UHFFFAOYSA-N,2.210423505762145e-11,antihypertensive,"antiadrenergic agent for blood pressure, ADHD",low,high,NA,NA
clopidogrel,2016,Total,Total,583192.05,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.674549012634337e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.005401771008497861
clopidogrel,2017,Total,Total,654759.825,GKTWGGQPFAXNFI-HNNXBMFYSA-N,1.9058528429556747e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006147912396631208
clopidogrel,2018,Total,Total,751511.1,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.136261508990303e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.006891166158033236
clopidogrel,2019,Total,Total,881861.775,GKTWGGQPFAXNFI-HNNXBMFYSA-N,2.547452853330901e-7,antithrombotic,"platelet aggregation inhibitor for strokes, heart diseases, circulation problems",low,low,3.1e-5,0.00821758984945452
cloprostenol,2016,Total,Total,19.2025,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.513711549241944e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2017,Total,Total,19.609,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.707721666874999e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2018,Total,Total,19.0495,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.4150515694992115e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
cloprostenol,2019,Total,Total,18.258000000000003,VJGGHXVGBSZVMZ-QIZQQNKQSA-N,5.274227267205861e-12,sex hormone,"cattle abortifacient, prostaglandin",NA,NA,NA,NA
clotrimazole,2016,Total,Total,205849.5,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.910661453225775e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2017,Total,Total,189772.8,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.5238427372305347e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2018,Total,Total,193022.2,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4868902966387065e-8,antifungal,topical antifungal,NA,NA,NA,NA
clotrimazole,2019,Total,Total,190337,VNFPBHJOKIVQEB-UHFFFAOYSA-N,5.4983053749488544e-8,antifungal,topical antifungal,NA,NA,NA,NA
cloxacillin,2016,Total,Total,636745,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8283183233548037e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2017,Total,Total,511970,LQOLIRLGBULYKD-JKIFEVAISA-N,1.4902250302361122e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2018,Total,Total,601620,LQOLIRLGBULYKD-JKIFEVAISA-N,1.7101778656878738e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
cloxacillin,2019,Total,Total,645520,LQOLIRLGBULYKD-JKIFEVAISA-N,1.8647273444663859e-7,antibacterial,beta-lactam penicillin antibiotic,low,NA,NA,NA
clozapine,2016,Total,Total,342467.625,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.833447203249364e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2017,Total,Total,343189.72500000003,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.989450911476223e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2018,Total,Total,347240.5,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.87073264137479e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
clozapine,2019,Total,Total,345373.15,QZUDBNBUXVUHMW-UHFFFAOYSA-N,9.976867592785517e-8,antipsychotic,atypical antipsychotic for schizophrenia,NA,NA,NA,NA
cobicistat,2016,Total,Total,27459,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,7.884442412739723e-9,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,1.6290170274255628e-5
cobicistat,2017,Total,Total,47232,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.3748131458505782e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,2.8405230286168972e-5
cobicistat,2018,Total,Total,57780,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.642466624770542e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.393526084236657e-5
cobicistat,2019,Total,Total,60192,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,1.73877909775252e-8,antibiotic,CTP3A-inhibitor used with antivirals to prolong anti-HIV effects,low,high,4.84e-4,3.592518797009339e-5
cobimetinib,2016,Total,Total,1.26,BSMCAPRUBJMWDF-KRWDZBQOSA-N,3.6179021231844026e-13,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2017,Total,Total,40.32,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.173620978165128e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2018,Total,Total,51.66,BSMCAPRUBJMWDF-KRWDZBQOSA-N,1.4684981972247523e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
cobimetinib,2019,Total,Total,151.2,BSMCAPRUBJMWDF-KRWDZBQOSA-N,4.3677465374166176e-11,antineoplastic,mitogen-activated protein kinase inhibitor for melanoma,NA,NA,NA,NA
codeine,2016,Total,Total,1943129.045,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.579405315497444e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2017,Total,Total,1785329.695,OROGSEYTTFOCAN-DNJOTXNNSA-N,5.19667753718539e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2018,Total,Total,1718023.555,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.883690463234922e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
codeine,2019,Total,Total,1730315.635,OROGSEYTTFOCAN-DNJOTXNNSA-N,4.998399552519236e-7,analgesic,opioid analgesic and antitussive,NA,NA,NA,NA
colchicine,2016,Total,Total,949.577,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.7265687654183137e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2017,Total,Total,1010.748,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.9420512312461473e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2018,Total,Total,718.022,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.0410646778314195e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colchicine,2019,Total,Total,810.6,IAKHMKGGTNLKSZ-INIZCTEOSA-N,2.3415974492261306e-10,antigout,antigout medication with serious side effects,NA,NA,NA,NA
colesevelam,2016,Total,Total,386912.25,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1109608339373449e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2017,Total,Total,399217.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1620288513160637e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2018,Total,Total,418837.5,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.1905964260164969e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colesevelam,2019,Total,Total,418050,VTAKZNRDSPNOAU-UHFFFAOYSA-M,1.2076299206131066e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",high,NA,NA,NA
colestipol,2016,Total,Total,540250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.551247319087598e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2017,Total,Total,439250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.278554103817045e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2018,Total,Total,388250,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.1036477450106661e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestipol,2019,Total,Total,358500,GMRWGQCZJGVHKL-UHFFFAOYSA-N,1.0356065698835037e-7,lipid-modifying,bile acid sequestrant that lowers cholesterol levels in blood,NA,NA,NA,NA
colestyramine,2016,Total,Total,2181800,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.264713374891849e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2017,Total,Total,2395000,KNDHRUPPBXRELB-UHFFFAOYSA-M,6.97128532417034e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2018,Total,Total,2466400,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.011041334949922e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colestyramine,2019,Total,Total,2465200,KNDHRUPPBXRELB-UHFFFAOYSA-M,7.121275637592226e-7,lipid-modifying,"bile acid sequestrant that lowers ""bad"" cholesterol levels in blood",NA,NA,NA,NA
colistin,2016,Total,Total,2972.2000000000003,YKQOSKADJPQZHB-QNPLFGSASA-N,8.534229119467207e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2017,Total,Total,2832,YKQOSKADJPQZHB-QNPLFGSASA-N,8.243290203778873e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2018,Total,Total,3049.2,YKQOSKADJPQZHB-QNPLFGSASA-N,8.667721066546101e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
colistin,2019,Total,Total,3225.6,YKQOSKADJPQZHB-QNPLFGSASA-N,9.317859279822118e-10,antibacterial,last-resort antibiotic taken topically or by injection,NA,NA,NA,NA
cortisone,2016,Total,Total,33984.45,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.7581280801789e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2017,Total,Total,33982.4,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.891482521924266e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2018,Total,Total,34960.275,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,9.937882464572511e-9,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
cortisone,2019,Total,Total,37744.17,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,1.0903238612775408e-8,steroid,"glucocorticoid steroid for inflammation in skin conditions, arthritis, etc.",NA,NA,NA,NA
crizotinib,2016,Total,Total,4302,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.235255153487246e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2017,Total,Total,4521,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.3159574509634283e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2018,Total,Total,3807,KTEIFNKAUNYNJU-GFCCVEGCSA-N,1.082185953703955e-9,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
crizotinib,2019,Total,Total,2367,KTEIFNKAUNYNJU-GFCCVEGCSA-N,6.837603210360539e-10,antineoplastic,"anaplastic lymphoma kinase inhibitor, used for non-small-cell lung cancer",NA,NA,NA,NA
cromoglicic acid,2016,Total,Total,35558.99,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.0210233763435949e-8,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2017,Total,Total,35699.97,IMZMKUWMOSJXDT-UHFFFAOYSA-N,1.039142701187146e-8,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2018,Total,Total,28338.370000000003,IMZMKUWMOSJXDT-UHFFFAOYSA-N,8.055525601488194e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cromoglicic acid,2019,Total,Total,25963.34,IMZMKUWMOSJXDT-UHFFFAOYSA-N,7.50008521063296e-9,antiallergic,"mast cell stabiliser for asthma, rhinitis, conjunctivitis, mast cell activation syndrome",NA,NA,NA,NA
cyclizine,2016,Total,Total,30906,UVKZSORBKUEBAZ-UHFFFAOYSA-N,8.874197065010884e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2017,Total,Total,32557.85,UVKZSORBKUEBAZ-UHFFFAOYSA-N,9.476829306536088e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2018,Total,Total,5394.9,UVKZSORBKUEBAZ-UHFFFAOYSA-N,1.5335658002725155e-9,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclizine,2019,Total,Total,2,UVKZSORBKUEBAZ-UHFFFAOYSA-N,5.777442509810341e-13,antiemetic,"piperazine antihistamine for nausea relief from motion sickness, vertigo",NA,NA,NA,NA
cyclopentolate,2016,Total,Total,1167.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.3528764359066884e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2017,Total,Total,1186.1,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.4524599260953816e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2018,Total,Total,1249.8,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5527081821360735e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclopentolate,2019,Total,Total,1219.7,SKYSRIRYMSLOIN-UHFFFAOYSA-N,3.5233733146078363e-10,ophthalmological,muscarinic antagonist used to dilate eyes during eye examinations,low,NA,NA,NA
cyclophosphamide,2016,Total,Total,18538.6,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.323082563560823e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2017,Total,Total,18727.8,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.451224939206568e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2018,Total,Total,17952.3,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.1031591533174464e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyclophosphamide,2019,Total,Total,19087.5,CMSMOCZEIVJLDB-UHFFFAOYSA-N,5.513846695300244e-9,antineoplastic,"alkylating agent used for cancers, kidney disease in children",NA,NA,NA,NA
cyproterone acetate,2016,Total,Total,6064.857768,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.741433475845922e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2017,Total,Total,6365.400638,UWFYSQMTEOIJJG-FDTZYFLXSA-N,1.8528193757893078e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2018,Total,Total,7399.896064,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.103510265124766e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cyproterone acetate,2019,Total,Total,7875.951566,UWFYSQMTEOIJJG-FDTZYFLXSA-N,2.275142869130786e-9,sex hormone,"antiandrogen and progestin for birth control, androgen conditions, feminising hormone therapy",NA,NA,NA,NA
cytarabine,2016,Total,Total,9321.5,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.676529733433604e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2017,Total,Total,8311.4,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.4192543149607252e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2018,Total,Total,8661,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,2.461994364336736e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
cytarabine,2019,Total,Total,5360,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,1.5483545926291714e-9,antineoplastic,"antimetabolite for leukaemia, including meningitis-associated",NA,NA,NA,NA
dabigatran etexilate,2016,Total,Total,1083636.35,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.11150019954349e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.00311150019954349
dabigatran etexilate,2017,Total,Total,1085194.7,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.1587481778611416e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0031587481778611415
dabigatran etexilate,2018,Total,Total,1086955.6,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.089803211504742e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030898032115047416
dabigatran etexilate,2019,Total,Total,1070971.9,KSGXQBZTULBEEQ-UHFFFAOYSA-N,3.0937392909361745e-7,anticoagulant,"prodrug of dabigatran, used to prevent clots and stroke after atrial fibrillation",low,low,1e-4,0.0030937392909361743
dabrafenib,2016,Total,Total,5592.3,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.6057455590066775e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.5292814847682644e-4
dabrafenib,2017,Total,Total,6479.8,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8861183567248e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.796303196880762e-4
dabrafenib,2018,Total,Total,6400.4,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.8193913785360638e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.7327536938438703e-4
dabrafenib,2019,Total,Total,5114.9,BFSMGDJOXZAERB-UHFFFAOYSA-N,1.4775520346714455e-9,antineoplastic,B-Raf enzyme inhibitor for metastatic melanoma,low,high,1.05e-5,1.4071924139728053e-4
dacarbazine,2016,Total,Total,14,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4.019891247982669e-12,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2017,Total,Total,36,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.0478758733617211e-11,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
dacarbazine,2019,Total,Total,606.5,FDKXTQMXEQVLRF-ZHACJKMWSA-N,1.7520094410999858e-10,antineoplastic,alkylating agent for skin cancer and lymphoma,NA,NA,NA,NA
daclatasvir,2016,Total,Total,1207.92,FKRSSPOQAMALKA-CUPIEXAXSA-N,3.468362168759447e-10,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,4.817169678832565e-6
daclatasvir,2017,Total,Total,168.84,FKRSSPOQAMALKA-CUPIEXAXSA-N,4.914537846066473e-11,antiviral,NS5A inhibitor used for hepatitis C infections,low,high,7.2e-5,6.825747008425656e-7
dacomitinib,2019,Total,Total,1.35,LVXJQMNHJWSHET-AATRIKPKSA-N,3.8997736941219803e-13,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,NA,NA,NA,NA
dapagliflozin,2016,Total,Total,30510.7733,JVHXJTBJCFBINQ-ADAARDCZSA-N,8.760713611275237e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,8.760713611275237e-5
dapagliflozin,2017,Total,Total,34991.5867,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0185233187104137e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0185233187104136e-4
dapagliflozin,2018,Total,Total,38308.9301,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.0889778317742752e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.0889778317742752e-4
dapagliflozin,2019,Total,Total,43180.9882,JVHXJTBJCFBINQ-ADAARDCZSA-N,1.2473783842114937e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,moderate,1e-4,1.2473783842114936e-4
dapoxetine,2016,Total,Total,23.4,USRHYDPUVLEVMC-FQEVSTJZSA-N,6.7189610859138906e-12,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2017,Total,Total,61.56,USRHYDPUVLEVMC-FQEVSTJZSA-N,1.7918677434485435e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2018,Total,Total,93.33,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.6530185200732896e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapoxetine,2019,Total,Total,85.86,USRHYDPUVLEVMC-FQEVSTJZSA-N,2.480256069461579e-11,urological,SSRI for premature ejaculation,NA,NA,NA,NA
dapsone,2016,Total,Total,7560,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1707412739106415e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2017,Total,Total,7500,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.1830747361702526e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2018,Total,Total,7240,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.0580578683521504e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
dapsone,2019,Total,Total,8300,MQJKPEGWNLWLTK-UHFFFAOYSA-N,2.397638641571291e-9,antibacterial,leprostatic for dermatitis herpetiformis and leprosy,NA,NA,NA,NA
daptomycin,2016,Total,Total,319,DOAKLVKFURWEDJ-RWDRXURGSA-N,9.159609343617655e-11,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2017,Total,Total,466,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.3564171027404504e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2018,Total,Total,546.5,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5534925760420582e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
daptomycin,2019,Total,Total,543,DOAKLVKFURWEDJ-RWDRXURGSA-N,1.5685756414135075e-10,antibacterial,"lipopeptide antibiotic for skin and bloodstream infections, including MRSA",low,NA,NA,NA
darifenacin,2016,Total,Total,6419.03955,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8431314933928294e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2017,Total,Total,6370.61775,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.8543379551763703e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2018,Total,Total,5534.04495,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.5731194410444727e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darifenacin,2019,Total,Total,5167.35135,HXGBXQDTNZMWGS-RUZDIDTESA-N,1.4927037676307927e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
darunavir,2016,Total,Total,62424,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.792412080457644e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.9068213621889832e-5
darunavir,2017,Total,Total,57120,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,1.6626297190672643e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,1.768755020284324e-5
darunavir,2018,Total,Total,82536,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,2.346185969921451e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,2.4959425211930332e-5
darunavir,2019,Total,Total,154224,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,4.4551014681649504e-8,antiviral,protease inhibitor used in combination for HIV therapy,low,moderate,9.4e-4,4.73946964698399e-5
dasabuvir,2016,Total,Total,12446,NBRBXGKOEOGLOI-UHFFFAOYSA-N,3.573683319456593e-9,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2017,Total,Total,3066,NBRBXGKOEOGLOI-UHFFFAOYSA-N,8.924409521463991e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2018,Total,Total,1596,NBRBXGKOEOGLOI-UHFFFAOYSA-N,4.536823698743137e-10,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasabuvir,2019,Total,Total,84,NBRBXGKOEOGLOI-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,antiviral used in combination for treatment of hepatitis C,NA,NA,NA,NA
dasatinib,2016,Total,Total,1740,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,4.996150551064175e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,2.775639195035653e-4
dasatinib,2017,Total,Total,2038.8,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,5.934470362805215e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.2969279793362307e-4
dasatinib,2018,Total,Total,2379,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,6.762596227637798e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,3.756997904243221e-4
dasatinib,2019,Total,Total,2601,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,7.513563984008349e-10,antineoplastic,protein tyrosine kinase inhibitor for leukaemia,low,moderate,1.8e-6,4.1742022133379715e-4
daunorubicin,2016,Total,Total,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.504587867102085e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2017,Total,Total,52.4,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.525241549004283e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2018,Total,Total,59.8,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.699887576346113e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
daunorubicin,2019,Total,Total,44.2,STQGQHZAVUOBTE-VGBVRHCVSA-N,1.2768147946680854e-11,antineoplastic,cytotoxic antibiotic for leukaemia,low,NA,NA,NA
decitabine,2016,Total,Total,16.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,4.665945198551313e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2017,Total,Total,33.25,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.678297997021454e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2018,Total,Total,33.2,XAUDJQYHKZQPEU-KVQBGUIXSA-N,9.437502932222569e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
decitabine,2019,Total,Total,25.6,XAUDJQYHKZQPEU-KVQBGUIXSA-N,7.395126412557236e-12,antineoplastic,antimetabolite for some blood and bone marrow cancers,NA,NA,NA,NA
deferasirox,2016,Total,Total,21378,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.138373935669537e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.019182418548967302
deferasirox,2017,Total,Total,21690.3,BOFQWVMAQOTZIW-UHFFFAOYSA-N,6.3135394599938174e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.01972981081248068
deferasirox,2018,Total,Total,20962.8,BOFQWVMAQOTZIW-UHFFFAOYSA-N,5.9589303152890124e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.018621657235278165
deferasirox,2019,Total,Total,26090.1,BOFQWVMAQOTZIW-UHFFFAOYSA-N,7.536702641260139e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,low,high,3.2e-7,0.023552195753937934
deferiprone,2016,Total,Total,18100,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.197145113463308e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2017,Total,Total,19650,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.719655808766062e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2018,Total,Total,20600,TZXKOCQBRNJULO-UHFFFAOYSA-N,5.855800012162195e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferiprone,2019,Total,Total,16450,TZXKOCQBRNJULO-UHFFFAOYSA-N,4.7519464643190056e-9,chelating agent,iron-chelating agent for transfusion-induced and genetic iron overload,NA,NA,NA,NA
deferoxamine,2016,Total,Total,6300,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.808951061592201e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2017,Total,Total,6655,UBQYURCVBFRUQT-UHFFFAOYSA-N,1.9371149825617374e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2018,Total,Total,7530,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.1404938879408415e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
deferoxamine,2019,Total,Total,8240,UBQYURCVBFRUQT-UHFFFAOYSA-N,2.38030631404186e-9,chelating agent,iron-chelating agent for iron poisoning,low,low,NA,NA
degarelix,2016,Total,Total,642.5600000000001,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.845015228788389e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2017,Total,Total,624.72,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.8184139322403736e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2018,Total,Total,569.6,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.6191571295764982e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
degarelix,2019,Total,Total,548.0799999999999,MEUCPCLKGZSHTA-XYAYPHGZSA-N,1.5832503453884256e-10,sex hormone,testosterone inhibitor for prostate cancer,NA,NA,NA,NA
deoxycholic acid,2017,Total,Total,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.3286130519149364e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2018,Total,Total,0.56,KXGVEGMKQFWNSR-LLQZFEROSA-N,1.5918679644712765e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
deoxycholic acid,2019,Total,Total,0.8,KXGVEGMKQFWNSR-LLQZFEROSA-N,2.310977003924136e-13,other,bile acid for topical destruction of fat cells,NA,NA,NA,NA
dequalinium,2016,Total,Total,158.34,PCSWXVJAIHCTMO-UHFFFAOYSA-P,4.5464970014684004e-11,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2017,Total,Total,530.7,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.544743683314071e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2018,Total,Total,628.86,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.7876108716739408e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
dequalinium,2019,Total,Total,663.18,PCSWXVJAIHCTMO-UHFFFAOYSA-P,1.9157421618280107e-10,antiseptic,"ammonium compound used as antiseptic and disinfectant in skin, mouth and vagina",NA,NA,NA,NA
desloratadine,2016,Total,Total,169054.615,JAUOIFJMECXRGI-UHFFFAOYSA-N,4.854151194782713e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0013483753318840868
desloratadine,2017,Total,Total,195117.744,JAUOIFJMECXRGI-UHFFFAOYSA-N,5.6794215667324655e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0015776171018701292
desloratadine,2018,Total,Total,215869.1405,JAUOIFJMECXRGI-UHFFFAOYSA-N,6.136342308569623e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0017045395301582287
desloratadine,2019,Total,Total,258165.445,JAUOIFJMECXRGI-UHFFFAOYSA-N,7.457680082535517e-8,antihistamine,"antihistamine for allergies, hives",low,high,3.6e-5,0.0020715778007043104
deslorelin,2016,Total,Total,55.3472,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.5892123205739028e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2017,Total,Total,63.8824,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,1.859467380345634e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2018,Total,Total,72.9675,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.074189744599247e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
deslorelin,2019,Total,Total,80.6896,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,2.3308976256979624e-11,sex hormone,"veterinary gonadotropin-releasing hormone agonist for horse ovulation, dog and ferret castration, etc.",NA,NA,NA,NA
desogestrel,2016,Total,Total,3250.642437,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.333735059155252e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4569389107982413
desogestrel,2017,Total,Total,3210.205131,RPLCPCMSCLEKRS-BPIQYHPVSA-N,9.344156959213623e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.4607988737828235
desogestrel,2018,Total,Total,3032.343783,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.619805223966676e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.1925204533209914
desogestrel,2019,Total,Total,2996.976339,RPLCPCMSCLEKRS-BPIQYHPVSA-N,8.657429250917183e-10,sex hormone,"progestin used for birth control and menopausal hormone therapy, often with an estrogen",low,moderate,2.7e-10,3.206455278117475
desonide,2016,Total,Total,3116.4700000000003,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.948478912571823e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2017,Total,Total,3100.3500000000004,WBGKWQHBNHJJPZ-LECWWXJVSA-N,9.024394344380591e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2018,Total,Total,3008.225,WBGKWQHBNHJJPZ-LECWWXJVSA-N,8.55124465611001e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desonide,2019,Total,Total,1222.965,WBGKWQHBNHJJPZ-LECWWXJVSA-N,3.5328049895051015e-10,steroid,"topical steroid for eczema, skin conditions",NA,NA,NA,NA
desoximetasone,2016,Total,Total,4289.125,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2315582892145476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2017,Total,Total,4195.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.2213211611504476e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2018,Total,Total,3734.875,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.0616835471079744e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoximetasone,2019,Total,Total,4119.25,VWVSBHGCDBMOOT-IIEHVVJPSA-N,1.1899365029268124e-9,steroid,"topical steroid for psoriasis, eczema",NA,NA,NA,NA
desoxycortone,2016,Total,Total,2,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.742701782832385e-13,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2017,Total,Total,7,ZESRJSPZRDMNHY-YFWFAHHUSA-N,2.037536420425569e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2018,Total,Total,20.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,5.770521371208377e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
desoxycortone,2019,Total,Total,25.3,ZESRJSPZRDMNHY-YFWFAHHUSA-N,7.308464774910081e-12,steroid,steroid hormone for canine hypoadrenocorticism,NA,NA,NA,NA
detomidine,2016,Total,Total,573.7252,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.647366364447933e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2017,Total,Total,633.9336000000001,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.8452325687592778e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2018,Total,Total,582.1104,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.6547194599027866e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
detomidine,2019,Total,Total,611.5088,RHDJRPPFURBGLQ-UHFFFAOYSA-N,1.7664784681215546e-10,analgesic,equine sedative and analgesic,NA,NA,NA,NA
dexamethasone,2016,Total,Total,7152.2916000000005,UREBDLICKHMUKA-CXSFZGCWSA-N,2.0536738861328547e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2017,Total,Total,7864.5864,UREBDLICKHMUKA-CXSFZGCWSA-N,2.2891973173690875e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2018,Total,Total,8253.3534,UREBDLICKHMUKA-CXSFZGCWSA-N,2.346115870878587e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamethasone,2019,Total,Total,10366.8578,UREBDLICKHMUKA-CXSFZGCWSA-N,2.9946962473439454e-9,steroid,"corticosteroid for many inflammatory conditions, including allergies and skin conditions",low,high,NA,NA
dexamfetamine,2016,Total,Total,14420.52,KWTSXDURSIMDCE-QMMMGPOBSA-N,4.140637295668503e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2017,Total,Total,18878.343,KWTSXDURSIMDCE-QMMMGPOBSA-N,5.4950444885408724e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2018,Total,Total,21401.635,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.083674489965575e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexamfetamine,2019,Total,Total,24003.256,KWTSXDURSIMDCE-QMMMGPOBSA-N,6.933871579413006e-9,stimulant,amphetamine enantiomer for ADHD and narcolepsy,NA,NA,NA,NA
dexchlorpheniramine,2016,Total,Total,173.3,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.976051094824262e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2017,Total,Total,176.75,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.1447794615745616e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2018,Total,Total,202.15,SOYKEARSMXGVTM-HNNXBMFYSA-N,5.7463590896047954e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexchlorpheniramine,2019,Total,Total,167.85,SOYKEARSMXGVTM-HNNXBMFYSA-N,4.8487186263583276e-11,antihistamine,antihistamine for allergic symptoms and the common cold,NA,NA,NA,NA
dexketoprofen,2016,Total,Total,10.5,DKYWVDODHFEZIM-NSHDSACASA-N,3.0149184359870024e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2017,Total,Total,15.5,DKYWVDODHFEZIM-NSHDSACASA-N,4.511687788085189e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2018,Total,Total,30.5,DKYWVDODHFEZIM-NSHDSACASA-N,8.669995163638201e-12,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexketoprofen,2019,Total,Total,35.5,DKYWVDODHFEZIM-NSHDSACASA-N,1.0254960454913355e-11,analgesic,NSAID for mild to moderate pain relief,NA,NA,NA,NA
dexmedetomidine,2016,Total,Total,43.229200000000006,CUHVIMMYOGQXCV-NSHDSACASA-N,1.2412620195520887e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2017,Total,Total,51.3737,CUHVIMMYOGQXCV-NSHDSACASA-N,1.4953683543145293e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2018,Total,Total,58.011300000000006,CUHVIMMYOGQXCV-NSHDSACASA-N,1.6490416079880816e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexmedetomidine,2019,Total,Total,64.56960000000001,CUHVIMMYOGQXCV-NSHDSACASA-N,1.865235759407249e-11,sedative,sedative for mechanical ventilation,NA,NA,NA,NA
dexrazoxane,2017,Total,Total,50,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.4553831574468352e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2018,Total,Total,60,BMKDZUISNHGIBY-ZETCQYMHSA-N,1.7055728190763675e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
dexrazoxane,2019,Total,Total,95,BMKDZUISNHGIBY-ZETCQYMHSA-N,2.744285192159912e-11,antineoplastic,cardioprotective agent used in combination with antineoplastics,NA,NA,NA,NA
diatrizoic acid,2016,Total,Total,849520,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.439270009275884e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2017,Total,Total,785510,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.286436048012127e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2018,Total,Total,732970,YVPYQUNUQOZFHG-UHFFFAOYSA-N,2.083556181997342e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diatrizoic acid,2019,Total,Total,672660,YVPYQUNUQOZFHG-UHFFFAOYSA-N,1.943127239324512e-7,diagnostic agent,contrast agent for X-ray imaging,NA,NA,NA,NA
diazepam,2016,Total,Total,110876.03,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.183639875771885e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2017,Total,Total,104435.425,AAOVKJBEBIDNHE-UHFFFAOYSA-N,3.0398711717160426e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2018,Total,Total,97114.912,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.7606092372365562e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
diazepam,2019,Total,Total,100692.862,AAOVKJBEBIDNHE-UHFFFAOYSA-N,2.9087361067663318e-8,anti-anxiety,"benzodiazepine anticonvulsant for anxiety, alcohol withdrawal, convulsive disorders",NA,NA,NA,NA
dibrompropamidine,2016,Total,Total,4940.7,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4186483349219983e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2017,Total,Total,5152.6875,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.4998269206173676e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2018,Total,Total,5390.475,GMJFVGRUYJHMCO-UHFFFAOYSA-N,1.5323079403184471e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dibrompropamidine,2019,Total,Total,8406,GMJFVGRUYJHMCO-UHFFFAOYSA-N,2.428259086873286e-9,antiseptic,antiseptic and disinfectant used in eye products for minor infections,NA,NA,NA,NA
dichlorobenzyl alcohol,2016,Total,Total,3892.752,DBHODFSFBXJZNY-UHFFFAOYSA-N,1.1177456925262164e-9,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2017,Total,Total,3343.536,DBHODFSFBXJZNY-UHFFFAOYSA-N,9.732251961434322e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2018,Total,Total,2321.3088,DBHODFSFBXJZNY-UHFFFAOYSA-N,6.598601989937966e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
dichlorobenzyl alcohol,2019,Total,Total,722.9088,DBHODFSFBXJZNY-UHFFFAOYSA-N,2.0882820159179909e-10,antiseptic,mild antiseptic used in lozenges,NA,NA,NA,NA
diclofenac,2016,Total,Total,2138041.438,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.139067188886058e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,12.278134377772117
diclofenac,2017,Total,Total,2248460.2090000003,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.544742236735982e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,13.089484473471964
diclofenac,2018,Total,Total,2273673.761,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.463193610347895e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,12.92638722069579
diclofenac,2019,Total,Total,2213365.855,DCOPUUMXTXDBNB-UHFFFAOYSA-N,6.393796990219855e-7,analgesic,"NSAID for mild-moderate pain, arthritis, etc.",low,moderate,5e-8,12.787593980439711
dicloxacillin,2016,Total,Total,2807037.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.059989627863681e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2017,Total,Total,2699355,YFAGHNZHGGCZAX-JKIFEVAISA-N,7.857191605939803e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2018,Total,Total,2868295,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.153476648487749e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dicloxacillin,2019,Total,Total,2968317.5,YFAGHNZHGGCZAX-JKIFEVAISA-N,8.574641853556979e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
dienogest,2016,Total,Total,1035.628,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.9736513809755686e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06758298593126293
dienogest,2017,Total,Total,994.407,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.89448639889447e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06578378179305615
dienogest,2018,Total,Total,959.019,AZFLJNIPTRTECV-FUMNGEBKSA-N,2.7261278989629975e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.06195745224915904
dienogest,2019,Total,Total,1100.813,AZFLJNIPTRTECV-FUMNGEBKSA-N,3.179941910775926e-10,sex hormone,"progestin and antiandrogen for birth control, menopausal hormone therapy, endometriosis",low,high,4.4e-9,0.07227140706308922
digoxin,2016,Total,Total,582.2961875,LTMHDMANZUZIPE-PUGKRICDSA-N,1.671976677046375e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2017,Total,Total,531.9445625,LTMHDMANZUZIPE-PUGKRICDSA-N,1.5483663139158506e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2018,Total,Total,481.7478125,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3694266244158302e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
digoxin,2019,Total,Total,452.9559375,LTMHDMANZUZIPE-PUGKRICDSA-N,1.3084634441917479e-10,cardiac,antiarrhythmic for heart failure and atrial fibrillation,low,NA,NA,NA
dihydrostreptomycin,2016,Total,Total,274265,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.875110522342622e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2017,Total,Total,252650,ASXBYYWOLISCLQ-HZYVHMACSA-N,7.354051094578859e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2018,Total,Total,189635,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.3906050257591166e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
dihydrostreptomycin,2019,Total,Total,179655,ASXBYYWOLISCLQ-HZYVHMACSA-N,5.189732170499885e-8,antibacterial,streptomycin antibiotic used for veterinary infections,NA,NA,NA,NA
diltiazem,2016,Total,Total,293739.3,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.434286008989685e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2017,Total,Total,288176.4,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.388141578673244e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2018,Total,Total,287198.1,HSUGRBWQSSZJOP-RTWAWAEBSA-N,8.163954550839608e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
diltiazem,2019,Total,Total,263529.6,HSUGRBWQSSZJOP-RTWAWAEBSA-N,7.612635568166577e-8,antihypertensive,"calcium channel blocker, dilates blood vessels, for angina, rhythm disorders, hypertension",NA,NA,NA,NA
dimethyl fumarate,2016,Total,Total,169174.32,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.857588345367282e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.013128617149641303
dimethyl fumarate,2017,Total,Total,159363.8184,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.63870834411552e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012537049578690593
dimethyl fumarate,2018,Total,Total,158516.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.506014231339342e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.01217841684145768
dimethyl fumarate,2019,Total,Total,161051.16,LDCRTTXIJACKKU-ONEGZZNKSA-N,4.6523190901913344e-8,immunosuppressant,"oral treatment for psoriasis, multiple sclerosis",low,low,3.7e-6,0.012573835378895499
dimethylaminodiphenylbuten,2016,Total,Total,9409,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7016540537334955e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2017,Total,Total,10666.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.104768889781333e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2018,Total,Total,11326,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.2195529581431566e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimethylaminodiphenylbuten,2019,Total,Total,11148.5,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.220490891031029e-9,analgesic,"aka ketobemidone, opioid analgesic",NA,NA,NA,NA
dimeticone,2016,Total,Total,52363,NA,1.503525467272261e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2017,Total,Total,66244,NA,1.9282080376381627e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2018,Total,Total,83859,NA,2.3837938505820853e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dimeticone,2019,Total,Total,75511,NA,2.1813023067914432e-8,antiparasitic,silicone polymer used as topical veterinary anti-flea treatment,NA,NA,NA,NA
dinoprost,2016,Total,Total,8.5,PXGPLTODNUVGFL-YNNPMVKQSA-N,2.4406482577037636e-12,sex hormone,"prostaglandin for labour and abortion induction in humans, uterine infections in animals",NA,NA,NA,NA
dinoprostone,2016,Total,Total,0.1915,XEYBRNLFEZDVAW-ARSRFYASSA-N,5.498636957062009e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dinoprostone,2017,Total,Total,0.117,XEYBRNLFEZDVAW-ARSRFYASSA-N,3.4055965884255945e-14,sex hormone,prostaglandin for cervix relaxation in induced labour,NA,NA,NA,NA
dipyridamole,2016,Total,Total,2103356.67,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.039475049370695e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.25164479372377896
dipyridamole,2017,Total,Total,2164230.735,IZEKFCXSFNUWAM-UHFFFAOYSA-N,6.299569921095569e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.2624820800456487
dipyridamole,2018,Total,Total,1924232.88,IZEKFCXSFNUWAM-UHFFFAOYSA-N,5.469865496168396e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.22791106234034986
dipyridamole,2019,Total,Total,1605438.675,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4.637664823919294e-7,antithrombotic,platelet aggregation inhibitor for blood clot prevention after heart valve replacement,low,high,2.4e-6,0.1932360343299706
disopyramide,2016,Total,Total,15559,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.467534851954454e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2017,Total,Total,15085.5,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.391036524332846e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2018,Total,Total,13962.25,UVTNFZQICZKOEM-UHFFFAOYSA-N,3.968939015524835e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disopyramide,2019,Total,Total,14100,UVTNFZQICZKOEM-UHFFFAOYSA-N,4.07309696941629e-9,cardiac,antiarrhythmic for irregular heartbeat,low,NA,NA,NA
disulfiram,2016,Total,Total,149374,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.289051680544024e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2017,Total,Total,143818,AUZONCFQVSMFAP-UHFFFAOYSA-N,4.1862058987537786e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2018,Total,Total,132497.8,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.7664107711236126e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
disulfiram,2019,Total,Total,104326,AUZONCFQVSMFAP-UHFFFAOYSA-N,3.0136873363923685e-8,other nervous system,alcohol metabolism inhibitor for chronic alcoholism,NA,NA,NA,NA
dobutamine,2016,Total,Total,1156.25,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.3199994681999727e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2017,Total,Total,1098.75,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.19820448848942e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2018,Total,Total,1325,JRWZLRBJNMZMFE-UHFFFAOYSA-N,3.7664733087936447e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
dobutamine,2019,Total,Total,1527.5,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4.412521716867648e-10,cardiac,heart muscle stimulator for weakened heart muscles,NA,NA,NA,NA
docetaxel,2016,Total,Total,898.46,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.5797939219017925e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2017,Total,Total,908.76,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.645187996322772e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2018,Total,Total,867.26,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.4652918051202836e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docetaxel,2019,Total,Total,995.14,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,2.8746820696063313e-10,antineoplastic,"mitotic inhibitor for breast, lung, prostate, stomach, and head cancer",NA,NA,NA,NA
docusate sodium,2016,Total,Total,30162.96,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.660844208375097e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2017,Total,Total,28812.120000000003,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.386534835667422e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2018,Total,Total,29620.08,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.419867224477923e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
docusate sodium,2019,Total,Total,28856.28,APSBXTVYXVQYAB-UHFFFAOYSA-M,8.335774937349496e-9,laxative,laxative and stool softener for constipation,NA,NA,NA,NA
dolutegravir,2016,Total,Total,17530.5,RHWKPHLQXYSBKR-BMIGLBTASA-N,5.033621680197156e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,5.298549137049638e-4
dolutegravir,2017,Total,Total,21798,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.344888413205222e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,6.678829908637076e-4
dolutegravir,2018,Total,Total,23759.85,RHWKPHLQXYSBKR-BMIGLBTASA-N,6.754025724221938e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.109500762338881e-4
dolutegravir,2019,Total,Total,25429.35,RHWKPHLQXYSBKR-BMIGLBTASA-N,7.345830384342279e-9,antiviral,antiviral used in combination for treatment of HIV,low,high,9.5e-6,7.732453036149767e-4
donepezil,2016,Total,Total,20993.0096,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.027829682846869e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2017,Total,Total,21579.606,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2813190233477345e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2018,Total,Total,21094.7276,ADEBPBSSDYVVLD-UHFFFAOYSA-N,5.99643233673001e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
donepezil,2019,Total,Total,21592.6614,ADEBPBSSDYVVLD-UHFFFAOYSA-N,6.2375179936150445e-9,other nervous system,cholinesterase inhibitor for Alzheimer's disease,NA,NA,NA,NA
dopamine,2016,Total,Total,1146,VYFYYTLLBUKUHU-UHFFFAOYSA-N,3.2905681215629567e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2017,Total,Total,522,VYFYYTLLBUKUHU-UHFFFAOYSA-N,1.5194200163744958e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2018,Total,Total,784,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.228615150259787e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
dopamine,2019,Total,Total,749,VYFYYTLLBUKUHU-UHFFFAOYSA-N,2.1636522199239727e-10,cardiac,ubiquitous neuromodulator used medically for shock-associated conditions,NA,NA,NA,NA
doramectin,2016,Total,Total,1018.5,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.9244708829073923e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2017,Total,Total,663,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.929838066774503e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2018,Total,Total,818,QLFZZSKTJWDQOS-YDBLARSUSA-N,2.3252642766741144e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doramectin,2019,Total,Total,692,QLFZZSKTJWDQOS-YDBLARSUSA-N,1.998995108394378e-10,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
doravirine,2019,Total,Total,84,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,2.4265258541203427e-11,antiviral,NNRTI antiviral for used in combination for treatment of HIV,NA,NA,NA,NA
dorzolamide,2016,Total,Total,20753.1,IAVUPMFITXYVAF-XPUUQOCRSA-N,5.958943218464939e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2017,Total,Total,21312.92,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.203692960802359e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2018,Total,Total,21852.98,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.211974783969913e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
dorzolamide,2019,Total,Total,23854.88,IAVUPMFITXYVAF-XPUUQOCRSA-N,6.891009888921225e-9,ophthalmological,reduces pressure in eye,NA,NA,NA,NA
doxazosin,2016,Total,Total,20090.384,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.768654200729361e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2017,Total,Total,20391.00000000001,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,5.935343592699686e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2018,Total,Total,14713.708,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4.182550072104416e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxazosin,2019,Total,Total,8302.724,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,2.3984255292411272e-9,antihypertensive,"antiadrenergic agent for blood pressure, enlarged prostate",NA,NA,NA,NA
doxepin,2016,Total,Total,22507.01,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.462552322661317e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2017,Total,Total,20741.165,ODQWQRRAPPTVAG-GZTJUZNOSA-N,6.0372684413651585e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2018,Total,Total,18060.3,ODQWQRRAPPTVAG-GZTJUZNOSA-N,5.13385946406082e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxepin,2019,Total,Total,16463.375,ODQWQRRAPPTVAG-GZTJUZNOSA-N,4.755810128997441e-9,antidepressant,"tricyclic antidepressant for alcoholism, manic depression etc.",NA,NA,NA,NA
doxorubicin,2016,Total,Total,599.3,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.7208005892257238e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2017,Total,Total,563.9200000000001,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6414393402948387e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2018,Total,Total,574.9,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.6342230228116726e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxorubicin,2019,Total,Total,677.84,AOJJSUZBOXZQNB-TZSSRYMLSA-N,1.9580908154249206e-10,antineoplastic,antibiotic and antineoplastic treatment for many cancers,low,NA,NA,NA
doxycycline,2016,Total,Total,341623.015,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.809195486485373e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2017,Total,Total,317192.185,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.232723274455212e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2018,Total,Total,303595.08999999997,SGKRLCUYIXIAHR-AKNGSSGZSA-N,8.630058891817392e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxycycline,2019,Total,Total,318083.255,SGKRLCUYIXIAHR-AKNGSSGZSA-N,9.188538595479213e-8,antibacterial,"tetracycline antibiotic for many bacterial infections, also malaria and anthrax",NA,NA,NA,NA
doxylamine,2016,Total,Total,1619.26275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,4.6494715406495356e-10,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2017,Total,Total,7104.46275,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.0679430858116852e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2018,Total,Total,9141.454,HCFDWZZGGLSKEP-UHFFFAOYSA-N,2.598569244872822e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
doxylamine,2019,Total,Total,11257.61175,HCFDWZZGGLSKEP-UHFFFAOYSA-N,3.252010234169519e-9,antihistamine,"antihistamine for allergy and cold symptoms, insomnia",NA,NA,NA,NA
dronedarone,2016,Total,Total,449262,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.2899888441794218e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.32249721104485546
dronedarone,2017,Total,Total,519206,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.5112873352906828e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.3778218338226707
dronedarone,2018,Total,Total,585632.8,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.664732309399311e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4161830773498278
dronedarone,2019,Total,Total,675602.7999999999,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,1.951628168233447e-7,cardiac,antiarrhythmic for patients recovered from atrial fibrillation,low,high,4e-7,0.4879070420583618
droperidol,2016,Total,Total,35.725,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0257901059584348e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2017,Total,Total,37.6,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0944481344000199e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2018,Total,Total,37.55,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0674043226052932e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
droperidol,2019,Total,Total,36.7,RMEDXOLNCUSCGS-UHFFFAOYSA-N,1.0601607005501975e-11,other nervous system,"sedative, tranquilizer and anti-nausea for surgery and other medical procedures",NA,NA,NA,NA
drospirenone,2016,Total,Total,37983.771,METQSPRSQINEEU-HXCATZOESA-N,1.0906473472019854e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.47419449878347186
drospirenone,2017,Total,Total,35234.64,METQSPRSQINEEU-HXCATZOESA-N,1.025598032294051e-8,sex hormone,progestin birth control,low,high,2.3e-8,0.4459121879539352
drospirenone,2018,Total,Total,34171.074,METQSPRSQINEEU-HXCATZOESA-N,9.713542502174529e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.4223279348771534
drospirenone,2019,Total,Total,33596.514,METQSPRSQINEEU-HXCATZOESA-N,9.705096408251912e-9,sex hormone,progestin birth control,low,high,2.3e-8,0.421960713402257
duloxetine,2016,Total,Total,71834.2884,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.0626144803158793e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.04796777861199719
duloxetine,2017,Total,Total,78300.54119999999,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.27914577762904e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.05300339017741953
duloxetine,2018,Total,Total,88763.8248,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.5232194482689467e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.0586795220527662
duloxetine,2019,Total,Total,103103.28,ZEUITGRIYCTCEM-KRWDZBQOSA-N,2.9783663638643915e-8,antidepressant,"SSNRI for depression, anxiety, chronic pain",low,moderate,4.3e-7,0.06926433404335794
dutasteride,2016,Total,Total,3128.1749999999997,JWJOTENAMICLJG-QWBYCMEYSA-N,8.982088074755847e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002138592398751392
dutasteride,2017,Total,Total,3410.16,JWJOTENAMICLJG-QWBYCMEYSA-N,9.926178856397798e-10,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.0023633759181899516
dutasteride,2018,Total,Total,3810.36,JWJOTENAMICLJG-QWBYCMEYSA-N,1.083141074482638e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.002578907320196757
dutasteride,2019,Total,Total,4359,JWJOTENAMICLJG-QWBYCMEYSA-N,1.2591935950131636e-9,urological,5-alpha-reductase inhibitor for enlarged prostates,low,high,4.2e-7,0.00299807998812658
dydrogesterone,2019,Total,Total,82.11,JGMOKGBVKVMRFX-HQZYFCCVSA-N,2.3719290224026353e-11,sex hormone,progestin for various reproductive and gynaecological disordered,NA,NA,NA,NA
ebastine,2016,Total,Total,34690.03,MJJALKDDGIKVBE-UHFFFAOYSA-N,9.960724856375446e-9,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2017,Total,Total,37772.35,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0994648401437392e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2018,Total,Total,38210.53000000001,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.0861806895083691e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ebastine,2019,Total,Total,42561.2,MJJALKDDGIKVBE-UHFFFAOYSA-N,1.2294744307426991e-8,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
econazole,2016,Total,Total,15091.0794,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.333178428762254e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.02166589214381127
econazole,2017,Total,Total,16123.1457,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.693070939368272e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.023465354696841363
econazole,2018,Total,Total,16213.1622,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4.6087881265994e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.023043940632997
econazole,2019,Total,Total,21504.8286,LEZWWPYKPKIXLL-UHFFFAOYSA-N,6.212145545991261e-9,antifungal,imidazole antifungal for various skin infections,NA,NA,2e-7,0.031060727729956307
edoxaban,2016,Total,Total,130.05,HGVDHZBSSITLCT-JLJPHGGASA-N,3.734191834286759e-11,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,1.6095654458132582e-7
edoxaban,2017,Total,Total,5286.4800000000005,HGVDHZBSSITLCT-JLJPHGGASA-N,1.538770790835909e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,6.632632719120298e-6
edoxaban,2018,Total,Total,21279.33,HGVDHZBSSITLCT-JLJPHGGASA-N,6.048907809359386e-9,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,2.6072878488618042e-5
edoxaban,2019,Total,Total,40912.29,HGVDHZBSSITLCT-JLJPHGGASA-N,1.1818420170984423e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",low,moderate,2.32e-4,5.094146625424321e-5
efavirenz,2016,Total,Total,137592,XPOQHMRABVBWPR-ZDUSSCGKSA-N,3.950749118517368e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.015195188917374492
efavirenz,2017,Total,Total,87066,XPOQHMRABVBWPR-ZDUSSCGKSA-N,2.5342877997253232e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.00974726076817432
efavirenz,2018,Total,Total,62352,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.7724312735841613e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.006817043359939081
efavirenz,2019,Total,Total,64836,XPOQHMRABVBWPR-ZDUSSCGKSA-N,1.8729313128303163e-8,antiviral,NNRTI antiviral for treatment of HIV,low,high,2.6e-6,0.0072035819724242936
eflornithine,2016,Total,Total,5385.45,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.5463516658177332e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2017,Total,Total,6365.25,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8527755285876934e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2018,Total,Total,6444.6,VLCYCQAOQCDTCN-UHFFFAOYSA-N,1.8319557649699262e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
eflornithine,2019,Total,Total,7903.95,VLCYCQAOQCDTCN-UHFFFAOYSA-N,2.283230836270772e-9,dermatological,hair growth inhibitor and antiprotozoal,NA,NA,NA,NA
elbasvir,2017,Total,Total,4765.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.3871547950257275e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2018,Total,Total,3778.6,BVAZQCUMNICBAQ-PZHYSIFUSA-N,1.0741129090269935e-9,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
elbasvir,2019,Total,Total,861,BVAZQCUMNICBAQ-PZHYSIFUSA-N,2.4871890004733516e-10,antiviral,antiviral often used in combination for hepatitis C,NA,NA,NA,NA
eletriptan,2016,Total,Total,36486.6,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0476583143474606e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2017,Total,Total,36664.8,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0672266478231344e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2018,Total,Total,37340,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.061434817738526e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eletriptan,2019,Total,Total,37276.2,PWVXXGRKLHYWKM-LJQANCHMSA-N,1.0768055124209611e-8,analgesic,antimigraine selective serotonin agonist,NA,NA,NA,NA
eliglustat,2016,Total,Total,70.56,FJZZPCZKBUKGGU-AUSIDOKSSA-N,2.0260251889832654e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2017,Total,Total,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.916914264336375e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2018,Total,Total,65.856,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.872036726218221e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eliglustat,2019,Total,Total,56.448,FJZZPCZKBUKGGU-AUSIDOKSSA-N,1.6306253739688706e-11,metabolic,metabolic agent for treatment of type 1 Gaucher disease,NA,NA,NA,NA
eltrombopag,2016,Total,Total,1215.55,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,3.490270576060953e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2017,Total,Total,1726.9,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.026602349189878e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2018,Total,Total,2057.3,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,5.848124934476351e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eltrombopag,2019,Total,Total,2347.8,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,6.782139762266361e-10,antihemorrhagic,"platelet-stimulating agent to reduce bleeding for immune thrombocytopenic purpura, etc.",NA,NA,NA,NA
eluxadoline,2017,Total,Total,1661.8,QFNHIDANIVGXPE-FNZWTVRRSA-N,4.8371114620903e-10,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2018,Total,Total,8265.6,QFNHIDANIVGXPE-FNZWTVRRSA-N,2.349597115559604e-9,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
eluxadoline,2019,Total,Total,316.4,QFNHIDANIVGXPE-FNZWTVRRSA-N,9.13991405051996e-11,alimentary,treatment for diarrhoea from IBS,NA,NA,NA,NA
elvitegravir,2016,Total,Total,25407,JUZYLCPPVHEVSV-LJQANCHMSA-N,7.29524120982112e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2017,Total,Total,43587,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.2687157136727041e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2018,Total,Total,47475,JUZYLCPPVHEVSV-LJQANCHMSA-N,1.3495344930941758e-8,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
elvitegravir,2019,Total,Total,33624,JUZYLCPPVHEVSV-LJQANCHMSA-N,9.713036347493145e-9,antiviral,integrase strand transfer inhibitor for HIV infections,NA,NA,NA,NA
emedastine,2016,Total,Total,31.7375,KBUZBQVCBVDWKX-UHFFFAOYSA-N,9.112949891632142e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2017,Total,Total,30.6275,KBUZBQVCBVDWKX-UHFFFAOYSA-N,8.914949530940588e-12,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2018,Total,Total,39.182500000000005,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1138101163909964e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emedastine,2019,Total,Total,38.427499999999995,KBUZBQVCBVDWKX-UHFFFAOYSA-N,1.1100633602286842e-11,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
emodepside,2016,Total,Total,2393.946124,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,6.873859337149738e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2017,Total,Total,2639.01194,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.681547059554194e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2018,Total,Total,2740.303384,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.789644946288983e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
emodepside,2019,Total,Total,2591.797656,ZMQMTKVVAMWKNY-YSXLEBCMSA-N,7.486980977300601e-10,anthelminthic,antinematode used with toltrazuril in cats,NA,NA,NA,NA
empagliflozin,2016,Total,Total,19498.119,OBWASQILIWPZMG-QZMOQZSNSA-N,5.5985941371589e-9,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,2.3327475571495418e-5
empagliflozin,2017,Total,Total,44557.269,OBWASQILIWPZMG-QZMOQZSNSA-N,1.2969579768885596e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,5.403991570368998e-5
empagliflozin,2018,Total,Total,68882.715,OBWASQILIWPZMG-QZMOQZSNSA-N,1.958074773469733e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,8.15864488945722e-5
empagliflozin,2019,Total,Total,96535.977,OBWASQILIWPZMG-QZMOQZSNSA-N,2.7886552862293668e-8,anti-diabetic,"SGLT-2 inhibitor for type 2 diabetes, and associated heart and kidney failure",low,low,2.4e-4,1.1619397025955695e-4
emtricitabine,2016,Total,Total,185142,XQSPYNMVSIKCOC-NTSWFWBYSA-N,5.316076467385768e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,8.714879454730768e-5
emtricitabine,2017,Total,Total,208338,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.064232325123176e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,9.941364467415043e-5
emtricitabine,2018,Total,Total,222060,XQSPYNMVSIKCOC-NTSWFWBYSA-N,6.312325003401636e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.0348073776068256e-4
emtricitabine,2019,Total,Total,248202,XQSPYNMVSIKCOC-NTSWFWBYSA-N,7.169863929099732e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV infections,low,moderate,6.1e-4,1.175387529360612e-4
enalapril,2016,Total,Total,318584.1288,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.147668222209313e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2017,Total,Total,313478.8807,GBXSMTUPTTWBMN-XIRDDKMYSA-N,9.124637663721314e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2018,Total,Total,305892.9873,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.695379411415875e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
enalapril,2019,Total,Total,307256.2993,GBXSMTUPTTWBMN-XIRDDKMYSA-N,8.875778024914148e-8,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,NA,NA,NA
encorafenib,2019,Total,Total,126.35,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,3.6498993055726825e-11,antineoplastic,small molecule BRAF inhibitor for melanomas,NA,NA,NA,NA
enoxaparin,2016,Total,Total,100177.6,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.876450410599348e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2017,Total,Total,95914.2,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.7918382247997445e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2018,Total,Total,90336.4,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.5679218068868392e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enoxaparin,2019,Total,Total,101000.1,HTTJABKRGRZYRN-UHFFFAOYSA-N,2.917611356175477e-8,anticoagulant,"heparin for DVT, angina, heart attacks",NA,NA,NA,NA
enrofloxacin,2016,Total,Total,18469.15,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.3031410316199375e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2017,Total,Total,18206.94,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.299614764929015e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2018,Total,Total,18346.29,SPFYMRJSYKOXGV-UHFFFAOYSA-N,5.215155592482095e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
enrofloxacin,2019,Total,Total,12959.97,SPFYMRJSYKOXGV-UHFFFAOYSA-N,3.743774080193336e-9,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
entacapone,2016,Total,Total,28821,JRURYQJSLYLRLN-BJMVGYQFSA-N,8.275520404150609e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2017,Total,Total,31330.2,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.119489079888166e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2018,Total,Total,32387,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.20639781523772e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entacapone,2019,Total,Total,33673,JRURYQJSLYLRLN-BJMVGYQFSA-N,9.72719108164218e-9,dopaminergic,used with carbidopa and levodopa for Parkinson's,NA,NA,NA,NA
entecavir,2016,Total,Total,52.455,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.5061671100923637e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2017,Total,Total,63.5925,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.8510290687987572e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2018,Total,Total,63.141,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.7948595561550154e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
entecavir,2019,Total,Total,57.366,QDGZDCVAUDNJFG-FXQIFTODSA-N,1.6571438350889002e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,NA,NA,NA,NA
enzalutamide,2016,Total,Total,26960.64,WXCXUHSOUPDCQV-UHFFFAOYSA-N,7.741345769715105e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2017,Total,Total,33116.16,WXCXUHSOUPDCQV-UHFFFAOYSA-N,9.639340300662918e-9,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2018,Total,Total,37022.72,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.0524157486712504e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
enzalutamide,2019,Total,Total,40185.6,WXCXUHSOUPDCQV-UHFFFAOYSA-N,1.160849968611172e-8,antineoplastic,antiandrogen testosterone inhibitor for prostate cancer,NA,NA,NA,NA
ephedrine,2016,Total,Total,18558.75,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.328868335607026e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2017,Total,Total,17555.5,KWGRBVOPPLSCSI-WPRPVWTQSA-N,5.109995804111582e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2018,Total,Total,15878.85,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.51375582636513e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
ephedrine,2019,Total,Total,15576.15,KWGRBVOPPLSCSI-WPRPVWTQSA-N,4.499515557459117e-9,stimulant,"stimulant for asthma, preventing hypotension during anaesthesia",low,NA,NA,NA
epinephrine,2016,Total,Total,271.69765,UCTWMZQNUQWSLP-VIFPVBQESA-N,7.801392895231848e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2017,Total,Total,291.7274,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.491502890515115e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2018,Total,Total,306.95865000000003,UCTWMZQNUQWSLP-VIFPVBQESA-N,8.725672167006269e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epinephrine,2019,Total,Total,324.8584,UCTWMZQNUQWSLP-VIFPVBQESA-N,9.384253649144859e-11,other hormone,"aka adrenaline, for anaphylaxis, septic shock",low,NA,NA,NA
epirubicin,2016,Total,Total,1315.33,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.7767739680064606e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2017,Total,Total,1127.27,AOJJSUZBOXZQNB-VTZDEGQISA-N,3.281219543790187e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2018,Total,Total,1006.18,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8601887651637655e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
epirubicin,2019,Total,Total,988.13,AOJJSUZBOXZQNB-VTZDEGQISA-N,2.8544321336094456e-10,antineoplastic,antibiotic antineoplastic for breast cancer,NA,NA,NA,NA
eplerenone,2016,Total,Total,15919.925,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.571169084002893e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2017,Total,Total,17031.66,JUKPWJGBANNWMW-VWBFHTRKSA-N,4.9575182214721925e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2018,Total,Total,23322.025,JUKPWJGBANNWMW-VWBFHTRKSA-N,6.629568654303253e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
eplerenone,2019,Total,Total,31719.375,JUKPWJGBANNWMW-VWBFHTRKSA-N,9.162843275480769e-9,cardiac,"aldosterone receptor antagonist and diuretic for heart failure, high blood pressure",NA,NA,NA,NA
epoprostenol,2016,Total,Total,0.524,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.504587867102085e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2017,Total,Total,0.495,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.440829325872367e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2018,Total,Total,0.4785,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.3601943232134034e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
epoprostenol,2019,Total,Total,0.528,KAQKFAOMNZTLHT-OZUDYXHBSA-N,1.52524482258993e-13,antihypertensive,prostaglandin for pulmonary arterial hypertension,NA,NA,NA,NA
eprinomectin,2016,Total,Total,4106.3564,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.1790790109612587e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2017,Total,Total,5427.3816,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.579783953935371e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2018,Total,Total,5763.41,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.638319240198821e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprinomectin,2019,Total,Total,5112.176,WPNHOHPRXXCPRA-TVXIRPTOSA-N,1.4767651470016094e-9,antiparasitic,avermectin antiparasitic for nematodes and arthropod infection in cattle and swine,NA,NA,NA,NA
eprosartan,2016,Total,Total,462785.4,OROAFUQRIXKEMV-LDADJPATSA-N,1.3288192708243993e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2017,Total,Total,420487.62,OROAFUQRIXKEMV-LDADJPATSA-N,1.22394120012581e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2018,Total,Total,382502.232,OROAFUQRIXKEMV-LDADJPATSA-N,1.0873090168920713e-7,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eprosartan,2019,Total,Total,333412.464,OROAFUQRIXKEMV-LDADJPATSA-N,9.631356714071049e-8,antihypertensive,angiotensin II receptor blocker for hypertension,NA,NA,NA,NA
eribulin,2016,Total,Total,1.826,UFNVPOGXISZXJD-JBQZKEIOSA-N,5.243086727725968e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2017,Total,Total,1.51976,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.423666214722804e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2018,Total,Total,1.41328,UFNVPOGXISZXJD-JBQZKEIOSA-N,4.017419922907082e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
eribulin,2019,Total,Total,1.19416,UFNVPOGXISZXJD-JBQZKEIOSA-N,3.4495953737575586e-13,antineoplastic,"mitotic inhibitor for metastatic breast cancer, liposarcoma",NA,NA,NA,NA
erlotinib,2016,Total,Total,2868,AAKJLRGGTJKAMG-UHFFFAOYSA-N,8.23503435658164e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,5.924485148619885e-4
erlotinib,2017,Total,Total,3227.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,9.393770589740595e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,6.758108337942874e-4
erlotinib,2018,Total,Total,2084.25,AAKJLRGGTJKAMG-UHFFFAOYSA-N,5.924733580266531e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,4.2623982591845545e-4
erlotinib,2019,Total,Total,1297.5,AAKJLRGGTJKAMG-UHFFFAOYSA-N,3.748115828239459e-10,antineoplastic,"tyrosine kinase inhibitor for non-small cell lung cancer, pancreatic cancer",low,high,1.39e-6,2.696486207366517e-4
ertapenem,2016,Total,Total,3578,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.0273693489487138e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,7.902841145759337e-5
ertapenem,2017,Total,Total,4296,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2504652088783204e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.61896314521785e-5
ertapenem,2018,Total,Total,4515,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.2834435463549666e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,9.872642664268974e-5
ertapenem,2019,Total,Total,4674,JUZNIMUFDBIJCM-ANEDZVCMSA-N,1.3501883145426768e-9,antibacterial,carbapenem antibiotic,low,high,1.3e-5,1.038606395802059e-4
ertugliflozin,2018,Total,Total,68.39,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.9440687516105464e-11,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
ertugliflozin,2019,Total,Total,560.28,MCIACXAZCBVDEE-CUUWFGFTSA-N,1.6184927446982687e-10,anti-diabetic,SGLT-2 inhibitor for type 2 diabetes,NA,NA,NA,NA
erythromycin,2016,Total,Total,1270675,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.6485537939502707e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2017,Total,Total,1150366,ULGZDMOVFRHVEP-RWJQBGPGSA-N,3.348446602598972e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2018,Total,Total,864442.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.457282719424038e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythromycin,2019,Total,Total,867991.5,ULGZDMOVFRHVEP-RWJQBGPGSA-N,2.507385495127021e-7,antibacterial,macrolide antibiotic,NA,NA,NA,NA
erythropoietin,2016,Total,Total,1012.9224,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.9084556361754294e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2017,Total,Total,948.5448,OXCMYAYHXIHQOA-UHFFFAOYSA-N,2.7609922520075536e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2018,Total,Total,1127.196,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.2041914322860087e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
erythropoietin,2019,Total,Total,1287.3504,OXCMYAYHXIHQOA-UHFFFAOYSA-N,3.7187964629906733e-10,blood,antianemic preparation for kidney diseases,NA,NA,NA,NA
escitalopram,2016,Total,Total,396431.7842,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.1382947569483817e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2017,Total,Total,389371.3374,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.133368972889018e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2018,Total,Total,374910.2026,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0657277519149569e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
escitalopram,2019,Total,Total,372772.82579999993,WSEQXVZVJXJVFP-FQEVSTJZSA-N,1.0768367851395225e-7,antidepressant,SSRI antidepressant for depression and anxiety,NA,NA,NA,NA
esketamine,2016,Total,Total,450.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.294261414305849e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2017,Total,Total,615.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,1.7908489752383303e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2018,Total,Total,814.25,YQEZLKZALYSWHR-ZDUSSCGKSA-N,2.314604446554887e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
esketamine,2019,Total,Total,1047.75,YQEZLKZALYSWHR-ZDUSSCGKSA-N,3.0266576948268923e-10,antidepressant,"hallucinogen, anaesthetic and antidepressant for treatment-resistant depression",NA,NA,NA,NA
eslicarbazepine,2016,Total,Total,150333.6,BMPDWHIDQYTSHX-AWEZNQCLSA-N,4.316605163698053e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2017,Total,Total,180806.64,BMPDWHIDQYTSHX-AWEZNQCLSA-N,5.2628587722110654e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2018,Total,Total,239031.12,BMPDWHIDQYTSHX-AWEZNQCLSA-N,6.794749686423025e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
eslicarbazepine,2019,Total,Total,301821.68,BMPDWHIDQYTSHX-AWEZNQCLSA-N,8.718787022071867e-8,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,NA,NA,NA,NA
esmolol,2016,Total,Total,89,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5555022933604115e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2017,Total,Total,86,AQNDDEOPVVGCPG-UHFFFAOYSA-N,2.5032590308085564e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2018,Total,Total,136.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,3.880178163398736e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esmolol,2019,Total,Total,142.5,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4.1164277882398677e-11,beta blocker,cardioselective beta blocker and antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
esomeprazole,2016,Total,Total,1635560.512,SUBDBMMJDZJVOS-DEOSSOPVSA-N,4.696268134096325e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.004696268134096324
esomeprazole,2017,Total,Total,1758601.6008,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.118878300926725e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005118878300926725
esomeprazole,2018,Total,Total,1831296.4908,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.205682530630692e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005205682530630692
esomeprazole,2019,Total,Total,1967701.7156,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5.684141769167089e-7,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,moderate,1e-4,0.005684141769167089
estradiol,2016,Total,Total,16764.89485500001,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.8137895786403016e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.034473946600754
estradiol,2017,Total,Total,16335.55707,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.754898925437914e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.887247313594786
estradiol,2018,Total,Total,16243.17705,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.617320211987509e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,11.543300529968773
estradiol,2019,Total,Total,16651.18926,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4.810064433481069e-9,sex hormone,"estrogen for menopause symptoms, ovarian failure, some cancers",low,moderate,4e-10,12.025161083702672
estriol,2016,Total,Total,3188.9082,PROQIPRRNZUXQM-ZXXIGWHRSA-N,9.156474402714406e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2017,Total,Total,2964.0368999999996,PROQIPRRNZUXQM-ZXXIGWHRSA-N,8.627618764621857e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2018,Total,Total,2712.0612,PROQIPRRNZUXQM-ZXXIGWHRSA-N,7.709363110652727e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
estriol,2019,Total,Total,2519.4287999999992,PROQIPRRNZUXQM-ZXXIGWHRSA-N,7.277927524780226e-10,sex hormone,"estrogen for menopause symptoms, and, in dogs, urinary incontinence",NA,NA,NA,NA
ethambutol,2016,Total,Total,10609.5,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.046359728248009e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2017,Total,Total,11253,AEUTYOVWOVBAKS-UWVGGRQHSA-N,3.275485334149847e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2018,Total,Total,9966,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.8329564524858467e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethambutol,2019,Total,Total,8679,AEUTYOVWOVBAKS-UWVGGRQHSA-N,2.507121177132197e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
ethinylestradiol,2016,Total,Total,2284.45398675,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.559468991253887e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.741339975011105
ethinylestradiol,2017,Total,Total,2211.705453,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.437757731059046e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,18.393593517311558
ethinylestradiol,2018,Total,Total,2102.425479,BFPYWIDHMRZLRN-SLHNCBLASA-N,5.976399585193354e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.075427386266725
ethinylestradiol,2019,Total,Total,2094.9751485,BFPYWIDHMRZLRN-SLHNCBLASA-N,6.051799239970065e-10,sex hormone,estrogen widely used in combination birth control pills,high,low,3.5e-11,17.290854971343045
ethylmorphine,2016,Total,Total,168526.865,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.838997640453264e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2017,Total,Total,165954.01750000002,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.830533639602747e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2018,Total,Total,163302.13,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.642061237087925e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
ethylmorphine,2019,Total,Total,161539.45,OGDVEMNWJVYAJL-LEPYJNQMSA-N,4.6664244272069105e-8,analgesic,opioid analgesic and antitussive,low,NA,NA,NA
etonogestrel,2016,Total,Total,3305.33,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.490762241924683e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.5150971266387714
etonogestrel,2017,Total,Total,3368.545,GCKFUYQCUCGESZ-BPIQYHPVSA-N,9.805047316203499e-10,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.6314990060012957
etonogestrel,2018,Total,Total,3550.718,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0093346848342003e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.738276610497038
etonogestrel,2019,Total,Total,3539.2419999999997,GCKFUYQCUCGESZ-BPIQYHPVSA-N,1.0223883591653083e-9,sex hormone,progestin used in birth control implants,low,moderate,2.7e-10,3.7866235524641048
etoposide,2016,Total,Total,3659.2,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0506847181870131e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2017,Total,Total,3609.8,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0507284243503171e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2018,Total,Total,3554.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,1.0103529118071891e-9,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoposide,2019,Total,Total,3086.3,VJJPUSNTGOMMGY-MRVIYFEKSA-N,8.915460409013827e-10,antineoplastic,mitotic inhibitor for small cell lung cancer,NA,NA,NA,NA
etoricoxib,2016,Total,Total,393101.82,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.1287332612743277e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0015049776816991036
etoricoxib,2017,Total,Total,442147.1478,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.286987024042553e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.0017159826987234042
etoricoxib,2018,Total,Total,475405.017,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.3513964584128973e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.00180186194455053
etoricoxib,2019,Total,Total,530281.7112,MNJVRJDLRVPLFE-UHFFFAOYSA-N,1.5318360502309253e-7,analgesic,NSAID for arthritis and related conditions,low,high,7.5e-5,0.002042448066974567
etravirine,2016,Total,Total,3480,PYGWGZALEOIKDF-UHFFFAOYSA-N,9.99230110212835e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0020392451228833366
etravirine,2017,Total,Total,2556,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.43991870086822e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0015183507552792286
etravirine,2018,Total,Total,2508,PYGWGZALEOIKDF-UHFFFAOYSA-N,7.129294383739217e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.0014549580374977995
etravirine,2019,Total,Total,2280,PYGWGZALEOIKDF-UHFFFAOYSA-N,6.586284461183787e-10,antiviral,NNRTI antiviral for HIV,low,high,4.9e-7,0.001344139685955875
everolimus,2016,Total,Total,802.059,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.30299282461838e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.16449948747274143
everolimus,2017,Total,Total,689.892,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0081143945146237e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14343674246533028
everolimus,2018,Total,Total,706.9499999999999,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.0095911740767302e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.14354222671976644
everolimus,2019,Total,Total,764.208,HKVAMNSJSFKALM-GKUWKFKPSA-N,2.2075838927685703e-10,immunosuppressant,"MTOR inhibiting immunosuppressant for organ transplants, some cancers",low,low,1.4e-9,0.1576845637691836
exemestane,2016,Total,Total,7017.25,BFYIZQONLCFLEV-DAELLWKTSA-N,2.0148987042790278e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2017,Total,Total,6853,BFYIZQONLCFLEV-DAELLWKTSA-N,1.9947481555966323e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2018,Total,Total,7102.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.01897182458165e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
exemestane,2019,Total,Total,7537.5,BFYIZQONLCFLEV-DAELLWKTSA-N,2.177373645884772e-9,antineoplastic,aromatase inhibitor for post-menopausal breast cancer,NA,NA,NA,NA
ezetimibe,2016,Total,Total,125693.8396,OLNTVTPDXPETLC-XPWALMASSA-N,3.60911118380984e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.007218222367619679
ezetimibe,2017,Total,Total,145311.6734,OLNTVTPDXPETLC-XPWALMASSA-N,4.229683240935505e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.00845936648187101
ezetimibe,2018,Total,Total,181550.2022,OLNTVTPDXPETLC-XPWALMASSA-N,5.1607848361689764e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.010321569672337952
ezetimibe,2019,Total,Total,206958.4234,OLNTVTPDXPETLC-XPWALMASSA-N,5.978451965572435e-8,lipid-modifying,cholesterol adsorption inhibitor for high cholesterol conditions,low,moderate,5e-6,0.01195690393114487
famotidine,2016,Total,Total,35431.3512,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0173584185220018e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2017,Total,Total,35443.1328,XUFQPHANEAPEMJ-UHFFFAOYSA-N,1.0316667704854297e-8,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2018,Total,Total,32979.636,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.374861790772076e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
famotidine,2019,Total,Total,32563.0032,XUFQPHANEAPEMJ-UHFFFAOYSA-N,9.406543946738508e-9,alimentary,"H2 antagonist reducing stomach acid for ulcers, acid disorders",NA,NA,NA,NA
fampridine,2016,Total,Total,10753.12,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.0875980697505288e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2017,Total,Total,10847.76,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.157529440005096e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2018,Total,Total,11444.16,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.2531413721935e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
fampridine,2019,Total,Total,11673.2,NUKYPUAOHBNCPY-UHFFFAOYSA-N,3.372062095275904e-9,other nervous system,potassium channel blocker for multiple sclerosis,low,NA,NA,NA
febantel,2016,Total,Total,9568.5,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.747452100451584e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2017,Total,Total,9452.1,HMCCXLBXIJMERM-UHFFFAOYSA-N,2.7512854285006462e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2018,Total,Total,6800.0999999999995,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.933010954500201e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febantel,2019,Total,Total,5323.8,HMCCXLBXIJMERM-UHFFFAOYSA-N,1.5378974216864144e-9,anthelminthic,broad-spectrum pro-benzimidazole veterinary anthelminthic,NA,NA,NA,NA
febuxostat,2017,Total,Total,1906.24,BQSJTQLCZDPROO-UHFFFAOYSA-N,5.54861918010291e-10,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2018,Total,Total,8012.48,BQSJTQLCZDPROO-UHFFFAOYSA-N,2.2776446835655022e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
febuxostat,2019,Total,Total,11303.04,BQSJTQLCZDPROO-UHFFFAOYSA-N,3.2651331893043335e-9,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
felbamate,2016,Total,Total,12748.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.6606278244486747e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2017,Total,Total,11507.4,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.3495352292007413e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2018,Total,Total,13672.8,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.886659340111226e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felbamate,2019,Total,Total,13081.2,WKGXYQFOCVYPAC-UHFFFAOYSA-N,3.778794047966552e-9,anticonvulsant,carbamate anticonvulsant for epilepsy,low,high,NA,NA
felodipine,2016,Total,Total,33237.5734,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.543673601060114e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.19087347202120228
felodipine,2017,Total,Total,32285.259199999997,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.397484494697096e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.18794968989394192
felodipine,2018,Total,Total,32900.6745,RZTAMFZIAATZDJ-UHFFFAOYSA-N,9.352416026079829e-9,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.1870483205215966
felodipine,2019,Total,Total,34789.8125,RZTAMFZIAATZDJ-UHFFFAOYSA-N,1.004980708229156e-8,antihypertensive,calcium channel blocker for hypertension,low,high,5e-8,0.2009961416458312
felypressin,2016,Total,Total,0.2567052,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.370907048511722e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2017,Total,Total,0.2695356,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.845551451446542e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2018,Total,Total,0.28032480000000004,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.968572656550318e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
felypressin,2019,Total,Total,0.27459,SFKQVVDKFKYTNA-DZCXQCEKSA-N,7.932139693844107e-14,blood,non-catecholamine vasoconstrictor used with local anaesthetics,NA,NA,NA,NA
fenbendazole,2016,Total,Total,847857.125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.4344953116623203e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2017,Total,Total,907688.6125,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.6420694376775737e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2018,Total,Total,823748.175,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.341604161739605e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fenbendazole,2019,Total,Total,813966.575,HDDSHPAODJUKPD-UHFFFAOYSA-N,2.3513225459848633e-7,anthelminthic,broad spectrum benzimidazole anthelminthic with many veterinary applications,NA,NA,NA,NA
fentanyl,2016,Total,Total,7638.800299999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.193367605075527e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.976006851419394e-4
fentanyl,2017,Total,Total,7574.263399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.2046910764851996e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9862081770136934e-4
fentanyl,2018,Total,Total,7407.372399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.105635504369413e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.8969689228553267e-4
fentanyl,2019,Total,Total,7367.357399999999,PJMPHNIQZUBGLI-UHFFFAOYSA-N,2.128224191386289e-9,analgesic,opioid treatment for moderate-severe chronic pain,low,high,1.11e-5,1.9173190913389991e-4
fesoterodine,2016,Total,Total,14490.68992,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.160785541902763e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2017,Total,Total,13885.55616,DCCSDBARQIPTGU-HSZRJFAPSA-N,4.04176091340923e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2018,Total,Total,13299.2664,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.780477880915936e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fesoterodine,2019,Total,Total,12869.67024,DCCSDBARQIPTGU-HSZRJFAPSA-N,3.7176889965908515e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
fexofenadine,2016,Total,Total,1176976.08,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.3795113164835365e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0016897556582417682
fexofenadine,2017,Total,Total,1280680.6800000002,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.7277621834791203e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0018638810917395601
fexofenadine,2018,Total,Total,1345346.34,RWTNPBWLLIMQHL-UHFFFAOYSA-N,3.824310249579789e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0019121551247898944
fexofenadine,2019,Total,Total,1538603.7,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4.444597211065739e-7,antihistamine,"antihistamine for allergies, some skin disorders",low,high,2e-4,0.0022222986055328692
fidaxomicin,2016,Total,Total,212,ZVGNESXIJDCBKN-UUEYKCAUSA-N,6.087263889802327e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2017,Total,Total,284,ZVGNESXIJDCBKN-UUEYKCAUSA-N,8.266576334298023e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2018,Total,Total,276,ZVGNESXIJDCBKN-UUEYKCAUSA-N,7.845634967751289e-11,antibacterial,macrolide antibiotic,NA,NA,NA,NA
fidaxomicin,2019,Total,Total,352,ZVGNESXIJDCBKN-UUEYKCAUSA-N,1.0168298817266201e-10,antibacterial,macrolide antibiotic,NA,NA,NA,NA
finasteride,2016,Total,Total,24501.47,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.03523177255071e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407046354510142
finasteride,2017,Total,Total,24178.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,7.0377730483351405e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.001407554609667028
finasteride,2018,Total,Total,24142.09,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.862682083282563e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0013725364166565124
finasteride,2019,Total,Total,21924.42,DBEPLOCGEIEOCV-WSBQPABSSA-N,6.333353805546802e-9,urological,"5-alpha-reductase inhibitor, for enlarged prostates, male pattern hair loss",low,high,5e-6,0.0012666707611093603
fingolimod,2016,Total,Total,207.1825,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.948936560608354e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.930510620989337e-5
fingolimod,2017,Total,Total,215.565,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.27459340670054e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.090932712660364e-5
fingolimod,2018,Total,Total,216.0795,KKGQTZUTZRNORY-UHFFFAOYSA-N,6.142322032660199e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,3.0257744003252214e-5
fingolimod,2019,Total,Total,204.3895,KKGQTZUTZRNORY-UHFFFAOYSA-N,5.904242929294403e-11,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,low,2.03e-6,2.9084940538396075e-5
firocoxib,2016,Total,Total,50877.425952,FULAPETWGIGNMT-UHFFFAOYSA-N,1.4608694236023652e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2017,Total,Total,64354.385976000005,FULAPETWGIGNMT-UHFFFAOYSA-N,1.8732057891460643e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2018,Total,Total,73775.904472,FULAPETWGIGNMT-UHFFFAOYSA-N,2.097169622836964e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
firocoxib,2019,Total,Total,88211.24,FULAPETWGIGNMT-UHFFFAOYSA-N,2.5481768390954117e-8,analgesic,"NSAID for pain management in dogs, horses",NA,NA,NA,NA
flecainide,2016,Total,Total,444214.9499999999,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.2754969926628992e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2017,Total,Total,454880.21,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.324049992579759e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2018,Total,Total,452896.64,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.287413665058358e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
flecainide,2019,Total,Total,460916.9,DJBNUMBKLMJRSA-UHFFFAOYSA-N,1.331460445775001e-7,cardiac,Group I antiarrhythmic for heart rhythm disorders,NA,NA,NA,NA
florfenicol,2016,Total,Total,17160,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.927238129670187e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2017,Total,Total,17930,AYIRNRDRBQJXIF-NXEZZACHSA-N,5.219004002604351e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2018,Total,Total,16690,AYIRNRDRBQJXIF-NXEZZACHSA-N,4.7443350583974295e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
florfenicol,2019,Total,Total,13650,AYIRNRDRBQJXIF-NXEZZACHSA-N,3.943104512945557e-9,antibacterial,amphenicol veterinary antibiotic,NA,NA,NA,NA
flubendazole,2016,Total,Total,250,CPEUVMUXAHMANV-UHFFFAOYSA-N,7.178377228540482e-11,anthelminthic,"imidazole anthelmintic for human, veterinary infections",NA,NA,NA,NA
fluconazole,2016,Total,Total,84246.62,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.4190160743580123e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2017,Total,Total,81141.325,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.3618343555583962e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2018,Total,Total,80490.30099999999,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.2880344930812563e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fluconazole,2019,Total,Total,80879.812,RFHAOTPXVQNOHP-UHFFFAOYSA-N,2.3363923201713427e-8,antifungal,"azole antifungal for internal infections, preventative use in the immunosuppressed",low,NA,NA,NA
fludarabine,2016,Total,Total,96.65,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.7751606365537495e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2017,Total,Total,87.45,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5454651423745147e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2018,Total,Total,89.9,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.5555166072494243e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludarabine,2019,Total,Total,81.4,HBUBKKRHXORPQB-FJFJXFQQSA-N,2.351419101492809e-11,antineoplastic,antimetabolite treatment for leukaemia,low,NA,NA,NA
fludrocortisone,2016,Total,Total,77.24,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.2178314285298668e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2017,Total,Total,80.97,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.356847485169405e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2018,Total,Total,80.31,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.282909218333718e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
fludrocortisone,2019,Total,Total,82.49,AAXVEMMRQDVLJB-BULBTXNYSA-N,2.382906163171275e-11,steroid,mineralocorticoid for inflammation in steroid-deficient conditions,NA,NA,NA,NA
flumazenil,2016,Total,Total,7.015,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.014252650328459e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2017,Total,Total,6.9399999999999995,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.020071822536207e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2018,Total,Total,7.92,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.2513561211808053e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flumazenil,2019,Total,Total,7.4,OFBIFZUFASYYRE-UHFFFAOYSA-N,2.137653728629826e-12,antidote,"antidote to benzodiazepines, post-surgery or overdose",NA,NA,NA,NA
flunixin,2016,Total,Total,19223.8,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.5198275266406615e-09,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2017,Total,Total,19617,NOOCSNJCXJYGPE-UHFFFAOYSA-N,5.710050279926913e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2018,Total,Total,16167.95,NOOCSNJCXJYGPE-UHFFFAOYSA-N,4.59593601003096e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
flunixin,2019,Total,Total,6154.15,NOOCSNJCXJYGPE-UHFFFAOYSA-N,1.7777623910874652e-9,analgesic,veterinary NSAID,NA,NA,NA,NA
fluocinolone acetonide,2016,Total,Total,197.62,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.67436363161668e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2017,Total,Total,202.68375,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.899650320763299e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2018,Total,Total,184.275,FEBLZLNTKCEFIT-VSXGLTOVSA-N,5.238240520588294e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinolone acetonide,2019,Total,Total,228.4431875,FEBLZLNTKCEFIT-VSXGLTOVSA-N,6.599086912695372e-11,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2016,Total,Total,21.3,WJOHZNCJWYWUJD-IUGZLZTKSA-N,6.1159773987164904e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2017,Total,Total,16.9,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.919195072170302e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2018,Total,Total,17.1,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4.860882534367648e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluocinonide,2019,Total,Total,19,WJOHZNCJWYWUJD-IUGZLZTKSA-N,5.4885703843198235e-12,steroid,topical corticosteroid for skin conditions,NA,NA,NA,NA
fluorescein,2016,Total,Total,4019.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,1.1541107772958246e-9,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,1.1541107772958245e-4
fluorescein,2017,Total,Total,3890.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,1.1323463118199355e-9,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,1.1323463118199355e-4
fluorescein,2018,Total,Total,3578.2,GNBHRKFJIUUOQI-UHFFFAOYSA-N,1.017146776869843e-9,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,1.0171467768698428e-4
fluorescein,2019,Total,Total,2757.4,GNBHRKFJIUUOQI-UHFFFAOYSA-N,7.965359988275516e-10,diagnostic agent,diagnostic dye used for eye exams,low,NA,1e-5,7.965359988275516e-5
fluoxetine,2016,Total,Total,96105.48,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.7595255566798107e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08623517364624408
fluoxetine,2017,Total,Total,90741.92,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.641285240847762e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.08254016377649256
fluoxetine,2018,Total,Total,88383.38,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5124048431016308e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07851265134692596
fluoxetine,2019,Total,Total,87378.72,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,2.5241276569040754e-8,antidepressant,"SSRI for depression, eating disorders, OCD, panic disorders, premenstrual dysphoric disorder",low,high,3.2e-7,0.07887898927825235
flupentixol,2016,Total,Total,2253.712499999999,NJMYODHXAKYRHW-DVZOWYKESA-N,6.471199395870812e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2017,Total,Total,2129.6025,NJMYODHXAKYRHW-DVZOWYKESA-N,6.198775221113346e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2018,Total,Total,1947.4855,NJMYODHXAKYRHW-DVZOWYKESA-N,5.535963890575582e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flupentixol,2019,Total,Total,1965.812,NJMYODHXAKYRHW-DVZOWYKESA-N,5.678682907547641e-10,antipsychotic,typical thioxanthene antipsychotic for schizophrenia,NA,NA,NA,NA
flurbiprofen,2016,Total,Total,3806.18,SYTBZMRGLBWNTM-UHFFFAOYSA-N,1.0928878335890484e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2017,Total,Total,7265.44,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.1147998014881067e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2018,Total,Total,8077.02,SYTBZMRGLBWNTM-UHFFFAOYSA-N,2.295990961856034e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flurbiprofen,2019,Total,Total,10417.54,SYTBZMRGLBWNTM-UHFFFAOYSA-N,3.009336922182481e-9,analgesic,NSAID for arthritis,NA,NA,NA,NA
flutamide,2016,Total,Total,14427,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.142497931046141e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2017,Total,Total,13860,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4.034322112442627e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2018,Total,Total,11466,MKXKFYHWDHIYRV-UHFFFAOYSA-N,3.259349657254938e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
flutamide,2019,Total,Total,8505,MKXKFYHWDHIYRV-UHFFFAOYSA-N,2.456857427296847e-9,antineoplastic,antiandrogen treatment for prostate cancer,NA,NA,NA,NA
fluticasone,2016,Total,Total,17882.717,MGNNYOODZCAHBA-GQKYHHCASA-N,5.134755539889351e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08853026792912673
fluticasone,2017,Total,Total,17071.5354,MGNNYOODZCAHBA-GQKYHHCASA-N,4.969125018583484e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08567456928592214
fluticasone,2018,Total,Total,16322.98,MGNNYOODZCAHBA-GQKYHHCASA-N,4.640005169054528e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.08000008912162979
fluticasone,2019,Total,Total,15177.8022,MGNNYOODZCAHBA-GQKYHHCASA-N,4.384443981788646e-9,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.07559386175497665
fluticasone furoate,2016,Total,Total,1262.8347,XTULMSXFIHGYFS-VLSRWLAYSA-N,3.6260415415563003e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.006251795761303965
fluticasone furoate,2017,Total,Total,1501.49244,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.3704936164195046e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.0075353338214129385
fluticasone furoate,2018,Total,Total,1645.16016,XTULMSXFIHGYFS-VLSRWLAYSA-N,4.676567419872213e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.008063047275641746
fluticasone furoate,2019,Total,Total,1907.83512,XTULMSXFIHGYFS-VLSRWLAYSA-N,5.511203861998557e-10,steroid,inhaled corticosteroid for asthma,low,high,5.8e-8,0.009502075624135442
fluvastatin,2016,Total,Total,146666.31,FJLGEFLZQAZZCD-MCBHFWOFSA-N,4.2113043995922366e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0022164759997853876
fluvastatin,2017,Total,Total,135773.68839999998,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.9520547864358945e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.00208002883496626
fluvastatin,2018,Total,Total,133801.1248,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8034593603454146e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020018207159712706
fluvastatin,2019,Total,Total,133494.1104,FJLGEFLZQAZZCD-MCBHFWOFSA-N,3.8562727411713746e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,high,1.9e-5,0.0020296172321954604
fluvoxamine,2016,Total,Total,18077.03999999999,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.190552491816614e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2017,Total,Total,17547.885000000002,CJOFXWAVKWHTFT-XSFVSMFZSA-N,5.107779255562791e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2018,Total,Total,16008.705,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.55066868610199e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fluvoxamine,2019,Total,Total,15773.355,CJOFXWAVKWHTFT-XSFVSMFZSA-N,4.556482584966474e-9,antidepressant,SSRI for OCD,NA,NA,NA,NA
fomepizole,2016,Total,Total,3.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.0049728119956673e-12,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2017,Total,Total,62,RIKMMFOAQPJVMX-UHFFFAOYSA-N,1.8046751152340755e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2018,Total,Total,126.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.5959160268860076e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
fomepizole,2019,Total,Total,132.5,RIKMMFOAQPJVMX-UHFFFAOYSA-N,3.827555662749351e-11,antidote,antidote to methanol and antifreeze poisoning,NA,NA,NA,NA
formoterol,2016,Total,Total,396.45546,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.1383627384778168e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.211024189870018e-6
formoterol,2017,Total,Total,409.81806,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.192884604283073e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.2690261747692265e-6
formoterol,2018,Total,Total,431.31168,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.22605579659694e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3043146772307874e-6
formoterol,2019,Total,Total,453.85374,BPZSYCZIITTYBL-UHFFFAOYSA-N,1.311056945356205e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,9.4e-5,1.3947414312300055e-6
fosfomycin,2017,Total,Total,1240,YMDXZJFXQJVXBF-STHAYSLISA-N,3.609350230468151e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2018,Total,Total,1320,YMDXZJFXQJVXBF-STHAYSLISA-N,3.7522602019680086e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosfomycin,2019,Total,Total,500,YMDXZJFXQJVXBF-STHAYSLISA-N,1.4443606274525851e-10,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
fosphenytoin,2016,Total,Total,1890,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.426853184776604e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2017,Total,Total,2225,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.476455050638416e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2018,Total,Total,1840,XWLUWCNOOVRFPX-UHFFFAOYSA-N,5.230423311834193e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
fosphenytoin,2019,Total,Total,2205,XWLUWCNOOVRFPX-UHFFFAOYSA-N,6.3696303670659e-10,anticonvulsant,hydantoin anticonvulsants for seizure control,NA,NA,NA,NA
frovatriptan,2016,Total,Total,14.49,XPSQPHWEGNHMSK-SECBINFHSA-N,4.160587441662063e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2017,Total,Total,13.265,XPSQPHWEGNHMSK-SECBINFHSA-N,3.8611315167064535e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2018,Total,Total,11.145,XPSQPHWEGNHMSK-SECBINFHSA-N,3.1681015114343525e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
frovatriptan,2019,Total,Total,12.255,XPSQPHWEGNHMSK-SECBINFHSA-N,3.540127897886287e-12,analgesic,triptan antimigraine treatment,NA,NA,NA,NA
fulvestrant,2016,Total,Total,3410,VWUXBMIQPBEWFH-WCCTWKNTSA-N,9.791306539729215e-10,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,1.7177730771454764
fulvestrant,2017,Total,Total,4920,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4320970269276854e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.512450924434536
fulvestrant,2018,Total,Total,5496.25,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.5623757678080807e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.7410101189615452
fulvestrant,2019,Total,Total,5082.5,VWUXBMIQPBEWFH-WCCTWKNTSA-N,1.4681925778055527e-9,antineoplastic,estrogen receptor antagonist for breast cancer,low,low,5.7e-10,2.575776452290443
furosemide,2016,Total,Total,910025.21,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.6130016979447076e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.001840142040806132
furosemide,2017,Total,Total,856420.09,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.492838749370205e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0017555202460353555
furosemide,2018,Total,Total,839546.43,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.386512618934334e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0016806426893903762
furosemide,2019,Total,Total,875445.1799999999,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,2.5289170989702826e-7,diuretic,"loop diuretic for oedema in heart, liver, kidney diseases",low,high,1.42e-4,0.0017809275344861143
fusidic acid,2016,Total,Total,45815.85,IECPWNUMDGFDKC-MZJAQBGESA-N,1.3155338173849057e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.003059380970662571
fusidic acid,2017,Total,Total,43044.05,IECPWNUMDGFDKC-MZJAQBGESA-N,1.2529117079659889e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.002913748158060439
fusidic acid,2018,Total,Total,39512.2,IECPWNUMDGFDKC-MZJAQBGESA-N,1.123182239031821e-8,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.0026120517186786533
fusidic acid,2019,Total,Total,33726.25,IECPWNUMDGFDKC-MZJAQBGESA-N,9.74257352232455e-9,antibacterial,"topical ribosome inhibiting bacteriostatic antibacterial for MRSA, acne",low,moderate,4.3e-6,0.002265714772633616
gabapentin,2016,Total,Total,9489062.7,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.724642864234914e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2017,Total,Total,10268756.8,UGJMXCAKCUNAIE-UHFFFAOYSA-N,2.988995138927531e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2018,Total,Total,11241014.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.195394798340554e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gabapentin,2019,Total,Total,12516304.5,UGJMXCAKCUNAIE-UHFFFAOYSA-N,3.615611484201523e-6,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
gadobenic acid,2016,Total,Total,27758.74,MXZROTBGJUUXID-UHFFFAOYSA-K,7.970508284359032e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.245916622144574e-5
gadobenic acid,2017,Total,Total,9260.15,MXZROTBGJUUXID-UHFFFAOYSA-K,2.6954132690862613e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.4503756991693283e-5
gadobenic acid,2018,Total,Total,1103.87,MXZROTBGJUUXID-UHFFFAOYSA-K,3.1378844463230494e-10,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,2.852622223930045e-6
gadobenic acid,2019,Total,Total,295.59000000000003,MXZROTBGJUUXID-UHFFFAOYSA-K,8.538771157374194e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,NA,1.1e-4,7.76251923397654e-7
gadobutrol,2016,Total,Total,24717.93,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,7.097385033946305e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,7.097385033946304e-5
gadobutrol,2017,Total,Total,27529.878,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,8.013304153553233e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,8.013304153553232e-5
gadobutrol,2018,Total,Total,33539.282999999996,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,9.533948242685014e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,9.533948242685014e-5
gadobutrol,2019,Total,Total,35852.337,ZPDFIIGFYAHNSK-CTHHTMFSSA-K,1.0356740792992308e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.0356740792992307e-4
gadodiamide,2016,Total,Total,54.43456,HZHFFEYYPYZMNU-UHFFFAOYSA-K,1.563007223798482e-11,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2017,Total,Total,11.966728,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.4832348761894896e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadodiamide,2018,Total,Total,1.079816,HZHFFEYYPYZMNU-UHFFFAOYSA-K,3.0695080320062783e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadopentetic acid,2016,Total,Total,4.7376,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3603311983173353e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.801655991586676e-9
gadopentetic acid,2017,Total,Total,4.7752,IZOOGPBRAOKZFK-UHFFFAOYSA-K,1.3899491306880253e-12,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,6.949745653440126e-9
gadopentetic acid,2018,Total,Total,2.5192,IZOOGPBRAOKZFK-UHFFFAOYSA-K,7.161131743028642e-13,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,2e-4,3.580565871514321e-9
gadoteric acid,2016,Total,Total,108961.9125,GFSTXYOTEVLASN-UHFFFAOYSA-K,3.1286788458728824e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2017,Total,Total,142024.05,GFSTXYOTEVLASN-UHFFFAOYSA-K,4.133988206447743e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2018,Total,Total,319547.13,GFSTXYOTEVLASN-UHFFFAOYSA-K,9.083514989031043e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteric acid,2019,Total,Total,385126.77,GFSTXYOTEVLASN-UHFFFAOYSA-K,1.112523886331975e-7,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,NA,NA,NA,NA
gadoteridol,2016,Total,Total,42593.25,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.2230016635581276e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2017,Total,Total,58862.475,DPNNNPAKRZOSMO-UHFFFAOYSA-K,1.7133490944127083e-8,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2018,Total,Total,30038.715,DPNNNPAKRZOSMO-UHFFFAOYSA-K,8.538869303996928e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoteridol,2019,Total,Total,6940.6050000000005,DPNNNPAKRZOSMO-UHFFFAOYSA-K,2.00494731854011e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,NA,NA
gadoxetic acid,2016,Total,Total,6676.624,PCZHWPSNPWAQNF-LMOVPXPDSA-K,1.917093027405074e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,1.917093027405074e-5
gadoxetic acid,2017,Total,Total,6966.912,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.027905276842849e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.027905276842849e-5
gadoxetic acid,2018,Total,Total,7266.2715,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.0655258610715444e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.0655258610715445e-5
gadoxetic acid,2019,Total,Total,8001.063,PCZHWPSNPWAQNF-LMOVPXPDSA-K,2.3112840749935326e-9,diagnostic agent,gadolinium contrast agent used for magnetic resonance imaging,low,high,1e-4,2.3112840749935324e-5
galantamine,2016,Total,Total,1093.11776,ASUTZQLVASHGKV-JDFRZJQESA-N,3.138724654598872e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,7.133465124088344e-4
galantamine,2017,Total,Total,925.65984,ASUTZQLVASHGKV-JDFRZJQESA-N,2.6943794813218644e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,6.123589730276964e-4
galantamine,2018,Total,Total,764.51872,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1732372475117604e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.939175562526728e-4
galantamine,2019,Total,Total,746.7734399999999,ASUTZQLVASHGKV-JDFRZJQESA-N,2.1572203087266508e-10,other nervous system,"cholinesterase inhibitor for Alzheimer's, dementia",NA,high,4.4e-7,4.902773428924206e-4
gamithromycin,2016,Total,Total,1867.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,5.36224778971974e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2017,Total,Total,4732.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.3775201585234294e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2018,Total,Total,3067.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,8.719741037527928e-10,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
gamithromycin,2019,Total,Total,4057.5,VWAMTBXLZPEDQO-UZSBJOJWSA-N,1.1720986491777726e-9,antibacterial,macrolide antibiotic for bovine respiratory disease,NA,NA,NA,NA
ganciclovir,2016,Total,Total,2415,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.934312402770105e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2017,Total,Total,2742.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,7.982776618595891e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2018,Total,Total,1800,IRSCQMHQWWYFCW-UHFFFAOYSA-N,5.116718457229103e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
ganciclovir,2019,Total,Total,2387.5,IRSCQMHQWWYFCW-UHFFFAOYSA-N,6.896821996086095e-10,antiviral,purine nucleoside for immunosuppression-related diseases,NA,NA,NA,NA
gefitinib,2016,Total,Total,2130,XGALLCVXEZPNRQ-UHFFFAOYSA-N,6.115977398716491e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.9112429370989035e-4
gefitinib,2017,Total,Total,1815,XGALLCVXEZPNRQ-UHFFFAOYSA-N,5.283040861532012e-10,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,1.6509502692287536e-4
gefitinib,2018,Total,Total,4035,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.1469977208288571e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,3.5843678775901786e-4
gefitinib,2019,Total,Total,4710,XGALLCVXEZPNRQ-UHFFFAOYSA-N,1.360587711060335e-9,antineoplastic,EGFR inhibitor for non-small-cell lung carcinoma,low,high,3.2e-6,4.251836597063547e-4
gemcitabine,2016,Total,Total,12382.2742,SDUQYLNIPVEERB-QPPQHZFASA-N,3.555385406192972e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,6.584047048505503e-4
gemcitabine,2017,Total,Total,14020.49296,SDUQYLNIPVEERB-QPPQHZFASA-N,4.081037862617184e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.557477523365156e-4
gemcitabine,2018,Total,Total,14185.31396,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0323476533734255e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.467310469210047e-4
gemcitabine,2019,Total,Total,14058.91928,SDUQYLNIPVEERB-QPPQHZFASA-N,4.0612298945132105e-9,antineoplastic,"antimetabolite for pancreas, lung, ovary and breast cancer",low,high,5.4e-6,7.52079610095039e-4
gentamicin,2016,Total,Total,26079.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,7.488253416742118e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2017,Total,Total,32411.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,9.434142918528172e-9,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2018,Total,Total,35897.6,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.0204328471679302e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
gentamicin,2019,Total,Total,39705.2,CEAZRRDELHUEMR-UHFFFAOYSA-N,1.1469725517026077e-8,antibacterial,aminoglycoside antibiotic,NA,high,NA,NA
glecaprevir,2017,Total,Total,8.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,2.445043704510683e-12,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2018,Total,Total,663.6,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.8863635378984627e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glecaprevir,2019,Total,Total,512.4,MLSQGNCUYAMAHD-ITNVBOSISA-N,1.4801807710134094e-10,antiviral,protease inhibitor used in combination with pibrentasvir for hepatitis C,NA,NA,NA,NA
glibenclamide,2016,Total,Total,1259.04625,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.6151635722717145e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,6.342392232055639e-6
glibenclamide,2017,Total,Total,1163.73775,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3.387368642070151e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,5.942752003631843e-6
glibenclamide,2018,Total,Total,968.8315,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.7540211211083096e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.831616001944402e-6
glibenclamide,2019,Total,Total,841.27225,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,2.4302010297368963e-10,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,5.7e-5,4.263510578485783e-6
glimepiride,2016,Total,Total,26242.2288,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.535064705762769e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0024306660341170223
glimepiride,2017,Total,Total,24436.9377,WIGIZIANZCJQQY-UHFFFAOYSA-N,7.1130215096315215e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0022945230676230713
glimepiride,2018,Total,Total,21204.7452,WIGIZIANZCJQQY-UHFFFAOYSA-N,6.027706174760012e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0019444213466967783
glimepiride,2019,Total,Total,19094.0382,WIGIZIANZCJQQY-UHFFFAOYSA-N,5.515735399031126e-9,anti-diabetic,sulfonylurea anti-diabetic agent,high,high,3.1e-6,0.0017792694835584279
glipizide,2016,Total,Total,7067.205,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,2.0292425376570974e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2017,Total,Total,6028.63,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.7547933128957426e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2018,Total,Total,5159.665,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.4666973965899443e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glipizide,2019,Total,Total,4390.65,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,1.2683363977849384e-9,anti-diabetic,sulfonylurea anti-diabetic agent,NA,NA,NA,NA
glycerol phenylbutyrate,2019,Total,Total,0.006215,ZSDBFLMJVAGKOU-UHFFFAOYSA-N,1.7953402599235634e-15,metabolic,treatment for hyperammonaemia from inborn urea cycle disorders,NA,NA,NA,NA
glyceryl trinitrate,2016,Total,Total,14910.57,SNIOPGDIGTZGOP-UHFFFAOYSA-N,4.2813478461023535e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.010703369615255883
glyceryl trinitrate,2017,Total,Total,12876.8725,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.748156671418064e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.00937039167854516
glyceryl trinitrate,2018,Total,Total,11425.0175,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.2476998842453053e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008119249710613263
glyceryl trinitrate,2019,Total,Total,11939.82375,SNIOPGDIGTZGOP-UHFFFAOYSA-N,3.449082264644655e-9,vasodilator,"aka nitroglycerin, vasodilator for angina",low,low,4e-7,0.008622705661611638
glycopyrronium bromide,2016,Total,Total,160.46486,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.607509188019745e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.3962149054605287e-6
glycopyrronium bromide,2017,Total,Total,162.98399,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4.7440830795896675e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.43760093320899e-6
glycopyrronium bromide,2018,Total,Total,180.48884,ANGKOCUUWGHLCE-UHFFFAOYSA-N,5.1306143275103894e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.5547316143970876e-6
glycopyrronium bromide,2019,Total,Total,210.60877,ANGKOCUUWGHLCE-UHFFFAOYSA-N,6.083900303684343e-11,alimentary,"muscarinic anticholinergen, for excessive sweating, stomach ulcers, lung disease. etc.",low,high,3.3e-5,1.843606152631619e-6
grapiprant,2019,Total,Total,5966.4,HZVLFTCYCLXTGV-UHFFFAOYSA-N,1.7235266495266206e-9,analgesic,analgesic and anti-inflammatory small molecule used for pain relief in dogs,NA,NA,NA,NA
grazoprevir,2017,Total,Total,9531.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.774309590051455e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2018,Total,Total,7557.2,OBMNJSNZOWALQB-NCQNOWPTSA-N,2.148225818053987e-9,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
grazoprevir,2019,Total,Total,1722,OBMNJSNZOWALQB-NCQNOWPTSA-N,4.974378000946702e-10,antiviral,antiviral used with elbasvir for hepatitis C,NA,NA,NA,NA
guanfacine,2016,Total,Total,30.436,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.739243573114325e-12,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2017,Total,Total,224.224,INJOMKTZOLKMBF-UHFFFAOYSA-N,6.526636661907183e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2018,Total,Total,310.576,INJOMKTZOLKMBF-UHFFFAOYSA-N,8.8284997309577e-11,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
guanfacine,2019,Total,Total,411.46,INJOMKTZOLKMBF-UHFFFAOYSA-N,1.1885932475432814e-10,antihypertensive,"antiadrenergic agent for hypertension, ADHD",NA,NA,NA,NA
haloperidol,2016,Total,Total,2485.3250000000003,LNEPOXFFQSENCJ-UHFFFAOYSA-N,7.13624015420895e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,5.097314395863536e-4
haloperidol,2017,Total,Total,2278.565,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.632370248295694e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.73740732021121e-4
haloperidol,2018,Total,Total,2117.817,LNEPOXFFQSENCJ-UHFFFAOYSA-N,6.020151851629759e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.300108465449828e-4
haloperidol,2019,Total,Total,2022.669,LNEPOXFFQSENCJ-UHFFFAOYSA-N,5.842926931937785e-10,antipsychotic,"typical antipsychotic for schizophrenia, Tourette's",high,NA,1.4e-6,4.173519237098418e-4
hexaminolevulinate,2016,Total,Total,146.965,RYQOILLJDKPETL-UHFFFAOYSA-N,4.219880837569808e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2017,Total,Total,159.545,RYQOILLJDKPETL-UHFFFAOYSA-N,4.6439821170971056e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2018,Total,Total,152.915,RYQOILLJDKPETL-UHFFFAOYSA-N,4.346794460484379e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hexaminolevulinate,2019,Total,Total,157.165,RYQOILLJDKPETL-UHFFFAOYSA-N,4.540058760271711e-11,diagnostic agent,malignancy photosensitizer used to check for bladder cancer,NA,NA,NA,NA
hyaluronic acid,2016,Total,Total,83.367,KIUKXJAPPMFGSW-MNSSHETKSA-N,2.3937590976469373e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2017,Total,Total,122.815,KIUKXJAPPMFGSW-MNSSHETKSA-N,3.574857649636661e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2018,Total,Total,144.586,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.110032526982928e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hyaluronic acid,2019,Total,Total,154.713,KIUKXJAPPMFGSW-MNSSHETKSA-N,4.469227315101436e-11,other musculoskeletal,natural glycosaminoglycan with broad applications; injected treatment for lameness in horses,NA,NA,NA,NA
hydralazine,2016,Total,Total,6614.35,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992119768638694e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2017,Total,Total,6524.85,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.8992313589733966e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2018,Total,Total,6598.325,RPTUSVTUFVMDQK-UHFFFAOYSA-N,1.875653961905345e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydralazine,2019,Total,Total,7004.025,RPTUSVTUFVMDQK-UHFFFAOYSA-N,2.0232675887387187e-9,antihypertensive,vasodilator for hypertension,NA,NA,NA,NA
hydrochlorothiazide,2016,Total,Total,1370138.17798,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.9341474787062307e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.9341474787062304e-4
hydrochlorothiazide,2017,Total,Total,1344980.24186,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.91492318220363e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.91492318220363e-4
hydrochlorothiazide,2018,Total,Total,1305368.66112,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.710668845467304e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.710668845467304e-4
hydrochlorothiazide,2019,Total,Total,1274101.87638,JZUFKLXOESDKRF-UHFFFAOYSA-N,3.680525171213466e-7,diuretic,"thiazide diuretic for oedema, hypertension",low,high,0.001,3.680525171213466e-4
hydrocodone,2016,Total,Total,133.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.8289464137034926e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2017,Total,Total,112.25,LLPOLZWFYMWNKH-CMKMFDCUSA-N,3.267335188468145e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2018,Total,Total,67.65,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.9230333535086045e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocodone,2019,Total,Total,55.35,LLPOLZWFYMWNKH-CMKMFDCUSA-N,1.5989072145900118e-11,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydrocortisone,2016,Total,Total,169796.1587,JYGXADMDTFJGBT-VWUMJDOOSA-N,4.875443516422903e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2017,Total,Total,172789.67748,JYGXADMDTFJGBT-VWUMJDOOSA-N,5.0295037277012547e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2018,Total,Total,172815.35347,JYGXADMDTFJGBT-VWUMJDOOSA-N,4.912486159958447e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone,2019,Total,Total,185360.30797,JYGXADMDTFJGBT-VWUMJDOOSA-N,5.354542614487072e-8,steroid,topical steroid for skin conditions,NA,NA,NA,NA
hydrocortisone aceponate,2016,Total,Total,211.844832,MFBMYAOAMQLLPK-FZNHGJLXSA-N,6.082808472051136e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2017,Total,Total,240.605664,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.003468619438246e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2018,Total,Total,256.53952,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.29244720551497e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydrocortisone aceponate,2019,Total,Total,275.802176,MFBMYAOAMQLLPK-FZNHGJLXSA-N,7.967156079602967e-11,steroid,"ester of hydrocortisone, veterinary topical steroid for canine skin conditions",NA,NA,NA,NA
hydromorphone,2016,Total,Total,2001.73168,WVLOADHCBXTIJK-YNHQPCIGSA-N,5.747674043744033e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2017,Total,Total,1683.50176,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.900280214072207e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2018,Total,Total,1407.76,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.001728652971579e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydromorphone,2019,Total,Total,1406.8,WVLOADHCBXTIJK-YNHQPCIGSA-N,4.0638530614005936e-10,analgesic,opioid analgesic for severe pain,NA,NA,NA,NA
hydroxycarbamide,2016,Total,Total,451650,VSNHCAURESNICA-UHFFFAOYSA-N,1.2968456301081234e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2017,Total,Total,473350,VSNHCAURESNICA-UHFFFAOYSA-N,1.377811235154919e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2018,Total,Total,509900,VSNHCAURESNICA-UHFFFAOYSA-N,1.4494526340783996e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxycarbamide,2019,Total,Total,547400,VSNHCAURESNICA-UHFFFAOYSA-N,1.5812860149350906e-7,antineoplastic,"antineoplastic for sickle cell disease, various cancers",NA,NA,NA,NA
hydroxychloroquine,2016,Total,Total,573923.8,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.647936614734969e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2017,Total,Total,572213.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.6655800718040404e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2018,Total,Total,566380.4,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.610005025829335e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxychloroquine,2019,Total,Total,565996.6,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,1.63500640862406e-7,antiprotozoal,"quinoline antimalarial, also used for arthritis, lupus",low,NA,NA,NA
hydroxyzine,2016,Total,Total,167392.595,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.806428768697197e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2017,Total,Total,150496.77,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.380609286163002e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2018,Total,Total,147143.27,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1827260303669184e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hydroxyzine,2019,Total,Total,143352.105,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,4.1410427264889787e-8,antihistamine,"antihistamine and sedative for allergic reactions, anxiety, post-anaesthesia",NA,NA,NA,NA
hyoscyamine,2016,Total,Total,150.3642,RKUNBYITZUJHSG-VFSICIBPSA-N,4.3174837970708273e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2017,Total,Total,161.3546,RKUNBYITZUJHSG-VFSICIBPSA-N,4.6966553443314215e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2018,Total,Total,166.2378,RKUNBYITZUJHSG-VFSICIBPSA-N,4.7255112197175556e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
hyoscyamine,2019,Total,Total,182.076,RKUNBYITZUJHSG-VFSICIBPSA-N,5.259668112081138e-11,alimentary,"antispasmodic treatment for digestive tract, bladder, kidneys, Parkinson's",low,NA,NA,NA
ibandronic acid,2016,Total,Total,369.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0621126947348496e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2017,Total,Total,351.9,MPBVHIBUJCELCL-UHFFFAOYSA-N,1.0242986662110824e-10,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2018,Total,Total,306.45,MPBVHIBUJCELCL-UHFFFAOYSA-N,8.711213173432547e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibandronic acid,2019,Total,Total,258.75,MPBVHIBUJCELCL-UHFFFAOYSA-N,7.474566247067129e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
ibrutinib,2016,Total,Total,10386.6,XYFPWWZEPKGCCK-GOSISDBHSA-N,2.982357316878343e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0019241014947602212
ibrutinib,2017,Total,Total,14044.8,XYFPWWZEPKGCCK-GOSISDBHSA-N,4.0881130739418615e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.002637492305768943
ibrutinib,2018,Total,Total,19324.199999999997,XYFPWWZEPKGCCK-GOSISDBHSA-N,5.493138378399256e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0035439602441285525
ibrutinib,2019,Total,Total,22408.4,XYFPWWZEPKGCCK-GOSISDBHSA-N,6.473162136841701e-9,antineoplastic,"Bruton's tyrosine kinase inhibitor for lymphomas, leukaemia, macroglobulinemia",low,moderate,1.55e-6,0.0041762336366720654
ibuprofen,2016,Total,Total,39219140.08,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.1261191282928453e-5,analgesic,NSAID for many minor pains,low,low,1e-6,11.261191282928452
ibuprofen,2017,Total,Total,39957409.49,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.1630668157390468e-5,analgesic,NSAID for many minor pains,low,low,1e-6,11.630668157390469
ibuprofen,2018,Total,Total,38012809.45,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.0805602429108217e-5,analgesic,NSAID for many minor pains,low,low,1e-6,10.805602429108218
ibuprofen,2019,Total,Total,38613959.05,HEFNNWSXXWATRW-UHFFFAOYSA-N,1.1154496424377285e-5,analgesic,NSAID for many minor pains,low,low,1e-6,11.154496424377285
ibutilide,2016,Total,Total,0.33408,ALOBUEHUHMBRLE-UHFFFAOYSA-N,9.592609058043216e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2017,Total,Total,0.2262,ALOBUEHUHMBRLE-UHFFFAOYSA-N,6.584153404289482e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2018,Total,Total,0.20532,ALOBUEHUHMBRLE-UHFFFAOYSA-N,5.83647018687933e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
ibutilide,2019,Total,Total,0.15399,ALOBUEHUHMBRLE-UHFFFAOYSA-N,4.4483418604284714e-14,cardiac,group III antiarrhythmic for irregular heartbeat,NA,NA,NA,NA
icatibant,2016,Total,Total,43.26,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.2421463956266448e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2017,Total,Total,47.28,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3762103136817271e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2018,Total,Total,46.11,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3107327114601884e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
icatibant,2019,Total,Total,48.03,QURWXBZNHXJZBE-SKXRKSCCSA-N,1.3874528187309534e-11,blood,bradykinin inhibitor for hereditary angioedema,NA,NA,NA,NA
idarubicin,2016,Total,Total,5.855,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.681175946924181e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2017,Total,Total,5.95,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.7319059573617337e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2018,Total,Total,5.125,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.4568434496277306e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idarubicin,2019,Total,Total,4.675,XDXDZDZNSLXDNA-TZNDIEGXSA-N,1.3504771866681672e-12,antineoplastic,antibiotic antineoplastic for leukaemia,NA,NA,NA,NA
idebenone,2017,Total,Total,2430,JGPMMRGNQUBGND-UHFFFAOYSA-N,7.073162145191619e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2018,Total,Total,1890,JGPMMRGNQUBGND-UHFFFAOYSA-N,5.372554380090558e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idebenone,2019,Total,Total,2376,JGPMMRGNQUBGND-UHFFFAOYSA-N,6.863601701654684e-10,other nervous system,quinone used for optic neuropathy,NA,NA,NA,NA
idelalisib,2016,Total,Total,1251,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.5920599651616565e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2017,Total,Total,978,IFSDAJWBUCMOAH-HNNXBMFYSA-N,2.8467294559660096e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2018,Total,Total,1401,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9825125325433184e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
idelalisib,2019,Total,Total,1368,IFSDAJWBUCMOAH-HNNXBMFYSA-N,3.9517706767102734e-10,antineoplastic,phosphoinositide 3-kinase inhibitor for blood cancers,NA,NA,NA,NA
ifosfamide,2016,Total,Total,11382,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.26817158460991e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2017,Total,Total,10942.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.1851060400723987e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2018,Total,Total,10785.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.065909273358027e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
ifosfamide,2019,Total,Total,11104.5,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3.207780517509446e-9,antineoplastic,alkylating treatment for testicular cancer,NA,NA,NA,NA
iloprost,2016,Total,Total,0.22312,HIFJCPQKFCZDDL-ACWOEMLNSA-N,6.406558108927811e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2017,Total,Total,0.10449,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0414597224323963e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2018,Total,Total,0.10188,HIFJCPQKFCZDDL-ACWOEMLNSA-N,2.8960626467916725e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
iloprost,2019,Total,Total,0.10397,HIFJCPQKFCZDDL-ACWOEMLNSA-N,3.0034034887249056e-14,antithrombotic,synthetic prostacyclin for pulmonary arterial hypertension,low,NA,NA,NA
imatinib,2016,Total,Total,62640,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.7986141983831033e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.873556456649066e-4
imatinib,2017,Total,Total,62232,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8114280930846287e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8869042636298215e-4
imatinib,2018,Total,Total,63588,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.8075660736571344e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,1.8828813267261817e-4
imatinib,2019,Total,Total,68550,KTUFNOKKBVMGRW-UHFFFAOYSA-N,1.9802184202374945e-8,antineoplastic,tyrosine kinase inhibitor for various cancers,low,moderate,9.6e-5,2.0627275210807235e-4
imepitoin,2016,Total,Total,57400,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6481554116728947e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2017,Total,Total,60530,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.7618868504051385e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2018,Total,Total,57240,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.6271164693988546e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imepitoin,2019,Total,Total,63500,IQHYCZKIFIHTAI-UHFFFAOYSA-N,1.8343379968647833e-8,anticonvulsant,canine imidazolone treatment for epilepsy,NA,NA,NA,NA
imidacloprid,2016,Total,Total,1438919.32,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.1316422721579817e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2017,Total,Total,1373892.38,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.9990796599930937e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2018,Total,Total,1254248.23,YWTYJOPNNQFBPC-UHFFFAOYSA-N,3.565352815771074e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imidacloprid,2019,Total,Total,1391246.68,YWTYJOPNNQFBPC-UHFFFAOYSA-N,4.018923855332252e-7,antiparasitic,topical veterinary neonicotinoid for fleas and various other parasites,NA,NA,NA,NA
imipenem,2016,Total,Total,8080,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.320051520264283e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2017,Total,Total,8565,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.493071348706428e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2018,Total,Total,7635,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.1703414122746773e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imipenem,2019,Total,Total,7800,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,2.253202578826033e-9,antibacterial,carbapenem beta-lactam antibiotic,NA,NA,NA,NA
imiquimod,2016,Total,Total,2332.6499999999996,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.697856656861981e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2017,Total,Total,2716.05,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.905786849566952e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2018,Total,Total,2518.2375,DOUYETYNHWVLEO-UHFFFAOYSA-N,7.158395719964706e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
imiquimod,2019,Total,Total,2211.3,DOUYETYNHWVLEO-UHFFFAOYSA-N,6.387829310971804e-10,antiviral,"dermatological immune response modifier for genital warts, carcinoma and actinic keratosis",low,NA,NA,NA
indacaterol,2016,Total,Total,462.6642000000001,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.3284712630963598e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.3284712630963596e-6
indacaterol,2017,Total,Total,419.40825,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.2207994062885028e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.2207994062885028e-6
indacaterol,2018,Total,Total,377.676,QZZUEBNBZAPZLX-QFIPXVFZSA-N,1.0735898666958103e-10,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,1.0735898666958103e-6
indacaterol,2019,Total,Total,330.53625,QZZUEBNBZAPZLX-QFIPXVFZSA-N,9.548270908916491e-11,respiratory,inhaled adrenergic bronchodilator for chronic obstructive pulmonary disease,low,high,1e-4,9.54827090891649e-7
ingenol mebutate,2016,Total,Total,1.582302,VDJHFHXMUKFKET-WDUFCVPESA-N,4.543344258189625e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2017,Total,Total,1.6694165,VDJHFHXMUKFKET-WDUFCVPESA-N,4.859281313727689e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2018,Total,Total,1.4774685,VDJHFHXMUKFKET-WDUFCVPESA-N,4.199883524402553e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
ingenol mebutate,2019,Total,Total,1.5530915,VDJHFHXMUKFKET-WDUFCVPESA-N,4.4864484268625544e-13,dermatological,milkweed sap extract cell death inducer for topical treatment of actinic keratosis,NA,NA,NA,NA
iodixanol,2016,Total,Total,1870054,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.369581219896417e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.369581219896416e-4
iodixanol,2017,Total,Total,1640141,NBQNWMBBSKPBAY-UHFFFAOYSA-N,4.77406717447602e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,4.774067174476019e-4
iodixanol,2018,Total,Total,1766954,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.022781191597107e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.022781191597106e-4
iodixanol,2019,Total,Total,1825304,NBQNWMBBSKPBAY-UHFFFAOYSA-N,5.272794461463427e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,5.272794461463427e-4
iohexol,2016,Total,Total,11716927,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.3643408786108454e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2017,Total,Total,12923588,NTHXOOBQLCIOLC-UHFFFAOYSA-N,3.761754461796406e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2018,Total,Total,15893883,NTHXOOBQLCIOLC-UHFFFAOYSA-N,4.518029139063326e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iohexol,2019,Total,Total,17866262,NTHXOOBQLCIOLC-UHFFFAOYSA-N,5.161065078510456e-6,diagnostic agent,iodine-containing radiopaque contrast agent,NA,NA,NA,NA
iomeprol,2016,Total,Total,3157700,NJKDOADNQSYQEV-UHFFFAOYSA-N,9.066864709824912e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,9.066864709824912e-4
iomeprol,2017,Total,Total,3951115,NJKDOADNQSYQEV-UHFFFAOYSA-N,1.1500772448271104e-6,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,0.0011500772448271104
iomeprol,2018,Total,Total,1280985,NJKDOADNQSYQEV-UHFFFAOYSA-N,3.641355329407568e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,3.6413553294075676e-4
iomeprol,2019,Total,Total,715315,NJKDOADNQSYQEV-UHFFFAOYSA-N,2.066345644452492e-7,diagnostic agent,iodine-containing radiopaque contrast agent,low,high,0.001,2.066345644452492e-4
ipratropium bromide,2016,Total,Total,3013.797,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.653668702497446e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2017,Total,Total,3072.089,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.94213317755538e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2018,Total,Total,2951.438,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.389820716648526e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
ipratropium bromide,2019,Total,Total,2945.5260000000003,LHLMOSXCXGLMMN-CLTUNHJMSA-M,8.508803563075807e-10,respiratory,"anticholinergic for chronic obstructive pulmonary disorder, asthma",low,high,NA,NA
irbesartan,2016,Total,Total,3025751.303,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.687993701072755e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012340900143569256
irbesartan,2017,Total,Total,2907397.66675,YOSHYTLCDANDAN-UHFFFAOYSA-N,8.462755192376352e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0012020959080080045
irbesartan,2018,Total,Total,2783303.261,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.911877315347028e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0011238462095663393
irbesartan,2019,Total,Total,2669838.14,YOSHYTLCDANDAN-UHFFFAOYSA-N,7.712418182174487e-7,antihypertensive,"angiotensin II receptor blocker for high blood pressure, diabetes kidney problems",low,moderate,7.04e-4,0.0010955139463316034
irinotecan,2016,Total,Total,3416.08,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.808764353149027e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2017,Total,Total,3671.28,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.068623815654283e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2018,Total,Total,3442.8199999999997,UWKQSNNFCGGAFS-XIFFEERXSA-N,9.786633688287496e-10,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
irinotecan,2019,Total,Total,3573.76,UWKQSNNFCGGAFS-XIFFEERXSA-N,1.03235964719299e-9,antineoplastic,cytotoxic alkaloid for colon and small-cell lung cancer,NA,NA,NA,NA
isavuconazole,2017,Total,Total,89.2,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.596403552885154e-11,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2018,Total,Total,355.6,DDFOUSQFMYRUQK-RCDICMHDSA-N,1.0108361574392606e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isavuconazole,2019,Total,Total,774.4,DDFOUSQFMYRUQK-RCDICMHDSA-N,2.2370257397985638e-10,antifungal,systemic triazole antifungal for invasive aspergillosis and mucomycosis,NA,NA,NA,NA
isoniazid,2016,Total,Total,6652,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.910022612970051e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2017,Total,Total,5565,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.6198414542383272e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2018,Total,Total,5374.5,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.527766852687656e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoniazid,2019,Total,Total,5328,QRXWMOHMRWLFEY-UHFFFAOYSA-N,1.5391106846134748e-9,antibacterial,hydrazide antibiotic for tuberculosis,low,NA,NA,NA
isoprenaline,2016,Total,Total,6.9,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.981232115077173e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2017,Total,Total,8.89,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.587671253940473e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2018,Total,Total,8.21,JWZZKOKVBUJMES-UHFFFAOYSA-N,2.3337921407694967e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isoprenaline,2019,Total,Total,6.6,JWZZKOKVBUJMES-UHFFFAOYSA-N,1.9065560282374125e-12,cardiac,"adrenoreceptor agonist for slow heart rate, heart block",NA,NA,NA,NA
isosorbide dinitrate,2016,Total,Total,8179.22,MOYKHGMNXAOIAT-JGWLITMVSA-N,2.348541063808915e-9,cardiac,nitrate for angina,NA,NA,NA,NA
isosorbide mononitrate,2016,Total,Total,384007.5385,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.1026203879825129e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2017,Total,Total,375319.61719999986,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0924676990645467e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2018,Total,Total,355909.5727,YWXYYJSYQOXTPL-SLPGGIOYSA-N,1.0117161554103408e-7,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isosorbide mononitrate,2019,Total,Total,330703.8683,YWXYYJSYQOXTPL-SLPGGIOYSA-N,9.553112934375701e-8,cardiac,"nitrate for angina, oesophageal spasms",low,NA,NA,NA
isotretinoin,2016,Total,Total,66031.8,SHGAZHPCJJPHSC-XFYACQKRSA-N,1.8960046779181575e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2017,Total,Total,71597.4,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.0840330015396805e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2018,Total,Total,80914.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.300084336621817e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isotretinoin,2019,Total,Total,88999.2,SHGAZHPCJJPHSC-XFYACQKRSA-N,2.5709388070955626e-8,anti-acne,"antineoplastic retinoid, used for acne, skin cancers",NA,NA,NA,NA
isradipine,2016,Total,Total,665.265,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.9102092507779935e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2017,Total,Total,629.785,HMJIYCCIJYRONP-UHFFFAOYSA-N,1.83315696362531e-10,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
isradipine,2018,Total,Total,212.305,HMJIYCCIJYRONP-UHFFFAOYSA-N,6.03502728923347e-11,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
itraconazole,2016,Total,Total,1122.58,VHVPQPYKVGDNFY-ZPGVKDDISA-N,3.223321083685989e-10,antifungal,azole antifungal,high,high,0.001,3.2233210836859885e-7
itraconazole,2017,Total,Total,935.1,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.721857581057071e-10,antifungal,azole antifungal,high,high,0.001,2.721857581057071e-7
itraconazole,2018,Total,Total,936.36,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.661716941450579e-10,antifungal,azole antifungal,high,high,0.001,2.661716941450579e-7
itraconazole,2019,Total,Total,962.96,VHVPQPYKVGDNFY-ZPGVKDDISA-N,2.7817230196234827e-10,antifungal,azole antifungal,high,high,0.001,2.7817230196234827e-7
ivabradine,2016,Total,Total,252.77,ACRHBAYQBXXRTO-OAQYLSRUSA-N,7.257913648232709e-11,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2017,Total,Total,358.8172,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.0444330189644651e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2018,Total,Total,415.38,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.1807680626465693e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivabradine,2019,Total,Total,567,ACRHBAYQBXXRTO-OAQYLSRUSA-N,1.6379049515312314e-10,cardiac,"slows heart's electrical activity, used for management of chronic heart failure",NA,NA,NA,NA
ivacaftor,2016,Total,Total,1848,PURKAOJPTOLRMP-UHFFFAOYSA-N,5.306256447337124e-10,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2017,Total,Total,4300.8,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.2518623767094694e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2018,Total,Total,5390,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.5321729158036032e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivacaftor,2019,Total,Total,6815.2,PURKAOJPTOLRMP-UHFFFAOYSA-N,1.9687213096429715e-9,respiratory,CTFR potentiator for cystic fibrosis,NA,NA,NA,NA
ivermectin,2016,Total,Total,24269.320855,AZSNMRSAGSSBNP-XPNPUAGNSA-N,6.9685736071069844e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2017,Total,Total,25257.930293,AZSNMRSAGSSBNP-XPNPUAGNSA-N,7.351993268079681e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2018,Total,Total,26355.307825000004,AZSNMRSAGSSBNP-XPNPUAGNSA-N,7.491816110785118e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ivermectin,2019,Total,Total,27449.464439,AZSNMRSAGSSBNP-XPNPUAGNSA-N,7.929385136070292e-9,anthelminthic,"human and veterinary treatment for parasitic worms, some antiviral effects",NA,NA,NA,NA
ixazomib,2017,Total,Total,0.012,MXAYKZJJDUDWDS-LBPRGKRZSA-N,3.4929195778724047e-15,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2018,Total,Total,0.24,MXAYKZJJDUDWDS-LBPRGKRZSA-N,6.822291276305471e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ixazomib,2019,Total,Total,0.192,MXAYKZJJDUDWDS-LBPRGKRZSA-N,5.546344809417927e-14,antineoplastic,proteasome inhibitor for multiple myeloma,low,NA,NA,NA
ketamine,2016,Total,Total,9954.5,YQEZLKZALYSWHR-UHFFFAOYSA-N,2.858286244860249e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2017,Total,Total,11197.3,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.259272365775889e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2018,Total,Total,12654.7,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.597252058927618e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketamine,2019,Total,Total,11764.2,YQEZLKZALYSWHR-UHFFFAOYSA-N,3.3983494586955403e-9,anaesthetic,surgical anaesthetic,NA,NA,NA,NA
ketobemidone,2016,Total,Total,11949.92,ALFGKMXHOUSVAD-UHFFFAOYSA-N,3.4312413444352184e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2017,Total,Total,9811.485,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.8558940037084523e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2018,Total,Total,9591.935,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.7266239363912132e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketobemidone,2019,Total,Total,9099.27,ALFGKMXHOUSVAD-UHFFFAOYSA-N,2.628525465312097e-9,analgesic,opioid painkiller for severe pain,NA,NA,NA,NA
ketoconazole,2016,Total,Total,175932.4,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.0516365356899014e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2017,Total,Total,176995.80000000002,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.151934125176571e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2018,Total,Total,191478.2,XMAYWYJOQHXEEK-OZXSUGGESA-N,5.4430002227611424e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoconazole,2019,Total,Total,222298.52,XMAYWYJOQHXEEK-OZXSUGGESA-N,6.421584596579622e-8,antifungal,azole antifungal with serious side effects,NA,NA,NA,NA
ketoprofen,2016,Total,Total,314173.89999999997,DKYWVDODHFEZIM-UHFFFAOYSA-N,9.021035078247016e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2017,Total,Total,301153.8,DKYWVDODHFEZIM-UHFFFAOYSA-N,8.765883366422253e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2018,Total,Total,286970.2,DKYWVDODHFEZIM-UHFFFAOYSA-N,8.157476216748484e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketoprofen,2019,Total,Total,279874.7,DKYWVDODHFEZIM-UHFFFAOYSA-N,8.084799946002082e-8,analgesic,"NSAID for mild-moderate pain, arthritis",low,high,NA,NA
ketorolac,2016,Total,Total,1791.15,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.143020149160112e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2017,Total,Total,1966.53,OZWKMVRBQXNZKK-UHFFFAOYSA-N,5.724109281227848e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2018,Total,Total,2210.76,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.284353609168783e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketorolac,2019,Total,Total,2277.54,OZWKMVRBQXNZKK-UHFFFAOYSA-N,6.579178206896721e-10,analgesic,NSAID for moderate-severe pain,NA,NA,NA,NA
ketotifen,2016,Total,Total,160.172,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4.599100149799144e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2017,Total,Total,176.0345,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,5.123952928591498e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2018,Total,Total,180.64325,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,5.135003619160285e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
ketotifen,2019,Total,Total,250.25525,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,7.229176598266072e-11,antihistamine,antihistamine for allergy symptoms,NA,NA,NA,NA
labetalol,2016,Total,Total,207503.95,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.9581665180488116e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2017,Total,Total,207948.35,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.052890524177192e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2018,Total,Total,206306.84999999992,SGUAFYQXFOLMHL-UHFFFAOYSA-N,5.864522595821087e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
labetalol,2019,Total,Total,213303.15,SGUAFYQXFOLMHL-UHFFFAOYSA-N,6.161733431432258e-8,beta blocker,beta blocker for hypertension,NA,NA,NA,NA
lacosamide,2016,Total,Total,59488.407,VPPJLAIAVCUEMN-GFCCVEGCSA-N,1.7081209046837927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,1.7081209046837927e-5
lacosamide,2017,Total,Total,69342.464,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.01839708402927e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.01839708402927e-5
lacosamide,2018,Total,Total,74852.92,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.1277850963416305e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.1277850963416306e-5
lacosamide,2019,Total,Total,92119.712,VPPJLAIAVCUEMN-GFCCVEGCSA-N,2.6610817005014293e-8,anticonvulsant,"anticonvulsant for partial onset, tonic-clonic seizures",low,high,0.001,2.6610817005014292e-5
lamivudine,2016,Total,Total,118844.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.4124397387982256e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.4124397387982256e-5
lamivudine,2017,Total,Total,130937.4,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.8112817327975845e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.8112817327975845e-5
lamivudine,2018,Total,Total,137233.2,JTEGQNOMFQHVDC-NKWVEPMBSA-N,3.90102026324785e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,3.90102026324785e-5
lamivudine,2019,Total,Total,140562,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4.0604443703198054e-8,antiviral,"nucleoside reverse transcriptase inhibitor for HIV, hepatitis B infections",low,high,0.001,4.060444370319805e-5
lamotrigine,2016,Total,Total,2377299.3282,PYZRQGJRPPTADH-UHFFFAOYSA-N,6.826060545190186e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004550707030126791
lamotrigine,2017,Total,Total,2487666.8492,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.241016867329032e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004827344578219355
lamotrigine,2018,Total,Total,2516154.5068,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.152474558990972e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.004768316372660649
lamotrigine,2019,Total,Total,2623016.7694,PYZRQGJRPPTADH-UHFFFAOYSA-N,7.577164293738475e-7,anticonvulsant,"anticonvulsant for epileptic seizures, bipolar disorder",low,high,1.5e-4,0.005051442862492317
lansoprazole,2016,Total,Total,292300.8531,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.392983151103988e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2017,Total,Total,283156.6404,MJIHNNLFOKEZEW-UHFFFAOYSA-N,8.2420281071478007e-08,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2018,Total,Total,267404.1549,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.601287638425445e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lansoprazole,2019,Total,Total,261259.5957,MJIHNNLFOKEZEW-UHFFFAOYSA-N,7.547061471465214e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",NA,NA,NA,NA
lapatinib,2016,Total,Total,4305,BCFGMOOMADDAQU-UHFFFAOYSA-N,1.236116558754671e-9,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.01236116558754671
lapatinib,2017,Total,Total,2373,BCFGMOOMADDAQU-UHFFFAOYSA-N,6.907248465242679e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.006907248465242679
lapatinib,2018,Total,Total,1323,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.76078806606339e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.00376078806606339
lapatinib,2019,Total,Total,1155,BCFGMOOMADDAQU-UHFFFAOYSA-N,3.3364730494154715e-10,antineoplastic,dual tyrosine kinase inhibitor for breast cancers,low,moderate,1e-7,0.0033364730494154717
latanoprost,2016,Total,Total,54.728325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.571442247744651e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2017,Total,Total,55.9576,GGXICVAJURFBLW-CEYXHVGTSA-N,1.6287949714229405e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2018,Total,Total,57.58145,GGXICVAJURFBLW-CEYXHVGTSA-N,1.636822600050082e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
latanoprost,2019,Total,Total,60.533325,GGXICVAJURFBLW-CEYXHVGTSA-N,1.7486390255758248e-11,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
ledipasvir,2016,Total,Total,1960.56,VRTWBAAJJOHBQU-KMWAZVGDSA-N,5.62945570367493e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2017,Total,Total,216.72,VRTWBAAJJOHBQU-KMWAZVGDSA-N,6.308212757637562e-11,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2018,Total,Total,549.36,VRTWBAAJJOHBQU-KMWAZVGDSA-N,1.5616224731463223e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
ledipasvir,2019,Total,Total,3354.12,VRTWBAAJJOHBQU-KMWAZVGDSA-N,9.68911773550253e-10,antiviral,"NS5A inhibitor used for hepatitis C infections, often with ribavirin",NA,NA,NA,NA
leflunomide,2016,Total,Total,10861.2,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.118631630184955e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011812998599185435
leflunomide,2017,Total,Total,10776.8,VHOGYURTWQBHIL-UHFFFAOYSA-N,3.13687464223461e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.001188210091755534
leflunomide,2018,Total,Total,10363,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.945808520681399e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,0.0011158365608641661
leflunomide,2019,Total,Total,8645,VHOGYURTWQBHIL-UHFFFAOYSA-N,2.4972995248655198e-9,immunosuppressant,selective immunosuppressant for rheumatoid arthritis,low,high,2.64e-6,9.459467897217878e-4
lenalidomide,2016,Total,Total,1184.7675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,3.4018832172459336e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2017,Total,Total,1734.9675,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.050084956435282e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2018,Total,Total,2057.9475,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.84996553181027e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenalidomide,2019,Total,Total,2054.115,GOTYRUGSSMKFNF-UHFFFAOYSA-N,5.933765660519534e-10,immunosuppressant,"immunosuppressant and antineoplastic for bone marrow cancer, anaemia, lymphomas",NA,NA,NA,NA
lenvatinib,2016,Total,Total,13.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,3.824639387366369e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2017,Total,Total,14.94,WOSKHXYHFSIKNG-UHFFFAOYSA-N,4.348684874451143e-12,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2018,Total,Total,43.32,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.2314235753731374e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lenvatinib,2019,Total,Total,48.84,WOSKHXYHFSIKNG-UHFFFAOYSA-N,1.4108514608956851e-11,antineoplastic,multiple kinase inhibitor for thyroid and other cancers,NA,NA,NA,NA
lercanidipine,2016,Total,Total,207515.2234,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,5.9584902169202033e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2017,Total,Total,213714.6424,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.220733820974667e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2018,Total,Total,231386.8572,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,6.57745223886375e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lercanidipine,2019,Total,Total,259667.2152,ZDXUKAKRHYTAKV-UHFFFAOYSA-N,7.50106203750275e-8,antihypertensive,calcium channel blocker for hypertension,NA,NA,NA,NA
lesinurad,2018,Total,Total,126,FGQFOYHRJSUHMR-UHFFFAOYSA-N,3.5817029200603715e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
lesinurad,2019,Total,Total,264,FGQFOYHRJSUHMR-UHFFFAOYSA-N,7.626224112949649e-11,antigout,antihyperuricemic agent for uric acid reduction for gout,NA,NA,NA,NA
letermovir,2019,Total,Total,376.32,FWYSMLBETOMXAG-QHCPKHFHSA-N,1.0870835826459135e-10,antiviral,antiviral for prevention of cytomegalovirus infection after bone marrow transplants,NA,NA,NA,NA
letrozole,2016,Total,Total,6260.475,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.797602047193879e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.035952040943877585
letrozole,2017,Total,Total,6850.075,HPJKCIUCZWXJDR-UHFFFAOYSA-N,1.9938967564495253e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.03987793512899051
letrozole,2018,Total,Total,7181.225,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.041350361278614e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.04082700722557229
letrozole,2019,Total,Total,7892.875,HPJKCIUCZWXJDR-UHFFFAOYSA-N,2.2800315774809646e-9,antineoplastic,"aromatase inhibitor, lowers estrogen levels to slow breast cancer",low,high,5e-8,0.0456006315496193
leuprorelin,2016,Total,Total,138.3825,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.973447147314013e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2017,Total,Total,121.35875,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.532469615176022e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2018,Total,Total,106.8375,GFIJNRVAKGFPGQ-LIJARHBVSA-N,3.036985600967857e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
leuprorelin,2019,Total,Total,100.965,GFIJNRVAKGFPGQ-LIJARHBVSA-N,2.9165974150150054e-11,antineoplastic,"antigonadotropin for cancers, endometriosis, hormone therapy",low,NA,NA,NA
levetiracetam,2016,Total,Total,4353771.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.2501205677547414e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2017,Total,Total,4592883,HPHUVLMMVZITSG-LURJTMIESA-N,1.3368809124647785e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2018,Total,Total,4874655.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.38567998719352e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levetiracetam,2019,Total,Total,5139031.5,HPHUVLMMVZITSG-LURJTMIESA-N,1.48452295236772e-6,anticonvulsant,pyrrolidine anticonvulsant for various seizures,low,high,NA,NA
levocabastine,2016,Total,Total,1655.514,ZCGOMHNNNFPNMX-YHYDXASRSA-N,4.753561599651986e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,4.7535615996519857e-5
levocabastine,2017,Total,Total,1899.112,ZCGOMHNNNFPNMX-YHYDXASRSA-N,5.527871237810347e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,5.527871237810347e-5
levocabastine,2018,Total,Total,1890.018,ZCGOMHNNNFPNMX-YHYDXASRSA-N,5.37260554727513e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,5.37260554727513e-5
levocabastine,2019,Total,Total,2235.8095000000003,ZCGOMHNNNFPNMX-YHYDXASRSA-N,6.458630424568903e-10,antihistamine,antihistamine for eye irritation due to allergies,low,high,1e-5,6.458630424568902e-5
levocetirizine,2016,Total,Total,710.082,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0388945836785928e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2017,Total,Total,766.039499999999,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.2297619724779864e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2018,Total,Total,713.385,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0278834425613237e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levocetirizine,2019,Total,Total,715.95,ZKLPARSLTMPFCP-OAQYLSRUSA-N,2.0681799824493566e-10,antihistamine,"antihistamine for allergies, hives",NA,NA,NA,NA
levofloxacin,2017,Total,Total,40.32,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.173620978165128e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,1.5859742948177405e-6
levofloxacin,2018,Total,Total,53.76,GSDSWSVVBLHKDQ-JTQLQIEISA-N,1.5281932458924248e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,2.0651260079627363e-6
levofloxacin,2019,Total,Total,134.4,GSDSWSVVBLHKDQ-JTQLQIEISA-N,3.882441366592549e-11,antibacterial,"fluroquinolone antibiotic for various bacteria, including anthrax and plague",low,NA,7.4e-6,5.246542387287228e-6
levomepromazine,2016,Total,Total,102377.38,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.939613813238543e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2017,Total,Total,92423.555,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.6902337059672243e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2018,Total,Total,85520.88999999998,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.4310350907869983e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomepromazine,2019,Total,Total,74070.30500000001,VRQVVMDWGGWHTJ-CQSZACIVSA-N,2.1396846441080873e-8,other nervous system,"phenothiazine antipsychotic and analgesic, used for schizophrenia, palliative care",low,high,NA,NA
levomethadone,2016,Total,Total,169.915,USSIQXCVUWKGNF-QGZVFWFLSA-N,4.878855867149824e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2017,Total,Total,310.805,USSIQXCVUWKGNF-QGZVFWFLSA-N,9.046807245005271e-11,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2018,Total,Total,449.595,USSIQXCVUWKGNF-QGZVFWFLSA-N,1.2780283526543988e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levomethadone,2019,Total,Total,765.625,USSIQXCVUWKGNF-QGZVFWFLSA-N,2.211677210786771e-10,analgesic,"synthetic opioid for pain management, opioid maintenance therapy",NA,NA,NA,NA
levonorgestrel,2016,Total,Total,7285.4594,WWYNJERNGUHSAO-XUDSTZEESA-N,2.0919110342566478e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,209.19110342566478
levonorgestrel,2017,Total,Total,7441.77875,WWYNJERNGUHSAO-XUDSTZEESA-N,2.1661278908391526e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,216.61278908391526
levonorgestrel,2018,Total,Total,7294.26755,WWYNJERNGUHSAO-XUDSTZEESA-N,2.073484078058461e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,207.3484078058461
levonorgestrel,2019,Total,Total,7379.2009,WWYNJERNGUHSAO-XUDSTZEESA-N,2.131645448404536e-9,sex hormone,"progestin for birth control including monthly, implanted and emergency",low,high,1e-11,213.16454484045363
levosimendan,2016,Total,Total,15.0375,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.3177939029671e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2017,Total,Total,15.15,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.4098109670639096e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2018,Total,Total,14.4875,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.118247702728146e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levosimendan,2019,Total,Total,16.3625,WHXMKTBCFHIYNQ-SECBINFHSA-N,4.7266701533385855e-12,cardiac,calcium sensitiser for management of chronic heart failure,low,NA,NA,NA
levothyroxine sodium,2016,Total,Total,7388.251575,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.121426274588334e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2017,Total,Total,7133.40885,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.0763686190944395e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2018,Total,Total,7579.60385,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.1545943843210982e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
levothyroxine sodium,2019,Total,Total,7705.6711,YDTFRJLNMPSCFM-YDALLXLXSA-M,2.22595358898785e-9,other hormone,"synthetic form of thyroid hormone thyroxine, for thyroid diseases, tumours",NA,NA,NA,NA
lidocaine,2016,Total,Total,638161.24,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.832384845341263e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2017,Total,Total,627004.064,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.825062308792635e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2018,Total,Total,621976.8,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.768044540293497e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
lidocaine,2019,Total,Total,650385.23,NNJVILVZKWQKPM-UHFFFAOYSA-N,1.878781637777388e-7,anaesthetic,"local anaesthetic for invasive procedures, also group I antiarrhythmic",low,NA,NA,NA
linagliptin,2016,Total,Total,10846.965,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.1145442621910243e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,9.73295081934695e-6
linagliptin,2017,Total,Total,12320.0925,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.586091024537414e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.1206534451679418e-5
linagliptin,2018,Total,Total,12987.468,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.6918454015706853e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.153701687990839e-5
linagliptin,2019,Total,Total,13415.778,LTXREWYXXSTFRX-QGZVFWFLSA-N,3.875444305968918e-9,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,moderate,3.2e-4,1.2110763456152868e-5
linezolid,2016,Total,Total,22374,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.4243604844545905e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2017,Total,Total,21606,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.2890016999592645e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2018,Total,Total,22014,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.257746673191193e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
linezolid,2019,Total,Total,23940,TYZROVQLWOKYKF-ZDUSSCGKSA-N,6.915598684242978e-9,antibacterial,oxazolidinone antibiotic and MAO inhibitor,low,NA,NA,NA
liothyronine sodium,2016,Total,Total,40.16572,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.153298759263732e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2017,Total,Total,45.3151,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3190166663603817e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2018,Total,Total,46.2898,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.3158437446746874e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
liothyronine sodium,2019,Total,Total,58.48984,SBXXSUDPJJJJLC-YDALLXLXSA-M,1.6896084400400264e-11,other hormone,"synthetic form of thyroid hormone triiodothyronine, for thyroid diseases, tumours",low,NA,NA,NA
lipegfilgrastim,2016,Total,Total,20.958,GAQMWPRWVIGRRV-IVDGIBIRSA-N,6.017777198230056e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2017,Total,Total,7.524,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.1900605753259976e-12,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2018,Total,Total,71.616,GAQMWPRWVIGRRV-IVDGIBIRSA-N,2.0357717168495523e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lipegfilgrastim,2019,Total,Total,38.256,GAQMWPRWVIGRRV-IVDGIBIRSA-N,1.1051092032765219e-11,immunostimulant,white blood cell boosting immunostimulant for neutropenia relief,NA,NA,NA,NA
lisdexamfetamine,2016,Total,Total,45990.978,VOBHXZCDAVEXEY-JSGCOSHPSA-N,1.320562356774025e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2017,Total,Total,74352.40800000001,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.1642248463763068e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2018,Total,Total,105380.181,VOBHXZCDAVEXEY-JSGCOSHPSA-N,2.995559539715798e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisdexamfetamine,2019,Total,Total,157686.582,VOBHXZCDAVEXEY-JSGCOSHPSA-N,4.5551258103674713e-8,stimulant,"CNS stimulant for ADHD, binge eating disorder",NA,NA,NA,NA
lisinopril,2016,Total,Total,151188.9495,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.3411652491910275e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.61763770765919e-4
lisinopril,2017,Total,Total,144476.25209999998,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4.2053660791476584e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.504471732623049e-4
lisinopril,2018,Total,Total,137568.0606,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.9105390822068435e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.258782568505703e-4
lisinopril,2019,Total,Total,132054.1359,RLAWWYSOJDYHDC-BZSNNMDCSA-N,3.814675891724659e-8,cardiac,"angiotensin converting enzyme inhibitor for hypertension, congestive heart failure",low,high,1.1999999999999999e-4,3.178896576437216e-4
loperamide,2016,Total,Total,28241.56,RDOIQAHITMMDAJ-UHFFFAOYSA-N,8.109142848098388e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.6218285696196775e-4
loperamide,2017,Total,Total,29913.697,RDOIQAHITMMDAJ-UHFFFAOYSA-N,8.707178158153583e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.7414356316307165e-4
loperamide,2018,Total,Total,31272.093999999997,RDOIQAHITMMDAJ-UHFFFAOYSA-N,8.889472253666859e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.7778944507333715e-4
loperamide,2019,Total,Total,32530.941000000003,RDOIQAHITMMDAJ-UHFFFAOYSA-N,9.397282070876609e-9,alimentary,treatment for diarrhoea,low,NA,5e-5,1.8794564141753217e-4
lopinavir,2016,Total,Total,27612,KJHKTHWMRKYKJE-SUGCFTRWSA-N,7.928374081378391e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2017,Total,Total,17604,KJHKTHWMRKYKJE-SUGCFTRWSA-N,5.124113020738817e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2018,Total,Total,11149.2,KJHKTHWMRKYKJE-SUGCFTRWSA-N,3.1692954124077063e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
lopinavir,2019,Total,Total,9900,KJHKTHWMRKYKJE-SUGCFTRWSA-N,2.8598340423561183e-9,antiviral,protease inhibitor used in combination with ritonavir for HIV,NA,NA,NA,NA
loratadine,2016,Total,Total,115440.23,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.3146940731579034e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2017,Total,Total,114493.81,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.3326472541183606e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2018,Total,Total,111358.04,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.1654874368269816e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
loratadine,2019,Total,Total,114115.56,JCCNYMKQOSZNPW-UHFFFAOYSA-N,3.2964804368740634e-8,antihistamine,"antihistamine for colds and allergic reactions, chronic skin reactions",NA,NA,NA,NA
losartan,2016,Total,Total,3027866.1195,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.694066081315213e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.694066081315212e-4
losartan,2017,Total,Total,3039786.7165,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.848108778849434e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.848108778849434e-4
losartan,2018,Total,Total,3032960.4255,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.621558105111824e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.621558105111823e-4
losartan,2019,Total,Total,3082248.4125,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,8.903756502086469e-7,antihypertensive,"angiotensin II receptor agonist for hypertension, lowering stroke risk, diabetes management",low,high,0.001,8.903756502086469e-4
lovastatin,2016,Total,Total,7570.83319999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.1738518657583276e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2017,Total,Total,7141.514799999999,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.0787280717154603e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2018,Total,Total,7115.6232,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.022702253451534e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
lovastatin,2019,Total,Total,6928.0512,PCZOHLXUXFIOCF-BXMDZJJMSA-N,2.001320875651127e-9,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
loxapine,2016,Total,Total,0.4732,XJGVXQDUIWGIRW-UHFFFAOYSA-N,1.3587232418181425e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2017,Total,Total,1.4651,XJGVXQDUIWGIRW-UHFFFAOYSA-N,4.2645637279507163e-13,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
loxapine,2018,Total,Total,0.3003,XJGVXQDUIWGIRW-UHFFFAOYSA-N,8.53639195947722e-14,antipsychotic,dibenzoxazepine antipsychotic for schizophrenia,NA,NA,NA,NA
lumacaftor,2016,Total,Total,1344,UFSKUSARDNFIRC-UHFFFAOYSA-N,3.8590955980633625e-10,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2017,Total,Total,5040,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.4670262227064096e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2018,Total,Total,6608,UFSKUSARDNFIRC-UHFFFAOYSA-N,1.8784041980761063e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lumacaftor,2019,Total,Total,8512,UFSKUSARDNFIRC-UHFFFAOYSA-N,2.458879532175281e-9,respiratory,"adjuvant for ivacaftor treatment of cystic fibrosis, protein folding chaperone",NA,NA,NA,NA
lurasidone,2016,Total,Total,4085.01016,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.1729497564360203e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2017,Total,Total,5081.82864,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.479201562337391e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2018,Total,Total,6887.00166,PQXKDMSYBGKCJA-CVTJIBDQSA-N,1.9577138060383033e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lurasidone,2019,Total,Total,9104.99996,PQXKDMSYBGKCJA-CVTJIBDQSA-N,2.630180691036272e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
lymecycline,2016,Total,Total,1073133.9,PZTCVADFMACKLU-UEPZRUIBSA-N,3.081343980373935e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2017,Total,Total,1097286.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.193944873064205e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2018,Total,Total,1083620.4,PZTCVADFMACKLU-UEPZRUIBSA-N,3.080322500727768e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
lymecycline,2019,Total,Total,1146855.6,PZTCVADFMACKLU-UEPZRUIBSA-N,3.312946148027023e-7,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
macitentan,2016,Total,Total,356.7,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.0242108629681559e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2017,Total,Total,436.8,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.2714227263455548e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2018,Total,Total,479.1,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.3618998960324794e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macitentan,2019,Total,Total,525.6,JGCMEBMXRHSZKX-UHFFFAOYSA-N,1.5183118915781576e-10,respiratory,endothelin receptor antagonist for pulmonary arterial hypertension,low,NA,NA,NA
macrogol,2016,Total,Total,89406689.94266,LYCAIKOWRPUZTN-UHFFFAOYSA-N,2.5671797886542795e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.027022945143729257
macrogol,2017,Total,Total,107272347.2196,LYCAIKOWRPUZTN-UHFFFAOYSA-N,3.122447348063893e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.03286786682172519
macrogol,2018,Total,Total,119421168.12416,LYCAIKOWRPUZTN-UHFFFAOYSA-N,3.39469163958194e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.035733596206125685
macrogol,2019,Total,Total,133176128.11248,LYCAIKOWRPUZTN-UHFFFAOYSA-N,3.84708711924495e-5,laxative,"polymer laxative for constipation, also used for bulking in many pharmaceuticals",low,low,9.5e-4,0.04049565388678895
malathion,2016,Total,Total,8060.525,JXSJBGJIGXNWCI-UHFFFAOYSA-N,2.3144595644032507e-9,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
malathion,2017,Total,Total,2174.975,JXSJBGJIGXNWCI-UHFFFAOYSA-N,6.33084396573586e-10,antiparasitic,organophosphate acetylcholinesterase inhibiting insecticide and acaricide,NA,NA,NA,NA
maraviroc,2016,Total,Total,855,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.4550050121608447e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.668483708870483e-7
maraviroc,2017,Total,Total,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1481455403915282e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3349408047734003e-7
maraviroc,2018,Total,Total,954,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.7118607823314245e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.9476747634037224e-7
maraviroc,2019,Total,Total,738,GSNHKUDZZFZSJB-HLMSNRGBSA-N,2.1318762861200159e-10,antiviral,chemokine receptor antagonist for HIV treatment,low,high,9.2e-4,2.3172568327391477e-7
maropitant,2016,Total,Total,756.792,OMPCVMLFFSQFIX-CONSDPRKSA-N,2.173015383816643e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2017,Total,Total,1060.856,OMPCVMLFFSQFIX-CONSDPRKSA-N,3.0879039097528395e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2018,Total,Total,1442.464,OMPCVMLFFSQFIX-CONSDPRKSA-N,4.100378984826955e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
maropitant,2019,Total,Total,1906.536,OMPCVMLFFSQFIX-CONSDPRKSA-N,5.507451066441885e-10,antiemetic,neurokinin receptor antagonic for motion sickness in dogs and cats,NA,NA,NA,NA
mavacoxib,2016,Total,Total,159.82,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.588992994661359e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2017,Total,Total,170.18,TTZNQDOUNXBMJV-UHFFFAOYSA-N,4.953542114686048e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2018,Total,Total,114.23,TTZNQDOUNXBMJV-UHFFFAOYSA-N,3.2471263853848907e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mavacoxib,2019,Total,Total,61.95,TTZNQDOUNXBMJV-UHFFFAOYSA-N,1.7895628174137533e-11,analgesic,veterinary COX-2 inhibitor for degenerative joint disease,NA,NA,NA,NA
mebendazole,2016,Total,Total,61423.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.7636756007363508e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20041768190185807
mebendazole,2017,Total,Total,63877.2,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.859316020497259e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.21128591142014308
mebendazole,2018,Total,Total,62027.4,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.763204124632958e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.20036410507192706
mebendazole,2019,Total,Total,65777.40000000001,OPXLLQIJSORQAM-UHFFFAOYSA-N,1.9001257347239938e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,low,NA,8.8e-8,0.2159233789459084
mecillinam,2016,Total,Total,11634,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.340529627073598e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2017,Total,Total,11510,BWWVAEOLVKTZFQ-NTZNESFSSA-N,3.3502920284426143e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2018,Total,Total,4429,BWWVAEOLVKTZFQ-NTZNESFSSA-N,1.258997002614872e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
mecillinam,2019,Total,Total,7300,BWWVAEOLVKTZFQ-NTZNESFSSA-N,2.108766516080774e-9,antibacterial,amidinopenicillin antibiotic,NA,NA,NA,NA
meclozine,2016,Total,Total,62298.6,OCJYIGYOJCODJL-UHFFFAOYSA-N,1.7888114064398083e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2017,Total,Total,72859.975,OCJYIGYOJCODJL-UHFFFAOYSA-N,2.1207836093399495e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2018,Total,Total,83020.075,OCJYIGYOJCODJL-UHFFFAOYSA-N,2.359946389294691e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
meclozine,2019,Total,Total,83509.225,OCJYIGYOJCODJL-UHFFFAOYSA-N,2.4123487323815825e-8,antihistamine,antihistamine and antiemetic for motion sickness and vertigo,NA,NA,NA,NA
medetomidine,2016,Total,Total,80.34,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.3068433061637697e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2017,Total,Total,76.09,CUHVIMMYOGQXCV-UHFFFAOYSA-N,2.2148020890025934e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2018,Total,Total,69.92,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9875608584969936e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medetomidine,2019,Total,Total,65.86,CUHVIMMYOGQXCV-UHFFFAOYSA-N,1.9025118184805452e-11,analgesic,canine surgical anaesthetic and analgesic,NA,NA,NA,NA
medroxyprogesterone acetate,2016,Total,Total,17214.412,PSGAAPLEWMOORI-PEINSRQWSA-N,4.94286172414056e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2017,Total,Total,16454.864,PSGAAPLEWMOORI-PEINSRQWSA-N,4.789626384735652e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2018,Total,Total,15057.08,PSGAAPLEWMOORI-PEINSRQWSA-N,4.2801577304430655e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
medroxyprogesterone acetate,2019,Total,Total,14449.196,PSGAAPLEWMOORI-PEINSRQWSA-N,4.173969960149077e-9,sex hormone,progestin for birth control and various hormone therapy,NA,NA,NA,NA
mefloquine,2016,Total,Total,8634,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.4791243596487406e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2017,Total,Total,8060,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.346077649804298e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2018,Total,Total,7916,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.250219072634754e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
mefloquine,2019,Total,Total,7282,XEEQGYMUWCZPDN-UHFFFAOYSA-N,2.103566817821945e-9,antiprotozoal,quinoline antimalarial,NA,NA,NA,NA
megestrol acetate,2016,Total,Total,5134.128,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.4741883009444832e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2017,Total,Total,4752.24,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.3832660112290292e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2018,Total,Total,5703.456,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,1.621276588066337e-9,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
megestrol acetate,2019,Total,Total,2689.824,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,7.770151760754046e-10,sex hormone,"progestin appetite stimulator, birth control, antineoplastic",NA,NA,NA,NA
meglumine amidotrizoate,2016,Total,Total,1.51536,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.351130286816442e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2017,Total,Total,1.40118,MIKKOBKEXMRYFQ-WZTVWXICSA-N,4.078507545102713e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2018,Total,Total,1.30746,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.7166137300493133e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
meglumine amidotrizoate,2019,Total,Total,1.19988,MIKKOBKEXMRYFQ-WZTVWXICSA-N,3.466118859335616e-13,diagnostic agent,"contrast medium for X-rays, with sodium amidotrizoate",NA,NA,NA,NA
melatonin,2016,Total,Total,15101.247,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.33609790349461e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2017,Total,Total,16070.9346,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.677873508253918e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2018,Total,Total,16984.3194,DRLFMBDRBRZALE-UHFFFAOYSA-N,4.827998919858573e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
melatonin,2019,Total,Total,18836.218200000003,DRLFMBDRBRZALE-UHFFFAOYSA-N,5.441258387637162e-9,other hormone,supplemental hormone for sleep,low,NA,NA,NA
meloxicam,2016,Total,Total,61799.399,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.7744775940763494e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2017,Total,Total,63903.462,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.8600804459468773e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2018,Total,Total,62684.0115,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.7818691034178408e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
meloxicam,2019,Total,Total,63033.4555,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,1.8208608267296922e-8,analgesic,NSAID for arthritis,NA,NA,NA,NA
melphalan,2016,Total,Total,53.05,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.5232516478962898e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2017,Total,Total,46,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.3389525048510883e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2018,Total,Total,33.5,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,9.522781573176384e-12,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
melphalan,2019,Total,Total,38.4,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,1.1092689618835856e-11,antineoplastic,alkylating treatment for myeloma,NA,NA,NA,NA
memantine,2016,Total,Total,33363.1714,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.579737193986122e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2017,Total,Total,32400.4736,BUGYDGFZZOZRHP-UHFFFAOYSA-N,9.431020714148164e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2018,Total,Total,31011.5332,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.815404683967393e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
memantine,2019,Total,Total,30630.0316,BUGYDGFZZOZRHP-UHFFFAOYSA-N,8.848162332133703e-9,other nervous system,neurotransmitter agonist and antagonist for Alzheimer's,NA,NA,NA,NA
menbutone,2019,Total,Total,900,FHGJSJFIQNQBCK-UHFFFAOYSA-N,2.5998491294146534e-10,alimentary,choleretic veterinary bile excretion stimulator,NA,NA,NA,NA
mepivacaine,2016,Total,Total,7958.4,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.285135893424663e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2017,Total,Total,8615.7,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.5078289339229392e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2018,Total,Total,9848.4,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.7995272252319502e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mepivacaine,2019,Total,Total,9095.1,INWLQCZOYSRPNW-UHFFFAOYSA-N,2.6273208685488013e-9,anaesthetic,"local anaesthetic for epidurals, spinal block, dental procedures",low,NA,NA,NA
mercaptopurine,2016,Total,Total,5904.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.6953173500644054e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2017,Total,Total,6181.25,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.7992174283936496e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2018,Total,Total,6047.5,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.719075270560722e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
mercaptopurine,2019,Total,Total,5930.75,GLVAUDGFNGKCSF-UHFFFAOYSA-N,1.713228358252884e-9,antineoplastic,antimetabolite for leukaemia,NA,NA,NA,NA
meropenem,2016,Total,Total,152350,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4.374503083072569e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2017,Total,Total,136675,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.9782898608809246e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2018,Total,Total,129585,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.683610896000185e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
meropenem,2019,Total,Total,124545,DMJNNHOOLUXYBV-PQTSNVLCSA-N,3.5977578869216446e-8,antibacterial,"carbapenem antibiotic for skin, stomach infections, meningitis",NA,NA,NA,NA
mesna,2016,Total,Total,20386,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.85353592724105e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2017,Total,Total,18418,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.361049398771162e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2018,Total,Total,19076,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.422584516116798e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
mesna,2019,Total,Total,18950,XOGTZOOQQBDUSI-UHFFFAOYSA-M,5.474126778045298e-9,antineoplastic,detoxifying agent used to prevent bleeding in bladder from chemotherapy,NA,NA,NA,NA
metamizole sodium,2016,Total,Total,32750,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.40367416938803e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2017,Total,Total,34150,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.940266965361884e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2018,Total,Total,31700,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.011109727453477e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metamizole sodium,2019,Total,Total,33100,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,9.561667353736114e-9,analgesic,"sodium salt of metamizole, a painkiller, antispasmodic, and anti-inflammatory",NA,NA,NA,NA
metformin,2016,Total,Total,69488813.456,XZWYZXLIPXDOLR-UHFFFAOYSA-N,1.9952676646033913e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.019952676646033913
metformin,2017,Total,Total,73431045.754,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1374061444815902e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021374061444815903
metformin,2018,Total,Total,74897300.814,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.1290466748424115e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.021290466748424115
metformin,2019,Total,Total,78024938.926,XZWYZXLIPXDOLR-UHFFFAOYSA-N,2.25392299488214e-5,anti-diabetic,non-sulfonylurea blood sugar control agent for type 2 diabetes,low,moderate,0.001,0.0225392299488214
methadone,2016,Total,Total,98002.923,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8140078031744248e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2017,Total,Total,96779.685,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8170304706402024e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2018,Total,Total,95411.485,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.7121872573952098e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methadone,2019,Total,Total,98445.98,USSIQXCVUWKGNF-UHFFFAOYSA-N,2.8438299488596932e-8,analgesic,"opioid painkiller for severe pain, opioid detoxification and withdrawal",low,NA,NA,NA
methenamine,2016,Total,Total,15596938,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.478428182966309e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2017,Total,Total,15766796,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.5893458690600255e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2018,Total,Total,15759884,VKYKSIONXSXAKP-UHFFFAOYSA-N,4.479938297032757e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methenamine,2019,Total,Total,13120813,VKYKSIONXSXAKP-UHFFFAOYSA-N,3.7902371394736073e-6,antibacterial,antibiotic for bladder infections,NA,NA,NA,NA
methoprene,2016,Total,Total,3529.836,NFGXHKASABOEEW-LDRANXPESA-N,1.0135397745152971e-9,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2017,Total,Total,2461.1454,NFGXHKASABOEEW-LDRANXPESA-N,7.163819126375508e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2018,Total,Total,2021.0688,NFGXHKASABOEEW-LDRANXPESA-N,5.745133351272152e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoprene,2019,Total,Total,1957.203,NFGXHKASABOEEW-LDRANXPESA-N,5.653813906264164e-10,other hormone,"insect juvenile hormone analogue used with insecticides to inhibit growth, applied topically for fleas",NA,NA,NA,NA
methoxsalen,2019,Total,Total,0.0576,QXKHYNVANLEOEG-UHFFFAOYSA-N,1.663903442825378e-14,dermatological,psoralen agent used with ultraviolet light A for psoriasis,NA,NA,NA,NA
methyl aminolevulinate,2016,Total,Total,1325.44,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.805803325518678e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2017,Total,Total,1259.2,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.6652369437141094e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2018,Total,Total,1025.92,YUUAYBAIHCDHHD-UHFFFAOYSA-N,2.9163021109113783e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methyl aminolevulinate,2019,Total,Total,1140.48,YUUAYBAIHCDHHD-UHFFFAOYSA-N,3.294528816794249e-10,antineoplastic,photosensitising agent for treatment of skin cancers,low,NA,NA,NA
methylnaltrexone bromide,2016,Total,Total,129.564,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.7202370689544754e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2017,Total,Total,124.5,IFGIYSGOEZJNBE-KNLJMPJLSA-N,3.623904062042619e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2018,Total,Total,46.355999999999995,IFGIYSGOEZJNBE-KNLJMPJLSA-N,1.3177255600184014e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylnaltrexone bromide,2019,Total,Total,97.212,IFGIYSGOEZJNBE-KNLJMPJLSA-N,2.8081837063184145e-11,laxative,opioid antagonist for treatment of opioid constipation without affecting pain relief,NA,NA,NA,NA
methylphenidate,2016,Total,Total,449505.8977,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.290689160057731e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2017,Total,Total,471897.4314,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3735831474039664e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2018,Total,Total,476990.1956,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.3559025209688e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylphenidate,2019,Total,Total,494619.477,DUGOZIWVEXMGBE-UHFFFAOYSA-N,1.4288177962999792e-7,stimulant,"stimulant for ADHD, narcolepsy",low,NA,NA,NA
methylprednisolone,2016,Total,Total,25117.601,VHRSUDSXCMQTMA-PJHHCJLFSA-N,7.2121446021586255e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2017,Total,Total,22609.799,VHRSUDSXCMQTMA-PJHHCJLFSA-N,6.5811841315716595e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2018,Total,Total,20784.897,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.9083592284169894e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylprednisolone,2019,Total,Total,18925.627,VHRSUDSXCMQTMA-PJHHCJLFSA-N,5.467086097730718e-9,steroid,corticosteroid for many inflammatory conditions,NA,NA,NA,NA
methylrosaniline,2016,Total,Total,2803.2799999999997,QFVDKARCPMTZCS-UHFFFAOYSA-N,8.049200526889184e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2017,Total,Total,2551.62,QFVDKARCPMTZCS-UHFFFAOYSA-N,7.427169544408987e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2018,Total,Total,778.4,QFVDKARCPMTZCS-UHFFFAOYSA-N,2.2126964706150738e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
methylrosaniline,2019,Total,Total,614.28,QFVDKARCPMTZCS-UHFFFAOYSA-N,1.774483692463148e-10,antiseptic,topical antiseptic with broad antibiotic properties,NA,NA,NA,NA
metoclopramide,2016,Total,Total,64983.21,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8658959796058563e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2017,Total,Total,64693.28,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8830702022398436e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2018,Total,Total,64785.495,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.8416063223734652e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoclopramide,2019,Total,Total,65947.70999999999,TTWJBBZEZQICBI-UHFFFAOYSA-N,1.9050455158932224e-8,alimentary,"increases stomach emptying into intestines, controlling heartburn, nausea",low,NA,NA,NA
metoprolol,2016,Total,Total,6866147.1280000005,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.971511767657754e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2700701051585964
metoprolol,2017,Total,Total,6845990.6295,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.992707891642631e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2729736837866618
metoprolol,2018,Total,Total,6856705.0345,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.949101622544548e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.26700022226637643
metoprolol,2019,Total,Total,6798429.0755,IUBSYMUCCVWXPE-UHFFFAOYSA-N,1.963876657036216e-6,beta blocker,"cardioselective beta blocker for angina, hypertension",low,high,7.2999999999999996e-6,0.2690241995940022
metronidazole,2016,Total,Total,993152.825,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.8516902493762604e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02281352199501008
metronidazole,2017,Total,Total,1004363.73,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.923468113184961e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.023387744905479686
metronidazole,2018,Total,Total,959935.85,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.7287341563616154e-07,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02182987325089292
metronidazole,2019,Total,Total,987940.2,VAOCPAMSLUNLGC-UHFFFAOYSA-N,2.853883854315265e-7,antibacterial,nitroimidazole antibiotic and antiprotozoal,low,high,1.25e-5,0.02283107083452212
metyrapone,2016,Total,Total,325,FJLBFSROUSIWMA-UHFFFAOYSA-N,9.331890397102626e-11,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2017,Total,Total,1712.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,4.98468731425541e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2018,Total,Total,3100,FJLBFSROUSIWMA-UHFFFAOYSA-N,8.812126231894564e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
metyrapone,2019,Total,Total,2187.5,FJLBFSROUSIWMA-UHFFFAOYSA-N,6.31907774510506e-10,diagnostic agent,adrenal corticosteroid inhibitor and pituitary function test,NA,NA,NA,NA
mianserin,2016,Total,Total,173771.217,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.9895813883542663e-08,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2017,Total,Total,165837.76499999998,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.8271498009925243e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2018,Total,Total,149158.389,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.240008233593657e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
mianserin,2019,Total,Total,156068.376,UEQUQVLFIPOEMF-UHFFFAOYSA-N,4.50838034969732e-8,antidepressant,tricyclic antidepressant for depression and bipolar disorder,NA,NA,NA,NA
micafungin,2016,Total,Total,384.3,PIEUQSKUWLMALL-YABMTYFHSA-N,1.1034601475712428e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2017,Total,Total,607.1999999999999,PIEUQSKUWLMALL-YABMTYFHSA-N,1.7674173064034363e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2018,Total,Total,335.65000000000003,PIEUQSKUWLMALL-YABMTYFHSA-N,9.541258612049711e-11,antifungal,echinocandin antifungal,NA,NA,NA,NA
micafungin,2019,Total,Total,349.85,PIEUQSKUWLMALL-YABMTYFHSA-N,1.0106191310285739e-10,antifungal,echinocandin antifungal,NA,NA,NA,NA
miconazole,2016,Total,Total,81645.6976006512,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.344334465859267e-8,antifungal,azole antifungal,high,high,2e-7,0.11721672329296336
miconazole,2017,Total,Total,83086.8795291108,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.4184649014296416e-8,antifungal,azole antifungal,high,high,2e-7,0.12092324507148208
miconazole,2018,Total,Total,83390.40361369439,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.3704734295887476e-8,antifungal,azole antifungal,high,high,2e-7,0.11852367147943739
miconazole,2019,Total,Total,91434.34381461496,BYBLEWFAAKGYCD-UHFFFAOYSA-N,2.6412833240558538e-8,antifungal,azole antifungal,high,high,2e-7,0.13206416620279268
midazolam,2016,Total,Total,6162.6,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.769498700344143e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2017,Total,Total,6242.8,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8171331950618206e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2018,Total,Total,6157.85,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.7504435973249015e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midazolam,2019,Total,Total,6539.32,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1.8890272676626482e-9,sedative,benzodiazepine used for pre-surgery relaxation,NA,NA,NA,NA
midodrine,2019,Total,Total,340.25,PTKSEFOSCHHMPD-UHFFFAOYSA-N,9.828874069814841e-11,cardiac,"antihypotensive, constricts blood vessels",NA,NA,NA,NA
midostaurin,2018,Total,Total,72.8,BMGQWWVMWDBQGC-IIFHNQTCSA-N,2.0694283538126592e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
midostaurin,2019,Total,Total,61.6,BMGQWWVMWDBQGC-IIFHNQTCSA-N,1.779452293021585e-11,antineoplastic,"protein kinase inhibitor for leukaemia, other cancers",NA,NA,NA,NA
mifepristone,2016,Total,Total,2740.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.8697985231935e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2017,Total,Total,2626.4,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.644836649436736e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2018,Total,Total,2763.8,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.856436928938774e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
mifepristone,2019,Total,Total,2751,VKHAHZOOUSRJNA-GCNJZUOMSA-N,7.946872172244123e-10,sex hormone,progestin abortifacient and treatment for hyperglycaemia with Cushing's,high,NA,NA,NA
miglustat,2016,Total,Total,630,UQRORFVVSGFNRO-UTINFBMNSA-N,1.8089510615922014e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2017,Total,Total,814.8,UQRORFVVSGFNRO-UTINFBMNSA-N,2.3716923933753617e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2018,Total,Total,915.6,UQRORFVVSGFNRO-UTINFBMNSA-N,2.602704121910537e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
miglustat,2019,Total,Total,1008,UQRORFVVSGFNRO-UTINFBMNSA-N,2.911831024944412e-10,metabolic,iminosugar treatment for Gaucher disease,NA,NA,NA,NA
milbemycin oxime,2016,Total,Total,3482.1718499999997,LKMMLHTWKLEARD-LEBVNCHQSA-N,9.998537245561872e-10,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2017,Total,Total,3796.2692,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.105005250962834e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2018,Total,Total,4060.1456,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.1541456628087514e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milbemycin oxime,2019,Total,Total,3846.8674,LKMMLHTWKLEARD-LEBVNCHQSA-N,1.111252762318179e-9,antiparasitic,broad spectrum anthelmintic and acaricide,NA,NA,NA,NA
milrinone,2019,Total,Total,10.1,PZRHRDRVRGEVNW-UHFFFAOYSA-N,2.9176084674542226e-12,vasodilator,inotropic vasodilator for life-threatening heart failure,low,high,NA,NA
minoxidil,2016,Total,Total,62955,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,1.807658953691064e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2017,Total,Total,85104,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,2.4771785646271093e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2018,Total,Total,105543,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.000187867396284e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
minoxidil,2019,Total,Total,117723,ZIMGGGWCDYVHOY-UHFFFAOYSA-N,3.4006893229120146e-8,vasodilator,vasodilator for hypertension; also topical hair growth stimulator,NA,NA,NA,NA
mirabegron,2016,Total,Total,303287.5425,PBAPPPCECJKMCM-IBGZPJMESA-N,8.708449555128015e-8,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2017,Total,Total,372761.0925000001,PBAPPPCECJKMCM-IBGZPJMESA-N,1.0850204315519639e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2018,Total,Total,436381.155,PBAPPPCECJKMCM-IBGZPJMESA-N,1.240466394541919e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirabegron,2019,Total,Total,516175.395,PBAPPPCECJKMCM-IBGZPJMESA-N,1.491086834795572e-7,urological,antispasmodic treatment for urinary incontinence,NA,NA,NA,NA
mirtazapine,2016,Total,Total,319535.925,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.174997630882476e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002867186759650774
mirtazapine,2017,Total,Total,326906.742,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.515491327252358e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.002973591039766362
mirtazapine,2018,Total,Total,337860.4368,RONZAEMNMFQXRA-UHFFFAOYSA-N,9.60409296078915e-8,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0030012790502466093
mirtazapine,2019,Total,Total,363507.1445999999,RONZAEMNMFQXRA-UHFFFAOYSA-N,1.050070814915907e-7,antidepressant,tetracyclic antidepressant,low,moderate,3.2e-5,0.0032814712966122094
misoprostol,2016,Total,Total,676.244,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.941733812214852e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2017,Total,Total,658.3222000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.916222084106694e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2018,Total,Total,621.0586000000001,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7654344453560368e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
misoprostol,2019,Total,Total,591.4346,OJLOPKGSLYJEMD-URPKTTJQSA-N,1.7084896999063375e-10,alimentary,"prostaglandin for inducing labour, treating stomach ulcers, reducing damage from NSAIDs",NA,NA,NA,NA
mitomycin,2017,Total,Total,39.42,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.1474240813310847e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2018,Total,Total,54.8,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.5577565080897488e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitomycin,2019,Total,Total,58.72,NWIBSHFKIJFRCO-WUDYKRTCSA-N,1.696257120880316e-11,antineoplastic,antibiotic treatment for stomach and pancreas cancer,NA,NA,NA,NA
mitotane,2016,Total,Total,9600,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.756496855759545e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2017,Total,Total,7300,JWBOIMRXGHLCPP-UHFFFAOYSA-N,2.124859409872379e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2018,Total,Total,4750,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.3502451484354574e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitotane,2019,Total,Total,5800,JWBOIMRXGHLCPP-UHFFFAOYSA-N,1.6754583278449986e-9,antineoplastic,treatment for adrenal gland cancer,NA,NA,NA,NA
mitoxantrone,2016,Total,Total,4.75,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.3638916734226917e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2017,Total,Total,4.35,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.2661833469787465e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2018,Total,Total,3.26,KKZJGLLVHKMTCM-UHFFFAOYSA-N,9.26694565031493e-13,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mitoxantrone,2019,Total,Total,3.49,KKZJGLLVHKMTCM-UHFFFAOYSA-N,1.0081637179619046e-12,antineoplastic,"antibiotic treatment for leukaemia, prostate cancer, multiple sclerosis",low,NA,NA,NA
mivacurium chloride,2016,Total,Total,233.4205,WMSYWJSZGVOIJW-ONUALHDOSA-L,6.702321607498134e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2017,Total,Total,272.68949999999995,WMSYWJSZGVOIJW-ONUALHDOSA-L,7.937354110251972e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2018,Total,Total,285.5295,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.116522570741094e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
mivacurium chloride,2019,Total,Total,299.3325,WMSYWJSZGVOIJW-ONUALHDOSA-L,8.646881550339019e-11,other musculoskeletal,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
moclobemide,2016,Total,Total,74501.91,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.1392112569070896e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2017,Total,Total,70062.95999999999,YHXISWVBGDMDLQ-UHFFFAOYSA-N,2.0393690388974263e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2018,Total,Total,61765.23,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.7557516242000038e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
moclobemide,2019,Total,Total,56384.52,YHXISWVBGDMDLQ-UHFFFAOYSA-N,1.6287916137162566e-8,antidepressant,MAO antidepressant,low,NA,NA,NA
modafinil,2016,Total,Total,36860.1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.0583828099269e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2017,Total,Total,41133.87,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.1973108319721531e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2018,Total,Total,44110.41,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.25389193890524e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
modafinil,2019,Total,Total,48698.369999999995,YFGHCGITMMYXAQ-UHFFFAOYSA-N,1.4067601649823629e-8,other nervous system,wakefulness treatment,NA,NA,NA,NA
mometasone,2016,Total,Total,14572.425,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.184254551384561e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.29887532509889725
mometasone,2017,Total,Total,15295.034,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.452026975235339e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.31800192680252426
mometasone,2018,Total,Total,15318.282,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.354407569024463e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.31102911207317596
mometasone,2019,Total,Total,16733.996,QLIIKPVHVRXHRI-CXSFZGCWSA-N,4.833984992469811e-9,steroid,topical steroid for skin conditions,low,moderate,1.4e-8,0.3452846423192722
montelukast,2016,Total,Total,90571.20506,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6006171038566978e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.01368745844135104
montelukast,2017,Total,Total,89291.39282,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5990637843039453e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013679283075283922
montelukast,2018,Total,Total,91333.7439,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.5962725176720332e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.013664592198273859
montelukast,2019,Total,Total,93387.5145,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2.6977049807891482e-8,respiratory,"leukotriene inhibitor for asthma attacks, chronic allergies, bronchoconstriction",high,high,1.9e-6,0.014198447267311306
morphine,2016,Total,Total,143800.62,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.1290203842320125e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2017,Total,Total,145812.63,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.244264916900542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2018,Total,Total,144049.465,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.094780868441542e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
morphine,2019,Total,Total,148051.625,BQJCRHHNABKAKU-KBQPJGBKSA-N,4.2767987596074974e-8,analgesic,opioid painkiller for moderate-severe pain,low,NA,NA,NA
moxidectin,2016,Total,Total,834.5274000000001,YZBLFMPOMVTDJY-LSGXYNIPSA-N,2.3962209939012376e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2017,Total,Total,642.7746,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.8709666537492526e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2018,Total,Total,574.6335,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6334654642178663e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxidectin,2019,Total,Total,573.168,YZBLFMPOMVTDJY-LSGXYNIPSA-N,1.6557225842314866e-10,anthelminthic,veterinary anthelmintic,NA,NA,NA,NA
moxonidine,2016,Total,Total,700.267344,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.0107132624240496e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2017,Total,Total,705.406072,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.053272232699059e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2018,Total,Total,674.0434680000001,WPNJAUFVNXKLIM-UHFFFAOYSA-N,1.9160503631612855e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
moxonidine,2019,Total,Total,750.183784,WPNJAUFVNXKLIM-UHFFFAOYSA-N,2.1670718419259892e-10,antihypertensive,alpha-2/imidazoline receptor agonist for high blood pressure,NA,NA,NA,NA
mycophenolic acid,2016,Total,Total,2255457,HPNSFSBZBAHARI-RUDMXATFSA-N,6.476208467500891e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,9.523835981618959
mycophenolic acid,2017,Total,Total,2364479,HPNSFSBZBAHARI-RUDMXATFSA-N,6.88244582547347e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.121243860990397
mycophenolic acid,2018,Total,Total,2429535,HPNSFSBZBAHARI-RUDMXATFSA-N,6.906248098324504e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.156247203418388
mycophenolic acid,2019,Total,Total,2551838.8,HPNSFSBZBAHARI-RUDMXATFSA-N,7.371550980651704e-7,immunosuppressant,"immunosuppressant used for organ transplantation, autoimmune conditions",low,high,6.8e-8,10.840516148017212
nabumetone,2016,Total,Total,394630,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1331212022795721e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2017,Total,Total,378785.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,1.1025560739701565e-7,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2018,Total,Total,335474.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,9.536269811553915e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nabumetone,2019,Total,Total,310164.5,BLXXJMDCKKHMKV-UHFFFAOYSA-N,8.959787836670347e-8,analgesic,NSAID for arthritis,low,NA,NA,NA
nalmefene,2016,Total,Total,468.90648,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.346395039338829e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2017,Total,Total,351.8172,WJBLNOPPDWQMCH-MBPVOVBZSA-N,1.0240576547602094e-10,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2018,Total,Total,325.60416,WJBLNOPPDWQMCH-MBPVOVBZSA-N,9.255693417903209e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
nalmefene,2019,Total,Total,290.92392,WJBLNOPPDWQMCH-MBPVOVBZSA-N,8.403981112643315e-11,other nervous system,opiate antagonist for opiate-induced depression,NA,NA,NA,NA
naloxegol,2016,Total,Total,1748.1625,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,5.01958795271536e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2017,Total,Total,2825.69,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,8.224923268331894e-10,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2018,Total,Total,3741.99,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.0637060722092626e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxegol,2019,Total,Total,4433.4825,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,1.280709513100011e-9,alimentary,opioid receptor antagonist for opioid-induced constipation,NA,NA,NA,NA
naloxone,2016,Total,Total,41013.1332,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.1776309657359104e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2017,Total,Total,44180.59196,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.2859937884923013e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2018,Total,Total,47347.738,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.3459169162924874e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naloxone,2019,Total,Total,49400.0052,UZHSEJADLWPNLE-GRGSLBFTSA-N,1.4270284501366594e-8,antidote,antidote for opioid overdoses,NA,NA,NA,NA
naltrexone,2016,Total,Total,7338.439,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.107123336425335e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2017,Total,Total,7045.358,DQCKKXVULJGBQN-XFWGSAIBSA-N,2.050739074276664e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2018,Total,Total,14907.313,DQCKKXVULJGBQN-XFWGSAIBSA-N,4.237584643043964e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
naltrexone,2019,Total,Total,25436.735,DQCKKXVULJGBQN-XFWGSAIBSA-N,7.347963704989027e-9,antidote,"antidote for opioid overdoses, alcoholism",NA,NA,NA,NA
nandrolone,2018,Total,Total,8.5,NPAGDVCDWIYMMC-IZPLOLCNSA-N,2.4162281603581873e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
nandrolone,2019,Total,Total,18,NPAGDVCDWIYMMC-IZPLOLCNSA-N,5.1996982588293064e-12,sex hormone,androgen for osteoporosis after menopause,NA,NA,NA,NA
naphazoline,2016,Total,Total,28.7736,CNIIGCLFLJGOGP-UHFFFAOYSA-N,8.261910200925295e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2017,Total,Total,21.1104,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.1447441213931325e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2018,Total,Total,21.5712,CNIIGCLFLJGOGP-UHFFFAOYSA-N,6.131875399143357e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naphazoline,2019,Total,Total,17.814,CNIIGCLFLJGOGP-UHFFFAOYSA-N,5.145968043488071e-12,antihistamine,vasoconstrictor for eye discomfort,NA,NA,NA,NA
naproxen,2016,Total,Total,11836198.075,CMWTZPSULFXXJA-VIFPVBQESA-N,3.398587789362987e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.2265725192908658
naproxen,2017,Total,Total,12952135.85,CMWTZPSULFXXJA-VIFPVBQESA-N,3.77006407381067e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.25133760492071133
naproxen,2018,Total,Total,13554028.4,CMWTZPSULFXXJA-VIFPVBQESA-N,3.8528970713381915e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.25685980475587944
naproxen,2019,Total,Total,14678428.375,CMWTZPSULFXXJA-VIFPVBQESA-N,4.2401888035465664e-6,analgesic,"NSAID for arthritis, gout, etc.",low,moderate,1.5e-5,0.2826792535697711
naratriptan,2016,Total,Total,313.875,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.012452610432576e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.012452610432576e-7
naratriptan,2017,Total,Total,330.645,AMKVXSZCKVJAGH-UHFFFAOYSA-N,9.624303281880175e-11,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,9.624303281880174e-7
naratriptan,2018,Total,Total,414.585,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.178508178661293e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.178508178661293e-6
naratriptan,2019,Total,Total,417.045,AMKVXSZCKVJAGH-UHFFFAOYSA-N,1.2047267557519268e-10,analgesic,antimigraine triptan selective 5-HT1 receptor subtype agonist,low,high,1e-4,1.2047267557519267e-6
nebivolol,2016,Total,Total,25.200000000000003,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,7.235804246368806e-12,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2017,Total,Total,47.4,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,1.3797032332595995e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2018,Total,Total,81.6,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,2.3195790339438596e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nebivolol,2019,Total,Total,109.65,KOHIRBRYDXPAMZ-UHFFFAOYSA-N,3.1674828560035196e-11,beta blocker,cardioselective beta blocker for hypertension,NA,NA,NA,NA
nelarabine,2017,Total,Total,7.5,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,2.1830747361702525e-12,antineoplastic,antimetabolite for leukaemia and lymphoma,low,high,1e-4,2.1830747361702525e-8
neomycin,2016,Total,Total,32200,PGBHMTALBVVCIT-VCIWKGPPSA-N,9.24574987036014e-9,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2017,Total,Total,40100,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.1672172922723617e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2018,Total,Total,36800,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0460846623668388e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neomycin,2019,Total,Total,35300,PGBHMTALBVVCIT-VCIWKGPPSA-N,1.0197186029815252e-8,antibacterial,aminoglycoside antibiotic,NA,NA,NA,NA
neostigmine,2016,Total,Total,120.3,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.45423512237368e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2017,Total,Total,118.1,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.4376150178894244e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2018,Total,Total,111.25,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.162416268704098e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
neostigmine,2019,Total,Total,117.525,ALWKGYPQUAPLQC-UHFFFAOYSA-N,3.394969654827302e-11,other nervous system,cholinergic muscle stimulant for anaesthesia reversal and urinary retention,low,NA,NA,NA
nepafenac,2016,Total,Total,271.246,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.788424438930766e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2017,Total,Total,299.604,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.720772310074031e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2018,Total,Total,273.159,QEFAQIPZVLVERP-UHFFFAOYSA-N,7.764876094768023e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
nepafenac,2019,Total,Total,301.9,QEFAQIPZVLVERP-UHFFFAOYSA-N,8.72104946855871e-11,analgesic,NSAID for ophthalmic pain,low,NA,NA,NA
netupitant,2016,Total,Total,1442.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,4.1424979310461407e-10,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2017,Total,Total,6062.4,WAXQNWCZJDTGBU-UHFFFAOYSA-N,1.7646229707411384e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2018,Total,Total,7616.7,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.165139415176495e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
netupitant,2019,Total,Total,8313,WAXQNWCZJDTGBU-UHFFFAOYSA-N,2.4013939792026683e-9,antiemetic,selective NK1 receptor antagonist used with palonosetron for chemotherapy-induced nausea and vomiting,NA,NA,NA,NA
nevirapine,2016,Total,Total,15546.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4.464031803866926e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,1.0381469311318433e-4
nevirapine,2017,Total,Total,12474.4,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.6310063318509604e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,8.444200771746419e-5
nevirapine,2018,Total,Total,10636.8,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.023639493658584e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.031719752694381e-5
nevirapine,2019,Total,Total,11765.6,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3.398753879671227e-9,antiviral,NNRTI antiviral for HIV,low,high,4.3e-5,7.904078789933086e-5
nicotine,2016,Total,Total,413358.859,SNICXCGAKADSCV-JTQLQIEISA-N,1.1868983282644304e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.4904538546547233
nicotine,2017,Total,Total,443459.232,SNICXCGAKADSCV-JTQLQIEISA-N,1.2908061945342172e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5333909894769492
nicotine,2018,Total,Total,452518.281,SNICXCGAKADSCV-JTQLQIEISA-N,1.2863381336812697e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5315446833393676
nicotine,2019,Total,Total,468355.722,SNICXCGAKADSCV-JTQLQIEISA-N,1.3529491289978573e-7,other nervous system,nicotinic acetylcholine receptor agonist used for smoking cessation treatments,low,low,2.42e-7,0.5590698880156435
nifedipine,2016,Total,Total,540610.2034,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.5522815894412792e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2017,Total,Total,574190.8116,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.6713352727267377e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2018,Total,Total,406169.141,HYIMSNHJOBLJNT-UHFFFAOYSA-N,1.1545850780619945e-7,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nifedipine,2019,Total,Total,319523.88,HYIMSNHJOBLJNT-UHFFFAOYSA-N,9.23015423605769e-8,antihypertensive,calcium channel blocker for hypertension and angina,low,moderate,NA,NA
nilotinib,2016,Total,Total,16940,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.864068410059031e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707955423303963
nilotinib,2017,Total,Total,16475.2,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.7955457191136206e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018444406611975463
nilotinib,2018,Total,Total,17110.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,4.8638388605873805e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.018707072540720696
nilotinib,2019,Total,Total,17972.4,HHZIURLSWUIHRB-UHFFFAOYSA-N,5.191725388165769e-9,antineoplastic,multiple kinase inhibitor for leukaemia,low,moderate,2.6e-7,0.019968174569868342
nimodipine,2016,Total,Total,1004.4,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.8839848353384235e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2017,Total,Total,1195.15,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.47880236124517e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2018,Total,Total,1105.75,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,3.1432285744894886e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nimodipine,2019,Total,Total,957.05,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,2.7646506770069927e-10,antihypertensive,calcium channel blocker for aneurysms,low,NA,NA,NA
nintedanib,2016,Total,Total,5280,CPMDPSXJELVGJG-UHFFFAOYSA-N,1.5160732706677494e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,3.9896665017572354e-4
nintedanib,2017,Total,Total,9339,CPMDPSXJELVGJG-UHFFFAOYSA-N,2.718364661479198e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,7.153591214418942e-4
nintedanib,2018,Total,Total,13311,CPMDPSXJELVGJG-UHFFFAOYSA-N,3.7838132991209215e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,9.957403418739267e-4
nintedanib,2019,Total,Total,19167,CPMDPSXJELVGJG-UHFFFAOYSA-N,5.536812029276741e-9,antineoplastic,"multiple kinase inhibitor for fibrosis, non-small cell lung cancer",low,moderate,3.8e-6,0.0014570557971780897
nitisinone,2016,Total,Total,304.62,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.746709085432006e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2017,Total,Total,293.09999999999997,OUBCNLGXQFSTLU-UHFFFAOYSA-N,8.531456068953345e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2018,Total,Total,317.58,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.027596931371212e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitisinone,2019,Total,Total,343.08,OUBCNLGXQFSTLU-UHFFFAOYSA-N,9.91062488132866e-11,metabolic,tyrosine breakdown inhibitor for hereditary tyrosinemia type 1,low,NA,NA,NA
nitrazepam,2016,Total,Total,25991.235,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.462995578625774e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2017,Total,Total,24605.77,KJONHKAYOJNZEC-UHFFFAOYSA-N,7.162164646802122e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2018,Total,Total,23234.9275,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.604810132868335e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrazepam,2019,Total,Total,22517.1975,KJONHKAYOJNZEC-UHFFFAOYSA-N,6.5045907019147564e-9,sedative,benzodiazepine for seizure disorders,low,NA,NA,NA
nitrofurantoin,2016,Total,Total,118891.905,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.4138037740391936e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2017,Total,Total,108327.375,NXFQHRVNIOXGAQ-YCRREMRBSA-N,3.1531567413085466e-8,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2018,Total,Total,25611.025,NXFQHRVNIOXGAQ-YCRREMRBSA-N,7.280244684780888e-9,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nitrofurantoin,2019,Total,Total,516.25,NXFQHRVNIOXGAQ-YCRREMRBSA-N,1.4913023478447943e-10,antibacterial,antibiotic for bladder infections,low,NA,NA,NA
nomegestrol acetate,2016,Total,Total,763.98,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1936546540241427e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2017,Total,Total,724.92,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.110072716992719e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2018,Total,Total,763.56,IIVBFTNIGYRNQY-YQLZSBIMSA-N,2.1705119695565852e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
nomegestrol acetate,2019,Total,Total,391.02,IIVBFTNIGYRNQY-YQLZSBIMSA-N,1.1295477850930195e-10,sex hormone,"progestin for birth control, menopause, gynaecological disorders",NA,NA,NA,NA
norelgestromin,2016,Total,Total,1316.304,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.7795706637747e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2017,Total,Total,1229.58,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.579020045466959e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2018,Total,Total,1179.954,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.354162450267394e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norelgestromin,2019,Total,Total,1153.602,ISHXLNHNDMZNMC-VTKCIJPMSA-N,3.332434617101115e-10,sex hormone,progestin for birth control,NA,NA,NA,NA
norepinephrine,2016,Total,Total,563.84,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.6189824866161062e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2017,Total,Total,608.43,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.7709975489707555e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2018,Total,Total,598.5500000000001,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.701451018096933e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norepinephrine,2019,Total,Total,625.4,SFLSHLFXELFNJZ-QMMMGPOBSA-N,1.8066062728176936e-10,cardiac,"adrenergic for hypotension during surgery, CPR",NA,NA,NA,NA
norethisterone,2016,Total,Total,11628.66711,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.338998367228066e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.677996734456132
norethisterone,2017,Total,Total,11288.048196,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.285687044981306e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.571374089962612
norethisterone,2018,Total,Total,11405.604126,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.242181397075145e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.4843627941502895
norethisterone,2019,Total,Total,11396.149746,VIKNJXKGJWUCNN-XGXHKTLJSA-N,3.292029999535235e-9,sex hormone,"progestin for birth control, menopause, gynaecological disorders with weak estrogenic and androgenic effects",low,high,5e-10,6.58405999907047
nortriptyline,2016,Total,Total,20790.865,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.969786875106372e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2017,Total,Total,20722.4,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.0318063883752604e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2018,Total,Total,20970.165,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,5.9610239059244294e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
nortriptyline,2019,Total,Total,22060.04,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,6.372530643205826e-9,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
noscapine,2016,Total,Total,230103.48,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.60707832415968e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2017,Total,Total,184830.55,AKNNEGZIBPJZJG-MSOLQXFVSA-N,5.3799853890327026e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2018,Total,Total,211380.54,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.008748391761414e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
noscapine,2019,Total,Total,220222.27,AKNNEGZIBPJZJG-MSOLQXFVSA-N,6.361607521524653e-8,respiratory,benzylisoquinoline alkaloid antitussive,low,NA,NA,NA
nystatin,2016,Total,Total,10140,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.911549803896019e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2017,Total,Total,7980,VQOXZBDYSJBXMA-RKEBNKJGSA-N,2.3227915192851486e-9,antifungal,topical antifungal,NA,NA,NA,NA
nystatin,2018,Total,Total,540,VQOXZBDYSJBXMA-RKEBNKJGSA-N,1.5350155371687308e-10,antifungal,topical antifungal,NA,NA,NA,NA
obeticholic acid,2017,Total,Total,5.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,1.615475304765987e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2018,Total,Total,29.55,ZXERDUOLZKYMJM-ZWECCWDJSA-N,8.399946133951109e-12,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
obeticholic acid,2019,Total,Total,73.5,ZXERDUOLZKYMJM-ZWECCWDJSA-N,2.1232101223553004e-11,metabolic,semi-synthetic bile acid analogue for liver autoimmune disorders,NA,NA,NA,NA
oclacitinib,2016,Total,Total,1577.108,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,4.528430461659608e-10,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2017,Total,Total,6505.176,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,1.893504717325474e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2018,Total,Total,7525.44,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.139197652598343e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
oclacitinib,2019,Total,Total,7460.288,HJWLJNBZVZDLAQ-UHFFFAOYSA-N,2.1550692513313983e-9,dermatological,veterinary Janus kinase inhibitor for canine dermatitis,NA,NA,NA,NA
ofloxacin,2016,Total,Total,9395,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.697634162485513e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2017,Total,Total,7144,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,2.079451455360038e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2018,Total,Total,6572,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.868170761161648e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
ofloxacin,2019,Total,Total,5720,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,1.6523485578057572e-9,antibacterial,fluoroquinolone antibiotic,NA,NA,NA,NA
olanzapine,2016,Total,Total,57957.4664,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6641622281186404e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015128747528351276
olanzapine,2017,Total,Total,57756.7583,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6811642651709542e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.015283311501554129
olanzapine,2018,Total,Total,57485.9054,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.6341066288372564e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01485551480761142
olanzapine,2019,Total,Total,59245.3109,KVWDHTXUZHCGIO-UHFFFAOYSA-N,1.7114318885029498e-8,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,low,1.1e-6,0.01555847171366318
olaparib,2016,Total,Total,2822.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,8.104100755933063e-10,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,2.532531486229082e-5
olaparib,2017,Total,Total,7750.4,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.2559603246951904e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.04987601467247e-5
olaparib,2018,Total,Total,8892.8,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.5278863275803867e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.899644773688709e-5
olaparib,2019,Total,Total,8372,FDLYAMZZIXQODN-UHFFFAOYSA-N,2.4184374346066086e-9,antineoplastic,"PARP inhibitor for ovarian, breast, prostate cancer",low,high,3.2e-5,7.557616983145652e-5
olmesartan medoxomil,2016,Total,Total,20498.5319,UQGKUQLKSCSZGY-UHFFFAOYSA-N,5.8858477843788265e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2017,Total,Total,21258.5905,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.187878912951858e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2018,Total,Total,21317.3982,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.0597291572245804e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olmesartan medoxomil,2019,Total,Total,22177.519,UQGKUQLKSCSZGY-UHFFFAOYSA-N,6.406467051636326e-9,antihypertensive,angiotensin II receptor blocker for high blood pressure,NA,NA,NA,NA
olodaterol,2016,Total,Total,3.993,COUYJEVMBVSIHV-SFHVURJKSA-N,1.1465304109424858e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2017,Total,Total,7.77735,COUYJEVMBVSIHV-SFHVURJKSA-N,2.263804839913829e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2018,Total,Total,10.5654,COUYJEVMBVSIHV-SFHVURJKSA-N,3.003343177111576e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olodaterol,2019,Total,Total,13.5762,COUYJEVMBVSIHV-SFHVURJKSA-N,3.9217857500843574e-12,respiratory,adrenergic bronchodilator for COPD symptoms,low,NA,NA,NA
olopatadine,2016,Total,Total,689.9449999999999,JBIMVDZLSHOPLA-LSCVHKIXSA-N,1.9810741907781447e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2017,Total,Total,754.46,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.1960567539346784e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2018,Total,Total,789.41,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.2439937318451255e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olopatadine,2019,Total,Total,870.375,JBIMVDZLSHOPLA-LSCVHKIXSA-N,2.514270762238088e-10,antihistamine,ophthalmic antihistamine for allergic eye irritation,low,NA,NA,NA
olsalazine,2016,Total,Total,79768.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2904335358193255e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2017,Total,Total,76207.5,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.2182222394225936e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2018,Total,Total,75384,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.1428816898875483e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
olsalazine,2019,Total,Total,69604,QQBDLJCYGRGAKP-UHFFFAOYSA-N,2.0106655422641947e-8,alimentary,5-aminosalicylate for ulcerative colitis,low,NA,NA,NA
ombitasvir,2016,Total,Total,641.9,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.8431201372000538e-10,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2017,Total,Total,158.2,PIDFDZJZLOTZTM-KHVQSSSXSA-N,4.604832310161786e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2018,Total,Total,80.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,2.28831019892746e-11,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
ombitasvir,2019,Total,Total,3.5,PIDFDZJZLOTZTM-KHVQSSSXSA-N,1.0110524392168097e-12,antiviral,antiviral taken with paritaprevir and ritonavir for hepatitis C,NA,NA,NA,NA
omeprazole,2016,Total,Total,271094.5404,SUBDBMMJDZJVOS-UHFFFAOYSA-N,7.78407550235603e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,7.784075502356031e-4
omeprazole,2017,Total,Total,276517.7992,SUBDBMMJDZJVOS-UHFFFAOYSA-N,8.048786953798919e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,8.04878695379892e-4
omeprazole,2018,Total,Total,283462.0087,SUBDBMMJDZJVOS-UHFFFAOYSA-N,8.057751621325149e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,8.05775162132515e-4
omeprazole,2019,Total,Total,300009.9856,SUBDBMMJDZJVOS-UHFFFAOYSA-N,8.666452220865141e-8,proton pump inhibitor,"proton pump inhibitor for stomach reflux and acid disorders, gastric ulcers",low,high,9.999999999999999e-5,8.666452220865142e-4
ondansetron,2016,Total,Total,10158.28,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.9167986333255283e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.114995729142276e-4
ondansetron,2017,Total,Total,9773.56,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.8448549224592172e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.890171632685055e-4
ondansetron,2018,Total,Total,9582.092,FELGMEQIXOGIFQ-UHFFFAOYSA-N,2.723825944181518e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,8.511956075567245e-4
ondansetron,2019,Total,Total,10485.448,FELGMEQIXOGIFQ-UHFFFAOYSA-N,3.028953650480291e-9,antiemetic,"5HT3 receptor antagonists for surgery, cancer treatment nausea",low,high,3.2e-6,9.46548015775091e-4
opium,2016,Total,Total,454.8,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.3058903854160843e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2017,Total,Total,436,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.2690941132936402e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2018,Total,Total,525.2,LGFMXOTUSSVQJV-NEYUFSEYSA-N,1.4929447409648472e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
opium,2019,Total,Total,709.5,LGFMXOTUSSVQJV-NEYUFSEYSA-N,2.0495477303552183e-10,analgesic,tincture of opiates taken for diarrhoea,NA,NA,NA,NA
osaterone acetate,2016,Total,Total,118.545,KKTIOMQDFOYCEN-OFUYBIASSA-N,3.4038429142293254e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2017,Total,Total,146.73749999999998,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.271185721317099e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2018,Total,Total,163.1175,KKTIOMQDFOYCEN-OFUYBIASSA-N,4.6368129052614894e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
osaterone acetate,2019,Total,Total,183.09375,KKTIOMQDFOYCEN-OFUYBIASSA-N,5.289068072652936e-11,sex hormone,antiandrogen and progestin for enlarged canine prostates,NA,NA,NA,NA
oseltamivir,2016,Total,Total,3850.05,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.105484449949691e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2017,Total,Total,3546.9,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.0324197042296358e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2018,Total,Total,6644.25,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.8887087005246924e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
oseltamivir,2019,Total,Total,5278.95,VSZGPKBBMSAYNT-RRFJBIMHSA-N,1.524941506858165e-9,antiviral,neuraminidase inhibitor for influenza,NA,NA,NA,NA
osimertinib,2017,Total,Total,9.6,DUYJMQONPNNFPI-UHFFFAOYSA-N,2.794335662297923e-12,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,3.725780883063897e-5
osimertinib,2018,Total,Total,120,DUYJMQONPNNFPI-UHFFFAOYSA-N,3.411145638152735e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,4.548194184203647e-4
osimertinib,2019,Total,Total,208.8,DUYJMQONPNNFPI-UHFFFAOYSA-N,6.031649980241996e-11,antineoplastic,tyrosine kinase inhibitor for non-small cell lung cancer,low,low,7.5e-8,8.042199973655995e-4
oxaliplatin,2016,Total,Total,1864.3,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.353059466867208e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2017,Total,Total,1898.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.526235387141378e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2018,Total,Total,1834.55,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.21493102539425e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxaliplatin,2019,Total,Total,1978.35,DRMCATBEKSVAPL-BNTLRKBRSA-N,5.714901694641644e-10,antineoplastic,alkylating agent for colon and rectal cancer,NA,NA,NA,NA
oxazepam,2016,Total,Total,541952.175,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5561348607911946e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2017,Total,Total,517128.355,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.5052397962103758e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2018,Total,Total,502380.275,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.428076903133518e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxazepam,2019,Total,Total,456991.805,ADIMAYPTOBDMTL-UHFFFAOYSA-N,1.320121940420979e-7,sedative,"benzodiazepine for anxiety disorders, alcohol withdrawal",NA,NA,NA,NA
oxcarbazepine,2016,Total,Total,952201.5,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.734104625832836e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021360192389319032
oxcarbazepine,2017,Total,Total,961171.05,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.79774431519098e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021857377462429533
oxcarbazepine,2018,Total,Total,958318.8,CTRLABGOLIVAIY-UHFFFAOYSA-N,2.724137495483137e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.021282324183462008
oxcarbazepine,2019,Total,Total,1066227,CTRLABGOLIVAIY-UHFFFAOYSA-N,3.0800325974537753e-7,anticonvulsant,dibenzazepine anticonvulsant for seizure conditions,low,high,1.28e-5,0.02406275466760762
oxfendazole,2016,Total,Total,160650,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.6128252070601145e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2017,Total,Total,149895,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.3630931677098666e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2018,Total,Total,157455,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.4758494704611585e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxfendazole,2019,Total,Total,145575,BEZZFPOZAYTVHN-UHFFFAOYSA-N,4.2052559668282024e-8,anthelminthic,benzimidazole treatment for parasitic worm infections,NA,NA,NA,NA
oxybuprocaine,2016,Total,Total,449.44,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.2904999446380936e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2017,Total,Total,468.12,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.362587927328025e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2018,Total,Total,482.52,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.3716216611012146e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybuprocaine,2019,Total,Total,531.92,CMHHMUWAYWTMGS-UHFFFAOYSA-N,1.5365686099091578e-10,anaesthetic,ester-type local anaesthetic,low,NA,NA,NA
oxybutynin,2016,Total,Total,369.9768,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0623332144833104e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2017,Total,Total,369.3288,XIQVNETUBQGFHX-UHFFFAOYSA-N,1.0750298301601012e-10,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2018,Total,Total,343.6828,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.769600701067656e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxybutynin,2019,Total,Total,341.0924,XIQVNETUBQGFHX-UHFFFAOYSA-N,9.853208657666163e-11,urological,urinary antispasmodic for overactive bladders,high,NA,NA,NA
oxyclozanide,2018,Total,Total,748,JYWIYHUXVMAGLG-UHFFFAOYSA-N,2.1262807811152047e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxyclozanide,2019,Total,Total,1496,JYWIYHUXVMAGLG-UHFFFAOYSA-N,4.3215269973381347e-10,anthelminthic,salicylanilide anthelmintic for liver flukes in animals,NA,NA,NA,NA
oxycodone,2016,Total,Total,329517.24381,BRUQQQPBMZOVGD-XFKAJCMBSA-N,9.461596317508505e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2017,Total,Total,358341.92017,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.0430495904451526e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2018,Total,Total,363479.17312,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.033233663289709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxycodone,2019,Total,Total,376641.07752,BRUQQQPBMZOVGD-XFKAJCMBSA-N,1.08801108610241e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
oxymetazoline,2016,Total,Total,781.9186,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2451626691249012e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2017,Total,Total,769.4276,WYWIFABBXFUGLM-UHFFFAOYSA-N,2.2396239398294808e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2018,Total,Total,679.2178,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9307590298547475e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxymetazoline,2019,Total,Total,681.5715,WYWIFABBXFUGLM-UHFFFAOYSA-N,1.9688700787875991e-10,antihistamine,"ophthalmic antihistamine for eye irritation, blepharoptosis",NA,NA,NA,NA
oxytetracycline,2016,Total,Total,109669.75,OWFJMIVZYSDULZ-PXOLEDIWSA-N,3.14900334423891e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2017,Total,Total,91133.35,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.6526788534341512e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2018,Total,Total,99164,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.8188570505148153e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
oxytetracycline,2019,Total,Total,78970.65,OWFJMIVZYSDULZ-PXOLEDIWSA-N,2.2812419516867697e-8,antibacterial,tetracycline antibiotic,NA,NA,NA,NA
palbociclib,2016,Total,Total,92.4,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.6531282236685623e-11,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2017,Total,Total,6135.15,AHJRHEGDXFFMBM-UHFFFAOYSA-N,1.7857987956819902e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2018,Total,Total,7519.575,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.137530455167696e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palbociclib,2019,Total,Total,7089.6,AHJRHEGDXFFMBM-UHFFFAOYSA-N,2.0479878208775703e-9,antineoplastic,selective cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
palifermin,2016,Total,Total,0.075,NA,2.1535131685621443e-14,antineoplastic,"treatment for chemotherapy-caused mouth sores, ulcers",NA,NA,NA,NA
paliperidone,2016,Total,Total,1382.118,PMXMIIMHBWHSKN-UHFFFAOYSA-N,3.9685457513423646e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.5874183005369458e-6
paliperidone,2017,Total,Total,1423.691,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.1440318056172836e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.6576127222469135e-6
paliperidone,2018,Total,Total,1506.598,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.2826876634580284e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.7130750653832113e-6
paliperidone,2019,Total,Total,1561.067,PMXMIIMHBWHSKN-UHFFFAOYSA-N,4.5094874232310496e-10,antipsychotic,atypical antipsychotic for schizophrenia,low,high,2.5e-4,1.8037949692924198e-6
pamidronic acid,2016,Total,Total,105.6,WRUUGTRCQOWXEG-UHFFFAOYSA-N,3.032146541335499e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2017,Total,Total,41.43000000000001,WRUUGTRCQOWXEG-UHFFFAOYSA-N,1.2059304842604478e-11,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2018,Total,Total,26.639999999999997,WRUUGTRCQOWXEG-UHFFFAOYSA-N,7.572743316699072e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
pamidronic acid,2019,Total,Total,14.25,WRUUGTRCQOWXEG-UHFFFAOYSA-N,4.116427788239868e-12,other musculoskeletal,"bisphosphonate for osteoporosis, cancer-associated fractures, hypercalcemia",NA,NA,NA,NA
panobinostat,2016,Total,Total,8.55,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.455005012160845e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2017,Total,Total,9.81,FPOHNWQLNRZRFC-ZHACJKMWSA-N,2.8554617549106904e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2018,Total,Total,4.05,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.151261652876548e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
panobinostat,2019,Total,Total,4.23,FPOHNWQLNRZRFC-ZHACJKMWSA-N,1.2219290908248873e-12,antineoplastic,non-selective histone deacetylase inhibitor for various cancers,NA,NA,NA,NA
pantoprazole,2016,Total,Total,1826878.9752,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.245610573950021e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.02017542528442316
pantoprazole,2017,Total,Total,1975594.656,IQPSEEYGBUAQFF-UHFFFAOYSA-N,5.750494376568748e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.022117286063725955
pantoprazole,2018,Total,Total,2154751.9728,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.125143994431435e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.023558246132428597
pantoprazole,2019,Total,Total,2363034.2632,IQPSEEYGBUAQFF-UHFFFAOYSA-N,6.826147302175019e-7,proton pump inhibitor,stomach acid product inhibitor for reflux disorders,low,high,2.6e-5,0.02625441270067315
papaverine,2016,Total,Total,90,XQYZDYMELSJDRZ-UHFFFAOYSA-N,2.5842158022745735e-11,vasodilator,"peripheral vasodilator for chest pain, circulation issues, heart attacks, etc.",low,NA,NA,NA
paracetamol,2016,Total,Total,258960351.165,RZVAJINKPMORJF-UHFFFAOYSA-N,7.435660351590731e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,8.08223951259862
paracetamol,2017,Total,Total,268387332.29,RZVAJINKPMORJF-UHFFFAOYSA-N,7.812128061739063e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,8.491443545368547
paracetamol,2018,Total,Total,279361699.96000004,RZVAJINKPMORJF-UHFFFAOYSA-N,7.941195369045727e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,8.631734096788835
paracetamol,2019,Total,Total,296495918.355,RZVAJINKPMORJF-UHFFFAOYSA-N,8.564940613447167e-5,analgesic,"minor pain relief, antipyretic",low,moderate,9.2e-6,9.309718058094747
parecoxib,2016,Total,Total,511.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.4689831160485242e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2017,Total,Total,679.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,1.9781567876017383e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2018,Total,Total,777.6,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.2104223735229722e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
parecoxib,2019,Total,Total,964.8,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,2.7870382667325083e-10,analgesic,COX-2 selective inhibitor for pain management,NA,NA,NA,NA
paritaprevir,2016,Total,Total,3851.4,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.1058720823200323e-9,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2017,Total,Total,949.2,UAUIUKWPKRJZJV-QPLHLKROSA-N,2.7628993860970716e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2018,Total,Total,483,UAUIUKWPKRJZJV-QPLHLKROSA-N,1.3729861193564758e-10,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paritaprevir,2019,Total,Total,21,UAUIUKWPKRJZJV-QPLHLKROSA-N,6.066314635300858e-12,antiviral,combination treatment for hepatitis C,NA,NA,NA,NA
paroxetine,2016,Total,Total,96786.6296,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.7790837517912887e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19850598227080632
paroxetine,2017,Total,Total,92756.0448,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.6999117070660822e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.19285083621900587
paroxetine,2018,Total,Total,89049.5236,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.531340783397659e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.18081005595697563
paroxetine,2019,Total,Total,86480.4608,AHOUBRCZNHFOSL-YOEHRIQHSA-N,2.4981794524695342e-8,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",low,high,1.4e-7,0.17844138946210958
pazopanib,2016,Total,Total,22512,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.463985126756133e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.0399907042225835e-4
pazopanib,2017,Total,Total,22806,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.638293657746504e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,4.148933536091565e-4
pazopanib,2018,Total,Total,16614,CUIHSIWYWATEQL-UHFFFAOYSA-N,4.7227311360224615e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,2.9517069600140384e-4
pazopanib,2019,Total,Total,20970,CUIHSIWYWATEQL-UHFFFAOYSA-N,6.057648471536143e-9,antineoplastic,"multiple tyrosine kinase inhibitor for carcinoma, sarcoma",low,high,1.6e-5,3.7860302947100895e-4
pemetrexed,2016,Total,Total,1646.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,4.726530702360195e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,3.938775585300162e-6
pemetrexed,2017,Total,Total,1209.8,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.5214450877583614e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.934537573131968e-6
pemetrexed,2018,Total,Total,1256.1,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,3.570616696736375e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,2.975513913946979e-6
pemetrexed,2019,Total,Total,2052.4,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,5.928811503567371e-10,antineoplastic,antimetabolite for lung cancer,low,low,1.2e-4,4.9406762529728095e-6
penciclovir,2016,Total,Total,602.44,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.7298166310247712e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2017,Total,Total,481.24,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.4007771813794298e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2018,Total,Total,379.14,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0777514643743568e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
penciclovir,2019,Total,Total,373.28,JNTOCHDNEULJHD-UHFFFAOYSA-N,1.0783018700310018e-10,antiviral,topical antiviral for cold sores,NA,NA,NA,NA
pentobarbital,2016,Total,Total,243500,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,6.99173942059843e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2017,Total,Total,254220,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.39975012572269e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2018,Total,Total,286010,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,8.130181366400533e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentobarbital,2019,Total,Total,260620,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,7.528585334533856e-8,sedative,"barbiturate for insomnia, seizure",NA,NA,NA,NA
pentoxifylline,2016,Total,Total,149479.2,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4.2920723416817944e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2017,Total,Total,134452.4,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.9135951687660967e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2018,Total,Total,121401.6,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.450987819206359e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
pentoxifylline,2019,Total,Total,116492,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,3.3651291642641314e-8,vasodilator,peripheral vasodilator for intermittent claudication,NA,NA,NA,NA
perampanel,2016,Total,Total,565.26064,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.6230616425464876e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2017,Total,Total,644.51352,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.8760282435095475e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2018,Total,Total,695.6502,PRMWGUBFXWROHD-UHFFFAOYSA-N,1.9774701211750648e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
perampanel,2019,Total,Total,782.96424,PRMWGUBFXWROHD-UHFFFAOYSA-N,2.2617654419186732e-10,anticonvulsant,AMPA receptor antagonist for seizures,NA,NA,NA,NA
pergolide,2016,Total,Total,54.68,YEHCICAEULNIGD-MZMPZRCHSA-N,1.5700546674263742e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2017,Total,Total,63.9,YEHCICAEULNIGD-MZMPZRCHSA-N,1.859979675217055e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2018,Total,Total,67.22,YEHCICAEULNIGD-MZMPZRCHSA-N,1.910810081638557e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
pergolide,2019,Total,Total,87.72,YEHCICAEULNIGD-MZMPZRCHSA-N,2.5339862848028156e-11,dopaminergic,ergoline-based dopamine receptor agonist for Parkinson's,NA,NA,NA,NA
perindopril,2016,Total,Total,34.35,IPVQLZZIHOAWMC-QXKUPLGCSA-N,9.86309031201462e-12,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2017,Total,Total,51.45,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.4975892690127932e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2018,Total,Total,61.5,IPVQLZZIHOAWMC-QXKUPLGCSA-N,1.7482121395532767e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perindopril,2019,Total,Total,84.75,IPVQLZZIHOAWMC-QXKUPLGCSA-N,2.4481912635321318e-11,antihypertensive,"angiotensin converting enzyme inhibitor for hypertension, coronary artery disease",NA,NA,NA,NA
perphenazine,2016,Total,Total,2466.96,RGCVKNLCSQQDEP-UHFFFAOYSA-N,7.08350779508809e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2017,Total,Total,2298.168,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.689430000366557e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2018,Total,Total,2226.756,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.329824180525361e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
perphenazine,2019,Total,Total,2184.558,RGCVKNLCSQQDEP-UHFFFAOYSA-N,6.310579127173128e-10,antipsychotic,"phenothiazine antipsychotic and antiemetic for schizophrenia, nausea",NA,NA,NA,NA
pethidine,2016,Total,Total,21194.6,XADCESSVHJOZHK-UHFFFAOYSA-N,6.0857133603209644e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2017,Total,Total,19139.9,XADCESSVHJOZHK-UHFFFAOYSA-N,5.571177619043336e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2018,Total,Total,18886.2,XADCESSVHJOZHK-UHFFFAOYSA-N,5.368631562606682e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
pethidine,2019,Total,Total,16755.7,XADCESSVHJOZHK-UHFFFAOYSA-N,4.840254673081457e-9,analgesic,phenylpiperidine opioid for pain management,low,NA,NA,NA
phenazone,2016,Total,Total,8277984,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.376899673752898e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2017,Total,Total,7763021,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.2596340028612176e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2018,Total,Total,7343160.5,VEQOALNAAJBPNY-UHFFFAOYSA-N,2.0873824924858714e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenazone,2019,Total,Total,6807970,VEQOALNAAJBPNY-UHFFFAOYSA-N,1.9666327641756753e-6,analgesic,NSAID and antipyretic used with caffeine for mild pain,low,NA,NA,NA
phenobarbital,2016,Total,Total,95350.60499999992,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.73785044663823e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2017,Total,Total,93540.9,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.7227570078483733e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2018,Total,Total,90399.6,DDBREPKUVSBGFI-UHFFFAOYSA-N,2.5697183435896e-8,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenobarbital,2019,Total,Total,28882.46,DDBREPKUVSBGFI-UHFFFAOYSA-N,8.343337609594841e-9,anticonvulsant,barbiturate for seizures,NA,NA,NA,NA
phenoxymethylpenicillin,2016,Total,Total,13360655.2,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.836312921842438e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2017,Total,Total,12987487.15,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.780354011133439e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2018,Total,Total,12311053.9,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.4995664843373515e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenoxymethylpenicillin,2019,Total,Total,12955160.4,BPLBGHOLXOTWMN-MBNYWOFBSA-N,3.7423847208185777e-6,antibacterial,penicillin beta-lactam antibiotic,low,NA,NA,NA
phenylbutazone,2018,Total,Total,736,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.0921693247336774e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylbutazone,2019,Total,Total,1024,VYMDGNCVAMGZFE-UHFFFAOYSA-N,2.958050565022895e-10,analgesic,NSAID for ankylosing spondylitis,NA,NA,NA,NA
phenylpropanolamine,2016,Total,Total,231900.7625,DLNKOYKMWOXYQA-VXNVDRBHSA-N,6.658684611244698e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2017,Total,Total,276868.0875,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.058983027640334e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2018,Total,Total,262740.8425,DLNKOYKMWOXYQA-VXNVDRBHSA-N,7.468727323820415e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenylpropanolamine,2019,Total,Total,279732.4,DLNKOYKMWOXYQA-VXNVDRBHSA-N,8.080689295656351e-8,urological,"selective norepinephrine releasing agent decongestant, and incontinence control in dogs",low,NA,NA,NA
phenytoin,2016,Total,Total,34721.4,CXOFVDLJLONNDW-UHFFFAOYSA-N,9.969732284121821e-9,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2017,Total,Total,101386.1,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.9511124467844112e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2018,Total,Total,100090.875,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.8452045972928387e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
phenytoin,2019,Total,Total,95765.575,CXOFVDLJLONNDW-UHFFFAOYSA-N,2.7664005199071523e-8,anticonvulsant,hydantoin anticonvulsant and group I antiarrhythmics,NA,NA,NA,NA
pibrentasvir,2017,Total,Total,3.36,VJYSBPDEJWLKKJ-NLIMODCCSA-N,9.78017481804273e-13,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2018,Total,Total,265.44,VJYSBPDEJWLKKJ-NLIMODCCSA-N,7.545454151593849e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pibrentasvir,2019,Total,Total,204.96,VJYSBPDEJWLKKJ-NLIMODCCSA-N,5.920723084053637e-11,antiviral,antiviral used in combination for hepatitis C,NA,NA,NA,NA
pilocarpine,2016,Total,Total,4093.357,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.175346427083471e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2017,Total,Total,3945.289,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.1483814323720534e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2018,Total,Total,3294.01,QCHFTSOMWOSFHM-WPRPVWTQSA-N,9.36362320294291e-10,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pilocarpine,2019,Total,Total,3521.756,QCHFTSOMWOSFHM-WPRPVWTQSA-N,1.0173371411789814e-9,ophthalmological,treatment for high eye pressure,NA,NA,NA,NA
pimecrolimus,2016,Total,Total,2820.3,KASDHRXLYQOAKZ-XDSKOBMDSA-N,8.098070919061089e-10,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2017,Total,Total,3484.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0143438454141463e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2018,Total,Total,3640.8,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.0349415866155399e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimecrolimus,2019,Total,Total,4461.6,KASDHRXLYQOAKZ-XDSKOBMDSA-N,1.2888318750884911e-9,dermatological,treatment for eczema,NA,NA,NA,NA
pimobendan,2016,Total,Total,2620.3125,GLBJJMFZWDBELO-UHFFFAOYSA-N,7.523836632663991e-10,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2017,Total,Total,3819.9125,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.1118872630841268e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2018,Total,Total,4348.78875,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.236195981317515e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pimobendan,2019,Total,Total,5381.145,GLBJJMFZWDBELO-UHFFFAOYSA-N,1.5544627937226683e-9,cardiac,veterinary cardiac stimulant used for heart failure in dogs,NA,NA,NA,NA
pioglitazone,2016,Total,Total,13208.934,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.792748441555765e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2017,Total,Total,11602.8321,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.377313283404698e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2018,Total,Total,13893.6366,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.949434823847433e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
pioglitazone,2019,Total,Total,11930.8368,HYAFETHFCAUJAY-UHFFFAOYSA-N,3.446486185296478e-9,anti-diabetic,thiazolidinedione for blood sugar control in type 2 diabetes,low,NA,NA,NA
piperacillin,2016,Total,Total,1429560,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.104768380332933e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2017,Total,Total,1165680,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.393022077945254e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2018,Total,Total,1198320,IVBHGBMCVLDMKU-GXNBUGAJSA-N,3.406370034259322e-7,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piperacillin,2019,Total,Total,141960,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4.10082869346338e-8,antibacterial,antipseudomonal penicillin antibiotic,NA,NA,NA,NA
piracetam,2016,Total,Total,108088.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.1036087223210664e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2017,Total,Total,109509.6,GMZVRMREEHBGGF-UHFFFAOYSA-N,3.187568548374798e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2018,Total,Total,103096.8,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.9306516635625412e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
piracetam,2019,Total,Total,99360,GMZVRMREEHBGGF-UHFFFAOYSA-N,2.8702334388737772e-8,other nervous system,racetam for involuntary spasms,low,NA,NA,NA
pirfenidone,2016,Total,Total,41245.092,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1842913168074289e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.1172559592522914e-5
pirfenidone,2017,Total,Total,39966.696,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.1633371243439557e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.0974878531546753e-5
pirfenidone,2018,Total,Total,47300.652,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.3445784395965037e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.2684702260344375e-5
pirfenidone,2019,Total,Total,60286.464,ISWRGOKTTBVCFA-UHFFFAOYSA-N,1.7415078993987538e-8,respiratory,treatment for idiopathic pulmonary fibrosis,low,high,0.00106,1.6429319805648622e-5
piroxicam,2016,Total,Total,32908.44,QYSPLQLAKJAUJT-UHFFFAOYSA-N,9.449167852911632e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2017,Total,Total,28692.1,QYSPLQLAKJAUJT-UHFFFAOYSA-N,8.351599818356068e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2018,Total,Total,26629.96,QYSPLQLAKJAUJT-UHFFFAOYSA-N,7.569889324848484e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
piroxicam,2019,Total,Total,21773.14,QYSPLQLAKJAUJT-UHFFFAOYSA-N,6.2896532304025965e-9,analgesic,NSAID for arthritis,low,NA,NA,NA
pitolisant,2018,Total,Total,73.71000000000001,NNACHAUCXXVJSP-UHFFFAOYSA-N,2.0952962082353174e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pitolisant,2019,Total,Total,238.95,NNACHAUCXXVJSP-UHFFFAOYSA-N,6.902599438595904e-11,other nervous system,"treatment for daytime sleepiness, cataplexy in narcolepsy",NA,NA,NA,NA
pivmecillinam,2016,Total,Total,1939166,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.568026022703973e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2017,Total,Total,1795218,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.225460082290785e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2018,Total,Total,1816464,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.163519375384559e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pivmecillinam,2019,Total,Total,1848556,NPGNOVNWUSPMDP-HLLBOEOZSA-N,5.339963008082483e-7,antibacterial,penicillin antibiotic,NA,NA,NA,NA
pixantrone,2018,Total,Total,0.928,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.637952626838116e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
pixantrone,2019,Total,Total,0.957,PEZPMAYDXJQYRV-UHFFFAOYSA-N,2.764506240944248e-13,antineoplastic,topoisomerase II poison and intercalating agent for lymphoma,NA,NA,NA,NA
plerixafor,2016,Total,Total,1.584,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.548219812003249e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2017,Total,Total,1.56,YIQPUIGJQJDJOS-UHFFFAOYSA-N,4.540795451234126e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2018,Total,Total,1.152,YIQPUIGJQJDJOS-UHFFFAOYSA-N,3.274699812626625e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
plerixafor,2019,Total,Total,1.752,YIQPUIGJQJDJOS-UHFFFAOYSA-N,5.061039638593859e-13,antineoplastic,"hematopoietic stem cell mobilizer for lymphoma, myeloma",low,NA,NA,NA
podophyllotoxin,2016,Total,Total,253.79,YJGVMLPVUAXIQN-XVVDYKMHSA-N,7.287201427325156e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2017,Total,Total,234.99,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.840009763368636e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2018,Total,Total,241.1675,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.85547888074333e-11,dermatological,topical treatment for warts,low,NA,NA,NA
podophyllotoxin,2019,Total,Total,221.865,YJGVMLPVUAXIQN-XVVDYKMHSA-N,6.409061412195355e-11,dermatological,topical treatment for warts,low,NA,NA,NA
pomalidomide,2016,Total,Total,41.265,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.1848629453428919e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2017,Total,Total,67.977,UVSMNLNDYGZFPF-UHFFFAOYSA-N,1.9786516178752705e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2018,Total,Total,73.815,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.098280960668701e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
pomalidomide,2019,Total,Total,78.246,UVSMNLNDYGZFPF-UHFFFAOYSA-N,2.2603088331130995e-11,antineoplastic,"immunosuppressant and antineoplastic for myeloma, sarcomas",NA,NA,NA,NA
ponatinib,2016,Total,Total,50.85,PHXJVRSECIGDHY-UHFFFAOYSA-N,1.460081928285134e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2017,Total,Total,92.25,PHXJVRSECIGDHY-UHFFFAOYSA-N,2.6851819254894103e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2018,Total,Total,119.7,PHXJVRSECIGDHY-UHFFFAOYSA-N,3.402617774057353e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
ponatinib,2019,Total,Total,145.35,PHXJVRSECIGDHY-UHFFFAOYSA-N,4.198756344004665e-11,antineoplastic,multiple tyrosine kinase inhibitor for leukaemia,NA,NA,NA,NA
posaconazole,2016,Total,Total,4580.1,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.3151074217775304e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.207579077506172e-4
posaconazole,2017,Total,Total,4315.2,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2560538802029162e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.0635460492754057e-4
posaconazole,2018,Total,Total,4299.6,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.2222134821501252e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,2.981008493049086e-4
posaconazole,2019,Total,Total,5096.7,RAGOYPUPXAKGKH-XAKZXMRKSA-N,1.472294561987518e-9,antifungal,azole systemic antifungal,low,low,4.1e-6,3.59096234631102e-4
potassium permanganate,2016,Total,Total,125805,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.6123029889461414e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2017,Total,Total,123675,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.5998902399447475e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2018,Total,Total,113475,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.2256645940781804e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
potassium permanganate,2019,Total,Total,109695,VZJVWSHVAAUDKD-UHFFFAOYSA-N,3.1687827805682274e-8,antiseptic,dermatological antiseptic,NA,NA,NA,NA
pradofloxacin,2016,Total,Total,173.46,LZLXHGFNOWILIY-APPDUMDISA-N,4.980645256250528e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2017,Total,Total,141.09,LZLXHGFNOWILIY-APPDUMDISA-N,4.1068001936834786e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pradofloxacin,2018,Total,Total,134.535,LZLXHGFNOWILIY-APPDUMDISA-N,3.8243206535739845e-11,antibacterial,veterinary fluoroquinolone antibiotic,NA,NA,NA,NA
pramipexole,2016,Total,Total,1579.1929008,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.5344169434302027e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.477738490614576e-6
pramipexole,2017,Total,Total,1642.4982564,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.780928597000707e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.8298979957152965e-6
pramipexole,2018,Total,Total,1668.3206548,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.742403937217611e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,6.774862767453731e-6
pramipexole,2019,Total,Total,1717.1190604,FASDKYOPVNHBLU-ZETCQYMHSA-N,4.960278326980276e-10,dopaminergic,antiparkinson agent and treatment for restless legs,low,high,7e-5,7.086111895686109e-6
prasterone,2019,Total,Total,206.388,FMGSKLZLMKYGDP-USOAJAOKSA-N,5.961974023573682e-11,sex hormone,androgen and estrogen for various gynaecological disorders and applications,NA,NA,NA,NA
prasugrel,2016,Total,Total,3764.3088,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.080865142844582e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.688763909708326e-5
prasugrel,2017,Total,Total,3945.018,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1483025506049195e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,6.043697634762734e-5
prasugrel,2018,Total,Total,3797.7856,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.0795666486732724e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.681929729859328e-5
prasugrel,2019,Total,Total,3890.2712,DTGLZDAWLRGWQN-UHFFFAOYSA-N,1.1237909102785442e-9,antithrombotic,platelet aggregation inhibitor for post cardiac surgery,low,low,1.9e-5,5.9146890014660216e-5
pravastatin,2016,Total,Total,178725.6696,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.131841107249159e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2017,Total,Total,172430.986,TUZYXOIXSAXUGO-PZAWKZKUSA-N,5.01906305692702e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2018,Total,Total,167017.8404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.74768481478458e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
pravastatin,2019,Total,Total,160755.9404,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4.6437910188574885e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",NA,NA,NA,NA
praziquantel,2016,Total,Total,38681.070297,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.1106692567822336e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2017,Total,Total,42742.837181,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2441441066943952e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2018,Total,Total,44943.927322,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.2775856803824488e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
praziquantel,2019,Total,Total,45877.980674,FSVJFNAIGNNGKK-UHFFFAOYSA-N,1.3252869790511244e-8,anthelminthic,"treatment for liver flukes, schistosoma worms",NA,NA,NA,NA
prednisone,2016,Total,Total,409.723,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1764585012837168e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2017,Total,Total,378.1,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.1005607436612966e-10,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
prednisone,2018,Total,Total,3.58,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,1.017658448715566e-12,steroid,corticosteroid and immunosuppressant for many immune and allergic disorders,NA,NA,NA,NA
pregabalin,2016,Total,Total,1791066.915,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.1427815829713e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2017,Total,Total,1945696.37,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.663467452806891e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2018,Total,Total,1993165.606,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.66581513585246e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
pregabalin,2019,Total,Total,1993225.119,AYXYPKUFHZROOJ-ZETCQYMHSA-N,5.757871767066187e-7,anticonvulsant,"gamma-aminobutyric acid analogue for seizure, nerve pain",NA,NA,NA,NA
prilocaine,2016,Total,Total,14261.4,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.094948360284289e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2017,Total,Total,14974.2,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.358639695248079e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2018,Total,Total,15573.6,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.426984809194619e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
prilocaine,2019,Total,Total,15255,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4.4067442743578375e-9,anaesthetic,amino amide local anaesthetic for dental surgery,NA,NA,NA,NA
probenecid,2016,Total,Total,389706,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1189826704902389e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2017,Total,Total,389573.5,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.1339574209752294e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2018,Total,Total,368371,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.047139274893301e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
probenecid,2019,Total,Total,363917.75,DBABZHXKTCFAPX-UHFFFAOYSA-N,1.0512569394622663e-7,antigout,treatment for gout and gouty arthritis,NA,NA,NA,NA
procaine,2016,Total,Total,1895397.839720175,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.442352276668849e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2017,Total,Total,1880531.9541237105,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.473789066144465e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2018,Total,Total,1809090.6423749097,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.142559711466751e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
procaine,2019,Total,Total,1847522.5354660428,MFDFERRIHVXMIY-UHFFFAOYSA-N,5.336977617117049e-7,anaesthetic,amino ester anaesthetic for dental procedures,NA,NA,NA,NA
prochlorperazine,2016,Total,Total,9142.84000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.625230178407565e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2017,Total,Total,8558.645,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.4912215567133136e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2018,Total,Total,8061.03000000001,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.291445610293198e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
prochlorperazine,2019,Total,Total,7872.605,WIKYUJGCLQQFNW-UHFFFAOYSA-N,2.2741761394972713e-9,antipsychotic,phenothiazine antipsychotic and antiemetic,NA,NA,NA,NA
progesterone,2016,Total,Total,64790.45,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.8603611636275623e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2017,Total,Total,67266.2,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.9579618909090063e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2018,Total,Total,69560.4,RJKFOVLPORLFTN-LEKSSAKUSA-N,1.9773387920679963e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
progesterone,2019,Total,Total,88798.8,RJKFOVLPORLFTN-LEKSSAKUSA-N,2.5651498097007324e-8,sex hormone,progestin for hormone replacement therapy,NA,NA,NA,NA
proguanil,2016,Total,Total,92181.6,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.6468571933217093e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005293714386643418
proguanil,2017,Total,Total,97745.7,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.845148909857022e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005690297819714044
proguanil,2018,Total,Total,96136.5,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.7327966886855868e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005465593377371173
proguanil,2019,Total,Total,97569,SSOLNOMRVKKSON-UHFFFAOYSA-N,2.8184964411984258e-8,antiparasitic,biguanide dihydrofolate reductase inhibiting antimalarial,low,high,5e-6,0.005636992882396851
promethazine,2016,Total,Total,59833.65,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.7180340426418446e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2017,Total,Total,56488.675,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.6442533236297622e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2018,Total,Total,54111.375,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.5381815067141412e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
promethazine,2019,Total,Total,54277.4,PWWVAXIEGOYWEE-UHFFFAOYSA-N,1.567922790409899e-8,antihistamine,"phenothiazine antihistamine for allergies, sleep aid",high,NA,NA,NA
propentofylline,2016,Total,Total,22908,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.577690622056214e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2017,Total,Total,23214,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.757052923394166e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2018,Total,Total,23299,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.6230235186100484e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propentofylline,2019,Total,Total,23473,RBQOQRRFDPXAGN-UHFFFAOYSA-N,6.780695401638906e-9,other nervous system,phosphodiesterase inhibitor stimulant for elderly dogs,NA,NA,NA,NA
propofol,2016,Total,Total,289961.1,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.325800629610196e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2017,Total,Total,307809,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.959600686211058e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2018,Total,Total,305307,OLBCVFGFOZPWHH-UHFFFAOYSA-N,8.678722011229142e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propofol,2019,Total,Total,332157,OLBCVFGFOZPWHH-UHFFFAOYSA-N,9.595089858655366e-8,anaesthetic,general anaesthetic for surgery,NA,NA,NA,NA
propranolol,2016,Total,Total,80145.38,AQHHHDLHHXJYJD-UHFFFAOYSA-N,2.3012550830588952e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.10005456882864762
propranolol,2017,Total,Total,144543.47999999998,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4.2073229262150694e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.1829270837484813
propranolol,2018,Total,Total,206155.41,AQHHHDLHHXJYJD-UHFFFAOYSA-N,5.8602177300257395e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.25479207521851044
propranolol,2019,Total,Total,226062.42,AQHHHDLHHXJYJD-UHFFFAOYSA-N,6.530313175892996e-8,beta blocker,non-cardioselective beta blocker and group II antiarrhythmic for heart failure and hypertension,low,low,2.3e-7,0.2839266598214346
propylthiouracil,2016,Total,Total,22577.6,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482821188603823e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2017,Total,Total,19912.7,KNAHARQHSZJURB-UHFFFAOYSA-N,5.796121639858319e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2018,Total,Total,21872.3,KNAHARQHSZJURB-UHFFFAOYSA-N,6.217466728447339e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
propylthiouracil,2019,Total,Total,22440,KNAHARQHSZJURB-UHFFFAOYSA-N,6.482290496007202e-9,antithyroid,"treatment for hyperthyroidism, Graves' disease, goitre",NA,NA,NA,NA
proxymetacaine,2016,Total,Total,394.275,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.1321018727131192e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2017,Total,Total,376.725,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.096558439978318e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2018,Total,Total,375.45,KCLANYCVBBTKTO-UHFFFAOYSA-N,1.0672621915370369e-10,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
proxymetacaine,2019,Total,Total,334.35,KCLANYCVBBTKTO-UHFFFAOYSA-N,9.658439515775437e-11,anaesthetic,topical aminoester anaesthetic for eye surgery,NA,NA,NA,NA
prucalopride,2016,Total,Total,121.4864,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.4883008293494413e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2017,Total,Total,136.16176,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3.9633506438463625e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2018,Total,Total,146.34536,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.1600444702324305e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
prucalopride,2019,Total,Total,171.09511999999998,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,4.9424610975455065e-11,alimentary,5-HT4 receptor agonist for chronic constipation,NA,NA,NA,NA
pyrantel,2016,Total,Total,12345.304542809828,YSAUAVHXTIETRK-AATRIKPKSA-N,3.544770120380137e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2017,Total,Total,16631.893990675977,YSAUAVHXTIETRK-AATRIKPKSA-N,4.8411556780942094e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2018,Total,Total,32461.605806916097,YSAUAVHXTIETRK-AATRIKPKSA-N,9.227605421307946e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrantel,2019,Total,Total,23870.71177254078,YSAUAVHXTIETRK-AATRIKPKSA-N,6.895583246705363e-9,anthelminthic,veterinary treatment for pinworm infection,NA,NA,NA,NA
pyrazinamide,2016,Total,Total,15432,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.431068695633469e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2017,Total,Total,16368,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.764342304217959e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2018,Total,Total,14496,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4.120663930888504e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyrazinamide,2019,Total,Total,12624,IPEHBUMCGVEMRF-UHFFFAOYSA-N,3.646721712192287e-9,antibacterial,antimycobacterial for tuberculosis,NA,NA,NA,NA
pyridostigmine,2016,Total,Total,39028.42,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.1206428855756556e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2017,Total,Total,43240.814999999995,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2586390773054892e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2018,Total,Total,43505.77,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.2367043130831344e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyridostigmine,2019,Total,Total,46642.03,RVOLLAQWKVFTGE-UHFFFAOYSA-N,1.347358234329246e-8,other nervous system,cholinergic muscle stimulant for myasthenia gravis and nerve gas exposure,low,NA,NA,NA
pyrvinium,2016,Total,Total,1437.2,QMHSXPLYMTVAMK-UHFFFAOYSA-N,4.126705501143352e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2017,Total,Total,2412.8,QMHSXPLYMTVAMK-UHFFFAOYSA-N,7.023096964575448e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2018,Total,Total,1334,QMHSXPLYMTVAMK-UHFFFAOYSA-N,3.792056901079791e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
pyrvinium,2019,Total,Total,2815.6,QMHSXPLYMTVAMK-UHFFFAOYSA-N,8.133483565310996e-10,anthelminthic,treatment for pinworm infection,NA,NA,NA,NA
quetiapine,2016,Total,Total,2024105.925,URKOMYMAXPYINW-UHFFFAOYSA-N,5.811918352069548e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.058119183520695485
quetiapine,2017,Total,Total,2167664.5,URKOMYMAXPYINW-UHFFFAOYSA-N,6.30956480859083e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06309564808590831
quetiapine,2018,Total,Total,2235867.525,URKOMYMAXPYINW-UHFFFAOYSA-N,6.355724796159251e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06355724796159251
quetiapine,2019,Total,Total,2349528.8000000003,URKOMYMAXPYINW-UHFFFAOYSA-N,6.78713378357184e-7,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder, depression",low,moderate,9.999999999999999e-6,0.06787133783571841
quinagolide,2016,Total,Total,4.388625,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.260128230584139e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2017,Total,Total,3.9095775,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,1.1379866492466208e-12,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2018,Total,Total,3.453975,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,9.818343129615491e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinagolide,2019,Total,Total,3.0753,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,8.883684475209872e-13,dopaminergic,selective dopamine D2 receptor agonist for hyperprolactinemia,NA,NA,NA,NA
quinine,2016,Total,Total,8640.39999999999,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.480962024219244e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2017,Total,Total,7407.3,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.1560919324311883e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2018,Total,Total,7110.7,LOUPRKONTZGTKE-WZBLMQSHSA-N,2.021302774101054e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
quinine,2019,Total,Total,5907.6,LOUPRKONTZGTKE-WZBLMQSHSA-N,1.7065409685477783e-9,antiprotozoal,quinoline antimalarial,low,NA,NA,NA
raloxifene,2016,Total,Total,5740.56,GZUITABIAKMVPG-UHFFFAOYSA-N,1.648316207322814e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2017,Total,Total,4662,GZUITABIAKMVPG-UHFFFAOYSA-N,1.356999256003429e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2018,Total,Total,4193.28,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1919907317960915e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raloxifene,2019,Total,Total,3911.04,GZUITABIAKMVPG-UHFFFAOYSA-N,1.1297904376784318e-9,sex hormone,selective estrogen receptor modulator for osteoporosis after menopause,NA,NA,NA,NA
raltegravir,2016,Total,Total,82722,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.3752388843973032e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,6.250628643150798e-5
raltegravir,2017,Total,Total,66102,CZFFBEXEKNGXKS-UHFFFAOYSA-N,1.9240747494710138e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.0633546038710884e-5
raltegravir,2018,Total,Total,77430,CZFFBEXEKNGXKS-UHFFFAOYSA-N,2.201041723018052e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,5.7922150605738206e-5
raltegravir,2019,Total,Total,132873,CZFFBEXEKNGXKS-UHFFFAOYSA-N,3.8383305930301476e-8,antiviral,"integrase-inhibiting antiretroviral for HIV, often in combination",low,high,3.8e-4,1.0100869981658282e-4
raltitrexed,2016,Total,Total,0.08,IVTVGDXNLFLDRM-HNNXBMFYSA-N,2.2970807131329543e-14,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2017,Total,Total,0.012,IVTVGDXNLFLDRM-HNNXBMFYSA-N,3.4929195778724047e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
raltitrexed,2018,Total,Total,0.006,IVTVGDXNLFLDRM-HNNXBMFYSA-N,1.7055728190763676e-15,antineoplastic,antimetabolite cytostatic,NA,NA,NA,NA
ramipril,2016,Total,Total,138640.30915,HDACQVRGBOVJII-JBDAPHQKSA-N,3.98084975264069e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,3.9808497526406904e-4
ramipril,2017,Total,Total,140762.69305,HDACQVRGBOVJII-JBDAPHQKSA-N,4.097273053236573e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0972730532365734e-4
ramipril,2018,Total,Total,143805.1765,HDACQVRGBOVJII-JBDAPHQKSA-N,4.0878366713479934e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.0878366713479935e-4
ramipril,2019,Total,Total,146951.5148,HDACQVRGBOVJII-JBDAPHQKSA-N,4.245019642432717e-8,antihypertensive,angiotensin converting enzyme inhibitor for hypertension and congestive heart failure,low,high,9.999999999999999e-5,4.2450196424327174e-4
ranitidine,2016,Total,Total,1062701.285,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.051388281993883e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.04921594003215941
ranitidine,2017,Total,Total,1466133.64,VMXUWOKSQNHOCA-UKTHLTGXSA-N,4.267572412444443e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.06883181310394262
ranitidine,2018,Total,Total,1792520.525,VMXUWOKSQNHOCA-UKTHLTGXSA-N,5.095457141794167e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.08218479260958333
ranitidine,2019,Total,Total,1234937.17,VMXUWOKSQNHOCA-UKTHLTGXSA-N,3.5673892514514393e-7,alimentary,"histamine-2 blocker for stomach acid disorders, ulcers",low,high,6.2e-6,0.057538536313732895
rasagiline,2016,Total,Total,654.68592,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8798329999896302e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2017,Total,Total,657.60604,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.9141375097026192e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2018,Total,Total,636.54976,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.8094699477426418e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
rasagiline,2019,Total,Total,603.1502399999999,RUOKEQAAGRXIBM-GFCCVEGCSA-N,1.7423329181891542e-10,dopaminergic,antiparkinson agent,low,NA,NA,NA
reboxetine,2016,Total,Total,458.3568,CBQGYUDMJHNJBX-RTBURBONSA-N,1.3161032062666736e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2017,Total,Total,415.8912,CBQGYUDMJHNJBX-RTBURBONSA-N,1.2105620956207064e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2018,Total,Total,400.032,CBQGYUDMJHNJBX-RTBURBONSA-N,1.1371395099345956e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
reboxetine,2019,Total,Total,366.5136,CBQGYUDMJHNJBX-RTBURBONSA-N,1.0587556265318115e-10,antidepressant,norepinephrine reuptake inhibitor for depression,NA,NA,NA,NA
regorafenib,2016,Total,Total,594.72,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.7076498021430383e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2017,Total,Total,769.4399999999999,FNHKPVJBJVTLMP-UHFFFAOYSA-N,2.239660033331785e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2018,Total,Total,584.64,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.6619101549080123e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
regorafenib,2019,Total,Total,665.28,FNHKPVJBJVTLMP-UHFFFAOYSA-N,1.9218084764633115e-10,antineoplastic,multiple tyrosine kinase inhibitor for various cancers,NA,NA,NA,NA
remifentanil,2016,Total,Total,427.1749999999999,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2265693170407118e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2017,Total,Total,393.86,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.1464344207840208e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2018,Total,Total,452.21,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.2854618075242068e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
remifentanil,2019,Total,Total,475.56,ZTVQQQVZCWLTDF-UHFFFAOYSA-N,1.373760279982703e-10,analgesic,opioid for surgical pain,NA,NA,NA,NA
repaglinide,2016,Total,Total,223.8552,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.427668280681501e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2017,Total,Total,209.0634,FAEKWTJYAYMJKF-QHCPKHFHSA-N,6.085347023971414e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2018,Total,Total,175.029,FAEKWTJYAYMJKF-QHCPKHFHSA-N,4.975411749168626e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
repaglinide,2019,Total,Total,132.615,FAEKWTJYAYMJKF-QHCPKHFHSA-N,3.8308776921924916e-11,anti-diabetic,meglitinide for type 2 diabetes blood sugar control,low,high,NA,NA
retapamulin,2016,Total,Total,115.25,STZYTFJPGGDRJD-FJJJPKKESA-N,3.3092319023571617e-11,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retapamulin,2017,Total,Total,29.7,STZYTFJPGGDRJD-FJJJPKKESA-N,8.644975955234199e-12,antibacterial,topical antibiotic for impetigo,low,high,NA,NA
retigabine,2016,Total,Total,583.254,PCOBBVZJEWWZFR-UHFFFAOYSA-N,1.6747268928220602e-10,anticonvulsant,potassium channel opener for partial epilepsies,low,high,3.2e-6,5.2335215400689384e-5
ribavirin,2016,Total,Total,70760.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,2.0317908615732298e-8,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.002944624437062652
ribavirin,2017,Total,Total,31796.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,9.255305436141105e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,0.0013413486139334935
ribavirin,2018,Total,Total,6628.8,IWUCXVSUMQZMFG-AFCXAGJDSA-N,1.884316850515571e-9,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,2.730893986254451e-4
ribavirin,2019,Total,Total,2826.4,IWUCXVSUMQZMFG-AFCXAGJDSA-N,8.164681754863973e-10,antiviral,"purine nucleoside for hepatitis C, in combination with interferon",low,NA,6.9e-6,1.1832872108498512e-4
ribociclib,2018,Total,Total,7593.6,RHXHGRAEPCAFML-UHFFFAOYSA-N,2.1585729598230502e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
ribociclib,2019,Total,Total,20668.2,RHXHGRAEPCAFML-UHFFFAOYSA-N,5.970466864063105e-9,antineoplastic,cyclin-dependent kinase inhibitor for breast cancer,NA,NA,NA,NA
rifampicin,2016,Total,Total,55719,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5998880031881885e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2017,Total,Total,54300,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.580546108987263e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2018,Total,Total,53874,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5314338342486704e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifampicin,2019,Total,Total,51981,JQXXHWHPUNPDRT-WLSIYKJHSA-N,1.5015861955122566e-8,antibacterial,"antibiotic for tuberculosis, leprosy, Legionnaires'",high,NA,NA,NA
rifaximin,2016,Total,Total,48192.144,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.3837655563365753e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2017,Total,Total,66513.524,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,1.9360532514407172e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2018,Total,Total,87425.492,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.4851757141596402e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rifaximin,2019,Total,Total,102902.184,NZCRJKRKKOLAOJ-XRCRFVBUSA-N,2.972557260969627e-8,antibacterial,"antibiotic for traveller's diarrhoea, IBS, liver failure",NA,NA,NA,NA
rilpivirine,2016,Total,Total,5196,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.4919539231798536e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,7.459769615899268e-4
rilpivirine,2017,Total,Total,6089.25,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.772438378296628e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.86219189148314e-4
rilpivirine,2018,Total,Total,6192.75,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7603643458891961e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.801821729445981e-4
rilpivirine,2019,Total,Total,5976,YIBOMRUWOWDFLG-ONEGZZNKSA-N,1.7262998219313296e-9,antiviral,NNRTI antiviral for HIV,low,high,2e-6,8.631499109656648e-4
riluzole,2016,Total,Total,8909.74,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.5582989891286512e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2017,Total,Total,9853.592,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.868150367430575e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2018,Total,Total,9749.6,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.771442126144492e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
riluzole,2019,Total,Total,9594.872,FTALBRSUTCGOEG-UHFFFAOYSA-N,2.7716910684494483e-9,other nervous system,sodium channel blocker for amyotrophic lateral sclerosis,low,high,NA,NA
rimexolone,2016,Total,Total,231.15,QTTRZHGPGKRAFB-OOKHYKNYSA-N,6.63712758550853e-11,steroid,ophthalmic steroid for eye swelling,low,NA,NA,NA
riociguat,2016,Total,Total,32.361,WXXSNCNJFUAIDG-UHFFFAOYSA-N,9.29197861971194e-12,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,3.0973262065706466e-5
riociguat,2017,Total,Total,41.349,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.203572763545384e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.011909211817947e-5
riociguat,2018,Total,Total,52.395,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.489391464258438e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,4.964638214194793e-5
riociguat,2019,Total,Total,58.695,WXXSNCNJFUAIDG-UHFFFAOYSA-N,1.69553494056659e-11,antihypertensive,vasodilator for chronic hypertension conditions,low,high,3e-7,5.6517831352219665e-5
risedronic acid,2016,Total,Total,490.4844,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.4083528191657364e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2017,Total,Total,432.6042000000001,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.2592097330415243e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2018,Total,Total,402.9018,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.1452972647282379e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risedronic acid,2019,Total,Total,369.0666,IIDJRNMFWXDHID-UHFFFAOYSA-N,1.0661305318955846e-10,other musculoskeletal,"bisphosphonate for osteoporosis, Paget's disease",NA,NA,NA,NA
risperidone,2016,Total,Total,5740.854,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.6484006250390214e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.8420700431707266e-4
risperidone,2017,Total,Total,5595.1026,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.628603617645399e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.807937271802412e-4
risperidone,2018,Total,Total,5455.5387,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5508030866898703e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.673798425327362e-4
risperidone,2019,Total,Total,5474.955199999999,RAPZEAPATHNIPO-UHFFFAOYSA-N,1.5815619455893587e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",low,high,5.8e-6,2.726830940671308e-4
ritonavir,2016,Total,Total,28187.6,NCDNCNXCDXHOMX-XGKFQTDJSA-N,8.093649038688306e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.005395766025792204
ritonavir,2017,Total,Total,17255.8,NCDNCNXCDXHOMX-XGKFQTDJSA-N,5.022760137654219e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0033485067584361457
ritonavir,2018,Total,Total,11269.3,NCDNCNXCDXHOMX-XGKFQTDJSA-N,3.203435295002884e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0021356235300019227
ritonavir,2019,Total,Total,8426,NCDNCNXCDXHOMX-XGKFQTDJSA-N,2.4340365293830966e-9,antiviral,protease inhibitor for HIV,high,high,1.5e-6,0.0016226910195887311
rivaroxaban,2016,Total,Total,169070.3082,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,4.854601801620805e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.005644885815838145
rivaroxaban,2017,Total,Total,184161.8191,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.3605201952582177e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006233163017742113
rivaroxaban,2018,Total,Total,194185.2613,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.5199517256420345e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.006418548518188412
rivaroxaban,2019,Total,Total,197577.293,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,5.7074572577572665e-8,antithrombotic,"Factor Xa inhibitor for clotting reduction for strokes, atrial fibrillation, DVT",high,moderate,8.6e-6,0.0066365782066944955
rivastigmine,2016,Total,Total,14043.4674,XSVMFMHYUFZWBK-NSHDSACASA-N,4.032372263756424e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.064744527512848e-5
rivastigmine,2017,Total,Total,14294.810880000001,XSVMFMHYUFZWBK-NSHDSACASA-N,4.160885398727954e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,8.321770797455908e-5
rivastigmine,2018,Total,Total,13959.97764,XSVMFMHYUFZWBK-NSHDSACASA-N,3.968293069616309e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.936586139232617e-5
rivastigmine,2019,Total,Total,13529.56272,XSVMFMHYUFZWBK-NSHDSACASA-N,3.908313539883661e-9,other nervous system,"cholinesterase inhibitor for dementia with Alzheimer's, Parkinson's",low,high,5e-5,7.816627079767322e-5
rizatriptan,2016,Total,Total,13631.64,ULFRLSNUDGIQQP-UHFFFAOYSA-N,3.914122166546462e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.077210590152564e-6
rizatriptan,2017,Total,Total,14095.38,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.102835729962594e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.273787218711035e-6
rizatriptan,2018,Total,Total,14536.35,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.132133908096793e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.304306154267493e-6
rizatriptan,2019,Total,Total,15653.52,ULFRLSNUDGIQQP-UHFFFAOYSA-N,4.521865593808318e-9,analgesic,"antimigraine agent, narrows blood vessels around brain",low,moderate,9.6e-4,4.710276660216998e-6
robenacoxib,2016,Total,Total,20767.56,ZEXGDYFACFXQPF-UHFFFAOYSA-N,5.963095191853927e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2017,Total,Total,26627.086,ZEXGDYFACFXQPF-UHFFFAOYSA-N,7.750522499257684e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2018,Total,Total,31275.343,ZEXGDYFACFXQPF-UHFFFAOYSA-N,8.890395821348391e-9,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
robenacoxib,2019,Total,Total,38554.181,ZEXGDYFACFXQPF-UHFFFAOYSA-N,1.1137228212016108e-8,analgesic,veterinary NSAID COX-2 inhibitor,NA,NA,NA,NA
rocuronium bromide,2016,Total,Total,4201,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.2062545094839426e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2017,Total,Total,5250.5,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.5282978536349215e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2018,Total,Total,5285,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.502325391469767e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
rocuronium bromide,2019,Total,Total,6153,OYTJKRAYGYRUJK-FMCCZJBLSA-M,1.7774301881431511e-9,muscle relaxant,neuromuscular blocking agent for surgery and intubation,low,NA,NA,NA
roflumilast,2016,Total,Total,136.6287,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.923089395380356e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.670344518309948e-4
roflumilast,2017,Total,Total,141.20925,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.1102712825139894e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.89318009823094e-4
roflumilast,2018,Total,Total,145.1148,MNDBXUUTURYVHR-UHFFFAOYSA-N,4.125064308761721e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.910790843763954e-4
roflumilast,2019,Total,Total,136.0363,MNDBXUUTURYVHR-UHFFFAOYSA-N,3.929709512486563e-11,respiratory,selective phosphodiesterase-4 inhibitors for COPD-associated inflammation,low,high,8.4e-8,4.678225610103051e-4
romifidine,2016,Total,Total,74.6,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.1420277649964795e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2017,Total,Total,76.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,2.223825464578764e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2018,Total,Total,49.2,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.3985697116426216e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
romifidine,2019,Total,Total,51.4,KDPNLRQZHDJRFU-UHFFFAOYSA-N,1.4848027250212575e-11,sedative,veterinary sedative for large animals,NA,NA,NA,NA
ropinirole,2016,Total,Total,6947.193105,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9947829114882182e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.116848299200341e-5
ropinirole,2017,Total,Total,6837.88758,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.9903492832893796e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,3.1099207551396556e-5
ropinirole,2018,Total,Total,6481.99653,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.8425861824858886e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.879040910134201e-5
ropinirole,2019,Total,Total,6159.6087,UHSKFQJFRQCDBE-UHFFFAOYSA-N,1.7793392573588803e-9,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,6.4e-5,2.7802175896232505e-5
ropivacaine,2016,Total,Total,15131.475,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.344777422969184e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2017,Total,Total,16307,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.746586629697108e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2018,Total,Total,16020.725,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.554085516982873e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
ropivacaine,2019,Total,Total,15631.05,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,4.515374637148546e-9,anaesthetic,"local anaesthetic for epidurals in surgery, childbirth",NA,NA,NA,NA
rosuvastatin,2016,Total,Total,102287.8436,BPRHUIZQVSMCRT-VEUZHWNKSA-N,2.9370429090190012e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.01631690505010556
rosuvastatin,2017,Total,Total,119689.1873,BPRHUIZQVSMCRT-VEUZHWNKSA-N,3.483872546498393e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.019354847480546628
rosuvastatin,2018,Total,Total,142017.5348,BPRHUIZQVSMCRT-VEUZHWNKSA-N,4.037020786451869e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.02242789325806594
rosuvastatin,2019,Total,Total,173128.051,BPRHUIZQVSMCRT-VEUZHWNKSA-N,5.0011868074400643e-8,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,1.8e-6,0.027784371152444802
rotigotine,2016,Total,Total,966.602,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.775453514344674e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002643289061280642
rotigotine,2017,Total,Total,936.432,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.725734721788509e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025959378302747704
rotigotine,2018,Total,Total,950.628,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.702275463088215e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.0025735956791316334
rotigotine,2019,Total,Total,893.172,KFQYTPMOWPVWEJ-INIZCTEOSA-N,2.5801249406861605e-10,dopaminergic,"dopaminergic antiparkinson agents, also for restless leg",low,high,1.05e-7,0.002457261848272534
rufinamide,2016,Total,Total,43827.4,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.2584384405845405e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2017,Total,Total,38479.56,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1200500705992988e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2018,Total,Total,39283.96,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1166942400280545e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rufinamide,2019,Total,Total,38156,POGQSBRIGCQNEG-UHFFFAOYSA-N,1.1022204820216169e-8,anticonvulsant,dibenzazepine anticonvulsant for severe childhood epilepsy,NA,NA,NA,NA
rupatadine,2016,Total,Total,270.68,WUZYKBABMWJHDL-UHFFFAOYSA-N,7.772172592885349e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
rupatadine,2017,Total,Total,170.66,WUZYKBABMWJHDL-UHFFFAOYSA-N,4.9675137929975375e-11,antihistamine,antihistamine for allergic skin diseases,NA,NA,NA,NA
ruxolitinib,2016,Total,Total,1009.96,HFNKQEVNSGCOJV-OAHLLOKOSA-N,2.8999495462946977e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2017,Total,Total,1403.92,HFNKQEVNSGCOJV-OAHLLOKOSA-N,4.0864830448055216e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2018,Total,Total,1772.68,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.039058041533826e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
ruxolitinib,2019,Total,Total,2014.04,HFNKQEVNSGCOJV-OAHLLOKOSA-N,5.818000156229208e-10,antineoplastic,"Janus-associated kinase inhibitor for myelofibrosis, transplant rejection",NA,NA,NA,NA
sacubitril,2016,Total,Total,10512.61008,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.018539232431885e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2017,Total,Total,33489.81272,PYNXFZCZUAOOQC-UTKZUKDTSA-N,9.748101875747356e-9,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2018,Total,Total,67862.4016,PYNXFZCZUAOOQC-UTKZUKDTSA-N,1.9290711267700764e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
sacubitril,2019,Total,Total,117765.8384,PYNXFZCZUAOOQC-UTKZUKDTSA-N,3.4019268048780754e-8,cardiac,angiotensin receptor blockers and neprilysin inhibitor for chronic heart failure,NA,NA,NA,NA
safinamide,2016,Total,Total,77,NEMGRZFTLSKBAP-LBPRGKRZSA-N,2.2109401863904684e-11,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2017,Total,Total,1774.1,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.16399051925286e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2018,Total,Total,2206,NEMGRZFTLSKBAP-LBPRGKRZSA-N,6.270822731470778e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
safinamide,2019,Total,Total,1818.5,NEMGRZFTLSKBAP-LBPRGKRZSA-N,5.253139602045053e-10,dopaminergic,MAO inhibitor for Parkinson's,NA,NA,NA,NA
salbutamol,2016,Total,Total,44240.736,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.2703067675050846e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2017,Total,Total,45049.084,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.311273562240154e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2018,Total,Total,40589.565,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.1538076467022245e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salbutamol,2019,Total,Total,45475.561,NDAUXUAQIAJITI-UHFFFAOYSA-N,1.3136621963943664e-8,respiratory,"β2 adrenergic receptor agonist for asthma, COPD, other bronchoconstriction",low,high,NA,NA
salicylic acid,2016,Total,Total,6898.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.9808014124434604e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.9808014124434604e-5
salicylic acid,2017,Total,Total,8101,YGSDEFSMJLZEOE-UHFFFAOYSA-N,2.3580117916953622e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,2.358011791695362e-5
salicylic acid,2018,Total,Total,8751.5,YGSDEFSMJLZEOE-UHFFFAOYSA-N,2.4877200876911383e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,2.487720087691138e-5
salicylic acid,2019,Total,Total,5777,YGSDEFSMJLZEOE-UHFFFAOYSA-N,1.668814268958717e-9,dermatological,used to remove outer layer of skin to counteract infections,low,low,1e-4,1.668814268958717e-5
salmeterol,2016,Total,Total,2013.138,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.780425590843811e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.627466177656278e-5
salmeterol,2017,Total,Total,1872.411,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.450150866436371e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.477341302925623e-5
salmeterol,2018,Total,Total,1761.201,GIIZNNXWQWCKIB-UHFFFAOYSA-N,5.006427590883529e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.2756489049470588e-5
salmeterol,2019,Total,Total,1623.759,GIIZNNXWQWCKIB-UHFFFAOYSA-N,4.690587136143565e-10,respiratory,"adrenergic bronchodilator for asthma, COPD",low,high,2.2e-5,2.1320850618834385e-5
sapropterin,2016,Total,Total,7272,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.088046368237855e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2017,Total,Total,10284,FNKQXYHWGSIFBK-RPDRRWSUSA-N,2.99343207823665e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2018,Total,Total,10692,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.039330763594087e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
sapropterin,2019,Total,Total,12744,FNKQXYHWGSIFBK-RPDRRWSUSA-N,3.6813863672511494e-9,metabolic,treatment for phenylketonuria,NA,NA,NA,NA
saquinavir,2016,Total,Total,1860,QWAXKHKRTORLEM-UGJKXSETSA-N,5.340712658034117e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
saquinavir,2017,Total,Total,720,QWAXKHKRTORLEM-UGJKXSETSA-N,2.0957517467234422e-10,antiviral,protease inhibitor for HIV,NA,NA,NA,NA
sarolaner,2017,Total,Total,21.2325,FLEFKKUZMDEUIP-QFIPXVFZSA-N,6.180284578097985e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2018,Total,Total,339.66749999999996,FLEFKKUZMDEUIP-QFIPXVFZSA-N,9.6554609253937e-11,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
sarolaner,2019,Total,Total,28.5,FLEFKKUZMDEUIP-QFIPXVFZSA-N,8.232855576479736e-12,antiparasitic,"canine treatment for flea and tick infections, taken orally",NA,NA,NA,NA
saxagliptin,2016,Total,Total,2371.77395,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.810195245570204e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.168626574284425e-7
saxagliptin,2017,Total,Total,2300.15765,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.695221406564984e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,7.04760148059472e-7
saxagliptin,2018,Total,Total,2266.2689,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.442144394263496e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.781204625540522e-7
saxagliptin,2019,Total,Total,2118.3939,QGJUIPDUBHWZPV-SGTAVMJGSA-N,6.119449485191458e-10,anti-diabetic,dipeptidyl peptidase 4 inhibitor for improving blood sugar in type 2 diabetes,low,low,9.5e-4,6.441525773885745e-7
scopolamine,2016,Total,Total,44.57,STECJAGHUSJQJN-USLFZFAMSA-N,1.279761092304197e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2017,Total,Total,49.73,STECJAGHUSJQJN-USLFZFAMSA-N,1.4475240883966219e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2018,Total,Total,44.759,STECJAGHUSJQJN-USLFZFAMSA-N,1.272328896817319e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
scopolamine,2019,Total,Total,46.662,STECJAGHUSJQJN-USLFZFAMSA-N,1.3479351119638504e-11,antiemetic,"Anticholinergic antiemetic and antispasmodic for motion sickness, surgical anaesthesia",low,NA,NA,NA
selamectin,2016,Total,Total,3724.74,AFJYYKSVHJGXSN-XHKIUTQPSA-N,1.0695035519293551e-9,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2017,Total,Total,3312.63,AFJYYKSVHJGXSN-XHKIUTQPSA-N,9.642291817706216e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2018,Total,Total,3004.11,AFJYYKSVHJGXSN-XHKIUTQPSA-N,8.53954726919251e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selamectin,2019,Total,Total,2728.845,AFJYYKSVHJGXSN-XHKIUTQPSA-N,7.882872552841698e-10,anthelminthic,topical antiparasitic and anthelmintic for a variety of veterinary infections,NA,NA,NA,NA
selegiline,2016,Total,Total,8055.545,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3130296316593256e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2017,Total,Total,8197.21,MEZLKOACVSPNER-GFCCVEGCSA-N,2.386016274410954e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2018,Total,Total,8213.96,MEZLKOACVSPNER-GFCCVEGCSA-N,2.334917818830086e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
selegiline,2019,Total,Total,8113.04,MEZLKOACVSPNER-GFCCVEGCSA-N,2.3436311089895843e-9,dopaminergic,MOA inhibitor for Parkinson's disease,NA,NA,NA,NA
sertindole,2016,Total,Total,470.36672,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.3505879007645107e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2017,Total,Total,380.9377599999999,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.1088207998790492e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2018,Total,Total,370.31064,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,1.0526529369979566e-10,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertindole,2019,Total,Total,287.06552,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,8.292522691744052e-11,antipsychotic,atypical indole antipsychotic for schizophrenia,NA,NA,NA,NA
sertraline,2016,Total,Total,714581.3295,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.051813737449193e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2017,Total,Total,761735.099,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.217232867041395e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2018,Total,Total,779108.4285,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.2147102646048393e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sertraline,2019,Total,Total,854781.554,VGKDLMBJGBXTGI-SJCJKPOMSA-N,2.469225643340672e-7,antidepressant,"SSRI for depression, panic disorder, OCD, anxiety, PTSD, etc.",NA,NA,NA,NA
sevelamer,2016,Total,Total,1675254.24,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,4.810242755372756e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2017,Total,Total,1746681.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.084180566956749e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2018,Total,Total,1820013.12,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.173608179723959e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sevelamer,2019,Total,Total,1904202.72,ZNSIZMQNQCNRBW-UHFFFAOYSA-N,5.500710870912238e-7,other,"phosphate binder for preventing low calcium levels, chronic kidney disease",NA,NA,NA,NA
sildenafil,2016,Total,Total,114983.038,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.3015664865904194e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2017,Total,Total,132569.13999999998,BNRNXUUZRGQAQC-UHFFFAOYSA-N,3.85877787106423e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2018,Total,Total,147312.64800000002,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.1875408055827446e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
sildenafil,2019,Total,Total,162538.39800000002,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4.695281250408362e-8,urological,"aka Viagra, antihypertensive and erectile dysfunction agent",NA,NA,NA,NA
silver nitrate,2016,Total,Total,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7945943071351204e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2017,Total,Total,20,SQGYOTSLMSWVJD-UHFFFAOYSA-N,5.821532629787339e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2018,Total,Total,6.25,SQGYOTSLMSWVJD-UHFFFAOYSA-N,1.7766383532045496e-12,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver nitrate,2019,Total,Total,1,SQGYOTSLMSWVJD-UHFFFAOYSA-N,2.888721254905171e-13,antiseptic,silver salt used for disinfection and removal of warts,NA,NA,NA,NA
silver sulfadiazine,2016,Total,Total,8238,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.3654188643486595e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2017,Total,Total,7642,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.224407617841742e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2018,Total,Total,7036.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,2.00021052357181e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
silver sulfadiazine,2019,Total,Total,6227.5,UEJSSZHHYBHCEL-UHFFFAOYSA-N,1.7989511614921946e-9,antibiotic,topical sulfonamide antibiotic used for severe burns,NA,NA,NA,NA
simeprevir,2016,Total,Total,63,JTZZSQYMACOLNN-VDWJNHBNSA-N,1.8089510615922013e-11,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,1.6749546866594455e-4
simeprevir,2017,Total,Total,21,JTZZSQYMACOLNN-VDWJNHBNSA-N,6.112609261276707e-12,antiviral,protease inhibitor for hepatitis C,high,high,1.08e-7,5.659823390071025e-5
simvastatin,2016,Total,Total,2294448.885,RYMZZMVNJRMUDD-HGQWONQESA-N,6.58816785125364e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,3.29408392562682
simvastatin,2017,Total,Total,2024665.9194,RYMZZMVNJRMUDD-HGQWONQESA-N,5.893329357102742e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.9466646785513713
simvastatin,2018,Total,Total,1838137.0484,RYMZZMVNJRMUDD-HGQWONQESA-N,5.225127645813836e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.6125638229069184
simvastatin,2019,Total,Total,1689347.999800001,RYMZZMVNJRMUDD-HGQWONQESA-N,4.880055473953799e-7,statin,"statin, used to regulate cholesterol and prevent cardiovascular disease",low,low,2e-7,2.4400277369768997
sitagliptin,2016,Total,Total,667651.558,MFFMDFFZMYYVKS-SECBINFHSA-N,1.9170618962187098e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0022822165431175116
sitagliptin,2017,Total,Total,805702.4115,MFFMDFFZMYYVKS-SECBINFHSA-N,2.3452114392227986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0027919183800271413
sitagliptin,2018,Total,Total,920545.22,MFFMDFFZMYYVKS-SECBINFHSA-N,2.6167615099377914e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0031151922737354663
sitagliptin,2019,Total,Total,1017783.571,MFFMDFFZMYYVKS-SECBINFHSA-N,2.940093034440986e-7,anti-diabetic,dipeptidyl peptidase 4 inhibitors for blood sugar control in type 2 diabetes,low,high,8.4e-5,0.0035001107552868884
sodium amidotrizoate,2016,Total,Total,0.2296,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.592621646691579e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2017,Total,Total,0.2123,ZEYOIOAKZLALAP-UHFFFAOYSA-M,6.179556886519263e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2018,Total,Total,0.1981,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.63123292431714e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium amidotrizoate,2019,Total,Total,0.1818,ZEYOIOAKZLALAP-UHFFFAOYSA-M,5.2516952414175994e-14,diagnostic agent,"contrast medium for X-rays, with meglumine amidotrizoate",NA,NA,NA,NA
sodium phenylbutyrate,2016,Total,Total,1629.412,VPZRWNZGLKXFOE-UHFFFAOYSA-M,4.67861359868424e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2017,Total,Total,2586.248,VPZRWNZGLKXFOE-UHFFFAOYSA-M,7.527963560361124e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2018,Total,Total,4668.524,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3270846066009467e-9,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sodium phenylbutyrate,2019,Total,Total,461.168,VPZRWNZGLKXFOE-UHFFFAOYSA-M,1.3321858036821078e-10,metabolic,aromatic fatty acid salt used for urea cycle disorders,NA,NA,NA,NA
sofosbuvir,2016,Total,Total,23553.6,TTZHDVOVKQGIBA-IQWMDFIBSA-N,6.763065035606043e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2017,Total,Total,20339.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,5.920265823188534e-9,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2018,Total,Total,67704,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.9245683690457733e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
sofosbuvir,2019,Total,Total,56347.2,TTZHDVOVKQGIBA-IQWMDFIBSA-N,1.6277135429439263e-8,antiviral,antiviral for chronic hepatitis C,NA,NA,NA,NA
solifenacin,2016,Total,Total,32045.152,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.20128757607674e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2017,Total,Total,31389.454,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.136736534610438e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2018,Total,Total,31586.715399999997,FBOUYBDGKBSUES-VXKWHMMOSA-N,8.978907205023485e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
solifenacin,2019,Total,Total,33839.6869,FBOUYBDGKBSUES-VXKWHMMOSA-N,9.775342280736606e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
sorafenib,2016,Total,Total,6899.2,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.9810024070058596e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.11652955335328585
sorafenib,2017,Total,Total,4838.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.408345173798153e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08284383375283252
sorafenib,2018,Total,Total,5174.4,MLDQJTXFUGDVEO-UHFFFAOYSA-N,1.4708859991714591e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.08652270583361524
sorafenib,2019,Total,Total,7145.6,MLDQJTXFUGDVEO-UHFFFAOYSA-N,2.064164659905038e-9,antineoplastic,multiple protein kinase inhibitor for carcinomas,high,high,1.7e-8,0.1214214505826493
sotalol,2016,Total,Total,211630.16,ZBMZVLHSJCTVON-UHFFFAOYSA-N,6.076644485665516e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2017,Total,Total,196055.88,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.706728513408357e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2018,Total,Total,176920.36,ZBMZVLHSJCTVON-UHFFFAOYSA-N,5.029175952620097e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
sotalol,2019,Total,Total,158257.8,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4.5716267061453147e-8,beta blocker,non-cardioselective beta blocker and group III antiarrhythmic for rhythm disorders,NA,NA,NA,NA
spiramycin,2016,Total,Total,12807.96,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.677614736322293e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2017,Total,Total,10700.58,ACTOXUHEUCPTEW-JMRHEKERSA-N,3.114688781382491e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2018,Total,Total,8354.5,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3748680194955852e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spiramycin,2019,Total,Total,8231.74,ACTOXUHEUCPTEW-JMRHEKERSA-N,2.3779202302853086e-9,antibacterial,macrolide antibiotic and antiparasitic,NA,NA,NA,NA
spironolactone,2016,Total,Total,216466.675,LXMSZDCAJNLERA-ZHYRCANASA-N,6.215517802231492e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2017,Total,Total,222218.45,LXMSZDCAJNLERA-ZHYRCANASA-N,6.468259788078834e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2018,Total,Total,231659.475,LXMSZDCAJNLERA-ZHYRCANASA-N,6.585201730691689e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
spironolactone,2019,Total,Total,243515.625,LXMSZDCAJNLERA-ZHYRCANASA-N,7.034487618390169e-8,diuretic,"potassium-sparing diuretic used for high blood pressure, heart failure, oedema",low,NA,NA,NA
stiripentol,2016,Total,Total,12165.75,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.493213710724654e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2017,Total,Total,11735.85,IBLNKMRFIPWSOY-FNORWQNLSA-N,3.416031685664488e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2018,Total,Total,15855,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.506976174409301e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
stiripentol,2019,Total,Total,17010,IBLNKMRFIPWSOY-FNORWQNLSA-N,4.913714854593695e-9,anticonvulsant,gamma-aminobutyric acid reuptake inhibitor for Dravet syndrome epilepsy,NA,NA,NA,NA
streptozocin,2019,Total,Total,92,ZSJLQEPLLKMAKR-GKHCUFPYSA-N,2.6576235545127567e-11,antineoplastic,alkylating agent for pancreatic cancer,NA,NA,NA,NA
sucralfate,2016,Total,Total,383530.2,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.1012497816550309e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2017,Total,Total,422074.8,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2285611102054828e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2018,Total,Total,428604.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.2183605931518314e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sucralfate,2019,Total,Total,487990.6,YZPQNHUVIVIUCT-JTJNLBSYSA-F,1.409668818413927e-7,alimentary,treatment for duodenal ulcers,NA,NA,NA,NA
sufentanil,2016,Total,Total,0.99815,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.8660388922670725e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2017,Total,Total,0.8852500000000001,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.5767558802596216e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2018,Total,Total,0.9484,GGCSSNBKKAUURC-UHFFFAOYSA-N,2.6959421026867123e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sufentanil,2019,Total,Total,1.11825,GGCSSNBKKAUURC-UHFFFAOYSA-N,3.230312543297707e-13,analgesic,opioid analgesic and anaesthetic for critical pain relief,low,NA,NA,NA
sugammadex,2016,Total,Total,1915,WHRODDIHRRDWEW-VTHZAVIASA-N,5.498636957062008e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,5.498636957062008e-7
sugammadex,2017,Total,Total,2108,WHRODDIHRRDWEW-VTHZAVIASA-N,6.135895391795857e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.135895391795857e-7
sugammadex,2018,Total,Total,2350,WHRODDIHRRDWEW-VTHZAVIASA-N,6.680160208049105e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,6.680160208049105e-7
sugammadex,2019,Total,Total,3229,WHRODDIHRRDWEW-VTHZAVIASA-N,9.327680932088795e-10,other nervous system,agent for reversing surgical muscle relaxants,low,low,0.001,9.327680932088795e-7
sulfadiazine,2016,Total,Total,1076297.5836,SEEPANYCNGTZFQ-UHFFFAOYSA-N,3.090428026098954e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2017,Total,Total,1008298.9074,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.934922495004012e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2018,Total,Total,937990.3008,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.6663512693362434e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadiazine,2019,Total,Total,963879.6822,SEEPANYCNGTZFQ-UHFFFAOYSA-N,2.784379725142381e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfadoxine,2016,Total,Total,52700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.5132019197763336e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2017,Total,Total,50700,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.4757585216510908e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2018,Total,Total,69900,PJSFRIWCGOHTNF-UHFFFAOYSA-N,1.986992334223968e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfadoxine,2019,Total,Total,104140,PJSFRIWCGOHTNF-UHFFFAOYSA-N,3.0083143148582445e-8,antibacterial,"sulfonamide antibiotic and antiprotozoal for malarial, various livestock infections",NA,NA,NA,NA
sulfamethoxazole,2016,Total,Total,1420137.76,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.077713823109795e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2017,Total,Total,1478592.4,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.303836951377788e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2018,Total,Total,1629399.2,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4.631764978241297e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfamethoxazole,2019,Total,Total,1759706,JLKIGFTWXXRPMT-UHFFFAOYSA-N,5.083300124584158e-7,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfanilamide,2016,Total,Total,1250,FDDDEECHVMSUSB-UHFFFAOYSA-N,3.5891886142702405e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfasalazine,2016,Total,Total,2687662,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.717220679525427e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2017,Total,Total,2588001.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.533067589094291e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2018,Total,Total,2561204.5,NCEXYHBECQHGNR-UHFFFAOYSA-N,7.280534632160131e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfasalazine,2019,Total,Total,2272402,NCEXYHBECQHGNR-UHFFFAOYSA-N,6.56433595708902e-7,alimentary,"5-aminosalicylate for ulcerative colitis, arthritis",NA,NA,NA,NA
sulfathiazole,2016,Total,Total,10120,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.905807102113187e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2017,Total,Total,7690,JNMRHUJNCSQMMB-UHFFFAOYSA-N,2.238379296153232e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2018,Total,Total,6580,JNMRHUJNCSQMMB-UHFFFAOYSA-N,1.8704448582537503e-9,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sulfathiazole,2019,Total,Total,3000,JNMRHUJNCSQMMB-UHFFFAOYSA-N,8.66616376471551e-10,antibacterial,sulfonamide antibiotic,NA,NA,NA,NA
sumatriptan,2016,Total,Total,136688.55,KQKPFRSPSRPDEB-UHFFFAOYSA-N,3.9248078988888685e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.5699231595555475e-4
sumatriptan,2017,Total,Total,145086.492,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.2231287365968994e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.6892514946387598e-4
sumatriptan,2018,Total,Total,146788.308,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.1726358047168354e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.669054321886734e-4
sumatriptan,2019,Total,Total,153388.296,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4.4309603090888574e-8,analgesic,"antimigraine agent, narrows blood vessels around brain",low,high,2.5e-4,1.772384123635543e-4
suxamethonium,2016,Total,Total,7300,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.096086150733821e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2017,Total,Total,7064,AXOIZCJOOAYSMI-UHFFFAOYSA-N,2.0561653248408886e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2018,Total,Total,6366,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.809612761040026e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxamethonium,2019,Total,Total,4928,AXOIZCJOOAYSMI-UHFFFAOYSA-N,1.423561834417268e-9,muscle relaxant,short-term paralytic for general anaesthesia,low,NA,NA,NA
suxibuzone,2016,Total,Total,82566,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3707595770066937e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2017,Total,Total,79515,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.3144958352877022e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2018,Total,Total,68823,ONWXNHPOAGOMTG-UHFFFAOYSA-N,1.9563773021215475e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
suxibuzone,2019,Total,Total,71199,ONWXNHPOAGOMTG-UHFFFAOYSA-N,2.056740646279932e-8,analgesic,NSAID for equine joint and muscle pain,NA,NA,NA,NA
tacrolimus,2016,Total,Total,4975.231,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.4285633966851472e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2017,Total,Total,5531.2725,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.6100241671497699e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2018,Total,Total,6047.978,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.719211147861975e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tacrolimus,2019,Total,Total,6737.598,QJJXYPPXXYFBGM-LFZNUXCKSA-N,1.9463042549606566e-9,immunosuppressant,"calcineurin inhibitor for organ transplants, skin immune disorders",NA,NA,NA,NA
tadalafil,2016,Total,Total,24370.78,WOXKDUGGOYFFRN-IIBYNOLFSA-N,6.9977060877507925e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.4578554349480816e-4
tadalafil,2017,Total,Total,26047.2452,WOXKDUGGOYFFRN-IIBYNOLFSA-N,7.581744392393584e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.5795300817486634e-4
tadalafil,2018,Total,Total,31090.7,WOXKDUGGOYFFRN-IIBYNOLFSA-N,8.837908807676271e-9,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,1.841231001599223e-4
tadalafil,2019,Total,Total,36057.74,WOXKDUGGOYFFRN-IIBYNOLFSA-N,1.0416075994184435e-8,urological,"agent for erectile dysfunction, enlarged prostate, arterial hypertension",low,moderate,4.8e-5,2.1700158321217574e-4
tafamidis,2018,Total,Total,3.6,TXEIIPDJKFWEEC-UHFFFAOYSA-N,1.0233436914458206e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafamidis,2019,Total,Total,10.8,TXEIIPDJKFWEEC-UHFFFAOYSA-N,3.1198189552975847e-12,other nervous system,transthyretin stabilizer for congenital heart failure,NA,NA,NA,NA
tafluprost,2016,Total,Total,12.05685,WSNODXPBBALQOF-VEJSHDCNSA-N,3.4619446995171325e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2017,Total,Total,14.321745,WSNODXPBBALQOF-VEJSHDCNSA-N,4.168725291649685e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2018,Total,Total,16.55181,WSNODXPBBALQOF-VEJSHDCNSA-N,4.705052873752735e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tafluprost,2019,Total,Total,18.6948,WSNODXPBBALQOF-VEJSHDCNSA-N,5.400406611620119e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,NA,NA,NA,NA
tamoxifen,2016,Total,Total,28435.44,NKANXQFJJICGDU-QPLCGJKRSA-N,8.164812599181166e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.0800471823449134
tamoxifen,2017,Total,Total,30268.52,NKANXQFJJICGDU-QPLCGJKRSA-N,8.810458841768536e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.086377047468319
tamoxifen,2018,Total,Total,30379.12,NKANXQFJJICGDU-QPLCGJKRSA-N,8.635633556576543e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08466307408408376
tamoxifen,2019,Total,Total,31762.74,NKANXQFJJICGDU-QPLCGJKRSA-N,9.175370215202666e-9,antineoplastic,selective estrogen receptor modulator for breast cancer,low,high,1.0199999999999999e-7,0.08995460995296733
tamsulosin,2016,Total,Total,8000.67796,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.2972753792379887e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2017,Total,Total,8528.67572,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.4824981996427518e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2018,Total,Total,9143.26032,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.599082713255248e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tamsulosin,2019,Total,Total,9985.11236,DRHKJLXJIQTDTD-OAHLLOKOSA-N,2.884420630694833e-9,urological,alpha-blocker for relaxing urinary muscles in enlarged prostate,NA,NA,NA,NA
tapentadol,2016,Total,Total,87252.395,KWTWDQCKEHXFFR-SMDDNHRTSA-N,2.5053224216144777e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2017,Total,Total,121340.285,KWTWDQCKEHXFFR-SMDDNHRTSA-N,3.5319321421759774e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2018,Total,Total,144810.5,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.1164142119476396e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tapentadol,2019,Total,Total,157934.555,KWTWDQCKEHXFFR-SMDDNHRTSA-N,4.562289059124896e-8,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tedizolid,2016,Total,Total,154.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,4.4448511799122665e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,1.4816170599707555e-5
tedizolid,2017,Total,Total,318,XFALPSLJIHVRKE-GFCCVEGCSA-N,9.256236881361871e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,3.08541229378729e-5
tedizolid,2018,Total,Total,104.4,XFALPSLJIHVRKE-GFCCVEGCSA-N,2.96769670519288e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,9.892322350642933e-6
tedizolid,2019,Total,Total,208.8,XFALPSLJIHVRKE-GFCCVEGCSA-N,6.031649980241996e-11,antibacterial,oxazolidinone antibiotic for skin infections,low,high,3e-6,2.0105499934139986e-5
teicoplanin,2016,Total,Total,83.19999999999999,BJNLLBUOHPVGFT-CAYRISATSA-N,2.388963941658272e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2017,Total,Total,62,BJNLLBUOHPVGFT-CAYRISATSA-N,1.8046751152340755e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
teicoplanin,2018,Total,Total,53.2,BJNLLBUOHPVGFT-CAYRISATSA-N,1.5122745662477126e-11,antibacterial,glycopeptide antibiotic,low,NA,NA,NA
telbivudine,2016,Total,Total,168,IQFYYKKMVGJFEH-CSMHCCOUSA-N,4.823869497579204e-11,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,high,9.49e-5,5.083108005879034e-7
telmisartan,2016,Total,Total,193137.27760000003,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.545648942024567e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011317650902090955
telmisartan,2017,Total,Total,187672.0288,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.462694196787947e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011148355503648871
telmisartan,2018,Total,Total,190748.8176,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.422266642825263e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.001106585029148013
telmisartan,2019,Total,Total,187731.6984,RMMXLENWKUUMAY-UHFFFAOYSA-N,5.4230454738752705e-8,antihypertensive,angiotensin II receptor blocker for high blood pressure,low,high,4.9e-5,0.0011067439742602594
temozolomide,2016,Total,Total,4205.3,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.2074891903672515e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,1.6099855871563355e-5
temozolomide,2017,Total,Total,5184.75,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.5091595651144955e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.0122127534859943e-5
temozolomide,2018,Total,Total,5879.1,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.671205526771979e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.228274035695972e-5
temozolomide,2019,Total,Total,5574.7,BPEGJWRSRHCHSN-UHFFFAOYSA-N,1.610375437971985e-9,antineoplastic,alkylating agent for brain tumours,low,moderate,7.5e-5,2.1471672506293138e-5
tenofovir alafenamide,2016,Total,Total,1915.35,LDEKQSIMHVQZJK-CAQYMETFSA-N,5.499641929874004e-10,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,5.499641929874004e-7
tenofovir alafenamide,2017,Total,Total,9023.4,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.6265008765811543e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.6265008765811544e-6
tenofovir alafenamide,2018,Total,Total,10650.9,LDEKQSIMHVQZJK-CAQYMETFSA-N,3.0276475897834133e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,3.0276475897834133e-6
tenofovir alafenamide,2019,Total,Total,7790.1,LDEKQSIMHVQZJK-CAQYMETFSA-N,2.250342744783677e-9,antiviral,nucleoside reverse transcriptase inhibitor for hepatitis B infections,low,moderate,0.001,2.250342744783677e-6
tenofovir disoproxil,2016,Total,Total,227416.35,JFVZFKDSXNQEJW-CQSZACIVSA-N,6.529921392951168e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2017,Total,Total,165110.4,JFVZFKDSXNQEJW-CQSZACIVSA-N,4.805977905586198e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2018,Total,Total,176664.6,JFVZFKDSXNQEJW-CQSZACIVSA-N,5.0219056642166474e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
tenofovir disoproxil,2019,Total,Total,260675.1,JFVZFKDSXNQEJW-CQSZACIVSA-N,7.530177019945309e-8,antiviral,nucleoside reverse transcriptase inhibitor for HIV,NA,NA,NA,NA
terazosin,2016,Total,Total,625.77914,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7968314914686584e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2017,Total,Total,613.15072,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.7847384617288004e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2018,Total,Total,402.0905,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.14299104601471e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terazosin,2019,Total,Total,378.028,VCKUSRYTPJJLNI-UHFFFAOYSA-N,1.0920175185492918e-10,urological,"alpha-blocker for relaxing urinary muscles in enlarged prostate, hypertension",NA,NA,NA,NA
terbinafine,2016,Total,Total,602958.62,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7313057710240773e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.2666146623095798
terbinafine,2017,Total,Total,615505.815,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.791593592923175e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.380365269666368
terbinafine,2018,Total,Total,638414.885,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.814771791916275e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.4240977205967456
terbinafine,2019,Total,Total,611014.7100000001,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1.7650511798367194e-7,antifungal,topical allylamine antifungal,high,low,5.3e-8,3.3302852449749425
terbutaline,2016,Total,Total,7447.31,XWTYSIMOBUGWOL-UHFFFAOYSA-N,2.138384020715272e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,8.909933419646967e-6
terbutaline,2017,Total,Total,6583.112499999999,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.916190211215545e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,7.984125880064771e-6
terbutaline,2018,Total,Total,5325.1125,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.5137278564206339e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.3071994017526415e-6
terbutaline,2019,Total,Total,5165.37,XWTYSIMOBUGWOL-UHFFFAOYSA-N,1.492131410844952e-9,respiratory,adrenergic bronchodilator for lung conditions,low,high,2.3999999999999998e-4,6.217214211853967e-6
teriflunomide,2016,Total,Total,5294.744,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.5203067904220535e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.067689301406845e-5
teriflunomide,2017,Total,Total,5747.896,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6730782058312064e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.576927352770688e-5
teriflunomide,2018,Total,Total,5942.72,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.6892902838969187e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.630967612989729e-5
teriflunomide,2019,Total,Total,5944.68,UTNUDOFZCWSZMS-YFHOEESVSA-N,1.717252346960967e-9,immunosuppressant,selective immunosuppressant for multiple sclerosis,low,high,3e-5,5.72417448986989e-5
testosterone,2016,Total,Total,96412.3,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.7683354354848542e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2017,Total,Total,107058.65,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1162271213799125e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2018,Total,Total,103507.86,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,2.942336542946033e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
testosterone,2019,Total,Total,107993.53,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,3.1196320550323916e-8,sex hormone,"androgen used for hormone replacement, breast cancer",high,moderate,NA,NA
tetrabenazine,2017,Total,Total,84,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.4450437045106828e-11,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2018,Total,Total,425.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,1.20981965299817e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetrabenazine,2019,Total,Total,789.6,MKJIEFSOBYUXJB-UHFFFAOYSA-N,2.2809343028731223e-10,other nervous system,VMAT2 inhibitor for Huntington's disease,NA,NA,NA,NA
tetracaine,2016,Total,Total,1543.9,GKCBAIGFKIBETG-UHFFFAOYSA-N,4.43307864125746e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2017,Total,Total,1059.6,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.0842479872613326e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2018,Total,Total,1220.4,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.469135114001332e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracaine,2019,Total,Total,1359.05,GKCBAIGFKIBETG-UHFFFAOYSA-N,3.9259166214788715e-10,anaesthetic,"local anaesthetic for labour, surgery",low,NA,NA,NA
tetracycline,2016,Total,Total,759502,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.1807967447323814e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2017,Total,Total,695828,NWXMGUDVXFXRIG-WESIUVDSSA-N,2.025392703359833e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2018,Total,Total,615128,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.748575995088013e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetracycline,2019,Total,Total,598636,NWXMGUDVXFXRIG-WESIUVDSSA-N,1.7292925371514117e-7,antibacterial,tetracycline antibiotic,low,high,NA,NA
tetryzoline,2016,Total,Total,285.6848,BYJAVTDNIXVSPW-UHFFFAOYSA-N,8.203013051440567e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2017,Total,Total,294.4928,BYJAVTDNIXVSPW-UHFFFAOYSA-N,8.571997222187185e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2018,Total,Total,277.4072,BYJAVTDNIXVSPW-UHFFFAOYSA-N,7.885636335601361e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
tetryzoline,2019,Total,Total,328.544,BYJAVTDNIXVSPW-UHFFFAOYSA-N,9.490720359715641e-11,respiratory,vasoconstrictive nasal decongestant and eye drop,NA,NA,NA,NA
thalidomide,2016,Total,Total,2161.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,6.206712086885242e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2017,Total,Total,953.4,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.775124604619625e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2018,Total,Total,754.6,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.145042082125045e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
thalidomide,2019,Total,Total,784,UEJJHQNACJXSKW-UHFFFAOYSA-N,2.2647574638456536e-10,immunosuppressant,"immunosuppressant and antineoplastic for myeloma, leprosy",NA,NA,NA,NA
theophylline,2016,Total,Total,358271.19,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,1.0287223007752401e-7,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2017,Total,Total,331665.26,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,9.65400066628451e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2018,Total,Total,282589.38,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,8.032946091460716e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
theophylline,2019,Total,Total,250207.92,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,7.227809366496124e-8,respiratory,methylxanthine bronchodilator for breathing problems,NA,NA,NA,NA
thiamazole,2016,Total,Total,855.2,PMRYVIKBURPHAH-UHFFFAOYSA-N,2.455579282339128e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2017,Total,Total,1147.775,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.3409048070770823e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2018,Total,Total,1379.275,PMRYVIKBURPHAH-UHFFFAOYSA-N,3.9207565833859286e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiamazole,2019,Total,Total,1568.675,PMRYVIKBURPHAH-UHFFFAOYSA-N,4.5314648145383674e-10,antithyroid,imidazole for hyperthyroidism,NA,NA,NA,NA
thiopental,2016,Total,Total,28305,IUJDSEJGGMCXSG-UHFFFAOYSA-N,8.127358698153533e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2017,Total,Total,26995,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.857613667055463e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2018,Total,Total,26225,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.45477453004629e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiopental,2019,Total,Total,24325,IUJDSEJGGMCXSG-UHFFFAOYSA-N,7.026814452556827e-9,anaesthetic,"general anaesthetic for surgery, seizures, skull and brain pressure",NA,NA,NA,NA
thiosulfate,2016,Total,Total,9705,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.786646040119415e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2017,Total,Total,12195,DHCDFWKWKRSZHF-UHFFFAOYSA-M,3.54967952101283e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2018,Total,Total,8400,DHCDFWKWKRSZHF-UHFFFAOYSA-M,2.3878019467069147e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiosulfate,2019,Total,Total,14745,DHCDFWKWKRSZHF-UHFFFAOYSA-M,4.259419490357674e-9,antidote,"sodium thiosulfate, antidote for cyanide poisoning",NA,NA,NA,NA
thiotepa,2016,Total,Total,9.92,FOCVUCIESVLUNU-UHFFFAOYSA-N,2.848380084284863e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2017,Total,Total,12.445,FOCVUCIESVLUNU-UHFFFAOYSA-N,3.622448678885173e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2018,Total,Total,21.13,FOCVUCIESVLUNU-UHFFFAOYSA-N,6.006458944513941e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
thiotepa,2019,Total,Total,16.064999999999998,FOCVUCIESVLUNU-UHFFFAOYSA-N,4.640730696005156e-12,antineoplastic,"alkylating agent for breast, ovary, bladder cancer",NA,NA,NA,NA
tiamulin,2016,Total,Total,59790,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.7167806979777416e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2017,Total,Total,42310,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.2315452278315118e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2018,Total,Total,34025,UURAUHCOJAIIRQ-QGLSALSOSA-N,9.672019194845568e-9,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tiamulin,2019,Total,Total,45030,UURAUHCOJAIIRQ-QGLSALSOSA-N,1.3007911810837985e-8,antibacterial,pleuromutilin veterinary antibiotic,NA,NA,NA,NA
tibolone,2016,Total,Total,4755.3492,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3654276164415276e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2017,Total,Total,4531.9197,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.3191359204563027e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2018,Total,Total,4267.83,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.2131824740731155e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
tibolone,2019,Total,Total,4168.3635,WZDGZWOAQTVYBX-XOINTXKNSA-N,1.204124024062091e-9,sex hormone,"progestogen, estrogen, androgen used in hormone therapy",low,NA,NA,NA
ticagrelor,2016,Total,Total,387609.4764,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1129628155825037e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002099929840721705
ticagrelor,2017,Total,Total,386672.9004,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1255144533665553e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.002123612176163312
ticagrelor,2018,Total,Total,385345.3596,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.0953909521516144e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0020667753814181404
ticagrelor,2019,Total,Total,400039.44,OEKWJQXRCDYSHL-FNOIDJSQSA-N,1.1556024331283617e-7,antithrombotic,platelet aggregation inhibitor for heart issues,low,low,5.3e-5,0.0021803819492987957
ticlopidine,2016,Total,Total,16633.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.776061505237124e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2017,Total,Total,15354.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4.469336138203486e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2018,Total,Total,13498.25,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.83704138418293e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
ticlopidine,2019,Total,Total,11178.5,PHWBOXQYWZNQIN-UHFFFAOYSA-N,3.229157054795745e-9,antithrombotic,platelet aggregation inhibitor for stroke prevention,NA,NA,NA,NA
tigecycline,2016,Total,Total,66,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.8950915883346872e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2017,Total,Total,43,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.2516295154042782e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2018,Total,Total,39.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.1228354392252754e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tigecycline,2019,Total,Total,45.5,SOVUOXKZCCAWOJ-HJYUBDRYSA-N,1.3143681709818526e-11,antibacterial,glycylcycline antibiotic,low,NA,NA,NA
tiludronic acid,2016,Total,Total,131,DKJJVAGXPKPDRL-UHFFFAOYSA-N,3.761469667755212e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2017,Total,Total,94,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.73612033600005e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2018,Total,Total,81.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,2.316736412578733e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
tiludronic acid,2019,Total,Total,38.5,DKJJVAGXPKPDRL-UHFFFAOYSA-N,1.1121576831384906e-11,metabolic,bisphosphonate treatment for Paget's disease,NA,NA,NA,NA
timolol,2016,Total,Total,10924.096,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.136691278751606e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2017,Total,Total,11247.6531,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.273928976508936e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2018,Total,Total,12316.64175,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.501154898516864e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
timolol,2019,Total,Total,12960.5875,BLJRIMJGRPQVNF-JTQLQIEISA-N,3.743952458730827e-9,beta blocker,"non-cardioselective antibiotic for hypertension, heart attacks, migraines",low,NA,NA,NA
tiotropium bromide,2016,Total,Total,128.35005,DQHNAVOVODVIMG-RGECMCKFSA-M,3.6853803048081294e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2017,Total,Total,120.37791,DQHNAVOVODVIMG-RGECMCKFSA-M,3.503919654853019e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2018,Total,Total,113.09136,DQHNAVOVODVIMG-RGECMCKFSA-M,3.2147591614730063e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tiotropium bromide,2019,Total,Total,109.02105,DQHNAVOVODVIMG-RGECMCKFSA-M,3.1493142436707934e-11,respiratory,anticholinergic bronchodilator for COPD,low,high,NA,NA
tipiracil,2017,Total,Total,32.1004,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,9.343676301461275e-12,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2018,Total,Total,109.648,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.116877474434759e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tipiracil,2019,Total,Total,105.4338,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,3.045688590454208e-11,antineoplastic,thymidine phosphorylase inhibitor used with trifluridine to prolong effects,NA,NA,NA,NA
tivozanib,2019,Total,Total,0.14973,SPMVMDHWKHCIDT-UHFFFAOYSA-N,4.3252823349695124e-14,antineoplastic,vascular endothelial growth factor inhibitor for carcinomas,NA,NA,NA,NA
tobramycin,2016,Total,Total,8141.445000000001,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.3376945358165907e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.583714776110962e-4
tobramycin,2017,Total,Total,7700.825,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.2415302006891046e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,4.395157256253146e-4
tobramycin,2018,Total,Total,6408.112,NLVFBUXFDBBNBW-PBSUHMDJSA-N,1.82158360813285e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.5717325649663726e-4
tobramycin,2019,Total,Total,7014.999,NLVFBUXFDBBNBW-PBSUHMDJSA-N,2.0264376714438513e-9,antibacterial,aminoglycoside antibiotic,NA,high,5.1e-6,3.973407198909512e-4
toceranib,2016,Total,Total,22.6,SRSGVKWWVXWSJT-ATVHPVEESA-N,6.489253014600596e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2017,Total,Total,29.7,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.644975955234199e-12,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
toceranib,2018,Total,Total,0.3,SRSGVKWWVXWSJT-ATVHPVEESA-N,8.527864095381839e-14,antibacterial,receptor tyrosine kinase inhibitor for canine cancers,NA,NA,NA,NA
tofacitinib,2017,Total,Total,74.48,UJLAWZDWDVHWOW-YPMHNXCESA-N,2.1679387513328056e-11,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2018,Total,Total,1246.77,UJLAWZDWDVHWOW-YPMHNXCESA-N,3.544095039399737e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tofacitinib,2019,Total,Total,1742.23,UJLAWZDWDVHWOW-YPMHNXCESA-N,5.032816831933436e-10,immunosuppressant,"treatment for arthritis, ulcerative colitis",NA,NA,NA,NA
tolfenamic acid,2016,Total,Total,5740,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6481554116728947e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2017,Total,Total,5654,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.6457472744408811e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2018,Total,Total,6188,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.7590141007407603e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolfenamic acid,2019,Total,Total,6716,YEZNLOUZAIOMLT-UHFFFAOYSA-N,1.940065194794312e-9,analgesic,COX inhibitor and NSAID for migraines,NA,NA,NA,NA
tolterodine,2016,Total,Total,8240.384320000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.366103486284402e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2017,Total,Total,7516.001920000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,2.187732521141215e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2018,Total,Total,6333.6224,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.8004090352888715e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
tolterodine,2019,Total,Total,5581.835840000001,OOGJQPCLVADCPB-HXUWFJFHSA-N,1.6124367832399459e-9,urological,urinary antispasmodic for overactive bladders,NA,NA,NA,NA
toltrazuril,2016,Total,Total,289252.16,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.30544447460059e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2017,Total,Total,304975,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.877109568846971e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2018,Total,Total,292275,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.308271594925757e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
toltrazuril,2019,Total,Total,294300,OCINXEZVIIVXFU-UHFFFAOYSA-N,8.501506653185917e-8,antiprotozoal,treatment for Coccidia protozoa,NA,NA,NA,NA
tolvaptan,2016,Total,Total,460.29,GYHCTFXIZSNGJT-UHFFFAOYSA-N,1.321654101809959e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,6.608270509049795e-6
tolvaptan,2017,Total,Total,1392.84,GYHCTFXIZSNGJT-UHFFFAOYSA-N,4.0542317540365004e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,2.02711587701825e-5
tolvaptan,2018,Total,Total,2364.285,GYHCTFXIZSNGJT-UHFFFAOYSA-N,6.720767054249949e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,3.360383527124974e-5
tolvaptan,2019,Total,Total,3174.18,GYHCTFXIZSNGJT-UHFFFAOYSA-N,9.169321232894894e-10,diuretic,competitive vasopressin receptor 2 antagonist for low blood sodium,low,high,2e-5,4.5846606164474465e-5
topiramate,2016,Total,Total,174637.829,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.0144648597413863e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.391897698646652e-4
topiramate,2017,Total,Total,178766.903,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.2034867947026414e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.595147091078109e-4
topiramate,2018,Total,Total,179698.065,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.1081355884103056e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.492618912269146e-4
topiramate,2019,Total,Total,185006.215,KJADKKWYZYXHBB-XBWDGYHZSA-N,5.3443138556005584e-8,anticonvulsant,"carbonic anhydrase inhibitor anticonvulsant for seizures, migraines",low,NA,9.3e-5,5.74657403828017e-4
topotecan,2016,Total,Total,2.498,UCFGDBYHRUNTLO-QHCPKHFHSA-N,7.17263452675765e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2017,Total,Total,0.8325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,2.4232129571489804e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2018,Total,Total,1.3325,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.7877929690320994e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
topotecan,2019,Total,Total,1.2625,UCFGDBYHRUNTLO-QHCPKHFHSA-N,3.6470105843177783e-13,antineoplastic,"topoisomerase inhibitor for lung, ovarian, other cancers",low,high,NA,NA
torasemide,2018,Total,Total,1.8,NGBFQHCMQULJNZ-UHFFFAOYSA-N,5.116718457229103e-13,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
torasemide,2019,Total,Total,10.89,NGBFQHCMQULJNZ-UHFFFAOYSA-N,3.145817446591731e-12,diuretic,"diuretic for oedema from heart failure, liver disease, kidney disease, high blood pressure",NA,NA,NA,NA
trabectedin,2016,Total,Total,0.25225000000000003,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.242982623597347e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2017,Total,Total,0.289,PKVRCIRHQMSYJX-AIFWHQITSA-N,8.412114650042706e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2018,Total,Total,0.36625,PKVRCIRHQMSYJX-AIFWHQITSA-N,1.041110074977866e-13,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
trabectedin,2019,Total,Total,0.27399999999999997,PKVRCIRHQMSYJX-AIFWHQITSA-N,7.915096238440167e-14,antineoplastic,"alkylating agent for liposarcoma, leiomyosarcoma, other cancers",low,NA,NA,NA
tramadol,2016,Total,Total,2502289.3175,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.184950662384841e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2017,Total,Total,2555566.15,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.438655864902504e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2018,Total,Total,2494378.925,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,7.090574824928215e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
tramadol,2019,Total,Total,2404390.2125,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,6.945613111934709e-7,analgesic,opioid for moderate-severe pain,NA,NA,NA,NA
trametinib,2016,Total,Total,24.42,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,7.011838876838343e-12,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2017,Total,Total,44.474999999999994,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2945633185489595e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2018,Total,Total,44.37,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.2612710997069735e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
trametinib,2019,Total,Total,35.4,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,1.0226073242364304e-11,antineoplastic,"mitogen-activated protein kinase inhibitor for melanoma, non-small cell lung cancer",NA,NA,NA,NA
travoprost,2016,Total,Total,12.95085,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.71864346920974e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2017,Total,Total,11.07165,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.2226985870292506e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2018,Total,Total,12.309325,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.4990750235295346e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
travoprost,2019,Total,Total,10.812275,MKPLKVHSHYCHOC-AHTXBMBWSA-N,3.1233648606379802e-12,ophthalmological,treatment for glaucoma or other causes of high eye pressure,high,high,NA,NA
treosulfan,2019,Total,Total,1247,YCPOZVAOBBQLRI-WDSKDSINSA-N,3.602235404866747e-10,antineoplastic,"alkylating agent, pre-bone marrow transplantation",NA,NA,NA,NA
treprostinil,2016,Total,Total,34.57,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.926260031625778e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2017,Total,Total,33.79,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.835479378025712e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2018,Total,Total,34.379999999999995,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.772932253307584e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
treprostinil,2019,Total,Total,33.21,PAJMKGZZBBTTOY-ZFORQUDYSA-N,9.593443287540072e-12,antithrombotic,platelet inhibitor for pulmonary arterial hypotension,NA,NA,NA,NA
tretinoin,2016,Total,Total,95.0475,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.729147238518806e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2017,Total,Total,106.53,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.1008393552562266e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2018,Total,Total,105.3975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,2.996051853310024e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
tretinoin,2019,Total,Total,111.6975,SHGAZHPCJJPHSC-YCNIQYBTSA-N,3.226629423697703e-11,dermatological,"retinoid treatment for acne, leukaemia",NA,NA,NA,NA
triamcinolone,2016,Total,Total,6909.47035,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.983951384868625e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.9839513848686247e-4
triamcinolone,2017,Total,Total,6826.05595,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.986905372283951e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.9869053722839508e-4
triamcinolone,2018,Total,Total,6628.28455,GFNANZIMVAIWHM-OBYCQNJPSA-N,1.8841703275973056e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,1.8841703275973055e-4
triamcinolone,2019,Total,Total,7006.9555,GFNANZIMVAIWHM-OBYCQNJPSA-N,2.024114128502468e-9,steroid,corticosteroid for various inflammation conditions,low,NA,1e-5,2.024114128502468e-4
tricaine mesilate,2016,Total,Total,5447000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.5640248305544e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2017,Total,Total,5504000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.602085779717476e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2018,Total,Total,5756000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.636212857767262e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
tricaine mesilate,2019,Total,Total,5653000,FQZJYWMRQDKBQN-UHFFFAOYSA-N,1.632994125397893e-6,anaesthetic,"aka MS-222, ester-type synthetic local anaesthetic for fish",NA,NA,NA,NA
trientine,2019,Total,Total,21.6,VILCJCGEZXAXTO-UHFFFAOYSA-N,6.239637910595169e-12,chelating agent,iron-chelating agent for copper build-up from Wilson's disease,NA,NA,NA,NA
trifluridine,2017,Total,Total,78.4,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,2.2820407908766374e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2018,Total,Total,267.8,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.612540015810854e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trifluridine,2019,Total,Total,257.5,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,7.438457231380814e-11,antiviral,"nucleoside analogue used for herpes and, with tiperacil, as an antineoplastic",NA,NA,NA,NA
trilostane,2016,Total,Total,3720.3,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.068228672133566e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2017,Total,Total,3850.5,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.1207905695498074e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2018,Total,Total,4262.1,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.2115536520308975e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trilostane,2019,Total,Total,4884.9,KVJXBPDAXMEYOA-CXANFOAXSA-N,1.4111114458086266e-9,steroid,anticorticosteroid for Cushing's syndrome in dogs,NA,NA,NA,NA
trimethoprim,2016,Total,Total,798733.0564,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.29344287349772e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2017,Total,Total,776550.8926000001,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.260358179980693e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2018,Total,Total,794144.0832,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.2574509378937357e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimethoprim,2019,Total,Total,843220.5618,IEDVJHCEMCRBQM-UHFFFAOYSA-N,2.435829159444739e-7,antibacterial,urinary antibiotic,NA,NA,NA,NA
trimipramine,2016,Total,Total,77649.3,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.2295838677284336e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2017,Total,Total,74164.78,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.1587634337549975e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2018,Total,Total,70475.37,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,2.0033479247725008e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
trimipramine,2019,Total,Total,35509.555,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,1.0257720628072416e-8,antidepressant,tricyclic antidepressant for depression,NA,NA,NA,NA
tropicamide,2016,Total,Total,346.4,BGDKAVGWHJFAGW-UHFFFAOYSA-N,9.946359487865692e-11,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2017,Total,Total,348.65,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.014838675687678e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2018,Total,Total,356.2,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0125417302583368e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
tropicamide,2019,Total,Total,352.45,BGDKAVGWHJFAGW-UHFFFAOYSA-N,1.0181298062913271e-10,ophthalmological,mydriatic for eye examination,low,NA,NA,NA
ulipristal,2016,Total,Total,3879.52,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.1139463210266947e-9,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0023700985553759464
ulipristal,2017,Total,Total,3669.06,HKDLNTKNLJPAIY-WKWWZUSTSA-N,1.0679776255323767e-9,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0022722928202816525
ulipristal,2018,Total,Total,2802.09,HKDLNTKNLJPAIY-WKWWZUSTSA-N,7.965280901009499e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0016947406172360636
ulipristal,2019,Total,Total,2789.7799999999997,HKDLNTKNLJPAIY-WKWWZUSTSA-N,8.058896782509346e-10,sex hormone,progesterone receptor modulator for emergency birth control,low,moderate,4.7e-7,0.0017146588898956055
umeclidinium bromide,2016,Total,Total,83.67060000000001,PEJHHXHHNGORMP-UHFFFAOYSA-M,2.4024765189532772e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,2.518319202257104e-6
umeclidinium bromide,2017,Total,Total,133.8126,PEJHHXHHNGORMP-UHFFFAOYSA-M,3.8949720858834067e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,4.082779964238372e-6
umeclidinium bromide,2018,Total,Total,184.46145,PEJHHXHHNGORMP-UHFFFAOYSA-M,5.2435405881235734e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,5.4963737821001815e-6
umeclidinium bromide,2019,Total,Total,249.24749999999997,PEJHHXHHNGORMP-UHFFFAOYSA-M,7.200065509819764e-11,respiratory,anticholinergic bronchodilator for COPD,low,NA,9.54e-6,7.547238479894931e-6
ursodeoxycholic acid,2016,Total,Total,638521.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.8334185603756817e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2017,Total,Total,675813,RUDATBOHQWOJDD-UZVSRGJWSA-N,1.967133715567236e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2018,Total,Total,723487.25,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.056600314247181e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
ursodeoxycholic acid,2019,Total,Total,777307.75,RUDATBOHQWOJDD-UZVSRGJWSA-N,2.2454254190275147e-7,metabolic,"secondary bile acid used for gallstone, liver diseases",NA,NA,NA,NA
valaciclovir,2016,Total,Total,1190973.91,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.419703998131928e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.001709851999065964
valaciclovir,2017,Total,Total,1372743.409999999,HDOVUKNUBWVHOX-QMMMGPOBSA-N,3.9957352768202675e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0019978676384101337
valaciclovir,2018,Total,Total,1685439.98,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4.791067696787694e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.002395533848393847
valaciclovir,2019,Total,Total,1955930.05,HDOVUKNUBWVHOX-QMMMGPOBSA-N,5.650136708542733e-7,antiviral,"treatment for heroes simplex and zoster, cytomegalovirus",low,high,2e-4,0.0028250683542713666
valganciclovir,2016,Total,Total,38610,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.108628579175792e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2017,Total,Total,45603,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3273967625809605e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2018,Total,Total,39771,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.1305389431247702e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valganciclovir,2019,Total,Total,46013,WPVFJKSGQUFQAP-GKAPJAKFSA-N,1.3291873110195162e-8,antiviral,"purine nucleoside for cytomegalovirus infections from organ transplants, AIDs",NA,NA,NA,NA
valproic acid,2016,Total,Total,5039748.3,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.447088577371824e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2017,Total,Total,5053161.15,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4708571259149362e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2018,Total,Total,5088836.65,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.446563578493273e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valproic acid,2019,Total,Total,5090799.85,NIJJYAXOARWZEE-UHFFFAOYSA-N,1.4705901731163052e-6,anticonvulsant,"treatment for epilepsy, bipolar disorder, migraines, with a wide range of side effects",NA,NA,NA,NA
valsartan,2016,Total,Total,5444853.22112,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.563408415009324e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002791800741088079
valsartan,2017,Total,Total,5833926.01488,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6981195327694572e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.003032356308516888
valsartan,2018,Total,Total,5759581.4616,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.6372309316935163e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.002923626663738422
valsartan,2019,Total,Total,6585188.6816,ACWBQPMHZXGDFX-QFIPXVFZSA-N,1.9022774512098876e-6,antihypertensive,"angiotensin II receptor blocker for hypertension, heart failure",low,low,5.6e-4,0.0033969240200176568
vancomycin,2016,Total,Total,70943,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0370224628973895e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2017,Total,Total,68898,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0054597756354408e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2018,Total,Total,66420.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,1.8880833238243645e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vancomycin,2019,Total,Total,71977.5,MYPYJXKWCTUITO-LYRMYLQWSA-N,2.0792293412493692e-8,antibacterial,glycopeptide antibiotics,low,NA,NA,NA
vandetanib,2016,Total,Total,174,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.996150551064175e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.9961505510641754e-5
vandetanib,2017,Total,Total,159,UHTHHESEBZOYNR-UHFFFAOYSA-N,4.6281184406809357e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,4.628118440680936e-5
vandetanib,2018,Total,Total,78,UHTHHESEBZOYNR-UHFFFAOYSA-N,2.217244664799278e-11,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,2.2172446647992782e-5
vandetanib,2019,Total,Total,33,UHTHHESEBZOYNR-UHFFFAOYSA-N,9.532780141187063e-12,antineoplastic,multiple protein kinase inhibitor for thyroid tumours,low,high,1e-6,9.532780141187063e-6
vardenafil,2016,Total,Total,3477.78,SECKRCOLJRRGGV-UHFFFAOYSA-N,9.985926703149406e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2017,Total,Total,3440.2799999999997,SECKRCOLJRRGGV-UHFFFAOYSA-N,1.0013851137802395e-9,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2018,Total,Total,2986.24,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.488749625397685e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
vardenafil,2019,Total,Total,2997.28,SECKRCOLJRRGGV-UHFFFAOYSA-N,8.65830644290217e-10,urological,"relaxes blood vessel muscles, for erectile dysfunction",NA,NA,NA,NA
varenicline,2016,Total,Total,1794.48112,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.152584963541526e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2017,Total,Total,1721.50796,JQSHBVHOMNKWFT-UHFFFAOYSA-N,5.01090738078932e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2018,Total,Total,1538.3765,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.3730219065097255e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
varenicline,2019,Total,Total,1447.68306,JQSHBVHOMNKWFT-UHFFFAOYSA-N,4.1819528257881567e-10,other nervous system,smoking cessation agent,NA,NA,NA,NA
vecuronium,2016,Total,Total,260,BGSZAXLLHYERSY-XQIGCQGXSA-N,7.465512317682101e-11,muscle relaxant,neuromuscular blocking agent for surgery and intubation,NA,NA,NA,NA
vedaprofen,2016,Total,Total,1737,VZUGVMQFWFVFBX-UHFFFAOYSA-N,4.987536498389927e-10,analgesic,veterinary NSAID,NA,NA,NA,NA
velpatasvir,2016,Total,Total,408.8,FHCUMDQMBHQXKK-CDIODLITSA-N,1.1738082444109396e-10,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2017,Total,Total,4194.4,FHCUMDQMBHQXKK-CDIODLITSA-N,1.2208918231190007e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2018,Total,Total,16290.4,FHCUMDQMBHQXKK-CDIODLITSA-N,4.630743908646943e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
velpatasvir,2019,Total,Total,10329.2,FHCUMDQMBHQXKK-CDIODLITSA-N,2.983817958616648e-9,antiviral,NS5A inhibitor for hepatitis C,NA,NA,NA,NA
vemurafenib,2016,Total,Total,7190.4,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.064616144963899e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2017,Total,Total,4139.52,GPXBXXGIAQBQNI-UHFFFAOYSA-N,1.2049175375828647e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2018,Total,Total,3454.08,GPXBXXGIAQBQNI-UHFFFAOYSA-N,9.81864160485883e-10,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
vemurafenib,2019,Total,Total,7620.48,GPXBXXGIAQBQNI-UHFFFAOYSA-N,2.201344254857975e-9,antineoplastic,B-Raf inhibitor for melanomas,NA,NA,NA,NA
venetoclax,2017,Total,Total,1.19,LQBVNQSMGBZMKD-UHFFFAOYSA-N,3.4638119147234674e-13,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2018,Total,Total,604.59,LQBVNQSMGBZMKD-UHFFFAOYSA-N,1.7186204511423018e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venetoclax,2019,Total,Total,2093.9100000000003,LQBVNQSMGBZMKD-UHFFFAOYSA-N,6.048722322858486e-10,antineoplastic,treatment for leukaemia,NA,NA,NA,NA
venlafaxine,2016,Total,Total,1370348.3595,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.934750983601042e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2017,Total,Total,1367537.226,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.980581291803933e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2018,Total,Total,1355433.264,PNVNVHUZROJLTJ-UHFFFAOYSA-N,3.852983555250604e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
venlafaxine,2019,Total,Total,1388562.3345,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4.011169529430894e-7,antidepressant,"serotonin-norepinephrine reuptake inhibitor for depression, anxiety, panic",NA,NA,NA,NA
verapamil,2016,Total,Total,768375.1111999999,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.206274560486136e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2017,Total,Total,762674.224,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.2199664404568698e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2018,Total,Total,740412.9216,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1047135899564695e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
verapamil,2019,Total,Total,728917.0784,SGTNSNPWRIOYBX-UHFFFAOYSA-N,2.1056382574374586e-7,antihypertensive,"calcium channel blocker, group IV antiarrhythmic for hypertension, angina, rhythm disorders",NA,NA,NA,NA
vernakalant,2016,Total,Total,2,VBHQKCBVWWUUKN-KZNAEPCWSA-N,5.742701782832385e-13,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2017,Total,Total,6,VBHQKCBVWWUUKN-KZNAEPCWSA-N,1.7464597889362021e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2018,Total,Total,11,VBHQKCBVWWUUKN-KZNAEPCWSA-N,3.1268835016400072e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
vernakalant,2019,Total,Total,9,VBHQKCBVWWUUKN-KZNAEPCWSA-N,2.5998491294146532e-12,cardiac,antiarrhythmic for atrial fibrillation,NA,NA,NA,NA
verteporfin,2016,Total,Total,3.315,NJLRKAMQPVVOIU-IDLGWYNRSA-N,9.51852820504468e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2017,Total,Total,3.06,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.906944923574631e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2018,Total,Total,2.85,NJLRKAMQPVVOIU-IDLGWYNRSA-N,8.101470890612746e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
verteporfin,2019,Total,Total,2.46,NJLRKAMQPVVOIU-IDLGWYNRSA-N,7.106254287066719e-13,antineoplastic,light sensitizer used for laser light therapy for eye diseases,NA,NA,NA,NA
vigabatrin,2016,Total,Total,42639.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2243296633454077e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2017,Total,Total,43862,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2767203210386615e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2018,Total,Total,39305.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.1173065406701028e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vigabatrin,2019,Total,Total,43813.5,PJDFLNIOAUIZSL-UHFFFAOYSA-N,1.2656498870178769e-8,anticonvulsant,gamma-aminobutyric acid analogue for complex partial seizures,low,NA,NA,NA
vilanterol,2016,Total,Total,119.1465,DAFYYTQWSAWIGS-DEOSSOPVSA-N,3.4211140898411936e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2017,Total,Total,163.98558,DAFYYTQWSAWIGS-DEOSSOPVSA-N,4.7732370239230105e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2018,Total,Total,201.80028,DAFYYTQWSAWIGS-DEOSSOPVSA-N,5.736417874166672e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vilanterol,2019,Total,Total,248.78238,DAFYYTQWSAWIGS-DEOSSOPVSA-N,7.186629489518949e-11,respiratory,"beta adrenoreceptor agonist for COPD, asthma",NA,NA,NA,NA
vildagliptin,2016,Total,Total,388078.935,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1143107959520966e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.9898407070573156e-4
vildagliptin,2017,Total,Total,401346.72,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.1682265131690617e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,2.0861187735161818e-4
vildagliptin,2018,Total,Total,370008.915,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0517952470665637e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8782057983331496e-4
vildagliptin,2019,Total,Total,354183.27,SYOKIDBDQMKNDQ-XWTIBIIYSA-N,1.0231367401808169e-7,anti-diabetic,dipeptidyl peptidase-4 inhibitor for type 2 diabetes,low,high,5.6e-4,1.8270298931800304e-4
vinblastine,2016,Total,Total,23.24,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.6730194716512315e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2017,Total,Total,22.14,JXLYSJRDGCGARV-CFWMRBGOSA-N,6.444436621174586e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2018,Total,Total,20.97,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.960977002671905e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinblastine,2019,Total,Total,18.35,JXLYSJRDGCGARV-CFWMRBGOSA-N,5.300803502750989e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2016,Total,Total,13.13,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.770083720429461e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2017,Total,Total,12.7,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.696673219914961e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2018,Total,Total,12.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.5077947645670624e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vincristine,2019,Total,Total,13.34,OGWKCGZFUXNPDA-XQKSVPLYSA-N,3.853554154043497e-12,antineoplastic,mitotic inhibitor for various cancers,NA,NA,NA,NA
vinflunine,2016,Total,Total,59.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7127608067297588e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2017,Total,Total,61.2,NMDYYWFGPIMTKO-HBVLKOHWSA-N,1.7813889847149263e-11,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2018,Total,Total,13.65,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.880178163398736e-12,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinflunine,2019,Total,Total,1.3,NMDYYWFGPIMTKO-HBVLKOHWSA-N,3.755337631376722e-13,antineoplastic,alkaloid derivative for bladder cancer,NA,NA,NA,NA
vinorelbine,2016,Total,Total,578.29,GBABOYUKABKIAF-IELIFDKJSA-N,1.66047350699707e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2017,Total,Total,528.64,GBABOYUKABKIAF-IELIFDKJSA-N,1.5387475047053895e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2018,Total,Total,485.12,GBABOYUKABKIAF-IELIFDKJSA-N,1.3790124766505454e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vinorelbine,2019,Total,Total,399.45,GBABOYUKABKIAF-IELIFDKJSA-N,1.1538997052718703e-10,antineoplastic,mitotic inhibitor for lung cancer,NA,NA,NA,NA
vismodegib,2016,Total,Total,201.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,5.7886433970950434e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2017,Total,Total,340.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,9.902427003268264e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2018,Total,Total,306.6,BPQMGSKTAYIVFO-UHFFFAOYSA-N,8.71547710548024e-11,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
vismodegib,2019,Total,Total,361.2,BPQMGSKTAYIVFO-UHFFFAOYSA-N,1.0434061172717476e-10,antineoplastic,cyclopamine-competitive antagonist of the smoothened receptor for basal-cell carcinomas,NA,NA,NA,NA
voriconazole,2016,Total,Total,5863.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.683501741146228e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2017,Total,Total,4776.8,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.3904148532984082e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2018,Total,Total,4883.1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.388080438805302e-9,antifungal,azole antifungal,NA,NA,NA,NA
voriconazole,2019,Total,Total,6599.4,BCEHBSKCWLPMDN-MGPLVRAMSA-N,1.906382704962118e-9,antifungal,azole antifungal,NA,NA,NA,NA
vortioxetine,2016,Total,Total,12130.0606,YQNWZWMKLDQSAC-UHFFFAOYSA-N,3.482966031674243e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2017,Total,Total,19275.368,YQNWZWMKLDQSAC-UHFFFAOYSA-N,5.6106091881579385e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2018,Total,Total,23910.0946,YQNWZWMKLDQSAC-UHFFFAOYSA-N,6.796734575217439e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
vortioxetine,2019,Total,Total,30263.8252,YQNWZWMKLDQSAC-UHFFFAOYSA-N,8.742375510997473e-9,antidepressant,serotonin reuptake inhibitor for depression,NA,NA,NA,NA
voxilaprevir,2017,Total,Total,8.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,2.445043704510683e-12,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2018,Total,Total,316.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.994053999262711e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
voxilaprevir,2019,Total,Total,288.4,MZBLZLWXUBZHSL-FZNJKFJKSA-N,8.331072099146512e-11,antiviral,protease inhibitor for hepatitis C,NA,NA,NA,NA
warfarin,2016,Total,Total,102193.1675,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.934324425977693e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.002667567659979721
warfarin,2017,Total,Total,86658.63,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.522430210988341e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0022931183736257647
warfarin,2018,Total,Total,72666.24,PJVWKTKQMONHTI-UHFFFAOYSA-N,2.065626063474665e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0018778418758860593
warfarin,2019,Total,Total,61197.5,PJVWKTKQMONHTI-UHFFFAOYSA-N,1.7678251899705918e-8,anticoagulant,coumarin anticoagulant for blood clots,low,high,1.1e-5,0.0016071138090641745
xylazine,2016,Total,Total,7361,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.113601391171459e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2017,Total,Total,7566,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2022857938485508e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2018,Total,Total,8115,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.306787237800787e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylazine,2019,Total,Total,7709,BPICBUSOMSTKRF-UHFFFAOYSA-N,2.2269152154063958e-9,other nervous system,"adrenergic agonist, veterinary sedative, anaesthetic, muscle relaxant, analgesic and emetic",NA,NA,NA,NA
xylometazoline,2016,Total,Total,50032.31,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.4366031791811128e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.0070768629516310974
xylometazoline,2017,Total,Total,56242.875,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6370986600277533e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008064525418855927
xylometazoline,2018,Total,Total,57843.65,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.6442759532694454e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.008099881543199239
xylometazoline,2019,Total,Total,61488.13,HUCJFAOMUPXHDK-UHFFFAOYSA-N,1.7762206805537227e-8,respiratory,nasal decongestant,low,high,2.03e-6,0.00874985556923016
zanamivir,2016,Total,Total,1.5,ARAIBEBZBOPLMB-UFGQHTETSA-N,4.307026337124289e-13,antiviral,neuraminidase inhibitor for influenza,low,high,NA,NA
zidovudine,2016,Total,Total,17280,HBOMLICNUCNMMY-XLPZGREQSA-N,4.961694340367181e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2017,Total,Total,11970,HBOMLICNUCNMMY-XLPZGREQSA-N,3.484187278927723e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2018,Total,Total,8154,HBOMLICNUCNMMY-XLPZGREQSA-N,2.317873461124783e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
zidovudine,2019,Total,Total,5940,HBOMLICNUCNMMY-XLPZGREQSA-N,1.7159004254136711e-9,antiviral,nucleoside reverse transcriptase inhibitor for HIV,low,high,NA,NA
ziprasidone,2016,Total,Total,18900.4104,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.426971025017188e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2017,Total,Total,17402.2128,MVWVFYHBGMAFLY-UHFFFAOYSA-N,5.065377482285146e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2018,Total,Total,17195.976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.8881648771815934e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
ziprasidone,2019,Total,Total,16329.2976,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4.717078905479198e-9,antipsychotic,"atypical antipsychotic for schizophrenia, bipolar disorder",NA,NA,NA,NA
zofenopril,2016,Total,Total,3.36,IAIDUHCBNLFXEF-MNEFBYGVSA-N,9.647738995158406e-13,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2017,Total,Total,17.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,5.1345917794724335e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2018,Total,Total,38.64,IAIDUHCBNLFXEF-MNEFBYGVSA-N,1.0983888954851808e-11,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zofenopril,2019,Total,Total,26.88,IAIDUHCBNLFXEF-MNEFBYGVSA-N,7.764882733185099e-12,antihypertensive,"angiotensin-converting enzyme inhibitor for high blood pressure, heart disease",NA,NA,NA,NA
zoledronic acid,2016,Total,Total,111.713,XRASPMIURGNCCH-UHFFFAOYSA-N,3.207672221327771e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.0347329746218615e-6
zoledronic acid,2017,Total,Total,141.513,XRASPMIURGNCCH-UHFFFAOYSA-N,4.11911273519548e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.328746043611445e-6
zoledronic acid,2018,Total,Total,160.505,XRASPMIURGNCCH-UHFFFAOYSA-N,4.5625494220975386e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.4717901361604963e-6
zoledronic acid,2019,Total,Total,181.311,XRASPMIURGNCCH-UHFFFAOYSA-N,5.2375693944811136e-11,metabolic,"bisphosphonate treatment for osteoporosis, hyperkalaemia, cancer-induced bone breakage, Paget's, etc.",low,low,3.1e-5,1.6895385143487462e-6
zolmitriptan,2016,Total,Total,3741.645,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.074357570611294e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0743575706112941e-5
zolmitriptan,2017,Total,Total,3886.32,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.1312169344897568e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.1312169344897569e-5
zolmitriptan,2018,Total,Total,3826.47,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.087720537501858e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0877205375018581e-5
zolmitriptan,2019,Total,Total,3796.875,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,1.0968113514718067e-9,analgesic,antimigraine medication,low,moderate,9.999999999999999e-5,1.0968113514718068e-5
zolpidem,2016,Total,Total,112751.9255,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.237503417933171e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.01471592462696896
zolpidem,2017,Total,Total,111564.9205,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.247394125151903e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014760882387054104
zolpidem,2018,Total,Total,111729.2415,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.1760392899736555e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.014436542227152979
zolpidem,2019,Total,Total,114395.1865,ZAFYATHCZYHLPB-UHFFFAOYSA-N,3.30455806701391e-8,sedative,sedative-hypnotic for insomnia,low,high,2.2e-6,0.015020718486426861
zonisamide,2016,Total,Total,64870.078,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8626475629153796e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2017,Total,Total,65644.614,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.9107613118539744e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2018,Total,Total,63057.96,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.7924990433734136e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zonisamide,2019,Total,Total,65638.636,UBQNRHZMVUUOMG-UHFFFAOYSA-N,1.8961172295618372e-8,anticonvulsant,carbonic anhydrase inhibitor for partial seizures,NA,NA,NA,NA
zopiclone,2016,Total,Total,393691.9724500001,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.130427796037707e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2017,Total,Total,374501.7356,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0900870368536956e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2018,Total,Total,356499.65585,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0133935383797323e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zopiclone,2019,Total,Total,360740.1669,GBBSUAFBMRNDJC-UHFFFAOYSA-N,1.0420777876220686e-7,sedative,sedative-hypnotic for insomnia,low,NA,NA,NA
zuclopenthixol,2016,Total,Total,16454.122,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.724555787217078e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2017,Total,Total,15475.242,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.504481312842775e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2018,Total,Total,14533.664,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.131370379998119e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
zuclopenthixol,2019,Total,Total,13971.81,WFPIAZLQTJBIFN-DVZOWYKESA-N,4.0360664516496606e-9,antipsychotic,typical psychotic for schizophrenia,NA,NA,NA,NA
